,Date,Title,Url
0,2019-01-01,2018최종가격대웅전일대비056올라주가17800원28일장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=13678
1,2019-01-01,신년특집해외시장개척대웅제약나보타,http://www.bosa.co.kr/news/articleView.html?idxno=2097143
2,2019-01-02,작년임상시험승인종근당한미CJ유한대웅順,http://www.dailymedi.com/detail.php?number=838642&thread=22r05
3,2019-01-02,대웅바이오글리아타민상표권무효분쟁승소,http://www.mdtoday.co.kr/mdtoday/index.html?no=342896
4,2019-01-02,기해년빛낼돼지띠CEO윤재춘대웅제약사장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1706126
5,2019-01-02,2일대웅제약주가194000원,http://www.anewsa.com/detail.php?number=1460364&thread=10r04
6,2019-01-02,대웅주가1월2일현재18150원및증권차트정보,http://www.cctvnews.co.kr/news/articleView.html?idxno=97173
7,2019-01-02,대웅제약시무식개최AI접목신약연구로개발역량강화할것,http://www.g-enews.com/ko-kr/news/article/news_all/20190102105333669425b4ac5ede_1/article.html
8,2019-01-02,대웅상반기나보타미국출시기업위상높아질것,http://www.dailypharm.com/Users/News/NewsView.html?ID=248132&REFERER=NP
9,2019-01-02,대웅제약신약개발가속화글로벌헬스케어그룹도약,http://kormedi.com/?p=1260126
10,2019-01-02,대웅제약2019년책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약원년,http://www.ekn.kr/news/article.html?no=406959
11,2019-01-02,대웅제약책임경영강화‥​글로벌헬스케어그룹도약원년,http://medipana.com/news/news_viewer.asp?NewsNum=232905&MainKind=A&NewsKind=5&vCount=12&vKind=1
12,2019-01-02,대웅제약책임경영강화‥​글로벌헬스케어그룹도약원년,http://medipana.com/news/news_viewer.asp?NewsNum=232905&MainKind=A&NewsKind=5&vCount=12&vKind=1
13,2019-01-02,대웅제약혁신신약개발글로벌헬스케어그룹원년도약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225956
14,2019-01-02,전승호대웅제약대표책임경영강화글로벌헬스케어그룹도약원년”,http://www.newsway.co.kr/news/view?tp=1&ud=2019010211132464139
15,2019-01-02,신년사전승호대웅제약사장글로벌헬스케어그룹도약원년만들자”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1706322
16,2019-01-02,전승호대웅제약사장글로벌헬스케어그룹도약할것,http://www.m-i.kr/news/articleView.html?idxno=484221
17,2019-01-02,대웅제약책임경영강화글로벌헬스케어그룹도약”,http://www.mhj21.com/118528
18,2019-01-02,전승호대웅제약사장2019년책임경영체제강화글로벌헬스케어그룹도약,http://www.wikileaks-kr.org/news/articleView.html?idxno=44369
19,2019-01-02,신년사전승호대웅제약사장책임경영혁신신약개발로도약,http://www.newspim.com/news/view/20190102000290
20,2019-01-02,대웅제약책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약,http://www.ceoscoredaily.com/news/article.html?no=50476
21,2019-01-02,신년사전승호대웅제약사장책임경영으로글로벌헬스케어그룹도약,http://www.wolyo.co.kr/news/articleView.html?idxno=74861
22,2019-01-02,1월2일대웅증권투자17950원084,http://www.nbntv.co.kr/news/articleView.html?idxno=154406
23,2019-01-02,신년사전승호대웅제약사장책임경영통해체제강화,http://www.ebn.co.kr/news/view/967248
24,2019-01-02,신년사전승호대웅제약사장책임경영혁신신약개발로글로벌도약,http://www.dailian.co.kr/news/view/762472/?sc=naver
25,2019-01-02,국내주식시장현황2일대웅주가17950원,http://www.anewsa.com/detail.php?number=1460568&thread=10r02
26,2019-01-02,대웅제약전승호사장글로벌헬스케어그룹도약원년만들자,http://www.medisobizanews.com/news/articleView.html?idxno=57153
27,2019-01-02,대웅제약2019년책임경영체제강화글로벌헬스케어그룹도약,http://www.getnews.co.kr/view.php?ud=20190102113047211541d0c69529_16
28,2019-01-02,대웅제약책임경영체제강화혁신신약개발로글로벌그룹으로도약”,http://www.ajunews.com/view/20190102113727201
29,2019-01-02,전승호대웅제약대표임직원모두책임경영에힘쓰자,http://www.insightkorea.co.kr//news/articleView.html?idxno=33166
30,2019-01-02,대웅제약2019년시무식가져책임경영체제강화,http://www.seoulwire.com/news/articleView.html?idxno=43256
31,2019-01-02,전승호대웅제약사장글로벌헬스케어그룹도약원년될것,http://www.newsprime.co.kr/news/article.html?no=441892
32,2019-01-02,대웅제약글로벌헬스케어그룹도약원년될것,http://www.economytalk.kr/news/articleView.html?idxno=176616
33,2019-01-02,대웅제약전승호사장2019년혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.wsobi.com/news/articleView.html?idxno=68366
34,2019-01-02,전승호대웅제약사장책임경영체제강화,http://www.dailymedi.com/detail.php?number=838659&thread=22r05
35,2019-01-02,대웅제약증권매매2일현재187500원,http://www.nbntv.co.kr/news/articleView.html?idxno=154675
36,2019-01-02,신년사전승호대웅제약회장책임경영체제강화,http://news.bizwatch.co.kr/article/consumer/2019/01/02/0050/naver
37,2019-01-02,대웅제약올해경영키워드는책임경영,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019010213392134753
38,2019-01-02,대웅제약책임경영혁신신약개발글로벌도약,http://www.bosa.co.kr/news/articleView.html?idxno=2097221
39,2019-01-02,신년사전승호대웅제약사장글로벌헬스케어그룹도약원년될것,http://www.newsis.com/view/?id=NISX20190102_0000518797&cID=13001&pID=13000
40,2019-01-02,2019신년사전승호대웅제약사장글로벌헬스케어그룹도약원년,http://www.shinailbo.co.kr/news/articleView.html?idxno=1130780
41,2019-01-02,대웅제약2019년글로벌헬스케어그룹도약원년선포,http://www.medigatenews.com/news/576133129
42,2019-01-02,신년사전승호대웅제약사장글로벌2020비전위해역량집중,http://news.mk.co.kr/newsRead.php?year=2019&no=3003
43,2019-01-02,2019신년사대웅제약전승호사장책임경영으로새로운미래성장추진할것”,http://www.news2day.co.kr/117881
44,2019-01-02,전승호대웅제약사장비상경영체제수준경영활동으로내실강화,http://www.businesskorea.co.kr/news/articleView.html?idxno=27933
45,2019-01-02,유통오늘한미약품2019년내실경영슬로건선포대웅제약올해키워드책임경영,http://www.sisaon.co.kr/news/articleView.html?idxno=80937
46,2019-01-02,전승호대웅제약사장혁신신약개발로도약책임경영강화,https://www.insight.co.kr/news/201924
47,2019-01-02,대웅제약신년사책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.fnnews.com/news/201901021600049339
48,2019-01-02,대웅제약신년사2019년책임경영체제강화혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.lawissue.co.kr/view.php?ud=201901021600483162d7f4c63cc6_12
49,2019-01-02,대웅제약2019년책임경영체제강화글로벌그룹도약할것,http://www.k-health.com/news/articleView.html?idxno=41655
50,2019-01-02,대웅제약혁신신약개발로글로벌헬스케어그룹도약원년될것,http://www.enewstoday.co.kr/news/articleView.html?idxno=1259533
51,2019-01-02,대웅제약책임경영강화로글로벌도약원년”다짐,http://www.edaily.co.kr/news/newspath.asp?newsid=04008166622353784
52,2019-01-02,책임경영강화대웅제약혁신신약개발로글로벌헬스케어도약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003447835
53,2019-01-02,신년사전승호대웅제약사장책임경영강화다짐,http://www.seoulfn.com/news/articleView.html?idxno=329714
54,2019-01-02,신년사전승호대웅제약사장책임경영혁신신약개발통해글로벌도약,http://www.ftoday.co.kr/news/articleView.html?idxno=105690
55,2019-01-02,전승호대웅제약사장올한해는도전의해로전사역량집중해야,http://www.asiatime.co.kr/news/articleView.html?idxno=220942
56,2019-01-02,전승호대웅제약대표글로벌헬스케어그룹으로도약하는원년,http://www.mdtoday.co.kr/mdtoday/index.html?no=343005
57,2019-01-02,2일공감주가마감대웅주가17400원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=66683
58,2019-01-02,대웅제약2019년시무식열어,http://www.kpanews.co.kr/article/show.asp?idx=200463&table=article&category=D
59,2019-01-02,대웅제약신년사책임경영체제강화혁신신약개발로글로벌도약,http://www.newscj.com/news/articleView.html?idxno=588143
60,2019-01-03,1월3일대웅오늘증시02917450원,http://www.nbntv.co.kr/news/articleView.html?idxno=155844
61,2019-01-03,1월3일대웅제약시세보기270180500원,http://www.nbntv.co.kr/news/articleView.html?idxno=156040
62,2019-01-03,대웅주가주가정보3일현재17300원증권그래프분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=97863
63,2019-01-03,ET투자뉴스대웅제약_현재주가근처인186000원대에주요매물대가존재,http://www.etnews.com/20190103000130
64,2019-01-03,서울제약대웅출신정종근부사장퇴임,http://www.dailypharm.com/Users/News/NewsView.html?ID=248203&REFERER=NP
65,2019-01-04,1월4일대웅오늘주식장17200원147,http://www.nbntv.co.kr/news/articleView.html?idxno=157233
66,2019-01-04,장중주가4일대웅주가17350원,http://www.anewsa.com/detail.php?number=1463749&thread=10r02
67,2019-01-04,1월4일대웅제약배당주식182500원139,http://www.nbntv.co.kr/news/articleView.html?idxno=157510
68,2019-01-04,대웅주가증권시세4일현재17400원및오늘거래가는,http://www.cctvnews.co.kr/news/articleView.html?idxno=98616
69,2019-01-04,1월4일대웅제약시세보기222184000원,http://www.nbntv.co.kr/news/articleView.html?idxno=158027
70,2019-01-04,주가와이어대웅주가1월4일현재17450원증권정보전망과주식평가,http://www.seoulwire.com/news/articleView.html?idxno=43771
71,2019-01-06,새해벽두글로벌제약산업MA열풍주목받는대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=01561286622355096
72,2019-01-07,대웅제약목표가23만원유지전일종가18만6000원하이투자證,http://www.newspim.com/news/view/20190107000079
73,2019-01-07,퀵리포트대웅제약매수유지목표가23만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019010708303217627
74,2019-01-07,ET투자뉴스대웅제약점점확고해지는펀BUYMAINTAIN하이투자증권,http://www.etnews.com/20190107000009
75,2019-01-07,대웅제약나보타中임상시험계획변경접수마쳐,http://www.metroseoul.co.kr/news/newsview?newscd=2019010700012
76,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://news.hankyung.com/article/2019010773946
77,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.m-i.kr/news/articleView.html?idxno=485403
78,2019-01-07,대웅제약나보타중국임상변경접수하반기개시전망,http://www.dailian.co.kr/news/view/763438/?sc=naver
79,2019-01-07,대웅제약나보타중국임상시험계획변경서류접수,http://www.newspim.com/news/view/20190107000160
80,2019-01-07,대웅보톨리눔톡신제제나보타中CFDA에임상시험변경접수,http://www.sedaily.com/NewsView/1VDY0ZKPSH
81,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.newsway.co.kr/news/view?tp=1&ud=2019010709271283417
82,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.ekn.kr/news/article.html?no=407817
83,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.enewstoday.co.kr/news/articleView.html?idxno=1260647
84,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226093
85,2019-01-07,1월7일대웅종목검색17450원058,http://www.nbntv.co.kr/news/articleView.html?idxno=159248
86,2019-01-07,대웅제약나보타변경한중국임상시험계획접수완료,http://www.econovill.com/news/articleView.html?idxno=354117
87,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://www.sporbiz.co.kr/news/articleView.html?idxno=302175
88,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1707741
89,2019-01-07,대웅제약나보타中임상시험제조시설변경접수완료,http://www.dailypharm.com/Users/News/NewsView.html?ID=248292&REFERER=NP
90,2019-01-07,대웅제약나보타제조시설변경中임상시험계획접수,http://medipana.com/news/news_viewer.asp?NewsNum=233096&MainKind=A&NewsKind=5&vCount=12&vKind=1
91,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.g-enews.com/ko-kr/news/article/news_all/201901071006255985f6d02acec0_1/article.html
92,2019-01-07,대웅제약나보타중국임상시험공장변경서류접수,http://www.medisobizanews.com/news/articleView.html?idxno=57223
93,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.shinailbo.co.kr/news/articleView.html?idxno=1131806
94,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.ceoscoredaily.com/news/article.html?no=50661
95,2019-01-07,대웅제약나보타中임상시험계획변경접수올하반기임상개시가능할듯,http://www.segye.com/content/html/2019/01/07/20190107000797.html?OutUrl=naver
96,2019-01-07,대웅제약나보타中임상시험계획변경접수완료,http://www.rapportian.com/news/articleView.html?idxno=115315
97,2019-01-07,대웅제약나보타중국임상시험신청제조시설변경접수완료,http://www.100ssd.co.kr/news/articleView.html?idxno=58719
98,2019-01-07,대웅제약나보타중국임상시험계획변경접수,http://www.newsprime.co.kr/news/article.html?no=442388
99,2019-01-07,대웅제약나보타중국임상시험계획변경접수마쳐,http://www.edaily.co.kr/news/newspath.asp?newsid=02427206622355424
100,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.fnnews.com/news/201901071040392599
101,2019-01-07,대웅제약中의약품당국에나보타임상시약생산공장변경신청,http://news.mk.co.kr/newsRead.php?year=2019&no=11921
102,2019-01-07,대웅나보타중국임상시험계획변경접수완료,http://www.bokuennews.com/news/article.html?no=170363
103,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123675&REFERER=NP
104,2019-01-07,종목상세정보7일대웅주가17300원,http://www.anewsa.com/detail.php?number=1467105&thread=10r02
105,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.etnews.com/20190107000111
106,2019-01-07,대웅제약나보타중국임상시험계획변경접수,http://www.dailymedi.com/detail.php?number=838874&thread=22r05
107,2019-01-07,대웅제약나보타중국임상시험계획변경,http://www.dt.co.kr/contents.html?article_no=2019010702109931102004&ref=naver
108,2019-01-07,대웅제약나보타中임상시험계획변경접수,http://kormedi.com/?p=1260696
109,2019-01-07,대웅제약중국서나보타임상계획변경접수 ,http://www.seoulfn.com/news/articleView.html?idxno=330095
110,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.newstomato.com/ReadNews.aspx?no=868006
111,2019-01-07,대웅제약점점확고해지는펀더멘털목표가23만원하이투자증권,http://www.ekn.kr/news/article.html?no=407893
112,2019-01-07,대웅제약나보타중국임상시험신청제조시설변경접수,http://www.seoulwire.com/news/articleView.html?idxno=44277
113,2019-01-07,1월7일대웅제약증권투자정보외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=67868
114,2019-01-07,대웅제약중국에나보타임상시험계획변경접수완료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019010710583173196
115,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.medigatenews.com/news/2398237937
116,2019-01-07,대웅제약中나보타생산능력높이기위해2공장변경접수,http://www.asiatime.co.kr/news/articleView.html?idxno=221628
117,2019-01-07,대웅제약나보타中임상시험계획변경접수,http://www.bosa.co.kr/news/articleView.html?idxno=2097501
118,2019-01-07,대웅나보타中CTA변경접수완료,http://www.whosaeng.com/sub_read.html?uid=107234§ion=sc5
119,2019-01-07,대웅제약보톡스나보타중국임상시험계획변경,http://news.mk.co.kr/newsRead.php?year=2019&no=12491
120,2019-01-07,대웅제약2공장서중국수출용나보타공급,http://www.finomy.com/news/articleView.html?idxno=61899
121,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=343304
122,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.economytalk.kr/news/articleView.html?idxno=176986
123,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901070458&t=NN
124,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.inthenews.co.kr/news/article.html?no=12852
125,2019-01-07,대웅제약나보타중국제조시설변경서류접수완료,http://www.kpanews.co.kr/article/show.asp?idx=200579&table=article&category=D
126,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.getnews.co.kr/view.php?ud=20190107153700183341d0c69529_16
127,2019-01-07,대웅제약중국정부에보톡스임상관련해제조공장변경신청,http://www.businesspost.co.kr/BP?command=article_view&num=109180
128,2019-01-07,장종리포트7일마감대웅주가17550원으로마감,http://www.anewsa.com/detail.php?number=1468031&thread=10r04
129,2019-01-07,대웅제약나보타中시장접수가속도 ,http://www.monews.co.kr/news/articleView.html?idxno=200062
130,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.ftoday.co.kr/news/articleView.html?idxno=105795
131,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,https://www.insight.co.kr/news/203033
132,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.businesskorea.co.kr/news/articleView.html?idxno=28069
133,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.newscj.com/news/articleView.html?idxno=589447
134,2019-01-07,대웅제약나보타중국임상시험계획변경접수완료,http://www.lawissue.co.kr/view.php?ud=201901072112521209d7f4c63cc6_12
135,2019-01-08,대웅화장품서재미본EGF이번엔약으로,http://www.kpanews.co.kr/article/show.asp?idx=200571&table=article&category=D
136,2019-01-08,빅데이터MSI시장심리톱5유한양행LG화학셀트리온쌍용차대웅제약,http://www.newsis.com/view/?id=NISX20190108_0000523448&cID=10401&pID=10400
137,2019-01-08,1월8일대웅주식그래프05717450원,http://www.nbntv.co.kr/news/articleView.html?idxno=161763
138,2019-01-08,주가종목정보대웅주가차트8일현재17750원,http://www.seoulwire.com/news/articleView.html?idxno=45687
139,2019-01-08,실시간분석대웅제약32상승증권사목표가23만원제시,http://www.itooza.com/common/iview.php?no=2019010810003811367
140,2019-01-08,대웅제약주식실시간8일현재189000원,http://www.nbntv.co.kr/news/articleView.html?idxno=161991
141,2019-01-08,증시현황8일대웅주가17700원,http://www.anewsa.com/detail.php?number=1469025&thread=10r02
142,2019-01-08,1월8일대웅제약증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=68644
143,2019-01-09,클릭e종목대웅제약1분기내한올바이오파마Evolus기대감반영,http://view.asiae.co.kr/news/view.htm?idxno=2019010907440584920
144,2019-01-09,퀵리포트대웅제약매수유지목표가24만원유지NH證,http://www.itooza.com/common/iview.php?no=2019010907481412317
145,2019-01-09,대웅제약2월나보타미국허가기대감유효매수NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1708612
146,2019-01-09,NH투자증권대웅제약1분기내자회사파트너사기대감반영”,http://www.newsway.co.kr/news/view?tp=1&ud=2019010907541048165
147,2019-01-09,대웅제약목표가24만원유지전일종가19만1500원NH證,http://www.newspim.com/news/view/20190109000081
148,2019-01-09,더벨대웅제약4조5000억보툴리눔톡신시장정조준,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201901080100010990000663
149,2019-01-09,실시간분석대웅제약31상승증권사목표가24만원제시,http://www.itooza.com/common/iview.php?no=2019010909073617613
150,2019-01-09,특징주대웅제약1Q한올바이오파마에볼루스기대감에투심개선4↑,http://view.asiae.co.kr/news/view.htm?idxno=2019010909124280271
151,2019-01-09,특징주대웅제약美에볼루스주가상승에동반강세,http://news.mt.co.kr/mtview.php?no=2019010909102575787
152,2019-01-09,한경로보뉴스대웅제약5이상상승20183Q매출액2580억23영업이익72억469,http://news.hankyung.com/article/201901095784L
153,2019-01-09,특징주대웅제약자회사파트너사기대감에5↑,http://www.sentv.co.kr/news/view/547323
154,2019-01-09,대웅제약나보타미국허가기대감에강세,http://news.hankyung.com/article/2019010958356
155,2019-01-09,특징주대웅제약주름개선치료제미국허가기대에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02099206622356080
156,2019-01-09,HotLine대웅제약나보타미국허가기대감에강세,http://news.mk.co.kr/newsRead.php?year=2019&no=16816
157,2019-01-09,특징주대웅제약나보타미국허가기대감에강세,http://www.newsprime.co.kr/news/article.html?no=442678
158,2019-01-09,특징주대웅제약자회사주가상승나보타美판매허가기대감에강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901090137&t=NN
159,2019-01-09,특징주대웅제약나보타美허가기대감속4대강세,http://moneys.mt.co.kr/news/mwView.php?no=2019010909438082446
160,2019-01-09,대웅제약나보타미국허가기대9일오전강세출발,http://www.choicenews.co.kr/news/articleView.html?idxno=47292
161,2019-01-09,대웅오늘주식시장9일현재18200원,http://www.nbntv.co.kr/news/articleView.html?idxno=163068
162,2019-01-09,대웅제약나보타미국판매허가기대감에장초반강세,http://www.whitepaper.co.kr/news/articleView.html?idxno=137665
163,2019-01-09,주가정보9일대웅주가18150원,http://www.anewsa.com/detail.php?number=1472097&thread=10r02
164,2019-01-09,1월9일대웅제약투자주식209195500원,http://www.nbntv.co.kr/news/articleView.html?idxno=163276
165,2019-01-09,특징주대웅제약나보타美허가기대감에강세,http://www.newsway.co.kr/news/view?tp=1&ud=2019010911115996450
166,2019-01-09,ET투자뉴스대웅제약Evolus주가BUY유지NH투자증권,http://www.etnews.com/20190109000149
167,2019-01-09,대웅제약나보타미국진출기대감에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=343520
168,2019-01-09,1월9일대웅제약오늘시세외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=69174
169,2019-01-09,대웅주가1월9일현재18100원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=99717
170,2019-01-09,대웅제약美파트너사Evolus최근2주간주가411상승,http://www.newsworks.co.kr/news/articleView.html?idxno=326079
171,2019-01-10,빅데이터MSI시장심리톱5대우건설대웅제약카카오한섬롯데칠성,http://www.newsis.com/view/?id=NISX20190110_0000525901&cID=10401&pID=10400
172,2019-01-10,아통증시10일대웅주가17950원,http://www.anewsa.com/detail.php?number=1475555&thread=10r02
173,2019-01-10,대웅제약주가오늘시세및증권정보와종목동정10일현재195000원,http://www.gokorea.kr/news/articleView.html?idxno=69953
174,2019-01-10,메디톡스中대웅美국산보톡스올해글로벌빅마켓정조준,http://biz.newdaily.co.kr/site/data/html/2019/01/10/2019011000148.html
175,2019-01-11,1월11일대웅종목검색05617900원,http://www.nbntv.co.kr/news/articleView.html?idxno=165290
176,2019-01-11,대웅주가종목그래프및증권정보와종목동정11일현재17850원,http://www.gokorea.kr/news/articleView.html?idxno=70687
177,2019-01-11,1월11일대웅제약주식실시간077193500원,http://www.nbntv.co.kr/news/articleView.html?idxno=165784
178,2019-01-11,대웅제약주가1월11일현재193500원,http://www.gokorea.kr/news/articleView.html?idxno=70999
179,2019-01-11,11일공감주가마감대웅17900원마감,http://www.gokorea.kr/news/articleView.html?idxno=71902
180,2019-01-14,아통증시14일대웅주가17800원,http://www.anewsa.com/detail.php?number=1482100&thread=10r02
181,2019-01-14,대웅주가증권투자정보14일현재17800원,http://www.gokorea.kr/news/articleView.html?idxno=72507
182,2019-01-14,대웅유나이티드모사프리드특허분쟁2라운드,http://www.dailypharm.com/Users/News/NewsView.html?ID=248466&REFERER=NP
183,2019-01-14,대웅제약오늘증권시세14일현재191000원,http://www.nbntv.co.kr/news/articleView.html?idxno=168278
184,2019-01-14,대웅제약주가1월14일현재191000원,http://www.gokorea.kr/news/articleView.html?idxno=72731
185,2019-01-14,대웅주가1월14일현재17700원증권시세,http://www.cctvnews.co.kr/news/articleView.html?idxno=100219
186,2019-01-14,글로벌무대밝히는K바이오대웅제약매출10RD투자섬유증치료제등파이프라인확보,http://www.sedaily.com/NewsView/1VE191KQJA
187,2019-01-15,콜린알포세레이트신제형출시대웅종근당에도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=248520&REFERER=NP
188,2019-01-15,대웅유나이티드모사프리드특허싸움2라운드시작,http://www.mdtoday.co.kr/mdtoday/index.html?no=343925
189,2019-01-15,아통증시15일대웅주가17500원,http://www.anewsa.com/detail.php?number=1485013&thread=10r02
190,2019-01-15,대웅오늘주식시장15일현재17550원,http://www.nbntv.co.kr/news/articleView.html?idxno=170009
191,2019-01-15,대웅제약투자주식15일현재190000원,http://www.nbntv.co.kr/news/articleView.html?idxno=170515
192,2019-01-15,대웅제약주가정보15일현재190000원,http://www.gokorea.kr/news/articleView.html?idxno=74556
193,2019-01-16,SK證제약바이오섹터연초에주목해야대웅제약등추천,http://www.newsis.com/view/?id=NISX20190116_0000531337&cID=10401&pID=10400
194,2019-01-16,제약∙바이오연초주목할섹터대웅제약∙한미약품톱픽”,http://www.fntimes.com/html/view.php?ud=2019011608372596251d6f57e61a_18
195,2019-01-16,장중시세16일대웅주가17450원,http://www.anewsa.com/detail.php?number=1487984&thread=10r02
196,2019-01-16,대웅제약송당암연구센터암환자맞춤산학협력체결,http://www.g-enews.com/ko-kr/news/article/news_all/201901161001465143f6d02acec0_1/article.html
197,2019-01-16,대웅제약연세대암환자맞춤형진단치료체계개발산학협력체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226393
198,2019-01-16,대웅제약유전체정보기반암환자맞춤형진단치료체계개발나서,http://www.wikileaks-kr.org/news/articleView.html?idxno=45481
199,2019-01-16,대웅제약연세의료원과유전자기반맞춤형항암치료개발,http://www.edaily.co.kr/news/newspath.asp?newsid=02394406622358376
200,2019-01-16,대웅제약송당암연구센터와암환자맞춤형항암치료개발,http://medipana.com/news/news_viewer.asp?NewsNum=233514&MainKind=A&NewsKind=5&vCount=12&vKind=1
201,2019-01-16,대웅제약연세대암연구센터와암환자맞춤형진단치료체계개발협력,http://www.koreaittimes.com/news/articleView.html?idxno=88664
202,2019-01-16,대웅제약연세의대송당암연구센터와산학협력,http://www.ebn.co.kr/news/view/968978
203,2019-01-16,대웅제약연세의대송당암연구센터와산학협력,http://news.heraldcorp.com/view.php?ud=20190116000198
204,2019-01-16,대웅제약연세의대송당암연구센터와공동연구,http://www.dailypharm.com/Users/News/NewsView.html?ID=248602&REFERER=NP
205,2019-01-16,대웅제약연세의대암연구센터암정복공동연구개발산학협력,http://view.asiae.co.kr/news/view.htm?idxno=2019011610280533020
206,2019-01-16,대웅제약산학협력통해암환자맞춤형진단치료체계개발,http://www.mhj21.com/118823
207,2019-01-16,대웅제약연세의대손잡고암환자맞춤형진단치료체계개발,http://www.medisobizanews.com/news/articleView.html?idxno=57411
208,2019-01-16,대웅제약연세대암연구센터유전체기반맞춤형항암치료개발,http://kormedi.com/?p=1261766
209,2019-01-16,대웅제약연세의대송당암연구센터와손잡고암정복나선다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1711384
210,2019-01-16,대웅제약송당암센터와암환자진단치료체계개발협력,http://www.dailian.co.kr/news/view/765558/?sc=naver
211,2019-01-16,주식종목검색대웅주가16일현재17400원,http://www.nbntv.co.kr/news/articleView.html?idxno=172264
212,2019-01-16,대웅연세의대암환자맞춤형진단치료산학협력,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123840&REFERER=NP
213,2019-01-16,대웅제약연세암병원과암정복위한산학협력협약체결,http://news.mk.co.kr/newsRead.php?year=2019&no=32540
214,2019-01-16,대웅제약연세암병원암환자맞춤형진단치료체계개발,http://www.newsis.com/view/?id=NISX20190116_0000531619&cID=13001&pID=13000
215,2019-01-16,대웅제약연세암병원과유전체암진단사업협력,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901160209&t=NN
216,2019-01-16,대웅제약연세의대송당암센터와산학협력협약,http://www.insightkorea.co.kr//news/articleView.html?idxno=33488
217,2019-01-16,대웅제약연세의대송당암연구센터암환자맞춤치료위한공동연구나서,http://www.news2day.co.kr/118801
218,2019-01-16,대웅제약연세의대와암환자유전체진단기술공동개발,http://news1.kr/articles/?3525868
219,2019-01-16,대웅제약연세의대송당암연구센터와맞춤형항암치료위한산학협력,http://www.mdtoday.co.kr/mdtoday/index.html?no=344082
220,2019-01-16,대웅제약연세의대송당암연구센터와암환자맞춤형진단개발협약맺어,https://cnbc.sbs.co.kr/article_hub/10000928035?division=NAVER
221,2019-01-16,대웅제약연세의대송당암연구센터암정복공동연구개발협약식,http://news.heraldcorp.com/view.php?ud=20190116000344
222,2019-01-16,연세암병원대웅암환자진단치료체계공동개발,http://www.dailymedi.com/detail.php?number=839204&thread=22r02
223,2019-01-16,대웅제약목표가26만원유지전일종가18만9500원SK證,http://www.newspim.com/news/view/20190116000394
224,2019-01-16,대웅제약암환자맞춤형진단치료체계개발앞장,http://www.wolyo.co.kr/news/articleView.html?idxno=75817
225,2019-01-16,대웅제약유전체기반암치료제시장공략,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019011611161758669
226,2019-01-16,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2019011611263019981
227,2019-01-16,대웅제약연세의대암연구센터맞춤형치료체계개발협력,http://yna.kr/AKR20190116077800017?did=1195m
228,2019-01-16,연세대의대대웅제약과암환자맞춤형치료체계개발협약,http://www.rapportian.com/news/articleView.html?idxno=115513
229,2019-01-16,대웅제약연세송담암연구센터와산학협력체결암치료체계개발추진,http://news.donga.com/3/all/20190116/93726887/2
230,2019-01-16,대웅제약연세의대와유전체기반항암치료체계개발,http://www.biospectator.com/view/news_view.php?varAtcId=6962
231,2019-01-16,대웅제약연세의대송당암연구센터암환자맞춤형진단치료체계개발,http://www.newsprime.co.kr/news/article.html?no=443452
232,2019-01-16,연세대의대대웅제약맞춤형암치료연구개발맞손,http://www.newsworks.co.kr/news/articleView.html?idxno=327945
233,2019-01-16,1월16일대웅종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=75880
234,2019-01-16,대웅제약송당암연구센터암환자진단치료체계개발협력체결,http://www.seoulwire.com/news/articleView.html?idxno=52454
235,2019-01-16,1월16일대웅제약오늘시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=76084
236,2019-01-16,주식현황대웅제약주가16일현재189500원,http://www.nbntv.co.kr/news/articleView.html?idxno=172742
237,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.vop.co.kr/A00001371275.html
238,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.economytalk.kr/news/articleView.html?idxno=177664
239,2019-01-16,대웅제약연세의대송당암연구센터와MOU,http://www.bosa.co.kr/news/articleView.html?idxno=2098044
240,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.100ssd.co.kr/news/articleView.html?idxno=58944
241,2019-01-16,대웅제약연세의대암진단치료체계개발협력키로,http://news.mk.co.kr/newsRead.php?year=2019&no=33063
242,2019-01-16,연대송당암연구센터대웅제약암환자맞춤형진단치료체계개발,http://www.inthenews.co.kr/news/article.html?no=13033
243,2019-01-16,대웅제약연세의대와암환자맞춤형진단치료체계개발,http://www.shinailbo.co.kr/news/articleView.html?idxno=1134556
244,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.sisajournal-e.com/news/articleView.html?idxno=194389
245,2019-01-16,대웅제약연세의대송당암연구센터와암환자맞춤형진단개발MOU,http://www.ajunews.com/view/20190116143209595
246,2019-01-16,세계무대휘젓는위대한도전제약한류첨병대웅제약,http://www.skyedaily.com/news/news_view.html?ID=80903
247,2019-01-16,대웅제약연세의대암연구센터암정복공동연구개발협력,http://www.etnews.com/20190116000224
248,2019-01-16,대웅제약암환자맞춤형진단치료체계개발위한산학협력체결,http://www.bokuennews.com/news/article.html?no=170692
249,2019-01-16,대웅제약연세의대송당암연구센터와암환자맞춤형진단치료체계개발위한산학협력체결,http://www.ekn.kr/news/article.html?no=409811
250,2019-01-16,대웅제약연세의대송당암연구센터와산학협력,http://www.newsway.co.kr/news/view?tp=1&ud=2019011614555210665
251,2019-01-16,연세의대송당암연구센터대웅제약과산학협력체결,http://www.asiatoday.co.kr/view.php?key=20190116010010045
252,2019-01-16,대웅제약연세의대암환자맞춤형암진단치료체계개발협력,http://www.straightnews.co.kr/news/articleView.html?idxno=41541
253,2019-01-16,ET투자뉴스대웅제약4분기매출액3분매수SK증권,http://www.etnews.com/20190116000261
254,2019-01-16,대웅제약연세의대와맞춤형항암치료협력,http://news.hankyung.com/article/201901160923f
255,2019-01-16,대웅제약연세의료원암환자맞춤치료기술개발맞손,http://biz.chosun.com/site/data/html_dir/2019/01/16/2019011601927.html
256,2019-01-16,대웅제약연세암병원산학협력체결,http://www.whosaeng.com/sub_read.html?uid=107449§ion=sc5
257,2019-01-16,대웅제약연세의대암연구센터맞춤형치료체계개발협력,http://www.seoulfn.com/news/articleView.html?idxno=331068
258,2019-01-16,연세의대대웅제약항암제공동연구나서,http://moneys.mt.co.kr/news/mwView.php?no=2019011615388047588
259,2019-01-16,대웅제약연세의대와암맞춤형진단치료개발목표로협력,http://www.econovill.com/news/articleView.html?idxno=354780
260,2019-01-16,연세의대송당암연구센터대웅제약과암환자맞춤형진단치료체계개발,http://health.chosun.com/site/data/html_dir/2019/01/16/2019011602355.html
261,2019-01-16,연세의대대웅제약과맞춤형암치료플랫폼개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064484
262,2019-01-16,16일마감보고대웅주가18000원으로장마감,http://www.anewsa.com/detail.php?number=1489608&thread=10r04
263,2019-01-16,사진표적항암제진단알고리즘개발대웅제약연세대의대맞손,http://www.sedaily.com/NewsView/1VE275UZ03
264,2019-01-16,대웅제약연세의대송당암연구센터와산학협력체결,http://www.medigatenews.com/news/2731891923
265,2019-01-16,대웅제약암환자맞춤형진단치료체계개발산학협력체결,http://www.getnews.co.kr/view.php?ud=20190116171154870241d0c69529_16
266,2019-01-16,대웅제약연세송당암연구센터와산학협력체결암치료체계개발추진,http://www.ftoday.co.kr/news/articleView.html?idxno=106016
267,2019-01-16,대웅제약송당암연구센터암환자맞춤진단체계산학협력,http://www.dt.co.kr/contents.html?article_no=2019011702101631102001&ref=naver
268,2019-01-16,대웅제약암정복위해연세의대송당암연구센터와산학협력체결,https://www.insight.co.kr/news/204978
269,2019-01-16,대웅제약암환자맞춤형진단치료체계개발위한산학협력체결,http://www.newscj.com/news/articleView.html?idxno=592495
270,2019-01-16,대웅제약연세대암연구센터손잡고맞춤형치료체계개발,http://www.businesspost.co.kr/BP?command=article_view&num=110592
271,2019-01-17,연세의대송당암연구센터대웅제약암환자맞춤형진단치료체계개발추진,http://medicalworldnews.co.kr/news/view.php?idx=1510929137
272,2019-01-17,설선물대웅제약과음에지친당신간건강엔우루사,http://news.mk.co.kr/newsRead.php?year=2019&no=34520
273,2019-01-17,2019제약산업이뛴다①대웅나보타미국유럽출시기대글로벌제약사도약원년,http://www.newsis.com/view/?id=NISX20190103_0000520217&cID=13001&pID=13000
274,2019-01-17,국내주가정보17일대웅주가17750원,http://www.anewsa.com/detail.php?number=1490588&thread=10r02
275,2019-01-17,대웅제약암환자맞춤진단치료체계개발나선다,http://www.monews.co.kr/news/articleView.html?idxno=200381
276,2019-01-17,유한양행한미약품대웅제약등RD성과주시,http://www.choicenews.co.kr/news/articleView.html?idxno=47526
277,2019-01-17,대웅제약의약품안전성유효성에맞는글로벌기준준수,http://medipana.com/news/news_viewer.asp?NewsNum=233564&MainKind=A&NewsKind=5&vCount=12&vKind=1
278,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226432
279,2019-01-17,대웅제약오라클클라우드로의약품안전보고체계표준화,http://www.dt.co.kr/contents.html?article_no=2019011702109931041002&ref=naver
280,2019-01-17,대웅제약의약품안전관리강화위해오라클서비스전면도입,http://news.mk.co.kr/newsRead.php?year=2019&no=35210
281,2019-01-17,대웅제약오라클클라우드도입의약품안전관리강화,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003463007
282,2019-01-17,유통오늘전자랜드세종시에파워센터세종점신규오픈대웅제약클라우드통해의약품안전관리,http://www.sisaon.co.kr/news/articleView.html?idxno=81452
283,2019-01-17,주식추천주대웅주가17일현재17800원,http://www.nbntv.co.kr/news/articleView.html?idxno=173458
284,2019-01-17,대웅제약클라우드시스템도입의약품안전관리,http://www.medisobizanews.com/news/articleView.html?idxno=57436
285,2019-01-17,대웅제약의약품안전관리위해오라클아거스클라우드서비스도입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1711891
286,2019-01-17,대웅제약실시간의약품안전관리클라우드서비스도입,http://www.newsis.com/view/?id=NISX20190117_0000532869&cID=13001&pID=13000
287,2019-01-17,대웅제약의약품안전관리에오라클클라우드도입,http://www.dt.co.kr/contents.html?article_no=2019011702109931650003&ref=naver
288,2019-01-17,해외시장진출비용절감목표대웅제약오라클서비스도입,http://moneys.mt.co.kr/news/mwView.php?no=2019011710528079412
289,2019-01-17,대웅제약진화된의약품안전관리클라우드시스템도입,http://www.100ssd.co.kr/news/articleView.html?idxno=58952
290,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123868&REFERER=NP
291,2019-01-17,대웅주가1월17일현재17650원,http://www.gokorea.kr/news/articleView.html?idxno=76978
292,2019-01-17,대웅제약첨단IT시스템클라우드로의약품안전관리한다,http://www.k-health.com/news/articleView.html?idxno=41933
293,2019-01-17,대웅제약의약품안전관리위해오라클아거스클라우드도입,http://techm.kr/bbs/board.php?bo_table=article&wr_id=5539
294,2019-01-17,1월17일대웅제약주식시세현황186500원106,http://www.nbntv.co.kr/news/articleView.html?idxno=173950
295,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.g-enews.com/ko-kr/news/article/news_all/201901171246347992f6d02acec0_1/article.html
296,2019-01-17,대웅제약주가및증권시세17일현재186500원,http://www.gokorea.kr/news/articleView.html?idxno=77276
297,2019-01-17,대웅제약의약품안전관리위해오라클클라우드도입,http://www.datanet.co.kr/news/articleView.html?idxno=130363
298,2019-01-17,대웅제약의약품안전관리위한클라우드시스템도입,http://www.insightkorea.co.kr//news/articleView.html?idxno=33528
299,2019-01-17,대웅제약의약품안전관리에클라우드도입,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019011713030501820&objId=A2019011713030501820&portalCode=naver
300,2019-01-17,대웅제약실시간의약품안전관리클라우스시스템도입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019011711245650302
301,2019-01-17,오라클아거스클라우드대웅제약의약품안전보고체계표준화,http://www.koreaittimes.com/news/articleView.html?idxno=88711
302,2019-01-17,대웅제약클라우드통해의약품안전관리실시,http://www.ftoday.co.kr/news/articleView.html?idxno=106033
303,2019-01-17,대웅제약클라우드통해의약품안전관리나선다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1134894
304,2019-01-17,대웅제약클라우드통한의약품안전관리도입,http://www.medigatenews.com/news/320969056
305,2019-01-17,대웅제약클라우드서비스통해의약품안전관리한다,http://www.businesskorea.co.kr/news/articleView.html?idxno=28398
306,2019-01-17,대웅제약실시간의약품안전관리클라우드서비스도입,http://www.wolyo.co.kr/news/articleView.html?idxno=75938
307,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1264003
308,2019-01-17,대웅제약오라클클라우드로의약품안전관리강화,http://www.etnews.com/20190117000147
309,2019-01-17,대웅제약의약품안전관리도글로벌기업수준으로,http://news.heraldcorp.com/view.php?ud=20190117000533
310,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.ekn.kr/news/article.html?no=410090
311,2019-01-17,대웅제약의약품안전관리클라우드시스템도입,http://www.newspim.com/news/view/20190117000493
312,2019-01-17,대웅제약클라우드로의약품안전관리,http://www.newstomato.com/ReadNews.aspx?no=870425
313,2019-01-17,대웅제약클라우드기반의약품안전관리강화,http://www.dailymedi.com/detail.php?number=839260&thread=22r05
314,2019-01-17,대웅제약의약품안전관리클라우드서비스도입,http://view.asiae.co.kr/news/view.htm?idxno=2019011715210316573
315,2019-01-17,대웅제약오라클클라우드시스템도입해의약품안전관리강화,http://www.businesspost.co.kr/BP?command=article_view&num=110686
316,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.bosa.co.kr/news/articleView.html?idxno=2098122
317,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.fnnews.com/news/201901171546042749
318,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.economytalk.kr/news/articleView.html?idxno=177755
319,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.ebn.co.kr/news/view/969224
320,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.bokuennews.com/news/article.html?no=170754
321,2019-01-17,대웅제약의약품관리에클라우드서비스도입,http://www.kpinews.co.kr/news/articleView.html?idxno=88243
322,2019-01-17,대웅제약클라우드서비스통해의약품안전관리,http://www.mdtoday.co.kr/mdtoday/index.html?no=344229
323,2019-01-17,장종리포트17일마감대웅주가17800원으로장마감,http://www.anewsa.com/detail.php?number=1492701&thread=10r04
324,2019-01-17,대웅제약클라우드서비스도입의약품안전관리강화,http://www.newsprime.co.kr/news/article.html?no=443679
325,2019-01-17,대웅제약클라우드서비스로의약품안전관리한다,http://www.seoulwire.com/news/articleView.html?idxno=52702
326,2019-01-17,대웅제약의약품개발약물감시플랫폼기술도입,http://www.rapportian.com/news/articleView.html?idxno=115553
327,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.newsway.co.kr/news/view?tp=1&ud=2019011716532097560
328,2019-01-17,클라우드로의약품안전관리나선대웅제약,http://www.monews.co.kr/news/articleView.html?idxno=200429
329,2019-01-17,뉴스투데이L대웅제약클라우드로의약품안전관리한다,http://www.news2day.co.kr/118918
330,2019-01-17,대웅제약오라클아거스클라우드도입,http://www.ddaily.co.kr/news/article.html?no=177049
331,2019-01-17,대웅제약클라우드통한의약품안전관리진행,http://www.asiatime.co.kr/news/articleView.html?idxno=223884
332,2019-01-17,대웅제약클라우드시스템으로의약품안전관리한다,http://www.inthenews.co.kr/news/article.html?no=13070
333,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.getnews.co.kr/view.php?ud=20190117181358803341d0c69529_16
334,2019-01-17,대웅제약오라클아거스클라우드로의약품안전관리,http://www.inews24.com/view/1152233
335,2019-01-17,대웅제약의약품안전관리위한클라우드서비스도입,http://www.dailian.co.kr/news/view/766063/?sc=naver
336,2019-01-17,대웅제약오라클아거스클라우드도입으로의약품안전보고체계표준화한다,//www.dailysecu.com/?mod=news&act=articleView&idxno=44453
337,2019-01-17,대웅제약클라우드통해의약품안전관리,http://www.wsobi.com/news/articleView.html?idxno=68770
338,2019-01-17,대웅제약의약품안전관리클라우드서비스도입,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3737899
339,2019-01-17,대웅제약클라우드통해의약품안전관리한다,http://www.newscj.com/news/articleView.html?idxno=593020
340,2019-01-17,대웅제약아거스클라우드로의약품안전보고체계표준화,http://www.itdaily.kr/news/articleView.html?idxno=92738
341,2019-01-18,대웅제약송당암연구센터암맞춤진단치료체계산학협력,http://www.kpanews.co.kr/article/show.asp?idx=200907&table=article&category=D
342,2019-01-18,대웅제약의약품안전관리 클라우드서비스도입,http://www.kpanews.co.kr/article/show.asp?idx=200910&table=article&category=D
343,2019-01-18,대웅제약클라우드통해의약품안전관리도입,http://www.lawissue.co.kr/view.php?ud=201901172324487417d7f4c63cc6_12
344,2019-01-18,클릭e종목대웅기업가치상승돋보여,http://view.asiae.co.kr/news/view.htm?idxno=2019011807245752351
345,2019-01-18,대웅보톡스나보타등에업고순항기대골든브릿지,http://www.edaily.co.kr/news/newspath.asp?newsid=01351366622359032
346,2019-01-18,대웅자회사실적개선에기업가치상승골든브릿지,http://www.sedaily.com/NewsView/1VE322YD0J
347,2019-01-18,오라클대웅제약글로벌시장규제준수돕는다,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20190118004454
348,2019-01-18,실시간분석대웅제약32상승증권사목표가26만원제시,http://www.itooza.com/common/iview.php?no=2019011809162712724
349,2019-01-18,대웅자회사가치상승기대에강세,http://news.hankyung.com/article/2019011872386
350,2019-01-18,주식실황18일대웅주가18500원,http://www.anewsa.com/detail.php?number=1493603&thread=10r02
351,2019-01-18,1월18일대웅주식추천주18500원393,http://www.nbntv.co.kr/news/articleView.html?idxno=175647
352,2019-01-18,대웅올해자회사실적개선에힘입어지분가치증가,http://www.newsworks.co.kr/news/articleView.html?idxno=328814
353,2019-01-18,대웅주가정보18일현재18000원,http://www.gokorea.kr/news/articleView.html?idxno=78590
354,2019-01-18,주식추천주대웅제약주가18일현재188500원,http://www.nbntv.co.kr/news/articleView.html?idxno=176106
355,2019-01-18,대웅제약클라우드로의약품안전관리,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064540
356,2019-01-18,대웅제약주가종목그래프18일현재189000원,http://www.gokorea.kr/news/articleView.html?idxno=78842
357,2019-01-18,대웅제약신약개발과글로벌진출속도,http://www.straightnews.co.kr/news/articleView.html?idxno=41665
358,2019-01-19,대웅제약클라우드통해의약품안전관리효율화,http://www.kukinews.com/news/article.html?no=623935
359,2019-01-19,대웅제약클라우드통해의약품안전관리한다,http://www.boannews.com/media/view.asp?idx=76259&kind=
360,2019-01-20,대웅제약나보타美FDA심사임박글로벌시장진출채비,http://www.etnews.com/20190118000113
361,2019-01-20,종목시세코오롱인더57900원358E158200원356대웅제약190000원354계양전기우9390원353신세계250500원351↑주식가격주가올라18일장,http://www.fintechpost.co.kr/news/articleView.html?idxno=17461
362,2019-01-20,종목시세대웅18300원281셀트리온201000원281휴켐스22000원28대원전선2025원279NI스틸2590원278↑주식가격주가올라18일장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=17471
363,2019-01-21,대웅야심작항궤양제복용편의성제고임상승인,http://www.dailymedi.com/detail.php?number=839344&thread=22r05
364,2019-01-21,대웅제약전승호사장10년안에매출영업익시총10조목표”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226413
365,2019-01-21,대웅전승호대표나보타1분기FDA허가기대”,http://www.whosaeng.com/sub_read.html?uid=107493§ion=sc5
366,2019-01-21,남다른대웅제약나보타미진출1조매출은기본,http://www.bosa.co.kr/news/articleView.html?idxno=2098215
367,2019-01-21,대웅제약주보판매로실적개선기대목표가↑한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1712828
368,2019-01-21,골든브릿지대웅매수목표가29000원,http://www.betanews.net:8080/article/962857.html
369,2019-01-21,대웅제약목표가8↑25만원제시한투證,http://www.newspim.com/news/view/20190121000073
370,2019-01-21,퀵리포트대웅제약매수유지목표가8↑25만원한투證,http://www.itooza.com/common/iview.php?no=2019012108335716833
371,2019-01-21,대웅제약올해영업이익580억원전망,http://www.nspna.com/news/?mode=view&newsid=333431
372,2019-01-21,ET투자뉴스대웅제약단기차익실현을고BUY유지한국투자증권,http://www.etnews.com/20190121000120
373,2019-01-21,대웅바이오2018년영업익464억원전년比54↑,http://www.edaily.co.kr/news/newspath.asp?newsid=02742086622360016
374,2019-01-21,대웅바이오지난해영업익463억전년비544↑,http://news.heraldcorp.com/view.php?ud=20190121000352
375,2019-01-21,대웅바이오지난해영업익4635억원전년비544↑,http://news.mt.co.kr/mtview.php?no=2019012111231323307
376,2019-01-21,공시대웅바이오지난해영업익463억5026만원전년比544↑,http://www.newsway.co.kr/news/view?tp=1&ud=2019012111332449476
377,2019-01-21,대웅자회사대웅바이오작년영업익544증가,http://yna.kr/AKR20190121069900008?did=1195m
378,2019-01-21,대웅바이오작년영업이익464억전년比544↑,http://www.newsworks.co.kr/news/articleView.html?idxno=329318
379,2019-01-21,국내주가정보21일대웅주가18000원,http://www.anewsa.com/detail.php?number=1497050&thread=10r02
380,2019-01-21,대웅제약올해영업이익은기존추정치대비24상향,http://www.newsworks.co.kr/news/articleView.html?idxno=329364
381,2019-01-21,대웅주가및증권시세및증권정보와종목동정21일현재17950원,http://www.gokorea.kr/news/articleView.html?idxno=79974
382,2019-01-21,대웅바이오지난해영업익전년비54증가한463억원,http://www.ceoscoredaily.com/news/article.html?no=51160
383,2019-01-21,대웅바이오지난해영업익463억전년比544↑,http://view.asiae.co.kr/news/view.htm?idxno=2019012113013747058
384,2019-01-21,대웅바이오작년영업이익463억원전년대비54증가,http://www.sedaily.com/NewsView/1VE4H6PCCQ
385,2019-01-21,공시대웅대웅바이오지난해영업이익464억전년比544↑,http://www.newsis.com/view/?id=NISX20190121_0000535991&cID=10401&pID=10400
386,2019-01-21,대웅바이오지난해영업익464억원전년比544↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=344460
387,2019-01-21,대웅바이오지난해영업이익463억전년비54↑,http://news.hankyung.com/article/2019012150226
388,2019-01-21,1월21일대웅주식현재가27317800원,http://www.nbntv.co.kr/news/articleView.html?idxno=178006
389,2019-01-21,대웅바이오작년영업익464억원전년대비544증가,http://www.seoulwire.com/news/articleView.html?idxno=54185
390,2019-01-21,대웅제약주가1월21일현재185000원,http://www.gokorea.kr/news/articleView.html?idxno=80356
391,2019-01-21,대웅지난해영업익463억전년比544↑,http://www.newsprime.co.kr/news/article.html?no=444000
392,2019-01-21,21일공감마감정보대웅주가17750원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=80950
393,2019-01-21,대웅대웅바이오지난해영업이익464억전년대비544늘어나,http://www.econonews.co.kr/news/articleView.html?idxno=50853
394,2019-01-22,FDA셧다운업무지연대웅제약나보타미진출늦어지나,http://www.econovill.com/news/articleView.html?idxno=355128
395,2019-01-22,빅데이터MSI시장심리톱5현대건설삼성엔지니어링삼성중공업삼성물산대웅제약,http://www.newsis.com/view/?id=NISX20190122_0000536779&cID=10401&pID=10400
396,2019-01-22,증시보고22일대웅주가17650원,http://www.anewsa.com/detail.php?number=1499552&thread=10r02
397,2019-01-22,주식창대웅주가22일현재17650원,http://www.nbntv.co.kr/news/articleView.html?idxno=178692
398,2019-01-22,대웅제약오늘주식22일현재185000원,http://www.nbntv.co.kr/news/articleView.html?idxno=179199
399,2019-01-22,1월22일대웅종목그래프및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=81289
400,2019-01-22,원료약업체의반전대웅바이오4년새매출2배↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=248786&REFERER=NP
401,2019-01-22,대웅제약주가1월22일현재184500원,http://www.gokorea.kr/news/articleView.html?idxno=81735
402,2019-01-22,기술수출기대되는신약파이프라인⑤대웅제약BestinClass꿈꾸는위산분비억제제DWP14012,http://www.news2day.co.kr/119174
403,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.g-enews.com/ko-kr/news/article/news_all/201901230922113279f6d02acec0_1/article.html
404,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226622
405,2019-01-23,대웅제약항혈전제안플원100mg출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=248842&REFERER=NP
406,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.ebn.co.kr/news/view/969808
407,2019-01-23,대웅제약항혈전제안플원라인업확대추가매출기대,http://moneys.mt.co.kr/news/mwView.php?no=2019012309228036420
408,2019-01-23,800억시장노리는대웅제약안플원일반정100mg출시,http://kormedi.com/?p=1262673
409,2019-01-23,대웅제약일반정제형항혈전제안플원100mg출시,http://news.mk.co.kr/newsRead.php?year=2019&no=47088
410,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019012300016
411,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1713952
412,2019-01-23,대웅제약항혈전제안플원정100mg내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=76284
413,2019-01-23,항혈전제안플원제품라인업추가대웅제약시장확대나서,http://www.100ssd.co.kr/news/articleView.html?idxno=59087
414,2019-01-23,대웅제약항혈전제안플원정용량추가100mg출시,http://medipana.com/news/news_viewer.asp?NewsNum=233803&MainKind=A&NewsKind=5&vCount=12&vKind=1
415,2019-01-23,대웅제약안플원서방정이어일반정출시,http://www.whosaeng.com/sub_read.html?uid=107572§ion=sc5
416,2019-01-23,대웅제약항혈전제안플원정100mg출시맞춤처방가능,http://www.medisobizanews.com/news/articleView.html?idxno=57531
417,2019-01-23,대웅제약항혈전제안플원정100㎎출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02240246622360672
418,2019-01-23,대웅제약항혈전제안플원정일반정100mg출시,http://www.k-health.com/news/articleView.html?idxno=42034
419,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012309354369150
420,2019-01-23,대웅제약항혈전제안플원라인업확대,http://www.dailysmart.co.kr/news/articleView.html?idxno=5343
421,2019-01-23,대웅제약용량줄인항혈전제안플원정100mg출시,http://news1.kr/articles/?3531246
422,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.bokuennews.com/news/article.html?no=170949
423,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123998&REFERER=NP
424,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.dailian.co.kr/news/view/767239/?sc=naver
425,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.bosa.co.kr/news/articleView.html?idxno=2098396
426,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003468645
427,2019-01-23,대웅제약항혈전제일반정100mg출시,http://www.rapportian.com/news/articleView.html?idxno=115641
428,2019-01-23,대웅제약항혈전제안플원정100mg로시장확대나서,http://www.econovill.com/news/articleView.html?idxno=355227
429,2019-01-23,대웅제약항혈전제안플원시장확대나서일반정출시,http://www.mhj21.com/118977
430,2019-01-23,대웅제약항혈전제라인업확대안플원정100mg출시,http://news.bizwatch.co.kr/article/consumer/2019/01/23/0007/naver
431,2019-01-23,대웅제약항혈전제안플원정100㎎출시,http://news.mk.co.kr/newsRead.php?year=2019&no=47476
432,2019-01-23,유통오늘대웅제약항혈전제안플원정100mg출시공영홈쇼핑24일식품명인전5시간진행,http://www.sisaon.co.kr/news/articleView.html?idxno=81653
433,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.dailymedi.com/detail.php?number=839442&thread=22r05
434,2019-01-23,대웅제약항혈전제안플원정100mg선봬,http://www.medigatenews.com/news/1657558382
435,2019-01-23,안플원정일반정으로확대대웅제약100mg선보여,http://www.sedaily.com/NewsView/1VE5D8Z5XZ
436,2019-01-23,1월23일대웅증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=82655
437,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019012311344504986
438,2019-01-23,대웅제약안플원정100mg출시,http://www.monews.co.kr/news/articleView.html?idxno=200523
439,2019-01-23,대웅주식그래프23일현재17550원,http://www.nbntv.co.kr/news/articleView.html?idxno=180942
440,2019-01-23,대웅제약항혈전제안플원정100mg출시라인업확대,http://www.economytalk.kr/news/articleView.html?idxno=178148
441,2019-01-23,대웅제약항혈전제안플원정100mg선봬,http://www.seoulwire.com/news/articleView.html?idxno=55190
442,2019-01-23,대웅제약항혈전제안플원정100mg도내놨다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064690
443,2019-01-23,대웅제약수족냉증해소안플원정100㎎출시,http://www.newsis.com/view/?id=NISX20190123_0000538237&cID=13001&pID=13000
444,2019-01-23,대웅제약항혈전제안플원정100mg출시제품군확대,http://news.hankyung.com/article/2019012331646
445,2019-01-23,오늘증권시세대웅제약주가23일현재182500원,http://www.nbntv.co.kr/news/articleView.html?idxno=181239
446,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1136472
447,2019-01-23,대웅제약항혈전제안플원정출시제품군확대,http://www.etnews.com/20190123000220
448,2019-01-23,대웅제약다양한처방솔루션위해안플원정100㎎출시,http://www.asiatime.co.kr/news/articleView.html?idxno=224801
449,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=344714
450,2019-01-23,대웅제약항혈전제안플원정100mg출시제품라인업확대,https://www.insight.co.kr/news/206377
451,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.koreaittimes.com/news/articleView.html?idxno=88842
452,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.getnews.co.kr/view.php?ud=20190123172934142641d0c69529_16
453,2019-01-23,빅데이터주식투자코스피대웅제약,http://www.leaders.kr/news/articleView.html?idxno=85332
454,2019-01-23,대웅제약항혈전제안플원일반정출시맞춤처방지원,http://news.donga.com/3/all/20190123/93831151/2
455,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.finomy.com/news/articleView.html?idxno=62364
456,2019-01-23,뉴스투데이L대웅제약항혈전제안플원소용량출시로시장확대,http://www.news2day.co.kr/119299
457,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.newscj.com/news/articleView.html?idxno=595010
458,2019-01-23,대웅제약항혈전제안플원정100mg출시,http://www.wsobi.com/news/articleView.html?idxno=69005
459,2019-01-24,대웅제약항혈전제안플원정100mg출시,http://www.kpanews.co.kr/article/show.asp?idx=201084&table=article&category=D
460,2019-01-24,대웅제약항혈전제안플원정100mg출시말초동맥질환치료제선두주자로자리매김할것,http://www.segye.com/content/html/2019/01/23/20190123005322.html?OutUrl=naver
461,2019-01-24,대웅실다루드판매종료글로벌판권이전영향,http://www.dailypharm.com/Users/News/NewsView.html?ID=248867&REFERER=NP
462,2019-01-24,대웅제약종근당등국내제약사13곳화이자젤잔즈특허회피성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=344734
463,2019-01-24,빅데이터MSI시장심리톱5삼성물산기업은행대우건설대웅제약GS리테일,http://www.newsis.com/view/?id=NISX20190124_0000539396&cID=10401&pID=10400
464,2019-01-24,대웅S케어유어린이집유아식판세척서비스출시,http://www.viva100.com/main/view.php?key=20190124000925354
465,2019-01-24,국내주식시장주가24일대웅주가17550원,http://www.anewsa.com/detail.php?number=1505010&thread=10r02
466,2019-01-24,1월24일대웅제약오늘시세및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=83049
467,2019-01-24,1월24일대웅주식창17550원029,http://www.nbntv.co.kr/news/articleView.html?idxno=182909
468,2019-01-24,ET투자뉴스대웅_거래비중기관2571외국인184,http://www.etnews.com/20190124000167
469,2019-01-24,1월24일대웅증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=83248
470,2019-01-24,대웅제약항혈전제안플원제품라인업추가시장확대나서,http://www.ekn.kr/news/article.html?no=411295
471,2019-01-24,24일대웅주가17800원으로장마감,http://www.anewsa.com/detail.php?number=1507318&thread=10r04
472,2019-01-24,24일공감마감정보대웅17800원마감,http://www.gokorea.kr/news/articleView.html?idxno=83524
473,2019-01-25,영월대웅생명과학영월군투자약속불이행논란,http://www.kado.net/?mod=news&act=articleView&idxno=950311
474,2019-01-25,대웅주가1월25일현재17600원,http://www.gokorea.kr/news/articleView.html?idxno=83870
475,2019-01-25,대웅S케어첨단세척후해당원으로직접배송시스템도입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1715067
476,2019-01-25,1월25일대웅주가그래프16917500원,http://www.nbntv.co.kr/news/articleView.html?idxno=185096
477,2019-01-25,주식실황25일대웅주가17500원,http://www.anewsa.com/detail.php?number=1507962&thread=10r02
478,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.g-enews.com/ko-kr/news/article/news_all/201901251012531632f6d02acec0_1/article.html
479,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.mhj21.com/119047
480,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226704
481,2019-01-25,대웅향남공장안전보건경영시스템ISO45001인증,http://www.dailypharm.com/Users/News/NewsView.html?ID=248945&REFERER=NP
482,2019-01-25,대웅제약향남공장안전보건경영시스템인증획득,http://www.whosaeng.com/sub_read.html?uid=107637§ion=sc5
483,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003471033
484,2019-01-25,대웅제약향남공장국제표준획득,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83713
485,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템획득,http://biz.chosun.com/site/data/html_dir/2019/01/25/2019012501217.html
486,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.medigatenews.com/news/769854422
487,2019-01-25,대웅제약향남공장ISO45001획득,http://www.bosa.co.kr/news/articleView.html?idxno=2098555
488,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준인증,http://kormedi.com/?p=1263048
489,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준ISO45001인증,http://www.medisobizanews.com/news/articleView.html?idxno=57585
490,2019-01-25,대웅향남공장국제표준안전보건경영시스템획득,http://www.dailymedi.com/detail.php?number=839527&thread=22r05
491,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019012510555061846
492,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012510443370574
493,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.seoulwire.com/news/articleView.html?idxno=56150
494,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준인증획득,http://www.newsprime.co.kr/news/article.html?no=444628
495,2019-01-25,대웅제약배당주식25일현재182500원,http://www.nbntv.co.kr/news/articleView.html?idxno=185588
496,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.bokuennews.com/news/article.html?no=171050
497,2019-01-25,대웅제약향남공장국제표준ISO45001인증획득,http://www.ekn.kr/news/article.html?no=411577
498,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준인증획득,http://www.straightnews.co.kr/news/articleView.html?idxno=42142
499,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064792
500,2019-01-25,대웅제약향남공장안전보건경영시스템획득 ,http://www.monews.co.kr/news/articleView.html?idxno=200581
501,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템인증,http://www.rapportian.com/news/articleView.html?idxno=115691
502,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템인증,http://www.edaily.co.kr/news/newspath.asp?newsid=02656806622361328
503,2019-01-25,대웅1분기FDA허가국산보톡스미국진출잰걸음,http://www.dailypharm.com/Users/News/NewsView.html?ID=248943&REFERER=NP
504,2019-01-25,대웅제약주가1월25일현재184000원,http://www.gokorea.kr/news/articleView.html?idxno=84291
505,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1266401
506,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.koreaittimes.com/news/articleView.html?idxno=88902
507,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019012513453201953&objId=A2019012513453201953&portalCode=naver
508,2019-01-25,대웅제약향남공장안전보건경영시스템국제표준획득,http://news.hankyung.com/article/2019012518236
509,2019-01-25,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.asiatoday.co.kr/view.php?key=20190125010016355
510,2019-01-25,대웅제약향남공장ISO45001획득,http://www.etnews.com/20190125000195
511,2019-01-25,대웅제약향남공장국제안전보건경영시스템인증획득,http://www.econovill.com/news/articleView.html?idxno=355417
512,2019-01-25,대웅제약향남공장보건경영국제인증획득,http://www.finomy.com/news/articleView.html?idxno=62417
513,2019-01-25,대웅제약향남공장안전보건국제표준ISO45001인증획득,http://news.donga.com/3/all/20190125/93861750/2
514,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.newstomato.com/ReadNews.aspx?no=872216
515,2019-01-25,대웅제약향남공장안전보건국제표준ISO45001획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1715223
516,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템인증획득,http://www.100ssd.co.kr/news/articleView.html?idxno=59170
517,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://medipana.com/news/news_viewer.asp?NewsNum=233940&MainKind=A&NewsKind=5&vCount=12&vKind=1
518,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.inthenews.co.kr/news/article.html?no=13208
519,2019-01-25,대웅제약향남공장안전보건경영시스템인증,http://news.bizwatch.co.kr/article/consumer/2019/01/25/0015/naver
520,2019-01-25,대웅제약향남공장ISO45001인증획득,http://news.mk.co.kr/newsRead.php?year=2019&no=53675
521,2019-01-25,대웅제약향남공장국제안전보건경영시스템ISO45001획득,http://www.ajunews.com/view/20190125164847781
522,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=344933
523,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.ebn.co.kr/news/view/970307
524,2019-01-25,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.getnews.co.kr/view.php?ud=20190125173949336441d0c69529_16
525,2019-01-25,대웅제약향남공장국제표준ISO45001획득,http://www.seoulfn.com/news/articleView.html?idxno=332044
526,2019-01-25,25일공감마감정보대웅주가17700원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=84533
527,2019-01-25,대웅제약향남공장안전보건국제표준ISO45001인증획득,https://www.insight.co.kr/news/206914
528,2019-01-25,뉴스투데이L대웅제약향남공장국제표준ISO45001획득,http://www.news2day.co.kr/119497
529,2019-01-25,대웅제약향남공장국제표준안전보건경영시스템획득,http://www.newscj.com/news/articleView.html?idxno=595824
530,2019-01-26,대웅제약향남공장안전보건경영시스템국제표준획득,http://www.wsobi.com/news/articleView.html?idxno=69148
531,2019-01-26,대웅제약질환정도별맞춤처방가능한항혈전제안플원정100mg출시,http://www.lawissue.co.kr/view.php?ud=201901261832288425d7f4c63cc6_12
532,2019-01-27,대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://yna.kr/AKR20190125079500017?did=1195m
533,2019-01-27,갑질대웅제약윤재승전회장네이버커넥트재단이사장사퇴,https://cnbc.sbs.co.kr/article_hub/10000929193?division=NAVER
534,2019-01-27,대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.newsis.com/view/?id=NISX20190127_0000541905&cID=13001&pID=13000
535,2019-01-27,갑질물의윤재승대웅제약전회장네이버커넥트재단이사장사퇴,http://www.newsway.co.kr/news/view?tp=1&ud=2019012709322264406
536,2019-01-27,폭언갑질윤재승대웅제약전회장네이버커넥트재단이사장사퇴,http://www.fetv.co.kr/news/article.html?no=19520
537,2019-01-27,갑질물의대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.viva100.com/main/view.php?key=20190127010008440
538,2019-01-27,갑질논란대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.ekn.kr/news/article.html?no=411771
539,2019-01-27,윤재승전대웅회장네이버사회공헌재단서도물러나,http://view.asiae.co.kr/news/view.htm?idxno=2019012710414221296
540,2019-01-27,대웅제약윤재승전회장네이버와결별갑질물의5개월만,http://www.sporbiz.co.kr/news/articleView.html?idxno=307968
541,2019-01-27,대웅제약윤재승전회장네이버커넥트재단이사장퇴진,http://www.wolyo.co.kr/news/articleView.html?idxno=76579
542,2019-01-27,윤재승전대웅제약회장6년여만에네이버커넥트재단이사장사퇴,http://sports.chosun.com/news/ntype.htm?id=201901280100200810015807&servicedate=20190127
543,2019-01-27,윤재승대웅제약前회장네이버커넥트재단이사장사퇴,http://www.shinailbo.co.kr/news/articleView.html?idxno=1137466
544,2019-01-27,갑질대웅제약윤재승전회장네이버커넥트재단이사장사퇴,http://www.meconomynews.com/news/articleView.html?idxno=20057
545,2019-01-27,욕설갑질윤재승대웅제약전회장네이버커넥트재단이사장사퇴,http://www.4th.kr/news/articleView.html?idxno=8409
546,2019-01-28,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.kukinews.com/news/article.html?no=626567
547,2019-01-28,대웅S케어유아식판위생위한세척서비스체험서비스무료진행,https://cnbc.sbs.co.kr/article_hub/10000929259?division=NAVER
548,2019-01-28,1월28일대웅주식추천주17900원113,http://www.nbntv.co.kr/news/articleView.html?idxno=187741
549,2019-01-28,유아식판세척대웅S케어토탈위생케어로완벽관리가능,http://www.kukinews.com/news/article.html?no=626609
550,2019-01-28,주식실황28일대웅주가17800원,http://www.anewsa.com/detail.php?number=1511266&thread=10r02
551,2019-01-28,대웅제약종근당올해신약효과로1조클럽이름올린다,http://www.ekn.kr/news/article.html?no=411762
552,2019-01-28,오늘증권시세대웅제약주가28일현재186500원,http://www.nbntv.co.kr/news/articleView.html?idxno=188231
553,2019-01-28,대웅제약윤재승전회장네이버커넥트재단이사장사퇴,https://www.insight.co.kr/news/207340
554,2019-01-28,갑질논란대웅제약윤재승커넥트재단이사장사임,http://www.mediasr.co.kr/news/articleView.html?idxno=51001
555,2019-01-28,대웅제약항혈전제안플원정100mg출시,http://www.kukinews.com/news/article.html?no=626852
556,2019-01-28,대웅제약향남공장국제표준ISO45001안전보건경영시스템획득,http://www.lawissue.co.kr/view.php?ud=201901282319482277d7f4c63cc6_12
557,2019-01-29,갑질논란대웅제약윤제승전회장커넥트재단에서도사퇴,http://www.mdtoday.co.kr/mdtoday/index.html?no=345090
558,2019-01-29,1월29일대웅주식장11317550원,http://www.nbntv.co.kr/news/articleView.html?idxno=190072
559,2019-01-29,증시보고29일대웅주가17500원,http://www.anewsa.com/detail.php?number=1514199&thread=10r02
560,2019-01-29,1월29일대웅제약주식종목시세189181500원,http://www.nbntv.co.kr/news/articleView.html?idxno=190566
561,2019-01-29,대웅제약주가증권투자정보및증권정보와종목동정29일현재181500원,http://www.gokorea.kr/news/articleView.html?idxno=86609
562,2019-01-29,44세젊은CEO전승호대표가이끄는대웅제약이올해풀어야할과제,https://www.insight.co.kr/news/207673
563,2019-01-29,29일공감마감정보대웅주가18000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=87137
564,2019-01-30,대웅제약윤영환창업주2세윤재승vs윤재훈엇갈리는경영행보,http://www.datanews.co.kr/news/article.html?no=102019
565,2019-01-30,대웅제약올해회사채상환액이현금성자산2배이익줄어재무부담가중,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=529776
566,2019-01-30,2018년한미약품17명대웅제약2명CP위반,http://daily.hankooki.com/lpage/ittech/201901/dh20190130093050145630.htm
567,2019-01-30,1월30일대웅오늘시세및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=87491
568,2019-01-30,주가그래프대웅주가30일현재18050원,http://www.nbntv.co.kr/news/articleView.html?idxno=192410
569,2019-01-30,증시보고30일대웅주가18100원,http://www.anewsa.com/detail.php?number=1517181&thread=10r02
570,2019-01-30,대웅제약자율책임경영강화대웅인상시행,http://www.asiatoday.co.kr/view.php?key=20190130010019112
571,2019-01-30,야근에찌든직장인피로날려주려탄생한대웅제약임팩타민,https://www.insight.co.kr/news/207824
572,2019-01-30,대웅제약종목검색30일현재181500원,http://www.nbntv.co.kr/news/articleView.html?idxno=192920
573,2019-01-30,1월30일대웅제약정보,http://www.gokorea.kr/news/articleView.html?idxno=87815
574,2019-01-31,대웅주가1월31일현재17950원,http://www.gokorea.kr/news/articleView.html?idxno=88741
575,2019-01-31,국내주식시장주가31일대웅주가18300원,http://www.anewsa.com/detail.php?number=1520253&thread=10r02
576,2019-01-31,한경로보뉴스대웅제약5이상상승주가상승세단기이평선역배열구간,http://news.hankyung.com/article/201901310527L
577,2019-01-31,2월2일대웅나보타美진출운명의날,http://www.cnbnews.com/news/article.html?no=398999
578,2019-01-31,대웅제약주가정보31일현재192000원,http://www.gokorea.kr/news/articleView.html?idxno=89076
579,2019-01-31,대웅제약나보타美허가임박앨러간방어전략가동,http://biz.newdaily.co.kr/site/data/html/2019/01/31/2019013100147.html
580,2019-01-31,대웅제약한국콜마1조클럽제약사첫합류유력,http://www.etnews.com/20190131000316
581,2019-01-31,31일마감보고대웅주가18300원으로종료,http://www.anewsa.com/detail.php?number=1522625&thread=10r04
582,2019-02-01,글로벌Biz24메디톡스보톡스제조비밀훔친혐의로대웅제약제소북미보톡스치료제판매앞두고비상,http://www.g-enews.com/ko-kr/news/article/news_all/201902010658478404b5d048c6f3_1/article.html
583,2019-02-01,한미약품1조클럽가입콜마대웅도입성전망,http://www.dailymedi.com/detail.php?number=839745&thread=22r12
584,2019-02-01,대웅제약전승호윤재춘대표체제늪에빠진수익성,http://www.datanews.co.kr/news/article.html?no=102003
585,2019-02-01,대웅나보타2일美시장진출여부판가름,http://news.mt.co.kr/mtview.php?no=2019020108254826848
586,2019-02-01,증시현황1일대웅주가18500원,http://www.anewsa.com/detail.php?number=1523401&thread=10r02
587,2019-02-01,대웅금일증시1일현재18500원,http://www.nbntv.co.kr/news/articleView.html?idxno=197043
588,2019-02-01,대웅앨러간제소는시장진입방해전략나보타순항,http://www.dailypharm.com/Users/News/NewsView.html?ID=249189&REFERER=NP
589,2019-02-01,대웅고지혈증약크레젯용량별로포장색깔차별,http://www.dailypharm.com/Users/News/NewsView.html?ID=249190&REFERER=NP
590,2019-02-01,메디톡스제소대웅제약반박연초부터기싸움,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83836
591,2019-02-01,유통오늘NS홈쇼핑2월적립금대잔치진행대웅제약나보타미국시장진출문제없어,http://www.sisaon.co.kr/news/articleView.html?idxno=82050
592,2019-02-01,대웅제약나보타미국진출문제없다,http://www.newsprime.co.kr/news/article.html?no=445636
593,2019-02-01,메디톡스미국ITC에대웅제약과에볼루스제소,http://www.dailypharm.com/Users/News/NewsView.html?ID=249192&REFERER=NP
594,2019-02-01,대웅제약VS메디톡스나보타진실게임2라운드돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226939
595,2019-02-01,대웅제약메디톡스ITC제소에나보타美발매문제없어,http://www.ceoscoredaily.com/news/article.html?no=51676
596,2019-02-01,메디톡스국제무역위에대웅제약제소대웅제약나보타승인문제없어,http://news.hankyung.com/article/2019020159826
597,2019-02-01,보톡스원료도용놓고메디톡스대웅제약미국ITC서다툼,http://yna.kr/AKR20190201078600017?did=1195m
598,2019-02-01,대웅제약앨러간美제소에나보타美진출문제없다,http://www.medisobizanews.com/news/articleView.html?idxno=57733
599,2019-02-01,대웅제약나보타미국시장진출문제없다,http://www.bosa.co.kr/news/articleView.html?idxno=2099002
600,2019-02-01,메디톡스앨러간美국제무역위에대웅에볼루스제소,http://www.biospectator.com/view/news_view.php?varAtcId=7068
601,2019-02-01,대웅제약나보타미국시장진출문제없어‥새봄에출시,http://medipana.com/news/news_viewer.asp?NewsNum=234267&MainKind=A&NewsKind=5&vCount=12&vKind=1
602,2019-02-01,메디톡스앨러간과미국ITC에대웅제약에볼루스제소,http://medipana.com/news/news_viewer.asp?NewsNum=234268&MainKind=A&NewsKind=5&vCount=12&vKind=1
603,2019-02-01,메디톡스美ITC에대웅제약제소나보타허가앞두고갈등,http://www.newspim.com/news/view/20190201000596
604,2019-02-01,메디톡스앨러간美ITC에대웅제약에볼루스제소,http://www.medisobizanews.com/news/articleView.html?idxno=57734
605,2019-02-01,대웅제약나보타미국시장진출문제없어,http://www.newsway.co.kr/news/view?tp=1&ud=2019020112192644700
606,2019-02-01,메디톡스앨러간과美ITC에대웅제약에볼루스제소,http://www.newsprime.co.kr/news/article.html?no=445648
607,2019-02-01,메디톡스앨러간과美국제무역위원회에대웅제약에볼루스제소,http://www.newsway.co.kr/news/view?tp=1&ud=2019020112173257283
608,2019-02-01,대웅제약나보타올봄미국시장발매한다,http://www.seoulwire.com/news/articleView.html?idxno=60633
609,2019-02-01,메디톡스VS대웅제약미국서또소송나보타영향없을것,http://kormedi.com/?p=1281541
610,2019-02-01,메디톡스엘러간미국국제무역위원회에대웅제약제소,http://www.etnews.com/20190201000156
611,2019-02-01,메디톡스앨러간과미국국제무역위원회에대웅제약에볼루스제소,http://www.sisafocus.co.kr/news/articleView.html?idxno=201684
612,2019-02-01,메디톡스美ITC에대웅제약에볼루스제소,http://www.mdtoday.co.kr/mdtoday/index.html?no=345605
613,2019-02-01,메디톡스vs대웅연초부터美나보타허가앞두고격돌,http://biz.newdaily.co.kr/site/data/html/2019/02/01/2019020100085.html
614,2019-02-01,대웅제약나보타미국시장진출문제없다,http://www.wikileaks-kr.org/news/articleView.html?idxno=46881
615,2019-02-01,작년제약바이오매출1조클럽5곳확정셀트리온대웅제약주목,http://news.mk.co.kr/newsRead.php?year=2019&no=68567
616,2019-02-01,메디톡스보톡스균주논란대웅제약에공개토론제안,http://www.ceoscoredaily.com/news/article.html?no=51683
617,2019-02-01,대웅제약메디톡스의보톡스균주출처논쟁美ITC서도불붙어,http://news.mk.co.kr/newsRead.php?year=2019&no=68574
618,2019-02-01,대웅제약나보타美수입금지피소현지진출문제없어,http://biz.chosun.com/site/data/html_dir/2019/02/01/2019020101409.html
619,2019-02-01,메디톡스美ITC에대웅제약제소대웅측문제없다”,http://www.edaily.co.kr/news/newspath.asp?newsid=03604726622386256
620,2019-02-01,나보타미국진출앞두고대웅제약메디톡스재격돌,http://moneys.mt.co.kr/news/mwView.php?no=2019020112218096295
621,2019-02-01,메디톡스美국제무역위원회에대웅제약제소,http://news.hankyung.com/article/201902016307f
622,2019-02-01,보톡스균주훔쳐갔다”메디톡스이번엔미국ITC에대웅제약제소,http://www.sedaily.com/NewsView/1VF57MPT8T
623,2019-02-01,메디톡스美ITC에대웅제약에볼루스제소,http://news.mt.co.kr/mtview.php?no=2019020111421968659
624,2019-02-01,메디톡스美ITC에대웅제약제소대웅발목잡기행위,http://news1.kr/articles/?3539809
625,2019-02-01,2월1일대웅제약실시간주식현황192500원052,http://www.nbntv.co.kr/news/articleView.html?idxno=197570
626,2019-02-01,메디톡스미국제무역위원회에대웅제약과에볼루스제소,http://www.insightkorea.co.kr//news/articleView.html?idxno=33845
627,2019-02-01,메디톡스대웅제약보툴리눔톡신전쟁재개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065007
628,2019-02-01,메디톡스대웅제약보톡스균주출처공방재점화,http://www.newstomato.com/ReadNews.aspx?no=874083
629,2019-02-01,메디톡스대웅제약보툴리눔균주다툼지속USITC서맞붙어,http://www.econovill.com/news/articleView.html?idxno=355919
630,2019-02-01,2월1일대웅제약증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=90506
631,2019-02-01,대웅제약vs메디톡스보톡스대전美ITC로확전,http://www.dt.co.kr/contents.html?article_no=2019020102109931102003&ref=naver
632,2019-02-01,대웅제약나보타미국시장진출문제없다 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1139159
633,2019-02-01,메디톡스앨러간미국ITC에대웅제약제소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902010396&t=NN
634,2019-02-01,메디톡스美ITC에대웅제약제소대웅제약측美진출문제없어,http://www.ekn.kr/news/article.html?no=413065
635,2019-02-01,나보타美수입금지피소대웅제약미국진출방해전략,http://www.newsis.com/view/?id=NISX20190201_0000548811&cID=13001&pID=13000
636,2019-02-01,메디톡스대웅제약보톡스균주출처두고재격돌 ,http://www.seoulfn.com/news/articleView.html?idxno=332800
637,2019-02-01,메디톡스미국ITC에대웅제약제소보톡스균주가져갔다,http://news.mk.co.kr/newsRead.php?year=2019&no=68936
638,2019-02-01,대웅제약나보타美진출문제없어,http://www.segye.com/content/html/2019/02/01/20190201002487.html?OutUrl=naver
639,2019-02-01,메디톡스대웅제약보툴리눔톡신분쟁확산,http://daily.hankooki.com/lpage/ittech/201902/dh20190201150156145630.htm
640,2019-02-01,메디톡스美국제무역위원회제소로대웅제약압박,http://www.mhj21.com/119215
641,2019-02-01,대웅제약메디톡스의美ITC제소발목잡기일뿐”,http://www.mhj21.com/119216
642,2019-02-01,대웅제약나보타美시장진출문제없다,http://www.ebn.co.kr/news/view/971430
643,2019-02-01,메디톡스대웅제약나보타미국진출또태클,http://news.bizwatch.co.kr/article/consumer/2019/02/01/0024/naver
644,2019-02-01,대웅제약ICT제소에도나보타미국시장진출문제없다,http://www.getnews.co.kr/view.php?ud=20190201161559208241d0c69529_16
645,2019-02-01,메디톡스앨러간미국국제무역위원회에대웅제약에볼루스제소,http://www.getnews.co.kr/view.php?ud=20190201162436166541d0c69529_16
646,2019-02-01,메디톡스와대웅제약보톡스원료도용놓고미국에서또공방,http://www.businesspost.co.kr/BP?command=article_view&num=112873
647,2019-02-01,대웅제약나보타미국보톡스시장진출문제없다,http://www.rapportian.com/news/articleView.html?idxno=115861
648,2019-02-01,메디톡스대웅제약보툴리눔톡신美허가앞두고불꽃공방,http://view.asiae.co.kr/news/view.htm?idxno=2019020117020641535
649,2019-02-01,장종리포트대웅주가18850원장마쳐,http://www.anewsa.com/detail.php?number=1525503&thread=10r04
650,2019-02-01,대웅제약나보타미국시장진출문제없어,http://www.businesskorea.co.kr/news/articleView.html?idxno=28907
651,2019-02-01,메디톡스대웅제약보톡스공방재점화,http://www.kpinews.co.kr/news/articleView.html?idxno=89606
652,2019-02-01,대웅제약나보타美수입금지피소미국진출방해전략,https://www.insight.co.kr/news/208545
653,2019-02-01,대웅제약앨러간메디톡스방어전략나보타美시장진출문제없어,http://www.ftoday.co.kr/news/articleView.html?idxno=106404
654,2019-02-02,메디톡스앨러간vs대웅제약에볼루스미국국제무역위원회ITC제소,http://medicalworldnews.co.kr/news/view.php?idx=1510929318
655,2019-02-02,대웅제약vs메디톡스나보타진실공방점입가경,http://www.ebn.co.kr/news/view/971488
656,2019-02-02,대웅제약보툴리눔톡신제제나보타美FDA품목허가1보,http://news1.kr/articles/?3540447
657,2019-02-02,대웅나보타FDA판매허가획득4월경출시계획,http://www.dailypharm.com/Users/News/NewsView.html?ID=249216&REFERER=NP
658,2019-02-02,대웅제약나보타국산보툴리눔최초美FDA허가획득,http://medipana.com/news/news_viewer.asp?NewsNum=234298&MainKind=A&NewsKind=5&vCount=12&vKind=1
659,2019-02-02,대웅나보타美FDA허가2조시장정조준,http://www.biospectator.com/view/news_view.php?varAtcId=7072
660,2019-02-02,대웅제약나보타美FDA판매허가획득,http://news.hankyung.com/article/201902028584f
661,2019-02-02,대웅제약나보타美FDA판매허가획득,http://www.ebn.co.kr/news/view/971494
662,2019-02-02,대웅제약보툴리눔톡신나보타美FDA판매허가획득,http://biz.chosun.com/site/data/html_dir/2019/02/02/2019020200326.html
663,2019-02-02,대웅제약나보타2조美시장진출FDA판매허가획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1718637
664,2019-02-02,대웅제약나보타국산최초美시장진출FDA판매허가,http://kormedi.com/?p=1281585
665,2019-02-02,대웅제약나보타미국판매허가획득,http://www.newspim.com/news/view/20190201001026
666,2019-02-02,대웅제약나보타美시판허가국산보툴리눔톡신최초상보,http://news1.kr/articles/?3540449
667,2019-02-02,대웅제약나보타최대시장미국뚫었다국산보툴리눔톡신첫진출,http://www.newspim.com/news/view/20190201001031
668,2019-02-02,대웅제약나보타FDA승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=345678
669,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://yna.kr/AKR20190201127400017?did=1195m
670,2019-02-02,대웅제약나보타美판매허가획득봄시판예정,http://news.hankyung.com/article/2019020287156
671,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인종합,http://yna.kr/AKR20190201127451017?did=1195m
672,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226954
673,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA허가획득,http://www.dailian.co.kr/news/view/770203/?sc=naver
674,2019-02-02,대웅제약나보타FDA판매허가획득,http://www.doctorsnews.co.kr/news/articleView.html?idxno=127618
675,2019-02-02,대웅제약나보타美FDA판매허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2099036
676,2019-02-02,대웅제약나보타FDA뚫었다국산제품중최초,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019020207262829382
677,2019-02-02,대웅제약나보타美FDA판매허가국산보툴리눔톡신최초,http://www.newsis.com/view/?id=NISX20190202_0000549352&cID=13001&pID=13000
678,2019-02-02,대웅제약나보타美FDA판매허가획득세계시장정조준,http://biz.newdaily.co.kr/site/data/html/2019/02/02/2019020200005.html
679,2019-02-02,대웅제약나보타美FDA허가국산보툴리눔톡신최초,http://www.medisobizanews.com/news/articleView.html?idxno=57743
680,2019-02-02,대웅제약나보타미FDA최종품목허가승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003478744
681,2019-02-02,대웅제약보툴리눔톡신나보타美FDA승인올해봄출시,http://www.asiatoday.co.kr/view.php?key=20190202010000506
682,2019-02-02,대웅제약보툴리눔톡신나보타美FDA허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01600646622386584
683,2019-02-02,대웅제약나보타美FDA판매허가획득올봄출시예정,http://www.mdtoday.co.kr/mdtoday/index.html?no=345679
684,2019-02-02,대웅제약보툴리눔톡신나보타FDA판매허가획득,http://www.kpanews.co.kr/article/show.asp?idx=201309&table=article&category=D
685,2019-02-02,대웅제약나보타美FDA판매허가획득올해RD결실맺는다,http://www.ekn.kr/news/article.html?no=413143
686,2019-02-02,대웅보툴리눔톡신나보타미FDA승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83855
687,2019-02-02,대웅제약나보타국산보툴리눔톡신최초미국FDA판매허가획득,http://www.mediapen.com/news/view/411749
688,2019-02-02,대웅제약나보타세계최대美시장주름잡는다,http://news.mt.co.kr/mtview.php?no=2019020209371829214
689,2019-02-02,대웅제약나보타국산보톡스최초로미국판매허가받아,http://news.mk.co.kr/newsRead.php?year=2019&no=70134
690,2019-02-02,대웅제약나보타국산보툴리눔톡신최초미FDA판매허가획득,http://www.fnnews.com/news/201902020958188200
691,2019-02-02,대웅제약나보타국산보톡스최초FDA판매허가획득,http://www.sedaily.com/NewsView/1VF5NHDK9T
692,2019-02-02,대웅제약나보타美진출글로벌제약사도약분수령,http://www.shinailbo.co.kr/news/articleView.html?idxno=1139258
693,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019020210255418431
694,2019-02-02,대웅제약나보타미국FDA판매허가쾌거,http://news.bizwatch.co.kr/article/consumer/2019/02/02/0001/naver
695,2019-02-02,대웅제약나보타FDA판매허가미국시장진출,http://www.etnews.com/20190202000006
696,2019-02-02,대웅제약나보타국산보툴리눔톡신최초FDA판매허가획득,http://www.econovill.com/news/articleView.html?idxno=355988
697,2019-02-02,메디톡스vs대웅제약나보타美허가앞두고또,http://www.dailysmart.co.kr/news/articleView.html?idxno=5912
698,2019-02-02,대웅제약나보타국산보톡스최초미국진출,http://www.dailysmart.co.kr/news/articleView.html?idxno=5941
699,2019-02-02,대웅제약나보타미국진출봄시판예정,http://www.cstimes.com/?mod=news&act=articleView&idxno=296225
700,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가미국진출,http://www.seoulwire.com/news/articleView.html?idxno=61529
701,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=201722
702,2019-02-02,대웅제약나보타미국FDA승인국산보톡스첫美진출,http://www.kyeongin.com/main/view.php?key=20190202010000211
703,2019-02-02,대웅제약나보타美FDA판매허가획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=46938
704,2019-02-02,대웅제약나보타2조원대美시장뚫었다FDA판매허가획득,http://www.dt.co.kr/contents.html?article_no=2019020202109931102001&ref=naver
705,2019-02-02,대웅제약나보타국산보톡스첫미국시장진출,http://www.ajunews.com/view/20190202125340872
706,2019-02-02,대웅제약오너십위기뚫고보툴리눔톡신나보타美FDA허가획득,http://www.betanews.net:8080/article/969775.html
707,2019-02-02,SR경제라이프대웅제약나보타FDA판매허가획득2조원대美시장뚫었다,http://www.srtimes.kr/news/articleView.html?idxno=32473
708,2019-02-02,대웅제약보툴리눔톡신나보타美FDA판매허가획득,http://www.newsworks.co.kr/news/articleView.html?idxno=333547
709,2019-02-02,대웅제약나보타미국FDA승인,http://www.seoul.co.kr/news/newsView.php?id=20190202500047&wlog_tag3=naver
710,2019-02-02,대웅제약자체개발한보툴리눔톡신나보타미국FDA승인,http://sports.khan.co.kr/news/sk_index.html?art_id=201902021401003&sec_id=564001&pt=nv
711,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://www.kukinews.com/news/article.html?no=628897
712,2019-02-02,대웅제약나보타미국FDA승인2조원대美진출,http://www.sporbiz.co.kr/news/articleView.html?idxno=310152
713,2019-02-02,대웅제약나보타국산보툴리눔톡신최초미국판매허가획득,http://www.newstomato.com/ReadNews.aspx?no=874233
714,2019-02-02,대웅제약나보타FDA승인2조원대미국시장진출한다,http://www.joongboo.com/news/articleView.html?idxno=1324703
715,2019-02-02,대웅제약자체개발보툴리눔톡신나보타미국FDA승인쾌거,http://www.kyeonggi.com/news/articleView.html?idxno=2044208
716,2019-02-02,대웅제약나보타美FDA판매허가획득미국시장진출,http://www.upinews.kr/news/newsview.php?ncode=1065594152452058
717,2019-02-02,대웅제약나보타마침내美대륙진출,http://www.whosaeng.com/107807
718,2019-02-02,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.lawissue.co.kr/view.php?ud=201902021547522858d7f4c63cc6_12
719,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://www.asiatime.co.kr/news/articleView.html?idxno=226915
720,2019-02-02,대웅제약나보타美FDA승인올해봄출시,http://sports.khan.co.kr/news/sk_index.html?art_id=201902021724003&sec_id=561801&pt=nv
721,2019-02-02,대웅제약보툴리눔톡신나보타미국FDA승인,http://www.busan.com/view/busan/view.php?code=2019020217362336171
722,2019-02-02,대웅제약국산보톡스효과얼마나좋길래,http://www.ggilbo.com/news/articleView.html?idxno=594576
723,2019-02-02,대웅제약나보타FDA허가획득국산제품첫美시장진출,http://www.rapportian.com/news/articleView.html?idxno=115870
724,2019-02-02,대웅제약보툴리눔톡신나보타美FDA판매허가국산최초,http://view.asiae.co.kr/news/view.htm?idxno=2019020218414304501
725,2019-02-02,대웅제약의독毒한도전통했다,http://www.sisaweek.com/news/articleView.html?idxno=118148
726,2019-02-02,대웅제약나보타미국FDA승인국산보톨리눔톡신최초,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902020030&t=NN
727,2019-02-02,대웅제약나보타미국FDA미간주름적응증승인국산보톨리눔톡신제제최초허가,http://www.greened.kr/news/articleView.html?idxno=92970
728,2019-02-03,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.wsobi.com/news/articleView.html?idxno=69408
729,2019-02-03,대웅제약보톡스미국시장첫진출,http://biz.chosun.com/site/data/html_dir/2019/02/03/2019020300067.html?utm_source=naver&utm_medium=original&utm_campaign=biz
730,2019-02-03,전승호대웅제약보톡스나보타로미국찍고글로벌간다,http://www.businesspost.co.kr/BP?command=article_view&num=112971
731,2019-02-03,유통오늘BGF설맞이사랑의연탄나눔대웅제약나보타美시장본격진출,http://www.sisaon.co.kr/news/articleView.html?idxno=82085
732,2019-02-03,대웅제약나보타국산최초美FDA판매허가획득,http://www.getnews.co.kr/view.php?ud=20190203103109402641d0c69529_16
733,2019-02-03,나보타는첫발대웅제약차세대먹거리개발박차,http://www.edaily.co.kr/news/newspath.asp?newsid=01377606622386912
734,2019-02-03,대웅제약나보타미국판매허가획득,http://www.finomy.com/news/articleView.html?idxno=62680
735,2019-02-04,종목썰쩐소문에사서뉴스에팔라대웅제약매도시점,http://news.hankyung.com/article/2019020407146
736,2019-02-04,대웅제약설낭보국산주름개선제미국FDA판매허가,http://news.heraldcorp.com/view.php?ud=20190204000009
737,2019-02-04,대웅제약나보타美FDA판매허가획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065023
738,2019-02-05,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가,http://www.kukinews.com/news/article.html?no=629089
739,2019-02-05,종목시세태원물산6440원304 13260원303대웅18850원301한올바이오파마35900원301HDC아이콘트롤스10400원297↑주식가격주가올라,http://www.fintechpost.co.kr/news/articleView.html?idxno=20050
740,2019-02-05,대웅제약나보타미국FDA판매허가국산보툴리눔톡신제제보톡스최초,http://www.econonews.co.kr/news/articleView.html?idxno=52724
741,2019-02-06,대웅제약나보타국산보톨리눔톡신최초美판매허가획득,http://www.ceoscoredaily.com/news/article.html?no=51725
742,2019-02-06,대웅제약나보타美FDA판매허가획득,http://www.dailymedi.com/detail.php?number=839779&thread=22r05
743,2019-02-06,대웅제약나보타미국시장진출확정넘어야할벽은,http://www.sporbiz.co.kr/news/articleView.html?idxno=310655
744,2019-02-06,대웅나보타美시장진출글로벌톡신시장도전장,http://news.mt.co.kr/mtview.php?no=2019020518512052211
745,2019-02-06,대웅제약헬스케어AI사업부출범,http://www.etnews.com/20190206000008
746,2019-02-06,이슈분석대웅제약메디톡스휴젤등해외시장날개단국산보톡스,http://www.etnews.com/20190206000004
747,2019-02-06,대웅제약나보타美FDA허가미국미용성형시장공략나선다,http://news.hankyung.com/article/2019020642901
748,2019-02-06,대웅제약나보타美FDA판매허가승인,http://www.kpinews.co.kr/news/articleView.html?idxno=89747
749,2019-02-06,양재준기자의알투바이오대웅제약의귀한자식나보타미국시장입성,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902060151&t=NN
750,2019-02-07,메디톡스vs대웅제약보톡스균주논란재점화,http://www.dailymedi.com/detail.php?number=839800&thread=22r05
751,2019-02-07,클릭e종목대웅제약나보타美FDA허가에목표주가상향,http://view.asiae.co.kr/news/view.htm?idxno=2019020706261723639
752,2019-02-07,대웅제약나보타세계시장공략기대된다,http://www.medisobizanews.com/news/articleView.html?idxno=57747
753,2019-02-07,대웅제약주보美허가가치상승의계기한국,http://news.hankyung.com/article/2019020749836
754,2019-02-07,대웅제약현실화되는큰그림하이투자증권,http://news.mt.co.kr/mtview.php?no=2019020707373629392
755,2019-02-07,퀵리포트대웅제약매수유지목표가23만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019020707415614898
756,2019-02-07,대웅제약나보타미국허가취득성공,http://www.asiatoday.co.kr/view.php?key=20190207010001139
757,2019-02-07,대웅제약나보타美진출성공목표가↑신영證,http://news.mt.co.kr/mtview.php?no=2019020707550748370
758,2019-02-07,대웅제약목표가23만원유지전일종가19만3000원하이투자證,http://www.newspim.com/news/view/20190207000092
759,2019-02-07,대웅제약목표가25↑30만원제시KTB證,http://www.newspim.com/news/view/20190207000181
760,2019-02-07,오늘의추천종목한국투자증권대웅제약케이아이엔엑스등,http://www.asiatoday.co.kr/view.php?key=20190207010001147
761,2019-02-07,대웅제약FDA승인으로美수출기대목표가↑KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01476006622388224
762,2019-02-07,대웅제약목표가24만원유지전일종가19만3000원NH證,http://www.newspim.com/news/view/20190207000110
763,2019-02-07,퀵리포트대웅제약매수유지목표가24만원유지NH證,http://www.itooza.com/common/iview.php?no=2019020708122513730
764,2019-02-07,대웅제약목표가11↑24만5000원제시신영證,http://www.newspim.com/news/view/20190207000117
765,2019-02-07,퀵리포트대웅제약매수유지목표가11↑24만5000원신영證,http://www.itooza.com/common/iview.php?no=2019020708171811595
766,2019-02-07,대웅제약나보타FDA승인상반기실적반영기대하이투자證,http://www.seoulfn.com/news/articleView.html?idxno=332911
767,2019-02-07,신영증권대웅제약나보타미국진출성공목표가↑”,http://www.newsway.co.kr/news/view?tp=1&ud=2019020708204988069
768,2019-02-07,대웅제약나보타미국FDA품목허가목표가↑KTB투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1718976
769,2019-02-07,대웅제약나보타미국품목허가최종승인목표가상향KTB,http://www.newstomato.com/ReadNews.aspx?no=874370
770,2019-02-07,I리포트대웅제약나보타미국시장입성목표가↑KTB證,http://www.inews24.com/view/1155854
771,2019-02-07,대웅제약나보타FDA품목허가취득으로실적모멘텀기대하이투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1718978
772,2019-02-07,HotLine대웅제약美FDA로부터나보타판매승인수출확대기대감,http://news.mk.co.kr/newsRead.php?year=2019&no=74570
773,2019-02-07,대웅제약주보미국시장점유율2025년16로상승전망,http://www.nspna.com/news/?mode=view&newsid=336965
774,2019-02-07,KTB투자대웅제약대미신약수출증가예상목표가↑,http://yna.kr/AKR20190207028900008?did=1195m
775,2019-02-07,하이로우대웅제약나보타FDA승인목표가↑KTB투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019020708352224505
776,2019-02-07,대웅제약美FDA승인이후추가모멘텀주목한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01643286622388224
777,2019-02-07,ET투자뉴스대웅제약현실화되는큰그림BUYMAINTAIN하이투자증권,http://www.etnews.com/20190207000007
778,2019-02-07,대웅제약주가더갈수있다미국에서나보타이르면3월판매,http://www.businesspost.co.kr/BP?command=article_view&num=113065
779,2019-02-07,대웅제약나보타美허가이어중장기모멘텀기대KTB,http://www.sedaily.com/NewsView/1VF7YVY4G5
780,2019-02-07,대웅제약목표가25만원유지전일종가19만3000원한투證,http://www.newspim.com/news/view/20190207000148
781,2019-02-07,퀵리포트대웅제약매수유지목표가25만원유지한투證,http://www.itooza.com/common/iview.php?no=2019020708435513220
782,2019-02-07,대웅제약나보타미FDA허가목표주가24만원으로상향,http://www.whitepaper.co.kr/news/articleView.html?idxno=142097
783,2019-02-07,대웅제약나보타美허가취득업종톱픽NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01715446622388224
784,2019-02-07,대웅제약목표가5↑19만원제시DB금투,http://www.newspim.com/news/view/20190207000178
785,2019-02-07,실시간분석대웅제약101상승증권사목표가25만원제시,http://www.itooza.com/common/iview.php?no=2019020709013011180
786,2019-02-07,대웅13급등전일보다2500원상승한21350원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902070077&t=NN
787,2019-02-07,대웅제약나보타美시장전격진출,http://daily.hankooki.com/lpage/ittech/201902/dh20190207090406145630.htm
788,2019-02-07,한경로보뉴스대웅제약5이상상승현실화되는큰그림하이투자증권BuyMaintain,http://news.hankyung.com/article/201902075267L
789,2019-02-07,대웅제약보톡스제품美판매허가취득,http://news.mt.co.kr/mtview.php?no=2019020709070390435
790,2019-02-07,특징주대웅제약나보타미국진출에장초반급등,http://www.newsway.co.kr/news/view?tp=1&ud=2019020709061055558
791,2019-02-07,한경로보뉴스대웅제약5이상상승현실화되는큰그림하이투자증권BuyMaintain,http://news.hankyung.com/article/201902075267L
792,2019-02-07,대웅제약나보타美FDA판매허가획득,http://www.newspim.com/news/view/20190207000179
793,2019-02-07,대웅제약미간주름치료제美FDA판매허가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719020
794,2019-02-07,대웅제약나보타美FDA판매허가획득,http://view.asiae.co.kr/news/view.htm?idxno=2019020709093185403
795,2019-02-07,대웅제약나보타美허가에주가급등,http://www.sedaily.com/NewsView/1VF7Y9CYPF
796,2019-02-07,퀵리포트대웅제약보유로하향목표가5↑19만원DB금투,http://www.itooza.com/common/iview.php?no=2019020709021919468
797,2019-02-07,한경로보뉴스대웅10이상상승전형적인상승세단기중기이평선정배열,http://news.hankyung.com/article/201902075285L
798,2019-02-07,특징주대웅제약나보타FDA품목허가급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719023
799,2019-02-07,퀵리포트대웅제약매수유지목표가25↑30만원KTB證,http://www.itooza.com/common/iview.php?no=2019020707464916529
800,2019-02-07,특징주대웅제약나보타美FDA품목허가승인소식에강세,http://www.seoulfn.com/news/articleView.html?idxno=332927
801,2019-02-07,공시대웅제약나보타美FDA판매허가획득,http://www.fnnews.com/news/201902070912269578
802,2019-02-07,특징주대웅제약美FDA판매허가소식에상승세,http://www.edaily.co.kr/news/newspath.asp?newsid=01905686622388224
803,2019-02-07,대웅제약나보타FDA품목허가취득성공NH,http://www.fnnews.com/news/201902070911397401
804,2019-02-07,특징주대웅제약美서보톡스판매허가소식에강세,http://www.inews24.com/view/1155877
805,2019-02-07,KTB투자證대웅제약대미신약수출증가예상목표가25↑”,http://www.kukinews.com/news/article.html?no=629316
806,2019-02-07,특징주대웅제약나보타FDA품목허가취득소식에강세,http://www.fetv.co.kr/news/article.html?no=20007
807,2019-02-07,대웅제약나보타美FDA판매허가획득,http://news.heraldcorp.com/view.php?ud=20190207000121
808,2019-02-07,특징주대웅제약나보타미FDA판매승인에강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902070099&t=NN
809,2019-02-07,특징주대웅제약나보타FDA품목허가에강세,http://www.ebn.co.kr/news/view/971684
810,2019-02-07,특징주대웅제약나보타의美허가소식에강세,http://www.newsis.com/view/?id=NISX20190207_0000550899&cID=10401&pID=10400
811,2019-02-07,특징주대웅제약나보타미국허가에상승,http://www.ekn.kr/news/article.html?no=413467
812,2019-02-07,공시대웅제약나보타美FDA판매허가획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019020709201499533
813,2019-02-07,특징주대웅대웅제약나보타미국판매승인에강세,http://yna.kr/AKR20190207038200008?did=1195m
814,2019-02-07,ET투자뉴스대웅제약_투심과거래량은보통현재주가는강세,http://www.etnews.com/20190207000027
815,2019-02-07,fnRASSI대웅424오르며거래량증가,http://www.fnnews.com/news/201902070924193161
816,2019-02-07,HotLine대웅제약나보타美승인소식에강세,http://news.mk.co.kr/newsRead.php?year=2019&no=74756
817,2019-02-07,특징주대웅제약미간주름개선제나보타美FDA판매허가획득,http://news.mt.co.kr/mtview.php?no=2019020709263433269
818,2019-02-07,특징주대웅제약나보타美FDA판매허가획득소식에강세,http://www.asiatoday.co.kr/view.php?key=20190207010001265
819,2019-02-07,대웅제약나보타美FDA판매허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01958166622388224
820,2019-02-07,특징주대웅대웅제약나보타미국판매승인에강세,http://www.asiatime.co.kr/news/articleView.html?idxno=227157
821,2019-02-07,보톡스대항마美진출한대웅제약설연휴후주가↑,http://news.heraldcorp.com/view.php?ud=20190207000149
822,2019-02-07,대웅제약코스닥서급상승세보여눈길나보타美FDA판매허가획득여파,http://www.topstarnews.net/news/articleView.html?idxno=581005
823,2019-02-07,나보타美판매허가에대웅제약강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=345734
824,2019-02-07,대웅제약나보타美진출목표가↑신영,http://news.mt.co.kr/mtview.php?no=2019020709314097321
825,2019-02-07,대웅제약069620종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902070153&t=NN
826,2019-02-07,대웅제약나보타미국FDA판매승인에주가강세,http://www.seoulwire.com/news/articleView.html?idxno=61903
827,2019-02-07,대웅제약나보타국내최초미국FDA판매허가글로벌시장진출신영證,http://www.itooza.com/common/iview.php?no=2019020709241774899
828,2019-02-07,대웅대웅제약나보타미국FDA판매승인에강세특징주,http://sports.khan.co.kr/news/sk_index.html?art_id=201902070949003&sec_id=564001&pt=nv
829,2019-02-07,대웅제약나보타美FDA판매허가획득,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019020709512400946&objId=A2019020709512400946&portalCode=naver
830,2019-02-07,대웅제약나보타미국FDA승인장초반상승,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20190207.99099000512
831,2019-02-07,특징주대웅대웅제약나보타미국FDA판매승인소식에강세,http://www.kyeongin.com/main/view.php?key=20190207000953488
832,2019-02-07,공시대웅제약나보타美FDA판매허가획득,http://www.newsis.com/view/?id=NISX20190207_0000550973&cID=10401&pID=10400
833,2019-02-07,대웅제약나보타미국진출시장에매우긍정적목표주가24만5000원으로올려,http://www.g-enews.com/ko-kr/news/article/news_all/2019020709590564794e4869c120_1/article.html
834,2019-02-07,특징주대웅제약나보타美판매승인에강세,http://news1.kr/articles/?3541828
835,2019-02-07,보톡스도전대웅제약나보타로美주름잡을까,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019020710034201040&objId=A2019020710034201040&portalCode=naver
836,2019-02-07,대웅대웅제약보툴리늄톡신미국수출기대에강세특징주,http://www.kukinews.com/news/article.html?no=629378
837,2019-02-07,대웅제약美FDA판매허가받은나보타어떤제품,http://www.ajunews.com/view/20190207101307054
838,2019-02-07,대웅제약나보타美FDA판매허가,http://www.ebn.co.kr/news/view/971708
839,2019-02-07,KTB투자대웅제약대미신약수출증가예상에목표가상향,http://www.enewstoday.co.kr/news/articleView.html?idxno=1269318
840,2019-02-07,대웅제약나보타미국진출호재에증권가일제히목표주가↑,http://moneys.mt.co.kr/news/mwView.php?no=2019020710218051547
841,2019-02-07,대웅제약메디톡스나보타균주전쟁누가최후승자,http://www.betanews.net:8080/article/970550.html
842,2019-02-07,대웅제약올해잇단낭보기대주가더간다,http://view.asiae.co.kr/news/view.htm?idxno=2019020710385308396
843,2019-02-07,대웅제약나보타美FDA판매허가획득에주가상승,https://news.imaeil.com/Finance/2019020710385514301
844,2019-02-07,2월7일대웅정보,http://www.gokorea.kr/news/articleView.html?idxno=91707
845,2019-02-07,특징주대웅제약나보타美진출기대감속강세,http://moneys.mt.co.kr/news/mwView.php?no=2019020710478096107
846,2019-02-07,대웅제약FDA판매허가취득소식에도상승폭시간지날수록줄어들어1대상승,http://www.econonews.co.kr/news/articleView.html?idxno=52842
847,2019-02-07,주식실황7일대웅현재주식거래가격19700원,http://www.anewsa.com/detail.php?number=1527583&thread=10r02
848,2019-02-07,대웅제약나보타美판매허가에목표주가도쑥,http://www.mdtoday.co.kr/mdtoday/index.html?no=345759
849,2019-02-07,2월7일대웅투자주식19800원504,http://www.nbntv.co.kr/news/articleView.html?idxno=200309
850,2019-02-07,2월7일대웅오늘증권시세19800원504,http://www.nbntv.co.kr/news/articleView.html?idxno=200322
851,2019-02-07,대웅제약보타보툴리눔톡신美FDA판매허가획득,http://www.straightnews.co.kr/news/articleView.html?idxno=42817
852,2019-02-07,대웅제약나보타국산보툴리눔톡신최초美FDA판매허가획득,http://www.inthenews.co.kr/news/article.html?no=13374
853,2019-02-07,대웅제약나보타美FDA판매허가획득,http://www.asiatime.co.kr/news/articleView.html?idxno=227207
854,2019-02-07,KTB투자증권대웅제약대미신약수출증가예상목표주가30만원으로상향조정,http://www.topstarnews.net/news/articleView.html?idxno=581170
855,2019-02-07,유대웅전일대비796상승일일회전율은088기록,http://www.sedaily.com/NewsView/1VF7YAWN4D
856,2019-02-07,대웅제약주가증권투자정보7일현재204500원,http://www.gokorea.kr/news/articleView.html?idxno=92030
857,2019-02-07,ET투자뉴스대웅제약나보타국내제품BUYKTB투자증권,http://www.etnews.com/20190207000220
858,2019-02-07,ET투자뉴스대웅제약제약업종ToppBUY유지NH투자증권,http://www.etnews.com/20190207000228
859,2019-02-07,대웅제약제약업종Toppick유지,http://news.mt.co.kr/mtview.php?no=2019020708451025197
860,2019-02-07,2월7일대웅제약주식그래프440201500원,http://www.nbntv.co.kr/news/articleView.html?idxno=201179
861,2019-02-07,ET투자뉴스대웅제약소문에사서뉴스에매수유지한국투자증권,http://www.etnews.com/20190207000278
862,2019-02-07,대웅제약나보타국내최초美FDA판매허가득한보툴리눔톡신,http://www.newsworks.co.kr/news/articleView.html?idxno=333993
863,2019-02-07,ET투자뉴스대웅제약JeuveauFDHOLD하향DB금융투자,http://www.etnews.com/20190207000298
864,2019-02-07,2월7일대웅제약주가그래프492202500원,http://www.nbntv.co.kr/news/articleView.html?idxno=201390
865,2019-02-07,나보타로첫발뗀대웅제약글로벌공략박차,http://www.newsway.co.kr/news/view?tp=1&ud=2019020713573566637
866,2019-02-07,대웅제약주보美출시허가이후에도다양한모멘텀대기중,http://www.newsworks.co.kr/news/articleView.html?idxno=334024
867,2019-02-07,대웅제약나보타미국허가모멘텀이끝이아니다,http://www.newsworks.co.kr/news/articleView.html?idxno=334031
868,2019-02-07,美진출성공한대웅제약나보타논란은여전,http://www.monews.co.kr/news/articleView.html?idxno=200698
869,2019-02-07,주식시장美보톡스시장진입한대웅제약에환호차기주자는,http://news.mk.co.kr/newsRead.php?year=2019&no=76078
870,2019-02-07,2월7일목요일특징주대웅,http://www.leaders.kr/news/articleView.html?idxno=86319
871,2019-02-07,대웅제약나보타美판매허가에훨훨,http://www.edaily.co.kr/news/newspath.asp?newsid=03886806622388224
872,2019-02-07,대웅제약나보타美FDA승인에경쟁력확보,http://www.newsprime.co.kr/news/article.html?no=445860
873,2019-02-07,대웅제약나보타FDA품목허가취득완료,http://www.newsworks.co.kr/news/articleView.html?idxno=334087
874,2019-02-07,나보타美판매허가대웅메디톡스보톡스전쟁향방은,http://www.kpinews.co.kr/news/articleView.html?idxno=89832
875,2019-02-07,장종리포트대웅주가20000원마감,http://www.anewsa.com/detail.php?number=1529054&thread=10r04
876,2019-02-07,대웅제약보톡스대장주메디톡스맹추격,http://news.hankyung.com/article/2019020778751
877,2019-02-07,주보로다시태어난대웅제약나보타美입성후전망은,http://www.inthenews.co.kr/news/article.html?no=13380
878,2019-02-07,대웅제약나보타FDA품목허가소식에함박웃음,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719452
879,2019-02-07,나보타효과대웅제약주가급등57상승,http://www.dailymedi.com/detail.php?number=839831&thread=22r05
880,2019-02-07,메디톡스앨러간과미국국제무역위원회ITC에대웅제약에볼루스제소,http://www.lawissue.co.kr/view.php?ud=201902072216065056d7f4c63cc6_12
881,2019-02-07,대웅제약나보타미국시장진출문제없어일축,http://www.lawissue.co.kr/view.php?ud=20190207221736301d7f4c63cc6_12
882,2019-02-08,전일주요공시동부제철현대모비스대웅제약외,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719459
883,2019-02-08,바이오株주가상승가능성높아져대웅제약美FDA승인시발탄,http://www.newspim.com/news/view/20190208000106
884,2019-02-08,대웅제약나보타미국보톡스시장서성공하려면,http://www.rapportian.com/news/articleView.html?idxno=115897
885,2019-02-08,빅데이터MSI시장심리톱5대웅제약현대차농심삼성전자CJ,http://www.newsis.com/view/?id=NISX20190208_0000552095&cID=10427&pID=10400
886,2019-02-08,대웅제약전일대비약3상승한210500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902080201&t=NN
887,2019-02-08,2월8일대웅증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=92882
888,2019-02-08,2월8일대웅증권매매20250원125,http://www.nbntv.co.kr/news/articleView.html?idxno=203275
889,2019-02-08,휴젤메디톡스대웅제약나보타출시영향제한적CS,http://www.choicenews.co.kr/news/articleView.html?idxno=48057
890,2019-02-08,대웅제약주가종목그래프및종목동정과증시정보8일현재208000원,http://www.gokorea.kr/news/articleView.html?idxno=93233
891,2019-02-08,증시실황8일대웅현재주가20100원,http://www.anewsa.com/detail.php?number=1530556&thread=10r02
892,2019-02-08,2월8일대웅제약주식추천주196208000원,http://www.nbntv.co.kr/news/articleView.html?idxno=203782
893,2019-02-08,美FDA장벽을넘는제약사들대웅제약이을주인공은누구,http://www.asiatime.co.kr/news/articleView.html?idxno=227384
894,2019-02-09,주목e해외주식에볼루스대웅제약주보로보톡스에도전장,http://www.edaily.co.kr/news/newspath.asp?newsid=01541606622388880
895,2019-02-09,신영증권대웅제약보툴리눔톡신나보타미국진출목표가245000원상향제시,http://www.betanews.net:8080/article/971590.html
896,2019-02-11,배당정책변화로우선주중소형지주에기회HDC대웅한화에주목,http://news.hankyung.com/article/2019021151636
897,2019-02-11,윤정훈기자의해외주식톡에볼루스오르는데대웅제약못올라왜,http://www.ajunews.com/view/20190210130845513
898,2019-02-11,뜨거워진보톡스전쟁대웅제약나보타로美시장잡을까,http://www.ekn.kr/news/article.html?no=413934
899,2019-02-11,배당정책변화로중소형지주재평가HDC대웅한화주목,http://www.businesspost.co.kr/BP?command=article_view&num=113506
900,2019-02-11,대웅오늘증권시세11일현재20100원,http://www.nbntv.co.kr/news/articleView.html?idxno=205644
901,2019-02-11,국내주식시장현황11일대웅현재주식거래가격20100원,http://www.anewsa.com/detail.php?number=1533026&thread=10r02
902,2019-02-11,대웅재단신진의과학자지원을위한제1회대웅학술상개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019021110220515129
903,2019-02-11,대웅재단대웅학술상개최​​고현용이승주이용호교수수상,http://kormedi.com/?p=1281990
904,2019-02-11,의과학대웅학술상에고현용이승주이용호박사,http://news.heraldcorp.com/view.php?ud=20190211000289
905,2019-02-11,제1회대웅학술상​​고현용박사이승주이용호교수수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227049
906,2019-02-11,대웅재단신진의과학자지원위한제1회대웅학술상개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1720263
907,2019-02-11,대웅재단제1회대웅학술상에고현용박사등3인선정,http://www.metroseoul.co.kr/news/newsview?newscd=2019021100031
908,2019-02-11,유통오늘대웅재단제1회대웅학술상개최몰테일신학기맞이배송비10할인쿠폰제공,http://www.sisaon.co.kr/news/articleView.html?idxno=82207
909,2019-02-11,대웅재단신진의과학자지원위한제1회대웅학술상시상,http://medipana.com/news/news_viewer.asp?NewsNum=234441&MainKind=A&NewsKind=5&vCount=12&vKind=1
910,2019-02-11,고현용박사등3명제1회대웅학술상수상,http://www.newsis.com/view/?id=NISX20190211_0000554191&cID=13001&pID=13000
911,2019-02-11,대웅제약교수3명에대웅학술상상금3000만원지급,http://moneys.mt.co.kr/news/mwView.php?no=2019021110518050427
912,2019-02-11,신진의과학자지원대웅학술상에고현용이승주이용호,http://yna.kr/AKR20190211058700017?did=1195m
913,2019-02-11,대웅재단제1회대웅학술상고현용박사등3명수여,http://www.medisobizanews.com/news/articleView.html?idxno=57816
914,2019-02-11,제1회대웅학술상에고현용박사이승주교수이용호교수,http://www.bokuennews.com/news/article.html?no=171526
915,2019-02-11,대웅재단신진의과학자지원제1회대웅학술상개최,http://www.g-enews.com/ko-kr/news/article/news_all/201902111101326486fa075a9870_1/article.html
916,2019-02-11,신진의과학자돕자대웅학술상첫시상,http://www.sedaily.com/NewsView/1VF9SPX31B
917,2019-02-11,뉴스투데이L대웅재단제1회대웅학술상개최로신진의과학자지원,http://www.news2day.co.kr/120174
918,2019-02-11,대웅재단대웅학술상시상식신진의과학자지원,http://www.newsprime.co.kr/news/article.html?no=446154
919,2019-02-11,대웅재단제1회대웅학술상개최,http://www.ebn.co.kr/news/view/972065
920,2019-02-11,대웅재단신진의과학자우수연구성과알리는대웅학술상개최,http://www.shinailbo.co.kr/news/articleView.html?idxno=1140432
921,2019-02-11,대웅제단신진의과학자지원하는제1회대웅학술상시상식개최,http://www.newspost.kr/news/articleView.html?idxno=68628
922,2019-02-11,2월11일대웅제약주식현황208000원097,http://www.nbntv.co.kr/news/articleView.html?idxno=206156
923,2019-02-11,수정중대웅재단제1회대웅학술상개최,http://daily.hankooki.com/lpage/ittech/201902/dh20190211113550145630.htm
924,2019-02-11,대웅제약주가2월11일현재209000원,http://www.gokorea.kr/news/articleView.html?idxno=94561
925,2019-02-11,대웅재단신진의과학자지원제1회대웅학술상열어,http://www.kpanews.co.kr/article/show.asp?idx=201396&table=article&category=D
926,2019-02-11,제1회대웅학술상고현용박사이승주이용호교수영예,http://www.monews.co.kr/news/articleView.html?idxno=200748
927,2019-02-11,대웅재단신진의과학자지원위한대웅학술상제정,http://www.bosa.co.kr/news/articleView.html?idxno=2099234
928,2019-02-11,제1회대웅학술상고현용박사이승주이용호교수,http://www.dailymedi.com/detail.php?number=839907&thread=22r05
929,2019-02-11,대웅재단제1회대웅학술상개최신진의과학자지원,http://www.econovill.com/news/articleView.html?idxno=356312
930,2019-02-11,대웅재단신진의과학자지원위한대웅학술상시상식개최,http://www.seoulwire.com/news/articleView.html?idxno=64638
931,2019-02-11,고현용박사등제1회대웅학술상수상,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065146
932,2019-02-11,대웅재단신진의과학자지원하는제1회대웅학술상개최,http://www.asiatime.co.kr/news/articleView.html?idxno=227724
933,2019-02-11,대웅재단신진의과학자지원제1회대웅학술상개최,http://www.koreaittimes.com/news/articleView.html?idxno=89162
934,2019-02-11,대웅재단신진의과학자3人에대웅학술상수여,http://www.mhj21.com/119320
935,2019-02-11,신진의과학자지원대웅학술상에고현용이승주이용호,http://view.asiae.co.kr/news/view.htm?idxno=2019021114134164807
936,2019-02-11,대웅재단대웅학술상에고현용이승주이용호교수선정,http://www.seoulfn.com/news/articleView.html?idxno=333231
937,2019-02-11,돈잘버는증권맨에게듣는다박근형차장제약바이오10개월간주가조정투심개선중대웅제약주목,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021113332146743
938,2019-02-11,대웅학술상에고현용이승주이용호신진의과학자지원,http://www.dt.co.kr/contents.html?article_no=2019021102109931102004&ref=naver
939,2019-02-11,대웅재단고현용박사등3명에게대웅학술상수여,http://www.fnnews.com/news/201902111456503536
940,2019-02-11,대웅재단제1회대웅학술상에고현용이승주이용호교수선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=29017
941,2019-02-11,대웅재단의과학발전지원나섰다,http://www.whosaeng.com/107884
942,2019-02-11,대웅재단신진의과학자지원위한제1회대웅학술상개최,http://www.ekn.kr/news/article.html?no=414219
943,2019-02-11,대웅재단제1회학술상시상식개최고현용이승주이용호수상영예,http://news.mk.co.kr/newsRead.php?year=2019&no=83323
944,2019-02-11,대웅재단제1회대웅학술상시상식개최,http://www.insightkorea.co.kr//news/articleView.html?idxno=33927
945,2019-02-11,대웅재단신진의과학자지원위한제1회대웅학술상개최,http://www.medigatenews.com/news/2016475561
946,2019-02-11,제1회대웅학술상에고현용이승주이용호씨,http://news.mk.co.kr/newsRead.php?year=2019&no=83617
947,2019-02-11,대웅대웅테라퓨틱스자회사편입,http://www.newspim.com/news/view/20190211000909
948,2019-02-11,대웅재단신진의과학자지원제1회대웅학술상개최,http://www.getnews.co.kr/view.php?ud=20190211174437970841d0c69529_16
949,2019-02-11,고현용이승주이용호제1회대웅학술賞수상,http://news.hankyung.com/article/2019021182041
950,2019-02-11,메디톡스대웅제약불붙은보톡스균주논란,http://www.dt.co.kr/contents.html?article_no=2019021202101631102001&ref=naver
951,2019-02-11,대웅대웅테라퓨틱스자회사편입,http://news.mt.co.kr/mtview.php?no=2019021118211523142
952,2019-02-11,대웅재단신진의과학자지원위한제1회대웅학술상개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=346057
953,2019-02-11,대웅학술상에고현용이승주이용호씨선정,http://www.fnnews.com/news/201902111826489258
954,2019-02-11,대웅대웅테라퓨틱스자회사편입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1720675
955,2019-02-11,대웅재단제1회대웅학술상개최의과학연구발전도모”,http://news.donga.com/3/all/20190211/94061298/2
956,2019-02-11,대웅재단신진의과학자지원을위한제1회대웅학술상개최,http://www.newscj.com/news/articleView.html?idxno=600531
957,2019-02-11,대웅재단신진의과학자우수연구성과알리는대웅학술상개최,https://www.insight.co.kr/news/210172
958,2019-02-11,대웅재단신진의과학자지원위한제1회대웅학술상개최,http://www.wsobi.com/news/articleView.html?idxno=69557
959,2019-02-12,대웅재단신진의과학자지원을위한제1회대웅학술상개최,http://www.lawissue.co.kr/view.php?ud=201902112355038161d7f4c63cc6_12
960,2019-02-12,유가증권기업공시11일대웅등,http://news.hankyung.com/article/2019021288651
961,2019-02-12,단신고현용박사등3명대웅학술상,http://news.donga.com/3/all/20190211/94062881/1
962,2019-02-12,대웅대웅테라퓨틱스자회사편입,http://www.mdtoday.co.kr/mdtoday/index.html?no=346077
963,2019-02-12,대웅제약나보타미국이어상반기중유럽허가전망,http://www.medisobizanews.com/news/articleView.html?idxno=57828
964,2019-02-12,더벨대웅제약나보타美출시첫해전체매출500억전망,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201902110100010510000676
965,2019-02-12,배당늘리는상장사들GS건설광주신세계HDC대웅한화등주목,http://www.econonews.co.kr/news/articleView.html?idxno=53413
966,2019-02-12,대웅주가2월12일현재20050원,http://www.gokorea.kr/news/articleView.html?idxno=95394
967,2019-02-12,종목상세정보12일대웅증시현황20050원,http://www.anewsa.com/detail.php?number=1536094&thread=10r02
968,2019-02-12,2월12일대웅주식종목시세20050원025,http://www.nbntv.co.kr/news/articleView.html?idxno=207944
969,2019-02-12,대웅제약크레젯정새로운블록버스터제품등극,http://www.g-enews.com/ko-kr/news/article/news_all/201902121044335255fa075a9870_1/article.html
970,2019-02-12,대웅제약크레젯정원외처방액100억원돌파,http://www.ceoscoredaily.com/news/article.html?no=51876
971,2019-02-12,대웅제약크레젯정지난해원외처방액105억원기록,http://www.ebn.co.kr/news/view/972237
972,2019-02-12,대웅제약크레젯정출시3년만에블록버스터등극,http://www.etoday.co.kr/news/section/newsview.php?idxno=1720932
973,2019-02-12,대웅제약크레젯정지난해원외처방액100억원돌파,http://www.econovill.com/news/articleView.html?idxno=356382
974,2019-02-12,대웅제약크레젯정지난해원외처방액100억넘어,http://news.mk.co.kr/newsRead.php?year=2019&no=84988
975,2019-02-12,대웅제약크레젯정새로운블록버스터로등극,http://medipana.com/news/news_viewer.asp?NewsNum=234490&MainKind=A&NewsKind=5&vCount=12&vKind=1
976,2019-02-12,대웅제약크레젯정새블록버스터제품등극,http://daily.hankooki.com/lpage/ittech/201902/dh20190212105504145630.htm
977,2019-02-12,대웅고지혈증약크레젯작년처방액105억달성전년비48↑,http://biz.chosun.com/site/data/html_dir/2019/02/12/2019021201276.html
978,2019-02-12,대웅제약크레젯정원외처방액105억48성장,http://www.bosa.co.kr/news/articleView.html?idxno=2099304
979,2019-02-12,대웅제약고지혈증치료제크레젯정출시3년만에블록버스터등극,http://www.newspim.com/news/view/20190212000326
980,2019-02-12,대웅제약크레젯정매출100억돌파블록버스터등극,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227104
981,2019-02-12,대웅제약고지혈증약크레젯정원외처방액100억돌파,http://view.asiae.co.kr/news/view.htm?idxno=2019021211184407141
982,2019-02-12,대웅제약크레젯정원외처방액100억원돌파,http://www.fetv.co.kr/news/article.html?no=20260
983,2019-02-12,대웅제약이상지질혈증복합제크레젯원외처방100억돌파,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902120260&t=NN
984,2019-02-12,대웅제약나보타美FDA승인글로벌진출가속,http://www.mhj21.com/119355
985,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.newsway.co.kr/news/view?tp=1&ud=2019021211243300874
986,2019-02-12,대웅제약주가및증권시세외매매동향12일현재206000원,http://www.gokorea.kr/news/articleView.html?idxno=95720
987,2019-02-12,대웅제약크레젯정2018년매출100억원돌파,http://www.dailypharm.com/Users/News/NewsView.html?ID=249373&REFERER=NP
988,2019-02-12,대웅제약크레젯정매출100억돌파새로운블록버스터,http://www.seoulwire.com/news/articleView.html?idxno=65459
989,2019-02-12,대웅제약금일증시12일현재206000원,http://www.nbntv.co.kr/news/articleView.html?idxno=208434
990,2019-02-12,대웅크레젯정지난해매출105억원기록,http://www.newsis.com/view/?id=NISX20190212_0000555633&cID=13001&pID=13000
991,2019-02-12,대웅제약고지혈증치료제크레젯정출시3년만에100억돌파,http://www.fnnews.com/news/201902121144584790
992,2019-02-12,대웅제약크레젯정출시3년만에처방액100억원돌파,http://www.medisobizanews.com/news/articleView.html?idxno=57845
993,2019-02-12,대웅고지혈증치료제크레젯블록버스터등극,http://www.dailymedi.com/detail.php?number=839948&thread=22r05
994,2019-02-12,대웅제약크레젯정블록버스터제품등극,http://www.koreaittimes.com/news/articleView.html?idxno=89198
995,2019-02-12,대웅제약크레젯정작년100억대처방액돌파,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065190
996,2019-02-12,대웅제약크레젯정지난해100억원처방액돌파,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021212341390908
997,2019-02-12,대웅제약크레젯정출시3년만에매출105억달성,http://www.asiatime.co.kr/news/articleView.html?idxno=227971
998,2019-02-12,대웅고지혈증치료제크레젯100억원돌파,http://www.monews.co.kr/news/articleView.html?idxno=200771
999,2019-02-12,대웅제약크레젯정폭풍매출성장출시3년만에100억돌파,http://www.enewstoday.co.kr/news/articleView.html?idxno=1270732
1000,2019-02-12,대웅제약고지혈증치료제크레젯정新주력제품등극,http://www.k-health.com/news/articleView.html?idxno=42338
1001,2019-02-12,대웅제약크레젯정105억원외처방실적기록,http://www.etnews.com/20190212000298
1002,2019-02-12,크레젯정원외처방100억돌파대웅제약대형품목으로육성,http://www.dt.co.kr/contents.html?article_no=2019021202109931102008&ref=naver
1003,2019-02-12,대웅제약크레젯정출시3년만에블록버스터제품등극,http://www.metroseoul.co.kr/news/newsview?newscd=2019021200040
1004,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.medigatenews.com/news/3679659726
1005,2019-02-12,대웅크레젯정3년만에블록버스터등극,http://www.whosaeng.com/107925
1006,2019-02-12,대웅제약고지혈증약크레젯연매출100억돌파,http://news.hankyung.com/article/201902121310f
1007,2019-02-12,대웅제약크레젯정지난해100억원넘게처방,http://www.ajunews.com/view/20190212145629518
1008,2019-02-12,대웅제약크레젯정국내처방액100억돌파,http://www.biospectator.com/view/news_view.php?varAtcId=7106
1009,2019-02-12,대웅제약고지혈증치료제크레젯정출시3년만에블록버스터등극,http://www.newsprime.co.kr/news/article.html?no=446398
1010,2019-02-12,대웅제약의고지혈증치료제크레젯출시3년만에블록버스터반열올라,http://news.mk.co.kr/newsRead.php?year=2019&no=85894
1011,2019-02-12,대웅제약크레젯정새로운블록버스터제품등극,http://www.edaily.co.kr/news/newspath.asp?newsid=03867126622389864
1012,2019-02-12,대웅크레젯정출시3년만에매출100억돌파,http://www.bokuennews.com/news/article.html?no=171589
1013,2019-02-12,대웅제약크레젯정출시3년만에100억돌파,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019021215352602874&objId=A2019021215352602874&portalCode=naver
1014,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.ekn.kr/news/article.html?no=414377
1015,2019-02-12,한국경제TV증시라인신영목의시장을이기는종목대웅제약이노메트리,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902120426&t=NNv
1016,2019-02-12,대웅제약고지혈증치료제크레젯정지난해처방액100억돌파,http://www.newstomato.com/ReadNews.aspx?no=875507
1017,2019-02-12,대웅제약고지혈증치료제크레젯정원외처방액105억원달성,http://www.joseilbo.com/news/news_read.php?uid=370344&class=27&grp=
1018,2019-02-12,대웅제약크레젯정출시3년만연매출100억원돌파,http://www.shinailbo.co.kr/news/articleView.html?idxno=1141002
1019,2019-02-12,대웅제약크레젯정블록버스터등극작년원외처방105억원,http://www.seoulfn.com/news/articleView.html?idxno=333399
1020,2019-02-12,대웅제약크레젯정작년매출105억원달성新블록버스터등극,http://www.inthenews.co.kr/news/article.html?no=13454
1021,2019-02-12,대웅제약고질혈증약크레젯정작년매출105억기록,http://www.rapportian.com/news/articleView.html?idxno=115962
1022,2019-02-12,대웅제약고지혈증약크레젯정지난해매출100억원돌파,http://kormedi.com/?p=1282116
1023,2019-02-12,대웅제약크레젯정블록버스터제품으로등극,http://www.mdtoday.co.kr/mdtoday/index.html?no=346177
1024,2019-02-12,대웅제약고지혈증치료제크레젯정새블록버스터제품등극,http://www.getnews.co.kr/view.php?ud=20190212171254156441d0c69529_16
1025,2019-02-12,대웅제약크레젯정새블록버스터제품등극,http://www.economytalk.kr/news/articleView.html?idxno=179225
1026,2019-02-12,대웅제약고지혈증치료제크레젯정원외처방액100억돌파,https://www.insight.co.kr/news/210361
1027,2019-02-12,장마감보고서12일대웅주가20100원장마쳐,http://www.anewsa.com/detail.php?number=1538339&thread=10r04
1028,2019-02-12,대웅제약크레젯정원외처방액100억돌파,http://www.wolyo.co.kr/news/articleView.html?idxno=77397
1029,2019-02-12,대웅제약고지혈증치료제크레젯정3년만에매출100억원돌파,http://news.donga.com/3/all/20190212/94076449/2
1030,2019-02-12,뉴스투데이L대웅제약크레젯정치열한경쟁속매출100억원돌파,http://www.news2day.co.kr/120337
1031,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.lawissue.co.kr/view.php?ud=201902121914272751d7f4c63cc6_12
1032,2019-02-12,대웅제약고지혈증치료제처방액100억원돌파,http://www.dailysmart.co.kr/news/articleView.html?idxno=6281
1033,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.newscj.com/news/articleView.html?idxno=600928
1034,2019-02-12,대웅제약크레젯정새로운블록버스터제품으로등극,http://www.wsobi.com/news/articleView.html?idxno=69615
1035,2019-02-13,대웅제약고지혈증약크레젯정지난해매출105억원기록,http://www.straightnews.co.kr/news/articleView.html?idxno=43182
1036,2019-02-13,대웅제약크레젯새블록버스터제품등극,http://www.kpanews.co.kr/article/show.asp?idx=201447&table=article&category=D
1037,2019-02-13,대웅주가2월13일현재19850원,http://www.gokorea.kr/news/articleView.html?idxno=96552
1038,2019-02-13,대웅오늘주식시세13일현재19850원,http://www.nbntv.co.kr/news/articleView.html?idxno=210226
1039,2019-02-13,장중시세13일대웅증시현황19900원,http://www.anewsa.com/detail.php?number=1538985&thread=10r02
1040,2019-02-13,대웅제약크레젯정지난해원외처방액105억원,http://www.kukinews.com/news/article.html?no=631306
1041,2019-02-13,대웅제약FDA승인이라쓰고미국진출이라읽는다이벤트,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227157
1042,2019-02-13,대웅제약나보타美진출기념사내이벤트진행,http://www.kpinews.co.kr/news/articleView.html?idxno=90222
1043,2019-02-13,대웅나보타美시장진출성공세계의주름살을지운다,http://news.heraldcorp.com/view.php?ud=20190213000383
1044,2019-02-13,2월13일대웅제약증권주식204000원097,http://www.nbntv.co.kr/news/articleView.html?idxno=210732
1045,2019-02-13,대웅제약임직원나보타FDA승인자축,http://www.seoulfn.com/news/articleView.html?idxno=333491
1046,2019-02-13,대웅제약FDA승인축하이벤트진행,http://www.newsprime.co.kr/news/article.html?no=446542
1047,2019-02-13,대웅제약주름살지우기나보타美진출성공이벤트,http://www.ebn.co.kr/news/view/972435
1048,2019-02-13,​대웅제약FDA승인축하성공적인미국진출기원이벤트진행,http://www.seoulwire.com/news/articleView.html?idxno=66519
1049,2019-02-13,대웅제약나보타美FDA승인기념사내이벤트진행,http://news.donga.com/3/all/20190213/94086894/2
1050,2019-02-13,대웅임직원FDA승인축하이벤트,http://www.bosa.co.kr/news/articleView.html?idxno=2099388
1051,2019-02-13,대웅제약임직원대상FDA승인축하이벤트​,http://www.insightkorea.co.kr//news/articleView.html?idxno=33974
1052,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1271119
1053,2019-02-13,대웅제약임직원대상FDA승인축하행사진행,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003487573
1054,2019-02-13,대웅제약임직원과나보타美진출축하이벤트,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021313153565760
1055,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.newsway.co.kr/news/view?tp=1&ud=2019021314151483367
1056,2019-02-13,대웅제약나보타자축이벤트진행FDA승인이라쓰고미국진출이라읽는다,http://moneys.mt.co.kr/news/mwView.php?no=2019021314058074169
1057,2019-02-13,전승호대웅제약사장역사적인출발선”나보타美성공기원,http://www.edaily.co.kr/news/newspath.asp?newsid=03903206622390192
1058,2019-02-13,대웅제약나보타美FDA승인축하이벤트,http://www.shinailbo.co.kr/news/articleView.html?idxno=1141352
1059,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.ekn.kr/news/article.html?no=414682
1060,2019-02-13,기획대웅제약메디톡스美최초진출희비가른cGMP인증전략,http://daily.hankooki.com/lpage/ittech/201902/dh20190213155507145630.htm
1061,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.getnews.co.kr/view.php?ud=20190213160750826341d0c69529_16
1062,2019-02-13,전승호사장나보타대웅제약성공의역사쓸것,http://www.rapportian.com/news/articleView.html?idxno=115978
1063,2019-02-13,대웅제약임직원대상FDA승인축하이벤트진행,http://www.asiatime.co.kr/news/articleView.html?idxno=228298
1064,2019-02-13,대웅제약나보타美FDA승인축하이벤트진행,http://www.ftoday.co.kr/news/articleView.html?idxno=106603
1065,2019-02-13,대웅제약임직원대상나보타FDA승인축하이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=346293
1066,2019-02-13,나보타FDA승인은여러분덕입니다전승호대웅제약사장임직원에감사서신,http://www.metroseoul.co.kr/news/newsview?newscd=2019021300062
1067,2019-02-13,대웅제약나보타美FDA승인기념임직원대상축하이벤트진행,https://www.insight.co.kr/news/210618
1068,2019-02-14,대웅제약임직원대상FDA승인축하이벤트진행,http://www.lawissue.co.kr/view.php?ud=201902140128227786d7f4c63cc6_12
1069,2019-02-14,대웅주가및증권시세14일현재19850원,http://www.gokorea.kr/news/articleView.html?idxno=97723
1070,2019-02-14,장중시세14일대웅거래가격19850원,http://www.anewsa.com/detail.php?number=1541982&thread=10r02
1071,2019-02-14,대웅주식종목14일현재19850원,http://www.nbntv.co.kr/news/articleView.html?idxno=212465
1072,2019-02-14,2월14일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=98047
1073,2019-02-14,시세보기대웅제약주가14일현재201000원,http://www.nbntv.co.kr/news/articleView.html?idxno=212950
1074,2019-02-15,더벨대웅연구소장이세운바이오벤처에지분투자,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201902130100016130001013
1075,2019-02-15,대웅주가오늘시세15일현재20000원,http://www.gokorea.kr/news/articleView.html?idxno=98897
1076,2019-02-15,대웅주식현재가15일현재20050원,http://www.nbntv.co.kr/news/articleView.html?idxno=214779
1077,2019-02-15,종목추적15일대웅거래가격20050원,http://www.anewsa.com/detail.php?number=1544911&thread=10r02
1078,2019-02-15,대웅제약주가및증권시세15일현재202500원,http://www.gokorea.kr/news/articleView.html?idxno=99222
1079,2019-02-15,대웅제약금일증시15일현재202500원,http://www.nbntv.co.kr/news/articleView.html?idxno=215267
1080,2019-02-15,대웅제약나보타상반기美출시보톡스보다가격낮췄다,http://news1.kr/articles/?3548722
1081,2019-02-15,강스템바이오텍퓨어스템AD대웅제약공동개발계약해지,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227265
1082,2019-02-15,강스템바이오텍대웅제약과의세포치료제공동개발계약변경,http://news.mt.co.kr/mtview.php?no=2019021517490256870
1083,2019-02-15,강스템바이오텍대웅제약과아토피치료제판권계약해지,http://news.hankyung.com/article/201902155117f
1084,2019-02-15,강스템바이오텍퓨어스템AD주독자개발대웅제약과계약변경,http://kormedi.com/?p=1282452
1085,2019-02-15,강스템바이오텍대웅제약과공동개발계약변경합의,https://www.sedaily.com/NewsView/1VFBOVWI6A
1086,2019-02-15,강스템바이오텍대웅제약과아토피치료제공동개발계약변경,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021518173585278
1087,2019-02-15,강스템바이오텍퓨어스템AD대웅제약공동개발서제외,http://medipana.com/news/news_viewer.asp?NewsNum=234670&MainKind=A&NewsKind=5&vCount=12&vKind=1
1088,2019-02-15,강스템바이오텍대웅제약과공동개발계약변경,http://view.asiae.co.kr/news/view.htm?idxno=2019021518303867332
1089,2019-02-17,대웅제약나보타美FDA승인받았지만균주출처제소에여전히발목,http://news.kmib.co.kr/article/view.asp?arcid=0924061877&code=14130000&cp=nv
1090,2019-02-18,오늘의추천종목한국투자증권대웅제약케이아이엔엑스등,http://www.asiatoday.co.kr/view.php?key=20190218010007267
1091,2019-02-18,국고처김종철종목상담대웅제약069620,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902160034&t=NNv
1092,2019-02-18,대웅제약나보타국내보툴리눔톡신최초美FDA승인획득,http://www.k-health.com/news/articleView.html?idxno=42431
1093,2019-02-18,대웅제약국민소화제베아제출시33주년기념TV광고캠페인선보여,http://www.seoulwire.com/news/articleView.html?idxno=69428
1094,2019-02-18,주식주가대웅주가18일현재19950원,http://www.nbntv.co.kr/news/articleView.html?idxno=217391
1095,2019-02-18,장중주가18일대웅증시현황19900원,http://www.anewsa.com/detail.php?number=1548339&thread=10r02
1096,2019-02-18,대웅제약베아제출시33주년맞아새TV광고선보여,http://www.edaily.co.kr/news/newspath.asp?newsid=02378006622391832
1097,2019-02-18,대웅제약베아제출시33주년기념신규광고온에어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1272308
1098,2019-02-18,대웅제약출시33주년베아제15년만에신규광고캠페인,http://www.medisobizanews.com/news/articleView.html?idxno=57946
1099,2019-02-18,대웅제약베아제33주년신규광고온에어,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021809514312194
1100,2019-02-18,대웅제약베아제33주년신규광고온에어,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021809514312194
1101,2019-02-18,대웅제약베아제출시33주년TV광고진행,http://moneys.mt.co.kr/news/mwView.php?no=2019021810118062273
1102,2019-02-18,베아제출시33주년대웅제약신규광고캠페인선봬,http://www.wolyo.co.kr/news/articleView.html?idxno=77773
1103,2019-02-18,대웅베아제15년만에새TV광고,http://www.whosaeng.com/108027
1104,2019-02-18,대웅제약나보타美FDA승인에메디톡스발목잡기,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=97710
1105,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.newsway.co.kr/news/view?tp=1&ud=2019021810525715388
1106,2019-02-18,유통오늘대웅제약33돌베아제신규광고캠페인선봬롯데그룹부산스타트업지원,http://www.sisaon.co.kr/news/articleView.html?idxno=82434
1107,2019-02-18,대웅제약출시33주년베아제신규TV광고선보여,http://www.mhj21.com/119489
1108,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인,http://daily.hankooki.com/lpage/ittech/201902/dh20190218111333145630.htm
1109,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.bokuennews.com/news/article.html?no=171816
1110,2019-02-18,대웅제약베아제출시33주년신규광고캠페인선보여,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227296
1111,2019-02-18,2월18일대웅제약증권투자정보외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=100547
1112,2019-02-18,대웅제약베아제출시33주년맞아새TV광고온에어,http://www.insightkorea.co.kr//news/articleView.html?idxno=34047
1113,2019-02-18,대웅제약주식증권18일현재203000원,http://www.nbntv.co.kr/news/articleView.html?idxno=217882
1114,2019-02-18,대웅베아제출시33주년맞아신규광고온에어,http://www.dailypharm.com/Users/News/NewsView.html?ID=249560&REFERER=NP
1115,2019-02-18,대웅제약15년만에소화제베아제광고선봬,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065381
1116,2019-02-18,대웅제약베아제출시33주년신규광고캠페인,http://kormedi.com/?p=1282534
1117,2019-02-18,대웅제약베아제출시33주년맞이신규광고캠페인,http://www.asiatime.co.kr/news/articleView.html?idxno=228984
1118,2019-02-18,이중으로강력하게대웅제약베아제출시33주년기념신규광고,https://www.insight.co.kr/news/211479
1119,2019-02-18,위에서한번장에서또한번대웅제약베아제신규광고선봬,http://www.shinailbo.co.kr/news/articleView.html?idxno=1142551
1120,2019-02-18,대웅제약베아제출시33주년맞아,http://www.wsobi.com/news/articleView.html?idxno=69809
1121,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.ekn.kr/news/article.html?no=415548
1122,2019-02-18,대웅제약AI플랫폼으로신약개발진단처방사후관리까지,http://view.asiae.co.kr/news/view.htm?idxno=2019021815220943570
1123,2019-02-18,대웅제약베아제출시33주년기념신규광고캠페인,http://www.g-enews.com/ko-kr/news/article/news_all/201902181526517974fa075a9870_1/article.html
1124,2019-02-18,대웅제약춘향가전수자이영태내세운종합소화제베아제광고론칭,http://news.mk.co.kr/newsRead.php?year=2019&no=98701
1125,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.mdtoday.co.kr/mdtoday/index.html?no=346686
1126,2019-02-18,대웅제약베아제출시33주년신규광고캠페인선보여,http://www.getnews.co.kr/view.php?ud=20190218161326591541d0c69529_16
1127,2019-02-18,대웅제약15년만에베아제광고캠페인론칭,http://www.dailysmart.co.kr/news/articleView.html?idxno=6561
1128,2019-02-18,오늘Who윤재춘대웅제약의한올바이오파마인수결실눈앞,http://www.businesspost.co.kr/BP?command=article_view&num=114647
1129,2019-02-18,대웅제약베아제출시33주년기념신규TV광고선봬,http://www.newsprime.co.kr/news/article.html?no=447204
1130,2019-02-18,대웅제약베아제 출시 33주년맞아신규광고론칭,http://www.businesskorea.co.kr/news/articleView.html?idxno=29226
1131,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.newscj.com/news/articleView.html?idxno=602755
1132,2019-02-18,대웅제약베아제출시33주년맞아신규광고캠페인선보여,http://www.lawissue.co.kr/view.php?ud=201902182241156167d7f4c63cc6_12
1133,2019-02-19,2월19일대웅오늘시세외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=101385
1134,2019-02-19,2월19일대웅주식증권19800원076,http://www.nbntv.co.kr/news/articleView.html?idxno=219691
1135,2019-02-19,증시실황19일대웅증시현황19800원,http://www.anewsa.com/detail.php?number=1551318&thread=10r02
1136,2019-02-19,오늘주식장대웅제약주가19일현재203000원,http://www.nbntv.co.kr/news/articleView.html?idxno=220198
1137,2019-02-19,대웅제약주가오늘시세19일현재202500원,http://www.gokorea.kr/news/articleView.html?idxno=101728
1138,2019-02-19,대웅제약강스템신약판권포기한까닭은,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019021914583902484&objId=A2019021914583902484&portalCode=naver
1139,2019-02-19,강스템바이오텍퓨어스템대웅제약의공동개발중단선언오히려호재,http://biz.newdaily.co.kr/site/data/html/2019/02/19/2019021900148.html
1140,2019-02-20,대웅제약FDA가메디톡스청원거부美진출걸림돌없다,http://medipana.com/news/news_viewer.asp?NewsNum=234829&MainKind=A&NewsKind=5&vCount=12&vKind=1
1141,2019-02-20,대웅제약FDA메디톡스청원거부미국진출걸림돌없어,http://www.sisafocus.co.kr/news/articleView.html?idxno=202967
1142,2019-02-20,대웅제약”미국FDA메디톡스가낸나보타승인저지청원서거부”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1724303
1143,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출이상무,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227384
1144,2019-02-20,대웅제약나보타미국진출탄탄대로FDA메디톡스청원거부,http://kpenews.com/View.aspx?No=21902
1145,2019-02-20,대웅제약FDA가메디톡스청원거부나보타美진출걸림돌없다,http://www.ekn.kr/news/article.html?no=415919
1146,2019-02-20,대웅제약美FDA메디톡스의나보타허가저지시민청원서거부,http://www.newspim.com/news/view/20190220000140
1147,2019-02-20,대웅제약메디톡스견제에도미국진출순항,http://moneys.mt.co.kr/news/mwView.php?no=2019022009158052404
1148,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출걸림돌없어,http://www.edaily.co.kr/news/newspath.asp?newsid=02017206622392488
1149,2019-02-20,美FDA나보타수입금지청원거부대웅미국진출걸림돌없어,http://www.newsis.com/view/?id=NISX20190220_0000563818&cID=13001&pID=13000
1150,2019-02-20,대웅제약FDA메디톡스청원거부나보타美진출이상무”,http://www.newsway.co.kr/news/view?tp=1&ud=2019022009294238914
1151,2019-02-20,대웅제약나보타미국진출재확인메디톡스청원거부,http://www.g-enews.com/ko-kr/news/article/news_all/201902200944316603fa075a9870_1/article.html
1152,2019-02-20,메디톡스제기FDA청원거절대웅제약나보타美진출이상무,http://biz.chosun.com/site/data/html_dir/2019/02/20/2019022000787.html
1153,2019-02-20,2월20일대웅오늘시세및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=102584
1154,2019-02-20,주식종목20일대웅현재가19900원,http://www.anewsa.com/detail.php?number=1554280&thread=10r02
1155,2019-02-20,대웅증권플러스20일현재19950원,http://www.nbntv.co.kr/news/articleView.html?idxno=222001
1156,2019-02-20,대웅제약FDA메디톡스가접수한시민청원거부,http://www.dailysmart.co.kr/news/articleView.html?idxno=6657
1157,2019-02-20,대웅제약나보타미국의약품시장진출이상무,http://www.fetv.co.kr/news/article.html?no=20864
1158,2019-02-20,대웅제약미FDA메디톡스청원거부나보타미국진출걸림돌제거,http://www.asiatoday.co.kr/view.php?key=20190220010009203
1159,2019-02-20,대웅제약FDA메디톡스청원거부나보타美진출이상없어,http://www.medisobizanews.com/news/articleView.html?idxno=58016
1160,2019-02-20,美FDA메디톡스문제제기거부대웅제약부정행위못찾아,http://news1.kr/articles/?3552337
1161,2019-02-20,대웅제약美FDA메디톡스청원거부나보타미국진출걸림돌제거,http://www.getnews.co.kr/view.php?ud=20190220113500585841d0c69529_16
1162,2019-02-20,2월20일대웅제약오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=102924
1163,2019-02-20,대웅제약미국진출걸림돌없음재확인,http://www.economytalk.kr/news/articleView.html?idxno=179767
1164,2019-02-20,대웅제약FDA메디톡스의균주출처공개청원거부,http://www.rapportian.com/news/articleView.html?idxno=116095
1165,2019-02-20,2월20일대웅제약배당주식201500원074,http://www.nbntv.co.kr/news/articleView.html?idxno=222490
1166,2019-02-20,대웅제약나보타미국진출재확인미FDA판매허가승인,http://www.100ssd.co.kr/news/articleView.html?idxno=59535
1167,2019-02-20,미FDA대웅나보타허가저지청원거부,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84121
1168,2019-02-20,美FDA메디톡스청원거부대웅제약나보타진출걸림돌제거,http://biz.newdaily.co.kr/site/data/html/2019/02/20/2019022000021.html
1169,2019-02-20,대웅제약미국당국이메디톡스청원거부해수출지장없어,http://www.businesspost.co.kr/BP?command=article_view&num=114999
1170,2019-02-20,대웅제약메디톡스의나보타승인저지FDA가거부,http://news.mk.co.kr/newsRead.php?year=2019&no=103584
1171,2019-02-20,대웅美FDA나보타균주출처공개청원거부,http://www.biospectator.com/view/news_view.php?varAtcId=7164
1172,2019-02-20,美FDA메디톡스청원거부대웅제약나보타부정행위없다,http://www.k-health.com/news/articleView.html?idxno=42493
1173,2019-02-20,메디톡스제기FDA청원거절대웅제약나보타이상무,http://www.ebn.co.kr/news/view/973401
1174,2019-02-20,FDA의메디톡스청원거부대웅제약나보타미국진출청신호,http://www.kukinews.com/news/article.html?no=633731
1175,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출이상무,http://www.mdtoday.co.kr/mdtoday/index.html?no=346887
1176,2019-02-20,대웅제약미FDA메디톡스청원거부로나보타미국진출순항,http://www.fnnews.com/news/201902201449136823
1177,2019-02-20,대웅제약나보타미국진출걸림돌없다,http://www.monews.co.kr/news/articleView.html?idxno=200931
1178,2019-02-20,대웅제약FDA메디톡스청원거부나보타美진출걸림돌사라져,http://www.metroseoul.co.kr/news/newsview?newscd=2019022000169
1179,2019-02-20,美FDA메디톡스가제기한대웅제약나보타관련청원거부,http://www.inthenews.co.kr/news/article.html?no=13636
1180,2019-02-20,FDA메디톡스청원거부대웅부정행위발견못해,http://www.kpinews.co.kr/news/articleView.html?idxno=90818
1181,2019-02-20,대웅제약나보타美진출걸림돌ZERO,http://www.whosaeng.com/108105
1182,2019-02-20,대웅제약vs메디톡스나보타균주놓고끈질긴소송전싸움승자는,http://www.wolyo.co.kr/news/articleView.html?idxno=77980
1183,2019-02-20,대웅제약FDA가메디톡스청원거부나보타미국진출걸림돌없어,http://www.etnews.com/20190220000320
1184,2019-02-20,대웅제약FDA로부터나보타미국진출걸림돌없음확인,http://www.seoulwire.com/news/articleView.html?idxno=72316
1185,2019-02-20,메디톡스청원FDA서거부대웅제약나보타진출걸림돌無,http://www.asiatime.co.kr/news/articleView.html?idxno=229573
1186,2019-02-20,대웅제약나보타미국FDA최종허가승인,http://www.skyedaily.com/news/news_view.html?ID=82043
1187,2019-02-20,작년1조매출제약사5곳올해종근당대웅1조클럽진입유력,http://www.newsprime.co.kr/news/article.html?no=447664
1188,2019-02-20,대웅제약FDA의메디톡스청원거부나보타美진출걸림돌없음재확인,http://www.segye.com/content/html/2019/02/20/20190220003976.html?OutUrl=naver
1189,2019-02-20,대웅제약나보타미국진출걸림돌없어져,http://www.wikileaks-kr.org/news/articleView.html?idxno=48221
1190,2019-02-20,FDA메디톡스청원거부대웅제약나보타미국진출이상無,http://www.shinailbo.co.kr/news/articleView.html?idxno=1143513
1191,2019-02-20,대웅제약VS메디톡스보톡스진실공방승자는누가될까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1724773
1192,2019-02-20,대웅제약FDA메디톡스청원거부나보타미국진출걸림돌없어,https://www.insight.co.kr/news/212015
1193,2019-02-20,대웅제약FDA의메디톡스청원거부나보타미국진출걸림돌없음재확인,http://www.newscj.com/news/articleView.html?idxno=603697
1194,2019-02-20,대웅제약FDA의메디톡스청원거부로나보타미국진출걸림돌없음재확인밝혀,http://www.lawissue.co.kr/view.php?ud=201902202305182519d7f4c63cc6_12
1195,2019-02-21,식약처녹십자대웅등12곳백신수입업체해외제조소실사,http://www.mdtoday.co.kr/mdtoday/index.html?no=346946
1196,2019-02-21,메디톡스공세차단성공대웅제약나보타,http://www.dailymedi.com/detail.php?number=840230&thread=22r05
1197,2019-02-21,더벨A급대웅제약2000억회사채만기대응여력은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201902200100029100001849
1198,2019-02-21,주식그래프대웅주가21일현재19800원,http://www.nbntv.co.kr/news/articleView.html?idxno=224183
1199,2019-02-21,증시보고21일대웅현재주가19800원,http://www.anewsa.com/detail.php?number=1557057&thread=10r02
1200,2019-02-21,대웅제약스마트오피스덕에업무능률올랐죠 ,http://www.seoulfn.com/news/articleView.html?idxno=334318
1201,2019-02-21,대웅모사프리드서방정가스모틴SR삼성서울병원랜딩,http://medipana.com/news/news_viewer.asp?NewsNum=234910&MainKind=A&NewsKind=5&vCount=12&vKind=1
1202,2019-02-21,2월21일대웅제약주식주가125197500원,http://www.nbntv.co.kr/news/articleView.html?idxno=224679
1203,2019-02-21,제약동향1월원외처방한미약품→종근당→대웅제약순바이오의약품보톡스수출감소세,http://www.ezyeconomy.com/news/articleView.html?idxno=88340
1204,2019-02-21,대웅제약FDA의메디톡스청원거부로나보타미국진출걸림돌없음재확인,http://www.wsobi.com/news/articleView.html?idxno=69963
1205,2019-02-21,1월원외처방증가율종근당한미대웅順,http://www.dailymedi.com/detail.php?number=840251&thread=22r12
1206,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.g-enews.com/ko-kr/news/article/news_all/201902220954118530fa075a9870_1/article.html
1207,2019-02-22,증시현황22일대웅현재주식거래가격19600원,http://www.anewsa.com/detail.php?number=1560041&thread=10r02
1208,2019-02-22,대웅주가오늘시세22일현재19600원,http://www.gokorea.kr/news/articleView.html?idxno=104666
1209,2019-02-22,대웅제약직원300여명공정거래자율준수프로그램교육실시,http://www.seoulwire.com/news/articleView.html?idxno=73614
1210,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://daily.hankooki.com/lpage/ittech/201902/dh20190222100330145630.htm
1211,2019-02-22,대웅주가그래프22일현재19650원,http://www.nbntv.co.kr/news/articleView.html?idxno=226505
1212,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.newsway.co.kr/news/view?tp=1&ud=2019022210031519279
1213,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227486
1214,2019-02-22,대웅제약직원대상컴플라이언스교육진행,http://www.mhj21.com/119607
1215,2019-02-22,대웅제약컴플라이언스준수문화확립에앞장,http://www.enewstoday.co.kr/news/articleView.html?idxno=1274075
1216,2019-02-22,대웅제약변호사초청해임직원300명에윤리경영교육,http://www.medisobizanews.com/news/articleView.html?idxno=58066
1217,2019-02-22,대웅제약윤리준법경영강화직원들에컴플라이언스교육,http://kpenews.com/View.aspx?No=22099
1218,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://moneys.mt.co.kr/news/mwView.php?no=2019022210068053844
1219,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.ekn.kr/news/article.html?no=416449
1220,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.edaily.co.kr/news/newspath.asp?newsid=02223846622393144
1221,2019-02-22,유통오늘롯데百플라워마켓바이소공원팝업스토어선봬대웅제약직원대상컴플라이언스교육,http://www.sisaon.co.kr/news/articleView.html?idxno=82622
1222,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.fetv.co.kr/news/article.html?no=21106
1223,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=347107
1224,2019-02-22,윤리경영박차대웅제약직원대상CP교육실시 ,http://www.monews.co.kr/news/articleView.html?idxno=200988
1225,2019-02-22,대웅제약임직원대상공정거래준수교육실시 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1143952
1226,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.m-i.kr/news/articleView.html?idxno=498490
1227,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.bosa.co.kr/news/articleView.html?idxno=2099947
1228,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065552
1229,2019-02-22,대웅제약준법경영강화힘쓸것,http://www.bokuennews.com/news/article.html?no=172033
1230,2019-02-22,대웅제약직원대상CP교육실시,http://www.asiatime.co.kr/news/articleView.html?idxno=229986
1231,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,http://www.econovill.com/news/articleView.html?idxno=357130
1232,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,http://www.rapportian.com/news/articleView.html?idxno=116145
1233,2019-02-22,2월22일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=104982
1234,2019-02-22,주식증권대웅제약주가22일현재197000원,http://www.nbntv.co.kr/news/articleView.html?idxno=227010
1235,2019-02-22,대웅제약공정거래자율준수프로그램교육실시,http://www.newsprime.co.kr/news/article.html?no=447968
1236,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.100ssd.co.kr/news/articleView.html?idxno=59625
1237,2019-02-22,대웅제약전직원대상공정거래준법경영교육실시,http://www.ezyeconomy.com/news/articleView.html?idxno=88384
1238,2019-02-22,대웅제약노경화광장변호사초청해CP교육실시,http://news.mk.co.kr/newsRead.php?year=2019&no=109516
1239,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1725734
1240,2019-02-22,대웅제약직원300명에컴플라이언스준수필요성피력,http://medipana.com/news/news_viewer.asp?NewsNum=234975&MainKind=A&NewsKind=5&vCount=12&vKind=1
1241,2019-02-22,대웅제약직원대상준법경영컴플라이언스교육실시,http://www.getnews.co.kr/view.php?ud=20190222161657714041d0c69529_16
1242,2019-02-22,대웅제약모든임직원대상으로컴플라이언스교육진행,http://www.k-health.com/news/articleView.html?idxno=42550
1243,2019-02-22,대웅제약임직원대상CP교육실시,http://www.dailymedi.com/detail.php?number=840295&thread=22r05
1244,2019-02-22,진격의대웅제약임직원대상CP교육,http://www.whosaeng.com/108161
1245,2019-02-22,미국에상륙한대웅제약나보타올해500억매출노린다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019022210342122021
1246,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.ftoday.co.kr/news/articleView.html?idxno=106794
1247,2019-02-22,대웅제약직원대상공정거래자율준수교육실시,https://www.insight.co.kr/news/212450
1248,2019-02-22,대웅제약공정거래자율준수임직원교육진행,http://news.donga.com/3/all/20190222/94247691/2
1249,2019-02-22,대웅제약직원대상컴플라이언스교육실시,http://www.newscj.com/news/articleView.html?idxno=604479
1250,2019-02-24,제약산업이모저모CJ헬스케어동국제약대웅제약한국오츠카제약,http://www.kukinews.com/news/article.html?no=635062
1251,2019-02-24,대웅제약직원대상컴플라이언스교육실시,http://www.wsobi.com/news/articleView.html?idxno=70062
1252,2019-02-25,대웅제약방문한성윤모의약품수출확대대책조만간발표,http://www.newspim.com/news/view/20190225000001
1253,2019-02-25,연구본부장없는대웅제약신약개발시스템확바꿨다”,http://www.edaily.co.kr/news/newspath.asp?newsid=01344806622394128
1254,2019-02-25,성윤모산업부장관대웅제약오송공장방문,http://www.dailypharm.com/Users/News/NewsView.html?ID=249788&REFERER=NP
1255,2019-02-25,대웅제약찾은성윤모장관신약개발지원대책마련하겠다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1144422
1256,2019-02-25,대웅주가오늘시세25일현재19850원,http://www.gokorea.kr/news/articleView.html?idxno=105953
1257,2019-02-25,주식시세25일대웅증시현황19850원,http://www.anewsa.com/detail.php?number=1563348&thread=10r02
1258,2019-02-25,2월25일대웅증권매매17919850원,http://www.nbntv.co.kr/news/articleView.html?idxno=229120
1259,2019-02-25,대웅제약방문한성윤모산업장관신약개발투자하라”지원약속,http://www.asiatoday.co.kr/view.php?key=20190225010011893
1260,2019-02-25,대웅제약오송공장방문한성윤모장관,http://news1.kr/photos/view/?3524033
1261,2019-02-25,성윤모장관의약품수출기업대웅제약오송공장현장방문,http://news1.kr/photos/view/?3524040
1262,2019-02-25,대웅제약오송공장생산라인살펴보는성윤모장관,http://news1.kr/photos/view/?3524028
1263,2019-02-25,대웅제약오송공장방문한성윤모장관,http://news1.kr/photos/view/?3524033
1264,2019-02-25,성윤모장관대웅제약공장방문수출지원책발표할것,http://www.sisaweek.com/news/articleView.html?idxno=118748
1265,2019-02-25,성윤모장관대웅제약오송공장방문,http://www.newsis.com/view/?id=NISI20190225_0014933695
1266,2019-02-25,대웅제약오송공장둘러보는성윤모장관,http://www.newsis.com/view/?id=NISI20190225_0014933693
1267,2019-02-25,성윤모장관대웅제약오송공장방문,http://www.newsis.com/view/?id=NISI20190225_0014933696
1268,2019-02-25,대웅제약오송공장둘러보는성윤모장관,http://www.newsis.com/view/?id=NISI20190225_0014933694
1269,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.newsway.co.kr/news/view?tp=1&ud=2019022511230027360
1270,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.g-enews.com/ko-kr/news/article/news_all/201902251123598971fa075a9870_1/article.html
1271,2019-02-25,대웅제약윤재춘전승호사장성윤모산업부장관면담,http://www.ebn.co.kr/news/view/973969
1272,2019-02-25,대웅제약윤재춘전승호사장성윤모산업부장관면담,http://www.ebn.co.kr/news/view/973969
1273,2019-02-25,성윤모산업부장관대웅제약오송스마트공장격려방문,http://medipana.com/news/news_viewer.asp?NewsNum=235046&MainKind=A&NewsKind=5&vCount=12&vKind=1
1274,2019-02-25,주식장대웅제약주가25일현재197000원,http://www.nbntv.co.kr/news/articleView.html?idxno=229617
1275,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227548
1276,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문윤재춘전승호사장과면담,http://www.ekn.kr/news/article.html?no=416843
1277,2019-02-25,성윤모산자대웅제약전격방문나보타성공극찬,http://news.heraldcorp.com/view.php?ud=20190225000474
1278,2019-02-25,성윤모산업부장관대웅제약공장방문윤재춘전승호사장면담,http://biz.newdaily.co.kr/site/data/html/2019/02/25/2019022500077.html
1279,2019-02-25,산업부성윤모장관대웅제약오송공장방문의약품수출활력대책논의,http://www.kukinews.com/news/article.html?no=635306
1280,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문맞아,http://www.bosa.co.kr/news/articleView.html?idxno=2100068
1281,2019-02-25,성윤모장관대웅제약오송공장방문신약개발투자지속”당부,http://www.etoday.co.kr/news/section/newsview.php?idxno=1726399
1282,2019-02-25,성윤모장관대웅제약공장방문신약개발투자지속할것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019022511243826972
1283,2019-02-25,성윤모장관대웅제약오송스마트공장방문나보타수출격려,http://www.metroseoul.co.kr/news/newsview?newscd=2019022500115
1284,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문,http://www.medigatenews.com/news/3488478394
1285,2019-02-25,성윤모산자부장관등대웅제약오송공장서면담,http://www.mhj21.com/119682
1286,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://www.dailysmart.co.kr/news/articleView.html?idxno=6881
1287,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019022514034002405&objId=A2019022514034002405&portalCode=naver
1288,2019-02-25,전승호대웅제약사장성윤모장관에게국내제약사정부지원필요,http://www.ajunews.com/view/20190225142843315
1289,2019-02-25,성윤모장관대웅제약찾아의약품수출신약개발지원대책마련,http://daily.hankooki.com/lpage/ittech/201902/dh20190225144611145630.htm
1290,2019-02-25,산업부장관대웅제약오송스마트공장방문신약개발에계속투자,http://www.asiatime.co.kr/news/articleView.html?idxno=230334
1291,2019-02-25,산자부성윤모장관대웅제약오송스마트공장방문,http://www.monews.co.kr/news/articleView.html?idxno=201023
1292,2019-02-25,성윤모장관대웅제약찾아현장애로청취윤재춘전승호사장지속적지원요청,http://kpenews.com/View.aspx?No=28430
1293,2019-02-25,성윤모산업부장관대웅제약오송공장방문,http://news.mk.co.kr/newsRead.php?year=2019&no=114252
1294,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문윤재춘전승호사장과면담,http://www.segye.com/content/html/2019/02/25/20190225002987.html?OutUrl=naver
1295,2019-02-25,사진기사성윤모산업부장관대웅제약오송공장방문,http://www.etnews.com/20190225000367
1296,2019-02-25,수출우수기업대웅제약오송공장에성윤모산자부장관방문,http://www.medisobizanews.com/news/articleView.html?idxno=58095
1297,2019-02-25,산자부장관대웅제약오송공장방문,http://www.whosaeng.com/108201
1298,2019-02-25,성윤모산자부장관윤재춘전승호대웅제약사장과조우,http://www.fetv.co.kr/news/article.html?no=21331
1299,2019-02-25,성윤모산업부장관대웅제약오송공장방문신약개발위한정부지원지속,http://www.businesskorea.co.kr/news/articleView.html?idxno=29458
1300,2019-02-25,성윤모산자부장관대웅오송스마트공장방문,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065623
1301,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://www.dt.co.kr/contents.html?article_no=2019022502109931102006&ref=naver
1302,2019-02-25,전승호대웅제약사장신약해외경쟁력확보하려면정부지원절실,http://www.ezyeconomy.com/news/articleView.html?idxno=88430
1303,2019-02-25,성윤모산업부장관대웅제약오송스마트공장방문,http://www.mdtoday.co.kr/mdtoday/index.html?no=347308
1304,2019-02-25,성윤모산업통상자원부장관대웅제약오송공장방문,http://www.newsprime.co.kr/news/article.html?no=448332
1305,2019-02-25,성윤모산업통상자원부장관대웅오송공장방문,http://www.dailymedi.com/detail.php?number=840374&thread=22r05
1306,2019-02-25,성윤모산업통상자원부장관대웅제약오송스마트공장견학,http://www.edaily.co.kr/news/newspath.asp?newsid=04234486622394128
1307,2019-02-25,ET투자뉴스대웅지분변동윤재승외8명003p증가3814보유,http://www.etnews.com/20190225000426
1308,2019-02-25,25일마감보고대웅주가19850원마감,http://www.anewsa.com/detail.php?number=1565677&thread=10r04
1309,2019-02-25,성윤모산업부장관대웅제약오송스마트공장격려방문,https://www.insight.co.kr/news/212995
1310,2019-02-25,대웅제약직원대상컴플라이언스교육실시,http://www.lawissue.co.kr/view.php?ud=201902252009256152d7f4c63cc6_12
1311,2019-02-25,성윤모산자부장관오송대웅제약방문간담회,http://www.cctimes.kr/news/articleView.html?idxno=561487
1312,2019-02-25,대웅제약성윤모산업부장관방문윤재춘전승호사장과면담,http://www.getnews.co.kr/view.php?ud=201902252134061441d0c69529_16
1313,2019-02-25,대웅제약오송스마트공장성윤모산업부장관방문윤재춘전승호사장과면담가져,http://www.lawissue.co.kr/view.php?ud=20190225222842882d7f4c63cc6_12
1314,2019-02-26,성윤모장관대웅제약스마트공장찾아임직원격려 ,http://www.seoulfn.com/news/articleView.html?idxno=334781
1315,2019-02-26,주가정보26일대웅현재가20000원,http://www.anewsa.com/detail.php?number=1566331&thread=10r02
1316,2019-02-26,2월26일대웅정보및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=106934
1317,2019-02-26,2월26일대웅주식종목시세19900원025,http://www.nbntv.co.kr/news/articleView.html?idxno=231481
1318,2019-02-26,성윤모장관대웅제약오송공장방문신약개발투자지속,http://www.rapportian.com/news/articleView.html?idxno=116206
1319,2019-02-26,대웅제약주가2월26일현재194000원,http://www.gokorea.kr/news/articleView.html?idxno=107272
1320,2019-02-26,2월26일대웅제약주식현재가178193500원,http://www.nbntv.co.kr/news/articleView.html?idxno=231985
1321,2019-02-27,바른의료연구소식약처대웅제약우루사허위과장광고엄정처분내려야,http://www.medigatenews.com/news/1015413251
1322,2019-02-27,대웅사포그릴레이트서방정안플원자체생산재추진,http://www.dailypharm.com/Users/News/NewsView.html?ID=249866&REFERER=NP
1323,2019-02-27,부동산으로돈벌자대웅제약자산의89투자부동산,http://www.datanews.co.kr/news/article.html?no=102246
1324,2019-02-27,대웅제약우루사TV광고허위과장내용으로오남용부추겨,http://www.mdtoday.co.kr/mdtoday/index.html?no=347486
1325,2019-02-27,대웅주가증권투자정보27일현재19800원,http://www.gokorea.kr/news/articleView.html?idxno=108098
1326,2019-02-27,장중주가27일대웅주가19850원,http://www.anewsa.com/detail.php?number=1569476&thread=10r02
1327,2019-02-27,2월27일대웅주식창19850원075,http://www.nbntv.co.kr/news/articleView.html?idxno=233845
1328,2019-02-27,대웅제약우루사TV광고는거짓과장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84274
1329,2019-02-27,대웅제약직원대상컴플라이언스교육실시,http://www.wsobi.com/news/articleView.html?idxno=70147
1330,2019-02-27,2월27일대웅제약증권그래프외주식시황,http://www.gokorea.kr/news/articleView.html?idxno=108429
1331,2019-02-27,증권플러스대웅제약주가27일현재194000원,http://www.nbntv.co.kr/news/articleView.html?idxno=234382
1332,2019-02-27,대웅제약우루사허위과장광고엄정한처분내려야”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065707
1333,2019-02-27,27일공감마감정보대웅20000원마감,http://www.gokorea.kr/news/articleView.html?idxno=108903
1334,2019-02-28,2월28일대웅증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=109235
1335,2019-02-28,대웅주가및증권차트정보28일현재20250원증권시세,http://www.cctvnews.co.kr/news/articleView.html?idxno=106314
1336,2019-02-28,2월28일대웅투자주식20150원075,http://www.nbntv.co.kr/news/articleView.html?idxno=236225
1337,2019-02-28,주가정보28일대웅현재주식거래가격20200원,http://www.anewsa.com/detail.php?number=1573025&thread=10r02
1338,2019-02-28,대웅제약우루사광고허위과장논란,http://www.doctorsnews.co.kr/news/articleView.html?idxno=127918
1339,2019-02-28,대웅제약주가증권투자정보28일현재198000원,http://www.gokorea.kr/news/articleView.html?idxno=109593
1340,2019-02-28,퀵리포트대웅제약중립으로유지목표가미제시미래에셋대우,http://www.itooza.com/common/iview.php?no=2019022812443018378
1341,2019-02-28,주식실시간대웅제약주가28일현재199000원,http://www.nbntv.co.kr/news/articleView.html?idxno=236678
1342,2019-02-28,대웅올로스타암로디핀3제복합올로맥스허가,http://www.dailypharm.com/Users/News/NewsView.html?ID=249967&REFERER=NP
1343,2019-02-28,대웅제약고혈압3제복합제올로맥스식약처허가,http://www.medisobizanews.com/news/articleView.html?idxno=58187
1344,2019-02-28,대웅제약올로맥스허가고혈압약라인업구축,http://www.edaily.co.kr/news/newspath.asp?newsid=03588326622395112
1345,2019-02-28,대웅제약고혈압치료제풀라인업구축식약처올로맥스허가,http://kpenews.com/View.aspx?No=28715
1346,2019-02-28,대웅제약고혈압복합신약올로맥스허가획득200억대품목으로키울것”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1728292
1347,2019-02-28,대웅제약올로맥스허가고혈압치료제라인업구축,http://www.ebn.co.kr/news/view/974613
1348,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업구축,http://www.newsway.co.kr/news/view?tp=1&ud=2019022814551314395
1349,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227706
1350,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.fnnews.com/news/201902281500361419
1351,2019-02-28,대웅제약올로맥스식약처허가고혈압치료제완벽라인업구축,http://www.asiatime.co.kr/news/articleView.html?idxno=231152
1352,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.ekn.kr/news/article.html?no=417713
1353,2019-02-28,대웅제약올로맥스허가로고혈압치료제풀라인업구축,http://www.fetv.co.kr/news/article.html?no=21719
1354,2019-02-28,대웅제약고혈압치료제라인업추가‥올로맥스허가,http://medipana.com/news/news_viewer.asp?NewsNum=235282&MainKind=A&NewsKind=5&vCount=12&vKind=1
1355,2019-02-28,대웅제약올로맥스판매허가고혈압치료제라인업확대,http://www.newsis.com/view/?id=NISX20190228_0000573135&cID=13001&pID=13000
1356,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업강화,http://www.econovill.com/news/articleView.html?idxno=357612
1357,2019-02-28,대웅제약올로맥스허가고혈압치료제라인업구축,http://www.newsprime.co.kr/news/article.html?no=448943
1358,2019-02-28,대웅제약3제복합제올로맥스추가허가,http://www.sisafocus.co.kr/news/articleView.html?idxno=203741
1359,2019-02-28,대웅올로맥스허가항고혈압제라인업,http://www.bosa.co.kr/news/articleView.html?idxno=2100388
1360,2019-02-28,대웅제약세계첫복합개량신약으로고혈압이상지질혈증동시관리,http://daily.hankooki.com/lpage/ittech/201902/dh20190228153014145630.htm
1361,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업강화,http://news.bizwatch.co.kr/article/consumer/2019/02/28/0021/naver
1362,2019-02-28,대웅제약세계첫고혈압복합신약개발라인업완성,http://news.heraldcorp.com/view.php?ud=20190228000692
1363,2019-02-28,대웅제약3제복합제올로맥스허가고혈압치료제라인업강화,http://www.newstomato.com/ReadNews.aspx?no=879331
1364,2019-02-28,대웅제약개량신약올로맥스허가고혈압치료제라인업확대,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902280516&t=NN
1365,2019-02-28,대웅제약올로맥스허가고혈압치료제라인업구축,http://www.bokuennews.com/news/article.html?no=172286
1366,2019-02-28,대웅제약암로디핀추가한고혈압치료제올로맥스허가완료,http://www.seoulwire.com/news/articleView.html?idxno=78705
1367,2019-02-28,대웅제약고혈압3제복합제올로맥스허가획득,http://www.rapportian.com/news/articleView.html?idxno=116279
1368,2019-02-28,대웅제약고혈압고지혈증한꺼번에치료하는올로맥스허가받아,http://news.mk.co.kr/newsRead.php?year=2019&no=123783
1369,2019-02-28,대웅제약고혈압이상지혈증복합제올로맥스허가,http://www.seoulfn.com/news/articleView.html?idxno=335163
1370,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업,http://www.g-enews.com/ko-kr/news/article/news_all/2019022816532588fa075a9870_1/article.html
1371,2019-02-28,대웅제약3제복합개량고혈압치료제올로맥스허가오는5월출시,http://news.donga.com/3/all/20190228/94340158/2
1372,2019-02-28,대웅제약고혈압치료제올로맥스판매권획득,http://www.ezyeconomy.com/news/articleView.html?idxno=88537
1373,2019-02-28,대웅제약고혈압이상지질혈증관리올로맥스허가,http://view.asiae.co.kr/news/view.htm?idxno=2019022817140159151
1374,2019-02-28,대웅제약고혈압치료신약올로맥스식약처허가받아,http://www.insightkorea.co.kr//news/articleView.html?idxno=34219
1375,2019-02-28,대웅제약고혈압치료제올로맥스허가,http://www.wolyo.co.kr/news/articleView.html?idxno=78591
1376,2019-02-28,대웅제약3제고혈압복합제출격라인업구축,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019022815212694500
1377,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.lawissue.co.kr/view.php?ud=201902281735099667d7f4c63cc6_12
1378,2019-02-28,대웅제약올로맥스허가획득라인업구축완료,http://www.monews.co.kr/news/articleView.html?idxno=201104
1379,2019-02-28,대웅세계최초3제복합제올로맥스허가,http://www.dailymedi.com/detail.php?number=840503&thread=22r05
1380,2019-02-28,대웅제약올로맥스허가로고혈압치료제라인업강화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1145798
1381,2019-02-28,대웅제약올로스타허가로고혈압치료제라인업완성,http://www.ajunews.com/view/20190228180232065
1382,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.mdtoday.co.kr/mdtoday/index.html?no=347701
1383,2019-02-28,대웅제약고혈압치료복합제올로맥스5월에내놓기로,http://www.businesspost.co.kr/BP?command=article_view&num=116415
1384,2019-02-28,대웅제약올로맥스허가로고혈압치료제완벽라인업구축,http://www.newscj.com/news/articleView.html?idxno=606706
1385,2019-02-28,대웅제약복합개량신약올로맥스식약처허가,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84320
1386,2019-03-02,대웅제약3제복합제올로맥스내놓는다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065773
1387,2019-03-03,대웅오너리스크수습특별관계인자사주1만5천주매입,http://www.fetv.co.kr/news/article.html?no=21730
1388,2019-03-03,대웅제약3제복합제올로맥스로고혈압시장공략,http://www.viva100.com/main/view.php?key=20190303010000364
1389,2019-03-04,대웅제약나보타미국성과지켜볼때미래에셋대우,http://www.ajunews.com/view/20190303111848643
1390,2019-03-04,단독美무역위대웅제약나보타균주조사착수,http://news.mt.co.kr/mtview.php?no=2019030309031773757
1391,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수,http://www.edaily.co.kr/news/newspath.asp?newsid=01958166622420040
1392,2019-03-04,美ITC대웅제약에볼루스상대로불공정혐의조사착수,http://biz.newdaily.co.kr/site/data/html/2019/03/04/2019030400029.html
1393,2019-03-04,메디톡스美국제무역위대웅제약에볼루스의나보타균주탈취혐의조사착수”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1728932
1394,2019-03-04,특징주대웅제약美국제무역위나보타균주조사소식에↓,http://news.mt.co.kr/mtview.php?no=2019030409325838823
1395,2019-03-04,美무역위대웅나보타균주출처제조공정조사착수,http://www.newsis.com/view/?id=NISX20190304_0000575191&cID=13001&pID=13000
1396,2019-03-04,미무역위대웅나보타균주출처제조공정조사착수,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=50069
1397,2019-03-04,美국제무역위워회ITC대웅제약불공정행의조사착수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030409351474398
1398,2019-03-04,메디톡스美ITC대웅제약불공정행위혐의조사착수,http://news.hankyung.com/article/2019030463366
1399,2019-03-04,대웅제약급락으로18만원선무너져메디톡스대웅제약에볼루스불공정행위ITC공식조사착수,http://www.econonews.co.kr/news/articleView.html?idxno=55887
1400,2019-03-04,대웅제약발목잡기그만vs메디톡스지재권탈취한불공정행위,http://www.dailysmart.co.kr/news/articleView.html?idxno=7151
1401,2019-03-04,美국제무역위대웅제약등불공정행위조사착수,http://www.medisobizanews.com/news/articleView.html?idxno=58206
1402,2019-03-04,대웅투자주식4일현재18600원,http://www.nbntv.co.kr/news/articleView.html?idxno=238825
1403,2019-03-04,대웅제약나보타균주탈취관련ITC공식조사받는다,http://www.mhj21.com/119837
1404,2019-03-04,국내주가정보4일대웅거래가격18600원,http://www.anewsa.com/detail.php?number=1576796&thread=10r02
1405,2019-03-04,미국국제무역위원회대웅제약및에볼루스혐의조사착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=347802
1406,2019-03-04,특징주대웅제약불공정행위조사착수소식에약세,http://www.edaily.co.kr/news/newspath.asp?newsid=02299286622420040
1407,2019-03-04,메디톡스ITC대웅제약불공정행위조사착수,http://www.kpinews.co.kr/news/articleView.html?idxno=91637
1408,2019-03-04,특징주대웅제약미국국제무역위나보타균주조사소식에급락,http://www.asiatime.co.kr/news/articleView.html?idxno=231486
1409,2019-03-04,美국제무역委대웅․에볼루스조사착수,http://www.whosaeng.com/108335
1410,2019-03-04,특징주대웅제약메디톡스와지적재산권분쟁소식에급락,http://moneys.mt.co.kr/news/mwView.php?no=2019030410138014967
1411,2019-03-04,美ITC메디톡스제소한나보타조사착수대웅조사협조할것,http://news.mk.co.kr/newsRead.php?year=2019&no=128360
1412,2019-03-04,대웅제약美무역위나보타균주조사소식에약세,http://www.seoulwire.com/news/articleView.html?idxno=79222
1413,2019-03-04,메디톡스미국국제무역위원회대웅제약조사착수,http://www.enewstoday.co.kr/news/articleView.html?idxno=1276871
1414,2019-03-04,대웅제약美국제무역위나보타균주조사소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=347810
1415,2019-03-04,미국국제무역위대웅제약나보타균주출처조사착수,http://www.viva100.com/main/view.php?key=20190304010000508
1416,2019-03-04,메디톡스美국제무역위원회대웅제약나보타균주탈취조사착수,http://www.insightkorea.co.kr//news/articleView.html?idxno=34257
1417,2019-03-04,대웅제약이지적재산권탈취”혐의美ITC조사,http://news.heraldcorp.com/view.php?ud=20190304000267
1418,2019-03-04,메디톡스ITC대웅제약나보타균주출처조사착수,http://www.rapportian.com/news/articleView.html?idxno=116319
1419,2019-03-04,美ITC대웅제약에볼루스불공정혐의조사착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=250010&REFERER=NP
1420,2019-03-04,美무역위대웅제약나보타균주출처제조공정조사착수,http://www.straightnews.co.kr/news/articleView.html?idxno=44446
1421,2019-03-04,美국제무역위원회대웅제약나보타균주출처조사착수,http://www.newspim.com/news/view/20190304000278
1422,2019-03-04,메디톡스ITC대웅제약불공정행위공식조사착수,http://www.sisafocus.co.kr/news/articleView.html?idxno=203939
1423,2019-03-04,美국제무역위워회ITC대웅제약에볼루스불공정행위조사착수,http://ilyo.co.kr/?ac=article_view&entry_id=327352
1424,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수,http://daily.hankooki.com/lpage/ittech/201903/dh20190304111912145630.htm
1425,2019-03-04,메디톡스미국국제무역위원회대웅제약혐의조사착수,http://medipana.com/news/news_viewer.asp?NewsNum=235362&MainKind=A&NewsKind=5&vCount=12&vKind=1
1426,2019-03-04,메디톡스국제무역위대웅제약에볼루스공식조사,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227757
1427,2019-03-04,美ITC대웅제약나보타보툴리눔톡신균주조사나서,http://news1.kr/articles/?3561824
1428,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수,http://www.asiatoday.co.kr/view.php?key=20190304010001156
1429,2019-03-04,오늘주식시장대웅제약주가4일현재185000원,http://www.nbntv.co.kr/news/articleView.html?idxno=239339
1430,2019-03-04,대웅제약복합개량신약올로맥스고혈압이상지질혈증동시관리,http://www.100ssd.co.kr/news/articleView.html?idxno=59781
1431,2019-03-04,광동대웅제약제약업계서금융부동산재테크에가장열중,http://www.newsfc.co.kr/news/articleView.html?idxno=35451
1432,2019-03-04,美국제무역委대웅제약조사착수주가하락,http://www.dailymedi.com/detail.php?number=840577&thread=22r05
1433,2019-03-04,미국제무역위원회대웅제약및에볼루스조사착수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124772&REFERER=NP
1434,2019-03-04,美국제무역위원회대웅제약및에볼루스조사착수,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065810
1435,2019-03-04,메디톡스미무역위대웅제약불공정혐의조사,http://www.seoulfn.com/news/articleView.html?idxno=335352
1436,2019-03-04,메디톡스ITC대웅제약불공정행위에공식조사,http://moneys.mt.co.kr/news/mwView.php?no=2019030411318090370
1437,2019-03-04,ET투자뉴스대웅제약_거래비중기관1932외국인1762,http://www.etnews.com/20190304000250
1438,2019-03-04,미국국제무역위원회ITC대웅제약및에볼루스혐의조사착수대웅제약주가하락,http://medicalworldnews.co.kr/news/view.php?idx=1510929646
1439,2019-03-04,대웅제약나보타세계시장진출자신감피력ITC소송적극대응해진실밝힐것,http://www.segye.com/content/html/2019/03/04/20190304002377.html?OutUrl=naver
1440,2019-03-04,대웅제약불공정행위조사착수소식에주가급락,https://www.insight.co.kr/news/214316
1441,2019-03-04,대웅제약국제무역위원회ITC소송에적극적으로대응하여진실밝힐것,http://www.fetv.co.kr/news/article.html?no=21869
1442,2019-03-04,대웅제약무너진19만원선끊이지않는균주논란,http://www.skyedaily.com/news/news_view.html?ID=82407
1443,2019-03-04,대웅제약나보타FDA판매승인에따라올봄미국시장진출예정,http://www.seoulwire.com/news/articleView.html?idxno=79540
1444,2019-03-04,대웅제약메디톡스ITC조사에보톡스전쟁재점화대웅미국진출이상무,http://moneys.mt.co.kr/news/mwView.php?no=2019030413368024173
1445,2019-03-04,대웅제약메디톡스미ITC공식조사개시신경전,http://www.asiatoday.co.kr/view.php?key=20190304010001252
1446,2019-03-04,美국제무역위원회대웅제약및에볼루스혐의조사착수,http://www.newsway.co.kr/news/view?tp=1&ud=2019030413535734270
1447,2019-03-04,대웅제약국제무역위원회소송에적극대응할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2019030413571551936
1448,2019-03-04,대웅제약나보타ITC소송에적극적으로대응하겠다,http://www.asiatime.co.kr/news/articleView.html?idxno=231571
1449,2019-03-04,대웅제약거래량강세주가는335하락,http://www.tfnews.co.kr/news/article.html?no=62404
1450,2019-03-04,대웅제약메디톡스의美ITC제소무고책임묻겠다”,http://news.heraldcorp.com/view.php?ud=20190304000568
1451,2019-03-04,대웅제약나보타이상無진실밝혀질것,http://www.viva100.com/main/view.php?key=20190304010000711
1452,2019-03-04,대웅제약ITC소송적극대응무고책임묻겠다,http://www.monews.co.kr/news/articleView.html?idxno=201131
1453,2019-03-04,대웅제약메디톡스ITC소송적극대응할것,http://www.newsprime.co.kr/news/article.html?no=449205
1454,2019-03-04,대웅제약나보타올봄예정대로미국시장진출한다,http://www.businesskorea.co.kr/news/articleView.html?idxno=29633
1455,2019-03-04,대웅제약국제무역위원회소송에적극대응할것”,http://www.mdtoday.co.kr/mdtoday/index.html?no=347840
1456,2019-03-04,대웅제약나보타미국수출문제없다,http://www.koreaittimes.com/news/articleView.html?idxno=89534
1457,2019-03-04,대웅제약ITC제소접수에나보타美수출영향없어,http://www.medisobizanews.com/news/articleView.html?idxno=58218
1458,2019-03-04,대웅제약나보타글로벌진출자신ICT소송에문제없다”,http://kpenews.com/View.aspx?No=28901
1459,2019-03-04,대웅제약ITC소송적극대응해진실밝힐것”,http://daily.hankooki.com/lpage/ittech/201903/dh20190304141650145630.htm
1460,2019-03-04,대웅제약메디톡스허위주장나보타美수출영향없어,http://www.newsis.com/view/?id=NISX20190304_0000575808&cID=13001&pID=13000
1461,2019-03-04,대웅제약ITC소송에적극대응나보타진실밝힐것,http://www.g-enews.com/ko-kr/news/article/news_all/201903041423421007fa075a9870_1/article.html
1462,2019-03-04,대웅제약나보타미국진출앞두고날벼락무역위불공정행위조사,http://www.ezyeconomy.com/news/articleView.html?idxno=88566
1463,2019-03-04,대웅제약나보타올봄예정대로미국시장진출,http://www.economytalk.kr/news/articleView.html?idxno=180482
1464,2019-03-04,美국제무역위원회대웅제약나보타불공정혐의조사착수,http://biz.chosun.com/site/data/html_dir/2019/03/04/2019030401703.html
1465,2019-03-04,대웅제약나보타균주관련美ITC조사따른미국진출영향없어,http://news.mk.co.kr/newsRead.php?year=2019&no=129491
1466,2019-03-04,대웅제약나보타올봄예정대로출시자신감피력,http://medipana.com/news/news_viewer.asp?NewsNum=235378&MainKind=A&NewsKind=5&vCount=12&vKind=1
1467,2019-03-04,대웅제약미국국제무역위소송적극대응해진실밝힐것,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227762
1468,2019-03-04,메디톡스미무역위나보타균주조사착수대웅소송에적극대응,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903040266&t=NN
1469,2019-03-04,대웅제약나보타ITC소송강경대응예고,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019030414545302735&objId=A2019030414545302735&portalCode=naver
1470,2019-03-04,대웅제약ITC소송나보타수출에영향없어,http://news.mt.co.kr/mtview.php?no=2019030414433254515
1471,2019-03-04,대웅제약美ITC영업비밀침해소송에적극대응,http://www.dailypharm.com/Users/News/NewsView.html?ID=250018&REFERER=NP
1472,2019-03-04,대웅제약나보타국제무역위원회제소적극대응,http://www.kpanews.co.kr/article/show.asp?idx=201871&table=article&category=D
1473,2019-03-04,대웅제약ITC소송적극대응나보타예정대로美진출,http://news.hankyung.com/article/2019030482066
1474,2019-03-04,나보타균주관련美ITC조사착수대웅통상적절차일뿐,http://www.wolyo.co.kr/news/articleView.html?idxno=78691
1475,2019-03-04,국산보툴리눔톡신美출시앞메디톡스대웅제약또신경전,http://view.asiae.co.kr/news/view.htm?idxno=2019030415121297869
1476,2019-03-04,대웅제약메디톡스美소송에적극대응할것,http://www.edaily.co.kr/news/newspath.asp?newsid=03732646622420040
1477,2019-03-04,대웅제약ITC소송적극대응”천명,http://www.whosaeng.com/108355
1478,2019-03-04,대웅제약나보타세계시장진출자신감피력,http://www.ekn.kr/news/article.html?no=418273
1479,2019-03-04,대웅제약올로맥스허가로고혈압치료제라인업구축,http://www.wsobi.com/news/articleView.html?idxno=70341
1480,2019-03-04,ITC조사착수메디톡스기술탈취규명vs대웅제약무고책임묻겠다,http://www.newstomato.com/ReadNews.aspx?no=879788
1481,2019-03-04,대웅제약무고책임엄중히물을것”,http://www.enewstoday.co.kr/news/articleView.html?idxno=1277068
1482,2019-03-04,대웅제약ITC소송에적극대응나보타진출자신감피력,http://www.ajunews.com/view/20190304161428806
1483,2019-03-04,성윤모산업부장관대웅제약오송스마트공장방문윤재춘전승호사장과면담가져,http://www.wsobi.com/news/articleView.html?idxno=70357
1484,2019-03-04,대웅제약ITC소송적극대응진실밝힐것,http://www.sisafocus.co.kr/news/articleView.html?idxno=203967
1485,2019-03-04,메디톡스미국국제무역위원회ITC에대웅제약및에볼루스혐의조사착수,http://www.lawissue.co.kr/view.php?ud=201903041626502822d7f4c63cc6_12
1486,2019-03-04,메디톡스美무역위에나보타제소대웅제약재갈물리기,http://www.shinailbo.co.kr/news/articleView.html?idxno=1146489
1487,2019-03-04,대웅제약나보타글로벌진출자신있다”,http://www.econovill.com/news/articleView.html?idxno=357792
1488,2019-03-04,대웅제약메디톡스의美ITC제소무고책임묻겠다,https://www.insight.co.kr/news/214419
1489,2019-03-04,대웅제약나보타美수출앞두고소송근거없는주장책임묻겠다,http://www.ntoday.co.kr/news/articleView.html?idxno=65738
1490,2019-03-04,메디톡스vs대웅제약보톡스전쟁미국국제무역위조사파장,http://www.insightkorea.co.kr//news/articleView.html?idxno=34275
1491,2019-03-04,대웅제약나보타미국출시앞두고메디톡스공세에다시직면,http://www.businesspost.co.kr/BP?command=article_view&num=116787
1492,2019-03-04,대웅제약메디톡스美ITC제소무고책임묻겠다,http://www.dailymedi.com/detail.php?number=840600&thread=22r05
1493,2019-03-05,대웅제약경쟁업체방해행위정면대응나보타세계화자신감피력,http://www.wikileaks-kr.org/news/articleView.html?idxno=49257
1494,2019-03-05,메디톡스VS대웅제약보톡스전쟁미국서맞붙는다,http://www.hankookilbo.com/news/npath/201903041617736495?did=NA
1495,2019-03-05,대웅제약메디톡스미국서보톡스균주공방팽팽,http://www.rapportian.com/news/articleView.html?idxno=116332
1496,2019-03-05,증시현황5일대웅현재가19650원,http://www.anewsa.com/detail.php?number=1579943&thread=10r02
1497,2019-03-05,주가그래프대웅주가5일현재19650원,http://www.nbntv.co.kr/news/articleView.html?idxno=241124
1498,2019-03-05,대웅제약목표가4↑24만원제시케이프證,http://www.newspim.com/news/view/20190305000299
1499,2019-03-05,퀵리포트대웅제약매수유지목표가4↑24만원케이프證,http://www.itooza.com/common/iview.php?no=2019030510475419866
1500,2019-03-05,메디톡스대웅제약나보타의혹관련민형사상책임질것,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227816
1501,2019-03-05,3월5일대웅제약주가그래프185500원159,http://www.nbntv.co.kr/news/articleView.html?idxno=241606
1502,2019-03-05,대웅제약주가3월5일현재185500원,http://www.gokorea.kr/news/articleView.html?idxno=112052
1503,2019-03-05,메디톡스대웅제약나보타의혹관련모든민형사상책임질것,http://biz.newdaily.co.kr/site/data/html/2019/03/05/2019030500087.html
1504,2019-03-05,메디톡스대웅주장반박민형사책임지겠다,http://www.dailymedi.com/detail.php?number=840632&thread=22r05
1505,2019-03-05,메디톡스대웅제약나보타의혹관련문제있다면민형사상책임질것,http://www.mdtoday.co.kr/mdtoday/index.html?no=347979
1506,2019-03-05,메디톡스대웅제약보톡스나보타균주공방2라운드,http://www.newsis.com/view/?id=NISX20190305_0000577259&cID=13001&pID=13000
1507,2019-03-05,이상로의새빨간투자더블체크로추천주옥석가리기대웅제약경동나비엔인선이엔티外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030513573149829
1508,2019-03-05,메디톡스대웅제약나보타의혹모든민형사상책임진다”,http://www.edaily.co.kr/news/newspath.asp?newsid=03414486622420368
1509,2019-03-05,연일대웅제약때리는메디톡스,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065868
1510,2019-03-05,보톡스전쟁메디톡스VS대웅제약날선공방美출시앞둔나보타앞날은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1729876
1511,2019-03-05,메디톡스대웅제약끊이지않는포성공개토론하자”,http://news.heraldcorp.com/view.php?ud=20190305000680
1512,2019-03-05,대웅작년연간연결영업익857억전년비15↑,http://www.newspim.com/news/view/20190305000815
1513,2019-03-05,메디톡스대웅제약보톡스문제없으면즉각법적조치취해라,http://moneys.mt.co.kr/news/mwView.php?no=2019030517298048833
1514,2019-03-05,잠정실적대웅작년연간연결영업익857억전년비15↑,http://www.itooza.com/common/iview.php?no=2019030517472619217
1515,2019-03-05,대웅지난해영업이익857억전년比15↑,http://news.mt.co.kr/mtview.php?no=2019030517471311524
1516,2019-03-05,대웅제약작년4Q영업익46억전년비262↓,http://www.newspim.com/news/view/20190305000823
1517,2019-03-05,대웅제약작년연간연결영업익245억전년비369↓,http://www.newspim.com/news/view/20190305000824
1518,2019-03-05,실적속보대웅제약별도20184Q영업이익47억원전년비262감소,http://www.fntimes.com/html/view.php?ud=2019030517595974495dfa8d28c8_18
1519,2019-03-05,잠정실적대웅제약작년연간연결영업익245억전년비369↓,http://www.itooza.com/common/iview.php?no=2019030518003419597
1520,2019-03-05,대웅제약작년영업익307억전년대비311↓,http://view.asiae.co.kr/news/view.htm?idxno=2019030518035212216
1521,2019-03-05,대웅제약지난해영업이익245억전년比369↓,http://news.mt.co.kr/mtview.php?no=2019030518031922643
1522,2019-03-05,대웅제약작년영업익308억전년비31↓,http://www.dailypharm.com/Users/News/NewsView.html?ID=250075&REFERER=NP
1523,2019-03-05,한경로보뉴스실적속보대웅작년4Q영업이익대폭하락전분기대비238↓연결잠정,http://news.hankyung.com/article/201903053573L
1524,2019-03-05,대웅제약작년영업익246억원37감소,http://yna.kr/AKR20190305172800008?did=1195m
1525,2019-03-05,한경로보뉴스실적속보대웅제약작년4Q영업이익대폭하락전분기대비532↓연결잠정,http://news.hankyung.com/article/201903053620L
1526,2019-03-05,대웅제약지난해영업익246억전년보다369감소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730025
1527,2019-03-05,ITC조사로코너몰린대웅제약또다시무고죄언급,http://www.mhj21.com/119888
1528,2019-03-05,실적발표광전자SK폴리텍대웅제약,http://www.businesspost.co.kr/BP?command=article_view&num=116993
1529,2019-03-05,대웅제약빛바랜매출1조적자전환,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019030518493003757&objId=A2019030518493003757&portalCode=naver
1530,2019-03-05,대웅제약1조원매출시대활짝‥74↑1조314억달성,http://medipana.com/news/news_viewer.asp?NewsNum=235471&MainKind=A&NewsKind=5&vCount=12&vKind=1
1531,2019-03-05,실적발표동양파일서연이화대웅아이에이치큐,http://www.businesspost.co.kr/BP?command=article_view&num=116999
1532,2019-03-05,대웅제약지난해첫매출1조돌파영업익은37감소,http://news1.kr/articles/?3563513
1533,2019-03-05,대웅제약지난해매출1조원돌파이익률감소,http://www.medisobizanews.com/news/articleView.html?idxno=58249
1534,2019-03-05,대웅제약우루사TV광고바른의료연구소vs식품의약품안전처,http://medicalworldnews.co.kr/news/view.php?idx=1510929688
1535,2019-03-05,메디톡스대웅제약나보타의혹관련모든민형사상책임질것,http://www.lawissue.co.kr/view.php?ud=201903052257098676d7f4c63cc6_12
1536,2019-03-05,나보타미국국제무역위원회제소대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510929690
1537,2019-03-06,대웅제약우루사TV광고가의약품오남용부추겨,http://www.kukinews.com/news/article.html?no=636618
1538,2019-03-06,대웅무고주장에메디톡스공개토론나서라”,http://www.whosaeng.com/108397
1539,2019-03-06,대웅제약첫매출1조돌파전문약일반약하모니,http://www.dailypharm.com/Users/News/NewsView.html?ID=250078&REFERER=NP
1540,2019-03-06,대웅지난해영업익857억원전년비15증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=348026
1541,2019-03-06,전일5일주요공시대웅제약外,http://www.newsway.co.kr/news/view?tp=1&ud=2019030607521012104
1542,2019-03-06,대웅제약목표가30만원유지전일종가18만7500원KTB證,http://www.newspim.com/news/view/20190306000183
1543,2019-03-06,ET투자뉴스대웅제약18년4분기실적발표,http://www.etnews.com/20190306000006
1544,2019-03-06,ET투자뉴스대웅18년4분기실적발표매출액상승세유지,http://www.etnews.com/20190306000010
1545,2019-03-06,대웅제약목표가22만원유지전일종가18만7500원유안타證,http://www.newspim.com/news/view/20190306000090
1546,2019-03-06,퀵리포트대웅제약매수유지목표가22만원유지유안타證,http://www.itooza.com/common/iview.php?no=2019030608153910426
1547,2019-03-06,대웅제약vs메디톡스국내외서계속되는소송戰이유는,http://daily.hankooki.com/lpage/ittech/201903/dh20190306081531145630.htm
1548,2019-03-06,대웅제약나보타미국수출2분기에본격화KTB투자증권,http://www.ajunews.com/view/20190306082053182
1549,2019-03-06,I리포트대웅제약나보타미국수출이상無KTB證,http://www.inews24.com/view/1161917
1550,2019-03-06,대웅제약목표가24만원유지전일종가18만7500원신한금투,http://www.newspim.com/news/view/20190306000099
1551,2019-03-06,컨센미달대웅제약작년4Q영업익46억컨센비321↓,http://www.itooza.com/common/iview.php?no=2019030517595110175
1552,2019-03-06,퀵리포트대웅제약매수유지목표가24만원유지신한금투,http://www.itooza.com/common/iview.php?no=2019030608254815039
1553,2019-03-06,대웅제약2분기부터나보타실적가시화KTB투자증권,http://www.newstomato.com/ReadNews.aspx?no=880182
1554,2019-03-06,STOCK대웅제약나보타美수출실적기대감,http://moneys.mt.co.kr/news/mwView.php?no=2019030608348026829
1555,2019-03-06,대웅제약나보타효과로실적개선기대매수신한금융투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730081
1556,2019-03-06,대웅제약메디톡스보톡스균주진실게임전선미국으로확대,http://news.mk.co.kr/newsRead.php?year=2019&no=133823
1557,2019-03-06,HotLine대웅제약작년4분기실적부진보다나보타기대감에주목,http://news.mk.co.kr/newsRead.php?year=2019&no=133829
1558,2019-03-06,대웅제약올해확실한실적개선기대신한,http://www.ebn.co.kr/news/view/975216
1559,2019-03-06,신한금투대웅제약올해영업익48증가예상매수의견,http://www.newsis.com/view/?id=NISX20190306_0000578068&cID=10401&pID=10400
1560,2019-03-06,KTB證대웅제약나보타수출실적확인시상승본격화전망,http://www.newsis.com/view/?id=NISX20190306_0000578052&cID=10401&pID=10400
1561,2019-03-06,대웅제약2분기나보타미국수출본격화주가상승기대KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01685926622420696
1562,2019-03-06,대웅제약주가오를힘갖춰보톡스나보타미국수출본격화,http://www.businesspost.co.kr/BP?command=article_view&num=117031
1563,2019-03-06,DB금융투자대웅제약영업이익기대치하회수출실적관건”,http://www.g-enews.com/ko-kr/news/article/news_all/201903060849111212c642673384_1/article.html
1564,2019-03-06,하이로우대웅제약나보타로실적개선가시화KTB투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030608512667059
1565,2019-03-06,대웅제약올해매출1조원돌파기대신한금투,https://www.sedaily.com/NewsView/1VGHEY2OVN
1566,2019-03-06,대웅제약매출액1조달성기대,http://www.newsprime.co.kr/news/article.html?no=449526
1567,2019-03-06,대웅제약나보타美수출로올해실적긍정적KTB투자證,http://www.seoulfn.com/news/articleView.html?idxno=335598
1568,2019-03-06,대웅제약목표가23만원유지전일종가18만7500원하이투자證,http://www.newspim.com/news/view/20190306000160
1569,2019-03-06,대웅제약목표가5↑20만원제시DB금투,http://www.newspim.com/news/view/20190306000159
1570,2019-03-06,퀵리포트대웅제약보유유지목표가5↑20만원DB금투,http://www.itooza.com/common/iview.php?no=2019030609043715604
1571,2019-03-06,퀵리포트대웅제약매수유지목표가23만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019030609050717937
1572,2019-03-06,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019030607555517656
1573,2019-03-06,ET투자뉴스대웅제약4Q18RevieBUY유지유안타증권,http://www.etnews.com/20190306000038
1574,2019-03-06,특징주대웅제약실적개선전망에상승세,http://www.newsis.com/view/?id=NISX20190306_0000578126&cID=10401&pID=10400
1575,2019-03-06,특징주대웅제약니보타美수출기대감오름세,http://www.seoulfn.com/news/articleView.html?idxno=335611
1576,2019-03-06,ET투자뉴스대웅제약나보타미국수출BUYKTB투자증권,http://www.etnews.com/20190306000044
1577,2019-03-06,주식시세6일대웅주가20400원,http://www.anewsa.com/detail.php?number=1583047&thread=10r02
1578,2019-03-06,3월6일대웅주식종목검색20350원330,http://www.nbntv.co.kr/news/articleView.html?idxno=243295
1579,2019-03-06,ET투자뉴스대웅제약올해는확실한실적BUY유지신한금융투자,http://www.etnews.com/20190306000071
1580,2019-03-06,대웅주가3월6일현재20300원,http://www.gokorea.kr/news/articleView.html?idxno=112914
1581,2019-03-06,대웅제약1조클럽가입2018년최대매출경신,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124840&REFERER=NP
1582,2019-03-06,대웅제약신약개발박차연간매출1조돌파,http://www.g-enews.com/ko-kr/news/article/news_all/201903061014039968fa075a9870_1/article.html
1583,2019-03-06,대웅제약연결최대매출경신하며1조클럽가입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227844
1584,2019-03-06,대웅제약작년매출1조원돌파역대최고매출신기록,http://www.fetv.co.kr/news/article.html?no=22117
1585,2019-03-06,대웅제약지난해연간매출1조돌파최대매출경신,http://www.ekn.kr/news/article.html?no=418673
1586,2019-03-06,대웅제약작년영업익246억원전년比37감소,http://www.seoulfn.com/news/articleView.html?idxno=335628
1587,2019-03-06,대웅제약연매출1조첫돌파영업익은전년比37↓,http://www.edaily.co.kr/news/newspath.asp?newsid=02466566622420696
1588,2019-03-06,대웅제약2018년연결매출1조돌파최고기록경신,http://www.kpinews.co.kr/news/articleView.html?idxno=91841
1589,2019-03-06,1조클럽이지만대웅제약작년영업이익246억원전년比369↓,http://news.mk.co.kr/newsRead.php?year=2019&no=134286
1590,2019-03-06,대웅제약연간매출액1조314억원1조클럽가입,http://www.mhj21.com/119896
1591,2019-03-06,대웅제약사상최대매출로1조클럽입성수익성회복할것”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730164
1592,2019-03-06,대웅제약작년연간매출1조돌파최대매출경신,http://www.seoulwire.com/news/articleView.html?idxno=81521
1593,2019-03-06,대웅제약역대최고매출경신1조클럽가입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1277818
1594,2019-03-06,대웅제약1조클럽가입작년최대매출경신,http://yna.kr/AKR20190306060400017?did=1195m
1595,2019-03-06,대웅제약1조클럽가입쾌거2018년1조314억매출,http://www.viva100.com/main/view.php?key=20190306010001570
1596,2019-03-06,​​대웅제약지난해1조원돌파자체최대매출경신,http://medipana.com/news/news_viewer.asp?NewsNum=235497&MainKind=A&NewsKind=5&vCount=12&vKind=1
1597,2019-03-06,대웅제약나보타신약기대감높아작년매출1조돌파,http://kpenews.com/View.aspx?No=29037
1598,2019-03-06,대웅제약지난해연간매출1조돌파최대매출경신,http://www.wolyo.co.kr/news/articleView.html?idxno=78858
1599,2019-03-06,대웅제약1조클럽가입,https://www.sedaily.com/NewsView/1VGHFMB5K3
1600,2019-03-06,대웅제약1조클럽가입지난해매출1조314억원,http://view.asiae.co.kr/news/view.htm?idxno=2019030611012903651
1601,2019-03-06,대웅제약매출1조클럽입성영업이익은37감소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903060299&t=NN
1602,2019-03-06,대웅제약매출1조클럽가입제약사중6번째,http://www.newsway.co.kr/news/view?tp=1&ud=2019030611013517783
1603,2019-03-06,대웅제약영업익전년比37↓RD투자비증가탓,http://www.newsis.com/view/?id=NISX20190306_0000578370&cID=13001&pID=13000
1604,2019-03-06,대웅제약지난해영업익246억원전년비37↓,http://www.ebn.co.kr/news/view/975271
1605,2019-03-06,대웅제약4번째1조클럽최대매출갱신,http://www.doctorsnews.co.kr/news/articleView.html?idxno=127983
1606,2019-03-06,대웅제약지난해사상최대매출올해실적개선전망에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=348071
1607,2019-03-06,대웅제약1조클럽입성영업익은37감소,http://www.newspim.com/news/view/20190306000343
1608,2019-03-06,1조클럽입성대웅제약지난해영업익246억전년比369↓,http://biz.newdaily.co.kr/site/data/html/2019/03/06/2019030600057.html
1609,2019-03-06,대웅제약지난해사상최대매출1조클럽가입,http://www.insightkorea.co.kr//news/articleView.html?idxno=34333
1610,2019-03-06,대웅제약매출1조돌파올해FDA승인나보타기대,http://www.dt.co.kr/contents.html?article_no=2019030602109931102001&ref=naver
1611,2019-03-06,대웅제약지난해매출1조원돌파창사이래최대,http://www.ceoscoredaily.com/news/article.html?no=52755
1612,2019-03-06,대웅제약2018년연간매출1조돌파,http://www.fnnews.com/news/201903061115319305
1613,2019-03-06,대웅제약작년매출1조원돌파로최대치경신,http://news.heraldcorp.com/view.php?ud=20190306000359
1614,2019-03-06,ITC대웅제약조사착수가가진의미는,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030610553148793
1615,2019-03-06,대웅제약빛바랜매출1조창사이래최대실적인데당기순손실,http://biz.chosun.com/site/data/html_dir/2019/03/06/2019030601127.html
1616,2019-03-06,대웅제약연매출1조클럽가입,http://www.seoulfn.com/news/articleView.html?idxno=335635
1617,2019-03-06,대웅제약지난해매출1조달성처방약일반약동반성장,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030610353894317
1618,2019-03-06,대웅제약지난해영업이익246억매출액은사상최대,http://www.econonews.co.kr/news/articleView.html?idxno=56257
1619,2019-03-06,대웅제약2018년연간매출1조돌파최대매출경신,http://daily.hankooki.com/lpage/ittech/201903/dh20190306112712145630.htm
1620,2019-03-06,대웅제약나보타미국시장출하주시골드만삭스,http://www.choicenews.co.kr/news/articleView.html?idxno=48686
1621,2019-03-06,대웅제약매출1조클럽가입올해나보타로성장,http://www.biospectator.com/view/news_view.php?varAtcId=7238
1622,2019-03-06,결국ITC까지간나보타대웅제약메디톡스지재권분쟁재점화,http://news.heraldcorp.com/view.php?ud=20190306000363
1623,2019-03-06,대웅제약1조클럽가입지난해최대실적경신,http://www.segye.com/content/html/2019/03/06/20190306001631.html?OutUrl=naver
1624,2019-03-06,대웅제약지난해연매출사상최대1조314억원ETC와OTC지속성장,http://www.asiatime.co.kr/news/articleView.html?idxno=232072
1625,2019-03-06,대웅제약지난해연매출1조돌파1조클럽가입,http://www.sisafocus.co.kr/news/articleView.html?idxno=204138
1626,2019-03-06,주식종목검색대웅제약주가6일현재191500원,http://www.nbntv.co.kr/news/articleView.html?idxno=243799
1627,2019-03-06,대웅美파트너경쟁사출신부사장선임나보타대중화총력,http://news1.kr/articles/?3563948
1628,2019-03-06,실적대웅제약1조클럽입성영업익전년比37하락,http://www.ezyeconomy.com/news/articleView.html?idxno=88644
1629,2019-03-06,3월6일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=113257
1630,2019-03-06,대웅제약지난해연간매출1조돌파,http://www.100ssd.co.kr/news/articleView.html?idxno=59817
1631,2019-03-06,대웅제약매출1조클럽첫입성,http://www.dailymedi.com/detail.php?number=840670&thread=22r05
1632,2019-03-06,대웅제약2018년1조돌파로최대매출경신,http://www.bosa.co.kr/news/articleView.html?idxno=2100667
1633,2019-03-06,대웅제약지난해1조원매출돌파최대매출경신,http://www.metroseoul.co.kr/news/newsview?newscd=2019030600056
1634,2019-03-06,대웅제약1조클럽가입ETCOTC성장견인,http://www.newsprime.co.kr/news/article.html?no=449608
1635,2019-03-06,대웅제약1조클럽가입2018년매출1조314억원,http://www.monews.co.kr/news/articleView.html?idxno=201187
1636,2019-03-06,미FDAITC엇박자속대웅제약메디톡스보톡스공방재점화,http://www.asiatoday.co.kr/view.php?key=20190306010003012
1637,2019-03-06,대웅제약2018년연간매출1조돌파로최대매출경신,http://www.medigatenews.com/news/807116148
1638,2019-03-06,증시분석대웅제약창사이래첫1조클럽유한양행GC녹십자한미약품이어4번째,http://www.news2day.co.kr/121823
1639,2019-03-06,대웅제약매출1조시대열었지만영업익순익은뚝,http://www.ajunews.com/view/20190306134503640
1640,2019-03-06,대웅제약매출최고기록경신하며1조클럽가입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065914
1641,2019-03-06,대웅제약지난해매출1억돌파영업이익전년比369↓,http://moneys.mt.co.kr/news/mwView.php?no=2019030614348021177
1642,2019-03-06,대웅제약작년매출액1조314억원기록역대최고액경신,http://www.inthenews.co.kr/news/article.html?no=13931
1643,2019-03-06,메디톡스vs대웅제약끝나지않은공방같은사안두고시각차여전,http://biz.newdaily.co.kr/site/data/html/2019/03/06/2019030600125.html
1644,2019-03-06,대웅제약지난해매출1조314억원1조클럽가입,http://www.mdtoday.co.kr/mdtoday/index.html?no=348094
1645,2019-03-06,대웅제약매출1조클럽가입영업익은36하락,http://www.etnews.com/20190306000276
1646,2019-03-06,대웅제약지난해매출1조클럽가입전년비89늘어,http://www.kpanews.co.kr/article/show.asp?idx=201953&table=article&category=D
1647,2019-03-06,대웅美파트너사엘러간출신부사장영입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227877
1648,2019-03-06,대웅제약나보타美수출이상무2분기실적으로확인전망,http://www.newsworks.co.kr/news/articleView.html?idxno=341401
1649,2019-03-06,대웅제약작년매출1조314억기록1조클럽가입,http://www.rapportian.com/news/articleView.html?idxno=116371
1650,2019-03-06,대웅제약연매출1조원돌파기록경신,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84392
1651,2019-03-06,대웅제약2018년매출1조돌파영업익하락요인미래투자,http://www.econovill.com/news/articleView.html?idxno=357946
1652,2019-03-06,대웅제약올해영업이익455억원으로기저효과예상,http://www.newsworks.co.kr/news/articleView.html?idxno=341429
1653,2019-03-06,대웅제약2018년연간매출1조돌파,http://www.economytalk.kr/news/articleView.html?idxno=180665
1654,2019-03-06,공시대웅제약보통주1주당600원현금배당,http://www.newsway.co.kr/news/view?tp=1&ud=2019030616593557727
1655,2019-03-06,대웅제약세무조사150억폭탄첫순손실,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019030617002203221&objId=A2019030617002203221&portalCode=naver
1656,2019-03-06,대웅제약보통주1주당600원현금배당결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730515
1657,2019-03-06,대웅주당100원현금배당,http://view.asiae.co.kr/news/view.htm?idxno=2019030617122601155
1658,2019-03-06,대웅보통주1주당100원현금배당결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730526
1659,2019-03-06,대웅제약매출1조클럽가입,http://news.mk.co.kr/newsRead.php?year=2019&no=135911
1660,2019-03-06,대웅제약주당600원현금배당결정,http://news.heraldcorp.com/view.php?ud=20190306000737
1661,2019-03-06,대웅제약2018년연간매출1조돌파최대매출경신,http://www.ftoday.co.kr/news/articleView.html?idxno=107064
1662,2019-03-06,대웅주당100원현금배당결정,http://www.edaily.co.kr/news/newspath.asp?newsid=04077046622420696
1663,2019-03-06,굿닥터대웅제약LSKGlobalPS선택과집중으로글로벌무대서주목,http://www.nextdaily.co.kr/news/article.html?id=20190306800070
1664,2019-03-06,대웅제약2018년매출1조돌파로최대매출경신,http://www.getnews.co.kr/view.php?ud=20190306173426877341d0c69529_16
1665,2019-03-06,대웅제약2018년연간매출1조314억원을기록최대매출경신,http://www.lawissue.co.kr/view.php?ud=201903061734579373d7f4c63cc6_12
1666,2019-03-06,유가증권시장공시우리금융지주삼부토건대웅제약,http://news.mk.co.kr/newsRead.php?year=2019&no=136021
1667,2019-03-06,대웅제약마곡CD센터설립에705억원투자결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730549
1668,2019-03-06,대웅제약705억규모신규시설투자,http://www.edaily.co.kr/news/newspath.asp?newsid=04155766622420696
1669,2019-03-06,대웅제약705억규모신규시설투자,http://news.mt.co.kr/mtview.php?no=2019030617570546630
1670,2019-03-06,공시대웅제약705억원규모신규시설투자,http://www.newsway.co.kr/news/view?tp=1&ud=2019030617592078956
1671,2019-03-06,대웅제약연구개발위해마곡에CD센터건립705억원투자,http://www.ceoscoredaily.com/news/article.html?no=52802
1672,2019-03-06,대웅제약705억투자해마곡CD센터건립,http://view.asiae.co.kr/news/view.htm?idxno=2019030618114938549
1673,2019-03-06,RD의힘대웅제약매출1조클럽가입,http://www.dt.co.kr/contents.html?article_no=2019030702101531102001&ref=naver
1674,2019-03-06,대웅제약1조클럽첫가입작년매출1조314억원 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1147321
1675,2019-03-06,대웅제약마곡CD센터에705억규모투자,http://www.dailian.co.kr/news/view/777265/?sc=naver
1676,2019-03-06,대웅제약705억원규모CD센터신규시설투자,http://www.newspim.com/news/view/20190306000938
1677,2019-03-06,대웅제약마곡신규센터구축에705억원투자,http://www.etnews.com/20190306000411
1678,2019-03-06,대웅제약705억투자통해마곡CD센터건립,https://www.sedaily.com/NewsView/1VGHH9EMJL
1679,2019-03-06,대웅주당100원현금배당,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903060591&t=NN
1680,2019-03-06,대웅제약주당600원현금배당,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903060585&t=NN
1681,2019-03-06,대웅제약마곡CD센터건립에705억원투자,http://www.dailypharm.com/Users/News/NewsView.html?ID=250125&REFERER=NP
1682,2019-03-06,대웅제약2018년연간매출1조돌파로최대매출경신,http://www.newscj.com/news/articleView.html?idxno=608704
1683,2019-03-06,실적발표롯데칠성음료대상한국토지신탁대웅제약,http://www.businesspost.co.kr/BP?command=article_view&num=117203
1684,2019-03-06,실적발표대웅한국전력공사제낙스SK증권,http://www.businesspost.co.kr/BP?command=article_view&num=117217
1685,2019-03-06,대웅제약마곡CD센터설립에705억원투자,http://medipana.com/news/news_viewer.asp?NewsNum=235536&MainKind=A&NewsKind=5&vCount=12&vKind=1
1686,2019-03-06,대웅제약나보타의세계시장진출자신감피력,http://www.wsobi.com/news/articleView.html?idxno=70473
1687,2019-03-06,대웅제약나보타효과기대감고조,http://www.wsobi.com/news/articleView.html?idxno=70476
1688,2019-03-07,대웅제약2018년연간매출1조원돌파최대매출경신,http://www.nextdaily.co.kr/news/article.html?id=20190306800069
1689,2019-03-07,㈜대웅윤재춘대표이사재선임열차에합류,http://medipana.com/news/news_viewer.asp?NewsNum=235539&MainKind=A&NewsKind=5&vCount=12&vKind=1
1690,2019-03-07,대웅제약2018년1조클럽가입자사최대매출경신,http://www.wikileaks-kr.org/news/articleView.html?idxno=49484
1691,2019-03-07,대웅제약마곡CD센터구축에705억원투자결정,http://www.itooza.com/common/iview.php?no=2019030708410964065
1692,2019-03-07,대웅제약지난해매출1조돌파최대기록,http://www.bokuennews.com/news/article.html?no=172534
1693,2019-03-07,빅데이터MSI시장심리톱5LG전자삼성화재LS대웅제약삼성물산,http://www.newsis.com/view/?id=NISX20190307_0000579548&cID=10401&pID=10400
1694,2019-03-07,대웅제약마곡CD센터건립705억신규시설투자,http://www.mdtoday.co.kr/mdtoday/index.html?no=348164
1695,2019-03-07,ET투자뉴스대웅제약흔들리지말고나보BUY유지하이투자증권,http://www.etnews.com/20190307000043
1696,2019-03-07,장중주가7일대웅현재가격19900원,http://www.anewsa.com/detail.php?number=1586237&thread=10r02
1697,2019-03-07,대웅제약주가오를힘충분보톡스제품미국수출로매출밝아,http://www.businesspost.co.kr/BP?command=article_view&num=117241
1698,2019-03-07,3월7일대웅오늘주식시장19950원025,http://www.nbntv.co.kr/news/articleView.html?idxno=245843
1699,2019-03-07,대웅주가3월7일현재19950원,http://www.gokorea.kr/news/articleView.html?idxno=114004
1700,2019-03-07,대웅제약매출1조클럽가입최대매출경신,http://www.upinews.kr/news/newsview.php?ncode=1065573761463608
1701,2019-03-07,아통경제7일대웅현재가격19900원,http://www.anewsa.com/detail.php?number=1586319&thread=10r02
1702,2019-03-07,3월7일대웅주식창05019900원,http://www.nbntv.co.kr/news/articleView.html?idxno=245922
1703,2019-03-07,대웅보통주1주당100원현금배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=348185
1704,2019-03-07,대웅제약보통주1주당600원현금결산배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=348188
1705,2019-03-07,3월7일대웅제약금일증시132187500원,http://www.nbntv.co.kr/news/articleView.html?idxno=246819
1706,2019-03-07,대웅제약종목검색7일현재188000원,http://www.nbntv.co.kr/news/articleView.html?idxno=246890
1707,2019-03-07,3월7일대웅제약오늘시세외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=114327
1708,2019-03-07,대웅제약지난해매출89증가,http://www.wsobi.com/news/articleView.html?idxno=70512
1709,2019-03-07,대웅제약ETCOTC지속성장1조클럽자양분,http://www.polinews.co.kr/news/article.html?no=384479
1710,2019-03-07,분석대웅바이오매출2767억영업익54증가순익94감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227923
1711,2019-03-07,7일마감보고대웅주가19400원으로마감,http://www.anewsa.com/detail.php?number=1589371&thread=10r04
1712,2019-03-07,대웅제약1000억투자마곡CD센터설립,http://www.dailymedi.com/detail.php?number=840724&thread=22r05
1713,2019-03-08,대웅제약705억들여마곡CD센터건립추진,http://www.news2day.co.kr/121985
1714,2019-03-08,국내주가정보8일대웅현재주식거래가격19500원,http://www.anewsa.com/detail.php?number=1590030&thread=10r02
1715,2019-03-08,대웅주가3월8일현재19450원,http://www.gokorea.kr/news/articleView.html?idxno=115177
1716,2019-03-08,3월8일대웅주식시세현황00019400원,http://www.nbntv.co.kr/news/articleView.html?idxno=248803
1717,2019-03-08,대웅제약지난해연매출1조돌파최대매출경신,https://www.insight.co.kr/news/214786
1718,2019-03-08,MSI급락주대웅제약어닝쇼크에시장심리↓,http://www.newsis.com/view/?id=NISX20190308_0000581253&cID=10401&pID=10400
1719,2019-03-08,대웅제약개발폐섬유증치료제신약개발지원대상선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=7458
1720,2019-03-08,대웅제약폐섬유증혁신신약정부과제선정글로벌임상지원,http://www.medisobizanews.com/news/articleView.html?idxno=58301
1721,2019-03-08,대웅제약세계최초특발성폐섬유증치료제개발지원받는다,http://www.seoulwire.com/news/articleView.html?idxno=83718
1722,2019-03-08,대웅제약폐섬유증저해제신약정부지원과제선정,http://www.ezyeconomy.com/news/articleView.html?idxno=88716
1723,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.fetv.co.kr/news/article.html?no=22360
1724,2019-03-08,대웅제약폐섬유증치료제정부지원과제선정,http://www.wolyo.co.kr/news/articleView.html?idxno=79057
1725,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.koreaittimes.com/news/articleView.html?idxno=89587
1726,2019-03-08,대웅제약폐섬유증치료제연구정부지원과제선정,http://www.rapportian.com/news/articleView.html?idxno=116417
1727,2019-03-08,대웅제약폐섬유증약후보물질범부처신약개발사업단지원대상선정,http://news.mk.co.kr/newsRead.php?year=2019&no=140532
1728,2019-03-08,대웅제약폐섬유증신약정부지원과제로선정,http://yna.kr/AKR20190308085600017?did=1195m
1729,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.newsway.co.kr/news/view?tp=1&ud=2019030813301221093
1730,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://daily.hankooki.com/lpage/ittech/201903/dh20190308133041145630.htm
1731,2019-03-08,대웅폐섬유증신약KDDF과제선정올해1상,http://www.biospectator.com/view/news_view.php?varAtcId=7252
1732,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.medigatenews.com/news/1018343666
1733,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019030813121441404
1734,2019-03-08,대웅제약폐섬유증신약정부지원임상연구비수혜,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124916&REFERER=NP
1735,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227953
1736,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.ekn.kr/news/article.html?no=419216
1737,2019-03-08,대웅제약폐섬유증신약개발비지원받는다정부과제선정,http://news1.kr/articles/?3566294
1738,2019-03-08,대웅제약PRS저해제DWN12088정부지원과제선정,http://medipana.com/news/news_viewer.asp?NewsNum=235645&MainKind=A&NewsKind=5&vCount=12&vKind=1
1739,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.seoulfn.com/news/articleView.html?idxno=336015
1740,2019-03-08,대웅폐섬유증신약개발가속도붙다,http://www.whosaeng.com/108469
1741,2019-03-08,대웅제약오늘증권시세8일현재185500원,http://www.nbntv.co.kr/news/articleView.html?idxno=249426
1742,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.fnnews.com/news/201903081444315390
1743,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.dailian.co.kr/news/view/777845/?sc=naver
1744,2019-03-08,대웅제약폐섬유증신약DWN12088정부과제선정,http://kormedi.com/?p=1283823
1745,2019-03-08,대웅제약폐섬유증치료제범부처신약개발사업단연구비지원사업선정,https://www.sedaily.com/NewsView/1VGIDQO3OJ
1746,2019-03-08,대웅제약폐섬유증신약정부지원과제선정임상1상비임상연구비지원,http://news.donga.com/3/all/20190308/94450548/2
1747,2019-03-08,대웅제약주가종목그래프8일현재184500원,http://www.gokorea.kr/news/articleView.html?idxno=115795
1748,2019-03-08,대웅제약폐섬유증치료제정부의신약개발지원대상에뽑혀,http://www.businesspost.co.kr/BP?command=article_view&num=117499
1749,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,https://www.sedaily.com/NewsView/1VGIE8086H
1750,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.viva100.com/main/view.php?key=20190308010002673
1751,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.newsprime.co.kr/news/article.html?no=450028
1752,2019-03-08,대웅제약폐섬유증신약정부지원에개발가속화,http://moneys.mt.co.kr/news/mwView.php?no=2019030815178042898
1753,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제로선정,http://www.mhj21.com/119977
1754,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1731449
1755,2019-03-08,대웅제약폐섬유증신약정부지원과제선정임상연구비수혜,http://www.inthenews.co.kr/news/article.html?no=13995
1756,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.ebn.co.kr/news/view/975674
1757,2019-03-08,대웅제약정부지원으로폐섬유증신약개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066023
1758,2019-03-08,대웅제약폐섬유증신약DWN12088신약개발사업지원대상선정,http://www.k-health.com/news/articleView.html?idxno=42798
1759,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://view.asiae.co.kr/news/view.htm?idxno=2019030816075552182
1760,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.ceoscoredaily.com/news/article.html?no=52881
1761,2019-03-08,분석대웅제약1조314억판관비상품매출증가수출감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227963
1762,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.100ssd.co.kr/news/articleView.html?idxno=59882
1763,2019-03-08,대웅제약개발중PRS저해제정부지원과제선정  ,http://www.monews.co.kr/news/articleView.html?idxno=201247
1764,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정글로벌신약기술수출발판마련할것,http://www.segye.com/content/html/2019/03/08/20190308003095.html?OutUrl=naver
1765,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2100867
1766,2019-03-08,장마감보고서8일대웅주가19350원마감해,http://www.anewsa.com/detail.php?number=1591923&thread=10r04
1767,2019-03-08,대웅특발성폐섬유증후보범부처사업단과제선정,http://www.dailypharm.com/Users/News/NewsView.html?ID=250190&REFERER=NP
1768,2019-03-08,8일공감마감정보대웅19350원마감,http://www.gokorea.kr/news/articleView.html?idxno=116183
1769,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.getnews.co.kr/view.php?ud=20190308171401914941d0c69529_16
1770,2019-03-08,대웅제약폐섬유증신약정부지원과제로선정,http://www.dt.co.kr/contents.html?article_no=2019030802109931102005&ref=naver
1771,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.ftoday.co.kr/news/articleView.html?idxno=107123
1772,2019-03-08,대웅제약폐섬유증신약정부지원과제선정임상시험7월중개시방침,https://www.insight.co.kr/news/215249
1773,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.economytalk.kr/news/articleView.html?idxno=180857
1774,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.bokuennews.com/news/article.html?no=172654
1775,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.econovill.com/news/articleView.html?idxno=358157
1776,2019-03-08,대웅제약폐섬유증치료제후보물질정부지원과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=348387
1777,2019-03-08,대웅제약폐섬유증신약정부지원과제선정,http://www.newscj.com/news/articleView.html?idxno=609473
1778,2019-03-08,대웅제약폐섬유증신약DWN12088정부지원과제선정돼,http://www.kpanews.co.kr/article/show.asp?idx=202035&table=article&category=D
1779,2019-03-09,대웅제약폐섬유증신약개발연구사업정부우선순위로책정,http://www.wikileaks-kr.org/news/articleView.html?idxno=49682
1780,2019-03-09,제약산업소식대웅제약일동제약일양약품동아제약,http://www.kukinews.com/news/article.html?no=639579
1781,2019-03-10,제약바이오한주간이모저모메디톡스VS대웅제약균주기원싸움재점화등,http://www.edaily.co.kr/news/newspath.asp?newsid=01207046622422008
1782,2019-03-10,대웅제약폐섬유증신약정부지원과제선정연구개발비지원,http://www.asiatime.co.kr/news/articleView.html?idxno=232537
1783,2019-03-11,제약빅5영업이익률최대폭하락녹십자2년연속꼴찌대웅제약,http://www.datanews.co.kr/news/article.html?no=102371
1784,2019-03-11,대웅제약50년역사성남공장폐쇄,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019031108311300336&objId=A2019031108311300336&portalCode=naver
1785,2019-03-11,10대제약사사외이사절반이상교수기업인출신대웅만대학병원경영임원선임,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=530225
1786,2019-03-11,주식추천주대웅주가11일현재19100원,http://www.nbntv.co.kr/news/articleView.html?idxno=251392
1787,2019-03-11,대웅주가3월11일현재18900원,http://www.gokorea.kr/news/articleView.html?idxno=116661
1788,2019-03-11,아통증시11일대웅거래가격19050원,http://www.anewsa.com/detail.php?number=1593864&thread=10r02
1789,2019-03-11,대웅제약주가3월11일현재179500원,http://www.gokorea.kr/news/articleView.html?idxno=116871
1790,2019-03-11,대웅제약폐섬유증신약정부지원과제선정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84469
1791,2019-03-11,대웅폐섬유증신약DWN12088지원과제선정,http://www.dailymedi.com/detail.php?number=840811&thread=22r05
1792,2019-03-11,ET투자뉴스대웅제약_상장주식수대비거래량은054로적정수준,http://www.etnews.com/20190311000153
1793,2019-03-11,장마감보고서11일대웅주가19300원으로장마감,http://www.anewsa.com/detail.php?number=1596267&thread=10r04
1794,2019-03-11,대웅제약반토막난복리후생비급증한광고비왜,http://www.sisajournal-e.com/news/articleView.html?idxno=196841
1795,2019-03-11,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.wsobi.com/news/articleView.html?idxno=70629
1796,2019-03-12,스마트FOCUS보툴리눔톡신전쟁대웅제약vs메디톡스승자는,http://www.dailysmart.co.kr/news/articleView.html?idxno=7557
1797,2019-03-12,한올바이오파마대웅안구건조증신약미국임상3상환자투약돌입,http://news.mk.co.kr/newsRead.php?year=2019&no=146820
1798,2019-03-12,대웅제약한올바이오파마안구건조증신약美3상착수,http://www.medisobizanews.com/news/articleView.html?idxno=58358
1799,2019-03-12,대웅제약한올안구건조증신약미국3상개시,http://www.dailypharm.com/Users/News/NewsView.html?ID=250271&REFERER=NP
1800,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.ebn.co.kr/news/view/975997
1801,2019-03-12,대웅제약나보타미국FDA승인기념심포지엄개최,http://www.seoulwire.com/news/articleView.html?idxno=85619
1802,2019-03-12,대웅제약나보타미FDA승인기념심포지엄개최,http://www.fnnews.com/news/201903120911500925
1803,2019-03-12,대웅제약나보타 美 FDA 승인기념심포지엄 개최,http://www.fetv.co.kr/news/article.html?no=22629
1804,2019-03-12,대웅제약나보타미국진출기념심포지엄개최,http://moneys.mt.co.kr/news/mwView.php?no=2019031209048074164
1805,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,https://www.sedaily.com/NewsView/1VGK77UCJT
1806,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.viva100.com/main/view.php?key=20190312010003629
1807,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.g-enews.com/ko-kr/news/article/news_all/201903120928303915fa075a9870_1/article.html
1808,2019-03-12,대웅제약나보타美FDA승인기념심포지엄,http://www.dailypharm.com/Users/News/NewsView.html?ID=250276&REFERER=NP
1809,2019-03-12,대웅제약美FDA의나보타승인기념심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2019&no=147109
1810,2019-03-12,장중주가12일대웅증시현황19500원,http://www.anewsa.com/detail.php?number=1597103&thread=10r02
1811,2019-03-12,대웅제약나보타美FDA승인기념심포지엄,http://www.k-health.com/news/articleView.html?idxno=42848
1812,2019-03-12,대웅제약美FDA나보타승인기념심포지엄개최,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903120153&t=NN
1813,2019-03-12,대웅나보타FDA승인기념심포지엄성료,http://www.dailymedi.com/detail.php?number=840849&thread=22r05
1814,2019-03-12,대웅제약미국진출나보타기대높아FDA승인기념전문가심포지엄,http://kpenews.com/View.aspx?No=29376
1815,2019-03-12,대웅제약나보타美FDA승인기념심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2101037
1816,2019-03-12,한올대웅안구건조증신약미국서임상3상,http://www.bosa.co.kr/news/articleView.html?idxno=2101035
1817,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019031210042557165
1818,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최시술법도공유,https://www.insight.co.kr/news/215814
1819,2019-03-12,대웅제약나보타美FDA승인기념심포지엄성료,http://www.bokuennews.com/news/article.html?no=172744
1820,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.wolyo.co.kr/news/articleView.html?idxno=79223
1821,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,http://yna.kr/AKR20190312061400017?did=1195m
1822,2019-03-12,대웅제약나보타FDA승인기념심포지엄,http://news.mt.co.kr/mtview.php?no=2019031210332930284
1823,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,https://www.sedaily.com/NewsView/1VGK7EE49I
1824,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=7589
1825,2019-03-12,한올바이오파마대웅제약안구건조증신약美3상개시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066122
1826,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.economytalk.kr/news/articleView.html?idxno=181080
1827,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최,http://www.ezyeconomy.com/news/articleView.html?idxno=88799
1828,2019-03-12,한울바이오파마대웅제약안구건조증치료제HL036임상개시,http://www.seoulwire.com/news/articleView.html?idxno=85946
1829,2019-03-12,주식그래프대웅제약주가12일현재184000원,http://www.nbntv.co.kr/news/articleView.html?idxno=254500
1830,2019-03-12,대웅제약나보타미국FDA승인기념심포지엄개최,http://www.econovill.com/news/articleView.html?idxno=358371
1831,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,http://www.asiatoday.co.kr/view.php?key=20190312010006413
1832,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최성황리에마무리,http://www.ftoday.co.kr/news/articleView.html?idxno=107187
1833,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.ekn.kr/news/article.html?no=419847
1834,2019-03-12,뉴스투데이L대웅제약나보타FDA승인기념심포지엄개최,http://www.news2day.co.kr/122266
1835,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066128
1836,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019031200067
1837,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최글로벌브랜드위상다져나갈것,http://www.segye.com/content/html/2019/03/12/20190312509043.html?OutUrl=naver
1838,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=348631
1839,2019-03-12,대웅제약한올바이오파마안구건조증신약미국임상3상시작,http://www.businesspost.co.kr/BP?command=article_view&num=117978
1840,2019-03-12,대웅제약나보타美FDA승인기념심포지엄성황리개최,http://www.wikileaks-kr.org/news/articleView.html?idxno=49951
1841,2019-03-12,대웅제약나보타美FDA승인심포지엄개최,http://www.asiatime.co.kr/news/articleView.html?idxno=233203
1842,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최,http://www.newstomato.com/ReadNews.aspx?no=881668
1843,2019-03-12,대웅제약나보타품질안전성뛰어나,http://www.finomy.com/news/articleView.html?idxno=63682
1844,2019-03-12,대웅제약폐섬유증신약DWN12088정부지원과제선정,http://www.munhwa.com/news/view.html?no=20190312MW163522685774
1845,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.100ssd.co.kr/news/articleView.html?idxno=59936
1846,2019-03-12,장종리포트대웅주가20050원으로장마감,http://www.anewsa.com/detail.php?number=1599507&thread=10r04
1847,2019-03-12,한올바이오대웅제약안구건조증신약미국임상3상개시,http://www.seoulfn.com/news/articleView.html?idxno=336418
1848,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.getnews.co.kr/view.php?ud=20190312173408209441d0c69529_16
1849,2019-03-12,대웅제약복리후생비줄고광고선전비확늘어난까닭은,http://www.insightkorea.co.kr//news/articleView.html?idxno=34583
1850,2019-03-12,대웅제약나보타FDA승인기념심포지엄개최 ,http://www.monews.co.kr/news/articleView.html?idxno=201320
1851,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=610687
1852,2019-03-12,대웅제약나보타FDA승인기념심포지엄열어,http://www.kpanews.co.kr/article/show.asp?idx=202135&table=article&category=D
1853,2019-03-12,대웅제약나보타美FDA승인기념심포지엄개최,http://www.lawissue.co.kr/view.php?ud=201903122218472709d7f4c63cc6_12
1854,2019-03-13,대웅제약소화기계질환최강자로서의면모입증,http://www.bosa.co.kr/news/articleView.html?idxno=2101116
1855,2019-03-13,기획유한양행대웅제약한미약품1조클럽의힘은안정적캐시카우,http://daily.hankooki.com/lpage/column/201903/dh20190313080014145650.htm
1856,2019-03-13,더벨대웅제약1조클럽1등공신은전승호대표,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903120100017220001097
1857,2019-03-13,매출1조클럽대웅제약적자전환에잉여현금흐름마이너스자금사정문제없나,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=530363
1858,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=02013926622422992
1859,2019-03-13,대웅제약나보타中시장진출초읽기,http://www.kpinews.co.kr/news/articleView.html?idxno=92277
1860,2019-03-13,장중시세13일대웅증시현황20600원,http://www.anewsa.com/detail.php?number=1600267&thread=10r02
1861,2019-03-13,대웅제약나보타올하반기중국임상3상돌입전망,http://biz.newdaily.co.kr/site/data/html/2019/03/13/2019031300027.html
1862,2019-03-13,대웅제약中나보타3상올해하반기돌입,http://www.biospectator.com/view/news_view.php?varAtcId=7277
1863,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.ekn.kr/news/article.html?no=420027
1864,2019-03-13,대웅제약나보타해외진출가속화올하반기중국서임상3상진행,http://moneys.mt.co.kr/news/mwView.php?no=2019031309228081208
1865,2019-03-13,대웅제약나보타中진출박차하반기임상3상돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1732857
1866,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2019031309323100499
1867,2019-03-13,3월13일대웅증권투자정보및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=119131
1868,2019-03-13,대웅제약나보타미국이어중국진출가속화,http://www.seoulwire.com/news/articleView.html?idxno=86679
1869,2019-03-13,대웅제약올하반기나보타중국임상3상돌입,http://www.newspim.com/news/view/20190313000216
1870,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.ceoscoredaily.com/news/article.html?no=53006
1871,2019-03-13,대웅제약나보타올하반기중국임상3상돌입 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1148960
1872,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.bokuennews.com/news/article.html?no=172812
1873,2019-03-13,3월13일대웅주가차트17520400원,http://www.nbntv.co.kr/news/articleView.html?idxno=256395
1874,2019-03-13,대웅제약나보타하반기中임상3상돌입제조시설변경승인,http://www.viva100.com/main/view.php?key=20190313010004131
1875,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228111
1876,2019-03-13,대웅제약나보타中임상시험신청승인하반기임상3상진행,http://www.ajunews.com/view/20190313094831740
1877,2019-03-13,대웅제약나보타중국진출속도하반기임상3상착수,http://www.medisobizanews.com/news/articleView.html?idxno=58397
1878,2019-03-13,대웅제약나보타중국진출본격화임상시설제조시설변경승인받아,http://kpenews.com/View.aspx?No=29458
1879,2019-03-13,대웅제약나보타올해하반기중국임상3상돌입현지진출박차,https://www.insight.co.kr/news/216021
1880,2019-03-13,대웅제약나보타제조시설변경中승인,http://news.mt.co.kr/mtview.php?no=2019031309375052204
1881,2019-03-13,대웅제약중국서하반기나보타임상3상돌입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903130199&t=NN
1882,2019-03-13,대웅제약나보타하반기中임상3상돌입,http://www.newsis.com/view/?id=NISX20190313_0000585703&cID=13001&pID=13000
1883,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.econovill.com/news/articleView.html?idxno=358446
1884,2019-03-13,대웅제약나보타제조시설변경중국CFDA최종승인,http://www.fnnews.com/news/201903131011037521
1885,2019-03-13,대웅제약올해하반기부터나보타중국임상3상돌입,http://news.mk.co.kr/newsRead.php?year=2019&no=150198
1886,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.dailian.co.kr/news/view/778872/?sc=naver
1887,2019-03-13,대웅제약나보타中임상3상승인하반기시작,http://news1.kr/articles/?3569774
1888,2019-03-13,대웅제약올하반기나보타中임상3상돌입,http://view.asiae.co.kr/news/view.htm?idxno=2019031310361479517
1889,2019-03-13,대웅제약주가3월13일현재188000원,http://www.gokorea.kr/news/articleView.html?idxno=119322
1890,2019-03-13,대웅제약나보타하반기중임상돌입,http://www.straightnews.co.kr/news/articleView.html?idxno=45117
1891,2019-03-13,대웅제약나보타올해하반기에중국임상3상돌입,http://www.rapportian.com/news/articleView.html?idxno=116511
1892,2019-03-13,대웅제약나보타中본격진출하반기중임상시험3상돌입,https://www.sedaily.com/NewsView/1VGKN4BNVN
1893,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.wolyo.co.kr/news/articleView.html?idxno=79296
1894,2019-03-13,대웅제약나보타올하반기중국임상3상진행,http://www.insightkorea.co.kr//news/articleView.html?idxno=34620
1895,2019-03-13,대웅제약나보타하반기中임상3상돌입,http://www.g-enews.com/ko-kr/news/article/news_all/201903131053305661fa075a9870_1/article.html
1896,2019-03-13,대웅제약나보타미국이어중국진출본격화,http://www.monews.co.kr/news/articleView.html?idxno=201339
1897,2019-03-13,대웅제약나보타오는하반기중국임상3상돌입,http://news.mk.co.kr/newsRead.php?year=2019&no=150391
1898,2019-03-13,대웅제약보툴리눔톡신나보타올하반기중국임상3상돌입,http://www.k-health.com/news/articleView.html?idxno=42883
1899,2019-03-13,대웅제약보툴리눔톡신나보타하반기에중국임상3상,http://yna.kr/AKR20190313067200017?did=1195m
1900,2019-03-13,대웅제약나보타中2공장으로제조시설변경본격임상3상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=348697
1901,2019-03-13,3월13일대웅제약증권매매326190000원,http://www.nbntv.co.kr/news/articleView.html?idxno=256886
1902,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125033&REFERER=NP
1903,2019-03-13,대웅제약나보타中임상시험제조시설변경최종승인획득,http://www.asiatime.co.kr/news/articleView.html?idxno=233364
1904,2019-03-13,매출액10연구개발투자대웅제약1조클럽의비결,http://news.heraldcorp.com/view.php?ud=20190313000400
1905,2019-03-13,대웅제약나보타올하반기中임상3상본격진행,http://daily.hankooki.com/lpage/ittech/201903/dh20190313114746145630.htm
1906,2019-03-13,대웅제약나보타올하반기내중국임상3상추진,http://www.ezyeconomy.com/news/articleView.html?idxno=88837
1907,2019-03-13,대웅나보타올하반기중국임상3상돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=250352&REFERER=NP
1908,2019-03-13,대웅제약중국에서보톡스나보타임상3상시작승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=118179
1909,2019-03-13,대웅제약나보타하반기中임상3상돌입,http://www.koreaittimes.com/news/articleView.html?idxno=89667
1910,2019-03-13,대웅제약나보타올하반기중국3상돌입,http://www.kpanews.co.kr/article/show.asp?idx=202164&table=article&category=D
1911,2019-03-13,대웅제약나보타중국진출본격화,http://www.m-i.kr/news/articleView.html?idxno=503754
1912,2019-03-13,대웅제약나보타15억중국시장본격타겟화,http://www.wikileaks-kr.org/news/articleView.html?idxno=50053
1913,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.bosa.co.kr/news/articleView.html?idxno=2101166
1914,2019-03-13,대웅제약하반기나보타중국3상돌입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066195
1915,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2019031300109
1916,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.newspost.kr/news/articleView.html?idxno=69510
1917,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.economytalk.kr/news/articleView.html?idxno=181180
1918,2019-03-13,대웅제약나보타올하반기중국임상3상진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031314440970632
1919,2019-03-13,대웅제약올해하반기中서나보타임상3상돌입,http://news.donga.com/3/all/20190313/94523526/2
1920,2019-03-13,대웅제약보툴리눔톡신나보타하반기에중국임상3상,http://www.asiatoday.co.kr/view.php?key=20190313010007514
1921,2019-03-13,대웅제약나보타 올하반기중국임상3상돌입 ,http://www.fetv.co.kr/news/article.html?no=22814
1922,2019-03-13,대웅제약하반기나보타중국임상3상개시,http://www.seoulfn.com/news/articleView.html?idxno=336554
1923,2019-03-13,기업분석광고로쌓은명성인가우루사대웅제약매출1조달성했지만영업이익과당기순이익되려고꾸라지고직원복리는줄어,http://www.newsworker.co.kr/news/articleView.html?idxno=27031
1924,2019-03-13,대웅제약나보타올해하반기중국서임상3상돌입,http://www.inthenews.co.kr/news/article.html?no=14084
1925,2019-03-13,대웅제약나보타올하반기中임상3상돌입거대시장진출차질없이준비,http://www.segye.com/content/html/2019/03/13/20190313512132.html?OutUrl=naver
1926,2019-03-13,13일대웅주가20500원장마쳐,http://www.anewsa.com/detail.php?number=1602670&thread=10r04
1927,2019-03-13,대웅제약나보타올해하반기중국임상3상돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=107222
1928,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.medigatenews.com/news/121923231
1929,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.getnews.co.kr/view.php?ud=20190313171656957941d0c69529_16
1930,2019-03-13,대웅제약나보타하반기중국임상3상개시,http://www.dt.co.kr/contents.html?article_no=2019031402101531102001&ref=naver
1931,2019-03-13,제약소식대웅제약나보타올하반기중국임상3상돌입外,http://www.kukinews.com/news/article.html?no=641100
1932,2019-03-13,대웅제약나보타올하반기중국임상3상돌입,http://www.wsobi.com/news/articleView.html?idxno=70734
1933,2019-03-14,대웅제약나보타올하반기중국임상3상돌입,http://www.lawissue.co.kr/view.php?ud=201903140012253955d7f4c63cc6_12
1934,2019-03-14,익스트림팀으로조직에활력을대웅제약연구조직개편RD전문성강화,http://www.wikileaks-kr.org/news/articleView.html?idxno=50121
1935,2019-03-14,생활경제talktalk대웅제약나보타中임상시험승인하반기진출본격화,http://www.ajunews.com/view/20190313150228102
1936,2019-03-14,대웅제약베트남트라파코사와기술이전생산돌입,http://www.seoulwire.com/news/articleView.html?idxno=87696
1937,2019-03-14,대웅제약베트남현지생산으로입찰정조준,http://www.dailypharm.com/Users/News/NewsView.html?ID=250388&REFERER=NP
1938,2019-03-14,대웅제약베트남최대제약트라파코와﻿기술이전본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228175
1939,2019-03-14,대웅제약베트남최대제약사트리파코기술이전본격화,http://www.viva100.com/main/view.php?key=20190314010004654
1940,2019-03-14,대웅주식종목시세14일현재20300원,http://www.nbntv.co.kr/news/articleView.html?idxno=258964
1941,2019-03-14,ET투자뉴스대웅제약_주가와투자심리는약세거래량은침체,http://www.etnews.com/20190314000037
1942,2019-03-14,우루사베트남간다대웅제약트라파코에생산기술이전진행,http://moneys.mt.co.kr/news/mwView.php?no=2019031409428041066
1943,2019-03-14,대웅제약베트남최대제약사와기술이전시장진출본격화,http://www.newspim.com/news/view/20190314000250
1944,2019-03-14,대웅제약베트남진출속도트라파코와기술이전미팅,http://www.medisobizanews.com/news/articleView.html?idxno=58422
1945,2019-03-14,대웅제약베트남제약사트라파코에기술이전본격화,http://news.hankyung.com/article/2019031438046
1946,2019-03-14,대웅제약베트남최대제약사트라코파와기술이전본격화,http://www.etnews.com/20190314000064
1947,2019-03-14,대웅제약베트남최대제약사와기술이전본격화현지사업혁신주도,https://www.insight.co.kr/news/216258
1948,2019-03-14,대웅제약베트남제약사트라파코에기술이전본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2019031400055
1949,2019-03-14,대웅제약베트남빅2제약사트라파코와협력현지사업혁신주도,http://www.econovill.com/news/articleView.html?idxno=358547
1950,2019-03-14,대웅제약나보타중국임상3상시작중국진출본격화,http://www.news2day.co.kr/122475
1951,2019-03-14,대웅제약베트남제약사와기술이전및현지생산본격화,http://www.dailysmart.co.kr/news/articleView.html?idxno=7701
1952,2019-03-14,대웅제약베트남트라파코와기술이전본격화현지사업혁신주도,http://www.ekn.kr/news/article.html?no=420331
1953,2019-03-14,3월14일대웅제약정보,http://www.gokorea.kr/news/articleView.html?idxno=120636
1954,2019-03-14,대웅제약연내베트남서우루사생산돌입2021년판매목표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1149411
1955,2019-03-14,대웅제약베트남제약사에기술이전2021년현지생산,http://yna.kr/AKR20190314061800017?did=1195m
1956,2019-03-14,대웅제약베트남진출본격화,https://www.sedaily.com/NewsView/1VGL3LE0DX
1957,2019-03-14,대웅제약베트남최대제약사와기술이전본격화,http://news.mk.co.kr/newsRead.php?year=2019&no=153394
1958,2019-03-14,대웅제약베트남기업과우루사등현지생산계약체결,http://www.rapportian.com/news/articleView.html?idxno=116538
1959,2019-03-14,대웅제약베트남최대제약사트라파코와기술이전본격화,http://www.newsway.co.kr/news/view?tp=1&ud=2019031410350695617
1960,2019-03-14,대웅제약베트남제약사트라파코에생산기술이전2021년판매목표”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1733427
1961,2019-03-14,대웅제약베트남현지협력본격화,http://www.edaily.co.kr/news/newspath.asp?newsid=02519046622423320
1962,2019-03-14,대웅제약2021년부터베트남현지생산판매트라파코와기술이전킥오프미팅,http://kpenews.com/View.aspx?No=29553
1963,2019-03-14,대웅제약베트남시장공략트라파코에생산기술이전,http://www.newsis.com/view/?id=NISX20190314_0000587250&cID=13001&pID=13000
1964,2019-03-14,대웅제약베트남에우루사등8개생산기술이전,http://www.biospectator.com/view/news_view.php?varAtcId=7285
1965,2019-03-14,대웅제약베트남최대제약사트라파코사와﻿기술이전본격화,http://www.dailian.co.kr/news/view/779343/?sc=naver
1966,2019-03-14,대웅제약베트남진출날개달았다,http://www.m-i.kr/news/articleView.html?idxno=504112
1967,2019-03-14,대웅제약베트남트라파코社와기술이전진행키로,http://www.mhj21.com/120097
1968,2019-03-14,대웅제약2021년베트남현지생산유통위한시동,http://www.bosa.co.kr/news/articleView.html?idxno=2101235
1969,2019-03-14,대웅제약베트남최대제약사트라파코社와기술이전본격화,http://www.fetv.co.kr/news/article.html?no=22919
1970,2019-03-14,대웅제약베트남최대제약사트라파코와﻿기술이전본격화,http://medipana.com/news/news_viewer.asp?NewsNum=235917&MainKind=A&NewsKind=5&vCount=12&vKind=1
1971,2019-03-14,대웅제약베트남제약사에우루사기술이전2021년현지생산,http://www.seoulfn.com/news/articleView.html?idxno=336637
1972,2019-03-14,대웅글로벌시장현지화로승부,http://www.whosaeng.com/108605
1973,2019-03-14,대웅제약베트남제약사트라파코社와기술이전본격화,http://www.kukinews.com/news/article.html?no=641305
1974,2019-03-14,대웅베트남트라파코에기술이전시장공략본격화,http://www.monews.co.kr/news/articleView.html?idxno=201365
1975,2019-03-14,대웅제약2021년부터베트남서제품생산,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125076&REFERER=NP
1976,2019-03-14,대웅제약베트남진출본격화현지빅2제약사와협력,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066232
1977,2019-03-14,대웅제약베트남트라파코社와기술이전계약,http://www.bokuennews.com/news/article.html?no=172882
1978,2019-03-14,대웅제약베트남제약사에기술이전2021년현지생산,http://www.asiatoday.co.kr/view.php?key=20190314010008294
1979,2019-03-14,대웅제약지분인수베트남제약사에기술이전본격화,http://news.mt.co.kr/mtview.php?no=2019031413233946224
1980,2019-03-14,대웅제약베트남트라파코와기술이전본격화현지사업혁신주도,http://www.wikileaks-kr.org/news/articleView.html?idxno=50178
1981,2019-03-14,대웅제약베트남최대제약사트라파코사와킥오프,http://www.100ssd.co.kr/news/articleView.html?idxno=59960
1982,2019-03-14,대웅제약베트남제약사트라파코와킥오프Kickoff미팅,http://www.newspost.kr/news/articleView.html?idxno=69543
1983,2019-03-14,대웅제약베트남진출본격화현지제약사와생산기술이전논의,http://www.ezyeconomy.com/news/articleView.html?idxno=88889
1984,2019-03-14,대웅제약베트남최대제약사와현지사업주도한다,http://www.k-health.com/news/articleView.html?idxno=42918
1985,2019-03-14,대웅제약트라파코와기술이전본격화,http://www.ebn.co.kr/news/view/976457
1986,2019-03-14,대웅제약베트남최대제약사에기술이전,http://kormedi.com/?p=1284265
1987,2019-03-14,대웅제약지분인수베트남제약사트라파코에기술이전,http://view.asiae.co.kr/news/view.htm?idxno=2019031414354592803
1988,2019-03-14,대웅제약베트남최대제약사트라파코社와현지사업나서,http://daily.hankooki.com/lpage/ittech/201903/dh20190314145201145630.htm
1989,2019-03-14,대웅제약베트남제약사트라파코와기술이전본격화,http://www.medigatenews.com/news/1009540673
1990,2019-03-14,대웅제약베트남최대제약사와기술이전본격화현지사업혁신주도,http://www.segye.com/content/html/2019/03/14/20190314511363.html?OutUrl=naver
1991,2019-03-14,대웅제약베트남기술이전본격추진현지공략속도↑,http://news.donga.com/3/all/20190314/94544813/2
1992,2019-03-14,대웅제약베트남트라파코에기술이전통한현지입찰시장진입추진,http://news.mk.co.kr/newsRead.php?year=2019&no=154792
1993,2019-03-14,대웅제약베트남제약사트라파코와기술이전및현지생산합의,http://www.fnnews.com/news/201903141615087572
1994,2019-03-14,대웅제약베트남트라파코社와현지공략착수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031415192844365
1995,2019-03-14,장종리포트대웅주가20600원으로종료,http://www.anewsa.com/detail.php?number=1606255&thread=10r04
1996,2019-03-14,대웅제약베트남에우루사등8개제품기술이전,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84562
1997,2019-03-14,대웅제약베트남제약사트라파코지분인수로현지사업혁신주도,http://www.mdtoday.co.kr/mdtoday/index.html?no=348886
1998,2019-03-14,대웅제약베트남트라파코와﻿기술이전본격화현지사업혁신주도,http://www.asiatime.co.kr/news/articleView.html?idxno=233638
1999,2019-03-14,전승호대웅제약대표1조클럽발담근비결은,http://www.wolyo.co.kr/news/articleView.html?idxno=79521
2000,2019-03-14,대웅제약베트남트라파코에기술이전시작2021년현지생산,http://www.dt.co.kr/contents.html?article_no=2019031402109931102003&ref=naver
2001,2019-03-14,대웅제약베트남제약사에기술이전현지생산유통계획,http://www.kpinews.co.kr/news/articleView.html?idxno=92446
2002,2019-03-14,대웅제약베트남트라파코사와기술이전본격화,http://www.economytalk.kr/news/articleView.html?idxno=181292
2003,2019-03-14,대웅제약베트남제약사트라파코社와기술이전본격화,http://www.getnews.co.kr/view.php?ud=20190314183345733641d0c69529_16
2004,2019-03-14,네이버대웅제약과헬스케어합작사설립,http://news.mt.co.kr/mtview.php?no=2019031418420972742
2005,2019-03-14,네이버대웅제약과의료빅데이터합작기업설립,http://yna.kr/AKR20190314169900017?did=1195m
2006,2019-03-14,네이버대웅제약과의료빅데이터합작기업설립,http://www.etnews.com/20190314000335
2007,2019-03-14,네이버대웅제약의료빅데이터기업다나아데이터설립,http://www.newsway.co.kr/news/view?tp=1&ud=2019031419472756606
2008,2019-03-14,대웅제약베트남진출속도현지사업박차,http://www.dailymedi.com/detail.php?number=840960&thread=22r05
2009,2019-03-14,대웅제약베트남최대제약사트라파코와기술이전본격화현지사업주도,http://www.businesskorea.co.kr/news/articleView.html?idxno=29993
2010,2019-03-14,네이버대웅제약과헬스케어합작사설립,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20190314195009
2011,2019-03-14,네이버대웅제약과의료빅데이터벤처다나아데이터설립,http://www.etoday.co.kr/news/section/newsview.php?idxno=1733826
2012,2019-03-14,네이버대웅제약등과헬스케어합작사설립,http://www.inews24.com/view/1164020
2013,2019-03-14,네이버대웅제약과헬스케어합작법인,http://www.dt.co.kr/contents.html?article_no=2019031502151531033001&ref=naver
2014,2019-03-14,대웅제약베트남제약사트라파코에기술이전,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3781277
2015,2019-03-14,네이버대웅제약등과의료빅데이터합작사설립,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903140567&t=NN
2016,2019-03-14,네이버이번엔헬스케어도전대웅제약과합작기업설립,http://view.asiae.co.kr/news/view.htm?idxno=2019031422554683980
2017,2019-03-14,한양대구리병원한명훈교수대한노인신경외과학회정기학술대회대웅젊은연구자상수상,http://medicalworldnews.co.kr/news/view.php?idx=1510929829
2018,2019-03-15,대웅제약베트남현지와시동케이프,http://news.mt.co.kr/mtview.php?no=2019031507540770382
2019,2019-03-15,네이버대웅제약과헬스케어시장공략속도,http://www.fetv.co.kr/news/article.html?no=22982
2020,2019-03-15,기획매출1조대웅제약전문의약품상위10개중8개도입품목,http://daily.hankooki.com/lpage/column/201903/dh20190315081510145650.htm
2021,2019-03-15,대웅제약베트남현지화전략시동,http://www.asiatoday.co.kr/view.php?key=20190315010008761
2022,2019-03-15,네이버대웅제약의료빅데이터다나아데이터설립,http://www.seoulwire.com/news/articleView.html?idxno=88593
2023,2019-03-15,네이버대웅제약과의료빅데이터합작기업설립,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031508161780725
2024,2019-03-15,대웅제약목표가3↑24만원제시KB證,http://www.newspim.com/news/view/20190315000129
2025,2019-03-15,퀵리포트대웅제약매수유지목표가3↑24만원KB證,http://www.itooza.com/common/iview.php?no=2019031509154014582
2026,2019-03-15,대웅제약베트남로컬사자격으로다양한입찰참가,http://news.heraldcorp.com/view.php?ud=20190315000131
2027,2019-03-15,대웅제약베트남제약사트라파코社와기술이전본격화,http://www.g-enews.com/ko-kr/news/article/news_all/201903150947132973fa075a9870_1/article.html
2028,2019-03-15,주식종목검색대웅주가15일현재20300원,http://www.nbntv.co.kr/news/articleView.html?idxno=261234
2029,2019-03-15,증시보고15일대웅현재가격20300원,http://www.anewsa.com/detail.php?number=1607175&thread=10r02
2030,2019-03-15,네이버와대웅제약의료보건빅데이터회사설립,http://www.gokorea.kr/news/articleView.html?idxno=121624
2031,2019-03-15,대웅제약네이버와합작벤처다나아데이터설립,http://www.econovill.com/news/articleView.html?idxno=358629
2032,2019-03-15,네이버헬스케어시장진출대웅제약과합작회사설립,http://www.segye.com/content/html/2019/03/15/20190315500492.html?OutUrl=naver
2033,2019-03-15,네이버대웅제약과의료빅데이터합작벤처설립,http://www.newsis.com/view/?id=NISX20190315_0000588620&cID=13001&pID=13000
2034,2019-03-15,3월15일대웅제약주식시세현황189500원052,http://www.nbntv.co.kr/news/articleView.html?idxno=261727
2035,2019-03-15,네이버대웅제약빅데이터및인공지능AI 기반의헬스케어사업진출,http://www.newsworks.co.kr/news/articleView.html?idxno=344012
2036,2019-03-15,대웅제약베트남제약사트라파코에기술이전,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1207349
2037,2019-03-15,대웅제약메디톡스미국서보툴리눔톡신2라운드공방,http://www.polinews.co.kr/news/article.html?no=385268
2038,2019-03-15,베트남입성대웅제약2021년부터제품생산판매,http://www.munhwa.com/news/view.html?no=2019031501071627107001
2039,2019-03-15,네이버대웅제약과헬스케어합작사설립다나아데이터로헬스케어빅데이터진출,http://techm.kr/bbs/board.php?bo_table=article&wr_id=5928
2040,2019-03-15,대웅제약베트남현지화전략시동”,http://www.wikitree.co.kr/main/news_view.php?id=411734
2041,2019-03-16,신약개발돋보기대웅한올손잡고개발하는안구건조증신약HL036,http://www.edaily.co.kr/news/newspath.asp?newsid=01312006622423976
2042,2019-03-16,대웅제약올해글로벌현지화로승부수베트남中대륙까지광폭행보,http://www.ekn.kr/news/article.html?no=420764
2043,2019-03-16,네이버대웅제약과빅데이터사업나서,http://www.bosa.co.kr/news/articleView.html?idxno=2101386
2044,2019-03-17,PICKUP대웅제약미국베트남시장진출박차,http://news.heraldcorp.com/view.php?ud=20190317000219
2045,2019-03-17,대웅제약나보타美FDA승인기념심포지엄개최,http://www.wsobi.com/news/articleView.html?idxno=70867
2046,2019-03-18,국고처김종철종목상담대웅제약069620,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903160056&t=NNv
2047,2019-03-18,주가그래프대웅주가18일현재20450원,http://www.nbntv.co.kr/news/articleView.html?idxno=263838
2048,2019-03-18,종목추적18일대웅현재주식거래가격20450원,http://www.anewsa.com/detail.php?number=1610842&thread=10r02
2049,2019-03-18,3월18일대웅제약실시간주식현황190000원080,http://www.nbntv.co.kr/news/articleView.html?idxno=264313
2050,2019-03-18,대웅제약전승호사장약학대실습생과소통간담회,http://www.edaily.co.kr/news/newspath.asp?newsid=02620726622424632
2051,2019-03-18,전승호대웅제약CEO약학대학생실습생과소통간담회,https://www.sedaily.com/NewsView/1VGMY7Z25F
2052,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228309
2053,2019-03-18,Biz인사이드대웅제약글로벌진출가시화제2나보타만든다,http://www.econovill.com/news/articleView.html?idxno=358718
2054,2019-03-18,대웅제약전승호사장약대실습생에차별성키우라,http://www.bosa.co.kr/news/articleView.html?idxno=2101442
2055,2019-03-18,전승호대웅제약사장약대실습생과소통간담회,http://www.dailypharm.com/Users/News/NewsView.html?ID=250511&REFERER=NP
2056,2019-03-18,유능한인재모십니다대웅우수실습생정규직채용,http://www.kpanews.co.kr/article/show.asp?idx=202255&table=article&category=D
2057,2019-03-18,대웅제약전승호사장약대실습생과소통간담회차별성갖춘인재성장해야,http://www.medisobizanews.com/news/articleView.html?idxno=58500
2058,2019-03-18,젊은피대웅제약전승호사장약학대실습생과소통,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125148&REFERER=NP
2059,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회,http://medipana.com/news/news_viewer.asp?NewsNum=236083&MainKind=A&NewsKind=5&vCount=12&vKind=1
2060,2019-03-18,전승호대웅제약사장직원성장우선되는회사로이끌것,http://www.m-i.kr/news/articleView.html?idxno=505017
2061,2019-03-18,전승호대웅제약사장약학대실습생과소통간담회실질적업무체험제공,http://www.businesskorea.co.kr/news/articleView.html?idxno=30057
2062,2019-03-18,대웅제약약대생실습생30명과소통간담회가져,http://www.seoulwire.com/news/articleView.html?idxno=90319
2063,2019-03-18,전승호대웅제약사장 팜DW실습생과소통,http://www.seoulfn.com/news/articleView.html?idxno=336940
2064,2019-03-18,대웅제약전승호사장약대생멘토로나서팜DW실습생과소통간담회,http://kpenews.com/View.aspx?No=29769
2065,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.fetv.co.kr/news/article.html?no=23246
2066,2019-03-18,대웅제약전승호대표이사약대생과소통,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031811255013745
2067,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회진행,http://www.inthenews.co.kr/news/article.html?no=14148
2068,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.newsway.co.kr/news/view?tp=1&ud=2019031813581776613
2069,2019-03-18,전승호대웅제약사장약학대실습생과소통경영방향은,http://www.shinailbo.co.kr/news/articleView.html?idxno=1150315
2070,2019-03-18,대웅제약약학대실습생과소통간담회개최,http://www.etnews.com/20190318000234
2071,2019-03-18,약대생만난대웅제약전승호사장소통행보눈길,http://www.viva100.com/main/view.php?key=20190318010005931
2072,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.wsobi.com/news/articleView.html?idxno=70930
2073,2019-03-18,대웅제약전승호사장약대생과소통간담회가져,http://www.ebn.co.kr/news/view/976926
2074,2019-03-18,대웅제약약학대학실습생과소통간담회가져,http://daily.hankooki.com/lpage/ittech/201903/dh20190318150657145630.htm
2075,2019-03-18,전승호대웅제약사장약대실습생과소통간담회가져,http://www.rapportian.com/news/articleView.html?idxno=116617
2076,2019-03-18,대웅제약전승호사장예비약사들에전한제약산업의미래,http://www.metroseoul.co.kr/news/newsview?newscd=2019031800191
2077,2019-03-18,전승호대웅제약사장약학전공실습생과소통우수자정규직채용,http://news.donga.com/3/all/20190318/94614322/2
2078,2019-03-18,전승호대웅제약사장회사서실습중인약대생들과간담회가져,http://news.mk.co.kr/newsRead.php?year=2019&no=162183
2079,2019-03-18,★주식인사이드대웅제약주가189000원3월18일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=600160
2080,2019-03-18,전승호대웅제약사장약대실습생과소통간담회개최,http://www.ezyeconomy.com/news/articleView.html?idxno=88987
2081,2019-03-18,약대생전승호사장님대웅제약을어떤방향으로이끌어가실건가요”,http://www.segye.com/content/html/2019/03/18/20190318532034.html?OutUrl=naver
2082,2019-03-18,전승호대웅제약사장약학대학실습생과소통간담회,http://www.newsprime.co.kr/news/article.html?no=451322
2083,2019-03-18,전승호대웅제약사장제약회사의커리어패스차별성키워야,http://www.ajunews.com/view/20190318161410386
2084,2019-03-18,전승호대웅제약사장차세대주역약대실습생과소통간담회가져,http://www.wikileaks-kr.org/news/articleView.html?idxno=50494
2085,2019-03-18,전승호대웅제약전승호사장팜DW실습생과소통간담회,http://www.mhj21.com/120202
2086,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.ekn.kr/news/article.html?no=421107
2087,2019-03-18,장종리포트18일마감대웅주가20350원마감해,http://www.anewsa.com/detail.php?number=1613170&thread=10r04
2088,2019-03-18,전승호대웅제약사장팜DW참여약대생과소통간담회열어,http://www.econovill.com/news/articleView.html?idxno=358827
2089,2019-03-18,나른한봄건강지키기대웅제약안구건조증신약HL036,https://www.sedaily.com/NewsView/1VGMZAN9R7
2090,2019-03-18,대웅제약전승호사장회사서실습중인약대생들과간담회가져,https://www.insight.co.kr/news/217154
2091,2019-03-18,대웅제약전승호사장약학대학생실습생과소통간담회가져,http://www.getnews.co.kr/view.php?ud=20190318183923693641d0c69529_16
2092,2019-03-18,제약산업이해도모전승호대웅제약사장약학대학생실습생과소통,http://www.iminju.net/news/articleView.html?idxno=44006
2093,2019-03-18,대웅제약전승호사장약대생소통간담회열어,http://www.kpanews.co.kr/article/show.asp?idx=202300&table=article&category=D
2094,2019-03-18,전승호대웅제약사장약학대학생실습생과소통간담회가져,http://www.dailian.co.kr/news/view/780384/?sc=naver
2095,2019-03-19,대웅제약안구건조증면역항암신약개발박차,http://news.mk.co.kr/newsRead.php?year=2019&no=163357
2096,2019-03-19,★주식인사이드대웅제약주가191000원3월19일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=600368
2097,2019-03-19,오늘의추천종목한국투자증권SK텔레콤대웅제약등,http://www.asiatoday.co.kr/view.php?key=20190319010010731
2098,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.g-enews.com/ko-kr/news/article/news_all/201903190934083186fa075a9870_1/article.html
2099,2019-03-19,대웅장티푸스예방백신비보티프국내판권확보,http://www.dailypharm.com/Users/News/NewsView.html?ID=250557&REFERER=NP
2100,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228356
2101,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031909311615771
2102,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.ceoscoredaily.com/news/article.html?no=53212
2103,2019-03-19,종목추적19일대웅현재주가20750원,http://www.anewsa.com/detail.php?number=1614252&thread=10r02
2104,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.edaily.co.kr/news/newspath.asp?newsid=02099206622424960
2105,2019-03-19,대웅제약경구용장티푸스백신비보티프국내판권확보,http://news1.kr/articles/?3574403
2106,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.edaily.co.kr/news/newspath.asp?newsid=02099206622424960
2107,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수상반기제품출시”,https://www.sedaily.com/NewsView/1VGNE22JM7
2108,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.sisafocus.co.kr/news/articleView.html?idxno=205025
2109,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.ekn.kr/news/article.html?no=421202
2110,2019-03-19,대웅제약비보티프국내판권확보상반기출시,http://www.ajunews.com/view/20190319094010840
2111,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.dailian.co.kr/news/view/780468/?sc=naver
2112,2019-03-19,대웅제약경구용장티푸스백신비보티프국내판권확보,http://www.k-health.com/news/articleView.html?idxno=42989
2113,2019-03-19,대웅제약장티푸스백신비보티프판권인수,http://www.ebn.co.kr/news/view/977041
2114,2019-03-19,대웅제약장티푸스백신비보티프판권인수상반기출시,http://medipana.com/news/news_viewer.asp?NewsNum=236140&MainKind=A&NewsKind=5&vCount=12&vKind=1
2115,2019-03-19,대웅제약비보티프판권인수장티푸스백신공급,http://www.viva100.com/main/view.php?key=20190319010006222
2116,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.kukinews.com/news/article.html?no=642723
2117,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1735150
2118,2019-03-19,3월19일대웅오늘주식장17220700원,http://www.nbntv.co.kr/news/articleView.html?idxno=266181
2119,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.wolyo.co.kr/news/articleView.html?idxno=79797
2120,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.fnnews.com/news/201903191005034300
2121,2019-03-19,대웅제약장티푸스백신비보티프판권확보,http://news.mt.co.kr/mtview.php?no=2019031909531016986
2122,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.newspost.kr/news/articleView.html?idxno=69714
2123,2019-03-19,대웅제약 경구용장티푸스백신비보티프판권인수,http://www.fetv.co.kr/news/article.html?no=23347
2124,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.mdtoday.co.kr/mdtoday/index.html?no=349219
2125,2019-03-19,대웅제약먹는장티푸스예방백신국내판권인수,http://biz.chosun.com/site/data/html_dir/2019/03/19/2019031900888.html
2126,2019-03-19,대웅제약경구용장티푸스백신비보티프올상반기출시,http://moneys.mt.co.kr/news/mwView.php?no=2019031910058025730
2127,2019-03-19,대웅경구용장티푸스백신비보티프상반기출시,http://www.whosaeng.com/108708
2128,2019-03-19,대웅제약먹는장티푸스백신비보티프국내판권인수,http://www.newspim.com/news/view/20190319000217
2129,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.shinailbo.co.kr/news/articleView.html?idxno=1150577
2130,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.econovill.com/news/articleView.html?idxno=358878
2131,2019-03-19,대웅제약장티푸스백신비보티프캡슐판권확보,http://www.medisobizanews.com/news/articleView.html?idxno=58518
2132,2019-03-19,대웅제약경구용장티푸스백신비보티프판권확보,http://www.mhj21.com/120211
2133,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.newsway.co.kr/news/view?tp=1&ud=2019031910314538765
2134,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.etnews.com/20190319000066
2135,2019-03-19,대웅제약경구용장티푸스백신판권인수,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019031910444101462&objId=A2019031910444101462&portalCode=naver
2136,2019-03-19,대웅제약먹는장티푸스백신비보티프국내판권확보,http://www.rapportian.com/news/articleView.html?idxno=116634
2137,2019-03-19,대웅제약주가오늘시세외매매동향19일현재188000원,http://www.gokorea.kr/news/articleView.html?idxno=124596
2138,2019-03-19,대웅제약장티푸스백신비보티프판권인수상반기출시계획,http://www.asiatime.co.kr/news/articleView.html?idxno=234528
2139,2019-03-19,대웅제약먹는장티푸스백신비보티프국내판권인수,http://www.newsis.com/view/?id=NISX20190319_0000591806&cID=13001&pID=13000
2140,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.joseilbo.com/news/news_read.php?uid=372598&class=17&grp=
2141,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시,http://yna.kr/AKR20190319069900017?did=1195m
2142,2019-03-19,대웅제약경구용장티푸스백신국내판권확보,http://www.kpinews.co.kr/news/articleView.html?idxno=92655
2143,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수한다,https://www.insight.co.kr/news/217268
2144,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125174&REFERER=NP
2145,2019-03-19,대웅제약국내유일FDA승인받은장티푸스백신비보티프판권인수,http://www.seoulwire.com/news/articleView.html?idxno=90784
2146,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.100ssd.co.kr/news/articleView.html?idxno=60090
2147,2019-03-19,대웅제약장티푸스백신비보티프판권인수상반기출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066385
2148,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.bosa.co.kr/news/articleView.html?idxno=2101522
2149,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.bokuennews.com/news/article.html?no=173074
2150,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://daily.hankooki.com/lpage/ittech/201903/dh20190319112629145630.htm
2151,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.economytalk.kr/news/articleView.html?idxno=181601
2152,2019-03-19,대웅경구용장티푸스백신비보티프판권인수,http://www.dailymedi.com/detail.php?number=841103&thread=22r05
2153,2019-03-19,3월19일대웅제약증권플러스026188500원,http://www.nbntv.co.kr/news/articleView.html?idxno=266679
2154,2019-03-19,대웅제약먹는장티푸스백신판권확보,http://www.asiatoday.co.kr/view.php?key=20190319010011052
2155,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시,http://www.sentv.co.kr/news/view/550411
2156,2019-03-19,대웅제약올상반기먹는장티푸스백신출시비보티프판권인수,http://kpenews.com/View.aspx?No=29846
2157,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.wikileaks-kr.org/news/articleView.html?idxno=50575
2158,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.biospectator.com/view/news_view.php?varAtcId=7313
2159,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.newstomato.com/ReadNews.aspx?no=883073
2160,2019-03-19,대웅제약먹는장티푸스백신상반기출시판권확보,http://www.dt.co.kr/contents.html?article_no=2019031902109931102001&ref=naver
2161,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://kormedi.com/?p=1284578
2162,2019-03-19,대웅제약장티푸스백신비보티프판권인수 ,http://www.monews.co.kr/news/articleView.html?idxno=201463
2163,2019-03-19,대웅제약장티푸스백신비보티프판권인수올상반기제품출시,http://www.newsprime.co.kr/news/article.html?no=451422
2164,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.medigatenews.com/news/2463015913
2165,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903190235&t=NN
2166,2019-03-19,대웅제약먹는장티푸스백신판권확보상반기출시예정,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3784741
2167,2019-03-19,대웅제약먹는약장티푸스백신비보티프판권획득,http://www.ezyeconomy.com/news/articleView.html?idxno=89024
2168,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.metroseoul.co.kr/news/newsview?newscd=2019031900146
2169,2019-03-19,주사기공포이제그만대웅제약경구용장티푸스백신비보티프판권인수,http://www.segye.com/content/html/2019/03/19/20190319529634.html?OutUrl=naver
2170,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.kpanews.co.kr/article/show.asp?idx=202344&table=article&category=D
2171,2019-03-19,스타★주식인사이드대웅제약주가187500원3월19일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=601547
2172,2019-03-19,대웅제약경구용장티푸스백신비보티프판권확보,http://www.dailysmart.co.kr/news/articleView.html?idxno=7917
2173,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.ntoday.co.kr/news/articleView.html?idxno=65950
2174,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수상반기출시,http://news.donga.com/3/all/20190319/94631876/2
2175,2019-03-19,대웅제약경구용장티푸스백신비보티프국내판권확보,http://www.businesspost.co.kr/BP?command=article_view&num=119085
2176,2019-03-19,대웅제약장티푸스백신비보티프판권확보상반기중출시키로,http://news.mk.co.kr/newsRead.php?year=2019&no=165457
2177,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.lawissue.co.kr/view.php?ud=201903191617207583d7f4c63cc6_12
2178,2019-03-19,장마감보고서19일대웅주가20200원마감,http://www.anewsa.com/detail.php?number=1616686&thread=10r04
2179,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.getnews.co.kr/view.php?ud=20190319173240654041d0c69529_16
2180,2019-03-19,대웅제약경구용장티푸스백신비보티프판권인수,http://www.businesskorea.co.kr/news/articleView.html?idxno=30133
2181,2019-03-19,대웅제약먹는장티푸스백신판권확보,http://www.seoulfn.com/news/articleView.html?idxno=337126
2182,2019-03-20,대웅바이오대웅제약세파계항생제사업인수,http://www.dailypharm.com/Users/News/NewsView.html?ID=250581&REFERER=NP
2183,2019-03-20,대웅제약역류성식도염신약3상순항중연말완료,http://www.medisobizanews.com/news/articleView.html?idxno=58540
2184,2019-03-20,더벨네이버의헬스케어파트너왜대웅일까,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903190100032510002079
2185,2019-03-20,★주식인사이드대웅제약주가190000원3월20일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=602654
2186,2019-03-20,대웅제약이만든마스크팩은달라DNC피어라미지크리스탈스킨마스크선봬,http://www.thekpm.com/view.php?ud=201903200938399126124506bdf1_17
2187,2019-03-20,대웅제약디엔컴퍼니프리미엄마스크4종출시,http://www.yakup.com/news/index.html?mode=view&cat=15&nid=228425
2188,2019-03-20,증시실황20일대웅현재주식거래가격20250원,http://www.anewsa.com/detail.php?number=1617736&thread=10r02
2189,2019-03-20,대웅제약계열사디엔컴퍼니보석담은마스크피어라미지론칭,http://www.ajunews.com/view/20190320095836799
2190,2019-03-20,대웅과보톡스맞장뜬메디톡스위험성낮춘코어톡스출시,http://news.heraldcorp.com/view.php?ud=20190320000182
2191,2019-03-20,대웅주가그래프20일현재20250원,http://www.nbntv.co.kr/news/articleView.html?idxno=268480
2192,2019-03-20,대웅제약뷰티브랜드피어라미지크리스탈스킨마스크4종韓中동시론칭해외공략시동,http://www.ezyeconomy.com/news/articleView.html?idxno=89060
2193,2019-03-20,대웅제약디엔컴퍼니화장품브랜드피어라미지론칭글로벌출사표,http://www.fetv.co.kr/news/article.html?no=23513
2194,2019-03-20,대웅제약주식창20일현재191500원,http://www.nbntv.co.kr/news/articleView.html?idxno=268993
2195,2019-03-20,AI신약개발지원센터개소유한한미대웅보령등24곳동참,http://www.medisobizanews.com/news/articleView.html?idxno=58561
2196,2019-03-20,스타★주식인사이드대웅제약주가193000원3월20일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=603726
2197,2019-03-20,20일대웅주가20500원으로마감,http://www.anewsa.com/detail.php?number=1619645&thread=10r04
2198,2019-03-20,대웅제약경구용장티푸스백신비보티프판권인수,http://www.wsobi.com/news/articleView.html?idxno=71011
2199,2019-03-20,대웅제약계열사디엔컴퍼니보석담은마스크피어라미지론칭,https://www.insight.co.kr/news/217647
2200,2019-03-21,대웅나보타2년내미성형시장2위성장할것,http://www.dailypharm.com/Users/News/NewsView.html?ID=250645&REFERER=NP
2201,2019-03-21,★주식인사이드대웅제약주가192500원3월21일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=604779
2202,2019-03-21,주가정보21일대웅현재주식거래가격20350원,http://www.anewsa.com/detail.php?number=1621324&thread=10r02
2203,2019-03-21,3월21일대웅투자주식07320350원,http://www.nbntv.co.kr/news/articleView.html?idxno=270934
2204,2019-03-21,대웅제약보수적→여성친화적환골탈태나선다,http://www.viva100.com/main/view.php?key=20190321010007165
2205,2019-03-21,3월21일대웅제약증권매매187500원335,http://www.nbntv.co.kr/news/articleView.html?idxno=271440
2206,2019-03-21,ET투자뉴스대웅제약_주가와투자심리는약세거래량은침체,http://www.etnews.com/20190321000141
2207,2019-03-21,대웅제약전일대비약4하락한186000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903210418&t=NN
2208,2019-03-21,대웅제약주가3월21일현재186000원,http://www.gokorea.kr/news/articleView.html?idxno=127357
2209,2019-03-21,스타★주식인사이드대웅제약주가185000원3월21일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=605846
2210,2019-03-21,대웅제약노갑용부사장산업경제발전기여산업포장수상,http://www.seoulwire.com/news/articleView.html?idxno=93767
2211,2019-03-21,대웅제약노갑용부사장제45회상공의날산업포장수상,http://www.medisobizanews.com/news/articleView.html?idxno=58597
2212,2019-03-21,대웅제약노갑용부사장경제발전기여공로인정,http://medipana.com/news/news_viewer.asp?NewsNum=236290&MainKind=A&NewsKind=5&vCount=12&vKind=1
2213,2019-03-21,대웅제약국민건강증진제약업발전기여노갑용부사장산업포장받아,http://kpenews.com/View.aspx?No=29986
2214,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.bosa.co.kr/news/articleView.html?idxno=2101705
2215,2019-03-21,대웅제약노갑용부사장상공의날산업포장,http://www.dailymedi.com/detail.php?number=841188&thread=22r05
2216,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1736462
2217,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.ebn.co.kr/news/view/977491
2218,2019-03-21,대웅제약노갑용부사장산업포장수상국가경제발전기여,http://www.newsis.com/view/?id=NISX20190321_0000595030&cID=13001&pID=13000
2219,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,http://www.newsprime.co.kr/news/article.html?no=451899
2220,2019-03-21,노갑용대웅제약부사장상공의날기념식서산업포장수상,http://news.mk.co.kr/newsRead.php?year=2019&no=171572
2221,2019-03-21,노갑용대웅제약부사장국가경제발전기여산업포장수상,http://www.asiatime.co.kr/news/articleView.html?idxno=235220
2222,2019-03-21,대웅제약노갑용부사장46회상공의날산업포장수상,http://www.shinailbo.co.kr/news/articleView.html?idxno=1151584
2223,2019-03-21,대웅제약제46회상공의날노갑용부사장산업포장수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=349551
2224,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.newsway.co.kr/news/view?tp=1&ud=2019032116255594562
2225,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228515
2226,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,http://www.wolyo.co.kr/news/articleView.html?idxno=79992
2227,2019-03-21,노갑용대웅제약부사장산업포장수상,http://www.dailypharm.com/Users/News/NewsView.html?ID=250692&REFERER=NP
2228,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.newspost.kr/news/articleView.html?idxno=69816
2229,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.metroseoul.co.kr/news/newsview?newscd=2019032100209
2230,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.newspost.kr/news/articleView.html?idxno=69816
2231,2019-03-21,동정노갑용대웅제약부사장산업포장수훈,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=5&ID=16285
2232,2019-03-21,대웅제약노갑용부사장상공의날산업포장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84686
2233,2019-03-21,대웅제약노갑용부사장상공의날기념식서산업포장수상,http://www.k-health.com/news/articleView.html?idxno=43058
2234,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상,https://www.sedaily.com/NewsView/1VGOD6J3VK
2235,2019-03-21,노갑용대웅제약부사장상공의날산업포장수상ETCOTC종합성장큰기여,http://www.segye.com/content/html/2019/03/21/20190321574756.html?OutUrl=naver
2236,2019-03-21,대웅제약노갑용부사장산업포장수상,http://www.whosaeng.com/108809
2237,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.skyedaily.com/news/news_view.html?ID=83021
2238,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.bokuennews.com/news/article.html?no=173231
2239,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.kpanews.co.kr/article/show.asp?idx=202431&table=article&category=D
2240,2019-03-21,대웅제약노갑용부사장산업포장수상,http://www.g-enews.com/ko-kr/news/article/news_all/201903211825462261fa075a9870_1/article.html
2241,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.getnews.co.kr/view.php?ud=20190321185040156241d0c69529_16
2242,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.ekn.kr/news/article.html?no=421868
2243,2019-03-21,대웅제약노갑용부사장상공의날산업포장수상,http://www.lawissue.co.kr/view.php?ud=201903212142402065d7f4c63cc6_12
2244,2019-03-22,대웅제약나보타FDA허가로23억마일스톤수령,http://www.dailypharm.com/Users/News/NewsView.html?ID=250706&REFERER=NP
2245,2019-03-22,더벨네이버대웅제약헬스케어협업에인성정보주목,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903210100038660002455
2246,2019-03-22,노갑용대웅제약부사장상공의날산업포장수상,http://www.ezyeconomy.com/news/articleView.html?idxno=89117
2247,2019-03-22,★주식인사이드대웅제약주가184000원3월22일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=606995
2248,2019-03-22,증시현황22일대웅현재가20200원,http://www.anewsa.com/detail.php?number=1624672&thread=10r02
2249,2019-03-22,3월22일대웅주식시세현황02520100원,http://www.nbntv.co.kr/news/articleView.html?idxno=273348
2250,2019-03-22,대웅주가3월22일현재20150원및종목차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=109429
2251,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.ekn.kr/news/article.html?no=421965
2252,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228551
2253,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내행사,http://www.edaily.co.kr/news/newspath.asp?newsid=02358326622425944
2254,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.fetv.co.kr/news/article.html?no=23774
2255,2019-03-22,대웅제약베아제TV광고론칭기념이벤트,http://www.ebn.co.kr/news/view/977623
2256,2019-03-22,동정대웅제약노갑용부사장상공의날산업포장수상 ,http://www.monews.co.kr/news/articleView.html?idxno=201561
2257,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트,http://www.bosa.co.kr/news/articleView.html?idxno=2101769
2258,2019-03-22,33돌맞은베아제대웅제약15년만에TV광고론칭,http://www.viva100.com/main/view.php?key=20190322010007672
2259,2019-03-22,실시간주식현황대웅제약주가22일현재186000원,http://www.nbntv.co.kr/news/articleView.html?idxno=273838
2260,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.newsway.co.kr/news/view?tp=1&ud=2019032211285419650
2261,2019-03-22,대웅제약국민소화제베아제33주년기념사내이벤트개최,http://www.medisobizanews.com/news/articleView.html?idxno=58616
2262,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://daily.hankooki.com/lpage/ittech/201903/dh20190322113733145630.htm
2263,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.segye.com/content/html/2019/03/22/20190322555487.html?OutUrl=naver
2264,2019-03-22,대웅제약베아제33주년기념사내이벤트진행,http://www.asiatime.co.kr/news/articleView.html?idxno=235331
2265,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1151770
2266,2019-03-22,대웅제약1위소화효소제베아제TV광고기념사내이벤트진행,http://www.seoulwire.com/news/articleView.html?idxno=94339
2267,2019-03-22,대웅제약베아제TV광고론칭기념사내이벤트,http://www.ezyeconomy.com/news/articleView.html?idxno=89140
2268,2019-03-22,대웅제약베아제TV광고론칭기념사내행사개최,http://news.mk.co.kr/newsRead.php?year=2019&no=173815
2269,2019-03-22,대웅제약베아제33주년TV광고론칭임직원관심높여,http://www.econovill.com/news/articleView.html?idxno=359256
2270,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=30242
2271,2019-03-22,스타★주식인사이드대웅제약주가186000원3월22일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=608030
2272,2019-03-22,대웅주식배당결정안건부결,http://yna.kr/AKR20190322129800008?did=1195m
2273,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트,http://www.mdtoday.co.kr/mdtoday/index.html?no=349693
2274,2019-03-22,장종리포트22일마감대웅주가20150원마감해,http://www.anewsa.com/detail.php?number=1626962&thread=10r04
2275,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.wikileaks-kr.org/news/articleView.html?idxno=50928
2276,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,http://www.getnews.co.kr/view.php?ud=2019032217535830741d0c69529_16
2277,2019-03-22,대웅제약베아제33주년TV광고론칭기념사내이벤트진행,https://www.insight.co.kr/news/218037
2278,2019-03-22,대웅대웅제약전자증권도입주식매수선택권부여,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228584
2279,2019-03-22,대웅임기만료윤재춘사내이사재선임,http://www.whosaeng.com/108850
2280,2019-03-22,전승호대웅제약대표매출1조원돌파새로운미래성장약속,http://www.newsprime.co.kr/news/article.html?no=452062
2281,2019-03-22,대웅제약베아제TV광고론칭기념사내이벤트,http://www.skyedaily.com/news/news_view.html?ID=83057
2282,2019-03-22,대웅대웅제약주주총회개최윤재춘대표사내이사재선임,http://www.mdtoday.co.kr/mdtoday/index.html?no=349721
2283,2019-03-22,대웅임기만료윤재춘사내이사재선임주주총회개최,http://medipana.com/news/news_viewer.asp?NewsNum=236385&MainKind=A&NewsKind=5&vCount=12&vKind=1
2284,2019-03-22,대웅윤재춘대표재선임대웅제약전승호대표나보타글로벌매출기대,http://daily.hankooki.com/lpage/ittech/201903/dh20190322191507145630.htm
2285,2019-03-22,주총현장전승호대웅제약대표글로벌매출이익성장본격화할것”,http://news.mk.co.kr/newsRead.php?year=2019&no=174844
2286,2019-03-22,대웅윤재춘대표재선임매출1조2000억,http://www.dailypharm.com/Users/News/NewsView.html?ID=250757&REFERER=NP
2287,2019-03-22,대웅대웅제약지속적경영실적창출책임경영강화다짐,http://www.medisobizanews.com/news/articleView.html?idxno=58629
2288,2019-03-22,대웅대웅제약주총책임경영내실강화로미래성장추진,http://www.kpanews.co.kr/article/show.asp?idx=202477&table=article&category=D
2289,2019-03-22,대웅베아제TV광고론칭기념사내이벤트,http://www.dailypharm.com/Users/News/NewsView.html?ID=250760&REFERER=NP
2290,2019-03-22,대웅대웅제약주주총회개최책임경영통해내실강화,http://www.ekn.kr/news/article.html?no=422100
2291,2019-03-22,대웅제약베아제TV광고론칭기념사내이벤트진행,http://www.newscj.com/news/articleView.html?idxno=613906
2292,2019-03-23,윤재춘대웅대표재신임지속적인성과창출약속,http://www.dailymedi.com/detail.php?number=841244&thread=22r05
2293,2019-03-23,대웅대웅제약주총서주주가치제고입장밝혀,http://www.edaily.co.kr/news/newspath.asp?newsid=01469446622426272
2294,2019-03-24,대웅제59기주주총회개최윤재춘대표재선임,http://www.getnews.co.kr/view.php?ud=20190324091520285441d0c69529_16
2295,2019-03-24,제약산업단신일동제약대웅제약한미약품한국오츠카제약,http://www.kukinews.com/news/article.html?no=644620
2296,2019-03-24,대웅제약베아제33주년TV광고론칭기념사내이벤트,http://www.metroseoul.co.kr/news/newsview?newscd=2019032200113
2297,2019-03-24,대웅주총서임기만료윤재춘사내이사재선임지속적인성과창출약속,https://www.insight.co.kr/news/218308
2298,2019-03-24,대웅제약우수임직원스톡옵션부여윤재춘대표재선임,http://news.heraldcorp.com/view.php?ud=20190324000186
2299,2019-03-24,대웅주식배당결정안건부결”,http://www.mdtoday.co.kr/mdtoday/index.html?no=349769
2300,2019-03-25,★주식인사이드대웅제약주가183000원3월25일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=609129
2301,2019-03-25,대웅주가3월25일현재20100원,http://www.gokorea.kr/news/articleView.html?idxno=129869
2302,2019-03-25,주식실황25일대웅현재가격20050원,http://www.anewsa.com/detail.php?number=1628478&thread=10r02
2303,2019-03-25,3월25일대웅주식추천주07420000원,http://www.nbntv.co.kr/news/articleView.html?idxno=276145
2304,2019-03-25,대웅제약베아제33주년기념사내이벤트진행,http://www.straightnews.co.kr/news/articleView.html?idxno=45755
2305,2019-03-25,전승호대웅제약사장나보타올해부터본격적인글로벌매출실현,http://www.rapportian.com/news/articleView.html?idxno=116738
2306,2019-03-25,대웅제59기및대웅제약제17기주주총회개최,http://www.k-health.com/news/articleView.html?idxno=43086
2307,2019-03-25,대웅제약나보타美3상결과SCI급국제학술지게재美시장본격진출예정,http://www.newspim.com/news/view/20190325000335
2308,2019-03-25,대웅제약나보타미국3상결과SCI급국제학술지게재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228624
2309,2019-03-25,3월25일대웅제약주식증권081184500원,http://www.nbntv.co.kr/news/articleView.html?idxno=276631
2310,2019-03-25,대웅나보타미간주름개선효과재확인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84736
2311,2019-03-25,대웅제약나보타美국제학술지게재전세계에우수성알려,http://www.seoulwire.com/news/articleView.html?idxno=95564
2312,2019-03-25,대웅제약나보타美3상임상결과SCI급국제학술지게재위약대비우수한주름개선효과안전성입증,http://www.segye.com/content/html/2019/03/25/20190325562585.html?OutUrl=naver
2313,2019-03-25,대웅나보타美3상결과SCI급국제학술지게재,http://www.dailypharm.com/Users/News/NewsView.html?ID=250792&REFERER=NP
2314,2019-03-25,대웅제약미국임상3상결과SCI급학술지게재,http://news.mk.co.kr/newsRead.php?year=2019&no=178345
2315,2019-03-25,대웅제약나보타美3상임상결과SCI급국제학술지게재,http://www.medisobizanews.com/news/articleView.html?idxno=58657
2316,2019-03-25,대웅제약나보타美3상임상결과SCI급국제학술지게재,http://www.sisafocus.co.kr/news/articleView.html?idxno=205606
2317,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.newsway.co.kr/news/view?tp=1&ud=2019032511351817126
2318,2019-03-25,대웅제약나보타美임상3상국제학술지게재,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019032511044578202
2319,2019-03-25,대웅제약나보타美3상결과주름개선효과안전성입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1737489
2320,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.economytalk.kr/news/articleView.html?idxno=181985
2321,2019-03-25,대웅제약나보타주름개선효과SCI급국제학술지실려,http://biz.chosun.com/site/data/html_dir/2019/03/25/2019032501223.html
2322,2019-03-25,대웅제약나보타美임상3상결과더마톨로직서저리게재,http://www.newsprime.co.kr/news/article.html?no=452141
2323,2019-03-25,대웅제약주름개선약나보타임상결과SCI급국제학술지실려,https://cnbc.sbs.co.kr/article_hub/10000935414?division=NAVER
2324,2019-03-25,대웅제약나보타美3상임상결과국제학술지게재,http://www.metroseoul.co.kr/news/newsview?newscd=2019032500107
2325,2019-03-25,대웅나보타美3상임상결과SCI급국제학술지게재,http://www.shinailbo.co.kr/news/articleView.html?idxno=1152358
2326,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.koreaittimes.com/news/articleView.html?idxno=89882
2327,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,https://www.sedaily.com/NewsView/1VGQ7090IE
2328,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.etnews.com/20190325000207
2329,2019-03-25,스타★주식인사이드대웅제약주가183500원3월25일14시14분기준,http://www.newsinside.kr/news/articleView.html?idxno=610160
2330,2019-03-25,대웅제약나보타효과안전성인정3상결과SCI급국제학술지게재,http://kpenews.com/View.aspx?No=30184
2331,2019-03-25,대웅윤재춘대표사내이사재선임,http://www.bokuennews.com/news/article.html?no=173348
2332,2019-03-25,대웅제약나보타미국3상임상결과국제학술지게재,http://www.ebn.co.kr/news/view/977891
2333,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.dailian.co.kr/news/view/782180/?sc=naver
2334,2019-03-25,대웅제약나보타주름개선효과SCI급국제학술지게재,http://www.newsis.com/view/?id=NISX20190325_0000598023&cID=13001&pID=13000
2335,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.mdtoday.co.kr/mdtoday/index.html?no=349838
2336,2019-03-25,美출시앞둔대웅제약나보타SCI급국제학술지에임상결과게재,http://www.inthenews.co.kr/news/article.html?no=14284
2337,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.wolyo.co.kr/news/articleView.html?idxno=80136
2338,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.ekn.kr/news/article.html?no=422435
2339,2019-03-25,대웅제약나보타美진출초읽기임상3상결과SCI급국제학술지게재,http://www.ezyeconomy.com/news/articleView.html?idxno=89196
2340,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.medigatenews.com/news/2695747953
2341,2019-03-25,대웅제약나보타미국3상임상결과국제학술지게재,http://www.asiatime.co.kr/news/articleView.html?idxno=235766
2342,2019-03-25,대웅제약나보타美3상결과국제학술지게재,http://www.biospectator.com/view/news_view.php?varAtcId=7343
2343,2019-03-25,대웅제약나보타美임상3상결과국제학술지게재,http://www.monews.co.kr/news/articleView.html?idxno=201611
2344,2019-03-25,윤해영원장대웅병원경영혁신대상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2101930
2345,2019-03-25,대웅제약나보타SCI급국제학술지게재,http://www.joseilbo.com/news/news_read.php?uid=373024&class=17&grp=
2346,2019-03-25,대웅제약나보타미국3상임상결과더마톨로직서저리게재,http://www.fnnews.com/news/201903251629152816
2347,2019-03-25,장마감보고서25일대웅주가20200원으로장마감,http://www.anewsa.com/detail.php?number=1630910&thread=10r04
2348,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.businesskorea.co.kr/news/articleView.html?idxno=30304
2349,2019-03-25,대웅제약나보타임상3상서주름개선효과우수입증,http://www.econovill.com/news/articleView.html?idxno=359411
2350,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,https://www.insight.co.kr/news/218575
2351,2019-03-25,대웅제59기대웅제약제17기주주총회개최,http://www.lawissue.co.kr/view.php?ud=201903251713191745d7f4c63cc6_12
2352,2019-03-25,대웅제약보툴리눔톡신나보타美3상임상서효과입증,http://view.asiae.co.kr/news/view.htm?idxno=2019032517360965760
2353,2019-03-25,대웅제약나보타美3상임상결과국제학술지게재,http://www.skyedaily.com/news/news_view.html?ID=83132
2354,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.wsobi.com/news/articleView.html?idxno=71223
2355,2019-03-25,대웅제약나보타미국3상임상결과SCI급국제학술지게재,http://www.ftoday.co.kr/news/articleView.html?idxno=107471
2356,2019-03-26,JOB현장에선대웅및일동제약의AI신약개발후보물질발굴10분의1단축기대,http://www.news2day.co.kr/123331
2357,2019-03-26,대웅제약당기순이익적자전환에도배당은그대로,http://www.datanews.co.kr/news/article.html?no=102556
2358,2019-03-26,대웅제약나보타미국3상위약대비우수효과입증,http://www.viva100.com/main/view.php?key=20190326010008709
2359,2019-03-26,★주식인사이드대웅제약주가182500원3월26일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=611274
2360,2019-03-26,강스템아토피신약파트너대웅→SK바이오랜드,http://www.dailypharm.com/Users/News/NewsView.html?ID=250835&REFERER=NP
2361,2019-03-26,3월26일대웅시세보기20200원000,http://www.nbntv.co.kr/news/articleView.html?idxno=278584
2362,2019-03-26,증시보고26일대웅현재주가20200원,http://www.anewsa.com/detail.php?number=1631929&thread=10r02
2363,2019-03-26,대웅제약대신SK바이오랜드와손잡은강스템바이오텍,http://news.hankyung.com/article/201903264939f
2364,2019-03-26,대웅제약주가증권그래프26일현재186500원,http://www.gokorea.kr/news/articleView.html?idxno=131381
2365,2019-03-26,대웅제약시세보기26일현재186500원,http://www.nbntv.co.kr/news/articleView.html?idxno=279072
2366,2019-03-26,대웅제약미국시장진출한목표향한선택과집중,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228691
2367,2019-03-26,스타★주식인사이드대웅제약주가186000원3월26일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=612331
2368,2019-03-26,대웅제약눈덩이적자에도고배당고수왜,http://www.newsfc.co.kr/news/articleView.html?idxno=35690
2369,2019-03-26,26일마감보고대웅주가20450원마감,http://www.anewsa.com/detail.php?number=1634358&thread=10r04
2370,2019-03-26,대웅제약가족친화중점둔혁신지향기업문화추진한다,http://www.lawissue.co.kr/view.php?ud=2019032617455673259817d053b9_12
2371,2019-03-26,대웅제약우루사미국진출중단TV광고논란이중고,http://www.wolyo.co.kr/news/articleView.html?idxno=80289
2372,2019-03-27,대웅동아ST미용치매분야임상탄력RD기대,http://www.dailypharm.com/Users/News/NewsView.html?ID=250877&REFERER=NP
2373,2019-03-27,대웅제약해외법인은밑빠진독11개중10곳적자내며사상최대손실,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=530580
2374,2019-03-27,★주식인사이드대웅제약주가185000원3월27일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=613423
2375,2019-03-27,대웅오늘주식시장27일현재20000원,http://www.nbntv.co.kr/news/articleView.html?idxno=281027
2376,2019-03-27,장중시세27일대웅현재주식거래가격20000원,http://www.anewsa.com/detail.php?number=1635442&thread=10r02
2377,2019-03-27,대웅제약오늘주식장27일현재184000원,http://www.nbntv.co.kr/news/articleView.html?idxno=281506
2378,2019-03-27,ET투자뉴스대웅_거래비중기관2563외국인2209,http://www.etnews.com/20190327000077
2379,2019-03-27,스타★주식인사이드대웅제약주가183000원3월27일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=614521
2380,2019-03-27,대웅제약주가3월27일현재185000원,http://www.gokorea.kr/news/articleView.html?idxno=133183
2381,2019-03-27,27일대웅주가20050원으로마감,http://www.anewsa.com/detail.php?number=1637613&thread=10r04
2382,2019-03-28,대웅턱밑지방치료제임상3상진행에스테틱라인업강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=350153
2383,2019-03-28,★주식인사이드대웅제약주가183500원3월28일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=615582
2384,2019-03-28,대웅시세보기28일현재19850원,http://www.nbntv.co.kr/news/articleView.html?idxno=283413
2385,2019-03-28,종목상세정보28일대웅현재가격19950원,http://www.anewsa.com/detail.php?number=1638922&thread=10r02
2386,2019-03-28,3월28일대웅제약주식추천주183500원027,http://www.nbntv.co.kr/news/articleView.html?idxno=283932
2387,2019-03-28,스타★주식인사이드대웅제약주가183500원3월28일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=616710
2388,2019-03-28,장마감보고서28일대웅주가20000원으로장마감,http://www.anewsa.com/detail.php?number=1641302&thread=10r04
2389,2019-03-29,대웅유나이티드모사프리드서방정소송쌍방취하,http://www.dailypharm.com/Users/News/NewsView.html?ID=250973&REFERER=NP
2390,2019-03-29,한투證대웅제약하반기실적개선예상매수의견,http://www.newsis.com/view/?id=NISX20190329_0000603142&cID=10401&pID=10400
2391,2019-03-29,대웅제약주보미국출시효과기대매수한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1739547
2392,2019-03-29,대웅제약美파트너사현지보톨리눔톡신출시기대한국투자증권,https://www.sedaily.com/NewsView/1VGS08Y2FQ
2393,2019-03-29,★주식인사이드대웅제약주가185000원3월29일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=617794
2394,2019-03-29,특징주대웅제약실적개선전망에상승세,http://www.newsis.com/view/?id=NISX20190329_0000603286&cID=10401&pID=10400
2395,2019-03-29,대웅제약목표가25만원유지전일종가18만3000원한투證,http://www.newspim.com/news/view/20190329000204
2396,2019-03-29,퀵리포트대웅제약매수유지목표가25만원유지한투證,http://www.itooza.com/common/iview.php?no=2019032909305718215
2397,2019-03-29,국내주식시장현황29일대웅거래가격19750원,http://www.anewsa.com/detail.php?number=1642318&thread=10r02
2398,2019-03-29,대웅제약주가오른다보톡스미국수출로수익성좋아져,http://www.businesspost.co.kr/BP?command=article_view&num=120743
2399,2019-03-29,대웅제약주식종목시세29일현재182500원,http://www.nbntv.co.kr/news/articleView.html?idxno=286356
2400,2019-03-29,대웅제약美주보매출하반기본격장기성장성뚜렷한국證,http://news.mt.co.kr/mtview.php?no=2019032910294495774
2401,2019-03-29,스타★주식인사이드대웅제약주가184000원3월29일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=618895
2402,2019-03-29,대웅제약매출비중확대로주가↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=350365
2403,2019-03-29,대웅제약미국보툴리눔톡신시장진출하반기본격매출발생전망,http://www.econovill.com/news/articleView.html?idxno=359835
2404,2019-04-01,대웅유나이티드모사프리드서방정특허분쟁종결,http://www.mdtoday.co.kr/mdtoday/index.html?no=350398
2405,2019-04-01,대웅제약목표가30만원유지전일종가18만4000원KTB證,http://www.newspim.com/news/view/20190401000168
2406,2019-04-01,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019040108102913073
2407,2019-04-01,★주식인사이드대웅제약주가185500원4월1일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=619972
2408,2019-04-01,대웅제약우루사미국진출무산공시누락의혹,http://www.polinews.co.kr/news/article.html?no=387052
2409,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228941
2410,2019-04-01,대웅제약 국내최초액상형아세트아미노펜 이지엔6 에이스 출시,http://www.fetv.co.kr/news/article.html?no=24717
2411,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.ebn.co.kr/news/view/978954
2412,2019-04-01,대웅제약액상형아세트아미노펜연질캡슐이지엔6에이스출시,http://www.fnnews.com/news/201904011454029518
2413,2019-04-01,대웅제약국내1위액상진통제이지엔6캡슐로나온다,http://www.seoulwire.com/news/articleView.html?idxno=100623
2414,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.medigatenews.com/news/2508506584
2415,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.asiatime.co.kr/news/articleView.html?idxno=237269
2416,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=350562
2417,2019-04-01,스타★주식인사이드대웅제약주가186500원4월1일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=621062
2418,2019-04-01,대웅제약임산부도안전한액상형진통제이지엔6에이스출시,http://www.newspim.com/news/view/20190401000982
2419,2019-04-01,대웅제약국내첫액상형아세트아미노펜이지엔6에이스출시,http://www.medisobizanews.com/news/articleView.html?idxno=58833
2420,2019-04-01,대웅제약국내최초액상형연질캡슐이지엔6에이스출시,http://daily.hankooki.com/lpage/ittech/201904/dh20190401152429145630.htm
2421,2019-04-01,대웅제약액상형진통제이지엔6에이스출시,http://www.bokuennews.com/news/article.html?no=173688
2422,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019040100206
2423,2019-04-01,대웅제약캡슐형해열진통제이지엔6에이스출시,http://www.ezyeconomy.com/news/articleView.html?idxno=89431
2424,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.newscj.com/news/articleView.html?idxno=616779
2425,2019-04-01,대웅제약효과빠른액상형진통제시장선점이지엔6에이스출시,http://kpenews.com/View.aspx?No=30597
2426,2019-04-01,대웅제약국내최초액상형아세트아미노펜출시,http://medipana.com/news/news_viewer.asp?NewsNum=236850&MainKind=A&NewsKind=5&vCount=12&vKind=1
2427,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019040115534046759
2428,2019-04-01,대웅제약효과빠른액상진통제이지엔6에이스출시,http://www.newsis.com/view/?id=NISX20190401_0000606039&cID=13001&pID=13000
2429,2019-04-01,대웅제약액상해열진통제이지엔6에이스출시,http://news1.kr/articles/?3586044
2430,2019-04-01,1일공감마감증시대웅19800원마감,http://www.gokorea.kr/news/articleView.html?idxno=137400
2431,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.economytalk.kr/news/articleView.html?idxno=182556
2432,2019-04-01,대웅액상형아세트아미노펜이지엔6에이스출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=251086&REFERER=NP
2433,2019-04-01,1일대웅주가19800원으로장마감,http://www.anewsa.com/detail.php?number=1647628&thread=10r04
2434,2019-04-01,대웅제약시세보기1일현재185500원,http://www.nbntv.co.kr/news/articleView.html?idxno=289443
2435,2019-04-01,대웅국내첫액상형아세트아미노펜이지엔6에이스선봬,http://www.kpanews.co.kr/article/show.asp?idx=202731&table=article&category=D
2436,2019-04-01,대웅제약지난해4분기연결영업이익34억전년비59↓,http://www.newspim.com/news/view/20190401001840
2437,2019-04-01,대웅제약액상형진통제이지엔6에이스출시,http://www.kpinews.co.kr/news/articleView.html?idxno=93446
2438,2019-04-01,실적속보대웅제약지난해4Q영업이익34억전년비59↓,http://www.itooza.com/common/iview.php?no=2019040117151682043
2439,2019-04-01,실적속보대웅지난해4Q영업이익181억전년비4↓,http://www.itooza.com/common/iview.php?no=2019040117175124933
2440,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.dailian.co.kr/news/view/784235/?sc=naver
2441,2019-04-01,대웅지난해4분기연결영업이익181억전년비4↓,http://www.newspim.com/news/view/20190401001866
2442,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1740553
2443,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.mhj21.com/120488
2444,2019-04-01,코스피대웅제약2018년매출액1조314억원영업이익245억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013193358&code=61141211&cp=nv
2445,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=80756
2446,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.koreaittimes.com/news/articleView.html?idxno=90042
2447,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,https://www.sedaily.com/NewsView/1VHP3IPKCN
2448,2019-04-01,대웅제약액상형해열진통제이지엔6에이스출시,http://www.viva100.com/main/view.php?key=20190401010000473
2449,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.getnews.co.kr/view.php?ud=20190401185503851841d0c69529_16
2450,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=51762
2451,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.rapportian.com/news/articleView.html?idxno=116890
2452,2019-04-01,대웅제약국내최초액상형아세트아미노펜이지엔6에이스출시,http://www.lawissue.co.kr/view.php?ud=201904011935478860d7f4c63cc6_12
2453,2019-04-01,대웅제약효과빠른액상진통제이지엔6에이스출시,http://news.mk.co.kr/newsRead.php?year=2019&no=197983
2454,2019-04-01,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.ajunews.com/view/20190401222606156
2455,2019-04-02,대웅제약국내첫액상형아세트아미노펜이지엔6에이스출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3796713
2456,2019-04-02,대웅제약액상형이지엔6에이스출시빠른진통효과눈길,http://www.sportsworldi.com/content/html/2019/04/01/20190401514609.html
2457,2019-04-02,일간보사창간특집대웅제약글로벌사업현지화전략승부,http://www.bosa.co.kr/news/articleView.html?idxno=2102481
2458,2019-04-02,★주식인사이드대웅제약주가185500원4월2일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=622126
2459,2019-04-02,대웅제약액상형아세트아미노펜이지엔6에이스출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=8480
2460,2019-04-02,종목추적2일대웅현재주가20200원,http://www.anewsa.com/detail.php?number=1648342&thread=10r02
2461,2019-04-02,대웅주가증권그래프외주식시황2일현재20250원,http://www.gokorea.kr/news/articleView.html?idxno=137842
2462,2019-04-02,대웅제약액상형진통제이지엔6에이스출시,http://www.bosa.co.kr/news/articleView.html?idxno=2102506
2463,2019-04-02,정현호메디톡스대표대웅제약나보타보툴리눔균주기원밝혀라,http://www.asiatoday.co.kr/view.php?key=20190402010001382
2464,2019-04-02,대웅003090종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904020238&t=NN
2465,2019-04-02,제약토크액상형아세트아미노펜진통제대웅제약이지엔6에이스,https://www.insight.co.kr/news/220151
2466,2019-04-02,정종근전대웅제약부사장아들511,http://medipana.com/news/news_viewer.asp?NewsNum=236899&MainKind=A&NewsKind=5&vCount=12&vKind=1
2467,2019-04-02,종목추적2일대웅현재주식거래가격20550원,http://www.anewsa.com/detail.php?number=1648757&thread=10r02
2468,2019-04-02,메디톡스정현호대표대웅균주출처밝혀라,http://www.dailymedi.com/detail.php?number=841566&thread=22r05
2469,2019-04-02,대웅제약개발SGLT2당뇨신약녹십자에서도입,http://www.dailypharm.com/Users/News/NewsView.html?ID=251117&REFERER=NP
2470,2019-04-02,ET투자뉴스대웅제약_주가거래량투심모두적정주순,http://www.etnews.com/20190402000218
2471,2019-04-02,ET투자뉴스대웅제약지분변동국민연금공단외1명107p증가927보유,http://www.etnews.com/20190402000230
2472,2019-04-02,주식실황2일대웅주가20350원,http://www.anewsa.com/detail.php?number=1649071&thread=10r02
2473,2019-04-02,4월2일대웅증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=138298
2474,2019-04-02,대웅제약거래량증가하며주가상승주가323↑,http://www.tfnews.co.kr/news/article.html?no=64155
2475,2019-04-02,4월2일대웅주가차트25320300원,http://www.nbntv.co.kr/news/articleView.html?idxno=290311
2476,2019-04-02,스타★주식인사이드대웅제약주가191500원4월2일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=623189
2477,2019-04-02,마켓브레인함보름대웅제약인사팀장채용제약실무부터교육시켜야죠,http://www.ajunews.com/view/20190402141527808
2478,2019-04-02,ET투자뉴스대웅제약지분변동국민연금공단외1명107p증가927보유,http://www.etnews.com/20190402000415
2479,2019-04-02,오늘주식시세대웅제약주가2일현재190500원,http://www.nbntv.co.kr/news/articleView.html?idxno=290882
2480,2019-04-02,2일기관순매수Top10TIGER2002009억KODEX코스닥150레버리지107억대웅제약58억코웨이37억기관순매수나서코스닥시장에서는JYPEnt에스엠위메이드상위,http://www.fintechpost.co.kr/news/articleView.html?idxno=29831
2481,2019-04-03,★주식인사이드대웅제약주가189000원4월3일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=624280
2482,2019-04-03,대웅제약항궤양제알비스발매20주년심포지엄개최,http://moneys.mt.co.kr/news/mwView.php?no=2019040309058048469
2483,2019-04-03,대웅제약국내1위알비스20주년심포지엄소화기질환선두주자입지굳힐것,http://www.seoulwire.com/news/articleView.html?idxno=101633
2484,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,https://www.sedaily.com/NewsView/1VHPZ8D6DP
2485,2019-04-03,대웅제약처방1위항궤양제알비스발매20주년심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2019&no=201825
2486,2019-04-03,대웅제약알비스발매20주년심포지엄열어,http://www.dailypharm.com/Users/News/NewsView.html?ID=251153&REFERER=NP
2487,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.ebn.co.kr/news/view/979270
2488,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.fetv.co.kr/news/article.html?no=24907
2489,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019040309381448854
2490,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.wolyo.co.kr/news/articleView.html?idxno=80876
2491,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.dailian.co.kr/news/view/784679/?sc=naver
2492,2019-04-03,대웅제약알비스발매20주년기념심포지엄성료,http://www.asiatime.co.kr/news/articleView.html?idxno=237692
2493,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄개최,http://www.newspim.com/news/view/20190403000158
2494,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229014
2495,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄개최,http://www.ezyeconomy.com/news/articleView.html?idxno=89486
2496,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.ekn.kr/news/article.html?no=424265
2497,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.fnnews.com/news/201904031013593157
2498,2019-04-03,대웅주가4월3일현재20350원,http://www.gokorea.kr/news/articleView.html?idxno=139598
2499,2019-04-03,더벨대웅제약A급흥행이을까적자전환부담,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904020100004630000293
2500,2019-04-03,대웅제약알비스발매20주년기념심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2102592
2501,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.etnews.com/20190403000097
2502,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://daily.hankooki.com/lpage/ittech/201904/dh20190403103849145630.htm
2503,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125536&REFERER=NP
2504,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.gokorea.kr/news/articleView.html?idxno=139602
2505,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1741250
2506,2019-04-03,대웅항궤양제알비스20周기념심포지엄,http://www.dailymedi.com/detail.php?number=841600&thread=22r05
2507,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019040300067
2508,2019-04-03,대웅제약알비스출시20주년광범위한항궤양제로시장1위굳건,http://www.medisobizanews.com/news/articleView.html?idxno=58880
2509,2019-04-03,20주년맞은대웅제약알비스소화기질환최신지견공유,http://www.viva100.com/main/view.php?key=20190403010001131
2510,2019-04-03,대웅제약알비스발매20주년기념심포지엄성료,http://www.whosaeng.com/109152
2511,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.newspost.kr/news/articleView.html?idxno=70248
2512,2019-04-03,스타★주식인사이드대웅제약주가190500원4월3일13시13분기준,http://www.newsinside.kr/news/articleView.html?idxno=625338
2513,2019-04-03,대웅제약항궤양제알비스발매20주년심포지엄성료,http://www.rapportian.com/news/articleView.html?idxno=116917
2514,2019-04-03,대웅제약주가4월3일현재191500원,http://www.gokorea.kr/news/articleView.html?idxno=139890
2515,2019-04-03,대웅제약항궤양제알비스발매20주년기념심포지엄진행,http://www.newsprime.co.kr/news/article.html?no=453572
2516,2019-04-03,대웅제약오늘주식시장3일현재190500원,http://www.nbntv.co.kr/news/articleView.html?idxno=291940
2517,2019-04-03,대웅제약항궤양제알비스20주년기념심포지엄개최,http://news.donga.com/3/all/20190403/94872252/2
2518,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최지속적인연구개발통해환자삶의질개선주력,http://www.segye.com/content/html/2019/04/03/20190403511126.html?OutUrl=naver
2519,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.joseilbo.com/news/news_read.php?uid=373743&class=27&grp=
2520,2019-04-03,장마감보고서3일대웅주가20450원으로장마감,http://www.anewsa.com/detail.php?number=1652196&thread=10r04
2521,2019-04-03,대웅제약알비스발매20주년심포지엄개최 ,http://www.monews.co.kr/news/articleView.html?idxno=201807
2522,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.skyedaily.com/news/news_view.html?ID=83436
2523,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=617723
2524,2019-04-03,대웅제약알비스발매20주년기념심포지엄개최,http://www.lawissue.co.kr/view.php?ud=20190403233324713d7f4c63cc6_12
2525,2019-04-04,★주식인사이드대웅제약주가190000원4월4일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=626406
2526,2019-04-04,증권주식대웅주가4일현재20150원,http://www.nbntv.co.kr/news/articleView.html?idxno=293239
2527,2019-04-04,주식시세4일대웅현재가격20150원,http://www.anewsa.com/detail.php?number=1653604&thread=10r02
2528,2019-04-04,4월4일대웅제약오늘주식시장190000원078,http://www.nbntv.co.kr/news/articleView.html?idxno=293744
2529,2019-04-04,코스피코스닥오름세JW생명과학대웅코오롱생명과학등은약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=350911
2530,2019-04-04,스타★주식인사이드대웅제약주가190000원4월4일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=627507
2531,2019-04-04,대웅제약미국에서보툴리눔톡신나보타적응증확대서둘러,http://www.businesspost.co.kr/BP?command=article_view&num=121687
2532,2019-04-04,주름잡는대웅제약나보타탈모등치료목적연구도활기,http://biz.chosun.com/site/data/html_dir/2019/04/04/2019040402234.html
2533,2019-04-04,대웅제약자회사시지바이오의지젤크루지젤리뉴정확하고바른정보전달한다,http://kor.theasian.asia/archives/216589
2534,2019-04-05,★주식인사이드대웅제약주가189000원4월5일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=628654
2535,2019-04-05,대웅임팩타민5월부터약국공급가15인상,http://www.dailypharm.com/Users/News/NewsView.html?ID=251233&REFERER=NP
2536,2019-04-05,4월5일대웅주식창19950원025,http://www.nbntv.co.kr/news/articleView.html?idxno=295659
2537,2019-04-05,대웅주가4월5일현재19950원,http://www.gokorea.kr/news/articleView.html?idxno=143367
2538,2019-04-05,장중시세5일대웅현재주식거래가격19950원,http://www.anewsa.com/detail.php?number=1656978&thread=10r02
2539,2019-04-05,대웅제약주식시세현황5일현재189000원,http://www.nbntv.co.kr/news/articleView.html?idxno=296195
2540,2019-04-05,4월5일대웅제약정보및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=143579
2541,2019-04-05,스타★주식인사이드대웅제약주가187000원4월5일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=629735
2542,2019-04-05,5일마감주가정보대웅19650원마감,http://www.gokorea.kr/news/articleView.html?idxno=144368
2543,2019-04-07,대웅제약젊은전문경영인전승호글로벌진출선봉에서다,http://www.businesspost.co.kr/BP?command=article_view&num=121993
2544,2019-04-08,대웅제약셀트리온제약등시설신축증설돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=351125
2545,2019-04-08,★주식인사이드대웅제약주가188000원4월8일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=630815
2546,2019-04-08,대웅주식현황8일현재19750원,http://www.nbntv.co.kr/news/articleView.html?idxno=298554
2547,2019-04-08,장중주가8일대웅주가19750원,http://www.anewsa.com/detail.php?number=1661001&thread=10r02
2548,2019-04-08,장중주가8일대웅현재가격19750원,http://www.anewsa.com/detail.php?number=1661066&thread=10r02
2549,2019-04-08,주식시세현황대웅제약주가8일현재186000원,http://www.nbntv.co.kr/news/articleView.html?idxno=299048
2550,2019-04-08,국민연금올해한올JW생과대웅주식사들였다,http://www.dailypharm.com/Users/News/NewsView.html?ID=251317&REFERER=NP
2551,2019-04-08,대웅제약액상형진통제이지엔6에이스출시,http://www.skyedaily.com/news/news_view.html?ID=83595
2552,2019-04-08,대웅제약알비스발매20주년기념심포지엄개최,http://www.skyedaily.com/news/news_view.html?ID=83594
2553,2019-04-08,스타★주식인사이드대웅제약주가185000원4월8일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=631901
2554,2019-04-08,8일마감증시대웅19800원마감,http://www.gokorea.kr/news/articleView.html?idxno=146659
2555,2019-04-09,대웅제약미국수출본격화로구조적실적개선기대NH,https://www.hankyung.com/article/2019040941256
2556,2019-04-09,단독대웅제약나보타유럽에서누시바로판매된다,http://news1.kr/articles/?3591985
2557,2019-04-09,대웅제약나보타수출본격화에실적개선시작NH,http://www.fnnews.com/news/201904090742399907
2558,2019-04-09,대웅제약목표가24만원유지전일종가18만5500원NH證,http://www.newspim.com/news/view/20190409000080
2559,2019-04-09,퀵리포트대웅제약매수유지목표가24만원유지NH證,http://www.itooza.com/common/iview.php?no=2019040908085016892
2560,2019-04-09,HotLine대웅제약이익구조개선과RD진전예상,http://news.mk.co.kr/newsRead.php?year=2019&no=215977
2561,2019-04-09,★주식인사이드대웅제약주가189000원4월9일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=632988
2562,2019-04-09,4월9일대웅주식종목시세05119900원,http://www.nbntv.co.kr/news/articleView.html?idxno=300889
2563,2019-04-09,주식실황9일대웅증시현황19750원,http://www.anewsa.com/detail.php?number=1664613&thread=10r02
2564,2019-04-09,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201904091030303638tpgetnews_16
2565,2019-04-09,주식종목시세대웅제약주가9일현재187500원,http://www.nbntv.co.kr/news/articleView.html?idxno=301404
2566,2019-04-09,대웅제약주가오늘시세및주체별매매동향9일현재188000원,http://www.gokorea.kr/news/articleView.html?idxno=147884
2567,2019-04-09,ET투자뉴스대웅제약구조적이익성장BUY유지NH투자증권,http://www.etnews.com/20190409000117
2568,2019-04-09,나신평대웅제약적자전환에도신용등급A유지,http://www.etoday.co.kr/news/section/newsview.php?idxno=1743103
2569,2019-04-09,스타★주식인사이드대웅제약주가188000원4월9일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=634037
2570,2019-04-09,9일마감주가정보대웅19900원마감,http://www.gokorea.kr/news/articleView.html?idxno=148668
2571,2019-04-09,대웅제약신제품효과로국내영업호조”,http://www.wikitree.co.kr/main/news_view.php?id=418771
2572,2019-04-09,대웅제약2분기중나보타기술료효과거둔다,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019040917413803617&objId=A2019040917413803617&portalCode=naver
2573,2019-04-09,대웅제약나보타유럽상품명누시바로결정,http://www.rapportian.com/news/articleView.html?idxno=117026
2574,2019-04-10,대웅제약안구건조증신약탄파너셉트황반변성치료제로개발,http://www.medisobizanews.com/news/articleView.html?idxno=59013
2575,2019-04-10,★주식인사이드대웅제약주가191500원4월10일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=635162
2576,2019-04-10,실시간분석대웅제약32상승증권사목표가24만원제시,http://www.itooza.com/common/iview.php?no=2019041009183726341
2577,2019-04-10,4월10일대웅주식종목20000원050,http://www.nbntv.co.kr/news/articleView.html?idxno=303289
2578,2019-04-10,국내주식시장현황10일대웅증시현황20000원,http://www.anewsa.com/detail.php?number=1668039&thread=10r02
2579,2019-04-10,대웅제약5이상상승구조적이익성장개시NH투자증권BUY유지,https://www.hankyung.com/article/201904109159L
2580,2019-04-10,4월10일대웅제약주식그래프194500원401,http://www.nbntv.co.kr/news/articleView.html?idxno=303781
2581,2019-04-10,스타★주식인사이드대웅제약주가194000원4월10일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=636242
2582,2019-04-10,휴텍스대웅바이오한국콜마알리코동구바이오영업대행사에수백억원대수수료지급,http://www.sisajournal-e.com/news/articleView.html?idxno=198444
2583,2019-04-10,10일마감정보대웅20150원마감,http://www.gokorea.kr/news/articleView.html?idxno=150694
2584,2019-04-11,대웅제약목표가13↑26만원제시하이투자證,http://www.newspim.com/news/view/20190411000076
2585,2019-04-11,퀵리포트대웅제약매수유지목표가13↑26만원하이투자證,http://www.itooza.com/common/iview.php?no=2019041108044614647
2586,2019-04-11,보톨리눔톡신지속성장메디톡스대웅제약주목대신,http://www.edaily.co.kr/news/newspath.asp?newsid=01469446622455136
2587,2019-04-11,대웅제약나보타성공스토리가시화목표가↑”하이투자증권,http://www.dailian.co.kr/news/view/786810/?sc=naver
2588,2019-04-11,대웅제약신약나보타매출확대본격화목표가↑하이,http://www.edaily.co.kr/news/newspath.asp?newsid=01561286622455136
2589,2019-04-11,대웅제약가시화되는나보타성공가능성목표가↑하이,https://www.hankyung.com/article/2019041129976
2590,2019-04-11,바이오뷰티산업비중확대메디톡스대웅제약선호대신증권,http://www.fnnews.com/news/201904110843458881
2591,2019-04-11,하이투자證대웅제약나보타성공가시화매수의견,http://www.newsis.com/view/?id=NISX20190411_0000617012&cID=10401&pID=10400
2592,2019-04-11,ET투자뉴스대웅제약가시화되는나보타BUY유지하이투자증권,http://www.etnews.com/20190411000011
2593,2019-04-11,대웅제약나보타영향으로이익증가전망하이투자證,http://www.seoulfn.com/news/articleView.html?idxno=339427
2594,2019-04-11,ET투자뉴스대웅제약나보타로예뻐지는BUY유지대신증권,http://www.etnews.com/20190411000022
2595,2019-04-11,대웅제약나보타출시효과로실적개선전망하이투자증권,https://www.sedaily.com/NewsView/1VHTOKJ4EN
2596,2019-04-11,★주식인사이드대웅제약주가195000원4월11일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=637352
2597,2019-04-11,실시간주식현황대웅주가11일현재20250원,http://www.nbntv.co.kr/news/articleView.html?idxno=305755
2598,2019-04-11,증시보고11일대웅현재주식거래가격20200원,http://www.anewsa.com/detail.php?number=1671702&thread=10r02
2599,2019-04-11,GET투자리포트대웅제약투자의견매수유지하이투자증권,http://www.getnews.co.kr/view.php?ud=201904111030303724tpgetnews_16
2600,2019-04-11,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=201904111030303732tpgetnews_16
2601,2019-04-11,대웅제약주가오른다보톡스나보타5월부터미국수출,http://www.businesspost.co.kr/BP?command=article_view&num=122661
2602,2019-04-11,바이오뷰티시장확대대웅제약메디톡스주목,http://news.heraldcorp.com/view.php?ud=20190411000311
2603,2019-04-11,4월11일대웅제약주식추천주026194000원,http://www.nbntv.co.kr/news/articleView.html?idxno=306236
2604,2019-04-11,바이오뷰티시장다변화대웅제약메디톡스주목,http://news.heraldcorp.com/view.php?ud=20190411000522
2605,2019-04-11,대웅제약목표가25만원신규제시전일종가19만3500원대신證,http://www.newspim.com/news/view/20190411000532
2606,2019-04-11,퀵리포트대웅제약매수목표가25만원신규제시대신證,http://www.itooza.com/common/iview.php?no=2019041112584815966
2607,2019-04-11,특징주대웅제약전사업부문양호한실적성장세유지기대,http://www.sisaon.co.kr/news/articleView.html?idxno=91818
2608,2019-04-11,스타★주식인사이드대웅제약주가195000원4월11일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=638469
2609,2019-04-11,11일마감주가정보대웅20350원마감,http://www.gokorea.kr/news/articleView.html?idxno=152745
2610,2019-04-11,대웅제약가시화되는나보타성공스토리하이투증,http://www.economytalk.kr/news/articleView.html?idxno=183333
2611,2019-04-12,★주식인사이드대웅제약주가197500원4월12일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=639588
2612,2019-04-12,4월12일대웅주가그래프20300원025,http://www.nbntv.co.kr/news/articleView.html?idxno=308199
2613,2019-04-12,주식종목12일대웅현재가20300원,http://www.anewsa.com/detail.php?number=1675169&thread=10r02
2614,2019-04-12,대웅제약나보타임상3상국제성형외과학술지에게재,http://moneys.mt.co.kr/news/mwView.php?no=2019041210258023654
2615,2019-04-12,대웅제약나보타보톡스대비비열등성입증임상결과국제학술지게재,http://www.koreaittimes.com/news/articleView.html?idxno=90273
2616,2019-04-12,대웅제약나보타보톡스대비효과안전성비열등성입증,http://www.viva100.com/main/view.php?key=20190412010004405
2617,2019-04-12,대웅제약나보타보톡스대비임상결과학술지게재,http://www.ebn.co.kr/news/view/980603
2618,2019-04-12,대웅제약나보타보톡스비교임상결과국제학술지에게재,http://news.mk.co.kr/newsRead.php?year=2019&no=225880
2619,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229349
2620,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.newsway.co.kr/news/view?tp=1&ud=2019041210460135439
2621,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.sisafocus.co.kr/news/articleView.html?idxno=207279
2622,2019-04-12,대웅제약나보타보톡스와효과차이없어논문으로입증,http://www.edaily.co.kr/news/newspath.asp?newsid=02751926622455464
2623,2019-04-12,대웅제약나보타보톡스보다미간주름에효과적,http://www.kpinews.co.kr/news/articleView.html?idxno=94104
2624,2019-04-12,대웅제약주가그래프12일현재200000원,http://www.nbntv.co.kr/news/articleView.html?idxno=308690
2625,2019-04-12,실시간분석대웅제약3상승증권사목표가26만원제시,http://www.itooza.com/common/iview.php?no=2019041210573212984
2626,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.etnews.com/20190412000140
2627,2019-04-12,대웅제약나보타보톡스대비3상결과국제학술지게재,http://www.medisobizanews.com/news/articleView.html?idxno=59074
2628,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://medipana.com/news/news_viewer.asp?NewsNum=237435&MainKind=A&NewsKind=5&vCount=12&vKind=1
2629,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.mediapen.com/news/view/426590
2630,2019-04-12,대웅제약나보타보톡스보다미간주름개선효과있어,http://www.newsis.com/view/?id=NISX20190412_0000618772&cID=13001&pID=13000
2631,2019-04-12,대웅제약나보타보톡스비교임상결과국제학술지게재,http://www.newspim.com/news/view/20190412000320
2632,2019-04-12,대웅제약나보타보톡스보다낫다임상결과국제학술지게재,http://kpenews.com/View.aspx?No=31284
2633,2019-04-12,대웅제약나보타보톡스대비비열등성입증국제학술지실려,http://www.etoday.co.kr/news/section/newsview.php?idxno=1744548
2634,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.medigatenews.com/news/1772101178
2635,2019-04-12,대웅제약나보타임상결과국제학술지게재,http://www.mdtoday.co.kr/mdtoday/index.html?no=351708
2636,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.bosa.co.kr/news/articleView.html?idxno=2103271
2637,2019-04-12,대웅제약세계를사로잡은나보타SCI급국제학술지게재,http://www.seoulwire.com/news/articleView.html?idxno=109059
2638,2019-04-12,대웅제약라이선스인신약물질다수임상진전,http://www.dailypharm.com/Users/News/NewsView.html?ID=251520&REFERER=NP
2639,2019-04-12,대웅제약나보타미간주름개선효과안정성보톡스대비비열등성입증,http://www.newsprime.co.kr/news/article.html?no=454917
2640,2019-04-12,대웅제약나보타유럽및캐나다3상임상결과국제학술지게재,http://www.businesskorea.co.kr/news/articleView.html?idxno=30845
2641,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.asiatime.co.kr/news/articleView.html?idxno=239632
2642,2019-04-12,대웅나보타보톡스대비동등한미간주름개선효과,http://www.biospectator.com/view/news_view.php?varAtcId=7459
2643,2019-04-12,메디톡스휴젤대웅보툴리눔톡신中美수출회복전망,http://www.mdtoday.co.kr/mdtoday/index.html?no=351734
2644,2019-04-12,대웅제약보툴리눔톡신나보타미간주름개선입증,http://www.econovill.com/news/articleView.html?idxno=360790
2645,2019-04-12,대웅제약나보타보톡스대비미간주름개선효과더높아유럽캐나다3상임상결과SCI급국제학술지게재,http://www.ezyeconomy.com/news/articleView.html?idxno=89799
2646,2019-04-12,대웅팜DW약대생실습프로그램구축우수인재적극채용,http://www.asiatoday.co.kr/view.php?key=20190412010008797
2647,2019-04-12,대웅제약나보타미간주름개선효과보톡스비열등성입증,http://www.monews.co.kr/news/articleView.html?idxno=202009
2648,2019-04-12,스타★주식인사이드대웅제약주가200000원4월12일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=640696
2649,2019-04-12,아스트라제네카대웅제약에계열사판매재하청금지통보,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019041215295402631&objId=A2019041215295402631&portalCode=naver
2650,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.newspost.kr/news/articleView.html?idxno=70529
2651,2019-04-12,대웅제약나보타보톡스대비비열등입증,http://daily.hankooki.com/lpage/ittech/201904/dh20190412154804145630.htm
2652,2019-04-12,대웅제약나보타보톡스와동등한미간주름개선효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=122935
2653,2019-04-12,대웅나보타미간주름개선효과보톡스에비열등,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85091
2654,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.wikileaks-kr.org/news/articleView.html?idxno=52804
2655,2019-04-12,대웅제약나보타임상국제학술지게재보톡스比비열등성입증”,http://www.inthenews.co.kr/news/article.html?no=14693
2656,2019-04-12,대웅제약나보타미간주름개선효과보톡스와동등이상 ,http://www.seoulfn.com/news/articleView.html?idxno=339704
2657,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.ekn.kr/news/article.html?no=426217
2658,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.dailian.co.kr/news/view/787387/?sc=naver
2659,2019-04-12,대웅나보타앨러간보톡스대비동등이상효과,http://www.dailymedi.com/detail.php?number=841971&thread=22r05
2660,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.getnews.co.kr/view.php?ud=20190412175143627141d0c69529_16
2661,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.100ssd.co.kr/news/articleView.html?idxno=60654
2662,2019-04-12,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.newscj.com/news/articleView.html?idxno=621166
2663,2019-04-13,대웅제약나보타보톡스대비비열등성입증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067247
2664,2019-04-13,대웅제약나보타보톡스대비임상결과국제학술지게재,http://www.lawissue.co.kr/view.php?ud=201904131043508794d7f4c63cc6_12
2665,2019-04-14,대웅제약나보타보톡스대비임상결과국제학술지게재우수한안전성입증,http://www.segye.com/content/html/2019/04/14/20190414504206.html?OutUrl=naver
2666,2019-04-14,美에보톡스본격수출대웅제약실적기지개,http://news.mk.co.kr/newsRead.php?year=2019&no=229552
2667,2019-04-14,대웅제약나보타보톡스대비임상결과국제학술지게재,https://www.insight.co.kr/news/222455
2668,2019-04-15,위상높아진한국장연구학회제1회대웅학술상제정,http://www.dailymedi.com/detail.php?number=842006&thread=22r03
2669,2019-04-15,아통경제15일대웅현재주가20450원,http://www.anewsa.com/detail.php?number=1679071&thread=10r02
2670,2019-04-15,대웅제약나보타글로벌위상확대의사교육프로그램개최,http://www.seoulwire.com/news/articleView.html?idxno=109974
2671,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알렸다,http://www.segye.com/content/html/2019/04/15/20190415503389.html?OutUrl=naver
2672,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.newsway.co.kr/news/view?tp=1&ud=2019041509463867517
2673,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229403
2674,2019-04-15,대웅제약6개국미용성형의사와톡신최신지견공유,http://medipana.com/news/news_viewer.asp?NewsNum=237506&MainKind=A&NewsKind=5&vCount=12&vKind=1
2675,2019-04-15,★주식인사이드대웅제약주가203500원4월15일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=641792
2676,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019041500033
2677,2019-04-15,FDA프리미엄대웅제약나보타브랜드가치↑,http://www.viva100.com/main/view.php?key=20190415010004931
2678,2019-04-15,대웅제약해외의사들과함께나보타마스터클래스성황리마쳐,http://www.medisobizanews.com/news/articleView.html?idxno=59099
2679,2019-04-15,대웅제약2019춘계해외의사마스터클래스개최,http://www.ezyeconomy.com/news/articleView.html?idxno=89832
2680,2019-04-15,대웅제약나보타해외의사교육프로그램개최,http://www.ebn.co.kr/news/view/980818
2681,2019-04-15,대웅제약해외의사교육프로그램개최나보타우수성홍보,http://www.newspim.com/news/view/20190415000233
2682,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.wolyo.co.kr/news/articleView.html?idxno=81730
2683,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.dailian.co.kr/news/view/787744/?sc=naver
2684,2019-04-15,대웅제약멕시코등6개국의사초청해나보타마스터클래스개최,http://news.mk.co.kr/newsRead.php?year=2019&no=230626
2685,2019-04-15,대웅제약해외의사교육나보타마스터클래스개최,http://news.mt.co.kr/mtview.php?no=2019041508480392939
2686,2019-04-15,4월15일대웅제약오늘주식202500원176,http://www.nbntv.co.kr/news/articleView.html?idxno=311434
2687,2019-04-15,대웅제약해외의사교육프로그램서나보타우수성전파,http://www.asiatime.co.kr/news/articleView.html?idxno=239937
2688,2019-04-15,대웅제약해외의사교육프로그램통해나보타소개,http://www.bosa.co.kr/news/articleView.html?idxno=2103366
2689,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.100ssd.co.kr/news/articleView.html?idxno=60726
2690,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://daily.hankooki.com/lpage/ittech/201904/dh20190415113844145630.htm
2691,2019-04-15,대웅제약6개국미용성형분야전문의대상나보타마스터클래스개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067286
2692,2019-04-15,대웅제약나보타마스터클래스개최임상결과시술법최신지견공유,http://www.newsprime.co.kr/news/article.html?no=455198
2693,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.etnews.com/20190415000243
2694,2019-04-15,대웅제약5거래일연속상승전일대비3상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904150435&t=NN
2695,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019041500031
2696,2019-04-15,대웅제약해외의사초청해나보타홍보,http://www.finomy.com/news/articleView.html?idxno=64790
2697,2019-04-15,스타★주식인사이드대웅제약주가203500원4월15일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=642919
2698,2019-04-15,대웅제약나보타마스터클래스개최해외의사45명참가,http://news.donga.com/3/all/20190415/95057754/1
2699,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.wikileaks-kr.org/news/articleView.html?idxno=52940
2700,2019-04-15,대웅제약해외의사교육프로그램성료,http://www.joseilbo.com/news/news_read.php?uid=374595&class=17&grp=
2701,2019-04-15,15일마감증시대웅20650원마감,http://www.gokorea.kr/news/articleView.html?idxno=156989
2702,2019-04-15,대웅제약5개국의사45명초청나보타교육,http://www.whosaeng.com/109426
2703,2019-04-15,나보타보러6개국의사45명내한대웅제약기술공유,http://news.heraldcorp.com/view.php?ud=20190415000755
2704,2019-04-15,대웅해외의사교육프로그램통해나보타우수성알려,http://www.bokuennews.com/news/article.html?no=174386
2705,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.economytalk.kr/news/articleView.html?idxno=183527
2706,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.newscj.com/news/articleView.html?idxno=621970
2707,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,https://www.insight.co.kr/news/222702
2708,2019-04-15,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.lawissue.co.kr/view.php?ud=201904152240322735d7f4c63cc6_12
2709,2019-04-16,대웅제약1000억조달추진유동사채절반차환,http://www.dailypharm.com/Users/News/NewsView.html?ID=251628&REFERER=NP
2710,2019-04-16,대웅제약나보타로올영업이익93증가목표가↑키움,https://www.hankyung.com/article/2019041681456
2711,2019-04-16,클릭e종목대웅제약나보타덕에이익성장폭높을것,http://view.asiae.co.kr/news/view.htm?idxno=2019041608045142874
2712,2019-04-16,대웅제약나보타로올해이익증가폭커목표가↑키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01623606622456776
2713,2019-04-16,대웅제약목표가4↑25만원제시키움證,http://www.newspim.com/news/view/20190416000124
2714,2019-04-16,퀵리포트대웅제약매수유지목표가4↑25만원키움證,http://www.itooza.com/common/iview.php?no=2019041608301314153
2715,2019-04-16,키움증권대웅제약나보타수출로실적개선목표가↑,http://yna.kr/AKR20190416028100008?did=1195m
2716,2019-04-16,GET투자리포트대웅제약투자의견매수유지키움증권,http://www.getnews.co.kr/view.php?ud=201904161030303927tpgetnews_16
2717,2019-04-16,대웅제약나보타로올해높은이익성장전망키움證,http://www.seoulfn.com/news/articleView.html?idxno=339921
2718,2019-04-16,대웅제약나보타수출로실적개선목표가↑키움증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1745493
2719,2019-04-16,키움證대웅제약나보타실적이올해성장동력목표가↑,http://www.newsis.com/view/?id=NISX20190416_0000621767&cID=10401&pID=10400
2720,2019-04-16,대웅제약나보타수출로실적개선기대키움증권,https://www.sedaily.com/NewsView/1VHVYYZNVT
2721,2019-04-16,ET투자뉴스대웅제약나보타로올해이익BUY유지키움증권,http://www.etnews.com/20190416000016
2722,2019-04-16,★주식인사이드대웅제약주가203500원4월16일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=644087
2723,2019-04-16,대웅제약해외의사교육프로그램통해나보타우수성알려,http://www.wsobi.com/news/articleView.html?idxno=72081
2724,2019-04-16,키움증권대웅제약나보타수출호조에실적개선가능성”,http://www.kukinews.com/news/article.html?no=652840
2725,2019-04-16,4월16일대웅투자주식12120900원,http://www.nbntv.co.kr/news/articleView.html?idxno=313375
2726,2019-04-16,종목추적16일대웅현재가20800원,http://www.anewsa.com/detail.php?number=1682452&thread=10r02
2727,2019-04-16,키움증권대웅제약나보타수출로실적개선목표가↑,https://www.insight.co.kr/news/222766
2728,2019-04-16,대웅제약주식주가16일현재207000원,http://www.nbntv.co.kr/news/articleView.html?idxno=313865
2729,2019-04-16,스타★주식인사이드대웅제약주가206000원4월16일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=645125
2730,2019-04-16,대웅제약전문경영인체제맞나윤재승막후경영의혹,http://www.shinailbo.co.kr/news/articleView.html?idxno=1159131
2731,2019-04-16,대웅제약나보타로올해이익성장폭높아”,http://www.wikitree.co.kr/main/news_view.php?id=420649
2732,2019-04-16,수익해결사내일공략주동운아나텍094170대웅제약069620,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019041618082165055
2733,2019-04-16,대웅제약해외의사교육프로그램서나보타알려,http://www.kpanews.co.kr/article/show.asp?idx=203190&table=article&category=D
2734,2019-04-17,★주식인사이드대웅제약주가208000원4월17일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=646200
2735,2019-04-17,GET투자리포트대웅제약투자의견Positive유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201904171030304004tpgetnews_16
2736,2019-04-17,장중시세17일대웅현재가격20600원,http://www.anewsa.com/detail.php?number=1685749&thread=10r02
2737,2019-04-17,4월17일대웅시세보기04820650원,http://www.nbntv.co.kr/news/articleView.html?idxno=315739
2738,2019-04-17,대웅제약회사채1천억발행4천400억몰려,http://news.einfomax.co.kr/news/articleView.html?idxno=4025956
2739,2019-04-17,더벨대웅제약회사채완판8연타석안타,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904160100031240001929
2740,2019-04-17,4월17일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=160338
2741,2019-04-17,4월17일대웅제약실시간증시206000원000,http://www.nbntv.co.kr/news/articleView.html?idxno=316228
2742,2019-04-17,스타★주식인사이드대웅제약주가205000원4월17일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=647243
2743,2019-04-17,17일마감주가정보대웅주가20800원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=161141
2744,2019-04-17,제약산업육성지원법발의에대웅제약녹십자기술수출기대품어,http://www.businesspost.co.kr/BP?command=article_view&num=123610
2745,2019-04-18,★주식인사이드대웅제약주가204000원4월18일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=648337
2746,2019-04-18,주식추천주대웅주가18일현재20850원,http://www.nbntv.co.kr/news/articleView.html?idxno=318077
2747,2019-04-18,증시보고18일대웅증시현황20850원,http://www.anewsa.com/detail.php?number=1689066&thread=10r02
2748,2019-04-18,대웅제약주식종목18일현재203500원,http://www.nbntv.co.kr/news/articleView.html?idxno=318578
2749,2019-04-18,대웅주가및증권차트정보18일현재20550원증권그래프분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=113255
2750,2019-04-18,3월원외처방1위한미약품종근당〉대웅제약順,http://www.dailymedi.com/detail.php?number=842161&thread=22r05
2751,2019-04-18,콜린알포세레이트5년새3배↑대웅종근당쌍두마차,http://www.dailypharm.com/Users/News/NewsView.html?ID=251742&REFERER=NP
2752,2019-04-18,스타★주식인사이드대웅제약주가202000원4월18일15시15분기준,http://www.newsinside.kr/news/articleView.html?idxno=649383
2753,2019-04-18,2018제약사연봉상승률은한미광동종근당대웅순으로한미가1위,http://www.news2day.co.kr/125293
2754,2019-04-19,한미약품원외처방1위질주대웅바이오껑충,http://www.dailypharm.com/Users/News/NewsView.html?ID=251760&REFERER=NP
2755,2019-04-19,대웅글리아타민이름소송방어전서도이겨,http://www.kpanews.co.kr/article/show.asp?idx=203255&table=article&category=D
2756,2019-04-19,대웅제약목표가18↑26만원제시유안타證,http://www.newspim.com/news/view/20190419000062
2757,2019-04-19,퀵리포트대웅제약매수유지목표가18↑26만원유안타證,http://www.itooza.com/common/iview.php?no=2019041908145118903
2758,2019-04-19,대웅제약나보타美수출개시로1분기호실적목표가↑유안타,http://www.edaily.co.kr/news/newspath.asp?newsid=01446486622457760
2759,2019-04-19,유안타증권대웅제약나보타美매출시작목표주가↑,http://yna.kr/AKR20190419025200008?did=1195m
2760,2019-04-19,HotLine대웅제약나보타미국시장안착기대목표가↑,http://news.mk.co.kr/newsRead.php?year=2019&no=243305
2761,2019-04-19,대웅제약주보미국런칭에목표가상향유안타,http://www.ebn.co.kr/news/view/981471
2762,2019-04-19,유안타證대웅제약나보타美매출시작목표주가18↑”,http://www.kukinews.com/news/article.html?no=654190
2763,2019-04-19,유안타증권대웅제약나보타미국매출시작목표가상향,http://www.sporbiz.co.kr/news/articleView.html?idxno=330551
2764,2019-04-19,4월19일대웅오늘증시20500원074,http://www.nbntv.co.kr/news/articleView.html?idxno=320472
2765,2019-04-19,주가정보19일대웅현재주가20550원,http://www.anewsa.com/detail.php?number=1692066&thread=10r02
2766,2019-04-19,GET투자리포트대웅제약투자의견매수유지유안타증권,http://www.getnews.co.kr/view.php?ud=201904191030304097tpgetnews_16
2767,2019-04-19,ET투자뉴스대웅제약봄주보의미국BUY유지유안타증권,http://www.etnews.com/20190419000075
2768,2019-04-19,특징주대웅제약나보타미국매출꾸준히증가,http://www.sisaon.co.kr/news/articleView.html?idxno=92277
2769,2019-04-19,대웅제약주가4월19일현재203500원,http://www.gokorea.kr/news/articleView.html?idxno=163113
2770,2019-04-19,4월19일대웅제약주식추천주203500원074,http://www.nbntv.co.kr/news/articleView.html?idxno=320974
2771,2019-04-19,대웅제약휴젤메디톡스같은톡신다른모멘텀,http://news.mt.co.kr/mtview.php?no=2019041910193840875
2772,2019-04-19,대웅제약나보타의美수출로실적개선기대”,http://www.wikitree.co.kr/main/news_view.php?id=421489
2773,2019-04-19,같은톡신다른모멘텀대웅제약휴젤메디톡스3대톡신파도주목,http://www.mdtoday.co.kr/mdtoday/index.html?no=352321
2774,2019-04-19,대웅제약목표주가상향보톡스와안구건조증치료제가치부각,http://www.businesspost.co.kr/BP?command=article_view&num=123917
2775,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.newsway.co.kr/news/view?tp=1&ud=2019041914453773838
2776,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.fetv.co.kr/news/article.html?no=26513
2777,2019-04-19,대웅제약온라인통해소비자와소통한다,http://www.m-i.kr/news/articleView.html?idxno=515254
2778,2019-04-19,대웅제약대웅제약뉴스룸공식오픈다양한정보빠르게전달하며고객과소통,http://www.segye.com/content/html/2019/04/19/20190419507310.html?OutUrl=naver
2779,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.bosa.co.kr/news/articleView.html?idxno=2103770
2780,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229653
2781,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸개설,http://www.newspim.com/news/view/20190419000490
2782,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.economytalk.kr/news/articleView.html?idxno=183890
2783,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸개설,http://www.seoulwire.com/news/articleView.html?idxno=114953
2784,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.mdtoday.co.kr/mdtoday/index.html?no=352345
2785,2019-04-19,대웅제약고객소통온라인공식채널뉴스룸오픈,http://medipana.com/news/news_viewer.asp?NewsNum=237788&MainKind=A&NewsKind=5&vCount=12&vKind=1
2786,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸오픈,http://www.etoday.co.kr/news/section/newsview.php?idxno=1747082
2787,2019-04-19,대웅제약온라인보도채널대웅제약뉴스룸오픈,http://www.medisobizanews.com/news/articleView.html?idxno=59213
2788,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.metroseoul.co.kr/news/newsview?newscd=2019041900075
2789,2019-04-19,대웅제약새온라인채널대웅제약뉴스룸오픈,http://daily.hankooki.com/lpage/ittech/201904/dh20190419152925145630.htm
2790,2019-04-19,대웅제약나보타미국시장진출초읽기,http://www.dailysmart.co.kr/news/articleView.html?idxno=9519
2791,2019-04-19,대웅제약소통의문연다대웅제약뉴스룸오픈,http://www.viva100.com/main/view.php?key=20190419010007131
2792,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸개설,http://news.mk.co.kr/newsRead.php?year=2019&no=244916
2793,2019-04-19,온라인공식채널뉴스룸개설한대웅제약고객과소통강화”,https://www.sedaily.com/NewsView/1VHXECG2PG
2794,2019-04-19,대웅제약커뮤니케이션채널뉴스룸개설,http://www.rapportian.com/news/articleView.html?idxno=117204
2795,2019-04-19,온라인공식채널대웅제약뉴스룸개설,http://www.bokuennews.com/news/article.html?no=174636
2796,2019-04-19,대웅제약고객과의소통의창대웅제약뉴스룸오픈,http://www.businesskorea.co.kr/news/articleView.html?idxno=31073
2797,2019-04-19,대웅제약홍보력강화온라인뉴스룸오픈,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85231
2798,2019-04-19,대웅제약소통강화위해뉴스룸공식개설,http://www.econovill.com/news/articleView.html?idxno=361318
2799,2019-04-19,대웅제약회사산업알리는대웅제약뉴스룸개설,http://www.dailysmart.co.kr/news/articleView.html?idxno=9526
2800,2019-04-19,19일마감주가정보대웅20600원마감,http://www.gokorea.kr/news/articleView.html?idxno=163807
2801,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.medigatenews.com/news/1695918610
2802,2019-04-19,대웅제약온라인소통채널뉴스룸오픈,http://www.newsis.com/view/?id=NISX20190419_0000626313&cID=13001&pID=13000
2803,2019-04-19,대웅제약온라인공식채널대웅제약뉴스룸공식오픈,http://www.ftoday.co.kr/news/articleView.html?idxno=107998
2804,2019-04-19,대웅제약소식을한곳에대웅제약뉴스룸오픈,http://www.sisaon.co.kr/news/articleView.html?idxno=92324
2805,2019-04-19,대웅제약온라인대웅제약뉴스룸오픈고객과의소통강화,http://www.getnews.co.kr/view.php?ud=20190419175150830541d0c69529_16
2806,2019-04-19,뉴스투데이L대웅제약온라인공식채널뉴스룸오픈,http://www.news2day.co.kr/125426
2807,2019-04-19,대웅제약자체보도매체채널뉴스룸공식오픈,http://www.inthenews.co.kr/news/article.html?no=14869
2808,2019-04-19,대웅제약대웅제약뉴스룸공식오픈,http://www.wikileaks-kr.org/news/articleView.html?idxno=53349
2809,2019-04-19,대웅제약소통강화위해대웅제약뉴스룸오픈,http://www.whosaeng.com/109549
2810,2019-04-19,대웅제약대웅제약뉴스룸공식채널오픈,http://www.lawissue.co.kr/view.php?ud=201904192125461712d7f4c63cc6_12
2811,2019-04-20,대웅제약1000억규모회사채발행이율연2087,http://www.kukinews.com/news/article.html?no=654558
2812,2019-04-20,경기도파주시사찰대웅전서불1개동전소,http://news.kbs.co.kr/news/view.do?ncd=4184387&ref=A
2813,2019-04-20,대웅제약대웅제약뉴스룸공식오픈,http://www.ekn.kr/news/article.html?no=427526
2814,2019-04-20,대웅제약대웅제약뉴스룸공식오픈,http://www.newscj.com/news/articleView.html?idxno=623826
2815,2019-04-21,대웅제약뉴스룸개설,http://www.dt.co.kr/contents.html?article_no=2019042102109931102004&ref=naver
2816,2019-04-22,오늘의추천종목한국투자증권대웅제약LG전자등,http://www.asiatoday.co.kr/view.php?key=20190422010014168
2817,2019-04-22,★주식인사이드대웅제약주가205000원4월22일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=650696
2818,2019-04-22,증시현황22일대웅현재주식거래가격21150원,http://www.anewsa.com/detail.php?number=1696031&thread=10r02
2819,2019-04-22,4월22일대웅배당주식21150원267,http://www.nbntv.co.kr/news/articleView.html?idxno=323381
2820,2019-04-22,4월22일대웅및증권시세및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=165080
2821,2019-04-22,4월22일대웅제약주식현황049203000원,http://www.nbntv.co.kr/news/articleView.html?idxno=323864
2822,2019-04-22,4월22일장마감대웅제약202500원,http://www.newsinside.kr/news/articleView.html?idxno=651766
2823,2019-04-22,대웅제약온라인공식채널대웅제약뉴스룸개설,http://sports.hankooki.com/lpage/economy/201904/sp20190422130626137020.htm
2824,2019-04-22,22일마감정보대웅21350원마감,http://www.gokorea.kr/news/articleView.html?idxno=165927
2825,2019-04-23,대웅제약중부국세청세무조사로153억세금추징당해,http://www.intn.co.kr/news/articleView.html?idxno=2005551
2826,2019-04-23,★주식인사이드대웅제약주가203500원4월23일9시9분기준,http://www.newsinside.kr/news/articleView.html?idxno=652883
2827,2019-04-23,오늘의신상품대웅제약탄력관리코스메슈티컬리더마3종출시,http://www.econovill.com/news/articleView.html?idxno=361499
2828,2019-04-23,대웅제약이지듀관리솔루션리더마3종출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019042309135957381
2829,2019-04-23,종목추적23일대웅주가21100원,http://www.anewsa.com/detail.php?number=1699324&thread=10r02
2830,2019-04-23,4월23일대웅오늘주식11721100원,http://www.nbntv.co.kr/news/articleView.html?idxno=325757
2831,2019-04-23,대웅제약이지듀피부탄력솔루션리더마3종내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=82398
2832,2019-04-23,4월23일대웅제약주식증권204000원025,http://www.nbntv.co.kr/news/articleView.html?idxno=326242
2833,2019-04-23,대웅제약대웅제약뉴스룸공식오픈,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=208915
2834,2019-04-23,대웅제약고객소통확대온라인뉴스룸오픈,http://www.dailymedi.com/detail.php?number=842309&thread=22r05
2835,2019-04-23,스타★주식인사이드대웅제약주가204500원4월23일13시33분기준,http://www.newsinside.kr/news/articleView.html?idxno=653915
2836,2019-04-23,23일마감보고대웅주가21300원으로마감,http://www.anewsa.com/detail.php?number=1701640&thread=10r04
2837,2019-04-23,의약품허가자진취하압도적1위대웅제약에무슨일이,http://www.bizhankook.com/article/17633
2838,2019-04-23,4월23일장마감대웅제약204500원,http://www.newsinside.kr/news/articleView.html?idxno=654973
2839,2019-04-24,대웅제약임팩타민공급가15인상이가탄F까스활명수등인상,http://www.mdtoday.co.kr/mdtoday/index.html?no=352648
2840,2019-04-24,오늘의추천종목한국투자증권대웅제약위지윅스튜디오등,http://www.asiatoday.co.kr/view.php?key=20190424010016040
2841,2019-04-24,대웅성장밸류에이션모멘텀갖춰한국투자證,http://news.mt.co.kr/mtview.php?no=2019042407585980515
2842,2019-04-24,GET투자리포트대웅투자의견NotRated한국투자증권,http://www.getnews.co.kr/view.php?ud=201904241030304210tpgetnews_16
2843,2019-04-24,대웅자회사대웅바이오1분기호실적전망,http://www.nspna.com/news/?mode=view&newsid=354766
2844,2019-04-24,★주식인사이드대웅제약주가203500원4월24일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=656023
2845,2019-04-24,ET투자뉴스대웅_거래비중기관2385외국인2281,http://www.etnews.com/20190424000036
2846,2019-04-24,대웅52주신고가경신20184Q매출액3261억161영업이익182억41,https://www.hankyung.com/article/201904246985L
2847,2019-04-24,fnRASSI대웅52주신고가305↑,http://www.fnnews.com/news/201904240916593982
2848,2019-04-24,대웅제약장애인일자리창출노력사내매점베어마트설립,http://www.ekn.kr/news/article.html?no=428245
2849,2019-04-24,대웅제약적극적인장애인일자리창출눈길,http://news.heraldcorp.com/view.php?ud=20190424000114
2850,2019-04-24,대웅제약장애인일자리창출노력,http://www.newsway.co.kr/news/view?tp=1&ud=2019042409200666064
2851,2019-04-24,대웅제약발달장애인정직원채용사내매점베어마트설립,http://medipana.com/news/news_viewer.asp?NewsNum=237985&MainKind=A&NewsKind=5&vCount=12&vKind=1
2852,2019-04-24,대웅제약장애인일자리창출노력,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229766
2853,2019-04-24,대웅제약장애인일자리창출앞장사내매점베어마트설립,http://moneys.mt.co.kr/news/mwView.php?no=2019042409278062404
2854,2019-04-24,대웅주식현재가24일현재21700원,http://www.nbntv.co.kr/news/articleView.html?idxno=328149
2855,2019-04-24,대웅제약사내매점베어마트서발달장애인정직원으로채용,http://www.econovill.com/news/articleView.html?idxno=361599
2856,2019-04-24,대웅제약사내매점베어마트설립장애인일자리창출앞장,http://www.newsprime.co.kr/news/article.html?no=456745
2857,2019-04-24,국내주가정보24일대웅증시현황21750원,http://www.anewsa.com/detail.php?number=1702736&thread=10r02
2858,2019-04-24,대웅제약장애인일자리창출에적극,http://www.wolyo.co.kr/news/articleView.html?idxno=82498
2859,2019-04-24,장애인채용에적극나서는대웅제약사내매점베어마트설립,http://www.segye.com/content/html/2019/04/24/20190424503846.html?OutUrl=naver
2860,2019-04-24,대웅제약발달장애인정규직원들로사내매점베어마트열어,http://www.medisobizanews.com/news/articleView.html?idxno=59283
2861,2019-04-24,대웅제약발달장애인채용한사내매점베어마트설립,http://www.mhj21.com/120968
2862,2019-04-24,4월24일대웅증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=168827
2863,2019-04-24,대웅베어마트오픈장애인일자리창출노력,http://www.dailypharm.com/Users/News/NewsView.html?ID=251938&REFERER=NP
2864,2019-04-24,대웅제약발달장애인일자리창출에앞장사내매점베어마트설립,http://kpenews.com/View.aspx?No=32013
2865,2019-04-24,대웅제약사내매점베어마트통해발달장애인일자리창출,http://www.newspim.com/news/view/20190424000179
2866,2019-04-24,대웅제약장애인일자리창출노력,http://www.bokuennews.com/news/article.html?no=174787
2867,2019-04-24,대웅제약베어마트열고발달장애인고용,http://www.dailian.co.kr/news/view/790056/?sc=naver
2868,2019-04-24,대웅제약장애인일자리확대동참사내매점베어마트에발달장애인고용,http://www.ezyeconomy.com/news/articleView.html?idxno=90103
2869,2019-04-24,대웅제약장애인일자리창출위해베어마트설립,http://www.viva100.com/main/view.php?key=20190424010008602
2870,2019-04-24,대웅제약장애인일자리창출노력,http://www.bosa.co.kr/news/articleView.html?idxno=2104031
2871,2019-04-24,장애인채용늘리는대웅제약사내매점에발달장애인일자리제공,http://www.ajunews.com/view/20190424101532607
2872,2019-04-24,대웅제약장애인일자리창출노력,http://www.ebn.co.kr/news/view/982066
2873,2019-04-24,대웅제약발달장애인정직원채용사내매점베어마트설립,http://www.newsis.com/view/?id=NISX20190424_0000630530&cID=13001&pID=13000
2874,2019-04-24,대웅제약장애인일자리창출위해사내매점설립,http://www.etnews.com/20190424000121
2875,2019-04-24,대웅제약주가및증권시세및증권정보와종목동정24일현재203500원,http://www.gokorea.kr/news/articleView.html?idxno=168981
2876,2019-04-24,장애인일자리창출발벗고나선대웅제약,http://www.dailymedi.com/detail.php?number=842348&thread=22r05
2877,2019-04-24,대웅제약 장애인일자리창출노력,http://www.fetv.co.kr/news/article.html?no=26910
2878,2019-04-24,대웅제약장애인일자리창출앞장,http://daily.hankooki.com/lpage/ittech/201904/dh20190424110328145630.htm
2879,2019-04-24,4월24일대웅제약시세보기024204000원,http://www.nbntv.co.kr/news/articleView.html?idxno=328641
2880,2019-04-24,대웅제약장애인일자리창출나서,http://www.m-i.kr/news/articleView.html?idxno=516530
2881,2019-04-24,대웅스멕타현탁액등8품목소아임산부투여금지,http://www.dailypharm.com/Users/News/NewsView.html?ID=251949&REFERER=NP
2882,2019-04-24,대웅제약장애인일자리창출내달중6명더채용,http://www.asiatime.co.kr/news/articleView.html?idxno=241793
2883,2019-04-24,대웅제약장애인고용시장확대노력,http://www.sisaon.co.kr/news/articleView.html?idxno=92552
2884,2019-04-24,대웅제약발달장애인고용사내매점베어마트설립,http://www.metroseoul.co.kr/news/newsview?newscd=2019042400082
2885,2019-04-24,대웅제약발달장애인채용해매점운영전승호장애인과동행,http://www.businesspost.co.kr/BP?command=article_view&num=124509
2886,2019-04-24,스타★주식인사이드대웅제약주가204000원4월24일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=657124
2887,2019-04-24,장애인일자리창출나선대웅제약 ,http://www.monews.co.kr/news/articleView.html?idxno=202214
2888,2019-04-24,대웅제약베어마트설립장애인일자리창출노력,http://www.ftoday.co.kr/news/articleView.html?idxno=108115
2889,2019-04-24,대웅자회사대웅바이오와대웅제약호조로기업가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=124519
2890,2019-04-24,대웅제약발달장애인정직원채용사내매점베어마트설립,http://www.mdtoday.co.kr/mdtoday/index.html?no=352709
2891,2019-04-24,대웅제약발달장애인정직원으로채용한사내매점베어마트설립,https://www.sedaily.com/NewsView/1VHZO6QZ8K
2892,2019-04-24,단독윤재승전대웅제약회장배임혐의로고발당해,http://www.shinailbo.co.kr/news/articleView.html?idxno=1161524
2893,2019-04-24,대웅제약장애인일자리창출적극나서,
2894,2019-04-24,대웅제약상생가능한장애인일자리창출추진,http://news.donga.com/3/all/20190424/95205960/1
2895,2019-04-24,장마감보고서24일대웅주가21300원으로마감,http://www.anewsa.com/detail.php?number=1705025&thread=10r04
2896,2019-04-24,대웅제약발달장애인직원이운영하는사내매점설립,http://www.rapportian.com/news/articleView.html?idxno=117261
2897,2019-04-24,4월24일장마감대웅제약203000원,http://www.newsinside.kr/news/articleView.html?idxno=658105
2898,2019-04-24,대웅제약사내매점베어마트오픈하고발달장애인12명고용,http://news.mk.co.kr/newsRead.php?year=2019&no=257157
2899,2019-04-24,대웅제약나보타유럽서판매되나유럽약사위의제에올라,http://news1.kr/articles/?3605435
2900,2019-04-24,24일마감주가정보대웅21300원마감,http://www.gokorea.kr/news/articleView.html?idxno=169633
2901,2019-04-24,대웅제약적극적인장애인일자리창출앞장,http://www.skyedaily.com/news/news_view.html?ID=84109
2902,2019-04-24,대웅디에타민일동벨빅제치고비만치료제1위,http://www.dailysmart.co.kr/news/articleView.html?idxno=9717
2903,2019-04-24,대웅제약장애인일자리창출노력,http://www.getnews.co.kr/view.php?ud=20190424185503822041d0c69529_16
2904,2019-04-24,대웅제약사내매점베어마트설립발달장애인일자리제공,http://www.newscj.com/news/articleView.html?idxno=625142
2905,2019-04-24,대웅제약장애인일자리창출본격적나서,http://www.lawissue.co.kr/view.php?ud=201904242323442408d7f4c63cc6_12
2906,2019-04-25,대웅제약베어마트통해장애인위한일자리창출나서,http://www.wikileaks-kr.org/news/articleView.html?idxno=53765
2907,2019-04-25,대웅제약임팩타민프리미엄우리가족을위한멀티케어비타민,http://news.donga.com/3/all/20190424/95204553/1
2908,2019-04-25,대웅제약바쁜생활에지친소중한이들에게감사의마음을담아,http://news.donga.com/3/all/20190424/95204720/1
2909,2019-04-25,대웅제약스멕타현탁액등8개품목2세미만소아임수유부사용금지,http://www.mdtoday.co.kr/mdtoday/index.html?no=352750
2910,2019-04-25,★주식인사이드대웅제약주가202000원4월25일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=659225
2911,2019-04-25,4월25일대웅주식증권07021450원,http://www.nbntv.co.kr/news/articleView.html?idxno=330530
2912,2019-04-25,국내주가정보25일대웅현재가21400원,http://www.anewsa.com/detail.php?number=1706054&thread=10r02
2913,2019-04-25,대웅제약실시간증시25일현재201500원,http://www.nbntv.co.kr/news/articleView.html?idxno=331022
2914,2019-04-25,스타★주식인사이드대웅제약주가202500원4월25일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=660320
2915,2019-04-25,대웅제약장애인일자리창출우리가앞장섭니다,http://www.kpanews.co.kr/article/show.asp?idx=203449&table=article&category=D
2916,2019-04-25,산청군율곡사대웅전서합동소방훈련,http://www.asiatoday.co.kr/view.php?key=20190425010017556
2917,2019-04-25,4월25일장마감주가정보대웅제약200500원,http://www.newsinside.kr/news/articleView.html?idxno=661392
2918,2019-04-25,25일마감증시대웅주가20750원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=171418
2919,2019-04-26,장애인12人정식채용대웅제약의아름다운실험,http://biz.chosun.com/site/data/html_dir/2019/04/25/2019042503717.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2920,2019-04-26,대웅제약발달장애인정직원채용사내매점설립,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3819612
2921,2019-04-26,오늘의추천종목한국투자증권대웅제약LG전자등,http://www.asiatoday.co.kr/view.php?key=20190426010018200
2922,2019-04-26,NH투자증권대웅제약2분기중신약나보타미국시장수출액100억원추정,http://www.betanews.net:8080/article/1002562.html
2923,2019-04-26,헬스특집피부자극없이상처지우는대웅제약이지덤,http://www.newscj.com/news/articleView.html?idxno=625707
2924,2019-04-26,주식종목26일대웅현재주식거래가격21050원,http://www.anewsa.com/detail.php?number=1709463&thread=10r02
2925,2019-04-26,실시간주식현황대웅주가26일현재21050원,http://www.nbntv.co.kr/news/articleView.html?idxno=332917
2926,2019-04-26,★주식인사이드대웅제약주가200500원4월26일9시49분기준,http://www.newsinside.kr/news/articleView.html?idxno=662482
2927,2019-04-26,4월26일대웅제약오늘주식200500원000,http://www.nbntv.co.kr/news/articleView.html?idxno=333407
2928,2019-04-26,대웅주가4월26일현재20900원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=114566
2929,2019-04-26,스타★주식인사이드대웅제약주가200500원4월26일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=663533
2930,2019-04-26,대웅제약발달장애인정직원채용사내매점설립,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1210989
2931,2019-04-26,ET투자뉴스영인프런티어036180수주공급계약주대웅제약과,http://www.etnews.com/20190426000409
2932,2019-04-26,4월26일장마감주가정보대웅제약200500원,http://www.newsinside.kr/news/articleView.html?idxno=664563
2933,2019-04-26,중부국세청은제약사세무조사강도세다대웅경동제약수백억원대추징금납부,http://www.sisajournal-e.com/news/articleView.html?idxno=199360
2934,2019-04-26,건협충남도세종시회신임회장으로정원웅대웅건설대표선출,http://www.cnews.co.kr/uhtml/read.jsp?idxno=201904261631391010061
2935,2019-04-26,대웅제약나보타유럽CHMP허가승인권고,http://www.ebn.co.kr/news/view/982589
2936,2019-04-26,대웅제약나보타유럽CHMP허가승인권고유럽진출청신호,http://www.viva100.com/main/view.php?key=20190426010009889
2937,2019-04-26,대웅제약나보타유럽약물사용자문위원회서허가승인권고,http://www.newspim.com/news/view/20190426001085
2938,2019-04-26,대웅제약나보타유럽CHMP허가승인권고받아,http://www.kpanews.co.kr/article/show.asp?idx=203500&table=article&category=D
2939,2019-04-26,대웅제약나보타유럽CHMP허가승인권고유럽진출눈앞,http://www.metroseoul.co.kr/news/newsview?newscd=2019042600123
2940,2019-04-26,대웅제약나보타세계최대시장미국유럽동시진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229896
2941,2019-04-26,유럽시장포문여나대웅제약나보타유럽CHMP허가승인권고,http://www.ajunews.com/view/20190426230315061
2942,2019-04-26,대웅제약나보타유럽약물사용위원회허가권고획득,http://biz.chosun.com/site/data/html_dir/2019/04/26/2019042603536.html
2943,2019-04-26,유럽CHMP대웅제약나보타허가승인권고,http://www.dailypharm.com/Users/News/NewsView.html?ID=252066&REFERER=NP
2944,2019-04-26,유럽CHMP대웅제약보툴리눔톡신나보타허가권고,http://medipana.com/news/news_viewer.asp?NewsNum=238176&MainKind=A&NewsKind=5&vCount=12&vKind=1
2945,2019-04-26,대웅제약나보타유럽CHMP허가승인권고받아진출임박”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1749824
2946,2019-04-26,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.fnnews.com/news/201904262323223143
2947,2019-04-26,대웅제약나보타유럽CHMP서허가승인권고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019042623084231274
2948,2019-04-26,대웅제약보툴리눔톡신나보타유럽허가눈앞,http://yna.kr/AKR20190426192100017?did=1195m
2949,2019-04-26,대웅제약보툴리눔톡신제제나보타유럽시판허가권고받아,http://news1.kr/articles/?3607935
2950,2019-04-27,대웅제약나보타유럽시장진출눈앞,http://www.dailysmart.co.kr/news/articleView.html?idxno=9887
2951,2019-04-27,대웅제약vs메디톡스6차전끝안보이는나보타분쟁,http://news.joins.com/article/olink/23044605
2952,2019-04-27,대웅제약나보타유럽CHMP허가승인권고,http://news.mt.co.kr/mtview.php?no=2019042623444026857
2953,2019-04-27,대웅제약나보타유럽약물사용자문위허가승인권고,http://www.kyeongin.com/main/view.php?key=20190427010012213
2954,2019-04-27,제약단신장애인일자리창출나선대웅제약外,http://www.sportsworldi.com/content/html/2019/04/26/20190426502401.html
2955,2019-04-27,대웅제약나보타유럽진출눈앞유럽CHMP허가승인권고받아,http://www.inthenews.co.kr/news/article.html?no=15060
2956,2019-04-27,대웅제약나보타CHMP허가승인권고유럽진출임박,http://www.seoulfn.com/news/articleView.html?idxno=341223
2957,2019-04-27,대웅제약유럽서나보타허가승인권고받아내,http://news.mk.co.kr/newsRead.php?year=2019&no=267693
2958,2019-04-27,대웅제약나보타유럽진출초읽기,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067705
2959,2019-04-27,대웅나보타CHMP허가승인권고유럽진출임박,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85388
2960,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.ekn.kr/news/article.html?no=428906
2961,2019-04-27,대웅제약나보타유럽CHMP허가승인권고유럽진출초읽기,http://www.medisobizanews.com/news/articleView.html?idxno=59358
2962,2019-04-27,대웅제약나보타미국이어유럽허가눈앞,http://www.biospectator.com/view/news_view.php?varAtcId=7541
2963,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.lawissue.co.kr/view.php?ud=201904270859044482d7f4c63cc6_12
2964,2019-04-27,대웅제약나보타유럽판매허가받아,http://www.newsis.com/view/?id=NISX20190427_0000634136&cID=13001&pID=13000
2965,2019-04-27,대웅제약나보타유럽시장진출성큼유럽CHMP허가승인권고받아,http://kpenews.com/View.aspx?No=32243
2966,2019-04-27,대웅제약나보타유럽시장진출눈앞,http://moneys.mt.co.kr/news/mwView.php?no=2019042709478046728
2967,2019-04-27,대웅제약보툴리눔톡신나보타유럽서허가승인권고받아,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904270070&t=NN
2968,2019-04-27,대웅제약나보타美이어유럽진출눈앞,http://www.newscj.com/news/articleView.html?idxno=626095
2969,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출청신호,http://www.dailian.co.kr/news/view/791058/?sc=naver
2970,2019-04-27,대웅제약나보타유럽판매허가받아보툴리눔톡신시장진출눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=62941
2971,2019-04-27,유럽사용허가권고의견획득대웅제약나보타3년간주가상승에대형호재,http://www.g-enews.com/ko-kr/news/article/news_all/2019042712080474394e4869c120_1/article.html
2972,2019-04-27,대웅제약보톨리눔톡신나보타유럽판매눈앞,http://www.cstimes.com/?mod=news&act=articleView&idxno=303322
2973,2019-04-27,대웅제약나보타미국이어유럽진출눈앞,http://www.upinews.kr/news/newsview.php?ncode=1065590438991607
2974,2019-04-27,대웅제약나보타유럽보톡스시장진출하나허가승인권고획득,https://www.hankyung.com/article/2019042700837
2975,2019-04-27,대웅제약나보타EMA산하CHMP로부터허가승인권고획득유럽진출눈앞,http://www.segye.com/content/html/2019/04/27/20190427503959.html?OutUrl=naver
2976,2019-04-27,대웅제약나보타유럽CHMP허가승인권고,http://www.newstomato.com/ReadNews.aspx?no=891892
2977,2019-04-27,대웅제약나보타유럽진출가시화,http://www.sisaon.co.kr/news/articleView.html?idxno=92785
2978,2019-04-27,대웅제약나보타미국이어유럽진출눈앞,http://www.mdtoday.co.kr/mdtoday/index.html?no=353005
2979,2019-04-27,대웅제약유럽서나보타허가승인권고받아,http://www.asiatime.co.kr/news/articleView.html?idxno=242437
2980,2019-04-27,대웅제약보툴리눔톡신나보타유럽서허가승인권고,http://view.asiae.co.kr/news/view.htm?idxno=2019042718173357675
2981,2019-04-27,대웅제약나보타유럽CHMP허가승인권고로유럽진출눈앞,http://www.newscj.com/news/articleView.html?idxno=626246
2982,2019-04-28,대웅제약보통리눔톡신나보타석달내유럽허가,http://news.heraldcorp.com/view.php?ud=20190428000046
2983,2019-04-28,대웅제약보툴리눔톡신나보타유럽허가눈앞,http://www.etnews.com/20190428000014
2984,2019-04-28,대웅제약나보타유럽판매허가눈앞,https://www.sedaily.com/NewsView/1VI1HJ8Y3V
2985,2019-04-28,미국유럽들썩이는나보타대웅제약함박웃음,http://www.viva100.com/main/view.php?key=20190428010010076
2986,2019-04-28,대웅제약나보타유럽진출눈앞허가승인권고받아,http://www.dt.co.kr/contents.html?article_no=2019042802109931102002&ref=naver
2987,2019-04-28,전승호대웅제약나보타미국과유럽수출로보톡스아성에도전,http://www.businesspost.co.kr/BP?command=article_view&num=125086
2988,2019-04-28,대웅제약나보타유럽허가임박국산첫美유럽동시진출,https://www.hankyung.com/article/2019042819071
2989,2019-04-28,대웅제약보툴리눔톡신나보타곧유럽허가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3821330
2990,2019-04-29,대웅제약나보타美이어유럽허가임박총35조시장정조준,http://www.etoday.co.kr/news/section/newsview.php?idxno=1749916
2991,2019-04-29,대웅제약나보타미국진출이어유럽상륙임박,http://www.dailymedi.com/detail.php?number=842492&thread=22r05
2992,2019-04-29,클릭e종목대웅제약나보타유럽출시가시권이익증대기대,http://view.asiae.co.kr/news/view.htm?idxno=2019042907120512363
2993,2019-04-29,퀵리포트대웅제약매수유지목표가25만원유지한투證,http://www.itooza.com/common/iview.php?no=2019042907431129117
2994,2019-04-29,대웅제약목표가25만원유지전일종가20만500원한투證,http://www.newspim.com/news/view/20190429000056
2995,2019-04-29,GET투자리포트대웅제약투자의견매수유지한국투자증권,http://www.getnews.co.kr/view.php?ud=201904291030304613tpgetnews_16
2996,2019-04-29,대웅제약나보타로유럽진출가시화한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1750021
2997,2019-04-29,대웅제약나보타유럽판매허가가능성↑한투,http://news.mt.co.kr/mtview.php?no=2019042908493629218
2998,2019-04-29,대웅제약나보타유럽출시효과기대한국투자증권,https://www.sedaily.com/NewsView/1VI1Y6NXWO
2999,2019-04-29,실시간분석대웅제약34상승증권사목표가25만원제시,http://www.itooza.com/common/iview.php?no=2019042909030527083
3000,2019-04-29,대웅제약나보타유럽판매허가권고에강세,https://www.hankyung.com/article/2019042930226
3001,2019-04-29,대웅제약발달장애인안정적일자리환경조성,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=209319
3002,2019-04-29,대웅주식종목시세29일현재21400원,http://www.nbntv.co.kr/news/articleView.html?idxno=335255
3003,2019-04-29,증시현황29일대웅주가21450원,http://www.anewsa.com/detail.php?number=1713216&thread=10r02
3004,2019-04-29,대웅제약나보타유럽진출가능성커져,http://www.rapportian.com/news/articleView.html?idxno=117322
3005,2019-04-29,ET투자뉴스대웅_투심과거래량은보통현재주가는강세,http://www.etnews.com/20190429000105
3006,2019-04-29,4월29일대웅제약및증권시세및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=174416
3007,2019-04-29,대웅제약유럽서나보타허가승인권고에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=353098
3008,2019-04-29,대웅제약나보타CHMP허가승인권고로유럽진출눈앞,http://kormedi.com/?p=1288171
3009,2019-04-29,4월29일대웅제약오늘증권시세050201500원,http://www.nbntv.co.kr/news/articleView.html?idxno=335734
3010,2019-04-29,대웅제약나보타유럽서허가승인권고유럽진출박차,http://www.sisaweek.com/news/articleView.html?idxno=121175
3011,2019-04-29,대웅제약나보타유럽CHMP허가승인권고,http://www.bosa.co.kr/news/articleView.html?idxno=2104255
3012,2019-04-29,대웅제약나보타유럽시장진출초읽기,http://www.koreaittimes.com/news/articleView.html?idxno=90528
3013,2019-04-29,대웅제약나보타미국에이어유럽유럽진출노크,http://www.bokuennews.com/news/article.html?no=174992
3014,2019-04-29,대웅제약나보타美이어유럽진출눈앞,https://www.sedaily.com/NewsView/1VI1XYPHOK
3015,2019-04-29,대웅제약나보타CHMP허가승인권고유럽진출박차,http://www.businesskorea.co.kr/news/articleView.html?idxno=31364
3016,2019-04-29,스타★주식인사이드대웅제약주가202500원4월29일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=666653
3017,2019-04-29,ET투자뉴스대웅제약나보타미국에이BUY유지한국투자증권,http://www.etnews.com/20190429000385
3018,2019-04-29,대웅제약나보타유럽에출시되면매출늘고브랜드가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=125161
3019,2019-04-29,대웅제약메디톡스해외서장군멍군,http://www.newstomato.com/ReadNews.aspx?no=892129
3020,2019-04-29,대웅제약전승호號나보타로글로벌보툴리눔톡신시장정조준,http://www.iminju.net/news/articleView.html?idxno=45007
3021,2019-04-29,29일마감주가정보대웅21600원마감,http://www.gokorea.kr/news/articleView.html?idxno=175050
3022,2019-04-29,4월29일장마감주가정보대웅제약205000원,http://www.newsinside.kr/news/articleView.html?idxno=667685
3023,2019-04-29,★주식인사이드대웅제약주가208000원4월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=665604
3024,2019-04-30,대웅제약나보타미국이어유럽진출초읽기,http://www.polinews.co.kr/news/article.html?no=390777
3025,2019-04-30,★주식인사이드대웅제약주가203500원4월30일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=668769
3026,2019-04-30,주가정보30일대웅거래가격21550원,http://www.anewsa.com/detail.php?number=1716404&thread=10r02
3027,2019-04-30,주식현재가대웅주가30일현재21600원,http://www.nbntv.co.kr/news/articleView.html?idxno=337559
3028,2019-04-30,대웅제약나보타유럽CHMP허가승인권고 ,http://www.monews.co.kr/news/articleView.html?idxno=202321
3029,2019-04-30,대웅제약주식종목검색30일현재202000원,http://www.nbntv.co.kr/news/articleView.html?idxno=338052
3030,2019-04-30,대웅제약올해1Q영업익101억전년비272↑,http://www.newspim.com/news/view/20190430000590
3031,2019-04-30,코스피대웅제약2019년1분기누적매출액2381억원영업이익102억원,http://news.kmib.co.kr/article/view.asp?arcid=0013274390&code=61141211&cp=nv
3032,2019-04-30,실적속보대웅제약별도20191Q영업이익102억원전년비272,http://www.fntimes.com/html/view.php?ud=2019043012375975115dfa8f3bd6_18
3033,2019-04-30,잠정실적대웅제약올해1Q영업익101억전년비272↑,http://www.itooza.com/common/iview.php?no=2019043012382419886
3034,2019-04-30,대웅제약1분기영업이익101억원전년비272↑,http://news.mt.co.kr/mtview.php?no=2019043012462043991
3035,2019-04-30,대웅제약1Q영업익102억원전년比27증가,http://news1.kr/articles/?3610161
3036,2019-04-30,공시대웅제약1Q영업익102억원전년比272↑,http://www.newsway.co.kr/news/view?tp=1&ud=2019043012531876166
3037,2019-04-30,대웅제약1분기영업익102억전년비272↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=252161&REFERER=NP
3038,2019-04-30,스타★주식인사이드대웅제약주가202500원4월30일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=669799
3039,2019-04-30,공시대웅제약1분기영업익102억원전년比27↑,http://www.newsis.com/view/?id=NISX20190430_0000636981&cID=10401&pID=10400
3040,2019-04-30,ET투자뉴스대웅제약19년1분기실적발표영업이익102억원전년동기대비272증가,http://www.etnews.com/20190430000215
3041,2019-04-30,실적속보대웅제약올해1Q영업이익대폭상승전분기보다1174올라개별잠정,https://www.hankyung.com/article/201904308893L
3042,2019-04-30,대웅제약1분기영업익102억원272증가,https://www.sedaily.com/NewsView/1VI2ELS6O4
3043,2019-04-30,대웅제약1분기영업이익101억9700만원272↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=353289
3044,2019-04-30,대웅제약1Q영업익102억나보타美매출로수익성향상,http://view.asiae.co.kr/news/view.htm?idxno=2019043013294448066
3045,2019-04-30,대웅제약1Q영업익27↑나보타미국매출발생,http://www.dailypharm.com/Users/News/NewsView.html?ID=252166&REFERER=NP
3046,2019-04-30,대웅제약1Q매출2381억‥나보타효과로수익성향상,http://medipana.com/news/news_viewer.asp?NewsNum=238308&MainKind=A&NewsKind=5&vCount=12&vKind=1
3047,2019-04-30,대웅제약1분기영업익102억원전년대비27증가,http://www.sisafocus.co.kr/news/articleView.html?idxno=208749
3048,2019-04-30,대웅제약나보타미국향신규매출발생으로수익성향상,http://www.wsobi.com/news/articleView.html?idxno=72873
3049,2019-04-30,대웅제약올1분기영업익102억원271증가,http://www.newsway.co.kr/news/view?tp=1&ud=2019043013223050050
3050,2019-04-30,대웅제약1분기영업이익27증가나보타美매출발생,https://www.hankyung.com/article/2019043089296
3051,2019-04-30,대웅제약올1분기매출액2381억원영업이익102억원기록,http://www.ekn.kr/news/article.html?no=429441
3052,2019-04-30,대웅제약1분기영업익102억원272증가,http://yna.kr/AKR20190430107000008?did=1195m
3053,2019-04-30,대웅제약보툴리눔톡신나보타미국매출증가로수익성개선,http://www.ceoscoredaily.com/news/article.html?no=54977
3054,2019-04-30,대웅제약1Q영업익102억272↑매출2381억103↑,http://www.upinews.kr/news/newsview.php?ncode=1065588254170042
3055,2019-04-30,대웅제약1분기영업익102억원전년비272↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904300332&t=NN
3056,2019-04-30,대웅제약1Q영업익102억원전년비272증가,http://view.asiae.co.kr/news/view.htm?idxno=2019043013512538819
3057,2019-04-30,대웅제약1분기영업익27증가나보타미국매출발생,http://www.newspim.com/news/view/20190430000657
3058,2019-04-30,대웅제약1분기영업익전년比272증가,http://www.ajunews.com/view/20190430135237183
3059,2019-04-30,대웅제약올해1분기실적개선매출2381억원,http://www.mhj21.com/121078
3060,2019-04-30,대웅제약1분기나보타美매출로영업이익27↑,http://www.kpinews.co.kr/news/articleView.html?idxno=95324
3061,2019-04-30,대웅제약1분기영업이익272늘었다나보타의힘”,https://www.sedaily.com/NewsView/1VI2FZV01N
3062,2019-04-30,대웅제약1분기영업익102억원전년대비27↑,http://moneys.mt.co.kr/news/mwView.php?no=2019043013538069590
3063,2019-04-30,대웅제약1분기매출2381억원전년比103↑,http://www.economytalk.kr/news/articleView.html?idxno=184481
3064,2019-04-30,대웅제약1분기매출2381억원전년比103↑,http://www.economytalk.kr/news/articleView.html?idxno=184481
3065,2019-04-30,대웅제약1Q영업익102억원전년대비272↑,http://www.viva100.com/main/view.php?key=20190430010010850
3066,2019-04-30,대웅제약1분기영업익102억원전년比272↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03299686622461368
3067,2019-04-30,대웅제약1Q영업익전년比27증가나보타美매출반영,http://www.newsis.com/view/?id=NISX20190430_0000637090&cID=13001&pID=13000
3068,2019-04-30,대웅제약1분기매출10영업이익27성장,http://news.heraldcorp.com/view.php?ud=20190430000625
3069,2019-04-30,대웅제약1분기영업이익27증가나보타미국매출로실적향상,http://biz.chosun.com/site/data/html_dir/2019/04/30/2019043001645.html
3070,2019-04-30,대웅제약1분기매출2381억원전년比103상승,http://www.medisobizanews.com/news/articleView.html?idxno=59415
3071,2019-04-30,전승호대웅제약대표나보타로미국이어유럽까지진출,http://www.newsway.co.kr/news/view?tp=1&ud=2019042918071464560
3072,2019-04-30,대웅제약1분기매출103영업이익272증가,http://www.koreaittimes.com/news/articleView.html?idxno=90574
3073,2019-04-30,대웅제약올1분기매출영업익두마리토끼,http://www.dailymedi.com/detail.php?number=842560&thread=22r05
3074,2019-04-30,대웅제약나보타美수출전년동기대비1107성장양호한이익개선기대,http://www.segye.com/content/html/2019/04/30/20190430509091.html?OutUrl=naver
3075,2019-04-30,대웅제약1분기영업이익102억원전년동기대비272↑,http://news.mk.co.kr/newsRead.php?year=2019&no=277825
3076,2019-04-30,대웅제약1분기매출2381억원103증가영업이익102억원,http://www.getnews.co.kr/view.php?ud=20190430145629395041d0c69529_16
3077,2019-04-30,대웅제약1Q영업익102억원전년비27↑,http://www.ebn.co.kr/news/view/982990
3078,2019-04-30,대웅제약1분기매출2381억원달성전년比103↑,http://www.inthenews.co.kr/news/article.html?no=15117
3079,2019-04-30,대웅제약美나보타수출실적반영본격화되나,http://www.biospectator.com/view/news_view.php?varAtcId=7560
3080,2019-04-30,대웅제약1Q영업익102억원전년比27↑,http://www.seoulfn.com/news/articleView.html?idxno=341541
3081,2019-04-30,대웅제약1분기영업이익272↑나보타수출실적가시화,http://news.donga.com/3/all/20190430/95321454/1
3082,2019-04-30,대웅제약1분기영업익102억원전년비272↑,http://www.dailian.co.kr/news/view/791908/?sc=naver
3083,2019-04-30,대웅제약1분기영업익102억전년比272↑,http://www.newsprime.co.kr/news/article.html?no=457819
3084,2019-04-30,30일마감보고대웅주가21650원으로마감,http://www.anewsa.com/detail.php?number=1718588&thread=10r04
3085,2019-04-30,대웅제약보툴리눔톡신나보타미국매출증가로1분기실적개선,http://www.etoday.co.kr/news/section/newsview.php?idxno=1750895
3086,2019-04-30,대웅제약1분기영업익102억나보타미국진출효과톡톡,http://www.newstomato.com/ReadNews.aspx?no=892521
3087,2019-04-30,실적대웅제약영업익102억전년比27증가전문및일반의약품고른성장세,http://www.ezyeconomy.com/news/articleView.html?idxno=90296
3088,2019-04-30,대웅제약1분기영업익102억전년比272↑,http://www.rapportian.com/news/articleView.html?idxno=117354
3089,2019-04-30,4월30일장마감주가정보대웅제약203000원,http://www.newsinside.kr/news/articleView.html?idxno=670845
3090,2019-04-30,대웅제약1분기실적전년比매출103영업익272증가,http://www.joseilbo.com/news/news_read.php?uid=375755&class=17&grp=
3091,2019-04-30,대웅제약2019년1분기영업이익102억원달성,http://www.sisaon.co.kr/news/articleView.html?idxno=92947
3092,2019-04-30,대웅제약1분기실적발표매출2381억원영업이익102억원,http://www.medigatenews.com/news/1861452453
3093,2019-04-30,대웅제약1분기실적매출2381억원영업이익102억원,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55126
3094,2019-04-30,보툴리눔톡신3사3색대웅제약메디톡스휴젤치열한경쟁,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019043016044862854
3095,2019-04-30,대웅제약실적대박1분기매출2381억원전년대비103성장,http://www.econovill.com/news/articleView.html?idxno=362135
3096,2019-04-30,대웅제약1분기성적표맑음영업이익102억원돌파,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019043016402217461
3097,2019-04-30,대웅제약1분기전년比매출103영업익272상승,http://www.wolyo.co.kr/news/articleView.html?idxno=83079
3098,2019-04-30,대웅제약1분기영업이익102억원전년비27증가,http://www.metroseoul.co.kr/news/newsview?newscd=2019043000121
3099,2019-04-30,일동다케다vs대웅유한활성비타민흡수율대전,http://weekly.cnbnews.com/news/article.html?no=127699
3100,2019-04-30,대웅제약나보타승승장구로1Q실적개선,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067801
3101,2019-04-30,대웅제약1Q매출2381억전년비10↑,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019043017154303555&objId=A2019043017154303555&portalCode=naver
3102,2019-04-30,대웅제약나보타미국매출신규발생등실적개선,http://www.100ssd.co.kr/news/articleView.html?idxno=61071
3103,2019-04-30,제약사1분기실적보니대웅제약한미약품종근당성공적GC녹십자아쉬움,http://daily.hankooki.com/lpage/ittech/201904/dh20190430172200145630.htm
3104,2019-04-30,휴젤중국에서도메디톡스대웅제약과보톡스경쟁불가피,http://www.businesspost.co.kr/BP?command=article_view&num=125432
3105,2019-04-30,대웅제약장애인일자리창출노력,http://www.wsobi.com/news/articleView.html?idxno=72899
3106,2019-04-30,대웅제약보톡스나보타의미국수출힘입어1분기실적늘어,http://www.businesspost.co.kr/BP?command=article_view&num=125465
3107,2019-04-30,대웅제약2019년1분기실적발표매출2381억원,http://www.newscj.com/news/articleView.html?idxno=627310
3108,2019-05-01,대웅제약2019년1분기매출2381억원영업이익102억원전년동기대비103272,http://www.lawissue.co.kr/view.php?ud=20190430235058364d7f4c63cc6_12
3109,2019-05-01,대웅제약1분기영업이익102억원전년대비27늘어나,http://www.econonews.co.kr/news/articleView.html?idxno=63332
3110,2019-05-01,대웅제약1분기매출2381억원전년比103↑,http://www.bokuennews.com/news/article.html?no=175068
3111,2019-05-01,한미대웅바이오원외처방시장서분전,http://www.newstomato.com/ReadNews.aspx?no=892487
3112,2019-05-01,나보타가보톡스아성깨뜨린다전승호대웅제약사장미국이어유럽진출눈앞,http://www.ekn.kr/news/article.html?no=429641
3113,2019-05-01,대웅제약1분기영업이익102억전년比272증가,http://www.polinews.co.kr/news/article.html?no=391024
3114,2019-05-02,글로벌현지화전략또하나의대웅을만드는일,http://www.dailypharm.com/Users/News/NewsView.html?ID=252193&REFERER=NP
3115,2019-05-02,오늘의추천종목한국투자증권대웅제약삼성전기등,http://www.asiatoday.co.kr/view.php?key=20190502010000651
3116,2019-05-02,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019050207393052869
3117,2019-05-02,대웅제약미국시장매출실적반영에목표가상향KB증권,http://www.ajunews.com/view/20190502073846277
3118,2019-05-02,대웅제약미국향나보타매출반영시작목표가↑,http://www.asiatoday.co.kr/view.php?key=20190502010000659
3119,2019-05-02,퀵리포트대웅제약매수유지목표가24만5000원유지신영證,http://www.itooza.com/common/iview.php?no=2019050207541215336
3120,2019-05-02,대웅제약목표가30만원유지전일종가20만3000원KTB證,http://www.newspim.com/news/view/20190502000126
3121,2019-05-02,대웅제약목표가24만5000원유지전일종가20만3000원신영證,http://www.newspim.com/news/view/20190502000153
3122,2019-05-02,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2019050208141114549
3123,2019-05-02,대웅제약목표가26만원유지전일종가20만3000원SK證,http://www.newspim.com/news/view/20190502000179
3124,2019-05-02,더벨대웅제약나보타수출계약금만130억,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904300100056710003520
3125,2019-05-02,신한금투대웅제약2분기나보타본격美수출목표가↑,http://www.newsis.com/view/?id=NISX20190502_0000638683&cID=10401&pID=10400
3126,2019-05-02,엇갈리는1분기실적한미약품대웅제약맑음녹십자흐림,http://www.rapportian.com/news/articleView.html?idxno=117361
3127,2019-05-02,대웅제약목표가4↑25만원제시KB證,http://www.newspim.com/news/view/20190502000204
3128,2019-05-02,유한양행듀오웰에이대웅제약올로맥스급여,http://www.medisobizanews.com/news/articleView.html?idxno=59440
3129,2019-05-02,대웅제약목표가26만원유지전일종가20만3000원유안타證,http://www.newspim.com/news/view/20190502000223
3130,2019-05-02,대웅제약나보타매출24분기부터본격화SK증권,http://www.fnnews.com/news/201905020823339578
3131,2019-05-02,퀵리포트대웅제약매수유지목표가26만원유지유안타證,http://www.itooza.com/common/iview.php?no=2019050208302729862
3132,2019-05-02,대웅제약1분기컨센서스상회신한금투,http://www.newstomato.com/ReadNews.aspx?no=892724
3133,2019-05-02,대웅제약전문의약품의힘에6분기만에영업익증가목표가↑신한,http://www.edaily.co.kr/news/newspath.asp?newsid=02017206622484984
3134,2019-05-02,대웅제약목표가8↑27만원제시대신證,http://www.newspim.com/news/view/20190502000286
3135,2019-05-02,대웅제약2분기영업이익률64전망,http://www.nspna.com/news/?mode=view&newsid=356496
3136,2019-05-02,SK증권대웅제약나보타매출액2분기부터본격화”,http://www.newsway.co.kr/news/view?tp=1&ud=2019050208475674473
3137,2019-05-02,대웅제약목표가4↑25만원제시신한금투,http://www.newspim.com/news/view/20190502000296
3138,2019-05-02,퀵리포트대웅제약매수유지목표가8↑27만원대신證,http://www.itooza.com/common/iview.php?no=2019050208491415849
3139,2019-05-02,퀵리포트대웅제약매수유지목표가4↑25만원신한금투,http://www.itooza.com/common/iview.php?no=2019050208523576147
3140,2019-05-02,대웅제약나보타유럽진출눈앞,http://weekly.cnbnews.com/news/article.html?no=127704
3141,2019-05-02,대웅제약컨센서스상회한1분기실적,http://www.newsprime.co.kr/news/article.html?no=458022
3142,2019-05-02,GET투자리포트대웅제약투자의견매수유지하이투자증권,http://www.getnews.co.kr/view.php?ud=201905021030304895tpgetnews_16
3143,2019-05-02,★주식인사이드대웅제약주가203500원5월2일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=672089
3144,2019-05-02,ET투자뉴스대웅제약나보타의이익개선효BUY유지하이투자증권,http://www.etnews.com/20190502000050
3145,2019-05-02,대웅52주신고가경신20184Q매출액3261억161영업이익182억41,https://www.hankyung.com/article/201905024701L
3146,2019-05-02,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=201905021030304904tpgetnews_16
3147,2019-05-02,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201905021030304912tpgetnews_16
3148,2019-05-02,5월2일대웅주식창21950원139,http://www.nbntv.co.kr/news/articleView.html?idxno=340184
3149,2019-05-02,fnRASSI대웅00309052주신고가139↑,http://www.fnnews.com/news/201905020939423962
3150,2019-05-02,국내주가정보2일대웅현재주식거래가격22000원,http://www.anewsa.com/detail.php?number=1720415&thread=10r02
3151,2019-05-02,ET투자뉴스대웅제약나보타수출시작BUY유지SK증권,http://www.etnews.com/20190502000074
3152,2019-05-02,KB증권대웅제약나보타미국매출확대가능성목표가상향”,http://www.sporbiz.co.kr/news/articleView.html?idxno=333911
3153,2019-05-02,대웅주가종목그래프2일현재21950원,http://www.gokorea.kr/news/articleView.html?idxno=178159
3154,2019-05-02,대웅제약주가상승가능나보타미국수출로이익늘어,http://www.businesspost.co.kr/BP?command=article_view&num=125598
3155,2019-05-02,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=201905021030304948tpgetnews_16
3156,2019-05-02,ET투자뉴스대웅제약미국향나보타매출BUY유지대신증권,http://www.etnews.com/20190502000095
3157,2019-05-02,5월2일대웅제약주식증권204500원074,http://www.nbntv.co.kr/news/articleView.html?idxno=340664
3158,2019-05-02,GET투자리포트대웅제약투자의견매수유지유안타증권,http://www.getnews.co.kr/view.php?ud=201905021030305058tpgetnews_16
3159,2019-05-02,대웅제약나보타유럽진출눈앞에웅비기대,http://view.asiae.co.kr/news/view.htm?idxno=2019050210312105646
3160,2019-05-02,스타★주식인사이드대웅제약주가203000원5월2일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=673152
3161,2019-05-02,ET투자뉴스대웅제약실적개선의시그널BUY유지유안타증권,http://www.etnews.com/20190502000317
3162,2019-05-02,ET투자뉴스대웅제약좋았던1분기보다BUY유지신한금융투자,http://www.etnews.com/20190502000472
3163,2019-05-02,대웅제약사회공헌활동참지마요대학생봉사단모집,http://moneys.mt.co.kr/news/mwView.php?no=2019050214528076943
3164,2019-05-02,대웅제약발달장애인과아름다운동행나서참지마요프로젝트봉사단모집,http://kpenews.com/View.aspx?No=32618
3165,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.ebn.co.kr/news/view/983268
3166,2019-05-02,대웅제약대학생교육봉사단모집발달장애인들건강한삶돕자,http://www.medisobizanews.com/news/articleView.html?idxno=59479
3167,2019-05-02,대웅제약사회공헌프로그램참지마요프로젝트봉사단모집,http://www.metroseoul.co.kr/news/newsview?newscd=2019050200176
3168,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230080
3169,2019-05-02,대웅제약참지마요프로젝트대학생봉사자모집,http://www.newsprime.co.kr/news/article.html?no=458157
3170,2019-05-02,대웅제약과발달장애인이함께하는아름다운동행참지마요프로젝트교육봉사단모집,http://www.etoday.co.kr/news/section/newsview.php?idxno=1751575
3171,2019-05-02,대웅제약종근당1분기순항1조클럽굳히기청신호,http://www.newstomato.com/ReadNews.aspx?no=892866
3172,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://medipana.com/news/news_viewer.asp?NewsNum=238420&MainKind=A&NewsKind=5&vCount=12&vKind=1
3173,2019-05-02,대웅제약참지마요프로젝트대학생봉사단모집질병증상표현진료처방돕는다”,https://www.sedaily.com/NewsView/1VIZHQECW3
3174,2019-05-02,5월2일장마감주가정보대웅제약203500원,http://www.newsinside.kr/news/articleView.html?idxno=674209
3175,2019-05-02,대웅제약과발달장애인이함께하는아름다운동행,http://news.donga.com/3/all/20190502/95356198/1
3176,2019-05-02,대웅제약발달장애인과함께하는참지마요프로젝트대학생교육봉사단모집,http://www.asiatime.co.kr/news/articleView.html?idxno=243462
3177,2019-05-02,대웅제약발달장애인이함께하는아름다운동행,http://daily.hankooki.com/lpage/ittech/201905/dh20190502163628145630.htm
3178,2019-05-02,국내영업빅3한미대웅종근당1분기경영실적들여다보니,http://www.sisajournal-e.com/news/articleView.html?idxno=199643
3179,2019-05-02,대웅제약발달장애인질병증상표현교육참여할대학생봉사자모집,http://news.mk.co.kr/newsRead.php?year=2019&no=286699
3180,2019-05-02,대웅제약1분기매출2381억원전년동기대비103증가,http://www.kukinews.com/news/article.html?no=658521
3181,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=353476
3182,2019-05-02,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.econovill.com/news/articleView.html?idxno=362303
3183,2019-05-02,대웅제약발달장애인이함께하는아름다운동행,http://www.newscj.com/news/articleView.html?idxno=628139
3184,2019-05-02,신한금융투자대웅제약2분기주름개선제나보타본격미국수출목표가↑,http://www.econonews.co.kr/news/articleView.html?idxno=63589
3185,2019-05-03,대웅제약발달장애인지원참지마요프로젝트대학생봉사자모집,http://www.polinews.co.kr/news/article.html?no=391276
3186,2019-05-03,대웅제약3제복합제올로맥스로고혈압고지혈증동시공략,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230099
3187,2019-05-03,대웅제약3제복합개량신약올로맥스출시,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85483
3188,2019-05-03,대웅고혈압고지혈증3제복합제올로맥스출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=252264&REFERER=NP
3189,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://medipana.com/news/news_viewer.asp?NewsNum=238445&MainKind=A&NewsKind=5&vCount=12&vKind=1
3190,2019-05-03,★주식인사이드대웅제약주가204000원5월3일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=675544
3191,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.newsway.co.kr/news/view?tp=1&ud=2019050309110650226
3192,2019-05-03,섞고또섞고대웅제약고혈압고지혈증3제복합제출시,http://moneys.mt.co.kr/news/mwView.php?no=2019050309028014248
3193,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.economytalk.kr/news/articleView.html?idxno=184603
3194,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019050309002193437
3195,2019-05-03,대웅제약올로맥스출시고혈압고지혈증공략,http://www.ebn.co.kr/news/view/983361
3196,2019-05-03,대웅제약올로맥스출시고혈압고지혈증동시공략,http://www.seoulwire.com/news/articleView.html?idxno=122704
3197,2019-05-03,대웅제약고혈압고지혈증한번에조절,http://www.sisaon.co.kr/news/articleView.html?idxno=93094
3198,2019-05-03,주식실황3일대웅현재가21400원,http://www.anewsa.com/detail.php?number=1723113&thread=10r02
3199,2019-05-03,GET투자리포트대웅제약투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201905031030305141tpgetnews_16
3200,2019-05-03,대웅종목검색3일현재21450원,http://www.nbntv.co.kr/news/articleView.html?idxno=342554
3201,2019-05-03,대웅제약세계최초3제복합개량신약올로맥스출시,http://www.viva100.com/main/view.php?key=20190503010000994
3202,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.newspim.com/news/view/20190503000190
3203,2019-05-03,대웅주가5월3일현재21350원,http://www.gokorea.kr/news/articleView.html?idxno=179056
3204,2019-05-03,대웅참지마요프로젝트대학생교육봉사단운영,http://www.dailymedi.com/detail.php?number=842675&thread=22r05
3205,2019-05-03,대웅제약과발달장애인이함께하는아름다운동행,http://www.seoulwire.com/news/articleView.html?idxno=122709
3206,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.medisobizanews.com/news/articleView.html?idxno=59495
3207,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://yna.kr/AKR20190503045500017?did=1195m
3208,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://view.asiae.co.kr/news/view.htm?idxno=2019050310063514740
3209,2019-05-03,주요리서치센터추천주현대차LG생건대웅제약아스트반도체IT車중국관련株저점매수를,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=288071
3210,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증시장동시공략,http://www.econovill.com/news/articleView.html?idxno=362326
3211,2019-05-03,대웅제약고혈압고지혈증복합신약올로맥스출시,http://www.upinews.kr/news/newsview.php?ncode=1065574657327894
3212,2019-05-03,대웅제약올로맥스출시고혈압고지혈증동시공략,http://www.asiatime.co.kr/news/articleView.html?idxno=243572
3213,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.joseilbo.com/news/news_read.php?uid=375931&class=27&grp=
3214,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.ekn.kr/news/article.html?no=430056
3215,2019-05-03,GET투자리포트대웅제약투자의견보유유지DB금융투자,http://www.getnews.co.kr/view.php?ud=201905021030305191tpgetnews_16
3216,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905030154&t=NN
3217,2019-05-03,대웅제약올로맥스출시해고혈압고지혈증동시공략,http://www.etoday.co.kr/news/section/newsview.php?idxno=1751937
3218,2019-05-03,대웅제약3제복합제올로맥스출시고혈압고지혈증동시공략,http://www.bokuennews.com/news/article.html?no=175194
3219,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=10189
3220,2019-05-03,대웅제약올로맥스출시고혈압고지혈동시공략,http://www.newstomato.com/ReadNews.aspx?no=893083
3221,2019-05-03,5월3일대웅제약증권플러스202000원074,http://www.nbntv.co.kr/news/articleView.html?idxno=343034
3222,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.asiatoday.co.kr/view.php?key=20190503010001889
3223,2019-05-03,대웅제약올로맥스출시고혈압고지혈증시장공략,http://www.newsis.com/view/?id=NISX20190503_0000640397&cID=13001&pID=13000
3224,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55176
3225,2019-05-03,대웅제약올로맥스출시고혈압고지혈증동시공략,http://www.dailymedi.com/detail.php?number=842687&thread=22r05
3226,2019-05-03,대웅제약고혈압고지혈증동시공략올로맥스출시,http://www.bosa.co.kr/news/articleView.html?idxno=2104558
3227,2019-05-03,대웅제약세계최초3제복합개량신약올로맥스출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067897
3228,2019-05-03,2019제약사경영분석③대웅제약보톡스나보타효과로실적상승세탔다,http://www.naeil.com/news_view/?id_art=312056
3229,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.medigatenews.com/news/1176448054
3230,2019-05-03,스타★주식인사이드대웅제약주가203000원5월3일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=676659
3231,2019-05-03,ET투자뉴스대웅제약나보타미국보툴BUY유지KB증권,http://www.etnews.com/20190503000234
3232,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.mdtoday.co.kr/mdtoday/index.html?no=353575
3233,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.etnews.com/20190503000275
3234,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019050314051670754
3235,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,https://www.sedaily.com/NewsView/1VIZYCFG6D
3236,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=238474&MainKind=A&NewsKind=5&vCount=12&vKind=1
3237,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230128
3238,2019-05-03,대웅제약나보타FDA승인기념태국서심포지엄개최,http://www.koreaittimes.com/news/articleView.html?idxno=90625
3239,2019-05-03,대웅제약美FDA승인기념태국NABOTASparklingNight심포지엄성황리마쳐,http://www.medisobizanews.com/news/articleView.html?idxno=59520
3240,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.fnnews.com/news/201905031433070871
3241,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2104574
3242,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.newsprime.co.kr/news/article.html?no=458347
3243,2019-05-03,대웅제약나보타美FDA승인기념태국심포지엄개최,http://www.ftoday.co.kr/news/articleView.html?idxno=108354
3244,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.seoulfn.com/news/articleView.html?idxno=341894
3245,2019-05-03,대웅제약참지마요프로젝트교육봉사단모집,http://www.skyedaily.com/news/news_view.html?ID=84380
3246,2019-05-03,대웅제약고혈압고지혈증한번에잡는올로맥스출시,http://www.ezyeconomy.com/news/articleView.html?idxno=90370
3247,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1298054
3248,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.ekn.kr/news/article.html?no=430122
3249,2019-05-03,대웅제약나보타NABOTASparklingNight개최,http://www.ebn.co.kr/news/view/983438
3250,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019050300094
3251,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019050300093
3252,2019-05-03,5월3일장마감주가정보대웅제약203000원,http://www.newsinside.kr/news/articleView.html?idxno=677690
3253,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄성료,http://www.m-i.kr/news/articleView.html?idxno=519555
3254,2019-05-03,대웅나보타태국심포지엄최신시술트렌드공유,http://www.dailypharm.com/Users/News/NewsView.html?ID=252291&REFERER=NP
3255,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.wsobi.com/news/articleView.html?idxno=73080
3256,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=353604
3257,2019-05-03,3일마감주가정보대웅21650원마감,http://www.gokorea.kr/news/articleView.html?idxno=179876
3258,2019-05-03,대웅제약올로맥스로고혈압고지혈증공략,http://daily.hankooki.com/lpage/ittech/201905/dh20190503164233145630.htm
3259,2019-05-03,대웅제약고혈압고지혈증치료3제복합제올로맥스출시,http://news.mk.co.kr/newsRead.php?year=2019&no=290127
3260,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.dt.co.kr/contents.html?article_no=2019050302109931102003&ref=naver
3261,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.finomy.com/news/articleView.html?idxno=65464
3262,2019-05-03,대웅제약올로맥스출시해고혈압과고지혈증동시에공략,http://www.businesspost.co.kr/BP?command=article_view&num=125869
3263,2019-05-03,대웅제약올로맥스출시고혈압고지혈증시장동시공략,http://biz.chosun.com/site/data/html_dir/2019/05/03/2019050302158.html
3264,2019-05-03,사람중심대웅제약인재육성프로그램에눈길,http://www.news2day.co.kr/126371
3265,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55192
3266,2019-05-03,대웅제약나보타첫수출국태국서미국시판승인기념심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2019&no=290243
3267,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.getnews.co.kr/view.php?ud=20190503172258351541d0c69529_16
3268,2019-05-03,대웅제약고혈압고지혈증3제복합제올로맥스출시,http://news.donga.com/3/all/20190503/95373556/1
3269,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄성료,http://daily.hankooki.com/lpage/ittech/201905/dh20190503190946145630.htm
3270,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=31539
3271,2019-05-03,대웅제약올로맥스 출시로고혈압 고지혈증동시공략,http://www.businesskorea.co.kr/news/articleView.html?idxno=31545
3272,2019-05-03,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.kpanews.co.kr/article/show.asp?idx=203682&table=article&category=D
3273,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄열어,http://www.kpanews.co.kr/article/show.asp?idx=203684&table=article&category=D
3274,2019-05-03,대웅제약고혈압고지혈증복합제올로맥스선봬,http://www.kpanews.co.kr/article/show.asp?idx=203686&table=article&category=D
3275,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.ajunews.com/view/20190503211932009
3276,2019-05-03,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=628439
3277,2019-05-03,대웅제약올로맥스출시로고혈압고지혈증동시공략,http://www.newscj.com/news/articleView.html?idxno=628436
3278,2019-05-04,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.lawissue.co.kr/view.php?ud=201905040011493549d7f4c63cc6_12
3279,2019-05-04,대웅제약이지엔6진통제시장블록버스터도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=252299&REFERER=NP
3280,2019-05-04,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.ekn.kr/news/article.html?no=430199
3281,2019-05-04,대웅제약나보타美승인기념태국심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067937
3282,2019-05-05,전승호대웅제약의새성장동력을바이오뷰티에서찾다,http://www.businesspost.co.kr/BP?command=article_view&num=125968
3283,2019-05-05,대웅제약나보타FDA승인기념태국심포지엄개최,http://www.seoulwire.com/news/articleView.html?idxno=123780
3284,2019-05-05,대웅제약나보타FDA승인기념태국NABOTASparklingNight개최,http://www.getnews.co.kr/view.php?ud=20190505102547524541d0c69529_16
3285,2019-05-05,대웅제약고혈압고지혈증복합제올로맥스출시,http://yna.kr/PYH20190503032800017?did=1196m
3286,2019-05-05,대웅제약올로맥스출시고혈압고지혈증시장공략,http://www.econonews.co.kr/news/articleView.html?idxno=63925
3287,2019-05-06,대웅제약나보타FDA승인기념태국심포지엄성료,http://www.newswatch.kr/news/articleView.html?idxno=19197
3288,2019-05-06,대웅제약고혈압고지혈증복합제올로맥스출시,http://www.newswatch.kr/news/articleView.html?idxno=19201
3289,2019-05-06,대웅제약발달장애인지원아름다운동행실시,http://www.kukinews.com/news/article.html?no=659277
3290,2019-05-07,대웅제약의신약가치성과로입증할것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55194
3291,2019-05-07,대웅제약B형간염치료제비리바정서울아산병원입성,http://medipana.com/news/news_viewer.asp?NewsNum=238495&MainKind=A&NewsKind=5&vCount=12&vKind=1
3292,2019-05-07,한국투자증권대웅나보타로열티등수출호조대웅바이오1분기실적훈풍예상,http://www.betanews.net:8080/article/1005740.html
3293,2019-05-07,★주식인사이드대웅제약주가199500원5월7일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=679412
3294,2019-05-07,대웅금일증시7일현재21050원,http://www.nbntv.co.kr/news/articleView.html?idxno=345538
3295,2019-05-07,국내주식시장현황7일대웅현재가격21100원,http://www.anewsa.com/detail.php?number=1727298&thread=10r02
3296,2019-05-07,대웅주가5월7일현재21100원,http://www.gokorea.kr/news/articleView.html?idxno=181282
3297,2019-05-07,대웅제약올로맥스출시고혈압고지혈증시장공략,http://www.monews.co.kr/news/articleView.html?idxno=202403
3298,2019-05-07,대웅제약NABOTASparklingNight개최,http://www.monews.co.kr/news/articleView.html?idxno=202405
3299,2019-05-07,대웅제약한미약품1분기성적순항1조클럽굳히기성공할까,http://www.ekn.kr/news/article.html?no=430373
3300,2019-05-07,대웅제약나보타FDA승인기념태국심포지엄NABOTASparklingNight개최,http://www.wsobi.com/news/articleView.html?idxno=73122
3301,2019-05-07,5월7일대웅제약주식시세현황123200500원,http://www.nbntv.co.kr/news/articleView.html?idxno=346025
3302,2019-05-07,대웅제약박준석신약센터장제2제3의나보타나온다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019050711055129389
3303,2019-05-07,스타★주식인사이드대웅제약주가200000원5월7일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=680535
3304,2019-05-07,박준석대웅신약센터장2023년부터매년기술수출목표”,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019050714060802229&objId=A2019050714060802229&portalCode=naver
3305,2019-05-07,5월7일장마감주가정보대웅제약201000원,http://www.newsinside.kr/news/articleView.html?idxno=681581
3306,2019-05-07,대웅종근당한미1분기매출순항GC녹십자는25↓,http://www.shinailbo.co.kr/news/articleView.html?idxno=1164955
3307,2019-05-07,박준석대웅제약신약센터장제2제3의나보타로신화이어간다,http://www.dailysmart.co.kr/news/articleView.html?idxno=10342
3308,2019-05-07,7일주가마감정보대웅21350원마감,http://www.gokorea.kr/news/articleView.html?idxno=182131
3309,2019-05-07,대웅제약고혈압고지혈증3제복합제올로맥스출시자체특허이층정제형적용,http://www.updownnews.co.kr/news/articleView.html?idxno=202968
3310,2019-05-08,대웅제약나보타글로벌진출드라이브NO1도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=252360&REFERER=NP
3311,2019-05-08,오늘의추천종목한국투자증권대웅제약LG전자등,http://www.asiatoday.co.kr/view.php?key=20190508010003856
3312,2019-05-08,DS투자증권대웅제약나보타매출기대감매수”,http://www.fnnews.com/news/201905080906037208
3313,2019-05-08,대웅제약나보타美매출기대감목표가↑DS,http://www.edaily.co.kr/news/newspath.asp?newsid=02017206622486952
3314,2019-05-08,★주식인사이드대웅제약주가197000원5월8일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=682919
3315,2019-05-08,GET투자리포트대웅제약투자의견매수DS투자증권,http://www.getnews.co.kr/view.php?ud=201905081030305395tpgetnews_16
3316,2019-05-08,국내주가정보8일대웅현재주식거래가격21000원,http://www.anewsa.com/detail.php?number=1730076&thread=10r02
3317,2019-05-08,ET투자뉴스대웅제약주가가1년이나쉬BUYDS투자증권,http://www.etnews.com/20190508000104
3318,2019-05-08,5월8일대웅오늘주식시세21000원164,http://www.nbntv.co.kr/news/articleView.html?idxno=347917
3319,2019-05-08,대웅일동동아에스티함박웃음제약1분기,http://news.heraldcorp.com/view.php?ud=20190508000421
3320,2019-05-08,대웅제약주가오늘시세8일현재198500원,http://www.gokorea.kr/news/articleView.html?idxno=183324
3321,2019-05-08,스타★주식인사이드대웅제약주가199000원5월8일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=684057
3322,2019-05-08,5월8일대웅제약주식시세현황199000원100,http://www.nbntv.co.kr/news/articleView.html?idxno=348432
3323,2019-05-08,5월8일장마감주가정보대웅제약198000원,http://www.newsinside.kr/news/articleView.html?idxno=685074
3324,2019-05-08,8일주가마감정보대웅주가21150원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=183945
3325,2019-05-09,대웅나보타2조원미국보톡스시장서진검승부,http://www.dailypharm.com/Users/News/NewsView.html?ID=252395&REFERER=NP
3326,2019-05-09,★주식인사이드대웅제약주가198000원5월9일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=686431
3327,2019-05-09,5월9일대웅주가그래프21200원024,http://www.nbntv.co.kr/news/articleView.html?idxno=350188
3328,2019-05-09,국내주가정보9일대웅현재가21000원,http://www.anewsa.com/detail.php?number=1733136&thread=10r02
3329,2019-05-09,대웅주가정보외주식시황9일현재21150원,http://www.gokorea.kr/news/articleView.html?idxno=184797
3330,2019-05-09,대웅제약오늘증권시세9일현재196500원,http://www.nbntv.co.kr/news/articleView.html?idxno=350688
3331,2019-05-09,스타★주식인사이드대웅제약주가197000원5월9일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=687551
3332,2019-05-09,5월9일장마감주가정보대웅제약193500원,http://www.newsinside.kr/news/articleView.html?idxno=688639
3333,2019-05-10,짙어지는대웅색채한올임원들4년만에대거교체,http://www.dailypharm.com/Users/News/NewsView.html?ID=252450&REFERER=NP
3334,2019-05-10,오늘의추천종목한국투자증권대웅제약BGF리테일등,http://www.asiatoday.co.kr/view.php?key=20190510010005689
3335,2019-05-10,★주식인사이드대웅제약주가195500원5월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=689929
3336,2019-05-10,대웅아리셉트정혈관성치매증상개선효능삭제,http://www.bokuennews.com/news/article.html?no=175428
3337,2019-05-10,스타★주식인사이드대웅제약주가189500원5월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=691085
3338,2019-05-10,5월10일장마감주가정보대웅제약189000원,http://www.newsinside.kr/news/articleView.html?idxno=692125
3339,2019-05-10,10일마감정보대웅20050원마감,http://www.gokorea.kr/news/articleView.html?idxno=186503
3340,2019-05-12,사진수덕사대웅전서관불의식하는황선봉예산군수,http://www.ccnnews.co.kr/news/articleView.html?idxno=146795
3341,2019-05-13,주요제약사7곳중가족친화기업대웅제약한미약품2곳뿐,http://www.ceoscoredaily.com/news/article.html?no=55384
3342,2019-05-13,USITC대웅제약나보타균주메디톡스지정전문가에게제출”,http://www.econovill.com/news/articleView.html?idxno=362902
3343,2019-05-13,메디톡스美ITC대웅제약에나보타균주및관련서류정보제출명령,http://news.mk.co.kr/newsRead.php?year=2019&no=312124
3344,2019-05-13,★주식인사이드대웅제약주가187000원5월13일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=693909
3345,2019-05-13,美국제무역위대웅제약은나보타균주제출하라,http://daily.hankooki.com/lpage/ittech/201905/dh20190513090521145630.htm
3346,2019-05-13,메디톡스美국제무역위대웅제약에나보타균주제출명령”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754735
3347,2019-05-13,美국제무역위원회대웅제약에나보타균주제출명령,https://www.hankyung.com/article/2019051377486
3348,2019-05-13,美무역위대웅제약나보타균주출처공개하라,http://news.mt.co.kr/mtview.php?no=2019051308505519044
3349,2019-05-13,美국제무역위원회대웅제약은나보타균주제출하라”,http://www.newsway.co.kr/news/view?tp=1&ud=2019051309142020316
3350,2019-05-13,美무역위대웅제약나보타균주관련정보제출명령,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051309125653499
3351,2019-05-13,대웅제약메디톡스균주포자감정통해허위주장입증확신,http://www.econovill.com/news/articleView.html?idxno=362904
3352,2019-05-13,美국제무역委대웅제약나보타균주15일까지메디톡스전문가에제출해야”,https://www.sedaily.com/NewsView/1VJ4IJ3II5
3353,2019-05-13,주식종목13일대웅현재가격18050원,http://www.anewsa.com/detail.php?number=1738756&thread=10r02
3354,2019-05-13,美ITC대웅제약에15일까지나보타균주제출명령,http://www.newsis.com/view/?id=NISX20190513_0000648350&cID=13001&pID=13000
3355,2019-05-13,대웅제약메디톡스허위주장종지부찍겠다”,http://www.whosaeng.com/109981
3356,2019-05-13,주가차트대웅주가13일현재18050원,http://www.nbntv.co.kr/news/articleView.html?idxno=354321
3357,2019-05-13,미국국제무역위원회대웅제약나보타균주15일까지제출하라”,http://www.newspim.com/news/view/20190513000251
3358,2019-05-13,대웅제약메디톡스균주감정통해허위주장입증확신,http://www.dailian.co.kr/news/view/794800/?sc=naver
3359,2019-05-13,대웅주가증권투자정보및매매동향13일현재18000원,http://www.gokorea.kr/news/articleView.html?idxno=187665
3360,2019-05-13,대웅제약나보타균주포자감정으로분쟁종결할것,http://www.newspim.com/news/view/20190513000274
3361,2019-05-13,대웅제약메디톡스균주포자감정을통해사실관계입증확신”,https://www.sedaily.com/NewsView/1VJ4JU2FDR
3362,2019-05-13,대웅제약국내외소송서메디톡스균주포자감정통해허위주장입증확신,http://www.sisafocus.co.kr/news/articleView.html?idxno=209680
3363,2019-05-13,메디톡스美ITC서류제출명령vs대웅제약포자검증으로분쟁종결,https://view.asiae.co.kr/news/view.htm?idxno=2019051309491262036
3364,2019-05-13,특징주대웅제약대웅나보타관련美소송본격화소식에급락,http://www.edaily.co.kr/news/newspath.asp?newsid=02302566622488592
3365,2019-05-13,대웅제약ITC균주증거수집절차성실임할것,http://www.bosa.co.kr/news/articleView.html?idxno=2104982
3366,2019-05-13,대웅제약美ITC증거수집성실히임해균주도용논란종지부찍을것,http://news.mk.co.kr/newsRead.php?year=2019&no=312352
3367,2019-05-13,대웅제약균주감정통해메디톡스허위주장입증확신,http://www.viva100.com/main/view.php?key=20190513010003625
3368,2019-05-13,보톡스논란미국ITC대웅제약나보타균주제출하라,http://yna.kr/AKR20190513038400017?did=1195m
3369,2019-05-13,메디톡스美행정법원대웅제약에나보타균주제출하라,http://www.medisobizanews.com/news/articleView.html?idxno=59689
3370,2019-05-13,종합美국제무역위나보타균주제출명령메디톡스VS대웅제약입장팽팽,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754789
3371,2019-05-13,대웅제약전일대비약9하락한171500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905130230&t=NN
3372,2019-05-13,대웅10하락전일보다2100원내린17950원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905130232&t=NN
3373,2019-05-13,fnRASSI대웅제약거래량확대되며6거래일연속하락,http://www.fnnews.com/news/201905131004485077
3374,2019-05-13,美국제무역위원회ITC대웅제약에나보타균주제출명령,http://news.mk.co.kr/newsRead.php?year=2019&no=312422
3375,2019-05-13,메디톡스미국ITC나보타균주정부제출명령대웅허위주장입증확신,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905130131&t=NN
3376,2019-05-13,대웅제약vs메디톡스보툴리눔균주출처공방美ITC증거수집개시,http://biz.chosun.com/site/data/html_dir/2019/05/13/2019051300937.html
3377,2019-05-13,대웅제약나보타균주포자감정통해분쟁종지부,http://www.ebn.co.kr/news/view/984534
3378,2019-05-13,특징주대웅대웅제약보톡스소송본격화소식에약세,http://yna.kr/AKR20190513049300008?did=1195m
3379,2019-05-13,대웅제약국내외소송서메디톡스균주포자감정진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230362
3380,2019-05-13,대웅제약메디톡스균주분쟁이번기회에종지부,http://www.medisobizanews.com/news/articleView.html?idxno=59692
3381,2019-05-13,대웅제약국내외소송에서균주포자감정통해허위주장입증할것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55270
3382,2019-05-13,미국국제무역위원회대웅제약오는15일까지나보타균주제출할것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55268
3383,2019-05-13,美ITC대웅제약은나보타균주를메디톡스지정전문가에게제출해야”,http://www.ceoscoredaily.com/news/article.html?no=55421
3384,2019-05-13,대웅제약美ITC의나보타균주제출요구성실히임할것,http://www.ceoscoredaily.com/news/article.html?no=55422
3385,2019-05-13,대웅제약나보타균주제출하고도용분쟁종결할것”,http://www.ajunews.com/view/20190513101614347
3386,2019-05-13,대웅제약나보타균주출처논쟁포자감정으로종지부찍을것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051310111085172
3387,2019-05-13,대웅제약균주감정통해메디톡스허위주장입증확신,http://www.newsway.co.kr/news/view?tp=1&ud=2019051310232302656
3388,2019-05-13,보톡스균주논란미국국제무역위원회ITC대웅제약균주정보제출하라”,http://www.ajunews.com/view/20190513102209354
3389,2019-05-13,특징주대웅대웅제약보톡스소송본격화소식에약세,http://www.ajunews.com/view/20190513102635360
3390,2019-05-13,메디톡스와소송대웅제약균주증거수집성실히임할것,http://www.newsprime.co.kr/news/article.html?no=459426
3391,2019-05-13,대웅제약미국나보타관련소송에하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=354313
3392,2019-05-13,대웅제약균주포자감정통해메디톡스허위주장입증확신,http://medipana.com/news/news_viewer.asp?NewsNum=238800&MainKind=A&NewsKind=5&vCount=12&vKind=1
3393,2019-05-13,美국제무역위대웅제약나보타균주제출하라”,http://health.chosun.com/site/data/html_dir/2019/05/13/2019051301063.html
3394,2019-05-13,보톡스논란美ITC조사본격화대웅메디톡스허위입증종합,http://yna.kr/AKR20190513038451017?did=1195m
3395,2019-05-13,美무역위대웅제약나보타균주출처공개명령,http://www.inews24.com/view/1178350
3396,2019-05-13,대웅제약나보타도용논란막바지국면美국제무역위나보타균주출처메디톡스에공개하라,http://www.ezyeconomy.com/news/articleView.html?idxno=90555
3397,2019-05-13,대웅제약메디톡스균주포자감정해허위주장입증확신,http://www.newsis.com/view/?id=NISX20190513_0000648460&cID=13001&pID=13000
3398,2019-05-13,대웅제약ITC결정존중메디톡스허위주장규명할것,http://news.mt.co.kr/mtview.php?no=2019051310095841478
3399,2019-05-13,미국ITC대웅제약나보타균주제출하라,http://www.asiatoday.co.kr/view.php?key=20190513010007097
3400,2019-05-13,대웅제약메디톡스보톡스출처논란미국ITC조사본격화,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3833225
3401,2019-05-13,대웅제약메디톡스의허위주장입증확신”,http://daily.hankooki.com/lpage/ittech/201905/dh20190513105543145630.htm
3402,2019-05-13,대웅대웅제약보톡스소송美ITC조사본격화소식에약세,http://www.seoulwire.com/news/articleView.html?idxno=128329
3403,2019-05-13,대웅제약메디톡스보톡스출처논란관련허위입증,http://www.kyeongin.com/main/view.php?key=20190513010004883
3404,2019-05-13,특징주대웅제약나보타관련미국소송본격화7급락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754862
3405,2019-05-13,대웅제약메디톡스보톡스공방재점화美ITC균주정보제출명령,http://sports.chosun.com/news/ntype.htm?id=201905140100093130006267&servicedate=20190513
3406,2019-05-13,보톡스논란진짜주인가린다美ITC대웅균주제출명령,http://news1.kr/articles/?3619678
3407,2019-05-13,대웅제약메디톡스나보타원료제출두고기싸움,http://www.finomy.com/news/articleView.html?idxno=65697
3408,2019-05-13,미ITC보톡스논란조사본격화대웅제약메디톡스허위입증총력,http://www.asiatoday.co.kr/view.php?key=20190513010007119
3409,2019-05-13,보톡스논란美ITC조사본격화대웅메디톡스허위입증종합,http://yna.kr/AKR20190513038452017?did=1195m
3410,2019-05-13,대웅제약vs메디톡스美ITC증거수집진실공방결과는,http://www.mdtoday.co.kr/mdtoday/index.html?no=354323
3411,2019-05-13,美ITC조사본격화보톡스논란대웅VS메디톡스허위입증할것,http://www.segye.com/content/html/2019/05/13/20190513505067.html?OutUrl=naver
3412,2019-05-13,대웅제약균주증거수집성실히임해도용분쟁종결할것,http://www.seoulwire.com/news/articleView.html?idxno=128344
3413,2019-05-13,메디톡스대웅제약과기술절취소송전서승기잡나,http://www.shinailbo.co.kr/news/articleView.html?idxno=1166396
3414,2019-05-13,5월13일대웅제약주가그래프899172000원,http://www.nbntv.co.kr/news/articleView.html?idxno=354805
3415,2019-05-13,미법원대웅나보타정보제출대웅검증자신,http://www.dailypharm.com/Users/News/NewsView.html?ID=252545&REFERER=NP
3416,2019-05-13,메디톡스대웅제약균주출처논란종지부찍나,http://www.dailymedi.com/detail.php?number=842972&thread=22r05
3417,2019-05-13,보톡스논란미국ITC대웅제약증거제출하라”,https://cnbc.sbs.co.kr/article_hub/10000941218?division=NAVER
3418,2019-05-13,메디톡스vs대웅제약균주논란끝내자종합,http://www.edaily.co.kr/news/newspath.asp?newsid=02961846622488592
3419,2019-05-13,국제무역위원회대웅제약나보타균주제출명령,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1126391&REFERER=NP
3420,2019-05-13,대웅제약보톡스메디톡스관련상대방의허위주장입증하고분쟁종결할수있다,http://www.econonews.co.kr/news/articleView.html?idxno=64834
3421,2019-05-13,메디톡스미국ITC대웅제약나보타균주출처제공명령,http://www.rapportian.com/news/articleView.html?idxno=117521
3422,2019-05-13,허위주장입증자신”美ITC명령에대웅제약메디톡스신경전치열,http://www.viva100.com/main/view.php?key=20190513010003738
3423,2019-05-13,대웅대웅제약주식2만6455주장내매수결정,http://news.mt.co.kr/mtview.php?no=2019051313020977485
3424,2019-05-13,나보타균주검증속도대웅제약도둑혐의벗나,http://news.bizwatch.co.kr/article/consumer/2019/05/13/0008/naver
3425,2019-05-13,공시대웅자회사대웅제약주식2만6544주장내취득결정,http://www.newsway.co.kr/news/view?tp=1&ud=2019051313051796548
3426,2019-05-13,대웅제약vs메디톡스보톡스전쟁마침표찍나,http://www.mhj21.com/121261
3427,2019-05-13,메디톡스vs대웅제약보톡스균주진실게임가려지나,http://www.straightnews.co.kr/news/articleView.html?idxno=48541
3428,2019-05-13,대웅50억대웅제약주식취득자회사지분확대,http://www.dailypharm.com/Users/News/NewsView.html?ID=252554&REFERER=NP
3429,2019-05-13,ITC나보타균주정보제출명령메디톡스vs대웅제약,http://medicalworldnews.co.kr/news/view.php?idx=1510930738
3430,2019-05-13,대웅제약메디톡스보툴리눔톡신균주전쟁2라운드,http://www.monews.co.kr/news/articleView.html?idxno=202519
3431,2019-05-13,대웅자회사대웅제약주식50억원규모인수결정,http://yna.kr/AKR20190513088300008?did=1195m
3432,2019-05-13,대웅자회사대웅제약주식2만6455주장내취득결정,http://www.newspim.com/news/view/20190513000606
3433,2019-05-13,대웅자회사대웅제약주식50억규모취득결정,http://news.heraldcorp.com/view.php?ud=20190513000537
3434,2019-05-13,대웅대웅제약주식장내매수결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=354358
3435,2019-05-13,대웅대웅제약주식2만6455주매입,http://www.ceoscoredaily.com/news/article.html?no=55454
3436,2019-05-13,대웅제약메디톡스보톡스균4년공방끝낼까,http://moneys.mt.co.kr/news/mwView.php?no=2019051311058031608
3437,2019-05-13,대웅자회사대웅제약주식50억원규모취득결정,http://www.seoulwire.com/news/articleView.html?idxno=128797
3438,2019-05-13,대웅50억원규모대웅제약주식매입자회사지분확대,https://view.asiae.co.kr/news/view.htm?idxno=2019051313530244693
3439,2019-05-13,대웅대웅제약지분확대지속성장가능성무게”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1754934
3440,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.mediapen.com/news/view/433284
3441,2019-05-13,美ITC대웅제약에나보타균주제출명령,https://www.hankyung.com/article/201905138805f
3442,2019-05-13,보톨리눔균주누가도용했나대웅제약vs메디톡스조사본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2019051300128
3443,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230381
3444,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.newsway.co.kr/news/view?tp=1&ud=2019051313580099632
3445,2019-05-13,대웅50억원규모대웅제약주식매입,http://www.edaily.co.kr/news/newspath.asp?newsid=03230806622488592
3446,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.wsobi.com/news/articleView.html?idxno=73469
3447,2019-05-13,대웅대웅제약주식2만6455주매입윤재춘대표나보타미국진출등성장기대,http://biz.chosun.com/site/data/html_dir/2019/05/13/2019051301402.html
3448,2019-05-13,대웅대웅제약주식2만6455주매입지분확대,http://www.ebn.co.kr/news/view/984577
3449,2019-05-13,대웅자회사대웅제약주식26만주매입,http://news.mt.co.kr/mtview.php?no=2019051314145538011
3450,2019-05-13,㈜대웅대웅제약2만6455주매입나보타수출기대커,http://www.metroseoul.co.kr/news/newsview?newscd=2019051300140
3451,2019-05-13,대웅자회사지분늘려지속성장박차대웅제약주식2만6455주매입,http://kpenews.com/View.aspx?No=33224
3452,2019-05-13,대웅제약vs메디톡스보톡스원료공방美ITC조사본격화,http://www.etnews.com/20190513000419
3453,2019-05-13,대웅제약나보타15일美전격출시보톡스보다가격경쟁력우위,http://news1.kr/articles/?3619935
3454,2019-05-13,㈜대웅대웅제약주식50억원규모매입자회사지분확대차원”,http://www.viva100.com/main/view.php?key=20190513010003885
3455,2019-05-13,대웅대웅제약주식50억원규모인수결정”,https://www.sedaily.com/NewsView/1VJ4JLZB8S
3456,2019-05-13,대웅vs메디톡스보톡스논란미국서증거제출명령,http://www.kukinews.com/news/article.html?no=661642
3457,2019-05-13,대웅자회사대웅제약주식50억어치매입,http://www.medisobizanews.com/news/articleView.html?idxno=59706
3458,2019-05-13,대웅50억원규모대웅제약주식매입자회사지분확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051314184722022
3459,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://kormedi.com/?p=1292700
3460,2019-05-13,대웅제약주식매입한지주사대웅지속성장가능성확신”,http://news.donga.com/3/all/20190513/95499533/1
3461,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://medipana.com/news/news_viewer.asp?NewsNum=238831&MainKind=A&NewsKind=5&vCount=12&vKind=1
3462,2019-05-13,대웅대웅제약주식50억원매입자회사지분확대,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905130474&t=NN
3463,2019-05-13,대웅제약오는15일나보타美론칭ITC조사본격화에찬물,http://biz.newdaily.co.kr/site/data/html/2019/05/13/2019051300139.html
3464,2019-05-13,대웅50억규모대웅제약주식매입,http://www.newstomato.com/ReadNews.aspx?no=894837
3465,2019-05-13,주대웅대웅제약주식50억원어치매입,http://news.mk.co.kr/newsRead.php?year=2019&no=313373
3466,2019-05-13,메디톡스vs대웅제약4년악연美에서곧종지부,http://news.mt.co.kr/mtview.php?no=2019051311200752098
3467,2019-05-13,대웅자회사대웅제약주식50억원어치매입,http://www.newsis.com/view/?id=NISX20190513_0000648888&cID=13001&pID=13000
3468,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.bosa.co.kr/news/articleView.html?idxno=2105030
3469,2019-05-13,대웅대웅제약주식50억원어치매입자회사지분확대,http://www.sisafocus.co.kr/news/articleView.html?idxno=209725
3470,2019-05-13,대웅50억원들여대웅제약주식매입지속성장가능성입증돼,http://www.newspim.com/news/view/20190513000727
3471,2019-05-13,대웅대웅제약주식50억어치매입지분확대,http://www.whosaeng.com/110001
3472,2019-05-13,대웅50억규모대웅제약주식매입,http://www.newsprime.co.kr/news/article.html?no=459487
3473,2019-05-13,대웅제약메디톡스보톡스공방美ITC조사본격화,https://cnbc.sbs.co.kr/article_hub/10000941246?division=NAVER
3474,2019-05-13,대웅대웅제약주식2만6455주매입자회사지분확대,http://www.newsprime.co.kr/news/article.html?no=459500
3475,2019-05-13,종근당대웅제약올해굿스타트,http://www.ebn.co.kr/news/view/984587
3476,2019-05-13,종목썰쩐대웅제약메디톡스공방종지부드디어유전체분석실시,https://www.hankyung.com/article/2019051399536
3477,2019-05-13,대웅제약vs메디톡스나보타균주분쟁새국면ITC자료제출하라,http://www.asiatime.co.kr/news/articleView.html?idxno=245190
3478,2019-05-13,대웅대웅제약주식50억원어치매입,http://www.kpanews.co.kr/article/show.asp?idx=203859&table=article&category=D
3479,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.economytalk.kr/news/articleView.html?idxno=185346
3480,2019-05-13,대웅제약국내외소송에서나보타균주포자감정,http://www.kpanews.co.kr/article/show.asp?idx=203860&table=article&category=D
3481,2019-05-13,대웅제약vs메디톡스보톡스전쟁2R진짜주인진실공방종지부찍을까,http://www.00news.co.kr/news/articleView.html?idxno=57905
3482,2019-05-13,대웅대웅제약지분확대,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051315512702688&objId=A2019051315512702688&portalCode=naver
3483,2019-05-13,대웅제약메디톡스균주출처공방재점화美ITC조사본격화,http://www.wolyo.co.kr/news/articleView.html?idxno=83868
3484,2019-05-13,대웅대웅제약주식50억어치매입,http://www.rapportian.com/news/articleView.html?idxno=117531
3485,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.asiatime.co.kr/news/articleView.html?idxno=245237
3486,2019-05-13,ITC대웅제약에나보타균주제출요구,http://www.bosa.co.kr/news/articleView.html?idxno=2105031
3487,2019-05-13,미국무역위대웅제약에게나보타균주출처공개해야명령,http://www.businesspost.co.kr/BP?command=article_view&num=127003
3488,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.ekn.kr/news/article.html?no=431721
3489,2019-05-13,대웅제약메디톡스균주전쟁ITC자료제출명령두고동상이몽,http://www.newstomato.com/ReadNews.aspx?no=894907
3490,2019-05-13,장종리포트13일마감대웅주가18300원장마쳐,http://www.anewsa.com/detail.php?number=1740231&thread=10r04
3491,2019-05-13,주대웅대웅제약주식매입통해자회사지분확대나서,http://www.inthenews.co.kr/news/article.html?no=15386
3492,2019-05-13,대웅 대웅제약주식26455주매입자회사지분확대,http://www.businesskorea.co.kr/news/articleView.html?idxno=31765
3493,2019-05-13,대웅대웅제약주식매입자회사지분확대,http://www.ajunews.com/view/20190513162801829
3494,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://daily.hankooki.com/lpage/ittech/201905/dh20190513163731145630.htm
3495,2019-05-13,대웅제약美ITC균주증거수집절차성실히임할것,http://www.ekn.kr/news/article.html?no=431754
3496,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.dailian.co.kr/news/view/795030/?sc=naver
3497,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55276
3498,2019-05-13,대웅제약VS메디톡스보톡스공방끝낼까,https://www.sedaily.com/NewsView/1VJ4L2DRD1
3499,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.medigatenews.com/news/3376551755
3500,2019-05-13,메디톡스vs대웅제약보톡스전쟁미국서크게붙었다,http://www.insightkorea.co.kr//news/articleView.html?idxno=36493
3501,2019-05-13,대웅제약과메디톡스자사주취득하며기싸움,http://www.mhj21.com/121276
3502,2019-05-13,메디톡스vs대웅보톡스전쟁유전자분석으로결판,https://www.hankyung.com/article/2019051307301
3503,2019-05-13,대웅대웅제약주식매입통한자회사지분확대,http://www.wolyo.co.kr/news/articleView.html?idxno=83909
3504,2019-05-13,13일마감정보대웅18300원마감,http://www.gokorea.kr/news/articleView.html?idxno=188561
3505,2019-05-13,대웅제약메디톡스보톡스대전,https://www.nocutnews.co.kr/news/5149916
3506,2019-05-13,대웅대웅제약주식2만6455주매입,http://www.dailysmart.co.kr/news/articleView.html?idxno=10703
3507,2019-05-13,대웅제약나보타균주출처논란종지부찍을것,http://www.newspost.kr/news/articleView.html?idxno=71275
3508,2019-05-13,전승호메디톡스공세뚫고대웅제약나보타미국수출이뤄낼까,http://www.businesspost.co.kr/BP?command=article_view&num=127039
3509,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.econovill.com/news/articleView.html?idxno=362988
3510,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.getnews.co.kr/view.php?ud=20190513183922157541d0c69529_16
3511,2019-05-13,대웅대웅제약주식50억어치매입성장가능성입증하고있어,http://www.businesspost.co.kr/BP?command=article_view&num=127067
3512,2019-05-13,대웅제약나보타균주공개명령에주가급락,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051319033003622&objId=A2019051319033003622&portalCode=naver
3513,2019-05-13,메디톡스대웅제약美보톡스소송전본격화,http://www.segye.com/content/html/2019/05/13/20190513511513.html?OutUrl=naver
3514,2019-05-13,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.lawissue.co.kr/view.php?ud=201905132150247842d7f4c63cc6_12
3515,2019-05-13,대웅제약vs메디톡스나보타분쟁엔드게임자사주취득氣싸움,http://www.upinews.kr/news/newsview.php?ncode=1065615403604769
3516,2019-05-13,대웅제약국내외소송에서메디톡스균주포자감정을통해허위주장입증확신,http://www.lawissue.co.kr/view.php?ud=201905132308018879d7f4c63cc6_12
3517,2019-05-13,미국국제무역위원회ITC대웅제약은나보타균주를오는15일까지메디톡스가지정한전문가에게제출하라”,http://www.lawissue.co.kr/view.php?ud=201905132321128972d7f4c63cc6_12
3518,2019-05-14,ITC보톡스공방증거제출명령메디톡스대웅제약소송본격화,http://www.hankookilbo.com/news/npath/201905131641756632?did=NA
3519,2019-05-14,㈜대웅대웅제약주식2만6455주매입,http://www.sisaon.co.kr/news/articleView.html?idxno=93640
3520,2019-05-14,메디톡스대웅제약보툴리눔균주논란이번엔끝장보나,http://www.rapportian.com/news/articleView.html?idxno=117538
3521,2019-05-14,대웅제약나보타출시는계획대로KTB증권,http://www.newstomato.com/ReadNews.aspx?no=894979
3522,2019-05-14,대웅제약16일기업설명회개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755266
3523,2019-05-14,대웅대웅제약주식2만6455주매입,http://www.kukinews.com/news/article.html?no=661904
3524,2019-05-14,대웅대웅제약주식매입통한자회사지분확대,http://www.bokuennews.com/news/article.html?no=175548
3525,2019-05-14,대웅제약균주제출위해메디톡스와조율중적법성증명할것,http://moneys.mt.co.kr/news/mwView.php?no=2019051409348025119
3526,2019-05-14,대웅제약메디톡스와보톨리눔균주정밀비교분석진행예정,http://www.econovill.com/news/articleView.html?idxno=363014
3527,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석할것,http://www.dailian.co.kr/news/view/795131/?sc=naver
3528,2019-05-14,주식종목14일대웅거래가격18550원,http://www.anewsa.com/detail.php?number=1742105&thread=10r02
3529,2019-05-14,대웅제약ITC소송의증거수집절차를통해균주정밀비교분석진행예정,http://www.sisafocus.co.kr/news/articleView.html?idxno=209771
3530,2019-05-14,5월14일대웅오늘시세및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=189375
3531,2019-05-14,대웅제약ITC 소송의증거수집절차를통해균주정밀비교분석진행예정 ,http://www.fetv.co.kr/news/article.html?no=28302
3532,2019-05-14,​대웅제약ITC증거수집절차서균주정밀비교분석진행,http://medipana.com/news/news_viewer.asp?NewsNum=238872&MainKind=A&NewsKind=5&vCount=12&vKind=1
3533,2019-05-14,대웅제약ITC증거수집절차통해균주정밀비교분석예정,http://news.mk.co.kr/newsRead.php?year=2019&no=314989
3534,2019-05-14,㈜대웅대웅제약주식매입통한자회사지분확대,http://www.ftoday.co.kr/news/articleView.html?idxno=108584
3535,2019-05-14,대웅제약목표가24만원신규제시전일종가17만4000원메리츠證,http://www.newspim.com/news/view/20190514000326
3536,2019-05-14,퀵리포트대웅제약매수목표가24만원신규제시메리츠證,http://www.itooza.com/common/iview.php?no=2019051409581814504
3537,2019-05-14,대웅나보타와메디톡스균주비교통해적법성증명,http://www.dailypharm.com/Users/News/NewsView.html?ID=252585&REFERER=NP
3538,2019-05-14,대웅제약ITC소송서양사균주비교분석할것,http://www.newspim.com/news/view/20190514000318
3539,2019-05-14,대웅제약ITC증거수집절차통해균주정밀비교분석진행,http://www.ekn.kr/news/article.html?no=431847
3540,2019-05-14,다시불붙은보톡스전쟁대웅제약도메디톡스균주제공요구맞불,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755334
3541,2019-05-14,대웅제약메디톡스와나보타균주정밀비교할것,http://www.metroseoul.co.kr/news/newsview?newscd=2019051400040
3542,2019-05-14,대웅제약나보타균주정밀비교분석하겠다,http://www.medisobizanews.com/news/articleView.html?idxno=59720
3543,2019-05-14,대웅제약ITC결정따라메디톡스에균주제출키로,https://www.sedaily.com/NewsView/1VJ50KF1I6
3544,2019-05-14,대웅제약메디톡스와나보타균주정밀비교분석할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2019051410312705125
3545,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230411
3546,2019-05-14,대웅제약ITC소송증거수집절차로균주정밀비교분석예정,http://www.asiatime.co.kr/news/articleView.html?idxno=245401
3547,2019-05-14,대웅제약ITC소송의증거수집절차진행균주정밀비교분석할것,http://www.segye.com/content/html/2019/05/14/20190514505165.html?OutUrl=naver
3548,2019-05-14,대웅제약메디톡스균주도전문가들검증대상,http://news.mt.co.kr/mtview.php?no=2019051409343028000
3549,2019-05-14,대웅제약주가5월14일현재177500원,http://www.gokorea.kr/news/articleView.html?idxno=189525
3550,2019-05-14,대웅제약美ITC에균주제출메디톡스와결착짓는다,http://www.inews24.com/view/1178594
3551,2019-05-14,실시간분석대웅제약31상승증권사목표가24만원제시,http://www.itooza.com/common/iview.php?no=2019051411173017137
3552,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석진행예정,http://www.mdtoday.co.kr/mdtoday/index.html?no=354451
3553,2019-05-14,대웅제약메디톡스균주와나보타균주정밀비교분석진행,http://www.ceoscoredaily.com/news/article.html?no=55518
3554,2019-05-14,대웅제약오늘주식장14일현재179000원,http://www.nbntv.co.kr/news/articleView.html?idxno=357149
3555,2019-05-14,대웅제약vs메디톡스균주전쟁포자생성여부가관건,http://www.newsis.com/view/?id=NISX20190514_0000649993&cID=13001&pID=13000
3556,2019-05-14,대웅제약ITC소송통해메디톡스주장허구성입증자신,http://www.rapportian.com/news/articleView.html?idxno=117543
3557,2019-05-14,대웅제약메디톡스균주요청정밀비교분석진행예정,http://www.ajunews.com/view/20190514114642438
3558,2019-05-14,대웅메디톡스균주와정밀비교분석진행,http://www.dailymedi.com/detail.php?number=843020&thread=22r05
3559,2019-05-14,대웅제약메디톡스균주받아포자형성여부비교할것,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068236
3560,2019-05-14,나보타분쟁재점화메디톡스대웅제약입장차여전,http://www.shinailbo.co.kr/news/articleView.html?idxno=1166840
3561,2019-05-14,대웅제약ITC소송의증거수집절차통해균주정밀비교분석진행예정,http://www.wsobi.com/news/articleView.html?idxno=73529
3562,2019-05-14,ET투자뉴스대웅제약_상장주식수대비거래량은037로적정수준,http://www.etnews.com/20190514000236
3563,2019-05-14,대웅제약균주정밀분석통해나보타적법성증명할것,http://www.viva100.com/main/view.php?key=20190514010004237
3564,2019-05-14,대웅제약ITC소송의증거수집절차를통해균주정밀비교분석진행예정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55294
3565,2019-05-14,증시상황실식량보다는개성공단대웅제약메디톡스균주공방,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003585493
3566,2019-05-14,대웅제약메디톡스균주제공받아정밀비교분석진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051412560851745
3567,2019-05-14,대웅제약ITC증거수집절차통해균주비교분석예정메디톡스대웅제약소송본격화,http://biz.chosun.com/site/data/html_dir/2019/05/14/2019051401595.html
3568,2019-05-14,대웅제약메디톡스균주비교해적법성증명,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051413473402069&objId=A2019051413473402069&portalCode=naver
3569,2019-05-14,대웅메디톡스벌이는美ITC소송경과에아전인수해석난무,http://news.mk.co.kr/newsRead.php?year=2019&no=315950
3570,2019-05-14,대웅제약메디톡스머리맞대긴하는데,http://www.bosa.co.kr/news/articleView.html?idxno=2105100
3571,2019-05-14,대웅제약메디톡스보톡스균주포자감정앞두고공방전포자생성여부가관건,http://www.ezyeconomy.com/news/articleView.html?idxno=90600
3572,2019-05-14,대웅제약포자검증vs메디톡스염기서열분석균주전쟁결판,http://www.newsis.com/view/?id=NISX20190514_0000650228&cID=13001&pID=13000
3573,2019-05-14,대웅제약안구건조증치료제임상3상진입해성공기대높여,http://www.businesspost.co.kr/BP?command=article_view&num=127188
3574,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석할것,http://www.seoulwire.com/news/articleView.html?idxno=129890
3575,2019-05-14,대웅제약ITC소송증거수집절차통해균주정밀비교분석진행예정,http://www.etnews.com/20190514000431
3576,2019-05-14,대웅제약메디톡스주장허구밝힌다,http://www.whosaeng.com/110037
3577,2019-05-14,나보타적법성증명할것”대웅제약ITC소송서균주비교진행,http://www.inthenews.co.kr/news/article.html?no=15419
3578,2019-05-14,장종리포트대웅주가18900원마감해,http://www.anewsa.com/detail.php?number=1743443&thread=10r04
3579,2019-05-14,대웅제약반격우리도메디톡스균주받아분석하겠다,http://news1.kr/articles/?3621204
3580,2019-05-14,대웅제약vs메디톡스균주출처논란美ITC개입으로재점화,http://www.wikileaks-kr.org/news/articleView.html?idxno=55321
3581,2019-05-14,메디톡스대웅제약보톡스전쟁종지부찍나,http://www.kpinews.co.kr/news/articleView.html?idxno=96206
3582,2019-05-14,대웅제약ITC소송의증거수집절차로균주정밀비교분석진행예정,http://www.newscj.com/news/articleView.html?idxno=631756
3583,2019-05-14,대웅제약ITC소송의증거수집절차를통해균주정밀비교분석진행예정,http://www.lawissue.co.kr/view.php?ud=201905142231221751d7f4c63cc6_12
3584,2019-05-15,제10대포항전문건설전기협의회회장진명주대웅기전대표선임,http://www.kyongbuk.co.kr/news/articleView.html?idxno=2002393
3585,2019-05-15,대웅제약ITC소송위해증거수집균주정밀비교예정,http://www.kpanews.co.kr/article/show.asp?idx=203915&table=article&category=D
3586,2019-05-15,정현호메디톡스대표대웅제약균주출처논란에로또6번당첨확률”반박,http://www.ajunews.com/view/20190514152755658
3587,2019-05-15,대웅제약나보타미국시장출격소송영향無,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068270
3588,2019-05-15,대웅보툴리눔톡신글로벌시장본격공략,http://www.dailypharm.com/Users/News/NewsView.html?ID=252625&REFERER=NP
3589,2019-05-15,이온바이오파마CEO영입대웅나보타치료사업본격화,http://medipana.com/news/news_viewer.asp?NewsNum=238929&MainKind=A&NewsKind=5&vCount=12&vKind=1
3590,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략,http://www.ebn.co.kr/news/view/984906
3591,2019-05-15,대웅제약보툴리눔톡신글로벌시장본격공략,http://www.sisafocus.co.kr/news/articleView.html?idxno=209887
3592,2019-05-15,대웅제약나보타치료적응증사업착수글로벌3조시장공략,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755755
3593,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략차세대성장동력될것,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=531526
3594,2019-05-15,대웅제약나보타치료적응증사업확대,http://moneys.mt.co.kr/news/mwView.php?no=2019051509068017437
3595,2019-05-15,대웅제약 보툴리눔톡신글로벌치료시장본격공략  ,http://www.fetv.co.kr/news/article.html?no=28407
3596,2019-05-15,대웅대웅제약주식매입자회사지분확대,http://www.monews.co.kr/news/articleView.html?idxno=202541
3597,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업착수,http://www.dailian.co.kr/news/view/795442/?sc=naver
3598,2019-05-15,대웅제약美파트너사새CEO영입나보타글로벌치료사업탄력,http://www.medisobizanews.com/news/articleView.html?idxno=59747
3599,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.newsway.co.kr/news/view?tp=1&ud=2019051509251432904
3600,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230460
3601,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업본격화,http://www.seoulwire.com/news/articleView.html?idxno=130341
3602,2019-05-15,대웅제약보툴리눔톡신치료시장공략본격화,http://news.mt.co.kr/mtview.php?no=2019051509111078421
3603,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.ekn.kr/news/article.html?no=432042
3604,2019-05-15,대웅제약톡신해외치료시장공략美파트너사신규CEO선임,http://www.newspim.com/news/view/20190515000283
3605,2019-05-15,대웅제약보툴리눔톡신의글로벌치료적응증사업본격화,http://www.inthenews.co.kr/news/article.html?no=15437
3606,2019-05-15,대웅제약미국파트너사치료용나보타개발위해앨러간출신CEO영입,http://news.mk.co.kr/newsRead.php?year=2019&no=317951
3607,2019-05-15,대웅제약보툴리눔톡신글로벌시장본격공략,http://www.koreaittimes.com/news/articleView.html?idxno=90777
3608,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.wolyo.co.kr/news/articleView.html?idxno=84053
3609,2019-05-15,아통증시15일대웅주가19000원,http://www.anewsa.com/detail.php?number=1745197&thread=10r02
3610,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업본격착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=354579
3611,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.ceoscoredaily.com/news/article.html?no=55573
3612,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.econovill.com/news/articleView.html?idxno=363109
3613,2019-05-15,5월15일대웅주식시세현황07919050원,http://www.nbntv.co.kr/news/articleView.html?idxno=358890
3614,2019-05-15,대웅제약국내외소송서메디톡스허위주장입증확신,http://www.skyedaily.com/news/news_view.html?ID=84721
3615,2019-05-15,대웅제약치료용보툴리눔톡신시장공략본격화,http://www.newsis.com/view/?id=NISX20190515_0000651212&cID=13001&pID=13000
3616,2019-05-15,대웅제약질병치료용보툴리눔톡신사업본격화,http://yna.kr/AKR20190515050800017?did=1195m
3617,2019-05-15,대웅제약나보타글로벌치료적응증사업본격착수,http://www.dailysmart.co.kr/news/articleView.html?idxno=10812
3618,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.bokuennews.com/news/article.html?no=175637
3619,2019-05-15,대웅이온바이오파마엘러간출신CEO선임,http://www.dailymedi.com/detail.php?number=843056&thread=22r05
3620,2019-05-15,대웅제약3조규모치료적응증시장진출착수,http://biz.chosun.com/site/data/html_dir/2019/05/15/2019051500946.html
3621,2019-05-15,메디톡스ITC행정명령대웅제약나보타균주에만해당,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230474
3622,2019-05-15,대웅제약나보타글로벌치료적응증사업본격화,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051510432301411&objId=A2019051510432301411&portalCode=naver
3623,2019-05-15,균주기원논란대웅제약의무리한아전인수해석눈쌀,http://www.edaily.co.kr/news/newspath.asp?newsid=03014326622489248
3624,2019-05-15,메디톡스대웅의균주요청여부는우리가결정할일”,http://www.whosaeng.com/110061
3625,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략실시,http://www.asiatime.co.kr/news/articleView.html?idxno=245641
3626,2019-05-15,대웅제약보툴리눔톡신치료시장공략,http://www.seoulfn.com/news/articleView.html?idxno=342965
3627,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.businesskorea.co.kr/news/articleView.html?idxno=31843
3628,2019-05-15,메디톡스ITC행정명령은대웅제약만해당우리는균주제공의무없어,http://www.etoday.co.kr/news/section/newsview.php?idxno=1755906
3629,2019-05-15,대웅제약보툴리눔톡신미용외치료분야공략,http://www.bosa.co.kr/news/articleView.html?idxno=2105159
3630,2019-05-15,대웅제약보툴리눔톡신제제글로벌진출박차,http://www.sisaon.co.kr/news/articleView.html?idxno=93729
3631,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55314
3632,2019-05-15,메디톡스美ITC행정명령대웅제약나보타균주만해당,http://www.medisobizanews.com/news/articleView.html?idxno=59758
3633,2019-05-15,뉴스투데이L대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.news2day.co.kr/127211
3634,2019-05-15,대웅제약질병치료용보툴리눔톡신사업본격화,http://www.dt.co.kr/contents.html?article_no=2019051502109931102001&ref=naver
3635,2019-05-15,메디톡스ITC의행정명령은대웅제약나보타균주에만해당,http://www.sisafocus.co.kr/news/articleView.html?idxno=209906
3636,2019-05-15,5월15일대웅제약증권매매173000원226,http://www.nbntv.co.kr/news/articleView.html?idxno=359378
3637,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략,https://view.asiae.co.kr/news/view.htm?idxno=2019051511510525806
3638,2019-05-15,메디톡스ITC증거제출명령은대웅제약에만해당된다반박,http://www.metroseoul.co.kr/news/newsview?newscd=2019051500098
3639,2019-05-15,대웅제약나보타치료적응증확대잰걸음,http://www.whosaeng.com/110074
3640,2019-05-15,메디톡스ITC행정명령은대웅제약나보타균주에만해당”,http://www.mdtoday.co.kr/mdtoday/index.html?no=354600
3641,2019-05-15,대웅제약나보타미용이외치료시장확대추진,http://www.rapportian.com/news/articleView.html?idxno=117563
3642,2019-05-15,균주출처2라운드대웅제약균주강제제출한다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051510571568021
3643,2019-05-15,메디톡스美ITC증거제출명령은대웅제약에만해당,http://news.mk.co.kr/newsRead.php?year=2019&no=318820
3644,2019-05-15,대웅제약미국파트너사가새CEO영입해나보타치료시장공략,http://www.businesspost.co.kr/BP?command=article_view&num=127346
3645,2019-05-15,대웅제약나보타글로벌치료적응증사업착수,http://www.newstomato.com/ReadNews.aspx?no=895328
3646,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장공략한다,http://www.medigatenews.com/news/690703760
3647,2019-05-15,상승세타던대웅제약나보타균주싸움으로삐끗,http://www.ajunews.com/view/20190515135838571
3648,2019-05-15,대웅제약질병치료용보툴리눔톡신사업본격화,http://www.asiatoday.co.kr/view.php?key=20190515010009170
3649,2019-05-15,대웅한올안구건조증치료제미국임상3상돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=04142646622489248
3650,2019-05-15,대웅제약한올바이오파마5조원안구건조증시장도전,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905150341&t=NN
3651,2019-05-15,메디톡스ITC의행정명령은대웅제약나보타균주에만해당되는것,http://www.lawissue.co.kr/view.php?ud=201905151449028349d7f4c63cc6_12
3652,2019-05-15,대웅제약글로벌치료용보톨리눔톡신사업본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2019051500106
3653,2019-05-15,대웅제약보툴리눔톡신나보타치료용으로사용범위확대,http://www.ezyeconomy.com/news/articleView.html?idxno=90640
3654,2019-05-15,대웅제약보툴리눔톡신글로벌치료적응증사업착수,http://www.newsprime.co.kr/news/article.html?no=459850
3655,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.economytalk.kr/news/articleView.html?idxno=185550
3656,2019-05-15,15일대웅주가18950원으로장마감,http://www.anewsa.com/detail.php?number=1747266&thread=10r04
3657,2019-05-15,대웅제약나보타치료적응증시장진출본격화,http://www.viva100.com/main/view.php?key=20190515010004947
3658,2019-05-15,메디톡스ITC의행정명령은대웅제약나보타균주만해당되는것,http://www.ceoscoredaily.com/news/article.html?no=55629
3659,2019-05-15,대웅1분기연결영업이익258억전년비38↑,http://www.newspim.com/news/view/20190515002067
3660,2019-05-15,실적속보대웅1Q영업이익258억전년비38↑,http://www.itooza.com/common/iview.php?no=2019051516552163044
3661,2019-05-15,대웅제약1분기연결영업이익126억전년비135↑,http://www.newspim.com/news/view/20190515002132
3662,2019-05-15,실적속보대웅제약1Q영업이익126억전년비135↑,http://www.itooza.com/common/iview.php?no=2019051517030012075
3663,2019-05-15,전승호대웅제약나보타잇는신약으로폐섬유증치료제힘쏟아,http://www.businesspost.co.kr/BP?command=article_view&num=127377
3664,2019-05-15,대웅제약치료용보툴리눔톡신사업추진美파트너사새CEO선임,http://news.donga.com/3/all/20190515/95539770/1
3665,2019-05-15,공시봇대웅제약최대주주지분020증가,http://www.ajunews.com/view/20190515171370877
3666,2019-05-15,대웅제약보툴리눔톡신치료시장공략 ,http://www.monews.co.kr/news/articleView.html?idxno=202566
3667,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.getnews.co.kr/view.php?ud=20190515180425728341d0c69529_16
3668,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.lawissue.co.kr/view.php?ud=201905152231201632d7f4c63cc6_12
3669,2019-05-15,대웅제약보툴리눔톡신글로벌치료시장본격공략,http://www.newswatch.kr/news/articleView.html?idxno=19570
3670,2019-05-16,ITC행정명령두고해석분분대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510930769
3671,2019-05-16,대웅제약보툴리눔톡신나보타치료적응증획득채비,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068288
3672,2019-05-16,대웅제약보툴리눔톡신제제주보미국공식발매,https://www.hankyung.com/article/2019051606206
3673,2019-05-16,대웅제약보툴리눔톡신미국공식발매최대시장공략,http://www.metroseoul.co.kr/news/newsview?newscd=2019051600004
3674,2019-05-16,대웅제약보툴리눔톡신美출시FDA승인4개월만에쾌거,http://www.medisobizanews.com/news/articleView.html?idxno=59772
3675,2019-05-16,대웅제약보툴리눔톡신나보타美공식발매,http://www.biospectator.com/view/news_view.php?varAtcId=7646
3676,2019-05-16,대웅제약나보타미국현지서공식출시돼,http://news.mk.co.kr/newsRead.php?year=2019&no=320767
3677,2019-05-16,대웅제약보툴리눔톡신나보타미국공식발매,http://www.econovill.com/news/articleView.html?idxno=363195
3678,2019-05-16,대웅제약보툴리눔톡신주보美출시,http://www.edaily.co.kr/news/newspath.asp?newsid=01899126622489576
3679,2019-05-16,대웅보톨리눔톡신나보타美공식발매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85702
3680,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.fetv.co.kr/news/article.html?no=28525
3681,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.sentv.co.kr/news/view/553722
3682,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.ekn.kr/news/article.html?no=432295
3683,2019-05-16,대웅제약보툴리눔톡신나보타美발매,http://news.mt.co.kr/mtview.php?no=2019051608223729075
3684,2019-05-16,대웅제약보툴리눔톡신주보미국공식출시,http://www.fnnews.com/news/201905160834037395
3685,2019-05-16,대웅제약나보타美공식출시,http://www.newsis.com/view/?id=NISX20190516_0000652332&cID=13001&pID=13000
3686,2019-05-16,대웅제약보툴리눔톡신주보미국출시최대시장공략,http://www.newspim.com/news/view/20190516000175
3687,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.bosa.co.kr/news/articleView.html?idxno=2105230
3688,2019-05-16,대웅제약보툴리눔톡신나보타주보미국공식발매,http://www.inthenews.co.kr/news/article.html?no=15473
3689,2019-05-16,대웅제약보툴리눔톡신주보미국공식발매,http://www.ajunews.com/view/20190516084748137
3690,2019-05-16,대웅제약보툴리눔톡신주보美출시2조시장공략자신”,http://www.viva100.com/main/view.php?key=20190516010005051
3691,2019-05-16,대웅제약보툴리눔톡신미국발매세계최대시장공략,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230535
3692,2019-05-16,대웅제약보툴리눔톡신주보미국공식출시,http://www.rpm9.com/news/article.html?id=20190516090007
3693,2019-05-16,대웅제약주보미국공식발매‥세계최대톡신시장공략,http://medipana.com/news/news_viewer.asp?NewsNum=239019&MainKind=A&NewsKind=5&vCount=12&vKind=1
3694,2019-05-16,대웅제약나보타미공식출시,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=52837
3695,2019-05-16,대웅제약보툴리눔톡신美공식발매현지파트너사에볼루스통해,http://news.mk.co.kr/newsRead.php?year=2019&no=320941
3696,2019-05-16,대웅제약나보타美공식발매세계최대톡신시장공략,http://news1.kr/articles/?3622651
3697,2019-05-16,대웅제약국내첫보툴리눔톡신주보미국출시,https://www.sedaily.com/NewsView/1VJ5WPKD2X
3698,2019-05-16,대웅제약보툴리눔톡신나보타미국공식발매,http://yna.kr/AKR20190516045300017?did=1195m
3699,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.ceoscoredaily.com/news/article.html?no=55657
3700,2019-05-16,대웅제약미국서보툴리눔톡신주보공식발매,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019051608261316026
3701,2019-05-16,대웅제약디엔컴퍼니성년x부부의날셀리시스EX제안,http://www.thekpm.com/view.php?ud=2019051609351944124506bdf1_17
3702,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.newsway.co.kr/news/view?tp=1&ud=2019051609323161240
3703,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.asiatoday.co.kr/view.php?key=20190516010009653
3704,2019-05-16,대웅제약보톡스주보美출시본격매출발생,http://www.dailypharm.com/Users/News/NewsView.html?ID=252679&REFERER=NP
3705,2019-05-16,대웅제약보툴리눔톡신나보타美공식발매,http://www.seoulwire.com/news/articleView.html?idxno=131390
3706,2019-05-16,대웅주가정보외증시동향16일현재18650원,http://www.gokorea.kr/news/articleView.html?idxno=192878
3707,2019-05-16,5월16일대웅시세보기15818650원,http://www.nbntv.co.kr/news/articleView.html?idxno=361400
3708,2019-05-16,국내주식시장현황16일대웅증시현황18650원,http://www.anewsa.com/detail.php?number=1748523&thread=10r02
3709,2019-05-16,대웅제약보툴리눔톡신美공식발매,http://www.etoday.co.kr/news/section/newsview.php?idxno=1756397
3710,2019-05-16,대웅제약글로벌시장공략강화현지화로승부수,http://www.newsis.com/view/?id=NISX20190516_0000652542&cID=13001&pID=13000
3711,2019-05-16,대웅제약글로벌시장공략강화현지화로승부한다,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=52845
3712,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.economytalk.kr/news/articleView.html?idxno=185650
3713,2019-05-16,대웅제약1Q영업익135↑RD비3수출30↓,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230549
3714,2019-05-16,대웅제약글로벌리더육성통해현지화전략박차,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230554
3715,2019-05-16,대웅제약나보타미국공식발매국산보톡스중처음,http://www.hankookilbo.com/news/npath/201905161075076559?did=NA
3716,2019-05-16,대웅제약보툴리눔톡신나보타美공식발매,https://view.asiae.co.kr/news/view.htm?idxno=2019051610262427582
3717,2019-05-16,대웅나보타미국시장발매유럽도초읽기,http://www.whosaeng.com/110099
3718,2019-05-16,대웅제약나보타美시장공식출시,http://www.rapportian.com/news/articleView.html?idxno=117580
3719,2019-05-16,대웅제약보툴리눔톡신나보타미국서공식발매,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905160262&t=NN
3720,2019-05-16,대웅제약보툴리눔톡신미국공식발매세계최대톡신시장공략,http://www.etnews.com/20190516000120
3721,2019-05-16,대웅제약5기글로벌우수인재프로그램킥오프글로벌리더육성본격화,http://www.businesskorea.co.kr/news/articleView.html?idxno=31889
3722,2019-05-16,대웅제약보톡스주보미국공식발매,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051610404001337&objId=A2019051610404001337&portalCode=naver
3723,2019-05-16,대웅제약직무전문가현지법인배치로글로벌사업강화,http://medipana.com/news/news_viewer.asp?NewsNum=239037&MainKind=A&NewsKind=5&vCount=12&vKind=1
3724,2019-05-16,대웅제약보툴리눔톡신주보미국공식발매,http://www.bokuennews.com/news/article.html?no=175720
3725,2019-05-16,대웅제약나보타美시장입성국내제약사위상높일것,http://www.dailysmart.co.kr/news/articleView.html?idxno=10897
3726,2019-05-16,대웅제약주보美공식출시,http://www.dt.co.kr/contents.html?article_no=2019051602109931102001&ref=naver
3727,2019-05-16,세계최대톡신시장공략대웅제약보툴리눔톡신美발매,http://www.koreaittimes.com/news/articleView.html?idxno=90801
3728,2019-05-16,대웅제약보툴리눔톡신미국공식출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55343
3729,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55346
3730,2019-05-16,대웅제약글로벌리더육성강화현지화전략에박차,http://www.medisobizanews.com/news/articleView.html?idxno=59784
3731,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.wolyo.co.kr/news/articleView.html?idxno=84176
3732,2019-05-16,대웅제약글로벌리더육성박차5기글로벌우수인재프로그램개시,http://kpenews.com/View.aspx?No=33545
3733,2019-05-16,대웅제약보톡스나보타美공식발매,http://www.kyeongin.com/main/view.php?key=20190516010006689
3734,2019-05-16,대웅제약보툴리눔톡신제제주보미국공식발매,http://www.kukinews.com/news/article.html?no=662833
3735,2019-05-16,대웅제약글로벌리더육성현지화전략박차,http://www.dailymedi.com/detail.php?number=843108&thread=22r05
3736,2019-05-16,대웅글로벌리더육성현지화전략박차,http://www.dailypharm.com/Users/News/NewsView.html?ID=252688&REFERER=NP
3737,2019-05-16,증권플러스대웅제약주가16일현재170000원,http://www.nbntv.co.kr/news/articleView.html?idxno=361881
3738,2019-05-16,대웅제약전일대비약4하락한169500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905160440&t=NN
3739,2019-05-16,대웅제약보툴리눔톡신주보미국공식발매,http://www.newsprime.co.kr/news/article.html?no=460003
3740,2019-05-16,대웅제약자체개발보툴리눔톡신美공식발매,http://www.dailymedi.com/detail.php?number=843115&thread=22r05
3741,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.wsobi.com/news/articleView.html?idxno=73718
3742,2019-05-16,대웅전일대비약5하락한17950원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905160558&t=NN
3743,2019-05-16,대웅제약나보타미국시장공식출시글로벌시장공략박차,http://news.donga.com/3/all/20190516/95554046/1
3744,2019-05-16,대웅제약보툴리눔톡신주보세계최대시장미국서공식발매,http://daily.hankooki.com/lpage/ittech/201905/dh20190516140044145630.htm
3745,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.mdtoday.co.kr/mdtoday/index.html?no=354753
3746,2019-05-16,대웅제약디엔컴퍼니성년x부부의날셀리시스EX제안,http://www.getnews.co.kr/view.php?ud=20190516143315532841d0c69529_16
3747,2019-05-16,대웅제약글로벌리더육성으로현지화전략박차,http://news.donga.com/3/all/20190516/95554972/1
3748,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.ekn.kr/news/article.html?no=432429
3749,2019-05-16,대웅제약나보타미국공식발매글로벌최대시장공략시동,http://www.newstomato.com/ReadNews.aspx?no=895762
3750,2019-05-16,스타★주식인사이드대웅제약주가167500원5월16일14시55분기준,http://www.newsinside.kr/news/articleView.html?idxno=706342
3751,2019-05-16,대웅제약글로벌리더육성현지화전략박차,http://www.ezyeconomy.com/news/articleView.html?idxno=90681
3752,2019-05-16,대웅제약미국에서자체개발보툴리눔톡신공식출시,http://www.businesspost.co.kr/BP?command=article_view&num=127537
3753,2019-05-16,대웅제약미국서보툴리눔톡신주보출시,http://www.finomy.com/news/articleView.html?idxno=65840
3754,2019-05-16,대웅제약우수인재현지법인배치글로벌사업강화,http://www.newsis.com/view/?id=NISX20190516_0000653152&cID=13001&pID=13000
3755,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.medigatenews.com/news/2350349416
3756,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.bosa.co.kr/news/articleView.html?idxno=2105283
3757,2019-05-16,대웅제약보툴리눔톡신나보타미국공식발매,http://www.seoulfn.com/news/articleView.html?idxno=343111
3758,2019-05-16,5월16일장마감주가정보대웅제약169500원,http://www.newsinside.kr/news/articleView.html?idxno=707356
3759,2019-05-16,대웅제약보툴리눔톡신미국공식발매,http://www.wsobi.com/news/articleView.html?idxno=73758
3760,2019-05-16,대웅제약제5기글로벌우수인재프로그램첫발,http://news.mk.co.kr/newsRead.php?year=2019&no=322874
3761,2019-05-16,16일마감주가정보대웅18200원마감,http://www.gokorea.kr/news/articleView.html?idxno=193709
3762,2019-05-16,대웅제약글로벌리더육성으로현지화전략강화,http://www.getnews.co.kr/view.php?ud=20190516170058645641d0c69529_16
3763,2019-05-16,대웅제약글로벌리더육성현지화전략박차,http://www.wolyo.co.kr/news/articleView.html?idxno=84205
3764,2019-05-16,국내최초로미국진출했지만불안한대웅제약주보,https://www.sedaily.com/NewsView/1VJ5Y9AMSD
3765,2019-05-16,대웅제약보툴리눔톡신미국공식발매전세계최대시장공략,http://www.getnews.co.kr/view.php?ud=20190516173928253241d0c69529_16
3766,2019-05-16,대웅제약보톡스주보국내제약사최초美출시,https://www.hankyung.com/article/2019051641751
3767,2019-05-16,대웅제약보툴리눔톡신나보타美공식출시,http://www.sporbiz.co.kr/news/articleView.html?idxno=338121
3768,2019-05-16,대웅제약보툴리눔톡신글로벌시장본격공략,http://www.skyedaily.com/news/news_view.html?ID=84784
3769,2019-05-16,대웅제약현지법인에직무전문가전진배치,http://www.mhj21.com/121345
3770,2019-05-16,대웅제약글로벌리더육성으로현지화전략에박차,http://www.newscj.com/news/articleView.html?idxno=632488
3771,2019-05-16,대웅제약나보타미국공식출시국내보툴리눔톡신최초,http://www.upinews.kr/news/newsview.php?ncode=1065603109746371
3772,2019-05-16,대웅제약나보타미국공식출시파트너사에볼루스통해보툴리눔톡신판매,http://www.econonews.co.kr/news/articleView.html?idxno=65430
3773,2019-05-17,대웅제약글로벌리더육성으로현지화전략에박차,http://www.lawissue.co.kr/view.php?ud=201905162338589449d7f4c63cc6_12
3774,2019-05-17,대웅제약보툴리눔톡신미국공식발매전세계최대톡신시장공략,http://www.lawissue.co.kr/view.php?ud=201905170051451900d7f4c63cc6_12
3775,2019-05-17,대웅제약자체개발보툴리눔톡신제제나보타美공식출시,http://www.dailian.co.kr/news/view/796057/?sc=naver
3776,2019-05-17,더벨대웅제약현지화전략으로2년내100개국진출,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905160100027770001740
3777,2019-05-17,대웅제약메디톡스제품제조허가관련보도전혀연관성없어,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230601
3778,2019-05-17,메디톡신생산공정조작의혹메디톡스대웅제약또충돌,http://www.kukinews.com/news/article.html?no=663130
3779,2019-05-17,제약지주사주수익원은녹십자임대대웅일동용역한미특허,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=531540
3780,2019-05-17,★주식인사이드대웅제약주가168500원5월17일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=709126
3781,2019-05-17,특징주대웅제약나보타판매美파트너사주가하락에약세,http://news.mk.co.kr/newsRead.php?year=2019&no=324008
3782,2019-05-17,대웅제약jTBC의메디톡스허가등관련보도와무관,http://www.medisobizanews.com/news/articleView.html?idxno=59803
3783,2019-05-17,대웅증권주식17일현재17800원,http://www.nbntv.co.kr/news/articleView.html?idxno=363730
3784,2019-05-17,종목추적17일대웅현재주식거래가격17600원,http://www.anewsa.com/detail.php?number=1751638&thread=10r02
3785,2019-05-17,대웅주가및증권시세17일현재17800원,http://www.gokorea.kr/news/articleView.html?idxno=194749
3786,2019-05-17,대웅제약장초반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=354834
3787,2019-05-17,5월17일대웅제약오늘증시265165000원,http://www.nbntv.co.kr/news/articleView.html?idxno=364222
3788,2019-05-17,대웅제약메디톡스또진흙탕싸움균주훔쳐간직원이악성제보,http://www.upinews.kr/news/newsview.php?ncode=1065574179081896
3789,2019-05-17,메디톡스불량보톡스유통의혹폭로출처는대웅제약,http://www.breaknews.com/655311
3790,2019-05-17,대웅자회사대웅제약주식2만9498주50억원에취득,http://www.edaily.co.kr/news/newspath.asp?newsid=02699446622489904
3791,2019-05-17,대웅50억원에대웅제약주식2만9498만주취득,http://news.mt.co.kr/mtview.php?no=2019051712164546376
3792,2019-05-17,공시대웅자회사대웅제약주식50억규모취득,http://www.newsway.co.kr/news/view?tp=1&ud=2019051712172807710
3793,2019-05-17,대웅제약전일대비약4하락한162500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905170411&t=NN
3794,2019-05-17,스타★주식인사이드대웅제약주가163000원5월17일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=710291
3795,2019-05-17,메디톡스대웅제약불량보톡스공방근본원인은보툴리눔균주장기소송,http://www.betanews.net:8080/article/1010103.html
3796,2019-05-17,JTBC보도후대웅제약vs메디톡스신경전격화,http://www.insightkorea.co.kr//news/articleView.html?idxno=36607
3797,2019-05-17,공시대웅자회사대웅제약주식50억규모인수결정,http://www.fnnews.com/news/201905171350498770
3798,2019-05-17,대웅대웅제약주식2만9498주50억에취득결정,https://view.asiae.co.kr/news/view.htm?idxno=2019051713554857612
3799,2019-05-17,대웅제약보툴리눔톡신글로벌치료시장공략,http://www.wsobi.com/news/articleView.html?idxno=73838
3800,2019-05-17,대웅50억원규모대웅제약주식2만9498주취득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1756966
3801,2019-05-17,대웅제약국산미간주름개선주보美출시,http://www.munhwa.com/news/view.html?no=2019051701071827107001
3802,2019-05-17,공시대웅50억규모자회사지분취득,http://www.newsis.com/view/?id=NISX20190517_0000654153&cID=10401&pID=10400
3803,2019-05-17,대웅대웅제약주식2만9498주50억원에취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=354870
3804,2019-05-17,대웅자회사대웅제약주식50억규모취득,http://news.heraldcorp.com/view.php?ud=20190517000440
3805,2019-05-17,메디톡신생산공정조작의혹대웅제약보도와연관없다”,http://www.mdtoday.co.kr/mdtoday/index.html?no=354848
3806,2019-05-17,대웅자회사대웅제약주식50억원규모인수결정,https://www.sedaily.com/NewsView/1VJ6EWK922
3807,2019-05-17,공시대웅자회사대웅제약주식50억원규모취득,http://moneys.mt.co.kr/news/mwView.php?no=2019051715038055160
3808,2019-05-17,대웅자회사대웅제약주식50억원규모인수결정,http://daily.hankooki.com/lpage/ittech/201905/dh20190517150024145630.htm
3809,2019-05-17,장종리포트대웅주가17800원마감,http://www.anewsa.com/detail.php?number=1753672&thread=10r04
3810,2019-05-17,5월17일장마감주가정보대웅제약163500원,http://www.newsinside.kr/news/articleView.html?idxno=711333
3811,2019-05-17,메디톡스대웅제약보톡스전쟁진흙탕싸움되나,http://www.kpinews.co.kr/news/articleView.html?idxno=96439
3812,2019-05-17,17일주가마감정보대웅17800원마감,http://www.gokorea.kr/news/articleView.html?idxno=195605
3813,2019-05-17,대웅제약메디톡스불량보톡스논란으로점유율확대기회잡아,http://www.businesspost.co.kr/BP?command=article_view&num=127771
3814,2019-05-17,대웅제약vs메디톡스균주전쟁최후승자는,http://www.economytalk.kr/news/articleView.html?idxno=185785
3815,2019-05-17,메디톡스토종보톡스메디톡신생산공정서조작의혹제기돼경쟁사대웅제약음해주장,http://www.ntoday.co.kr/news/articleView.html?idxno=66814
3816,2019-05-17,대웅제약보툴리눔톡신미국공식발매,http://www.kpanews.co.kr/article/show.asp?idx=204012&table=article&category=D
3817,2019-05-18,대웅50억규모대웅제약지분취득자회사지분확대위해,http://www.econonews.co.kr/news/articleView.html?idxno=65547
3818,2019-05-18,끝나지않는보톡스전쟁메디톡스대웅제약비방전,http://yna.kr/AKR20190517124300017?did=1195m
3819,2019-05-18,균주도용둘러싼대웅제약메디톡스소송전막바지로치닫나,https://www.sedaily.com/NewsView/1VJ6UL9034
3820,2019-05-19,대웅제약현지화전략일환글로벌리더육성본격화,http://www.viva100.com/main/view.php?key=20190519010005839
3821,2019-05-19,대형제약사1분기실적희비대웅광동만호조,http://www.finomy.com/news/articleView.html?idxno=65887
3822,2019-05-20,대웅제약메디톡스보톡스공방점입가경,http://www.polinews.co.kr/news/article.html?no=393048
3823,2019-05-20,영업활동현금흐름‥유한886억보령229억대웅189억,http://medipana.com/news/news_viewer.asp?NewsNum=239139&MainKind=A&NewsKind=5&vCount=12&vKind=1
3824,2019-05-20,★주식인사이드대웅제약주가161000원5월20일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=714009
3825,2019-05-20,5월20일대웅증권매매11217600원,http://www.nbntv.co.kr/news/articleView.html?idxno=366708
3826,2019-05-20,장중시세20일대웅현재가17550원,http://www.anewsa.com/detail.php?number=1755365&thread=10r02
3827,2019-05-20,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201905201030306265tpgetnews_16
3828,2019-05-20,ET투자뉴스대웅제약바이오시밀러콜레BUY유지NH투자증권,http://www.etnews.com/20190520000058
3829,2019-05-20,메디톡스vs대웅제약화해불가끝까지간다,http://news.mt.co.kr/mtview.php?no=2019051821563573206
3830,2019-05-20,대웅제약주가5월20일현재159500원,http://www.gokorea.kr/news/articleView.html?idxno=197128
3831,2019-05-20,대웅제약배당주식20일현재158500원,http://www.nbntv.co.kr/news/articleView.html?idxno=367213
3832,2019-05-20,스타★주식인사이드대웅제약주가158500원5월20일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=715840
3833,2019-05-20,대웅제약보툴리눔톡신美공식발매세계최대시장공략,http://news.heraldcorp.com/view.php?ud=20190520000652
3834,2019-05-20,장마감보고서20일대웅주가17550원으로장마감,http://www.anewsa.com/detail.php?number=1757632&thread=10r04
3835,2019-05-20,5월20일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=716873
3836,2019-05-20,대웅제약전승호글로벌시장공략강화2년내100개국진출자신,http://www.newsway.co.kr/news/view?tp=1&ud=2019052015441656195
3837,2019-05-20,20일마감주가정보대웅주가17550원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=197844
3838,2019-05-20,대웅제약메디톡스톡신공방이르면12월판가름,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019052016471145051
3839,2019-05-20,대웅제약보툴리눔톡신주보미국공략가속화한다,http://www.wikileaks-kr.org/news/articleView.html?idxno=55863
3840,2019-05-20,대웅메디톡스ITC서균주제출요청받아메디톡스법적강제력없어,http://news.mk.co.kr/newsRead.php?year=2019&no=331592
3841,2019-05-20,메디톡스검정통과위해불량제품바꿔치기의혹메디톡스대웅제약악의적행위,http://www.betanews.net:8080/article/1010849.html
3842,2019-05-21,ET투자뉴스대웅_거래비중기관3201외국인1705,http://www.etnews.com/20190521000022
3843,2019-05-21,제약업종주요종목오전시황1위씨케이에이치14432위서울제약3933위대웅제약385,http://www.anewsa.com/detail.php?number=1758512&thread=10r04
3844,2019-05-21,★주식인사이드대웅제약주가162500원5월21일9시17분기준,http://www.newsinside.kr/news/articleView.html?idxno=718650
3845,2019-05-21,대웅주식시세현황21일현재18400원,http://www.nbntv.co.kr/news/articleView.html?idxno=369118
3846,2019-05-21,주식실황21일대웅주가18350원,http://www.anewsa.com/detail.php?number=1758600&thread=10r02
3847,2019-05-21,대웅5이상상승주가반등시도단기이평선역배열구간,https://www.hankyung.com/article/201905217215L
3848,2019-05-21,대웅제약5이상상승외국인기관각각4일연속순매수4일연속순매도,https://www.hankyung.com/article/201905217249L
3849,2019-05-21,5월21일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=199073
3850,2019-05-21,대웅제약주식시세현황21일현재162000원,http://www.nbntv.co.kr/news/articleView.html?idxno=369622
3851,2019-05-21,대웅제약신약개발파이프라인통해넥스트나보타연구박차,http://www.ajunews.com/view/20190521110313510
3852,2019-05-21,대웅제약대웅RD위원회글로벌연구개발성과기대,http://www.betanews.net:8080/article/1011230.html
3853,2019-05-21,대웅제약APA항궤양제안구건조증치료제임상3상순항,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230734
3854,2019-05-21,대웅제약전승호사장난치성치료제개발주력넥스트나보타준비,http://biz.chosun.com/site/data/html_dir/2019/05/21/2019052101216.html
3855,2019-05-21,대웅RD위원회글로벌연구개발성과기대”,http://www.econovill.com/news/articleView.html?idxno=363558
3856,2019-05-21,대웅제약신약개발잘나갑니다,http://www.medisobizanews.com/news/articleView.html?idxno=59879
3857,2019-05-21,대웅RD위원회글로벌연구개발씽크탱크,http://www.dailypharm.com/Users/News/NewsView.html?ID=252851&REFERER=NP
3858,2019-05-21,스타★주식인사이드대웅제약주가162500원5월21일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=719787
3859,2019-05-21,대웅제약신약개발순항中넥스트나보타성과기대,http://www.viva100.com/main/view.php?key=20190521010006689
3860,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.bosa.co.kr/news/articleView.html?idxno=2105556
3861,2019-05-21,대웅RD위원회신약개발현황보고항궤양제안구건조증섬유증치료제임상순항,http://www.ezyeconomy.com/news/articleView.html?idxno=90813
3862,2019-05-21,대웅제약RD위원회글로벌도전약물나온다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019052113280389320
3863,2019-05-21,대웅제약글로벌신약연구개발어디까지왔나,http://medipana.com/news/news_viewer.asp?NewsNum=239275&MainKind=A&NewsKind=5&vCount=12&vKind=1
3864,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.etnews.com/20190521000200
3865,2019-05-21,대웅제약난치질환치료제로넥스트나보타준비,http://www.metroseoul.co.kr/news/newsview?newscd=2019052100112
3866,2019-05-21,대웅제약난치성질환치료제개발박차RD위원회글로벌연구개발성과기대,http://kpenews.com/View.aspx?No=33870
3867,2019-05-21,전승호대웅제약사장넥스트나보타위한준비이상무,http://www.ebn.co.kr/news/view/985752
3868,2019-05-21,전승호대웅제약사장대웅RD위원회주도글로벌연구개발성과기대,http://www.businesskorea.co.kr/news/articleView.html?idxno=32062
3869,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.ekn.kr/news/article.html?no=433205
3870,2019-05-21,제약업종내상승종목이글벳690JW생명과학499대웅제약481순,http://aitimes.co.kr/news/view/48414
3871,2019-05-21,대웅제약넥스트나보타신약개발박차난치성질환치료제개발순항”,http://news.donga.com/3/all/20190521/95625213/1
3872,2019-05-21,대웅제약항궤양제안구건조증치료제연구개발박차,http://www.rapportian.com/news/articleView.html?idxno=117653
3873,2019-05-21,대웅제약난치성질환치료제개발제2의나보타준비,http://www.newsprime.co.kr/news/article.html?no=460519
3874,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55419
3875,2019-05-21,21일마감보고대웅주가17800원으로종료,http://www.anewsa.com/detail.php?number=1760787&thread=10r04
3876,2019-05-21,대웅제약난치성질환치료제개발넥스트나보타연구집중할것”,https://www.sedaily.com/NewsView/1VJ88CNJ74
3877,2019-05-21,5월21일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=721255
3878,2019-05-21,대웅제약넥스트나보타준비난치성치료제개발박차,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905210384&t=NN
3879,2019-05-21,대웅제약APA항궤양제안구건조증치료제임상순항중,http://www.mdtoday.co.kr/mdtoday/index.html?no=355179
3880,2019-05-21,대웅제약글로벌RD성과기대,http://www.dailymedi.com/detail.php?number=843281&thread=22r05
3881,2019-05-21,대웅제약난치성치료제개발주력넥스트나보타준비,http://www.seoulwire.com/news/articleView.html?idxno=135492
3882,2019-05-21,대웅제약차세대APA항궤양제와안구건조증치료제임상3상순항”,http://www.dailian.co.kr/news/view/797177/?sc=naver
3883,2019-05-21,대웅제약글로벌50위제약사도약,http://www.monews.co.kr/news/articleView.html?idxno=202693
3884,2019-05-21,대웅제약차세대APA항궤양제등신약개발순항,http://www.shinailbo.co.kr/news/articleView.html?idxno=1169045
3885,2019-05-21,대웅제약항궤양제와안구건조증치료제개발가시화,http://www.bokuennews.com/news/article.html?no=175972
3886,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.asiatime.co.kr/news/articleView.html?idxno=246862
3887,2019-05-21,대웅제약RD위원회글로벌연구개발성과기대,http://www.getnews.co.kr/view.php?ud=20190521180223480741d0c69529_16
3888,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.medigatenews.com/news/3268807523
3889,2019-05-21,전승호대웅제약난치성질환치료제로제2의나보타토대다져,http://www.businesspost.co.kr/BP?command=article_view&num=128206
3890,2019-05-21,대웅제약메로페넴이어나보타로미국진출본격화,http://www.finomy.com/news/articleView.html?idxno=65990
3891,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.wikileaks-kr.org/news/articleView.html?idxno=55982
3892,2019-05-21,대웅RD위원회글로벌연구개발성과기대,http://www.newscj.com/news/articleView.html?idxno=633866
3893,2019-05-22,대웅제약차세대APA항궤양제와안구건조증치료제임상3상지속순항중,http://www.lawissue.co.kr/view.php?ud=201905212348506006d7f4c63cc6_12
3894,2019-05-22,대웅황제88침향단왕들의자양강장제침향으로기력보충,http://news.donga.com/3/all/20190521/95625881/1
3895,2019-05-22,★주식인사이드대웅제약주가163500원5월22일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=722936
3896,2019-05-22,종목상세정보22일대웅현재주가17650원,http://www.anewsa.com/detail.php?number=1761758&thread=10r02
3897,2019-05-22,5월22일대웅주식현황08417650원,http://www.nbntv.co.kr/news/articleView.html?idxno=371640
3898,2019-05-22,대웅제약오늘주식22일현재162500원,http://www.nbntv.co.kr/news/articleView.html?idxno=372138
3899,2019-05-22,주가정보대웅11시13분현재가17500원종목동정,http://aitimes.co.kr/news/view/48659
3900,2019-05-22,대웅제약보툴리눔톡신나보타美공식출시,http://news.heraldcorp.com/view.php?ud=20190522000377
3901,2019-05-22,스타★주식인사이드대웅제약주가163000원5월22일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=724484
3902,2019-05-22,극으로치닫는메디톡스대웅제약원료탈취공방전종지부찍나,http://www.enewstoday.co.kr/news/articleView.html?idxno=1303930
3903,2019-05-22,대웅제약vs메디톡스끝까지간다균주싸움점입가경,http://www.newsway.co.kr/news/view?tp=1&ud=2019052214563418776
3904,2019-05-22,대웅제약차세대APA항궤양제등임상3상지속,http://www.100ssd.co.kr/news/articleView.html?idxno=61515
3905,2019-05-22,신약개발성과기대하는대웅제약RD위원회통해글로벌제약사도약노린다,http://www.updownnews.co.kr/news/articleView.html?idxno=203795
3906,2019-05-22,5월22일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=725551
3907,2019-05-22,대웅제약메로페넴이어나보타로미국본격공략,http://www.viva100.com/main/view.php?key=20190522010007318
3908,2019-05-23,대웅제약보툴리눔톡신나보타美시장공식출시제품명주보,http://www.betanews.net:8080/article/1011867.html
3909,2019-05-23,제약바이오말말말②대웅VS메디톡스물러설수없는싸움,http://www.mdtoday.co.kr/mdtoday/index.html?no=355338
3910,2019-05-23,보톡스논란에주가추락한대웅제약메디톡스바닥설솔솔,http://www.edaily.co.kr/news/newspath.asp?newsid=01134886622491872
3911,2019-05-23,★주식인사이드대웅제약주가162500원5월23일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=727095
3912,2019-05-23,5월23일대웅증권투자정보및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=202941
3913,2019-05-23,국내주식시장현황23일대웅현재주식거래가격17750원,http://www.anewsa.com/detail.php?number=1765160&thread=10r02
3914,2019-05-23,대웅오늘증권시세23일현재17750원,http://www.nbntv.co.kr/news/articleView.html?idxno=373922
3915,2019-05-23,휴온스휴메딕스국내보툴리눔톡신시장진출대웅메디톡스휴젤과4강구도,http://www.upinews.kr/news/newsview.php?ncode=1065575041002799
3916,2019-05-23,코막히나코메키나졸음유발줄인대웅제약의비염치료제 ,http://kormedi.com/?p=1293524
3917,2019-05-23,대웅제약제2의나보타는항궤양제섬유증치료제주목,http://news1.kr/articles/?3628440
3918,2019-05-23,공시봇대웅제약최대주주지분010증가,http://www.ajunews.com/view/20190523111070475
3919,2019-05-23,대웅제약상습탈세국세청요주의기업,http://www.ekoreanews.co.kr/news/articleView.html?idxno=31797
3920,2019-05-23,대웅웅대웅제약보통주1만2343주장내매수,http://www.newspim.com/news/view/20190523000313
3921,2019-05-23,주식현재가대웅11시20분현재가17700원연중최고가얼마,http://aitimes.co.kr/news/view/49151
3922,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.economytalk.kr/news/articleView.html?idxno=186329
3923,2019-05-23,5월23일대웅제약증권매매160500원123,http://www.nbntv.co.kr/news/articleView.html?idxno=374432
3924,2019-05-23,대웅제약우루사미국소화기학회서임상시험결과공개,http://www.newspim.com/news/view/20190523000345
3925,2019-05-23,대웅제약우루사위절제후담석예방효과있다,http://www.medisobizanews.com/news/articleView.html?idxno=59951
3926,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.dailian.co.kr/news/view/797712/?sc=naver
3927,2019-05-23,대웅제약우루사위절제후담석예방미국소화기학회서임상결과공개,http://kpenews.com/View.aspx?No=40217
3928,2019-05-23,메디톡스대웅주가동반급락투자자선택은달랐다,http://www.dailypharm.com/Users/News/NewsView.html?ID=252943&REFERER=NP
3929,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=239399&MainKind=A&NewsKind=5&vCount=12&vKind=1
3930,2019-05-23,상장제약1Q전년비영업이익증가율톱5국제진양제일대웅한독,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230799
3931,2019-05-23,스타★주식인사이드대웅제약주가161000원5월23일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=728660
3932,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2105710
3933,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.wsobi.com/news/articleView.html?idxno=74275
3934,2019-05-23,대웅제약vs메디톡스화해불가보톡스전쟁점입가경,http://ilyo.co.kr/?ac=article_view&entry_id=335816
3935,2019-05-23,대웅제약우루사우수성입증미국소화기학회DDW에서우루사300mg임상시험결과구두발표,http://www.updownnews.co.kr/news/articleView.html?idxno=203859
3936,2019-05-23,나보타균주정보공개두고대웅메디톡스온도차,http://www.shinailbo.co.kr/news/articleView.html?idxno=1169707
3937,2019-05-23,대웅제약전문의약품우루사위절제후담석예방효과입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019052300157
3938,2019-05-23,대웅제약우루사300mg위절제후담석예방효과입증,http://www.fnnews.com/news/201905231430301966
3939,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230855
3940,2019-05-23,대웅제약우루사적응증추가목표미국학회서임상결과알려,http://moneys.mt.co.kr/news/mwView.php?no=2019052314378042143
3941,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019052315205908275
3942,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.betanews.net:8080/article/1012300.html
3943,2019-05-23,대웅제약우루사위암환자담석예방효과입증적응증추가추진,http://news.donga.com/3/all/20190523/95665456/1
3944,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.fetv.co.kr/news/article.html?no=29220
3945,2019-05-23,대웅제약우루사위절제후담석예방효과입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1759027
3946,2019-05-23,대웅제약미국학회에서위암환자대상우루사담석예방입증,http://www.businesspost.co.kr/BP?command=article_view&num=128517
3947,2019-05-23,대웅RD위원회글로벌연구개발성과기대,http://www.wsobi.com/news/articleView.html?idxno=74236
3948,2019-05-23,1Q대웅셀트리온신규해외매출로이익↑100억대품목대부분매출증가,http://www.medigatenews.com/news/2946802923
3949,2019-05-23,대웅제약美DDW서우루사의위절제후담석예방효과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=343545
3950,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.dailymedi.com/detail.php?number=843365&thread=22r05
3951,2019-05-23,5월23일장마감주가정보대웅제약159000원,http://www.newsinside.kr/news/articleView.html?idxno=730721
3952,2019-05-23,대웅제약美소화기학회서우루사300mg임상결과공개,http://www.ebn.co.kr/news/view/986202
3953,2019-05-23,23일마감정보대웅주가17750원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=204000
3954,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1304485
3955,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=355459
3956,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.getnews.co.kr/view.php?ud=20190523182823737341d0c69529_16
3957,2019-05-23,대웅제약우루사위절제위암환자담석예방효과입증,http://www.polinews.co.kr/news/article.html?no=393549
3958,2019-05-23,대웅제약우루사위절제후담석예방효과입증,http://www.lawissue.co.kr/view.php?ud=201905232351562549d7f4c63cc6_12
3959,2019-05-24,더벨대웅제약美줄기세포치료제회사지분20획득,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905230100040280002513
3960,2019-05-24,대웅제약해외법인늘리고연구생산도현지에서글로벌2020잰걸음,http://www.rapportian.com/news/articleView.html?idxno=117714
3961,2019-05-24,★주식인사이드대웅제약주가159500원5월24일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=731640
3962,2019-05-24,대웅제약우루사위절제후담석예방효과,http://www.sisaon.co.kr/news/articleView.html?idxno=94259
3963,2019-05-24,아통경제24일대웅주가17700원,http://www.anewsa.com/detail.php?number=1768323&thread=10r02
3964,2019-05-24,5월24일대웅배당주식02817700원,http://www.nbntv.co.kr/news/articleView.html?idxno=376365
3965,2019-05-24,대웅제약우루사300mg임상결과발표위절제후담석예방효과입증,http://www.ezyeconomy.com/news/articleView.html?idxno=90937
3966,2019-05-24,종목시황대웅11시21분현재가17800원연중최고가얼마,http://aitimes.co.kr/news/view/49628
3967,2019-05-24,대웅제약이지덤과함께다둥이마라톤즐기세요,http://www.ibabynews.com/news/articleView.html?idxno=74902
3968,2019-05-24,스타★주식인사이드대웅제약주가160000원5월24일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=733262
3969,2019-05-24,메조미디어큐피트대웅제약과이지덤뷰티특집퀴즈쇼진행,http://biz.newdaily.co.kr/site/data/html/2019/05/24/2019052400092.html
3970,2019-05-24,대웅제약사회공헌프로그램으로장애인과동행하는삶앞장,http://www.g-enews.com/ko-kr/news/article/news_all/201905231825125528f67c3fc824_1/article.html
3971,2019-05-24,SR경제라이프생방송 모바일 퀴즈쇼큐피트대웅제약과이지덤뷰티특집퀴즈쇼진행,http://www.srtimes.kr/news/articleView.html?idxno=40250
3972,2019-05-24,대웅제약차별화된줄기세포치료제연구순항,http://daily.hankooki.com/lpage/ittech/201905/dh20190524145228145630.htm
3973,2019-05-24,대웅제약진행중인줄기세포치료제연구첫공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1759392
3974,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55483
3975,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.bosa.co.kr/news/articleView.html?idxno=2105796
3976,2019-05-24,대웅제약줄기세포치료제연구박차미래의학춘계포럼서DWMSC공개,http://kpenews.com/View.aspx?No=40317
3977,2019-05-24,대웅제약K바이오이끌줄기세포치료제첫공개,http://www.medisobizanews.com/news/articleView.html?idxno=59985
3978,2019-05-24,대웅제약개발중인차별화된줄기세포치료제공개,http://www.metroseoul.co.kr/news/newsview?newscd=2019052400081
3979,2019-05-24,대웅제약넥스트나보타줄기세포치료제DWMSC공개,http://www.viva100.com/main/view.php?key=20190524010007966
3980,2019-05-24,대웅제약차별화된줄기세포치료제연구순항,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230920
3981,2019-05-24,대웅제약연구진행중인줄기세포치료제공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=355546
3982,2019-05-24,대웅제약줄기세포치료제최초공개,https://www.sedaily.com/NewsView/1VJ9MJRDNW
3983,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.ebn.co.kr/news/view/986352
3984,2019-05-24,넥스트나보타준비하는대웅제약줄기세포연구,http://www.mhj21.com/121504
3985,2019-05-24,대웅제약줄기세포치료제공개,http://www.newspim.com/news/view/20190524000545
3986,2019-05-24,대웅제약미래의학춘계포럼서줄기세포치료제공개,http://medipana.com/news/news_viewer.asp?NewsNum=239477&MainKind=A&NewsKind=5&vCount=12&vKind=1
3987,2019-05-24,대웅제약줄기세포연구진행10일연구내용발표,http://www.newsprime.co.kr/news/article.html?no=461053
3988,2019-05-24,5월24일장마감주가정보대웅제약159500원,http://www.newsinside.kr/news/articleView.html?idxno=734433
3989,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.ekn.kr/news/article.html?no=433922
3990,2019-05-24,대웅제약줄기세포치료제첫공개기술차별화로미래K바이오이끌것”,http://news.donga.com/3/all/20190524/95685984/1
3991,2019-05-24,대웅제약미래의학춘계포럼서줄기세포치료제첫공개,http://moneys.mt.co.kr/news/mwView.php?no=2019052416558018038
3992,2019-05-24,대웅제약연구중인줄기세포치료제DWMSC첫공개,http://www.medigatenews.com/news/1377035999
3993,2019-05-24,대웅제약제3회미래의학춘계포럼서줄기세포치료제공개발표,http://www.getnews.co.kr/view.php?ud=20190524172129938541d0c69529_16
3994,2019-05-24,대웅제약개발중인줄기세포치료제첫공개,http://www.seoulwire.com/news/articleView.html?idxno=138469
3995,2019-05-24,대웅제약상업화가능한줄기세포연구내용처음공개,http://www.businesspost.co.kr/BP?command=article_view&num=128726
3996,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.asiatime.co.kr/news/articleView.html?idxno=247589
3997,2019-05-24,대웅제약제3회미래의학춘계포럼서줄기세포치료제첫공개발표,http://www.updownnews.co.kr/news/articleView.html?idxno=203963
3998,2019-05-24,대웅제약미래의학춘계포럼서줄기세포치료제연구경과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=348244
3999,2019-05-24,대웅제약차별화된줄기세포치료제연구순항중,http://www.newscj.com/news/articleView.html?idxno=634908
4000,2019-05-24,대웅제약줄기세포치료제공개발표,http://www.kpanews.co.kr/article/show.asp?idx=204198&table=article&category=D
4001,2019-05-25,대웅제약차별화된줄기세포치료제연구순항중,http://www.betanews.net:8080/article/1012803.html
4002,2019-05-25,대웅제약제2의나보타는항궤양제섬유증치료제주목,http://www.fntoday.co.kr/news/articleView.html?idxno=189818
4003,2019-05-26,대웅제약줄기세포치료제연구순항,http://www.dt.co.kr/contents.html?article_no=2019052602109931102006&ref=naver
4004,2019-05-27,RD투자한미유한녹십자대웅종근당順,http://www.dailymedi.com/detail.php?number=843454&thread=22r05
4005,2019-05-27,대웅제약한올바이오파마안구건조증치료신약개발에총력,http://www.mdtoday.co.kr/mdtoday/index.html?no=355560
4006,2019-05-27,더벨대웅균주논란속대웅제약주가방어총력,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905240100042230002637
4007,2019-05-27,★주식인사이드대웅제약주가156000원5월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=738125
4008,2019-05-27,대웅제약발달장애인채용이어사회공헌프로그램으로장애인과동행하는삶에앞장서,http://www.seoulwire.com/news/articleView.html?idxno=138719
4009,2019-05-27,주식시세27일대웅현재가17400원,http://www.anewsa.com/detail.php?number=1771956&thread=10r02
4010,2019-05-27,5월27일대웅시세보기02917400원,http://www.nbntv.co.kr/news/articleView.html?idxno=379166
4011,2019-05-27,주식현재가대웅제약주가27일현재157000원,http://www.nbntv.co.kr/news/articleView.html?idxno=379662
4012,2019-05-27,종목시황대웅11시16분현재가17050원거래정보는,http://aitimes.co.kr/news/view/50077
4013,2019-05-27,스타★주식인사이드대웅제약주가157000원5월27일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=739615
4014,2019-05-27,대웅제약줄기세포치료제연구첫공개,http://www.bokuennews.com/news/article.html?no=176231
4015,2019-05-27,5월27일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=740699
4016,2019-05-27,27일마감정보대웅주가17250원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=208458
4017,2019-05-27,건강하게여름나기대웅제약나보타눈가미간주름팽팽하게,https://www.sedaily.com/NewsView/1VJB05IGRO
4018,2019-05-27,대웅제약제3회미래의학춘계포럼통해줄기세포치료제공개발표,http://www.lawissue.co.kr/view.php?ud=201905272221155270d7f4c63cc6_12
4019,2019-05-28,★주식인사이드대웅제약주가158500원5월28일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=742010
4020,2019-05-28,5월28일대웅정보,http://www.gokorea.kr/news/articleView.html?idxno=209498
4021,2019-05-28,5월28일대웅주식추천주17300원029,http://www.nbntv.co.kr/news/articleView.html?idxno=381628
4022,2019-05-28,아통증시28일대웅현재가17300원,http://www.anewsa.com/detail.php?number=1775112&thread=10r02
4023,2019-05-28,주가정보대웅11시17분현재가17350원거래정보는,http://aitimes.co.kr/news/view/50555
4024,2019-05-28,5월28일대웅제약종목검색156000원000,http://www.nbntv.co.kr/news/articleView.html?idxno=382136
4025,2019-05-28,더벨대웅제약나보타제품명으로부서명만든이유,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905280100048860003061
4026,2019-05-28,대웅제약최대주주가9451주장내매수,http://news.mt.co.kr/mtview.php?no=2019052815034620809
4027,2019-05-28,공시대웅제약최대주주대웅이9451주장내매수,http://www.newsway.co.kr/news/view?tp=1&ud=2019052815383432206
4028,2019-05-28,대웅제약최대주주대웅9451주장내매수,http://www.mdtoday.co.kr/mdtoday/index.html?no=355847
4029,2019-05-28,5월28일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=745084
4030,2019-05-28,28일주가마감정보대웅주가18150원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=210537
4031,2019-05-29,★주식인사이드대웅제약주가155500원5월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=745982
4032,2019-05-29,증시보고29일대웅주가17050원,http://www.anewsa.com/detail.php?number=1778322&thread=10r02
4033,2019-05-29,한국다이이찌산쿄대웅제약3중복합제공동판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85967
4034,2019-05-29,ET투자뉴스대웅제약_주가등락폭이작아,http://www.etnews.com/20190529000083
4035,2019-05-29,다이이찌산쿄대웅제약올로맥스도입,http://www.whosaeng.com/110375
4036,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판촉계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2106060
4037,2019-05-29,대웅제약한국다이이찌산쿄올로맥스정공동판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=60078
4038,2019-05-29,5월29일대웅제약주식주가417149500원,http://www.nbntv.co.kr/news/articleView.html?idxno=384593
4039,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068788
4040,2019-05-29,주가정보대웅11시16분현재가17000원연중최고가얼마,http://aitimes.co.kr/news/view/51064
4041,2019-05-29,다이이찌산쿄대웅올로맥스공동판촉계약체결,http://www.bokuennews.com/news/article.html?no=176342
4042,2019-05-29,한국다이이찌산쿄대웅제약과올로맥스공동판매계약,http://www.rapportian.com/news/articleView.html?idxno=117803
4043,2019-05-29,대웅제약장애인과동행하는삶앞장,http://www.m-i.kr/news/articleView.html?idxno=607448
4044,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판촉계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231095
4045,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019052900050
4046,2019-05-29,대웅제약우루사존재감쑤욱,http://www.whosaeng.com/110384
4047,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증추가,http://www.medisobizanews.com/news/articleView.html?idxno=60088
4048,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.inthenews.co.kr/news/article.html?no=15840
4049,2019-05-29,다이이찌산쿄대웅제약올로맥스공동판촉계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=355913
4050,2019-05-29,스타★주식인사이드대웅제약주가148000원5월29일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=747610
4051,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231099
4052,2019-05-29,대웅제약우루사300㎎위절제후담석예방,http://www.dt.co.kr/contents.html?article_no=2019052902109931102004&ref=naver
4053,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방에대한적응증획득,http://www.updownnews.co.kr/news/articleView.html?idxno=204131
4054,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.seoulwire.com/news/articleView.html?idxno=141218
4055,2019-05-29,대웅제약 우루사 300mg전세계최초로 위절제후담석예방에대한적응증획득,http://www.fetv.co.kr/news/article.html?no=29743
4056,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.etnews.com/20190529000211
4057,2019-05-29,대웅제약우루사위절제후담석예방효과입증,http://biz.chosun.com/site/data/html_dir/2019/05/29/2019052901598.html
4058,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.asiatoday.co.kr/view.php?key=20190529010018253
4059,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.ebn.co.kr/news/view/986978
4060,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증승인획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1760853
4061,2019-05-29,대웅제약우루사300mg전세계최초위절제후담석예방적응증획득,http://www.segye.com/content/html/2019/05/29/20190529508198.html?OutUrl=naver
4062,2019-05-29,대웅제약우루사전세계최초신규적응증획득,http://www.mhj21.com/121611
4063,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.biospectator.com/view/news_view.php?varAtcId=7735
4064,2019-05-29,대웅제약우루사위절제후담석예방적응증획득전세계최초,http://daily.hankooki.com/lpage/ittech/201905/dh20190529144021145630.htm
4065,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=56830
4066,2019-05-29,대웅제약전문약우루사300㎎적응증추가영역확대앞장,http://moneys.mt.co.kr/news/mwView.php?no=2019052914508074836
4067,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.newstomato.com/ReadNews.aspx?no=898401
4068,2019-05-29,대웅제약오송스마트공장바이오헬스산업전초기지로,http://www.newstomato.com/ReadNews.aspx?no=898411
4069,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방에대한적응증획득,http://www.fnnews.com/news/201905291518113367
4070,2019-05-29,대웅제약우루사세계최초위절제후담석예방적응증획득,http://news.donga.com/3/all/20190529/95753870/1
4071,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.newsprime.co.kr/news/article.html?no=461606
4072,2019-05-29,대웅제약우루사위절제후담석예방효과입증,http://news.bizwatch.co.kr/article/consumer/2019/05/29/0017/naver
4073,2019-05-29,29일대웅주가17300원마감,http://www.anewsa.com/detail.php?number=1780212&thread=10r04
4074,2019-05-29,대웅제약우루사300㎎위절제후담석예방적응증획득,http://www.ajunews.com/view/20190529154553223
4075,2019-05-29,대웅제약우루사위절제후담석예방적응증추가,http://www.rapportian.com/news/articleView.html?idxno=117809
4076,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.economytalk.kr/news/articleView.html?idxno=186887
4077,2019-05-29,대웅제약우루사위절제후담석예방효과입증,http://www.newsis.com/view/?id=NISX20190529_0000665700&cID=13001&pID=13000
4078,2019-05-29,5월29일장마감주가정보대웅제약148500원,http://www.newsinside.kr/news/articleView.html?idxno=748949
4079,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=355924
4080,2019-05-29,대웅제약해외의사교육프로그램으로나보타홍보,http://www.monews.co.kr/news/articleView.html?idxno=202034
4081,2019-05-29,대웅제약우루사300mg세계최초위절제후담석예방적응증획득,http://www.viva100.com/main/view.php?key=20190529010009616
4082,2019-05-29,대웅제약우루사300mg전세계최초로위절제후담석예방에대한적응증획득,https://www.sedaily.com/NewsView/1VJBXBQ6NF
4083,2019-05-29,다이이찌대웅고혈압이상지질혈증복합제올로맥스공동판매,http://www.monews.co.kr/news/articleView.html?idxno=202864
4084,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.econovill.com/news/articleView.html?idxno=364246
4085,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.monews.co.kr/news/articleView.html?idxno=202881
4086,2019-05-29,대웅제약우루사300mg위절제후담석예방에대한적응증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019052916411367536
4087,2019-05-29,29일마감증시대웅주가17300원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=212688
4088,2019-05-29,대웅제약우루사위절제후담석예방적응증획득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1171638
4089,2019-05-29,대웅제약우루사300mg전세계최초위절제후담석예방에대한적응증획득,http://www.betanews.net:8080/article/1014363.html
4090,2019-05-29,대웅제약우루사300mg위절제후담석예방효능추가,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905290333&t=NN
4091,2019-05-29,대웅우루사위절제후담석예방적응증추가,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85985
4092,2019-05-29,대웅제약우루사300mg세계최초위절제담석예방인정,http://www.newspost.kr/news/articleView.html?idxno=71743
4093,2019-05-29,대웅제약우루사정위절제후담석예방적응증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=97156
4094,2019-05-29,대웅제약우루사300mg위절제후담석예방적응증획득,http://www.k-health.com/news/articleView.html?idxno=44129
4095,2019-05-29,대웅우루사300mg세계최초로위절제후담석예방적응증획득,http://www.getnews.co.kr/view.php?ud=20190529183045206641d0c69529_16
4096,2019-05-29,대웅제약우루사300mg위절제후담석예방에대한적응증획득,http://www.medigatenews.com/news/2545908376
4097,2019-05-29,대웅제약우루사위절제뒤담석예방적응증최초로획득,http://www.businesspost.co.kr/BP?command=article_view&num=129389
4098,2019-05-29,대웅제약우루사300mg세계최초로위절제후담석예방적응증획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=32354
4099,2019-05-29,대웅제약우루사300mg세계최초로위절제후담석예방적응증획득,http://www.asiatime.co.kr/news/articleView.html?idxno=248555
4100,2019-05-29,한국다이이찌산쿄대웅제약올로맥스공동판촉계약,http://www.kpanews.co.kr/article/show.asp?idx=204318&table=article&category=D
4101,2019-05-29,대웅제약우루사300mg전세계최초로위절제후담석예방에대한적응증획득,http://www.lawissue.co.kr/view.php?ud=201905292345549174d7f4c63cc6_12
4102,2019-05-30,대웅메디톡스보툴리눔싸움마무리될까,http://weekly.cnbnews.com/news/article.html?no=128161
4103,2019-05-30,★주식인사이드대웅제약주가149000원5월30일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=750477
4104,2019-05-30,대웅제약우루사300㎎위절제후담석예방효과입증,http://www.ezyeconomy.com/news/articleView.html?idxno=91096
4105,2019-05-30,장중시세30일대웅거래가격17400원,http://www.anewsa.com/detail.php?number=1781561&thread=10r02
4106,2019-05-30,5월30일대웅오늘주식시세05817400원,http://www.nbntv.co.kr/news/articleView.html?idxno=386481
4107,2019-05-30,대웅제약우루사위절제후담석예방적응증획득,http://www.joseilbo.com/news/news_read.php?uid=377579&class=27&grp=
4108,2019-05-30,주식현재가대웅10시14분현재가17450원연중최고가얼마,http://aitimes.co.kr/news/view/51786
4109,2019-05-30,특징주대웅제약시너지기술수출한올바이오파마개선되고있다,http://www.sisaon.co.kr/news/articleView.html?idxno=94586
4110,2019-05-30,대웅제약나보타전세계80개국공략4조원시장잡는다,http://www.metroseoul.co.kr/news/newsview?newscd=2019053000063
4111,2019-05-30,한올바이오파마대웅제약에인수된뒤영업과신약개발시너지내,http://www.businesspost.co.kr/BP?command=article_view&num=129450
4112,2019-05-30,대웅제약우루사300㎎위절제후담석예방공인,http://news.heraldcorp.com/view.php?ud=20190530000336
4113,2019-05-30,대웅제약창립이래최다건수임상진행‥1000억이상투자,http://medipana.com/news/news_viewer.asp?NewsNum=239767&MainKind=A&NewsKind=5&vCount=12&vKind=1
4114,2019-05-30,대웅제약올30여건임상시험추가혁신신약의명가꿈꾼다,http://www.medisobizanews.com/news/articleView.html?idxno=60117
4115,2019-05-30,대웅제약올해창립이래최다건수임상돌입,http://www.monews.co.kr/news/articleView.html?idxno=202897
4116,2019-05-30,대웅제약올30여건임상시험추가1000억이상투자,http://www.seoulwire.com/news/articleView.html?idxno=142204
4117,2019-05-30,대웅제약우루사위절제후담석예방적응증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068843
4118,2019-05-30,대웅제약신약RD경쟁력업그레이드올해30여건신규임상추가,http://kpenews.com/View.aspx?No=40883
4119,2019-05-30,스타★주식인사이드대웅제약주가146500원5월30일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=752873
4120,2019-05-30,대웅제약올해창사이래가장많은임상진행신약RD경쟁력강화”,https://www.sedaily.com/NewsView/1VJCCXE7H2
4121,2019-05-30,대웅제약30여건신규임상추가창립이래최다,http://www.kpinews.co.kr/news/articleView.html?idxno=97200
4122,2019-05-30,대웅제약올30여건신규임상시험RD투자도1000억,http://daily.hankooki.com/lpage/ittech/201905/dh20190530140536145630.htm
4123,2019-05-30,대웅제약올해창사이래최다임상진행1천억원이상투자,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905300294&t=NN
4124,2019-05-30,대웅제약나보타혼란속RD고삐더죈다,http://www.whosaeng.com/110419
4125,2019-05-30,대웅제약올해창사이래가장많은임상진행RD역량강화,https://view.asiae.co.kr/news/view.htm?idxno=2019053014293481538
4126,2019-05-30,대웅제약연구개발비에1000억투자신약RD경쟁력강화로미래성장비전제시​,http://www.updownnews.co.kr/news/articleView.html?idxno=204161
4127,2019-05-30,대웅제약올해신규임상30여건추가창립이래최다,http://www.viva100.com/main/view.php?key=20190530010009944
4128,2019-05-30,대웅제약신약RD경쟁력강화올신규임상30여건추가,http://www.wikileaks-kr.org/news/articleView.html?idxno=56945
4129,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.economytalk.kr/news/articleView.html?idxno=187007
4130,2019-05-30,대웅제약올해창립이래최다임상진행목표,http://www.newstomato.com/ReadNews.aspx?no=898644
4131,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231156
4132,2019-05-30,대웅제약신약RD경쟁력강화창립이후최다건수임상실시,http://www.asiatime.co.kr/news/articleView.html?idxno=248718
4133,2019-05-30,대웅제약신약RD경쟁력강화미래성장비전제시,http://www.wolyo.co.kr/news/articleView.html?idxno=85270
4134,2019-05-30,대웅제약올해신규임상30여건추가신약경쟁력강화”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1761317
4135,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.newsway.co.kr/news/view?tp=1&ud=2019053015345019119
4136,2019-05-30,대웅제약올해신규임상시험추가신약RD경쟁력강화,http://www.newsprime.co.kr/news/article.html?no=461803
4137,2019-05-30,장마감보고서30일대웅주가17300원으로마감,http://www.anewsa.com/detail.php?number=1783648&thread=18
4138,2019-05-30,5월30일장마감주가정보대웅제약148000원,http://www.newsinside.kr/news/articleView.html?idxno=753182
4139,2019-05-30,대웅제약올해30여건신규임상시험진행,http://www.ajunews.com/view/20190530161452300
4140,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.ekn.kr/news/article.html?no=435037
4141,2019-05-30,대웅제약올해신약파이프라인공격적임상추진,http://www.bokuennews.com/news/article.html?no=176416
4142,2019-05-30,대웅제약신약RD경쟁력강화국내외40여건임상예정,http://www.dt.co.kr/contents.html?article_no=2019053002109931102003&ref=naver
4143,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55593
4144,2019-05-30,대웅제약나보타차별화된경쟁력으로글로벌시장공략,http://www.upinews.kr/news/newsview.php?ncode=1065602798180290
4145,2019-05-30,대웅제약올해신규임상30건추가창사이래최다임상진행,http://www.newspim.com/news/view/20190530001143
4146,2019-05-30,대웅제약올해30여건신규임상시험추가한다,http://www.medigatenews.com/news/2457822073
4147,2019-05-30,대웅제약올해40여건의임상진행전승호연구개발경쟁력강화,http://www.businesspost.co.kr/BP?command=article_view&num=129555
4148,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.newscj.com/news/articleView.html?idxno=636972
4149,2019-05-30,대웅제약신약RD경쟁력강화로미래성장비전제시​,http://www.lawissue.co.kr/view.php?ud=201905302321256703d7f4c63cc6_12
4150,2019-05-31,식약처대웅제약SGLT2억제당뇨치료제국내2상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=356156
4151,2019-05-31,대웅제약신약RD경쟁력강화로미래성장비전제시,http://www.betanews.net:8080/article/1014986.html
4152,2019-05-31,대웅제약기술로탄생한이지듀리더마체험이벤트,http://www.sportsseoul.com/news/read/770290
4153,2019-05-31,한화證대웅제약나보타美출시기대목표가23만원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905310072&t=NN
4154,2019-05-31,★주식인사이드대웅제약주가146500원5월31일9시3분기준,http://www.newsinside.kr/news/articleView.html?idxno=754897
4155,2019-05-31,대웅제약디엔컴퍼니이지듀리더마출시기념체험이벤트열어,http://www.econovill.com/news/articleView.html?idxno=364371
4156,2019-05-31,대웅제약오송스마트공장바이오헬스산업전초기지로부상,http://www.getnews.co.kr/view.php?ud=20190531092426504441d0c69529_16
4157,2019-05-31,증시실황31일대웅현재주가17650원,http://www.anewsa.com/detail.php?number=1784669&thread=18
4158,2019-05-31,퀵리포트대웅제약매수목표가23만원제시한화證,http://www.itooza.com/common/iview.php?no=2019053108101218250
4159,2019-05-31,대웅제약우루사위암수술후담석예방추가,http://www.sportsseoul.com/news/read/770329
4160,2019-05-31,대웅제약우루사위암수술후담석예방추가,http://www.sportsseoul.com/news/read/770329
4161,2019-05-31,디엔컴퍼니대웅제약이지듀리더마출시기념1만명체험키트이벤트실시,http://www.techholic.co.kr/news/articleView.html?idxno=182670
4162,2019-05-31,대웅제약디엔컴퍼니이지듀리더마출시기념이벤트1만명대상5일분체험키트제공,http://www.ezyeconomy.com/news/articleView.html?idxno=91146
4163,2019-05-31,5월31일대웅제약주식증권270152000원,http://www.nbntv.co.kr/news/articleView.html?idxno=388060
4164,2019-05-31,대웅제약올30건임상시험혁신신약개발박차,http://www.munhwa.com/news/view.html?no=2019053101071827107001
4165,2019-05-31,스타★주식인사이드대웅제약주가151500원5월31일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=756545
4166,2019-05-31,대웅제약살빠지는당뇨병치료제임상2상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231175
4167,2019-05-31,대웅전일대비약4상승한18000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905310401&t=NN
4168,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.getnews.co.kr/view.php?ud=20190531145144157041d0c69529_16
4169,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상IND승인,http://www.viva100.com/main/view.php?key=20190531010010322
4170,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55615
4171,2019-05-31,대웅제약디엔컴퍼니이지듀리더마1만명체험키트이벤트,http://www.kpinews.co.kr/news/articleView.html?idxno=97294
4172,2019-05-31,대웅제약SGLT2억제제2상임상승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86046
4173,2019-05-31,대웅SGLT2당뇨신약DWP16001국내임상2상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=253276&REFERER=NP
4174,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.fnnews.com/news/201905311456583898
4175,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://medipana.com/news/news_viewer.asp?NewsNum=240859&MainKind=A&NewsKind=5&vCount=12&vKind=1
4176,2019-05-31,대웅제약韓식약처서당뇨약SGLT2억제제후보물질임상2상승인,http://news.mk.co.kr/newsRead.php?year=2019&no=370888
4177,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231206
4178,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.etnews.com/20190531000275
4179,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2019053115112132126
4180,2019-05-31,대웅제약SGLT2당뇨신약국내2상승인환자200명대상평가,http://www.medisobizanews.com/news/articleView.html?idxno=60153
4181,2019-05-31,대웅제약당뇨병치료신약DWP16001국내임상2상승인,https://www.hankyung.com/article/2019053149116
4182,2019-05-31,대웅제약당뇨병치료제신약국내임상2상계획승인,http://www.kpinews.co.kr/news/articleView.html?idxno=97296
4183,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상IND승인,http://www.wikileaks-kr.org/news/articleView.html?idxno=57040
4184,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://biz.chosun.com/site/data/html_dir/2019/05/31/2019053101979.html
4185,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.ekn.kr/news/article.html?no=435193
4186,2019-05-31,대웅제약당뇨병치료제후보물질임상2상승인,http://www.rapportian.com/news/articleView.html?idxno=117852
4187,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://news.mk.co.kr/newsRead.php?year=2019&no=371101
4188,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.joseilbo.com/news/news_read.php?uid=377709&class=27&grp=
4189,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newspim.com/news/view/20190531000753
4190,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.inthenews.co.kr/news/article.html?no=15914
4191,2019-05-31,대웅제약당뇨병치료제DWP16001임상2상승인,http://www.ebn.co.kr/news/view/987384
4192,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newstomato.com/ReadNews.aspx?no=898983
4193,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.seoulwire.com/news/articleView.html?idxno=143593
4194,2019-05-31,장마감보고서31일대웅주가18050원으로종료,http://www.anewsa.com/detail.php?number=1786477&thread=18
4195,2019-05-31,대웅제약창립이래최다올40여건임상진행,http://www.dailymedi.com/detail.php?number=843673&thread=22r05
4196,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1761804
4197,2019-05-31,대웅제약당뇨병치료제DWP16001식약처2상승인,http://news.heraldcorp.com/view.php?ud=20190531000542
4198,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.metroseoul.co.kr/news/newsview?newscd=2019053100089
4199,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.ajunews.com/view/20190531161640142
4200,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newsis.com/view/?id=NISX20190531_0000668446&cID=13001&pID=13000
4201,2019-05-31,대웅제약당뇨병치료신약DWP16001임상2상승인,http://news.donga.com/3/all/20190531/95791027/1
4202,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=356231
4203,2019-05-31,5월31일장마감주가정보대웅제약153000원,http://www.newsinside.kr/news/articleView.html?idxno=758493
4204,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.dailian.co.kr/news/view/799815/?sc=naver
4205,2019-05-31,대웅제약당뇨병치료제신약식약처2상승인,http://www.skyedaily.com/news/news_view.html?ID=85272
4206,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://news1.kr/articles/?3635505
4207,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.asiatime.co.kr/news/articleView.html?idxno=249014
4208,2019-05-31,대웅제약뷰티브랜드이지듀리더마1만명무료체험행사,http://www.busan.com/view/busan/view.php?code=2019053116502038001
4209,2019-05-31,31일마감증시대웅18050원마감,http://www.gokorea.kr/news/articleView.html?idxno=216759
4210,2019-05-31,대웅SGLT2당뇨신약임상2상승인,http://www.whosaeng.com/110467
4211,2019-05-31,대웅제약제3회미래의학춘계포럼개최,http://www.wsobi.com/news/articleView.html?idxno=74901
4212,2019-05-31,대웅제약향후나보타의행보에기대를,http://www.wikitree.co.kr/main/news_view.php?id=432930
4213,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.wolyo.co.kr/news/articleView.html?idxno=85419
4214,2019-05-31,대웅제약당뇨병신약DWP16001임상2상승인,http://www.mhj21.com/121662
4215,2019-05-31,대웅제약당뇨병신약임상2상승인,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019053118071903212&objId=A2019053118071903212&portalCode=naver
4216,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://daily.hankooki.com/lpage/ittech/201905/dh20190531183411145630.htm
4217,2019-05-31,대웅제약이지듀이지듀리더마출시기념이벤트개최,http://www.k-health.com/news/articleView.html?idxno=44186
4218,2019-05-31,대웅제약당뇨병치료제DWP16001의국내임상2상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=129766
4219,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.newscj.com/news/articleView.html?idxno=637390
4220,2019-05-31,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.betanews.net:8080/article/1015373.html
4221,2019-05-31,대웅제약당뇨병치료제DWP16001한국임상2상승인,http://www.econovill.com/news/articleView.html?idxno=364455
4222,2019-06-02,전승호대웅제약주1회부착치매패치제개발로글로벌진출추진,http://www.businesspost.co.kr/BP?command=article_view&num=129803
4223,2019-06-02,대웅제약당뇨병치료제신약DWP16001국내임상2상최종승인,http://www.econonews.co.kr/news/articleView.html?idxno=67766
4224,2019-06-02,대웅제약SGLT2억제제당뇨약국내임상2상승인,http://www.dailymedi.com/detail.php?number=843713&thread=22r05
4225,2019-06-02,대웅제약당뇨병치료제DWP16001국내임상2상승인,http://www.dt.co.kr/contents.html?article_no=2019060202109931102004&ref=naver
4226,2019-06-03,대웅제약베트남현지화전략통해신사업모델구축,http://www.ajunews.com/view/20190602112757625
4227,2019-06-03,더벨thebellnote대웅제약의이너inner이노베이션,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905310100056750003584
4228,2019-06-03,대웅제약제약빅5중광고선전비최다매출의6,http://www.datanews.co.kr/news/article.html?no=103297
4229,2019-06-03,대웅제약SGLT2억제제당뇨신약개발전진,http://www.monews.co.kr/news/articleView.html?idxno=202928
4230,2019-06-03,★주식인사이드대웅제약주가149500원6월3일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=759970
4231,2019-06-03,주식현재가대웅9시28분현재가18100원종목동정,http://aitimes.co.kr/news/view/53734
4232,2019-06-03,대웅주가증권그래프3일현재18050원,http://www.gokorea.kr/news/articleView.html?idxno=218074
4233,2019-06-03,장중주가3일대웅거래가격18050원,http://www.anewsa.com/detail.php?number=1788406&thread=18
4234,2019-06-03,대웅제약주가증권투자정보및주체별매매동향3일현재153500원,http://www.gokorea.kr/news/articleView.html?idxno=218283
4235,2019-06-03,주식장대웅제약주가3일현재154500원,http://www.nbntv.co.kr/news/articleView.html?idxno=389739
4236,2019-06-03,스타★주식인사이드대웅제약주가155500원6월3일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=761714
4237,2019-06-03,공정위대웅제약비방광고메디톡스에과징금2100만원,http://www.upinews.kr/news/newsview.php?ncode=1065578503407061
4238,2019-06-03,대웅제약나보타100개국수출로글로벌제약사톱50목표세워,http://www.businesspost.co.kr/BP?command=article_view&num=129903
4239,2019-06-03,대웅제약오송스마트공장글로벌사업진출가속화,http://daily.hankooki.com/lpage/ittech/201906/dh20190603163217145630.htm
4240,2019-06-03,6월3일장마감주가정보대웅제약155000원,http://www.newsinside.kr/news/articleView.html?idxno=763571
4241,2019-06-04,★주식인사이드대웅제약주가155500원6월4일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=764525
4242,2019-06-04,대웅주가6월4일현재18200원,http://www.gokorea.kr/news/articleView.html?idxno=220169
4243,2019-06-04,증시현황4일대웅현재가18200원,http://www.anewsa.com/detail.php?number=1791553&thread=18
4244,2019-06-04,대웅제약올해30여건신규임상시험추가,http://weekly.cnbnews.com/news/article.html?no=128219
4245,2019-06-04,6월4일대웅제약종목검색154500원032,http://www.nbntv.co.kr/news/articleView.html?idxno=391041
4246,2019-06-04,스타★주식인사이드대웅제약주가154500원6월4일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=766210
4247,2019-06-04,보톡스전쟁상대웅제약메디톡스보톡스칼날대치왜,http://www.sporbiz.co.kr/news/articleView.html?idxno=343744
4248,2019-06-04,6월4일장마감주가정보대웅제약154000원,http://www.newsinside.kr/news/articleView.html?idxno=767242
4249,2019-06-04,대웅제약글로벌RD네트워크적극강화로차세대제약산업선도,http://www.ftoday.co.kr/news/articleView.html?idxno=109117
4250,2019-06-05,증권사추천주무작정따라하기급락하는대웅제약소송노이즈에흔들,http://www.newstomato.com/ReadNews.aspx?no=899550
4251,2019-06-05,★주식인사이드대웅제약주가154500원6월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=769522
4252,2019-06-05,주식실황5일대웅현재가17800원,http://www.anewsa.com/detail.php?number=1794660&thread=18
4253,2019-06-05,대웅제약올로맥스고혈압이상지질혈증동시에잡는다,http://www.bosa.co.kr/news/articleView.html?idxno=2106541
4254,2019-06-05,대웅제약당뇨치료신약임상2상승인,http://weekly.cnbnews.com/news/article.html?no=128260
4255,2019-06-05,스타★주식인사이드대웅제약주가151500원6월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=770559
4256,2019-06-05,메디톡스중국허가심사중단설대웅제약음해주장,http://news.bizwatch.co.kr/article/consumer/2019/06/05/0016/naver
4257,2019-06-05,6월5일장마감주가정보대웅제약152500원,http://www.newsinside.kr/news/articleView.html?idxno=771797
4258,2019-06-05,5일마감증시대웅주가17450원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=223252
4259,2019-06-05,대웅제약류마티스관절염신약임상시작,http://www.finomy.com/news/articleView.html?idxno=66456
4260,2019-06-06,청룡사대웅전서목재곡자나와치수단위알수있어,http://www.btnnews.tv/news/articleView.html?idxno=54555
4261,2019-06-06,대웅제약RD현지화전략으로글로벌시장승부수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1763651
4262,2019-06-07,국내10개제약사대웅제약올로스타특허회피첫도전,http://medipana.com/news/news_viewer.asp?NewsNum=241122&MainKind=A&NewsKind=5&vCount=12&vKind=1
4263,2019-06-07,류마티스관절염치료제경쟁에대웅제약가세하나,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069095
4264,2019-06-07,★주식인사이드대웅제약주가154500원6월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=774769
4265,2019-06-07,6월7일대웅및증권시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=224628
4266,2019-06-07,주가정보7일대웅주가17650원,http://www.anewsa.com/detail.php?number=1798237&thread=18
4267,2019-06-07,대웅제약보툴리눔톡신나보타미국시장본격공략돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231423
4268,2019-06-07,대웅제약미국서나보타마케팅돌입2년내점유율2위달성목표,http://moneys.mt.co.kr/news/mwView.php?no=2019060709458067092
4269,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.asiatoday.co.kr/view.php?key=20190607010003754
4270,2019-06-07,대웅제약보툴리눔톡신미국시장공략위해소비자대상체험프로그램론칭,http://news.mk.co.kr/newsRead.php?year=2019&no=392024
4271,2019-06-07,대웅제약보툴리눔톡신나보타미국시장본격공략,http://medipana.com/news/news_viewer.asp?NewsNum=241132&MainKind=A&NewsKind=5&vCount=12&vKind=1
4272,2019-06-07,대웅제약보툴리눔톡신주보미국시장본격공략,http://www.ajunews.com/view/20190607095428298
4273,2019-06-07,대웅보툴리눔톡신주보美소비자대상체험프로그램,http://www.dailypharm.com/Users/News/NewsView.html?ID=253490&REFERER=NP
4274,2019-06-07,대웅제약보툴리눔톡신주보미국시장본격공략나서,http://daily.hankooki.com/lpage/ittech/201906/dh20190607095523145630.htm
4275,2019-06-07,대웅제약보툴리눔톡신미국시장공략,http://www.nextdaily.co.kr/news/article.html?id=20190607800016
4276,2019-06-07,대웅제약보툴리눔톡신미국시장공략본격화,http://www.mdtoday.co.kr/mdtoday/index.html?no=356725
4277,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.dailian.co.kr/news/view/801283/?sc=naver
4278,2019-06-07,대웅제약보툴리눔톡신나보타미국시장본격공략,http://www.seoulwire.com/news/articleView.html?idxno=147301
4279,2019-06-07,대웅제약보툴리눔톡신美소비자러브콜받을까,http://www.bokuennews.com/news/article.html?no=176732
4280,2019-06-07,대웅제약보툴리눔톡신나보타미국시장공략마케팅본격화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1763820
4281,2019-06-07,대웅제약보툴리눔톡신소비자마케팅시작하며美시장본격공략,http://www.dailysmart.co.kr/news/articleView.html?idxno=12026
4282,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.bosa.co.kr/news/articleView.html?idxno=2106617
4283,2019-06-07,대웅제약 보툴리눔톡신美시장본격공략,http://www.medisobizanews.com/news/articleView.html?idxno=60277
4284,2019-06-07,대웅제약보툴리눔톡신美본격공략체험프로그램론칭,http://www.newsprime.co.kr/news/article.html?no=462742
4285,2019-06-07,대웅제약나보타美소비자공략나선다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1173975
4286,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나선다,http://www.newspim.com/news/view/20190607000201
4287,2019-06-07,대웅제약보툴리눔톡신美시장본격공략나서,http://www.sisafocus.co.kr/news/articleView.html?idxno=211673
4288,2019-06-07,대웅제약나보타美마케팅본격화”,http://weekly.cnbnews.com/news/article.html?no=128293
4289,2019-06-07,대웅제약美에서보툴리눔톡신주보마케팅활동펼쳐,https://www.sedaily.com/NewsView/1VKBPPMOQW
4290,2019-06-07,대웅제약주보미국시장본격공략,http://www.finomy.com/news/articleView.html?idxno=66491
4291,2019-06-07,대웅제약보툴리눔톡신주보로미국시장본격공략,http://www.sporbiz.co.kr/news/articleView.html?idxno=344584
4292,2019-06-07,대웅제약주보미국마케팅본격개시,http://www.viva100.com/main/view.php?key=20190607010001922
4293,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략,http://www.economytalk.kr/news/articleView.html?idxno=187737
4294,2019-06-07,대웅제약보툴리눔톡신미국소비자공략본격화,http://biz.chosun.com/site/data/html_dir/2019/06/07/2019060701077.html
4295,2019-06-07,대웅보툴리눔톡신주보2년내美시장2위목표,http://news.mt.co.kr/mtview.php?no=2019060710141124682
4296,2019-06-07,대웅제약보툴리눔톡신美시장공략나서,http://www.ebn.co.kr/news/view/988248
4297,2019-06-07,대웅제약보툴리눔톡신주보미국시장서마케팅돌입,http://news1.kr/articles/?3640224
4298,2019-06-07,대웅오늘주식시세7일현재17850원,http://www.nbntv.co.kr/news/articleView.html?idxno=393675
4299,2019-06-07,대웅제약보툴리눔톡신美소비자마케팅본격돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2019060700019
4300,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.econovill.com/news/articleView.html?idxno=364886
4301,2019-06-07,6월7일대웅제약실시간주식현황295157000원,http://www.nbntv.co.kr/news/articleView.html?idxno=393771
4302,2019-06-07,대웅제약전일대비약4상승한159000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906070309&t=NN
4303,2019-06-07,대웅주가및종목차트7일현재18050원증권그래프분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=120381
4304,2019-06-07,대웅제약美서나보타마케팅돌입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069111
4305,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략2년안에미국톡신시장2위목표,http://www.updownnews.co.kr/news/articleView.html?idxno=204498
4306,2019-06-07,대웅제약글로벌50위제약사진입세계RD네트워크강화,http://kpenews.com/View.aspx?No=53669
4307,2019-06-07,스타★주식인사이드대웅제약주가158000원6월7일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=776219
4308,2019-06-07,대웅제약보툴리눔톡신주보미국소비자공략나서,http://www.wikileaks-kr.org/news/articleView.html?idxno=57542
4309,2019-06-07,ET투자뉴스대웅제약_상장주식수대비거래량은05로적정수준,http://www.etnews.com/20190607000147
4310,2019-06-07,대웅제약보툴리눔톡신美마케팅돌입시장공략본격화,http://www.ezyeconomy.com/news/articleView.html?idxno=91315
4311,2019-06-07,제약업종오후시황상승률상위종목한국유니온제약693현성바이탈672대웅430등,http://www.gokorea.kr/news/articleView.html?idxno=225394
4312,2019-06-07,대웅제약미국에서보툴리눔톡신마케팅시작,http://www.businesspost.co.kr/BP?command=article_view&num=130587
4313,2019-06-07,제약업종내상승종목현성바이탈941한국유니온제약609대웅430등,http://aitimes.co.kr/news/view/56660
4314,2019-06-07,대웅제약나보타美시장공략본격화,http://www.wolyo.co.kr/news/articleView.html?idxno=85907
4315,2019-06-07,대웅제약나보타미국소비자공략본격화,http://www.newstomato.com/ReadNews.aspx?no=900216
4316,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.enewstoday.co.kr/news/articleView.html?idxno=1309700
4317,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.lawissue.co.kr/view.php?ud=201906071522126006d7f4c63cc6_12
4318,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.joseilbo.com/news/news_read.php?uid=378049&class=27&grp=
4319,2019-06-07,6월7일장마감주가정보대웅제약157000원,http://www.newsinside.kr/news/articleView.html?idxno=777228
4320,2019-06-07,대웅나보타미국시장본격마케팅,http://www.doctorsnews.co.kr/news/articleView.html?idxno=129509
4321,2019-06-07,대웅제약나보타美시장공략박차내달소비자마케팅전개,http://news.donga.com/3/all/20190607/95887594/1
4322,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.betanews.net:8080/article/1017484.html
4323,2019-06-07,7일마감증시대웅18100원마감,http://www.gokorea.kr/news/articleView.html?idxno=225644
4324,2019-06-07,가격경쟁력내세운대웅제약보툴리눔톡신미국시장정조준,http://www.iminju.net/news/articleView.html?idxno=46026
4325,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55705
4326,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.getnews.co.kr/view.php?ud=20190607182905243841d0c69529_16
4327,2019-06-07,대웅제약2년내美톡신시장2위야망,http://www.whosaeng.com/110580
4328,2019-06-07,대웅제약보툴리눔톡신미국시장마케팅돌입,http://www.kpanews.co.kr/article/show.asp?idx=204554&table=article&category=D
4329,2019-06-07,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.newscj.com/news/articleView.html?idxno=639498
4330,2019-06-08,대웅제약보툴리눔톡신美시장본격공략나서,http://www.ekn.kr/news/article.html?no=436420
4331,2019-06-08,대웅제약미국보톡스시장점유율2위진입작전본격화,http://www.seoulfn.com/news/articleView.html?idxno=345341
4332,2019-06-08,대웅제약7월부터美소비자대상보툴리눔톡신체험마케팅,http://news.heraldcorp.com/view.php?ud=20190608000042
4333,2019-06-09,국내10개제약사대웅올로스타에특허도전,http://www.mdtoday.co.kr/mdtoday/index.html?no=356802
4334,2019-06-09,대웅제약보툴리눔톡신주보미국시장본격공략,http://www.polinews.co.kr/news/article.html?no=394954
4335,2019-06-10,대웅제약아리셉트등도네페질성분의약품허가사항변경,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=231454
4336,2019-06-10,신약개발의지강화한한미약품RD비중더줄인대웅제약,http://www.datanews.co.kr/news/article.html?no=103273
4337,2019-06-10,★주식인사이드대웅제약주가158000원6월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=780801
4338,2019-06-10,아통경제10일대웅현재주식거래가격18000원,http://www.anewsa.com/detail.php?number=1801491&thread=18
4339,2019-06-10,대웅제약주가오늘시세10일현재159000원,http://www.gokorea.kr/news/articleView.html?idxno=227177
4340,2019-06-10,대웅제약보툴리눔톡신주보미국서마케팅활동돌입,http://www.rapportian.com/news/articleView.html?idxno=117969
4341,2019-06-10,6월10일대웅증권플러스05518200원,http://www.nbntv.co.kr/news/articleView.html?idxno=395491
4342,2019-06-10,6월10일대웅제약오늘주식158500원096,http://www.nbntv.co.kr/news/articleView.html?idxno=395604
4343,2019-06-10,대웅세파클러급여삭제등의약품변경사항확인해야,http://www.kpanews.co.kr/article/show.asp?idx=204568&table=article&category=B
4344,2019-06-10,스타★주식인사이드대웅제약주가158500원6월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=782372
4345,2019-06-10,대웅제약보툴리눔톡신미국시장본격공략나서,http://www.wsobi.com/news/articleView.html?idxno=75293
4346,2019-06-10,6월10일장마감주가정보대웅제약159000원,http://www.newsinside.kr/news/articleView.html?idxno=784197
4347,2019-06-10,10일주가마감정보대웅18100원마감,http://www.gokorea.kr/news/articleView.html?idxno=228030
4348,2019-06-11,대웅제약미국보툴리눔톡신시장공략나서 ,http://www.monews.co.kr/news/articleView.html?idxno=203067
4349,2019-06-11,주식현재가대웅9시28분현재가18000원종목동정,http://aitimes.co.kr/news/view/57699
4350,2019-06-11,증시현황11일대웅현재주가18000원,http://www.anewsa.com/detail.php?number=1804643&thread=18
4351,2019-06-11,대웅제약나보타유럽허가지연보완자료제출요구,http://news.mt.co.kr/mtview.php?no=2019061109332417899
4352,2019-06-11,대웅제약글로벌제약기업으로외연확대박차,http://www.iminju.net/news/articleView.html?idxno=46098
4353,2019-06-11,주가차트대웅제약주가11일현재157000원,http://www.nbntv.co.kr/news/articleView.html?idxno=396841
4354,2019-06-11,대웅주가주가정보11일현재18000원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=120873
4355,2019-06-11,스타★주식인사이드대웅제약주가157000원6월11일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=785811
4356,2019-06-11,대웅제약나보타EU집행위자료요구에유럽허가지연가능성↑,http://www.newstomato.com/ReadNews.aspx?no=900734
4357,2019-06-11,대웅제약나보타추가자료제출요구에유럽허가지연,http://moneys.mt.co.kr/news/mwView.php?no=2019061113198091965
4358,2019-06-11,함양대웅한우촌조미순대표지역인재육성장학금전달,http://www.anewsa.com/detail.php?number=1806442&thread=01r01
4359,2019-06-11,보톡스전쟁하메디톡스정현호대표가사태해결출발메디대웅당당해야,http://www.sporbiz.co.kr/news/articleView.html?idxno=345813
4360,2019-06-11,6월11일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=786984
4361,2019-06-11,대웅제약연구소현지화전략글로벌50위제약사진입목표,http://www.wolyo.co.kr/news/articleView.html?idxno=86216
4362,2019-06-11,대웅제약유럽연합에서보완자료요구해나보타유럽진출지연,http://www.businesspost.co.kr/BP?command=article_view&num=131040
4363,2019-06-12,대웅제약나보타보완자료요구로유럽허가지연,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069228
4364,2019-06-12,★주식인사이드대웅제약주가156500원6월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=788732
4365,2019-06-12,주가정보대웅9시30분현재가18000원거래정보는,http://aitimes.co.kr/news/view/58437
4366,2019-06-12,6월12일대웅정보,http://www.gokorea.kr/news/articleView.html?idxno=231201
4367,2019-06-12,증시현황12일대웅현재주가18000원,http://www.anewsa.com/detail.php?number=1807779&thread=18
4368,2019-06-12,6월12일대웅주식현재가18000원000,http://www.nbntv.co.kr/news/articleView.html?idxno=398484
4369,2019-06-12,함양대웅한우촌장학기금500만원기탁,http://www.knnews.co.kr/news/articleView.php?idxno=1290560
4370,2019-06-12,금일증시대웅제약주가12일현재155500원,http://www.nbntv.co.kr/news/articleView.html?idxno=399014
4371,2019-06-12,스타★주식인사이드대웅제약주가156000원6월12일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=790307
4372,2019-06-12,보톡스양대강자희비교차메디톡스중국진출주춤vs대웅제약미국출시진행,http://www.sporbiz.co.kr/news/articleView.html?idxno=346193
4373,2019-06-12,특징주분석매매동향대웅주가18050원마감,http://www.anewsa.com/detail.php?number=1809988&thread=18
4374,2019-06-12,6월12일장마감주가정보대웅제약156000원,http://www.newsinside.kr/news/articleView.html?idxno=791616
4375,2019-06-12,12일주가마감정보대웅18050원마감,http://www.gokorea.kr/news/articleView.html?idxno=232262
4376,2019-06-12,함양대웅한우촌조미순대표장학금기부화제,http://www.pressian.com/news/article.html?no=244563&utm_source=naver&utm_medium=search
4377,2019-06-12,대웅제약메디톡스보톡스전쟁글로벌진출발목잡나,http://www.kpinews.co.kr/news/articleView.html?idxno=97882
4378,2019-06-12,조미순대웅한우촌대표，함양군장학회장학금기탁,http://www.gnmaeil.com/news/articleView.html?idxno=417325
4379,2019-06-13,★주식인사이드대웅제약주가155500원6월13일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=793229
4380,2019-06-13,대웅제약 이온채널플랫폼바탕난청치료제개발추진,http://medipana.com/news/news_viewer.asp?NewsNum=241369&MainKind=A&NewsKind=5&vCount=12&vKind=1
4381,2019-06-13,대웅제약연세대와난청치료혁신신약개발추진,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231629
4382,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.segye.com/content/html/2019/06/13/20190613503891.html?OutUrl=naver
4383,2019-06-13,주식실황13일대웅거래가격18000원,http://www.anewsa.com/detail.php?number=1811481&thread=18
4384,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.viva100.com/main/view.php?key=20190613010003673
4385,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.dailian.co.kr/news/view/802737/?sc=naver
4386,2019-06-13,대웅제약이온채널플랫폼활용난청치료제개발,http://www.dailypharm.com/Users/News/NewsView.html?ID=253661&REFERER=NP
4387,2019-06-13,대웅제약연세대와난청치료제신약개발자체개발플랫폼활용,http://www.metroseoul.co.kr/news/newsview?newscd=2019061300018
4388,2019-06-13,대웅제약이온채널플랫폼기술력활용연세대와난청치료제신약개발,http://kpenews.com/View.aspx?No=54232
4389,2019-06-13,대웅제약 이온채널 플랫폼 기술로난청치료제신약개발 추진,http://www.medisobizanews.com/news/articleView.html?idxno=60403
4390,2019-06-13,대웅제약자체기술로2022년까지소음성난청치료제개발한다,http://moneys.mt.co.kr/news/mwView.php?no=2019061309428015883
4391,2019-06-13,대웅제약이온채널플랫폼기술을바탕으로연세대와난청치료제신약개발추진,http://www.etnews.com/20190613000062
4392,2019-06-13,대웅제약연세대와난청치료제신약개발자체개발플랫폼활용,http://www.seoulwire.com/news/articleView.html?idxno=151632
4393,2019-06-13,대웅제약연세대와치료제없는난청신약개발추진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019061309441177327
4394,2019-06-13,대웅제약이온채널플랫폼기술로연세대와난청치료제신약개발추진,http://www.asiatime.co.kr/news/articleView.html?idxno=251135
4395,2019-06-13,대웅제약난청치료제개발추진,http://www.rapportian.com/news/articleView.html?idxno=118045
4396,2019-06-13,대웅제약연세대와난청치료제혁신신약개발추진2022년1상목표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1765779
4397,2019-06-13,대웅제약연세대소음성난청치료제혁신신약개발나서,https://view.asiae.co.kr/article/2019061310171172875
4398,2019-06-13,대웅제약이온채널플랫폼기술을바탕으로연세대와난청치료제신약개발추진,http://www.fetv.co.kr/news/article.html?no=30830
4399,2019-06-13,대웅제약연세대공동개발소음성난청치료제정부지원선정,http://www.newspim.com/news/view/20190613000321
4400,2019-06-13,대웅제약소음성난청혁신신약개발착수,http://www.sportsseoul.com/news/read/775552
4401,2019-06-13,대웅제약이온채널플랫폼기술활용난청치료제신약개발추진,http://www.ceoscoredaily.com/news/article.html?no=56657
4402,2019-06-13,대웅제약연세대와난청치료신약개발추진,http://news.heraldcorp.com/view.php?ud=20190613000290
4403,2019-06-13,대웅제약난청치료혁신신약개발나서,http://www.newstomato.com/ReadNews.aspx?no=901284
4404,2019-06-13,대웅제약이온채널플랫폼기술을바탕으로연세대와신약개발추진,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55812
4405,2019-06-13,대웅제약연세대와손잡고소음성난청치료제신약개발착수,http://www.ezyeconomy.com/news/articleView.html?idxno=91450
4406,2019-06-13,대웅제약이온채널플랫폼기술로난청치료제신약개발추진,http://daily.hankooki.com/lpage/ittech/201906/dh20190613110300145630.htm
4407,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.economytalk.kr/news/articleView.html?idxno=188305
4408,2019-06-13,대웅제약연세대와난청치료제신약개발FirstinClass추진,http://www.koreaittimes.com/news/articleView.html?idxno=91263
4409,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.bosa.co.kr/news/articleView.html?idxno=2106986
4410,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.sisafocus.co.kr/news/articleView.html?idxno=212139
4411,2019-06-13,대웅제약이온채널플랫폼기술바탕으로연세대와난청치료제신약개발추진,http://www.wsobi.com/news/articleView.html?idxno=75572
4412,2019-06-13,대웅제약자체기술로소음성난청치료제신약개발추진,http://www.sporbiz.co.kr/news/articleView.html?idxno=346550
4413,2019-06-13,대웅제약이온채널플랫폼기술바탕연세대와난청치료제신약개발추진,http://www.ekn.kr/news/article.html?no=437318
4414,2019-06-13,스타★주식인사이드대웅제약주가157500원6월13일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=794843
4415,2019-06-13,대웅제약이온채널플랫폼기술로연세대와난청치료제신약개발,http://www.mdtoday.co.kr/mdtoday/index.html?no=357230
4416,2019-06-13,대웅제약연세대와난청치료신약개발추진,http://biz.chosun.com/site/data/html_dir/2019/06/13/2019061301468.html
4417,2019-06-13,대웅제약난청치료제프로젝트과기부서후보물질도출RD지원받기로,http://news.mk.co.kr/newsRead.php?year=2019&no=414746
4418,2019-06-13,대웅제약소음성난청치료제신약개발나선다,http://www.joseilbo.com/news/news_read.php?uid=378415&class=17&grp=
4419,2019-06-13,대웅제약연세대와손잡고소음성난청치료제신약개발추진,http://www.businesspost.co.kr/BP?command=article_view&num=131275
4420,2019-06-13,대웅제약이온채널플랫폼기술로난청치료제신약개발추진,http://www.getnews.co.kr/view.php?ud=20190613150524508941d0c69529_16
4421,2019-06-13,대웅제약난청치료제신약개발나선다,http://www.bokuennews.com/news/article.html?no=177010
4422,2019-06-13,대웅제약난청치료제혁신신약개발추진연세대이비인후과협업,http://news.donga.com/3/all/20190613/95979911/1
4423,2019-06-13,대웅제약이온채널플랫폼기술난청치료제신약개발추진,http://www.ajunews.com/view/20190613153758001
4424,2019-06-13,대웅난청치료혁신신약개발착수,http://www.whosaeng.com/110727
4425,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.ebn.co.kr/news/view/989047
4426,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.shinailbo.co.kr/news/articleView.html?idxno=1175922
4427,2019-06-13,대웅제약연세대소음성난청치료제개발 ,http://www.seoulfn.com/news/articleView.html?idxno=345931
4428,2019-06-13,6월13일장마감주가정보대웅제약158000원,http://www.newsinside.kr/news/articleView.html?idxno=795917
4429,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.medigatenews.com/news/3425349422
4430,2019-06-13,대웅제약연세대와난청치료신약개발추진,http://www.dailymedi.com/detail.php?number=844145&thread=22r05
4431,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.100ssd.co.kr/news/articleView.html?idxno=62004
4432,2019-06-13,대웅제약연세대이온채널플랫폼기술활용난청치료제개발추진,http://www.wolyo.co.kr/news/articleView.html?idxno=86365
4433,2019-06-13,대웅제약이온채널플랫폼기술기반연세대와난청치료제신약개발추진,http://www.enewstoday.co.kr/news/articleView.html?idxno=1311845
4434,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://news.mt.co.kr/mtview.php?no=2019061317373875398
4435,2019-06-13,대웅제약소음성난청치료제신약개발나선다,http://www.mhj21.com/121899
4436,2019-06-13,대웅제약연세대와난청치료용혁신신약개발추진,http://www.econovill.com/news/articleView.html?idxno=365406
4437,2019-06-13,대웅제약이온채널플랫폼기술바탕으로연세대와난청치료제신약개발추진,https://www.insight.co.kr/news/232102
4438,2019-06-13,대웅연세대 이온채널플랫폼기반신약개발추진,http://www.kpanews.co.kr/article/show.asp?idx=204706&table=article&category=D
4439,2019-06-13,대웅제약연세대와난청치료제신약개발추진,http://www.newscj.com/news/articleView.html?idxno=641317
4440,2019-06-14,대웅제약이온채널플랫폼기술로연세대와난청치료제신약개발추진,http://www.lawissue.co.kr/view.php?ud=201906140312001496d7f4c63cc6_12
4441,2019-06-14,대웅디엔컴퍼니에스테메드미라클스파5종출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1766185
4442,2019-06-14,★주식인사이드대웅제약주가155500원6월14일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=797778
4443,2019-06-14,주가정보대웅9시27분현재가18050원종목동정,http://aitimes.co.kr/news/view/59858
4444,2019-06-14,증시보고14일대웅주가18000원,http://www.anewsa.com/detail.php?number=1815187&thread=18
4445,2019-06-14,대웅주가그래프14일현재17950원,http://nbntv.co.kr/news/view/401120
4446,2019-06-14,뉴스워커_대웅그룹디엔컴퍼니에스테메드미라클스파5종출시,http://www.newsworker.co.kr/news/articleView.html?idxno=31522
4447,2019-06-14,6월14일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=235591
4448,2019-06-14,6월14일대웅제약주식증권155000원190,http://nbntv.co.kr/news/view/401644
4449,2019-06-14,난청치료신약개발나선대웅제약퍼스트인클래스목표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069337
4450,2019-06-14,스타★주식인사이드대웅제약주가155500원6월14일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=799364
4451,2019-06-14,대웅디엔컴퍼니피부휴식제공위한에스테메드미라클스파5종출시,http://www.techholic.co.kr/news/articleView.html?idxno=183025
4452,2019-06-14,ET투자뉴스대웅_거래비중기관3732외국인2429,http://www.etnews.com/20190614000158
4453,2019-06-14,대웅디엔컴퍼니안심성분활용한에스테메드미라클스파5종출시,http://www.updownnews.co.kr/news/articleView.html?idxno=204828
4454,2019-06-14,6월14일장마감주가정보대웅제약154500원,http://www.newsinside.kr/news/articleView.html?idxno=800537
4455,2019-06-14,14일마감주가정보대웅주가17800원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=236399
4456,2019-06-14,대웅제약나보타성공비결은선택과집중”전담조직설립해전사역량투입,http://news.donga.com/3/all/20190614/96000118/1
4457,2019-06-14,대웅제약연세대와난청치료제혁신신약개발추진,http://www.polinews.co.kr/news/article.html?no=395619
4458,2019-06-16,컬투쇼빅맨본명은대웅큰대수컷웅써서예명지은것,http://biz.heraldcorp.com/view.php?ud=201906161519457295843_1
4459,2019-06-17,대웅제약연세대와난청치료제신약개발나서 ,http://www.monews.co.kr/news/articleView.html?idxno=203183
4460,2019-06-17,★주식인사이드대웅제약주가153500원6월17일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=804410
4461,2019-06-17,대웅주가6월17일현재17750원,http://www.gokorea.kr/news/articleView.html?idxno=237580
4462,2019-06-17,6월17일대웅주식증권17700원056,http://nbntv.co.kr/news/view/404521
4463,2019-06-17,종목추적17일대웅증시현황17700원,http://www.anewsa.com/detail.php?number=1818776&thread=18
4464,2019-06-17,부음김효상대웅건설업무이사태진건설산업대표이사씨부친상,http://www.cnews.co.kr/uhtml/read.jsp?idxno=201906171033345730970
4465,2019-06-17,6월17일대웅제약종목검색153500원065,http://nbntv.co.kr/news/view/405056
4466,2019-06-17,스타★주식인사이드대웅제약주가154000원6월17일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=806461
4467,2019-06-17,ET투자뉴스대웅_거래비중기관3766외국인2486,http://www.etnews.com/20190617000214
4468,2019-06-17,대웅제약美에서두번째IR나보타앞세워기업가치알린다,http://www.metroseoul.co.kr/news/newsview?newscd=2019061700108
4469,2019-06-17,보톡스분쟁에발목잡힌메디톡스대웅제약글로벌진출적신호,http://www.enewstoday.co.kr/news/articleView.html?idxno=1312832
4470,2019-06-17,6월17일장마감주가정보대웅제약154000원,http://www.newsinside.kr/news/articleView.html?idxno=806896
4471,2019-06-17,보톡스때문에주름깊어가는대웅메디톡스,http://www.newsway.co.kr/news/view?tp=1&ud=2019061714483703844
4472,2019-06-17,17일마감정보대웅17000원마감,http://www.gokorea.kr/news/articleView.html?idxno=238658
4473,2019-06-17,전승호대웅제약사장나보타잇는폐섬유증신약도전발빠른행보,http://www.ekn.kr/news/article.html?no=438003
4474,2019-06-18,대웅올로스타잡아라후발제약사잇따라특허도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=253774&REFERER=NP
4475,2019-06-18,★주식인사이드대웅제약주가154000원6월18일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=808544
4476,2019-06-18,현재가대웅9시27분현재가17100원거래정보는,http://aitimes.co.kr/news/view/61660
4477,2019-06-18,대웅주가차트18일현재17100원,http://nbntv.co.kr/news/view/407446
4478,2019-06-18,국내주식시장주가18일대웅증시현황17150원,http://www.anewsa.com/detail.php?number=1821844&thread=18
4479,2019-06-18,6월18일대웅제약주식현재가032154500원,http://nbntv.co.kr/news/view/407981
4480,2019-06-18,스타★주식인사이드대웅제약주가153500원6월18일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=810117
4481,2019-06-18,6월18일장마감주가정보대웅제약152500원,http://www.newsinside.kr/news/articleView.html?idxno=811621
4482,2019-06-18,18일마감주가정보대웅17000원마감,http://www.gokorea.kr/news/articleView.html?idxno=240842
4483,2019-06-19,지긋지긋메디톡스대웅제약그래도갈길간다,http://news.bizwatch.co.kr/article/consumer/2019/06/18/0026/naver
4484,2019-06-19,★주식인사이드대웅제약주가154000원6월19일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=813048
4485,2019-06-19,6월19일대웅증권주식02917050원,http://nbntv.co.kr/news/view/410339
4486,2019-06-19,증시보고19일대웅증시현황17050원,http://www.anewsa.com/detail.php?number=1824852&thread=18
4487,2019-06-19,6월19일대웅제약주식창153500원066,http://nbntv.co.kr/news/view/410886
4488,2019-06-19,바른의료연구소감사원대웅제약우루사TV광고에서간수치개선부분사용할수없다판단,http://www.medigatenews.com/news/1432987227
4489,2019-06-19,바른의료연구소대웅제약우루사TV광고간수치개선부분사용할수없어,http://www.mdtoday.co.kr/mdtoday/index.html?no=357753
4490,2019-06-19,스타★주식인사이드대웅제약주가153000원6월19일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=814597
4491,2019-06-19,종목현재가대웅14시23분현재가17050원연중최고가얼마,http://aitimes.co.kr/news/view/62540
4492,2019-06-19,대웅제약넥스트나보타준비한창RD경쟁력승부수,http://www.wolyo.co.kr/news/articleView.html?idxno=86849
4493,2019-06-19,19일마감주가정보대웅주가16950원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=242851
4494,2019-06-19,전승호대웅제약나보타로엘러간보톡스의아성미국과유럽도전,http://www.businesspost.co.kr/BP?command=article_view&num=132078
4495,2019-06-20,대웅올로스타한미이소티논등대조약신규지정,http://www.dailypharm.com/Users/News/NewsView.html?ID=253870&REFERER=NP
4496,2019-06-20,★주식인사이드대웅제약주가154500원6월20일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=817405
4497,2019-06-20,증시현황20일대웅주가17050원,http://www.anewsa.com/detail.php?number=1827920&thread=18
4498,2019-06-20,대웅실시간주식현황20일현재17050원,http://nbntv.co.kr/news/view/413248
4499,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.fetv.co.kr/news/article.html?no=31295
4500,2019-06-20,대웅제약생명공학연구원실험동물자원센터와전략적제휴체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231885
4501,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.viva100.com/main/view.php?key=20190620010006016
4502,2019-06-20,​대웅제약 생명硏실험동물자원센터와모델링공동연구,http://medipana.com/news/news_viewer.asp?NewsNum=241697&MainKind=A&NewsKind=5&vCount=12&vKind=1
4503,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.newsway.co.kr/news/view?tp=1&ud=2019062009480619215
4504,2019-06-20,대웅제약한국생명공학硏과모델링및시뮬레이션공동연구나선다,http://daily.hankooki.com/lpage/ittech/201906/dh20190620094810145630.htm
4505,2019-06-20,대웅제약생명연과전략적제휴체결,http://www.whosaeng.com/110893
4506,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터MOU체결,http://biz.chosun.com/site/data/html_dir/2019/06/20/2019062000882.html
4507,2019-06-20,대웅제약생명연실험동물자원센터와공동연구개발MOU체결,http://www.edaily.co.kr/news/newspath.asp?newsid=02023766622523688
4508,2019-06-20,대웅제약생명공학연구원실험동물자원센터와MOU,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3866413
4509,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.newspim.com/news/view/20190620000243
4510,2019-06-20,대웅제약우루사간수치개선TV광고철퇴,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062009044113860
4511,2019-06-20,대웅제약생명공학硏모델링공동연구개발맞손,https://view.asiae.co.kr/article/2019062010103775135
4512,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.betanews.net:8080/article/1021713.html
4513,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU,http://www.segye.com/content/html/2019/06/20/20190620504693.html?OutUrl=naver
4514,2019-06-20,대웅제약생명硏실험동물자원센터와약효예측등기술개발MOU,http://www.medisobizanews.com/news/articleView.html?idxno=60564
4515,2019-06-20,대웅제약생명硏실험동물자원센터와공동연구MOU,http://www.kpinews.co.kr/news/articleView.html?idxno=98245
4516,2019-06-20,대웅제약생명硏실험동물자원센터와MOU,http://www.bosa.co.kr/news/articleView.html?idxno=2107396
4517,2019-06-20,대웅제약한생연공동연구개발MOU오픈컬래버레이션확대,http://moneys.mt.co.kr/news/mwView.php?no=2019062010098063137
4518,2019-06-20,대웅제약생명연과동물임상전략적제휴,http://news.mt.co.kr/mtview.php?no=2019062009531269001
4519,2019-06-20,대웅제약생명공학연구원과연구개발업무협약맺어,http://www.rapportian.com/news/articleView.html?idxno=118174
4520,2019-06-20,대웅제약한국생명공학연구원과공동연구개발MOU체결,https://www.sedaily.com/NewsView/1VKHP3M2PB
4521,2019-06-20,대웅제약생명공학연구원과모델링시뮬레이션기법개발맞손,http://news.mk.co.kr/newsRead.php?year=2019&no=438234
4522,2019-06-20,대웅제약생명공학硏실험동물자원센터협력MOU,http://news.heraldcorp.com/view.php?ud=20190620000266
4523,2019-06-20,대웅제약생명공학硏실험동물자원센터와MOU체결,http://www.dailymedi.com/detail.php?number=844387&thread=22r05
4524,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.seoulwire.com/news/articleView.html?idxno=157091
4525,2019-06-20,대웅제약한국생명공학연구원과공동연구개발MOU체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1313921
4526,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터공동연구개발MOU,http://www.newsprime.co.kr/news/article.html?no=464344
4527,2019-06-20,대웅제약생명硏실험동물자원센터와공동연구MOU,http://kormedi.com/?p=1295789
4528,2019-06-20,6월20일대웅제약주식추천주154500원131,http://nbntv.co.kr/news/view/413802
4529,2019-06-20,대웅제약생명연과협약모델링시뮬레이션기법활용,http://www.dailypharm.com/Users/News/NewsView.html?ID=253891&REFERER=NP
4530,2019-06-20,대웅제약모델링및시뮬레이션기술로임상기간비용축소박차,http://www.100ssd.co.kr/news/articleView.html?idxno=62185
4531,2019-06-20,대웅제약한국생명공학연구원과산연협력MOU통한콜라보레이션,http://www.updownnews.co.kr/news/articleView.html?idxno=205061
4532,2019-06-20,대웅제약모델링연구착수신약성공률↑비용시간↓,http://www.econovill.com/news/articleView.html?idxno=365885
4533,2019-06-20,종목현재가대웅11시29분현재가16950원연중최고가얼마,http://aitimes.co.kr/news/view/63285
4534,2019-06-20,대웅제약모델링시뮬레이션협업강화한국생명공학연구원과MOU,http://kpenews.com/View.aspx?No=55014
4535,2019-06-20,대웅제약생명硏실험동물자원센터와MOU체결,http://www.ebn.co.kr/news/view/989841
4536,2019-06-20,대웅제약BestInClass항궤양제DWP14012연구박차,http://medipana.com/news/news_viewer.asp?NewsNum=241719&MainKind=A&NewsKind=5&vCount=12&vKind=1
4537,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.etnews.com/20190620000109
4538,2019-06-20,대웅올로맥스시장연착륙블록버스터도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=253893&REFERER=NP
4539,2019-06-20,스타★주식인사이드대웅제약주가154000원6월20일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=819774
4540,2019-06-20,대웅제약신약개발에모델링시뮬레이션활용,http://www.finomy.com/news/articleView.html?idxno=66899
4541,2019-06-20,대웅제약한국생명공학연구원과약물효과예측기술개발,http://www.businesspost.co.kr/BP?command=article_view&num=132207
4542,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴,http://www.dailian.co.kr/news/view/804500/?sc=naver
4543,2019-06-20,대웅제약한국생명공학연구원공동연구개발MOU체결,http://www.wolyo.co.kr/news/articleView.html?idxno=86936
4544,2019-06-20,대웅제약모델링시뮬레이션도입해신약개발기간단축”생명硏과업무협약,http://www.donga.com/news/article/all/20190620/96085891/1
4545,2019-06-20,대웅제약시뮬레이션기법신약개발적극활용,http://www.sisaon.co.kr/news/articleView.html?idxno=95771
4546,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.medigatenews.com/news/785603280
4547,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.wsobi.com/news/articleView.html?idxno=76030
4548,2019-06-20,대웅제약생명공학연구원실험동물자원센터와MOU체결,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062014473386915
4549,2019-06-20,대웅제약생명공학연구원실험동물자원센터와MOU,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1215521
4550,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU,http://www.bokuennews.com/news/article.html?no=177345
4551,2019-06-20,​대웅제약한국생명공학硏실험동물자원센터와MOU신약개발성공률제고”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1768441
4552,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴MOU체결,http://www.newstomato.com/ReadNews.aspx?no=902846
4553,2019-06-20,대웅제약생명연실험동물자원센터신약기술공동연구,http://www.seoulfn.com/news/articleView.html?idxno=346694
4554,2019-06-20,6월20일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=820096
4555,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU,http://www.mhj21.com/122084
4556,2019-06-20,대웅제약생명공학연구원공동연구개발업무협약,http://www.metroseoul.co.kr/news/newsview?newscd=2019062000177
4557,2019-06-20,대웅제약생명硏과공동RD추진,http://weekly.cnbnews.com/news/article.html?no=128541
4558,2019-06-20,대웅제약생명硏실험동물자원센터와MOU체결,http://www.wikileaks-kr.org/news/articleView.html?idxno=58510
4559,2019-06-20,대웅제약모델링시뮬레이션기술로신약개발박차,http://www.k-health.com/news/articleView.html?idxno=44437
4560,2019-06-20,대웅제약생명연실험동물센자원센터와MOU체결,http://www.biospectator.com/view/news_view.php?varAtcId=7883
4561,2019-06-20,대웅제약생명공학연구원과모델링시뮬레이션기법개발MOU,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906200516&t=NN
4562,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.getnews.co.kr/view.php?ud=20190620192806969241d0c69529_16
4563,2019-06-20,대웅제약 한국생명공학연구원실험동물자원센터와MOU 체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=33098
4564,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.lawissue.co.kr/view.php?ud=201906202158221752d7f4c63cc6_12
4565,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.newscj.com/news/articleView.html?idxno=643551
4566,2019-06-20,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55930
4567,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와전략적MOU체결,http://www.polinews.co.kr/news/article.html?no=396842
4568,2019-06-21,대웅제약한국생명공학연구원과약효예측모델링기술개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069524
4569,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴체결,http://www.ekn.kr/news/article.html?no=438733
4570,2019-06-21,신약개발드라이브거는대웅임상모델링연구진행,http://www.monews.co.kr/news/articleView.html?idxno=203284
4571,2019-06-21,★주식인사이드대웅제약주가155500원6월21일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=822169
4572,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.asiatime.co.kr/news/articleView.html?idxno=252804
4573,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와MOU체결,http://www.sporbiz.co.kr/news/articleView.html?idxno=349142
4574,2019-06-21,증시보고21일대웅현재가격17200원,http://www.anewsa.com/detail.php?number=1831040&thread=18
4575,2019-06-21,6월21일대웅투자주식17100원172,http://nbntv.co.kr/news/view/416064
4576,2019-06-21,대웅제약주가6월21일현재153500원,http://www.gokorea.kr/news/articleView.html?idxno=246192
4577,2019-06-21,종목현재가대웅11시27분현재가17100원종목동정,http://aitimes.co.kr/news/view/64020
4578,2019-06-21,대웅제약증권플러스21일현재154000원,http://nbntv.co.kr/news/view/416605
4579,2019-06-21,스타★주식인사이드대웅제약주가154000원6월21일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=824143
4580,2019-06-21,대웅제약한국생명공학연구원실험동물자원센터와전략적제휴,http://www.kukinews.com/news/article.html?no=674528
4581,2019-06-21,6월21일장마감주가정보대웅제약154500원,http://www.newsinside.kr/news/articleView.html?idxno=824843
4582,2019-06-21,대웅제약생명공학연구원실험동물자원센터와전략적제휴,http://www.joseilbo.com/news/news_read.php?uid=378908&class=27&grp=
4583,2019-06-21,21일마감주가정보대웅주가16900원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=246935
4584,2019-06-21,우루사타격대웅제약바른의료연구소가잘못된주장,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062117042559153
4585,2019-06-21,바른의료연구소대웅제약우루사효과놓고설왕설래감사원답변에또마찰,http://www.ntoday.co.kr/news/articleView.html?idxno=67266
4586,2019-06-21,대웅제약우루사광고관련바른의료연주장사실과달라,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231968
4587,2019-06-21,대웅제약바른의료연구소우르사관련주장일부사실과달라,http://www.mdtoday.co.kr/mdtoday/index.html?no=358006
4588,2019-06-21,대웅제약우루사저격에깨알반박,http://www.whosaeng.com/110935
4589,2019-06-22,대웅제약간판제품우루사효능구설수,http://www.ajunews.com/view/20190621222804053
4590,2019-06-22,대웅나보타미국발매한달만에시술5천건돌파,http://www.dailypharm.com/Users/News/NewsView.html?ID=253962&REFERER=NP
4591,2019-06-22,우루사간수치개선거짓대웅이미검증됐다,http://www.kpanews.co.kr/article/show.asp?idx=204900&table=article&category=D
4592,2019-06-24,우루사효능재논란에대웅제약한숨,http://www.bosa.co.kr/news/articleView.html?idxno=2107546
4593,2019-06-24,대웅제약나보타주연구자임상시험유독많은이유는,http://www.ceoscoredaily.com/news/article.html?no=57016
4594,2019-06-24,대웅제약주식매수의견유지나보타미국수출로2분기실적기대,http://www.businesspost.co.kr/BP?command=article_view&num=132579
4595,2019-06-24,퀵리포트대웅매수유지목표가6↓2만7000원상상인證,http://www.itooza.com/common/iview.php?no=2019062407301816938
4596,2019-06-24,퀵리포트대웅제약매수유지목표가30만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019062407502211325
4597,2019-06-24,대웅제약나보타수출호조에높아진2Q기대감KTB,http://www.ebn.co.kr/news/view/990191
4598,2019-06-24,★주식인사이드대웅제약주가160000원6월24일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=826889
4599,2019-06-24,대웅제약5이상상승주가상승흐름단기이평선정배열중기이평선역배열,https://www.hankyung.com/finance/article/201906243015L
4600,2019-06-24,제약업종주요종목오전시황1위대웅제약5182위코오롱생명과학3963위광동제약381,http://www.anewsa.com/detail.php?number=1834104&thread=18
4601,2019-06-24,ET투자뉴스대웅_투심약세거래량침체현재주가는보통,http://www.etnews.com/20190624000028
4602,2019-06-24,대웅5이상상승주가20일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/201906243036L
4603,2019-06-24,증시현황24일대웅거래가격17700원,http://www.anewsa.com/detail.php?number=1834215&thread=18
4604,2019-06-24,6월24일대웅증권투자정보외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=247937
4605,2019-06-24,6월24일대웅주식종목62117950원,http://nbntv.co.kr/news/view/418939
4606,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232000
4607,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득미용치료분야에서지속적으로적응증확대해나갈것,http://www.segye.com/content/html/2019/06/24/20190624503226.html?OutUrl=naver
4608,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련적응증추가획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1769328
4609,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://news.heraldcorp.com/view.php?ud=20190624000186
4610,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=33155
4611,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1314887
4612,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득총4개적응증확보,http://www.viva100.com/main/view.php?key=20190624010007053
4613,2019-06-24,대웅나보타눈꺼풀경련에적응증,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86454
4614,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newspim.com/news/view/20190624000194
4615,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득총4개의적응증확보”,https://www.sedaily.com/NewsView/1VKJIPV7PW
4616,2019-06-24,장중수급포착대웅외국인기관동시순매수주가385,http://www.newspim.com/news/view/20190624000302
4617,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,https://view.asiae.co.kr/article/2019062410204580986
4618,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062410090893182
4619,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.medisobizanews.com/news/articleView.html?idxno=60638
4620,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.ekn.kr/news/article.html?no=439140
4621,2019-06-24,대웅제약나보타적응증추가획득으로경쟁사차별화,http://moneys.mt.co.kr/news/mwView.php?no=2019062410208082007
4622,2019-06-24,대웅제약나보타주눈꺼풀경련적응증추가,http://www.dailypharm.com/Users/News/NewsView.html?ID=253988&REFERER=NP
4623,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://www.kpinews.co.kr/news/articleView.html?idxno=98437
4624,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.etnews.com/20190624000075
4625,2019-06-24,대웅나보타눈꺼풀경련적응증획득,http://www.whosaeng.com/110943
4626,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://daily.hankooki.com/lpage/ittech/201906/dh20190624103550145630.htm
4627,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=358084
4628,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.mk.co.kr/newsRead.php?year=2019&no=449162
4629,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.econovill.com/news/articleView.html?idxno=366128
4630,2019-06-24,대웅제약나보타식약처로부터눈꺼풀경련적응증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=12625
4631,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019062400063
4632,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.fetv.co.kr/news/article.html?no=31505
4633,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.ajunews.com/view/20190624105139958
4634,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.dailian.co.kr/news/view/805276/?sc=naver
4635,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://medipana.com/news/news_viewer.asp?NewsNum=241834&MainKind=A&NewsKind=5&vCount=12&vKind=1
4636,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://biz.chosun.com/site/data/html_dir/2019/06/24/2019062401116.html
4637,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.seoulwire.com/news/articleView.html?idxno=159308
4638,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.dailymedi.com/detail.php?number=844493&thread=22r05
4639,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.bokuennews.com/news/article.html?no=177466
4640,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.biospectator.com/view/news_view.php?varAtcId=7897
4641,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.mt.co.kr/mtview.php?no=2019062409583070800
4642,2019-06-24,종목현재가대웅11시23분현재가17400원종목동정,http://aitimes.co.kr/news/view/64797
4643,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019062411243516114
4644,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련개선추가,http://www.sportsseoul.com/news/read/780299
4645,2019-06-24,6월24일대웅제약주식장160000원356,http://nbntv.co.kr/news/view/419480
4646,2019-06-24,대웅나보타눈꺼풀경련치료적응증획득,http://www.doctorsnews.co.kr/news/articleView.html?idxno=129710
4647,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득치료분야로확대,http://www.koreaittimes.com/news/articleView.html?idxno=91455
4648,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2107602
4649,2019-06-24,대웅제약나보타식품의약품안전처로부터눈꺼풀경련적응증따내,http://www.businesspost.co.kr/BP?command=article_view&num=132617
4650,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련적응증획득,https://www.hankyung.com/it/article/201906243588f
4651,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069600
4652,2019-06-24,대웅제약바른의료연구소우루사광고지적사실아냐”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069605
4653,2019-06-24,식약처대웅제약나보타눈꺼풀경련적응증추가승인,http://www.ezyeconomy.com/news/articleView.html?idxno=91703
4654,2019-06-24,대웅제약보툴리눔톡신나보타눈꺼풀경련적응증추가,http://news1.kr/articles/?3653004
4655,2019-06-24,스타★주식인사이드대웅제약주가158500원6월24일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=829262
4656,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가,http://www.shinailbo.co.kr/news/articleView.html?idxno=1178775
4657,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득총4개적응증확보,http://www.wolyo.co.kr/news/articleView.html?idxno=87256
4658,2019-06-24,대웅대웅바이오의CNS계열고성장하나실적성장둔화”,http://www.wikitree.co.kr/main/news_view.php?id=439263
4659,2019-06-24,대웅제약나보타미국으로의수출지속”,http://www.wikitree.co.kr/main/news_view.php?id=439274
4660,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newstomato.com/ReadNews.aspx?no=903309
4661,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=58727
4662,2019-06-24,대웅제약우루사간기능개선효과있다바른의료연구소주장반박나서,http://www.medigatenews.com/news/3017778715
4663,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.medigatenews.com/news/1869566252
4664,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55979
4665,2019-06-24,대웅제약나보타눈꺼풀경련적응증받아,http://news.mk.co.kr/newsRead.php?year=2019&no=450184
4666,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.ebn.co.kr/news/view/990311
4667,2019-06-24,대웅제약나보타식약처로부터눈꺼풀경련적응증획득,http://www.mhj21.com/122134
4668,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.marketnews.co.kr/view.php?ud=20190624144916515323217b15af_24
4669,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.paxnetnews.com/articles/49963
4670,2019-06-24,대웅제약나보타눈꺼풀경련적응증추가획득,http://www.newsprime.co.kr/news/article.html?no=464729
4671,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.economytalk.kr/news/articleView.html?idxno=189309
4672,2019-06-24,대웅제약나보타식약처로부터눈꺼풀경련적응증받아총4총획득,http://www.updownnews.co.kr/news/articleView.html?idxno=205187
4673,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.joseilbo.com/news/news_read.php?uid=379007&class=27&grp=
4674,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.fnnews.com/news/201906241549050718
4675,2019-06-24,대웅제약나보타美판매중단가능성공시안해,http://www.shinailbo.co.kr/news/articleView.html?idxno=1178798
4676,2019-06-24,대웅제약나보타100유닛눈꺼풀경련적응증획득치료분야경쟁력↑,http://www.donga.com/news/article/all/20190624/96158540/1
4677,2019-06-24,24일마감주가정보대웅17250원마감,http://www.gokorea.kr/news/articleView.html?idxno=248912
4678,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.getnews.co.kr/view.php?ud=2019062416232398241d0c69529_16
4679,2019-06-24,6월24일장마감주가정보대웅제약158500원,http://www.newsinside.kr/news/articleView.html?idxno=830430
4680,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906240317&t=NN
4681,2019-06-24,인기종목종목정보24일대웅마감증시17250원,http://nbntv.co.kr/news/view/420944
4682,2019-06-24,대웅제약전일대비약5상승한161500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906240367&t=NN
4683,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://weekly.cnbnews.com/news/article.html?no=128609
4684,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.asiatime.co.kr/news/articleView.html?idxno=253439
4685,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.seoulfn.com/news/articleView.html?idxno=347006
4686,2019-06-24,특징주주가정보6월24일대웅제약158500원으로장마감,http://nbntv.co.kr/news/view/421668
4687,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.newscj.com/news/articleView.html?idxno=644499
4688,2019-06-24,대웅제약나보타눈꺼풀경련적응증획득,http://www.lawissue.co.kr/view.php?ud=201906242351095671d7f4c63cc6_12
4689,2019-06-25,대웅제약나보타눈꺼풀경련적응증획득,http://www.kpanews.co.kr/article/show.asp?idx=204943&table=article&category=D
4690,2019-06-25,★주식인사이드대웅제약주가157500원6월25일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=831686
4691,2019-06-25,GET투자리포트대웅투자의견매수유지상상인증권,http://www.getnews.co.kr/view.php?ud=201906241030307253tpgetnews_16
4692,2019-06-25,ET투자뉴스대웅그럼에도크게저평BUY유지상상인증권,http://www.etnews.com/20190625000036
4693,2019-06-25,종목추적25일대웅현재가격17150원,http://www.anewsa.com/detail.php?number=1837361&thread=18
4694,2019-06-25,주식현황대웅주가25일현재17150원,http://nbntv.co.kr/news/view/422113
4695,2019-06-25,ET투자뉴스대웅제약_투심과거래량은약세현재주가는보통,http://www.etnews.com/20190625000097
4696,2019-06-25,증권플러스대웅제약주가25일현재155500원,http://nbntv.co.kr/news/view/422656
4697,2019-06-25,대웅제약만성통증치료제DWP17061글로벌심포지엄서주목,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232084
4698,2019-06-25,대웅제약글로벌심포지엄에서만성통증치료제전임상결과발표,https://www.hankyung.com/it/article/201906257052f
4699,2019-06-25,대웅제약만성통증치료제글로벌심포지엄서시선집중,http://www.medisobizanews.com/news/articleView.html?idxno=60673
4700,2019-06-25,대웅제약2019이온채널심포지엄비마약성통증치료제전임상결과발표,http://www.segye.com/content/html/2019/06/25/20190625507058.html?OutUrl=naver
4701,2019-06-25,대웅제약Nav17만성통증치료제글로벌심포지엄서주목받아,http://www.businesskorea.co.kr/news/articleView.html?idxno=33231
4702,2019-06-25,대웅제약Nav17만성통증치료제DWP17061글로벌심포지엄서주목,http://www.betanews.net:8080/article/1023536.html
4703,2019-06-25,대웅제약나보타에웃고우루사에울고,http://www.econovill.com/news/articleView.html?idxno=366233
4704,2019-06-25,스타★주식인사이드대웅제약주가153000원6월25일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=833243
4705,2019-06-25,대웅제약만성통증신약후보물질글로벌심포지엄서소개,http://www.sportsseoul.com/news/read/780855
4706,2019-06-25,대웅제약개발중인만성통증치료제국제심포지엄서주목,http://www.metroseoul.co.kr/news/newsview?newscd=2019062500077
4707,2019-06-25,대웅제약비마약성통증치료제전임상결과공개통증신호전달억제,http://www.ceoscoredaily.com/news/article.html?no=57115
4708,2019-06-25,대웅제약글로벌심포지엄서만성통증치료제전임상결과공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1769856
4709,2019-06-25,대웅제약Nav17타겟만성통증신약세계적주목,http://www.bosa.co.kr/news/articleView.html?idxno=2107697
4710,2019-06-25,대웅제약비마약성만성통증신약효능입증,http://news.mt.co.kr/mtview.php?no=2019062512031648964
4711,2019-06-25,대웅만성통증치료제DWP17061글로벌심포지엄서주목,http://medipana.com/news/news_viewer.asp?NewsNum=241911&MainKind=A&NewsKind=5&vCount=12&vKind=1
4712,2019-06-25,대웅제약비마약성만성통증치료제DWP1706전임상결과공개,http://www.viva100.com/main/view.php?key=20190625010007639
4713,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,https://www.sedaily.com/NewsView/1VKJZUFLZF
4714,2019-06-25,비마약통증치료제관심폭발대웅제약전임상결과발표,http://kpenews.com/View.aspx?No=55543
4715,2019-06-25,대웅제약비마약성만성통증치료제DWP17061전임상결과발표유효성입증,http://www.ezyeconomy.com/news/articleView.html?idxno=91743
4716,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,http://www.etnews.com/20190625000235
4717,2019-06-25,신약개발통한글로벌시장진출초읽기대웅제약2019이온채널심포지엄참석해전임상결과공개,http://www.updownnews.co.kr/news/articleView.html?idxno=205238
4718,2019-06-25,대웅제약2019이온채널심포지엄서비마약성통증치료제전임상결과공개,http://www.ekn.kr/news/article.html?no=439433
4719,2019-06-25,대웅제약만성통증신약후보영국심포지엄서소개,http://www.dailypharm.com/Users/News/NewsView.html?ID=254055&REFERER=NP
4720,2019-06-25,뉴스투데이L대웅제약글로벌무대서만성통증치료제DWP17061주목받아,http://www.news2day.co.kr/130449
4721,2019-06-25,대웅제약이온채널심포지엄서비마약성통증치료제전임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=454600
4722,2019-06-25,대웅제약영국에서열린심포지엄에서만성통증치료제효능공개,http://www.businesspost.co.kr/BP?command=article_view&num=132804
4723,2019-06-25,대웅제약비마약성만성통증치료제DWP17061전임상결과공개,http://www.newsprime.co.kr/news/article.html?no=464924
4724,2019-06-25,대웅제약비마약성통증치료제전임상결과공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1179400
4725,2019-06-25,6월25일장마감주가정보대웅제약152000원,http://www.newsinside.kr/news/articleView.html?idxno=834562
4726,2019-06-25,25일장마감증권시세대웅17100원마감,http://www.gokorea.kr/news/articleView.html?idxno=250443
4727,2019-06-25,대웅제약만성통증치료제DWP17061전임상결과공개,http://www.ebn.co.kr/news/view/990591
4728,2019-06-25,대웅제약글로벌심포지엄서만성통증치료제DWP17061전임상결과공개,http://www.seoulwire.com/news/articleView.html?idxno=160970
4729,2019-06-25,대웅제약만성통증치료제DWP17061글로벌심포지엄서주목,http://www.wolyo.co.kr/news/articleView.html?idxno=87403
4730,2019-06-25,대웅제약진통제혁신신약전임상결과공개,http://weekly.cnbnews.com/news/article.html?no=128629
4731,2019-06-25,대웅제약비마약성통증치료제DWP17061개발중,http://www.econovill.com/news/articleView.html?idxno=366250
4732,2019-06-25,상장주주식시세25일대웅마감증시17100원,http://nbntv.co.kr/news/view/424200
4733,2019-06-25,대웅제약비마약성만성통증치료제전임상결과발표,http://www.newspim.com/news/view/20190625001017
4734,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,http://www.joseilbo.com/news/news_read.php?uid=379099&class=27&grp=
4735,2019-06-25,대웅英서혁신신약DWP17061전임상공개,http://www.whosaeng.com/111001
4736,2019-06-25,25일마감주가정보대웅제약주가152000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=250629
4737,2019-06-25,전승호치료용나보타위해대웅제약의적응증임상에힘실어,http://www.businesspost.co.kr/BP?command=article_view&num=132859
4738,2019-06-25,대웅제약2019이온채널심포지엄에서비마약성통증치료제전임상결과발표,http://www.getnews.co.kr/view.php?ud=20190625181644951841d0c69529_16
4739,2019-06-25,대웅제약비마약성통증치료제전임상결과발표,http://www.medigatenews.com/news/1332276408
4740,2019-06-25,인기종목매매동향6월25일대웅제약152000원으로장마감,http://nbntv.co.kr/news/view/424851
4741,2019-06-25,대웅제약英서만성통증치료제신약후보전임상결과공개,http://www.donga.com/news/article/all/20190625/96182031/1
4742,2019-06-25,대웅제약비마약성만성통증치료제글로벌심포지엄서주목,https://www.insight.co.kr/news/233940
4743,2019-06-25,대웅제약만성통증치료제DWP17061글로벌심포지엄서주목,http://www.newscj.com/news/articleView.html?idxno=645027
4744,2019-06-25,대웅이온채널심포지엄서비마약성통증치료제전임상발표,http://www.kpanews.co.kr/article/show.asp?idx=204986&table=article&category=D
4745,2019-06-26,대웅제약英캠브리지서만성통증치료신약연구발표,http://news.heraldcorp.com/view.php?ud=20190626000031
4746,2019-06-26,★주식인사이드대웅제약주가154500원6월26일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=836564
4747,2019-06-26,애브비의앨러간인수메디톡스휴젤대웅제약등국내톡신필러업체주가에긍정적”한국투자증권,http://www.fntimes.com/html/view.php?ud=201906260902369823f09e13944d_18
4748,2019-06-26,국내주식시장현황26일대웅현재가17300원,http://www.anewsa.com/detail.php?number=1840611&thread=18
4749,2019-06-26,6월26일대웅주식종목11717300원,http://nbntv.co.kr/news/view/426722
4750,2019-06-26,대웅제약통증치료제DWP17061글로벌심포지엄서주목,http://kormedi.com/?p=1296189
4751,2019-06-26,대웅제약80여개국가와나보타판매계약4조시장정조준,http://www.insightkorea.co.kr//news/articleView.html?idxno=42499
4752,2019-06-26,대웅제약나보타주100단위눈꺼풀경련적응증추가획득,http://news.heraldcorp.com/view.php?ud=20190626000352
4753,2019-06-26,주식창대웅제약주가26일현재152500원,http://nbntv.co.kr/news/view/427268
4754,2019-06-26,스타★주식인사이드대웅제약주가153000원6월26일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=838091
4755,2019-06-26,대웅제약만성통증치료제후보물질통증신호전달억제효능,http://www.monews.co.kr/news/articleView.html?idxno=203398
4756,2019-06-26,대웅그룹디엔컴퍼니주름개선DWEGF링클컨트롤앰플출시,http://www.ceoscoredaily.com/news/article.html?no=57196
4757,2019-06-26,대웅제약나보타눈꺼풀경련적응증획득,http://www.kukinews.com/news/article.html?no=675858
4758,2019-06-26,대웅제약디엔컴퍼니주름개선앰플출시,http://www.inews24.com/view/1189037
4759,2019-06-26,6월26일장마감주가정보대웅제약153000원,http://www.newsinside.kr/news/articleView.html?idxno=839274
4760,2019-06-26,26일상장기업장마감정보대웅17100원마감,http://www.gokorea.kr/news/articleView.html?idxno=252230
4761,2019-06-26,대웅제약디엔컴퍼니주름개선DWEGF링클컨트롤앰플출시,http://www.ekn.kr/news/article.html?no=439664
4762,2019-06-26,인기종목주가정보26일대웅마감증시17100원,http://nbntv.co.kr/news/view/428536
4763,2019-06-26,대웅제약DWP17061통증효과적으로억제,http://www.finomy.com/news/articleView.html?idxno=67104
4764,2019-06-26,26일마감주가정보대웅제약주가153000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=252582
4765,2019-06-26,인기주분석종목정보26일대웅제약마감증시153000원,http://nbntv.co.kr/news/view/429366
4766,2019-06-27,넥스트나보타로글로벌대웅비상,http://news.mt.co.kr/mtview.php?no=2019062015263184994
4767,2019-06-27,아통증시27일대웅증시현황17150원,http://www.anewsa.com/detail.php?number=1843870&thread=18
4768,2019-06-27,6월27일대웅주식장17150원029,http://nbntv.co.kr/news/view/430881
4769,2019-06-27,6월27일대웅제약주식창153000원000,http://nbntv.co.kr/news/view/431423
4770,2019-06-27,스타★주식인사이드대웅제약주가153500원6월27일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=841894
4771,2019-06-27,돈잘버는증권맨에게듣는다개별호재만발한제약株낮아진주가대비양호한실적메디톡스휴젤대웅제약등주목,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062715001129952
4772,2019-06-27,27일오늘의증시마감대웅주가16900원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=254121
4773,2019-06-27,6월27일장마감주가정보대웅제약152000원,http://www.newsinside.kr/news/articleView.html?idxno=843890
4774,2019-06-27,특징주분석주가정보6월27일대웅16900원으로장마감,http://nbntv.co.kr/news/view/432753
4775,2019-06-27,27일장마감매매동향대웅제약주가152000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=254354
4776,2019-06-27,인기주매매동향6월27일대웅제약152000원으로장마감,http://nbntv.co.kr/news/view/433467
4777,2019-06-28,대웅알비스정소화성궤양제리딩1000억매출도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=253908&REFERER=NP
4778,2019-06-28,미국제약사애브비보톡스업체앨러간인수에국내보톡스株↑메디톡스대웅제약등수혜,http://www.econonews.co.kr/news/articleView.html?idxno=72171
4779,2019-06-28,더벨보톡스1위엘러간빅딜에대웅제약메디톡스희비,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201906270100047090002970
4780,2019-06-28,★주식인사이드대웅제약주가152000원6월28일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=845209
4781,2019-06-28,대웅그룹이지듀 DWEGF링클컨트롤 앰플 홈쇼핑 방송,http://www.medisobizanews.com/news/articleView.html?idxno=60752
4782,2019-06-28,장중시세28일대웅현재주식거래가격16800원,http://www.anewsa.com/detail.php?number=1846986&thread=18
4783,2019-06-28,오늘주식대웅주가28일현재16800원,http://nbntv.co.kr/news/view/434929
4784,2019-06-28,우루사간기능개선효과있다”대웅제약바른의료연구소에전면반박,http://www.todaykorea.co.kr/news/view.php?no=262699
4785,2019-06-28,대웅제약직원성장위해CDP제도활용,http://www.econovill.com/news/articleView.html?idxno=366502
4786,2019-06-28,6월28일대웅제약종목검색148500원230,http://nbntv.co.kr/news/view/435487
4787,2019-06-28,주가정보대웅11시23분현재가16850원연중최고가얼마,http://aitimes.co.kr/news/view/68026
4788,2019-06-28,스타★주식인사이드대웅제약주가149500원6월28일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=847552
4789,2019-06-28,6월28일장마감주가정보대웅제약150000원,http://www.newsinside.kr/news/articleView.html?idxno=847914
4790,2019-06-28,28일증시종목마감동향대웅주가17050원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=255863
4791,2019-06-28,28일마감정보대웅제약150000원마감,http://www.gokorea.kr/news/articleView.html?idxno=256116
4792,2019-06-28,인기주주가정보28일대웅제약마감증시150000원,http://nbntv.co.kr/news/view/437583
4793,2019-06-29,대웅제약만성통증치료제DWP17061통증신호전달억제효과,http://www.sisaon.co.kr/news/articleView.html?idxno=96388
4794,2019-07-01,임상시험최다승인국내제약사는종근당〉대웅〉한미順,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232270
4795,2019-07-01,★주식인사이드대웅제약주가150500원7월1일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=852618
4796,2019-07-01,증시현황1일대웅현재주가17150원,http://www.anewsa.com/detail.php?number=1850732&thread=18
4797,2019-07-01,7월1일대웅주식그래프05917150원,http://nbntv.co.kr/news/view/439511
4798,2019-07-01,대웅제약올로맥스출시기념전국심포지엄우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232295
4799,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.fetv.co.kr/news/article.html?no=31912
4800,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려심혈관질환예방위한중요한치료옵션,http://www.segye.com/content/html/2019/07/01/20190701504161.html?OutUrl=naver
4801,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.ebn.co.kr/news/view/991296
4802,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56099
4803,2019-07-01,대웅제약전국800여의료진에올로맥스제품우수성알렸다,https://www.sedaily.com/NewsView/1VLIWUJZR0
4804,2019-07-01,대웅제약세계첫3제복합제올로맥스전국심포지엄성황리마쳐,http://www.medisobizanews.com/news/articleView.html?idxno=60803
4805,2019-07-01,대웅제약심포지엄통해올로맥스제품우수성알려,http://daily.hankooki.com/lpage/ittech/201907/dh20190701104828145630.htm
4806,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://moneys.mt.co.kr/news/mwView.php?no=2019070110438090608
4807,2019-07-01,7월1일대웅제약주가그래프033149500원,http://nbntv.co.kr/news/view/440068
4808,2019-07-01,대웅제약고혈압등치료신약올로맥스순회심포지움완료,http://news.heraldcorp.com/view.php?ud=20190701000315
4809,2019-07-01,대웅제약올로맥스출시기념전국심포지엄개최,http://www.youthdaily.co.kr/news/articleView.html?idxno=12561
4810,2019-07-01,대웅올로맥스전국16개도시심포지엄성료,http://www.dailypharm.com/Users/News/NewsView.html?ID=254234&REFERER=NP
4811,2019-07-01,대웅제약올로맥스출시기념전국16개도시순회,http://www.newsis.com/view/?id=NISX20190701_0000697035&cID=13001&pID=13000
4812,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.seoulwire.com/news/articleView.html?idxno=164783
4813,2019-07-01,대웅제약올로맥스출시기념전국심포지엄‥우수성알려,http://medipana.com/news/news_viewer.asp?NewsNum=242172&MainKind=A&NewsKind=5&vCount=12&vKind=1
4814,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성공리에마쳐,http://www.insightkorea.co.kr//news/articleView.html?idxno=42968
4815,2019-07-01,종목현재가대웅11시28분현재가16900원거래정보는,http://aitimes.co.kr/news/view/69061
4816,2019-07-01,대웅제약올로맥스출시기념심포지엄성료,http://www.bosa.co.kr/news/articleView.html?idxno=2108044
4817,2019-07-01,대웅제약올로맥스출시기념심포지엄제품우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019070100081
4818,2019-07-01,올로맥스차별화시장검증통해안착대웅제약전국릴레이심포지엄통해우수성재확인,http://www.updownnews.co.kr/news/articleView.html?idxno=205436
4819,2019-07-01,대웅제약올로맥스전국심포지엄통해우수성알려,http://www.economytalk.kr/news/articleView.html?idxno=190028
4820,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.wikileaks-kr.org/news/articleView.html?idxno=59236
4821,2019-07-01,스타★주식인사이드대웅제약주가149500원7월1일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=854213
4822,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.newsway.co.kr/news/view?tp=1&ud=2019070113070515582
4823,2019-07-01,대웅제약고혈압이상지질혈증치료제올로맥스심혈관질환예방극대화,http://www.econovill.com/news/articleView.html?idxno=366693
4824,2019-07-01,대웅제약올로맥스고혈압고지혈환자복약순응도↑,http://news.mt.co.kr/mtview.php?no=2019070111363931537
4825,2019-07-01,대웅제약증권사목표주가높은데주가는하락세왜,https://www.hankyung.com/finance/article/201907012449M
4826,2019-07-01,대웅제약올로맥스론칭심포지엄마무리800여의료진이목집중,http://www.viva100.com/main/view.php?key=20190701010000309
4827,2019-07-01,대웅제약올로맥스출시기념전국16개도시서심포지엄개최,http://www.newspim.com/news/view/20190701000794
4828,2019-07-01,대웅제약올로맥스전국심포지엄통해제품우수성알려,http://www.wolyo.co.kr/news/articleView.html?idxno=87851
4829,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.bokuennews.com/news/article.html?no=177759
4830,2019-07-01,대웅제약개량신약올로맥스전국심포지엄성료복약순응도주목”,http://www.donga.com/news/article/all/20190701/96269453/1
4831,2019-07-01,대웅제약고혈압고지혈증치료3제복합제올로맥스심포지엄성료,http://news.mk.co.kr/newsRead.php?year=2019&no=475584
4832,2019-07-01,대웅제약올로맥스출시기념전국심포지엄개최,http://www.shinailbo.co.kr/news/articleView.html?idxno=1181209
4833,2019-07-01,대웅제약올로맥스출시기념심포지엄성료,http://www.marketnews.co.kr/view.php?ud=20190701151830872323217b15af_24
4834,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.medigatenews.com/news/2554197881
4835,2019-07-01,대웅제약올로맥스출시기념전국심포지엄마무리,http://www.mdtoday.co.kr/mdtoday/index.html?no=358713
4836,2019-07-01,7월1일장마감주가정보대웅제약151500원,http://www.newsinside.kr/news/articleView.html?idxno=855393
4837,2019-07-01,1일마감증시대웅16850원마감,http://www.gokorea.kr/news/articleView.html?idxno=257915
4838,2019-07-01,특징주분석매매동향7월1일대웅16850원으로장마감,http://nbntv.co.kr/news/view/441631
4839,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.mhj21.com/122286
4840,2019-07-01,1일증시종목마감동향대웅제약151500원마감,http://www.gokorea.kr/news/articleView.html?idxno=258140
4841,2019-07-01,대웅제약올로맥스출시기념전국심포지엄통해제품우수성알려,http://www.businesskorea.co.kr/news/articleView.html?idxno=33450
4842,2019-07-01,특징주매매동향7월1일대웅제약151500원으로장마감,http://nbntv.co.kr/news/view/442224
4843,2019-07-01,대웅제약전국순회심포지엄서올로맥스우수성전파,http://www.polinews.co.kr/news/article.html?no=398552
4844,2019-07-01,대웅제약올로맥스출시기념전국심포지엄성료,http://www.lawissue.co.kr/view.php?ud=201907012307302051d7f4c63cc6_12
4845,2019-07-02,대웅제약올2분기도순항나보타안고1조클럽간다,http://www.ekn.kr/news/article.html?no=440518
4846,2019-07-02,대웅제약올로맥스전국심포지엄개최 ,http://www.monews.co.kr/news/articleView.html?idxno=203478
4847,2019-07-02,대웅제약올로맥스출시기념전국심포지엄성료,http://weekly.cnbnews.com/news/article.html?no=128769
4848,2019-07-02,★주식인사이드대웅제약주가150500원7월2일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=857482
4849,2019-07-02,대웅제약올로맥스출시기념전국심포지엄성료,http://www.nbnnews.co.kr/news/articleView.html?idxno=287510
4850,2019-07-02,7월2일대웅증권투자정보및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=258686
4851,2019-07-02,7월2일대웅오늘증권시세08917000원,http://nbntv.co.kr/news/view/443872
4852,2019-07-02,증시현황2일대웅주가17000원,http://www.anewsa.com/detail.php?number=1853860&thread=18
4853,2019-07-02,대웅올로맥스전국의료진관심폭발,http://www.whosaeng.com/111144
4854,2019-07-02,대웅제약올로맥스출시기념전국심포지엄개최,http://www.wsobi.com/news/articleView.html?idxno=76806
4855,2019-07-02,대웅제약욜로맥스출시기념심포지엄서임상3상결과공개고혈압고지혈환자복약효과높아,http://www.ezyeconomy.com/news/articleView.html?idxno=91914
4856,2019-07-02,7월2일대웅제약오늘주식시장330156500원,http://nbntv.co.kr/news/view/444410
4857,2019-07-02,대웅제약전일대비약4상승한158000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907020320&t=NN
4858,2019-07-02,스타★주식인사이드대웅제약주가158000원7월2일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=859873
4859,2019-07-02,7월2일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=860335
4860,2019-07-02,특징주매매동향2일대웅마감증시17350원,http://nbntv.co.kr/news/view/445726
4861,2019-07-02,증시매매동향2일대웅제약마감증시157500원,http://nbntv.co.kr/news/view/446465
4862,2019-07-03,증권사추천주무작정따라하기대웅제약악재에연우까지수익률와장창,http://www.newstomato.com/ReadNews.aspx?no=905196
4863,2019-07-03,★주식인사이드대웅제약주가157000원7월3일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=862335
4864,2019-07-03,주식시세3일대웅현재주가17300원,http://www.anewsa.com/detail.php?number=1856955&thread=18
4865,2019-07-03,대웅배당주식3일현재17250원,http://nbntv.co.kr/news/view/447893
4866,2019-07-03,실시간증시대웅제약주가3일현재158000원,http://nbntv.co.kr/news/view/448416
4867,2019-07-03,스타★주식인사이드대웅제약주가158000원7월3일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=863889
4868,2019-07-03,7월3일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=865930
4869,2019-07-03,특징주분석매매동향7월3일대웅16850원으로장마감,http://nbntv.co.kr/news/view/449387
4870,2019-07-03,3일코스닥코스피마감정보대웅제약157500원마감,http://www.gokorea.kr/news/articleView.html?idxno=261495
4871,2019-07-03,특징주주가정보3일대웅제약마감증시157500원,http://nbntv.co.kr/news/view/450299
4872,2019-07-04,대웅제약메디톡스균주싸움변곡점포자감정개시,http://www.newsis.com/view/?id=NISX20190703_0000700472&cID=13001&pID=13000
4873,2019-07-04,국민연금상반기한올종근당JW대웅주식담았다,http://www.dailypharm.com/Users/News/NewsView.html?ID=254343&REFERER=NP
4874,2019-07-04,★주식인사이드대웅제약주가154500원7월4일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=867164
4875,2019-07-04,한미약품얀센기술반환소식에52주신저가경신한미사이언스유한양행대웅제약등관련주현황은,http://www.topstarnews.net/news/articleView.html?idxno=642305
4876,2019-07-04,제약업종주요종목오전시황1위우리들제약16072위현성바이탈4423위대웅148,http://www.anewsa.com/detail.php?number=1859951&thread=18
4877,2019-07-04,증시보고4일대웅현재가17200원,http://www.anewsa.com/detail.php?number=1859998&thread=18
4878,2019-07-04,대웅주식시세현황4일현재17200원,http://nbntv.co.kr/news/view/452056
4879,2019-07-04,장중수급포착대웅외국인기관동시순매수주가178,http://www.newspim.com/news/view/20190704000358
4880,2019-07-04,제약업종오전시황상승률상위종목우리들제약1482노바렉스234대웅208등,http://www.gokorea.kr/news/articleView.html?idxno=262298
4881,2019-07-04,종목현재가대웅11시27분현재가16800원거래정보는,http://aitimes.co.kr/news/view/71338
4882,2019-07-04,대웅제약실시간주식현황4일현재153000원,http://nbntv.co.kr/news/view/452596
4883,2019-07-04,스타★주식인사이드대웅제약주가153500원7월4일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=869004
4884,2019-07-04,7월4일장마감주가정보대웅제약155000원,http://www.newsinside.kr/news/articleView.html?idxno=869826
4885,2019-07-04,4일오늘의증시마감대웅주가16500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=263000
4886,2019-07-04,인기주분석주가정보7월4일대웅16500원으로장마감,http://nbntv.co.kr/news/view/453793
4887,2019-07-04,4일장마감매매동향대웅제약주가155000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=263235
4888,2019-07-04,인기주종목정보7월4일대웅제약155000원으로장마감,http://nbntv.co.kr/news/view/454727
4889,2019-07-04,대웅제약메디톡스균주싸움변곡점포자감정개시감정인및기관선정,http://www.econonews.co.kr/news/articleView.html?idxno=73609
4890,2019-07-05,★주식인사이드대웅제약주가156500원7월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=871960
4891,2019-07-05,대웅오늘증시5일현재16850원,http://nbntv.co.kr/news/view/456303
4892,2019-07-05,종목시황대웅11시23분현재가16850원연중최고가얼마,http://aitimes.co.kr/news/view/72093
4893,2019-07-05,7월5일대웅제약주식그래프032154500원,http://nbntv.co.kr/news/view/456848
4894,2019-07-05,스타★주식인사이드대웅제약주가155000원7월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=874404
4895,2019-07-05,대웅제약올로맥스출시전국심포지엄개최,http://www.g-enews.com/ko-kr/news/article/news_all/2019070515282086269d76442fa_1/article.html
4896,2019-07-05,7월5일장마감주가정보대웅제약158000원,http://www.newsinside.kr/news/articleView.html?idxno=874786
4897,2019-07-05,5일장마감매매동향대웅제약158000원마감,http://www.gokorea.kr/news/articleView.html?idxno=265025
4898,2019-07-08,★주식인사이드대웅제약주가156500원7월8일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=879930
4899,2019-07-08,대웅주가7월8일현재16850원,http://www.gokorea.kr/news/articleView.html?idxno=265866
4900,2019-07-08,국내주식시장주가8일대웅현재주식거래가격16850원,http://www.anewsa.com/detail.php?number=1865077&thread=18
4901,2019-07-08,7월8일대웅주식증권16700원089,http://nbntv.co.kr/news/view/460698
4902,2019-07-08,대웅제약전일대비약3하락한152500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907080496&t=NN
4903,2019-07-08,스타★주식인사이드대웅제약주가152000원7월8일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=881462
4904,2019-07-08,ET투자뉴스대웅제약_투심과거래량은약세현재주가는보통,http://www.etnews.com/20190708000179
4905,2019-07-08,7월8일장마감주가정보대웅제약151500원,http://www.newsinside.kr/news/articleView.html?idxno=882661
4906,2019-07-08,특징주종목정보8일대웅마감증시16350원,http://nbntv.co.kr/news/view/462332
4907,2019-07-08,8일주식장마감동향대웅제약151500원마감,http://www.gokorea.kr/news/articleView.html?idxno=267054
4908,2019-07-08,상장주종목정보7월8일대웅제약151500원으로장마감,http://nbntv.co.kr/news/view/463316
4909,2019-07-09,대웅제약확실히달라진이익레벨NH투자증권,http://news.mt.co.kr/mtview.php?no=2019070907374775102
4910,2019-07-09,클릭e종목대웅제약나보타美수출본격화2Q영업익증가기대,https://view.asiae.co.kr/article/2019070907584805156
4911,2019-07-09,퀵리포트대웅제약매수유지목표가16↓20만원NH證,http://www.itooza.com/common/iview.php?no=2019070908121010507
4912,2019-07-09,대웅제약보톡스균주소송부담목표가↓NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01466166622552880
4913,2019-07-09,HotLine대웅제약실적시즌상위제약사중최선호목표가↓,http://news.mk.co.kr/newsRead.php?year=2019&no=500052
4914,2019-07-09,하이로우대웅제약나보타美수출본격화2Q영업익↑NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070908493646320
4915,2019-07-09,룬드벡에빅사단독판매접고대웅제약선택,http://www.monews.co.kr/news/articleView.html?idxno=203596
4916,2019-07-09,★주식인사이드대웅제약주가151000원7월9일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=884707
4917,2019-07-09,대웅제약국제미용성형학회서나보타글로벌임상결과발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1774757
4918,2019-07-09,대웅제약목표주가하향제약업종가치하락에도나보타실적은호조,http://www.businesspost.co.kr/BP?command=article_view&num=134580
4919,2019-07-09,대웅제약 나보타세계의료진에미용성형의최강자알려,http://www.medisobizanews.com/news/articleView.html?idxno=60974
4920,2019-07-09,종목추적9일대웅현재주가16400원,http://www.anewsa.com/detail.php?number=1868037&thread=18
4921,2019-07-09,대웅주가증권그래프9일현재16300원,http://www.gokorea.kr/news/articleView.html?idxno=267662
4922,2019-07-09,대웅제약미국수출본격화기대,http://www.choicenews.co.kr/news/articleView.html?idxno=62366
4923,2019-07-09,주식증권대웅주가9일현재16300원,http://nbntv.co.kr/news/view/464976
4924,2019-07-09,대웅제약나보타국제미용학회서K뷰티亞공감대확산,http://news.heraldcorp.com/view.php?ud=20190709000127
4925,2019-07-09,대웅제약나보타IMCASAsia2019참가‥우수성알려,http://medipana.com/news/news_viewer.asp?NewsNum=242557&MainKind=A&NewsKind=5&vCount=12&vKind=1
4926,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.etnews.com/20190709000043
4927,2019-07-09,대웅제약IMCAS아시아2019참가전세계의료진에나보타우수성알려,http://www.asiatime.co.kr/news/articleView.html?idxno=256481
4928,2019-07-09,대웅제약나보타전세계의료진대상우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232588
4929,2019-07-09,대웅제약아시아대표미용성형학회참가나보타우수성홍보,http://www.newspim.com/news/view/20190709000177
4930,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.ceoscoredaily.com/news/article.html?no=57739
4931,2019-07-09,대웅제약2분기영업익전년대비약85성장전망,http://www.econovill.com/news/articleView.html?idxno=367224
4932,2019-07-09,대웅제약세계최대국제미용성형학회참가나보타우수성알렸다”,https://www.sedaily.com/NewsView/1VLMKNILEJ
4933,2019-07-09,대웅제약국제노화학회에서나보타우수성알려,https://www.sedaily.com/NewsView/1VLMKL30YE
4934,2019-07-09,대웅제약나보타IMCASAsia2019서전세계의료진만나,http://www.newsis.com/view/?id=NISX20190709_0000705028&cID=13001&pID=13000
4935,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.dailian.co.kr/news/view/809204/?sc=naver
4936,2019-07-09,대웅제약발리국제미용성형학회참가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3882895
4937,2019-07-09,대웅제약IMCASAsia2019참가나보타우수성알려,http://www.viva100.com/main/view.php?key=20190709010003041
4938,2019-07-09,대웅제약나보타포자감정개시이르면이번주결판,http://news.mt.co.kr/mtview.php?no=2019070817193733257
4939,2019-07-09,대웅제약아시아시장잡아라임카스아시아참가,http://news1.kr/articles/?3665634
4940,2019-07-09,대웅제약나보타글로벌브랜드육성박차,http://www.whosaeng.com/111304
4941,2019-07-09,대웅제약나보타국제미용성형학회참가,https://www.hankyung.com/it/article/201907091054f
4942,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.mdtoday.co.kr/mdtoday/index.html?no=359416
4943,2019-07-09,리포트브리핑대웅제약확실히달라진이익레벨목표가200000원NH투자증권,http://www.newspim.com/news/view/20190709000459
4944,2019-07-09,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201907091030307851tpgetnews_16
4945,2019-07-09,뉴스투데이L대웅제약IMCASAsia2019서나보타우수성알려,http://www.news2day.co.kr/131449
4946,2019-07-09,대웅제약IMCASAsia2019참가나보타알리기나서,http://inthenews.co.kr/article-6071/
4947,2019-07-09,ET투자뉴스대웅제약확실히달라진이익BUY유지NH투자증권,http://www.etnews.com/20190709000122
4948,2019-07-09,IMCAS아시아2019나보타우수성알린대웅제약세계의료진주목,http://www.sisaweek.com/news/articleView.html?idxno=124005
4949,2019-07-09,대웅제약나보타전세계의료진대상우수성알려,http://www.bosa.co.kr/news/articleView.html?idxno=2108591
4950,2019-07-09,대웅제약나보타들고IMCASAsia2019참가 ,http://www.monews.co.kr/news/articleView.html?idxno=203608
4951,2019-07-09,대웅제약전일대비약4하락한146000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907090259&t=NN
4952,2019-07-09,대웅나보타전세계의료진에우수성홍보,http://www.dailymedi.com/detail.php?number=845050&thread=22r05
4953,2019-07-09,대웅제약IMCASAsia2019참가나보타우수성세계의료진에알려,http://www.wikileaks-kr.org/news/articleView.html?idxno=59794
4954,2019-07-09,대웅제약투자주식9일현재146000원,http://nbntv.co.kr/news/view/465511
4955,2019-07-09,대웅제약IMCASAsia2019참가,http://www.fetv.co.kr/news/article.html?no=32352
4956,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.bokuennews.com/news/article.html?no=178168
4957,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.ebn.co.kr/news/view/992377
4958,2019-07-09,대웅제약국제미용성형학회IMCASAsia2019참가,http://www.youthdaily.co.kr/news/articleView.html?idxno=13161
4959,2019-07-09,스타★주식인사이드대웅제약주가146500원7월9일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=887153
4960,2019-07-09,세계3대미용성형학회참석한대웅제약나보타글로벌브랜드육성박차우수성알려,http://www.updownnews.co.kr/news/articleView.html?idxno=205786
4961,2019-07-09,대웅제약국제학회서보툴리눔나보타우수성알려,http://health.chosun.com/site/data/html_dir/2019/07/09/2019070901400.html
4962,2019-07-09,대웅제약발리국제미용성형학회참가,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1217168
4963,2019-07-09,대웅제약나보타아시아학회참가우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2019070900121
4964,2019-07-09,식약처대웅제약항궤양제DWP14012임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232605
4965,2019-07-09,대웅제약나보타우수성세계미용성형의료진에어필,http://www.sisaon.co.kr/news/articleView.html?idxno=96988
4966,2019-07-09,대웅제약국제미용성형학회서나보타성과홍보아시아진출교두보마련,http://www.ezyeconomy.com/news/articleView.html?idxno=92093
4967,2019-07-09,대웅제약국제미용성형학회에서나보타임상결과발표,http://www.joseilbo.com/news/news_read.php?uid=379950&class=27&grp=
4968,2019-07-09,대웅제약국제미용성형학회에서보툴리눔톡신나보타우수성알려,http://www.businesspost.co.kr/BP?command=article_view&num=134625
4969,2019-07-09,대웅제약나보타로IMCASAsia2019참가,http://www.kpanews.co.kr/article/show.asp?idx=205336&table=article&category=D
4970,2019-07-09,인기주종목정보대웅주가16100원마감,http://www.anewsa.com/detail.php?number=1869497&thread=18
4971,2019-07-09,대웅제약나보타IMCASAsia2019참가우수성알려,http://www.getnews.co.kr/view.php?ud=20190709154450593641d0c69529_16
4972,2019-07-09,대웅제약나보타IMCASAsia2019참가,http://www.economytalk.kr/news/articleView.html?idxno=190911
4973,2019-07-09,7월9일장마감주가정보대웅제약146500원,http://www.newsinside.kr/news/articleView.html?idxno=887527
4974,2019-07-09,9일상장기업장마감정보대웅주가16100원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=268594
4975,2019-07-09,인기주종목정보9일대웅마감증시16100원,http://nbntv.co.kr/news/view/466382
4976,2019-07-09,대웅제약국제미용학회서나보타우수성알려,http://www.seoulwire.com/news/articleView.html?idxno=172033
4977,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.enewstoday.co.kr/news/articleView.html?idxno=1320090
4978,2019-07-09,대웅제약나보타IMCASAsia2019참가전세계의료진대상우수성알려,http://www.medigatenews.com/news/1752340616
4979,2019-07-09,9일주가마감정보대웅제약주가146500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=268827
4980,2019-07-09,대웅제약국제미용성형학회아시아학술대회서나보타홍보나서,http://news.mk.co.kr/newsRead.php?year=2019&no=503245
4981,2019-07-09,인기종목종목정보7월9일대웅제약146500원으로장마감,http://nbntv.co.kr/news/view/467107
4982,2019-07-09,대웅제약세계3대미용성형학회IMCAS아시아참가나보타글로벌임상발표,http://www.donga.com/news/article/all/20190709/96400636/1
4983,2019-07-09,대웅제약IMCASAsia2019참가해나보타우수성알려,http://www.newscj.com/news/articleView.html?idxno=649866
4984,2019-07-10,대웅도공급중단축소되는이소트레티노인시장,http://www.dailypharm.com/Users/News/NewsView.html?ID=254532&REFERER=NP
4985,2019-07-10,대웅제약국제미용성형학회서나보타우수성알려,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070099
4986,2019-07-10,법원나보타포자감정실시자신감내비치는대웅제약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070119
4987,2019-07-10,대웅제약주가오를힘다져새수익원나보타수출로실적늘어,http://www.businesspost.co.kr/BP?command=article_view&num=134743
4988,2019-07-10,퀵리포트대웅제약매수유지목표가24만원유지메리츠證,http://www.itooza.com/common/iview.php?no=2019071008074719447
4989,2019-07-10,★주식인사이드대웅제약주가147500원7월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=889627
4990,2019-07-10,GET투자리포트대웅제약투자의견매수메리츠종금증권,http://www.getnews.co.kr/view.php?ud=201907101030307867tpgetnews_16
4991,2019-07-10,리포트브리핑대웅제약나보타주보순항중목표가240000원메리츠종금증권,http://www.newspim.com/news/view/20190710000205
4992,2019-07-10,대웅제약자체개발나보타세계시장에소개,http://www.beyondpost.co.kr/view.php?ud=2019071009174325930145927ff6_30
4993,2019-07-10,ET투자뉴스대웅제약나보타주보순항중BUY메리츠종금증권,http://www.etnews.com/20190710000038
4994,2019-07-10,종목상세정보10일대웅주가16400원,http://www.anewsa.com/detail.php?number=1871003&thread=18
4995,2019-07-10,7월10일대웅증권주식16400원186,http://nbntv.co.kr/news/view/468749
4996,2019-07-10,대웅제약RD비중확대통해넥스트나보타개발박차,http://www.wikileaks-kr.org/news/articleView.html?idxno=59872
4997,2019-07-10,대웅제약나보타IMCAS아시아참가,http://www.wsobi.com/news/articleView.html?idxno=77337
4998,2019-07-10,스타★주식인사이드대웅제약주가151500원7월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=891260
4999,2019-07-10,대웅제약에투영된윤재승전회장의그림자여전,http://www.shinailbo.co.kr/news/articleView.html?idxno=1184140
5000,2019-07-10,10일마감증시대웅16200원마감,http://www.gokorea.kr/news/articleView.html?idxno=270434
5001,2019-07-10,상반기임상국내사선전종근당대웅제약선봉에,http://www.newstomato.com/ReadNews.aspx?no=906895
5002,2019-07-10,7월10일장마감주가정보대웅제약150500원,http://www.newsinside.kr/news/articleView.html?idxno=893209
5003,2019-07-10,대웅제약2분기매출액2271억원영업이익132억원전망”,http://www.wikitree.co.kr/main/news_view.php?id=444073
5004,2019-07-10,인기종목주가정보10일대웅마감증시16200원,http://nbntv.co.kr/news/view/470565
5005,2019-07-10,10일증시종목마감동향대웅제약주가150500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=270664
5006,2019-07-10,대웅제약인도네시아학술행사에서나보타홍보,http://weekly.cnbnews.com/news/article.html?no=128934
5007,2019-07-10,인기주매매동향7월10일대웅제약150500원으로장마감,http://nbntv.co.kr/news/view/471470
5008,2019-07-11,메디톡스메디톡신허가전유통의혹에대웅제약과균추출처다툼덩달아관심↑현재재판과정은,http://www.newsinside.kr/news/articleView.html?idxno=894323
5009,2019-07-11,★주식인사이드대웅제약주가154000원7월11일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=894394
5010,2019-07-11,제약업종주요종목오전시황1위팜스웰바이오6672위압타바이오6283위대웅제약432,http://www.anewsa.com/detail.php?number=1873905&thread=18
5011,2019-07-11,대웅제약5이상상승나보타주보순항중메리츠종금증권BUY,https://www.hankyung.com/finance/article/201907116514L
5012,2019-07-11,메디톡스보톡스메디톡신이슈에52주신저가경신대웅제약신라젠등관련주는,http://www.topstarnews.net/news/articleView.html?idxno=644747
5013,2019-07-11,주식실황11일대웅거래가격16750원,http://www.anewsa.com/detail.php?number=1874011&thread=18
5014,2019-07-11,7월11일대웅종목검색16750원340,http://nbntv.co.kr/news/view/473112
5015,2019-07-11,특징주대웅제약실적견조나보타순항에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02286166622553536
5016,2019-07-11,대웅제약나보타수출기여로실적개선전망에上,http://www.mdtoday.co.kr/mdtoday/index.html?no=359621
5017,2019-07-11,대웅제약나보타국제미용성형학회참가,http://www.nbnnews.co.kr/news/articleView.html?idxno=291562
5018,2019-07-11,7월11일대웅제약주식주가157500원465,http://nbntv.co.kr/news/view/473672
5019,2019-07-11,주식현재가대웅11시25분현재가16850원연중최고가얼마,http://aitimes.co.kr/news/view/75374
5020,2019-07-11,대웅제약글로벌RD네트워크로현지지배력강화장기전돌입,http://www.ceoscoredaily.com/news/article.html?no=57784
5021,2019-07-11,美진출제약바이오대표주자셀트리온유한대웅신라젠,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232678
5022,2019-07-11,스타★주식인사이드대웅제약주가157500원7월11일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=895724
5023,2019-07-11,특징주대웅제약나보타수출확대기대감4급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1775812
5024,2019-07-11,대웅제약쿨비즈와스마트오피스로업무환경유연성자율성강화,http://www.lawissue.co.kr/view.php?ud=2019071114574527689817d053b9_12
5025,2019-07-11,대웅제약글로벌무대서나보타우수성알려IMCASAsia2019참가,http://www.g-enews.com/ko-kr/news/article/news_all/20190711144639643169d76442fa_1/article.html
5026,2019-07-11,7월11일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=896866
5027,2019-07-11,파월효과코스피껑충삼성전자SK하이닉스대웅제약아시아나계열급등,http://www.choicenews.co.kr/news/articleView.html?idxno=62476
5028,2019-07-11,인기종목주가정보7월11일대웅16600원으로장마감,http://nbntv.co.kr/news/view/475035
5029,2019-07-11,동아대웅제약이어종근당도인도네시아진출,http://www.finomy.com/news/articleView.html?idxno=67566
5030,2019-07-11,11일주가마감정보대웅제약주가157500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=272421
5031,2019-07-11,삼성전자SK하이닉스대웅제약아시아나계열급등코스피2080회복,http://www.betanews.net:8080/article/1029481.html
5032,2019-07-11,특징주분석종목정보11일대웅제약마감증시157500원,http://nbntv.co.kr/news/view/475739
5033,2019-07-12,대웅제약vs종근당1조클럽진입경쟁,http://www.sportsseoul.com/news/read/789587
5034,2019-07-12,★주식인사이드대웅제약주가155000원7월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=898997
5035,2019-07-12,주식종목12일대웅현재가격16300원,http://www.anewsa.com/detail.php?number=1876980&thread=18
5036,2019-07-12,대웅제약직원자율성높이고효율올리고사내문화눈길,http://www.mhj21.com/122576
5037,2019-07-12,7월12일대웅오늘주식16300원181,http://nbntv.co.kr/news/view/477244
5038,2019-07-12,보톡스3년전쟁새국면메디톡스대웅제약진위가리기로,https://view.asiae.co.kr/article/2019071211130899058
5039,2019-07-12,대웅제약투자주식12일현재155500원,http://nbntv.co.kr/news/view/477783
5040,2019-07-12,주가정보대웅11시23분현재가16250원연중최고가얼마,http://aitimes.co.kr/news/view/76154
5041,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션진행한다,http://www.sisafocus.co.kr/news/articleView.html?idxno=215028
5042,2019-07-12,대웅제약룬드벡알츠하이머치료제에빅사공동프로모션,http://medipana.com/news/news_viewer.asp?NewsNum=242773&MainKind=A&NewsKind=5&vCount=12&vKind=1
5043,2019-07-12,대웅제약한국룬드벡과치매치료제에빅사공동판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=61095
5044,2019-07-12,대웅제약알츠하이머병치료제에빅사판매,http://www.whosaeng.com/111401
5045,2019-07-12,대웅제약룬드벡치매약에빅사공동판매계약,https://www.hankyung.com/it/article/201907120245f
5046,2019-07-12,대웅제약한국룬드벡에빅사코프로모션계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2108845
5047,2019-07-12,대웅제약룬드벡알츠하이머치료제에박사공동프로모션,http://www.econovill.com/news/articleView.html?idxno=367445
5048,2019-07-12,스타★주식인사이드대웅제약주가154000원7월12일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=900717
5049,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사코프로모션계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232735
5050,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션계약체결,https://www.sedaily.com/NewsView/1VLNZ8ECX7
5051,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.newsway.co.kr/news/view?tp=1&ud=2019071213112163255
5052,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.fnnews.com/news/201907121347110838
5053,2019-07-12,대웅제약룬드벡치매약에빅사공동판매,https://cnbc.sbs.co.kr/article_hub/10000948314?division=NAVER
5054,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션,http://www.dailian.co.kr/news/view/810189/?sc=naver
5055,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.etnews.com/20190712000143
5056,2019-07-12,대웅제약한국룬드벡과치매치료제에빅사공동판매계약,http://www.seoulwire.com/news/articleView.html?idxno=174390
5057,2019-07-12,대웅제약한국룬드벡과공동으로알츠하이머병치료제에빅사영업마케팅진행,http://www.newspim.com/news/view/20190712000612
5058,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제공동판매,http://www.seoulfn.com/news/articleView.html?idxno=349103
5059,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.ceoscoredaily.com/news/article.html?no=57916
5060,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.lawissue.co.kr/view.php?ud=201907121420462000204ead0791_12
5061,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.upinews.kr/news/newsview.php?ncode=1065590375675893
5062,2019-07-12,대웅제약한국룬드벡과알츠하이머치료제공동프로모션,http://news.mt.co.kr/mtview.php?no=2019071213225741800
5063,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제공동프로모션계약,http://www.newsprime.co.kr/news/article.html?no=467251
5064,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동판매계약체결,http://www.getnews.co.kr/view.php?ud=20190712143200192041d0c69529_16
5065,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제공동프로모션,http://news.heraldcorp.com/view.php?ud=20190712000442
5066,2019-07-12,대웅제약룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56278
5067,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1776209
5068,2019-07-12,대웅제약룬드벡알츠하이머약에빅사공동판매,http://www.newsis.com/view/?id=NISX20190712_0000709299&cID=13001&pID=13000
5069,2019-07-12,대웅제약한국룬드벡과공동프로모션통해알츠하이머병치료제에빅사병의원에공급,http://www.updownnews.co.kr/news/articleView.html?idxno=205938
5070,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약체결,http://www.ajunews.com/view/20190712150739588
5071,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션계약체결,http://inthenews.co.kr/article-6879/
5072,2019-07-12,대웅제약한국룬드백과손잡고알츠하이머치료제에빅사공급,http://www.insightkorea.co.kr//news/articleView.html?idxno=44283
5073,2019-07-12,대웅제약한국룬드벡알츠하이머치료제공동판매한다,http://moneys.mt.co.kr/news/mwView.php?no=2019071215438082483
5074,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사프로모션계약,http://biz.chosun.com/site/data/html_dir/2019/07/12/2019071201933.html
5075,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=359750
5076,2019-07-12,대웅제약한국룬드벡과알츠하이머병치료제공동판매계약,http://www.rapportian.com/news/articleView.html?idxno=118601
5077,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.medigatenews.com/news/1877785649
5078,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약체결,http://www.wolyo.co.kr/news/articleView.html?idxno=88879
5079,2019-07-12,대웅제약룬드벡의치매약에빅사공동판매키로,http://news.mk.co.kr/newsRead.php?year=2019&no=515048
5080,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1321198
5081,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션,http://daily.hankooki.com/lpage/ittech/201907/dh20190712162425145630.htm
5082,2019-07-12,12일마감주가정보대웅16450원마감,http://www.gokorea.kr/news/articleView.html?idxno=273985
5083,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약,http://www.newstomato.com/ReadNews.aspx?no=907427
5084,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제프로모션계약,http://www.ebn.co.kr/news/view/992962
5085,2019-07-12,대웅제약한국룬드벡치매치료제에빅사공동판매계약,http://health.chosun.com/site/data/html_dir/2019/07/12/2019071202004.html
5086,2019-07-12,7월12일장마감주가정보대웅제약154000원,http://www.newsinside.kr/news/articleView.html?idxno=902704
5087,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동프로모션계약,http://www.asiatime.co.kr/news/articleView.html?idxno=257377
5088,2019-07-12,인기주분석매매동향7월12일대웅16450원으로장마감,http://nbntv.co.kr/news/view/479130
5089,2019-07-12,대웅한국루드벡알츠하이머치료제에빅사공동프로모션계약,http://kormedi.com/?p=1297392
5090,2019-07-12,대웅제약한국룬드벡알츠하이머치매환자들의더나은삶위해,http://www.k-health.com/news/articleView.html?idxno=44719
5091,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.segye.com/content/html/2019/07/12/20190712509101.html?OutUrl=naver
5092,2019-07-12,대웅제약한국룬드벡과알츠하이머치료제에빅사공동판매,http://www.finomy.com/news/articleView.html?idxno=67600
5093,2019-07-12,대웅제약알츠하이머병치료제에빅사마케팅진행,http://www.economytalk.kr/news/articleView.html?idxno=191320
5094,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션,http://www.edaily.co.kr/news/newspath.asp?newsid=03539126622553864
5095,2019-07-12,12일마감증시대웅제약154000원마감,http://www.gokorea.kr/news/articleView.html?idxno=274180
5096,2019-07-12,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.wikileaks-kr.org/news/articleView.html?idxno=60090
5097,2019-07-12,대웅제약룬드벡에빅사공동프로모션,http://www.fnnews.com/news/201907121746462323
5098,2019-07-12,대웅룬드벡AD치료제코프로모션,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86853
5099,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약,http://www.kpinews.co.kr/news/articleView.html?idxno=99466
5100,2019-07-12,대웅제약한국룬드벡알츠하이머치료제에빅사공동영업마케팅진행,http://www.donga.com/news/article/all/20190712/96450428/1
5101,2019-07-12,상장주매매동향12일대웅제약마감증시154000원,http://nbntv.co.kr/news/view/479847
5102,2019-07-12,대웅제약한국룬드벡에빅사공동프로모션계약,http://www.kpanews.co.kr/article/show.asp?idx=205422&table=article&category=D
5103,2019-07-12,대웅제약룬드벡의치매약에빅사공동판매,http://www.nbnnews.co.kr/news/articleView.html?idxno=292330
5104,2019-07-12,대웅제약한국룬드벡과에빅사공동프로모션계약체결,http://www.newscj.com/news/articleView.html?idxno=650988
5105,2019-07-13,대웅제약한국룬드벡알츠하이머약에빅사공동판매프로모션계약체결,http://www.econonews.co.kr/news/articleView.html?idxno=75562
5106,2019-07-14,대웅제약한국룬드벡알츠하이머병치료제에빅사공동프로모션계약체결,http://www.viva100.com/main/view.php?key=20190714010004676
5107,2019-07-14,대웅제약룬드벡알츠하이머치매치료제에빅사공동판매,http://www.sportsseoul.com/news/read/790380
5108,2019-07-14,대웅제약알츠하이머치료제에빅사시장확장가속화,http://www.sisaon.co.kr/news/articleView.html?idxno=97286
5109,2019-07-15,현지제약사지분품은대웅제약58조베트남시장공략,http://news.mt.co.kr/mtview.php?no=2019071214363568793
5110,2019-07-15,대웅제약ITC메디톡스에침해영업비밀소명지시,https://www.hankyung.com/finance/article/2019071537296
5111,2019-07-15,대웅제약메디톡스엘러간ITC소송유리한전환점맞아,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232763
5112,2019-07-15,美국제무역위메디톡스에대웅침해영업비밀밝혀라,http://www.bosa.co.kr/news/articleView.html?idxno=2108894
5113,2019-07-15,대웅제약ITC메디톡스에침해영업비밀밝혀라명령,http://www.newsis.com/view/?id=NISX20190715_0000710489&cID=13001&pID=13000
5114,2019-07-15,대웅제약美소송에서승기잡나ITC대웅제약이침해했다고주장하는메디톡스영업비밀무엇인지명확히밝힐것,http://www.segye.com/content/html/2019/07/15/20190715502061.html?OutUrl=naver
5115,2019-07-15,대웅제약美ITC메디톡스에균주영업비밀침해규명명령,http://www.medisobizanews.com/news/articleView.html?idxno=61117
5116,2019-07-15,대웅제약ITC소송에서유리한전환점맞았다는데,http://medipana.com/news/news_viewer.asp?NewsNum=242812&MainKind=A&NewsKind=5&vCount=12&vKind=1
5117,2019-07-15,ITC메디톡스영업비밀이뭐냐”대웅제약유리한고지점령”,http://news.heraldcorp.com/view.php?ud=20190715000064
5118,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.newsway.co.kr/news/view?tp=1&ud=2019071508583574613
5119,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.newsway.co.kr/news/view?tp=1&ud=2019071508583574613
5120,2019-07-15,대웅제약메디톡스와의ITC소송에서유리한상황,http://www.ajunews.com/view/20190715084624614
5121,2019-07-15,대웅제약ITC메디톡스에침해당한영업비밀소명지시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019071509004584430
5122,2019-07-15,대웅제약국제보툴리눔소송서유리해져ITC메디톡스에영업비밀소명명령,http://www.newspim.com/news/view/20190715000039
5123,2019-07-15,대웅제약ITC메디톡스에대웅침해영업비밀밝혀라명령,http://www.seoulwire.com/news/articleView.html?idxno=175499
5124,2019-07-15,대웅제약ITC메디톡스에침해영업비밀소명지시,http://moneys.mt.co.kr/news/mwView.php?no=2019071509048070036
5125,2019-07-15,★주식인사이드대웅제약주가153500원7월15일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=906947
5126,2019-07-15,대웅제약ITC소송전환점맞아ITC메디톡스대웅이침해한비밀뭔지밝혀라,http://www.asiatime.co.kr/news/articleView.html?idxno=257639
5127,2019-07-15,대웅제약ITC가메디톡스에침해당한영업비밀설명하라고명령,http://news.mk.co.kr/newsRead.php?year=2019&no=521149
5128,2019-07-15,대웅실시간주식현황15일현재16500원,http://nbntv.co.kr/news/view/481796
5129,2019-07-15,메디톡스4거래일연속하락대웅제약ITC메디톡스에침해당한영업비밀설명하라고명령,http://www.econonews.co.kr/news/articleView.html?idxno=75736
5130,2019-07-15,대웅주가종목그래프15일현재16450원,http://www.gokorea.kr/news/articleView.html?idxno=274961
5131,2019-07-15,대웅제약ITC메디톡스에영업비밀명확히밝힐것명령”,http://daily.hankooki.com/lpage/ittech/201907/dh20190715094055145630.htm
5132,2019-07-15,대웅제약ITC메디톡스에영업비밀설명요구”,http://www.shinailbo.co.kr/news/articleView.html?idxno=1185343
5133,2019-07-15,대웅제약고함량비타민임팩타민TV광고첫전개,http://www.dailypharm.com/Users/News/NewsView.html?ID=254699&REFERER=NP
5134,2019-07-15,대웅제약임팩타민SKY캐슬염정아오나라모델발탁,http://medipana.com/news/news_viewer.asp?NewsNum=242830&MainKind=A&NewsKind=5&vCount=12&vKind=1
5135,2019-07-15,대웅제약미국ITC메디톡스에영업비밀소명지시,http://www.sportsseoul.com/news/read/790751
5136,2019-07-15,대웅제약보톡스관련ITC소송에서유리한전환점맞아,http://www.getnews.co.kr/view.php?ud=20190715095708427541d0c69529_16
5137,2019-07-15,대웅제약美ITC메디톡스에침해당한영업비밀밝혀라명령”,http://www.mdtoday.co.kr/mdtoday/index.html?no=359823
5138,2019-07-15,대웅제약보톡스관련ITC소송서유리한고지선점ITC메디톡스영업기밀침해했다는구체적사유소명해야,http://www.ezyeconomy.com/news/articleView.html?idxno=92210
5139,2019-07-15,미국ITC메디톡스에대웅제약이침해했다는영업비밀밝혀라,http://news1.kr/articles/?3670242
5140,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.mdtoday.co.kr/mdtoday/index.html?no=359825
5141,2019-07-15,대웅제약메디톡스와ITC소송서유리승리확신,http://www.upinews.kr/news/newsview.php?ncode=1065574502847508
5142,2019-07-15,대웅제약ITC가메디톡스에영업비밀설명요구했다”,http://www.hankookilbo.com/news/npath/201907151077063496?did=NA
5143,2019-07-15,대웅제약비타민B임팩타민소비자마케팅강화,http://www.newsprime.co.kr/news/article.html?no=467386
5144,2019-07-15,대웅제약ITC소송에서유리한전환점맞아”,http://www.viva100.com/main/view.php?key=20190715010004961
5145,2019-07-15,ITC메디톡스에대웅제약이침해한영업비밀밝힐것명령,http://www.newsprime.co.kr/news/article.html?no=467390
5146,2019-07-15,제약오늘​​​​​​​대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.sisaon.co.kr/news/articleView.html?idxno=97310
5147,2019-07-15,대웅제약ITC소송유리한전환점맞아,http://www.bokuennews.com/news/article.html?no=178373
5148,2019-07-15,대웅제약염정아오나라모델임팩타민TV광고온에어,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232779
5149,2019-07-15,대웅제약ITC메디톡스에침해당한영업비밀밝혀라명령,http://www.rapportian.com/news/articleView.html?idxno=118625
5150,2019-07-15,대웅제약美ITC메디톡스에침해영업비밀밝혀라명령,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907150231&t=NN
5151,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.medisobizanews.com/news/articleView.html?idxno=61129
5152,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.dailysmart.co.kr/news/articleView.html?idxno=13396
5153,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.wikileaks-kr.org/news/articleView.html?idxno=60213
5154,2019-07-15,대웅제약보툴리눔톡신소송전서전환점맞나,http://www.monews.co.kr/news/articleView.html?idxno=203719
5155,2019-07-15,대웅이침해한영업비밀무엇인가,http://www.whosaeng.com/111432
5156,2019-07-15,대웅제약ITC메디톡스에침해영업비밀밝혀라명령소송유리한고지선점,http://www.updownnews.co.kr/news/articleView.html?idxno=205983
5157,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고,http://www.bosa.co.kr/news/articleView.html?idxno=2108929
5158,2019-07-15,주가정보대웅11시28분현재가16450원연중최고가얼마,http://aitimes.co.kr/news/view/77243
5159,2019-07-15,대웅제약고함량비타민임팩타민TV광고온에어,http://www.newsis.com/view/?id=NISX20190715_0000710869&cID=13001&pID=13000
5160,2019-07-15,대웅제약ITC메디톡스에침해영업비밀밝혀라명령,http://biz.chosun.com/site/data/html_dir/2019/07/15/2019071501154.html
5161,2019-07-15,대웅제약주가종목그래프15일현재154000원,http://www.gokorea.kr/news/articleView.html?idxno=275295
5162,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56290
5163,2019-07-15,대웅제약ITC소송에서유리한명령나와”,http://weekly.cnbnews.com/news/article.html?no=128995
5164,2019-07-15,스타★주식인사이드대웅제약주가154000원7월15일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=908615
5165,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1321657
5166,2019-07-15,대웅제약ITC소송에서유리한전환점맞아,http://www.asiatoday.co.kr/view.php?key=20190715010009146
5167,2019-07-15,대웅제약ITC메디톡스에침해영업비밀소명지시,http://www.dailian.co.kr/news/view/810613/?sc=naver
5168,2019-07-15,대웅제약소송전환점맞나ITC메디톡스에영업비밀밝혀라명령,http://www.metroseoul.co.kr/news/newsview?newscd=2019071500161
5169,2019-07-15,대웅제약비타민B더블임팩트”임팩타민광고시작,http://www.econovill.com/news/articleView.html?idxno=367578
5170,2019-07-15,美ITC침해당한영업비밀소명명령메디톡스vs대웅시각차,http://biz.newdaily.co.kr/site/data/html/2019/07/15/2019071500138.html
5171,2019-07-15,제약업종내상승종목중앙백신441동화약품294대웅제약195순,http://aitimes.co.kr/news/view/77736
5172,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.wikileaks-kr.org/news/articleView.html?idxno=60241
5173,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.getnews.co.kr/view.php?ud=20190715153216386541d0c69529_16
5174,2019-07-15,대웅우리가유리”주장에메디톡스보완제출명령일뿐”일축,http://weekly.cnbnews.com/news/article.html?no=128997
5175,2019-07-15,대웅제약보톡스소송서유리한전환점美ITC메디톡스영업비밀밝혀라”,http://www.donga.com/news/article/all/20190715/96486046/1
5176,2019-07-15,7월15일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=910599
5177,2019-07-15,7월15일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=910598
5178,2019-07-15,대웅제약비파민B임팩타민TV광고전개염정아오나라발탁,http://www.donga.com/news/article/all/20190715/96486719/1
5179,2019-07-15,대웅제약vs메디톡스사활건보톡스전쟁4년전말,http://www.insightkorea.co.kr//news/articleView.html?idxno=44732
5180,2019-07-15,인기종목주가정보7월15일대웅16450원으로장마감,http://nbntv.co.kr/news/view/483622
5181,2019-07-15,대웅제약비타민B임팩타민TV광고선보여,http://www.finomy.com/news/articleView.html?idxno=67654
5182,2019-07-15,15일장마감매매동향대웅제약주가155500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=276221
5183,2019-07-15,대웅제약임펙타민출시후첫TV광고송출,http://weekly.cnbnews.com/news/article.html?no=129007
5184,2019-07-15,메디톡스ITC명령은대웅제약의영업비밀침해행위설명하라는것,http://news.mk.co.kr/newsRead.php?year=2019&no=524205
5185,2019-07-15,대웅제약메디톡스대웅제약침해주장영업비밀밝혀라”,https://jhealthmedia.joins.com/article/article_view.asp?pno=20651
5186,2019-07-15,대웅제약룬드벡공동프로모션계약알츠하이머치료제에빅사시장확대,http://www.dt.co.kr/contents.html?article_no=2019071602101931102002&ref=naver
5187,2019-07-15,대웅제약알츠하이머치료제에빅사코프로모션진행,http://weekly.cnbnews.com/news/article.html?no=129012
5188,2019-07-15,ITC메디톡스에영업비밀공개명령대웅제약메디톡스다른해석,http://www.newspim.com/news/view/20190715000925
5189,2019-07-15,대웅제약VS메디톡스독한보톡스전쟁왜,http://www.etoday.co.kr/news/section/newsview.php?idxno=1776943
5190,2019-07-15,인기종목매매동향7월15일대웅제약155500원으로장마감,http://nbntv.co.kr/news/view/484488
5191,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.newscj.com/news/articleView.html?idxno=651578
5192,2019-07-15,대웅제약비타민B의더블임팩트임팩타민TV광고선봬,http://www.kpanews.co.kr/article/show.asp?idx=205480&table=article&category=D
5193,2019-07-15,대웅제약미국국제무역위원회ITC메디톡스에침해영업비밀밝혀라명령,http://www.econonews.co.kr/news/articleView.html?idxno=75916
5194,2019-07-16,아리셉트위탁제조대웅치매약판매영향력강화,http://www.dailypharm.com/Users/News/NewsView.html?ID=254720&REFERER=NP
5195,2019-07-16,임상시험승인대웅종근당경동한미약품콜마,http://www.dailymedi.com/detail.php?number=845294&thread=22r05
5196,2019-07-16,대웅제약vs메디톡스보톡스균주소송승자는,http://www.econovill.com/news/articleView.html?idxno=367609
5197,2019-07-16,美ITC메디톡스에대웅제약에게침해당한영업비밀실체공개요구,http://www.industrynews.co.kr/news/articleView.html?idxno=33361
5198,2019-07-16,★주식인사이드대웅제약주가161500원7월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=911828
5199,2019-07-16,제약업종주요종목오전시황1위KPX생명과학5572위대웅제약4503위압타바이오311,http://www.anewsa.com/detail.php?number=1881562&thread=18
5200,2019-07-16,대웅제약5이상상승나보타주보순항중메리츠종금증권BUY,https://www.hankyung.com/finance/article/201907166754L
5201,2019-07-16,대웅제약5이상상승나보타주보순항중메리츠종금증권,http://www.betanews.net:8080/article/1030626.html
5202,2019-07-16,7월16일대웅주식시세현황24316850원,http://nbntv.co.kr/news/view/486147
5203,2019-07-16,증시실황16일대웅현재주식거래가격16850원,http://www.anewsa.com/detail.php?number=1881736&thread=18
5204,2019-07-16,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.nbnnews.co.kr/news/articleView.html?idxno=293444
5205,2019-07-16,제약업종오전시황상승률상위종목KPX생명과학1790테라젠이텍스404대웅제약289등,http://www.gokorea.kr/news/articleView.html?idxno=276914
5206,2019-07-16,대웅제약비타민B의더블임팩트임팩타민TV광고온에어,http://www.wsobi.com/news/articleView.html?idxno=77721
5207,2019-07-16,대웅제약ITC소송에서유리한전환점맞아,http://www.wsobi.com/news/articleView.html?idxno=77726
5208,2019-07-16,종목현재가대웅11시26분현재가16500원연중최고가얼마,http://aitimes.co.kr/news/view/77998
5209,2019-07-16,7월16일대웅제약주식그래프225159000원,http://nbntv.co.kr/news/view/486672
5210,2019-07-16,대웅제약디엔컴퍼니호텔마리나베이서울과손잡고스파패키지할인이벤트전개,http://www.ezyeconomy.com/news/articleView.html?idxno=92262
5211,2019-07-16,대웅제약한국룬드벡과알츠하이머병치료제에빅사공동프로모션계약체결,http://www.wsobi.com/news/articleView.html?idxno=77704
5212,2019-07-16,스타★주식인사이드대웅제약주가158500원7월16일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=913451
5213,2019-07-16,영업비밀공개명령한ITC대웅제약메디톡스해석온도차,http://www.shinailbo.co.kr/news/articleView.html?idxno=1185858
5214,2019-07-16,7월16일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=914844
5215,2019-07-16,16일장마감증권시세대웅주가16400원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=277980
5216,2019-07-16,특징주분석주가정보대웅주가16400원마감해,http://www.anewsa.com/detail.php?number=1883772&thread=18
5217,2019-07-16,전승호대웅제약빈혈치료제할랄인증추진해20억이슬람시장공략,http://www.businesspost.co.kr/BP?command=article_view&num=135573
5218,2019-07-16,16일장마감증권시세대웅제약주가155500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=278226
5219,2019-07-16,특징주종목정보7월16일대웅제약155500원으로장마감,http://nbntv.co.kr/news/view/488413
5220,2019-07-17,대웅제약NEWTOX마케팅활발2년내보톡스시장점유율2위넘본다,http://www.ceoscoredaily.com/news/article.html?no=58022
5221,2019-07-17,메디톡스vs대웅제약국내외균주다툼계속,http://www.mdtoday.co.kr/mdtoday/index.html?no=359991
5222,2019-07-17,★주식인사이드대웅제약주가155000원7월17일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=916739
5223,2019-07-17,대웅제약직원자율성높아지니업무효율따라와”,http://www.dailian.co.kr/news/view/811206/?sc=naver
5224,2019-07-17,7월17일대웅주식시세현황16350원030,http://nbntv.co.kr/news/view/489812
5225,2019-07-17,주식종목17일대웅현재주가16300원,http://www.anewsa.com/detail.php?number=1886244&thread=18
5226,2019-07-17,7월17일대웅오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=278803
5227,2019-07-17,대웅제약주가그래프17일현재159000원,http://nbntv.co.kr/news/view/490348
5228,2019-07-17,현재가대웅11시27분현재가16500원종목동정,http://aitimes.co.kr/news/view/78780
5229,2019-07-17,스타★주식인사이드대웅제약주가159500원7월17일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=918336
5230,2019-07-17,제약업종주요종목오후시황1위안트로젠7032위현성바이탈6853위대웅제약257,http://www.anewsa.com/detail.php?number=1887359&thread=18
5231,2019-07-17,대웅제약이침해했다고주장하는메디톡스의영업비밀이무엇인가,http://www.kukinews.com/news/article.html?no=682789
5232,2019-07-17,대웅제약종근당1조클럽굳히기청신호,http://www.ebn.co.kr/news/view/993470
5233,2019-07-17,7월17일장마감주가정보대웅제약158500원,http://www.newsinside.kr/news/articleView.html?idxno=919657
5234,2019-07-17,17일마감정보대웅주가16400원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=279964
5235,2019-07-17,인기종목주가정보대웅주가16400원마감,http://www.anewsa.com/detail.php?number=1888504&thread=18
5236,2019-07-17,인기주종목정보7월17일대웅16400원으로장마감,http://nbntv.co.kr/news/view/491666
5237,2019-07-17,17일마감정보대웅제약158500원마감,http://www.gokorea.kr/news/articleView.html?idxno=280178
5238,2019-07-17,상장주주식시세7월17일대웅제약158500원으로장마감,http://nbntv.co.kr/news/view/492512
5239,2019-07-18,막말퇴진윤재승전대웅제약회장관계사통해지배력행사,http://www.ajunews.com/view/20190717151010024
5240,2019-07-18,대웅제약글로벌진출15년세계시장공략속도,http://www.kpinews.co.kr/news/articleView.html?idxno=99720
5241,2019-07-18,유한대웅한미JW중외등잭팟기대FirstinClass,http://www.dailymedi.com/detail.php?number=845390&thread=22r05
5242,2019-07-18,대웅제약원하는직무에자유롭게도전직원육성프로그램주목,http://www.metroseoul.co.kr/news/newsview?newscd=2019071800040
5243,2019-07-18,제약업종내상승종목씨케이에이치2389뉴트리400대웅제약347등,http://aitimes.co.kr/news/view/79448
5244,2019-07-18,스타★주식인사이드대웅제약주가162000원7월18일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=922259
5245,2019-07-18,7월18일장마감주가정보대웅제약160500원,http://www.newsinside.kr/news/articleView.html?idxno=923450
5246,2019-07-18,상장주주식시세대웅주가16150원장마쳐,http://www.anewsa.com/detail.php?number=1891279&thread=18
5247,2019-07-18,18일마감증시대웅16150원마감,http://www.gokorea.kr/news/articleView.html?idxno=281133
5248,2019-07-18,18일장마감증권시세대웅제약160500원마감,http://www.gokorea.kr/news/articleView.html?idxno=281381
5249,2019-07-18,특징주주가정보18일대웅제약마감증시160500원,http://nbntv.co.kr/news/view/494893
5250,2019-07-19,대웅제약의바이오중간성적표는,http://moneys.mt.co.kr/news/mwView.php?no=2019070817218054228
5251,2019-07-19,대웅제약관계사디엔컴퍼니자외선차단제출시,http://moneys.mt.co.kr/news/mwView.php?no=2019071908468055777
5252,2019-07-19,종목추적19일대웅현재주식거래가격16500원,http://www.anewsa.com/detail.php?number=1892272&thread=18
5253,2019-07-19,대웅실시간증시19일현재16600원,http://nbntv.co.kr/news/view/495424
5254,2019-07-19,주식종목검색대웅제약주가19일현재166000원,http://nbntv.co.kr/news/view/495964
5255,2019-07-19,오늘의신상품대웅제약디엔컴퍼니이지듀이지썬아웃도어선블록출시,http://www.econovill.com/news/articleView.html?idxno=367892
5256,2019-07-19,현재가대웅12시34분현재가16600원거래정보는,http://aitimes.co.kr/news/view/80673
5257,2019-07-19,스타★주식인사이드대웅제약주가167500원7월19일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=926257
5258,2019-07-19,메디톡스대웅제약보톡스분쟁전세역전되나,http://www.enewstoday.co.kr/news/articleView.html?idxno=1323071
5259,2019-07-19,인기주매매동향대웅주가16650원으로장마감,http://www.anewsa.com/detail.php?number=1894525&thread=18
5260,2019-07-19,7월19일장마감주가정보대웅제약167000원,http://www.newsinside.kr/news/articleView.html?idxno=927609
5261,2019-07-19,19일상장기업장마감정보대웅16650원마감,http://www.gokorea.kr/news/articleView.html?idxno=283208
5262,2019-07-19,특징주분석종목정보7월19일대웅16650원으로장마감,http://nbntv.co.kr/news/view/497612
5263,2019-07-19,19일증시종목마감동향대웅제약167000원마감,http://www.gokorea.kr/news/articleView.html?idxno=283443
5264,2019-07-19,인기주분석매매동향7월19일대웅제약167000원으로장마감,http://nbntv.co.kr/news/view/498137
5265,2019-07-22,신약개발이미래넥스트나보타에도전대웅제약RD매진,http://www.newsis.com/view/?id=NISX20190719_0000715871&cID=13001&pID=13000
5266,2019-07-22,★주식인사이드대웅제약주가165000원7월22일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=931921
5267,2019-07-22,아통증시22일대웅현재가격16700원,http://www.anewsa.com/detail.php?number=1897381&thread=18
5268,2019-07-22,대웅주식추천주22일현재16700원,http://nbntv.co.kr/news/view/500325
5269,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.segye.com/content/html/2019/07/22/20190722503027.html?OutUrl=naver
5270,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233021
5271,2019-07-22,대웅제약발달장애인지원봉사단제1기창단,http://www.insightkorea.co.kr//news/articleView.html?idxno=45823
5272,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.wsobi.com/news/articleView.html?idxno=78060
5273,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.viva100.com/main/view.php?key=20190722010007303
5274,2019-07-22,대웅제약소화기PM3인방초격차1위꿈아닌현실”,http://www.viva100.com/main/view.php?key=20190722010007274
5275,2019-07-22,대웅제약발달장애인위해참지마요프로젝트가동,http://www.whosaeng.com/111581
5276,2019-07-22,대웅주가증권투자정보22일현재16800원,http://www.gokorea.kr/news/articleView.html?idxno=284452
5277,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.newsway.co.kr/news/view?tp=1&ud=2019072210470319613
5278,2019-07-22,대웅제약발달장애인을위한참지마요교육봉사단창단,http://www.medisobizanews.com/news/articleView.html?idxno=61303
5279,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트교육봉사단창단,http://www.dailysmart.co.kr/news/articleView.html?idxno=13605
5280,2019-07-22,대웅제약참치마요프로젝트교육봉사단창단식,http://www.newsprime.co.kr/news/article.html?no=468345
5281,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.newswatch.kr/news/articleView.html?idxno=21903
5282,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.seoulwire.com/news/articleView.html?idxno=179702
5283,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.segyefn.com/newsView/20190722000926?OutUrl=naver
5284,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56396
5285,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://medipana.com/news/news_viewer.asp?NewsNum=243193&MainKind=A&NewsKind=5&vCount=12&vKind=1
5286,2019-07-22,아프면참지마요대웅제약발달장애인에질병증상표현교육지원,http://www.100ssd.co.kr/news/articleView.html?idxno=62922
5287,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.newsis.com/view/?id=NISX20190722_0000717937&cID=13001&pID=13000
5288,2019-07-22,대웅참지마요프로젝트제1기교육봉사단창단,http://www.dailymedi.com/detail.php?number=845503&thread=22r05
5289,2019-07-22,대웅제약발달장애인위한제1기교육봉사단창단식,http://www.youthdaily.co.kr/news/articleView.html?idxno=14007
5290,2019-07-22,대웅제약발달장애인위한교육봉사단창단,http://www.bosa.co.kr/news/articleView.html?idxno=2109356
5291,2019-07-22,대웅제약발달장애인지원봉사단창단,http://www.finomy.com/news/articleView.html?idxno=67849
5292,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.asiatime.co.kr/news/articleView.html?idxno=259230
5293,2019-07-22,현재가대웅11시55분현재가16750원연중최고가얼마,http://aitimes.co.kr/news/view/82019
5294,2019-07-22,대웅제약발달장애인도우미역할톡톡,http://www.sisaon.co.kr/news/articleView.html?idxno=97747
5295,2019-07-22,대웅제약발달장애인건강한삶위한봉사단창단,http://www.straightnews.co.kr/news/articleView.html?idxno=52308
5296,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.mdtoday.co.kr/mdtoday/index.html?no=360392
5297,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.businesskorea.co.kr/news/articleView.html?idxno=34149
5298,2019-07-22,스타★주식인사이드대웅제약주가169500원7월22일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=933475
5299,2019-07-22,대웅제약발달장애인교육봉사단창단,http://news.mt.co.kr/mtview.php?no=2019072210212811805
5300,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.metroseoul.co.kr/news/newsview?newscd=2019072200129
5301,2019-07-22,대웅제약발달장애인위한교육봉사단창단,http://www.dt.co.kr/contents.html?article_no=2019072202109919807017&ref=naver
5302,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.etnews.com/20190722000179
5303,2019-07-22,잡인사이드대웅리틀베어어린이집상용직채용,http://www.newsinside.kr/news/articleView.html?idxno=934521
5304,2019-07-22,대웅제약발달장애인위한교육봉사단창단,http://www.seoulfn.com/news/articleView.html?idxno=349984
5305,2019-07-22,발달장애인도우리와하나대웅제약발달장애인건강한삶위한교육봉사단창단,http://www.updownnews.co.kr/news/articleView.html?idxno=206285
5306,2019-07-22,대웅제약발달장애인건강한삶위한교육봉사단창단,http://daily.hankooki.com/lpage/ittech/201907/dh20190722150820145630.htm
5307,2019-07-22,대웅제약주가7월22일현재169500원,http://www.gokorea.kr/news/articleView.html?idxno=285121
5308,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.econovill.com/news/articleView.html?idxno=368044
5309,2019-07-22,대웅제약발달장애인에질병증상표현법교육할참지마요봉사단창단,http://news.mk.co.kr/newsRead.php?year=2019&no=551448
5310,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.lawissue.co.kr/view.php?ud=201907221555136534204ead0791_12
5311,2019-07-22,인기주분석종목정보대웅주가16700원으로마감,http://www.anewsa.com/detail.php?number=1899616&thread=18
5312,2019-07-22,대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.enewstoday.co.kr/news/articleView.html?idxno=1323644
5313,2019-07-22,대웅제약발달장애인돕는참지마요봉사단창단,http://health.chosun.com/site/data/html_dir/2019/07/22/2019072201790.html
5314,2019-07-22,22일마감정보대웅16700원마감,http://www.gokorea.kr/news/articleView.html?idxno=285382
5315,2019-07-22,대웅제약발달장애인위해참지마요프로젝트진행,http://www.mhj21.com/122852
5316,2019-07-22,특징주분석주가정보7월22일대웅16700원으로장마감,http://nbntv.co.kr/news/view/502439
5317,2019-07-22,7월22일장마감주가정보대웅제약168500원,http://www.newsinside.kr/news/articleView.html?idxno=935541
5318,2019-07-22,뉴스워커_대웅제약발달장애인건강한삶위한참지마요프로젝트제1기교육봉사단창단,http://www.newsworker.co.kr/news/articleView.html?idxno=34197
5319,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.bokuennews.com/news/article.html?no=178696
5320,2019-07-22,22일주가마감정보대웅제약168500원마감,http://www.gokorea.kr/news/articleView.html?idxno=285740
5321,2019-07-22,상장주주식시세22일대웅제약마감증시168500원,http://nbntv.co.kr/news/view/502959
5322,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.getnews.co.kr/view.php?ud=20190722175948374541d0c69529_16
5323,2019-07-22,뉴스투데이L대웅제약발달장애닝건강교육책임질참지마요교육봉사단창단,http://www.news2day.co.kr/132377
5324,2019-07-22,대웅제약발달장애인위한참지마요프로젝트제1기교육봉사단창단,http://www.newscj.com/news/articleView.html?idxno=653486
5325,2019-07-22,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.kpanews.co.kr/article/show.asp?idx=205625&table=article&category=D
5326,2019-07-23,대웅바이오베아셉트도네페질제네릭1위등극,http://www.dailypharm.com/Users/News/NewsView.html?ID=254960&REFERER=NP
5327,2019-07-23,대웅제약참지마요프로젝트제1기교육봉사단창단,http://www.polinews.co.kr/news/article.html?no=402811
5328,2019-07-23,핫클릭新상품대웅계열디엔컴퍼니이중막선블록출시,http://news.heraldcorp.com/view.php?ud=20190723000056
5329,2019-07-23,★주식인사이드대웅제약주가169000원7월23일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=936813
5330,2019-07-23,대웅제약상반기원외처방실적9성장3628억원,http://www.bosa.co.kr/news/articleView.html?idxno=2109405
5331,2019-07-23,7월23일대웅주식현황16700원000,http://nbntv.co.kr/news/view/504640
5332,2019-07-23,종목추적23일대웅현재주가16700원,http://www.anewsa.com/detail.php?number=1901852&thread=18
5333,2019-07-23,대웅제약상반기원외처방상위제약사중1위최강면모과시,http://www.medisobizanews.com/news/articleView.html?idxno=61330
5334,2019-07-23,7월23일대웅증권그래프외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=287419
5335,2019-07-23,7월23일대웅제약실시간주식현황089170000원,http://nbntv.co.kr/news/view/505177
5336,2019-07-23,사회공헌대웅제약발달장애인건강한삶지원참지마요프로젝트제1기교육봉사단창설,http://www.ezyeconomy.com/news/articleView.html?idxno=92432
5337,2019-07-23,대웅제약원외처방시장명가재확인,http://www.whosaeng.com/111614
5338,2019-07-23,스타★주식인사이드대웅제약주가166500원7월23일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=937474
5339,2019-07-23,7월23일장마감주가정보대웅제약166500원,http://www.newsinside.kr/news/articleView.html?idxno=938038
5340,2019-07-23,인기주분석종목정보23일대웅마감증시16550원,http://nbntv.co.kr/news/view/506816
5341,2019-07-23,23일코스닥코스피마감정보대웅16550원마감,http://www.gokorea.kr/news/articleView.html?idxno=288630
5342,2019-07-23,대웅제약발달장애인위한교육봉사단창단,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3895535
5343,2019-07-23,특징주매매동향23일대웅제약마감증시166500원,http://nbntv.co.kr/news/view/507363
5344,2019-07-23,23일마감주가정보대웅제약166500원마감,http://www.gokorea.kr/news/articleView.html?idxno=289074
5345,2019-07-24,제약업계소식일양약품셀트리온동아에스티대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/2019072316105117969d76442fa_1/article.html
5346,2019-07-24,대웅제약상반기원외처방3628억상위5개사중최고성장률,http://www.rapportian.com/news/articleView.html?idxno=118857
5347,2019-07-24,★주식인사이드대웅제약주가167000원7월24일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=938873
5348,2019-07-24,대웅주가종목그래프24일현재16500원,http://www.gokorea.kr/news/articleView.html?idxno=290279
5349,2019-07-24,증권플러스대웅주가24일현재16500원,http://nbntv.co.kr/news/view/509028
5350,2019-07-24,종목현재가대웅10시33분현재가16350원거래정보는,http://aitimes.co.kr/news/view/84086
5351,2019-07-24,대웅제약오늘증권시세24일현재165000원,http://nbntv.co.kr/news/view/509579
5352,2019-07-24,대웅제약주가7월24일현재164000원,http://www.gokorea.kr/news/articleView.html?idxno=290885
5353,2019-07-24,스타★주식인사이드대웅제약주가164000원7월24일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=939511
5354,2019-07-24,7월24일장마감주가정보대웅제약164000원,http://www.newsinside.kr/news/articleView.html?idxno=940092
5355,2019-07-24,상장주매매동향대웅주가16150원마감해,http://aitimes.co.kr/news/view/85000
5356,2019-07-24,24일주식장마감동향대웅16150원마감,http://www.gokorea.kr/news/articleView.html?idxno=291577
5357,2019-07-24,상장주매매동향24일대웅마감증시16150원,http://nbntv.co.kr/news/view/511216
5358,2019-07-24,24일증시종목마감동향대웅제약주가164000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=292008
5359,2019-07-24,인기종목주가정보24일대웅제약마감증시164000원,http://nbntv.co.kr/news/view/511741
5360,2019-07-25,대웅제약임팩타민소비자대상마케팅강화,http://www.asiatoday.co.kr/view.php?key=20190725010015644
5361,2019-07-25,★주식인사이드대웅제약주가164500원7월25일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=941248
5362,2019-07-25,대웅투자주식25일현재16150원,http://nbntv.co.kr/news/view/513353
5363,2019-07-25,대웅제약아큐네탄연질캡슐10mg생산중단,http://www.bokuennews.com/news/article.html?no=178856
5364,2019-07-25,국민연금대웅제약주가상승에보유지분가치2년새두배로커져,http://www.ceoscoredaily.com/news/article.html?no=58398
5365,2019-07-25,대웅제약Next나보타신약파이프라인들,http://www.biospectator.com/view/news_view.php?varAtcId=8107
5366,2019-07-25,주식현재가대웅10시40분현재가16100원거래정보는,http://aitimes.co.kr/news/view/85953
5367,2019-07-25,주식현재가대웅제약주가25일현재162500원,http://nbntv.co.kr/news/view/513889
5368,2019-07-25,스타★주식인사이드대웅제약주가161500원7월25일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=941847
5369,2019-07-25,7월25일장마감주가정보대웅제약162000원,http://www.newsinside.kr/news/articleView.html?idxno=942188
5370,2019-07-25,대웅제약참지마요프로젝트봉사단창단,http://weekly.cnbnews.com/news/article.html?no=129191
5371,2019-07-25,특징주분석주가정보대웅주가16150원으로종료,http://aitimes.co.kr/news/view/86874
5372,2019-07-25,25일주가마감정보대웅16150원마감,http://www.gokorea.kr/news/articleView.html?idxno=294497
5373,2019-07-25,증시매매동향25일대웅마감증시16150원,http://nbntv.co.kr/news/view/515505
5374,2019-07-25,25일마감주가정보대웅제약주가162000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=294882
5375,2019-07-25,인기주종목정보25일대웅제약마감증시162000원,http://nbntv.co.kr/news/view/516031
5376,2019-07-26,금일증시대웅주가26일현재15700원,http://nbntv.co.kr/news/view/517683
5377,2019-07-26,종목현재가대웅10시36분현재가15750원거래정보는,http://aitimes.co.kr/news/view/87832
5378,2019-07-26,7월26일대웅증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=296465
5379,2019-07-26,대웅제약주식장26일현재161500원,http://nbntv.co.kr/news/view/518224
5380,2019-07-26,스타★주식인사이드대웅제약주가160000원7월26일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=943943
5381,2019-07-26,대웅제약넥스트나보타연구박차파이프라인충분,http://www.dailypharm.com/Users/News/NewsView.html?ID=255157&REFERER=NP
5382,2019-07-26,대웅제약글로벌RD네트워크구축현지지배력강화장기전,http://www.polinews.co.kr/news/article.html?no=403679
5383,2019-07-26,대웅제약현지화전략으로글로벌헬스케어그룹앞당긴다,http://www.insightkorea.co.kr//news/articleView.html?idxno=46496
5384,2019-07-26,대웅제약베트남지분투자현지화전략으로지속성장,http://www.bosa.co.kr/news/articleView.html?idxno=2109717
5385,2019-07-26,대웅제약주가오늘시세26일현재161000원,http://www.gokorea.kr/news/articleView.html?idxno=297079
5386,2019-07-26,7월26일장마감주가정보대웅제약160000원,http://www.newsinside.kr/news/articleView.html?idxno=944497
5387,2019-07-26,26일주식장마감동향대웅15750원마감,http://www.gokorea.kr/news/articleView.html?idxno=297310
5388,2019-07-26,특징주분석종목정보26일대웅마감증시15750원,http://nbntv.co.kr/news/view/519741
5389,2019-07-26,메디톡스대웅제약중기부기술침해조사첫사례나와,http://www.newspim.com/news/view/20190726000855
5390,2019-07-26,대웅제약오송스마트공장을전초기지로삼아글로벌사업속도붙여,http://www.businesspost.co.kr/BP?command=article_view&num=137079
5391,2019-07-29,대웅전문약처방파죽지세상위5개사중성장률1위,http://www.dailymedi.com/detail.php?number=845721&thread=22r05
5392,2019-07-29,대웅제약소화기계분야1위비결오리지널리티강화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070696
5393,2019-07-29,증권주식대웅주가29일현재15600원,http://nbntv.co.kr/news/view/522545
5394,2019-07-29,대웅주가7월29일현재15350원,http://www.gokorea.kr/news/articleView.html?idxno=299468
5395,2019-07-29,국내의약품생산실적한미종근당셀트리온대웅순,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87064
5396,2019-07-29,7월29일대웅제약증권플러스154500원344,http://nbntv.co.kr/news/view/523090
5397,2019-07-29,시클러캡슐등11품목대웅→대웅바이오허가변경,https://www.kpanews.co.kr/article/show.asp?idx=205765&category=B
5398,2019-07-29,지난해의약품생산실적한미약품종근당셀트리온대웅제약순,http://medicalworldnews.co.kr/news/view.php?idx=1510931829
5399,2019-07-29,한미종근당셀트리온대웅제약녹십자順,http://www.dailymedi.com/detail.php?number=845742&thread=22r05
5400,2019-07-29,스타★주식인사이드대웅제약주가155000원7월29일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=948765
5401,2019-07-29,7월29일대웅제약오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=300079
5402,2019-07-29,7월29일장마감주가정보대웅제약155000원,http://www.newsinside.kr/news/articleView.html?idxno=949083
5403,2019-07-29,29일주가마감정보대웅15600원마감,http://www.gokorea.kr/news/articleView.html?idxno=300365
5404,2019-07-29,특징주분석매매동향29일대웅마감증시15600원,http://nbntv.co.kr/news/view/524724
5405,2019-07-29,29일장마감증권시세대웅제약주가155000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=300753
5406,2019-07-29,인기주분석종목정보29일대웅제약마감증시155000원,http://nbntv.co.kr/news/view/525249
5407,2019-07-30,★주식인사이드대웅제약주가155500원7월30일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=949938
5408,2019-07-30,7월30일대웅주식그래프03215650원,http://nbntv.co.kr/news/view/526916
5409,2019-07-30,대웅주가7월30일현재15500원,http://www.gokorea.kr/news/articleView.html?idxno=302446
5410,2019-07-30,7월30일대웅제약실시간증시158000원194,http://nbntv.co.kr/news/view/527450
5411,2019-07-30,대웅주가7월30일현재15800원및종목차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=128025
5412,2019-07-30,스타★주식인사이드대웅제약주가159000원7월30일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=950571
5413,2019-07-30,대웅제약주가정보30일현재160500원,http://www.gokorea.kr/news/articleView.html?idxno=303049
5414,2019-07-30,7월30일장마감주가정보대웅제약158000원,http://www.newsinside.kr/news/articleView.html?idxno=951158
5415,2019-07-30,상장주매매동향7월30일대웅제약158000원으로장마감,http://nbntv.co.kr/news/view/529565
5416,2019-07-30,30일마감정보대웅제약주가158000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=303906
5417,2019-07-31,대웅제약고지혈증약크레스토장기집권특허만료前매출로U턴성장,http://www.medisobizanews.com/news/articleView.html?idxno=61490
5418,2019-07-31,★주식인사이드대웅제약주가158500원7월31일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=951986
5419,2019-07-31,주식그래프대웅주가31일현재15650원,http://nbntv.co.kr/news/view/531229
5420,2019-07-31,대웅주가증권투자정보31일현재15300원,http://www.gokorea.kr/news/articleView.html?idxno=305243
5421,2019-07-31,7월31일대웅제약주식추천주222154500원,http://nbntv.co.kr/news/view/531774
5422,2019-07-31,스타★주식인사이드대웅제약주가155000원7월31일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=952556
5423,2019-07-31,컨센부합대웅제약올해2Q영업익170억컨센비34↑,http://www.itooza.com/common/iview.php?no=2019073115404719809
5424,2019-07-31,7월31일대웅제약오늘시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=305919
5425,2019-07-31,실적속보대웅제약별도20192Q영업이익17095억원,http://www.fntimes.com/html/view.php?ud=2019073115410012225dfa8f2ce9_18
5426,2019-07-31,코스피대웅제약2019년2분기누적매출액5016억원영업이익273억원,http://news.kmib.co.kr/article/view.asp?arcid=0013556692&code=61141211&cp=nv
5427,2019-07-31,대웅제약2Q영업익171억전년비71↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=255324&REFERER=NP
5428,2019-07-31,대웅제약2Q영업익171억원전년比706↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03883526622560096
5429,2019-07-31,공시대웅제약2분기영업익171억전년比706↑,http://www.newsway.co.kr/news/view?tp=1&ud=2019073115491217826
5430,2019-07-31,대웅제약2분기영업익170억전년比706↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783119
5431,2019-07-31,대웅제약2Q영업익171억전년比71↑,http://news.mt.co.kr/mtview.php?no=2019073115562324538
5432,2019-07-31,대웅제약2분기영업이익171억원706증가,http://yna.kr/AKR20190731126400008?did=1195m
5433,2019-07-31,대웅제약2분기영업익170억전년比706↑,http://www.sportsseoul.com/news/read/798633
5434,2019-07-31,공시대웅제약0696202분기영업익170억전년比706↑,http://www.startuptoday.co.kr/news/articleView.html?idxno=27947
5435,2019-07-31,대웅제약2분기역대최대분기매출달성,http://www.economytalk.kr/news/articleView.html?idxno=193166
5436,2019-07-31,대웅제약2분기영업익171억원전년동기대비706증가,https://www.sedaily.com/NewsView/1VLWPBTH84
5437,2019-07-31,7월31일장마감주가정보대웅제약158500원,http://www.newsinside.kr/news/articleView.html?idxno=953096
5438,2019-07-31,대웅제약올2분기역대최대분기매출달성전년동기대비영업이익은706폭발적성장,http://www.segye.com/content/html/2019/07/31/20190731510394.html?OutUrl=naver
5439,2019-07-31,대웅제약2분기역대최대분기매출2634억달성,http://www.fnnews.com/news/201907311610318499
5440,2019-07-31,대웅제약2분기영업익171억원전년比706↑,http://www.seoulwire.com/news/articleView.html?idxno=186721
5441,2019-07-31,인기주분석종목정보대웅주가15550원마감,http://aitimes.co.kr/news/view/94603
5442,2019-07-31,대웅제약2분기역대최대분기매출달성나보타덕분,http://www.newsway.co.kr/news/view?tp=1&ud=2019073116111120221
5443,2019-07-31,대웅분기최대매출달성미국진출나보타186억,http://www.dailypharm.com/Users/News/NewsView.html?ID=255330&REFERER=NP
5444,2019-07-31,대웅제약2분기매출액2634억원창사이래최대분기매출달성,http://www.ceoscoredaily.com/news/article.html?no=58700
5445,2019-07-31,대웅제약2분기매출2643억원역대최대분기매출달성,http://www.viva100.com/main/view.php?key=20190731010010796
5446,2019-07-31,대웅제약2Q매출액2634억영업익171억기록역대분기최대매출,http://www.dailysmart.co.kr/news/articleView.html?idxno=13946
5447,2019-07-31,대웅제약나보타美진출로2분기영업익70증가,http://www.kpinews.co.kr/news/articleView.html?idxno=100446
5448,2019-07-31,대웅제약2Q역대최대분기매출달성‥영업이익급증,http://medipana.com/news/news_viewer.asp?NewsNum=243657&MainKind=A&NewsKind=5&vCount=12&vKind=1
5449,2019-07-31,대웅제약2분기영업익171억원전년대비71증가,http://moneys.mt.co.kr/news/mwView.php?no=2019073116158045136
5450,2019-07-31,대웅제약2Q2634억매출역대최대분기매출달성,http://www.newsis.com/view/?id=NISX20190731_0000728115&cID=13001&pID=13000
5451,2019-07-31,대웅제약나보타수출등에업고역대최대분기매출,http://www.newspim.com/news/view/20190731000959
5452,2019-07-31,대웅제약2분기영업이익171억원706증가종합,http://yna.kr/AKR20190731126451008?did=1195m
5453,2019-07-31,대웅제약2분기역대최대매출영업이익급증,http://www.mhj21.com/123088
5454,2019-07-31,대웅제약2분기영업이익171억원전년比706↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=361212
5455,2019-07-31,대웅제약2분기매출2634억원역대분기최대,http://www.medisobizanews.com/news/articleView.html?idxno=61519
5456,2019-07-31,특징주종목정보31일대웅마감증시15550원,http://nbntv.co.kr/news/view/533357
5457,2019-07-31,대웅제약2분기사상최대매출달성,http://www.dailian.co.kr/news/view/814874/?sc=naver
5458,2019-07-31,대웅제약2분기영업이익706증가한171억,http://www.mediapen.com/news/view/451947
5459,2019-07-31,대웅제약2분기역대최대분기매출달성으로영업이익급증,http://www.medigatenews.com/news/2104257328
5460,2019-07-31,대웅제약2분기역대최대매출달성영업익급증,http://www.metroseoul.co.kr/news/newsview?newscd=2019073100237
5461,2019-07-31,대웅제약2분기영업이익171억원706↑,http://www.asiatoday.co.kr/view.php?key=20190731010019970
5462,2019-07-31,대웅제약2분기영업익171억전년比706증가,http://biz.newdaily.co.kr/site/data/html/2019/07/31/2019073100181.html
5463,2019-07-31,대웅제약2분기매출2634억원전년比106↑,http://news.mt.co.kr/mtview.php?no=2019073116382846137
5464,2019-07-31,대웅제약2Q매출2634억나보타미국출시로분기최대실적,http://news1.kr/articles/?3684738
5465,2019-07-31,대웅제약2분기매출2634억원달성역대최대분기매출기록,http://inthenews.co.kr/article-10275/
5466,2019-07-31,대웅제약2분기영업이익171억원전년동기대비706↑,http://news.mk.co.kr/newsRead.php?year=2019&no=585833
5467,2019-07-31,대웅제약역대최대분기매출달성,http://www.newstomato.com/ReadNews.aspx?no=911276
5468,2019-07-31,대웅제약실적발표영업이익171억원전분기대비676증가개별잠정,http://www.newspim.com/news/view/20190731001025
5469,2019-07-31,ETCOTC부문에서안정적인성장견인대웅제약2Q사상최대분기매출및영업이익대폭성장,http://www.updownnews.co.kr/news/articleView.html?idxno=206686
5470,2019-07-31,대웅제약2019년2분기역대최대분기매출달성,http://daily.hankooki.com/lpage/ittech/201907/dh20190731170735145630.htm
5471,2019-07-31,나보타의힘대웅제약2분기매출역대최대영업이익70↑,http://www.donga.com/news/article/all/20190731/96776743/1
5472,2019-07-31,대웅제약2분기매출역대최대영업이익전년대비706급증,http://www.econovill.com/news/articleView.html?idxno=368717
5473,2019-07-31,대웅제약2Q영업익171억원전년比706↑,http://www.wolyo.co.kr/news/articleView.html?idxno=90144
5474,2019-07-31,대웅제약2분기매출2634억원분기매출역대최대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783200
5475,2019-07-31,대웅제약2Q역대최대매출VS유한양행영업익98↓,http://www.edaily.co.kr/news/newspath.asp?newsid=04234486622560096
5476,2019-07-31,대웅제약2Q영업익171억나보타미국진출로706↑,http://www.ajunews.com/view/20190731171700760
5477,2019-07-31,대웅제약ETCOTC고른성장세2분기영업익전년比71↑,http://www.newsprime.co.kr/news/article.html?no=469816
5478,2019-07-31,대웅제약2분기영업익170억전년비706↑,http://www.ebn.co.kr/news/view/995395
5479,2019-07-31,대웅제약2분기영업익170억전년대비706↑,http://biz.chosun.com/site/data/html_dir/2019/07/31/2019073101928.html
5480,2019-07-31,대웅제약2분기최대실적전년比매출106↑영업이익706↑,http://www.joseilbo.com/news/news_read.php?uid=381385&class=17&grp=
5481,2019-07-31,31일마감증시대웅제약주가158500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=306444
5482,2019-07-31,실적대웅제약2Q영업이익171억706↑전문일반의약품호조세,http://www.ezyeconomy.com/news/articleView.html?idxno=92670
5483,2019-07-31,공시대웅제약2분기영업익171억전년比706↑,http://www.newsis.com/view/?id=NISX20190731_0000728106&cID=10401&pID=10400
5484,2019-07-31,대웅제약2분기역대최대분기매출달성,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070815
5485,2019-07-31,대웅제약2분기영업익171억원분기최대매출,https://view.asiae.co.kr/article/2019073117500496046
5486,2019-07-31,대웅제약2분기영업이익171억원전년비706↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907310622&t=NN
5487,2019-07-31,대웅제약2분기영업익171억전년比706↑,http://www.segyefn.com/newsView/20190731000631?OutUrl=naver
5488,2019-07-31,대웅제약2분기역대최대분기매출2634억달성,http://www.nbnnews.co.kr/news/articleView.html?idxno=299983
5489,2019-07-31,대웅제약19년2분기역대최대분기매출달성,http://www.lawissue.co.kr/view.php?ud=201907311809138925204ead0791_12
5490,2019-07-31,인기종목주가정보31일대웅제약마감증시158500원,http://nbntv.co.kr/news/view/533891
5491,2019-07-31,대웅제약2Q사상최대매출영업이익71↑,http://www.upinews.kr/news/newsview.php?ncode=1065603813872511
5492,2019-07-31,대웅분기매출역대최대달성영업익급증171억,http://www.dailymedi.com/detail.php?number=845838&thread=22r05
5493,2019-07-31,대웅제약2Q영업익171억원전년比706증가,http://www.seoulfn.com/news/articleView.html?idxno=351132
5494,2019-07-31,대웅제약19년2분기역대최대매출달성영업이익급증,http://www.getnews.co.kr/view.php?ud=20190731184623749641d0c69529_16
5495,2019-07-31,대웅제약의약품부문성장과나보타미국수출로2분기실적급등,http://www.businesspost.co.kr/BP?command=article_view&num=137675
5496,2019-07-31,대웅제약2분기영업이익171억원전년比706↑,http://www.nspna.com/news/?mode=view&newsid=374957
5497,2019-07-31,대웅제약역대최대분기매출달성으로영업이익급증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56596
5498,2019-07-31,대웅제약2분기역대최대매출달성매출2634억원영업익171억원기록,http://www.g-enews.com/ko-kr/news/article/news_all/20190731180232849869d76442fa_1/article.html
5499,2019-07-31,대웅제약2Q매출2634억원전년比106↑,http://www.newswatch.kr/news/articleView.html?idxno=22183
5500,2019-07-31,뉴스워커_대웅제약2분기역대최대분기매출달성으로영업이익급증,http://www.newsworker.co.kr/news/articleView.html?idxno=35061
5501,2019-08-01,대웅제약2분기영업이익171억전년대비706늘어나,http://www.econonews.co.kr/news/articleView.html?idxno=78941
5502,2019-08-01,대웅제약2분기매출액2634억역대최대분기매출달성,http://www.thefirstmedia.net/news/articleView.html?idxno=47175
5503,2019-08-01,대웅제약2분기역대최대분기매출달성영업익급증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233415
5504,2019-08-01,보령제약대웅제약상반기영업익쑥유한양행실적나홀로뒷걸음질,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=532856
5505,2019-08-01,클릭e종목대웅제약호실적은나보타덕분,https://view.asiae.co.kr/article/2019080107330064535
5506,2019-08-01,퀵리포트대웅제약매수유지목표가16↓21만원한투證,http://www.itooza.com/common/iview.php?no=2019080107532510522
5507,2019-08-01,빅데이터MSI시장심리톱5삼성SDI대웅제약코웨이대우건설KB금융,http://www.newsis.com/view/?id=NISX20190801_0000728484&cID=10401&pID=10400
5508,2019-08-01,대웅제약2Q어닝서프라이즈신영,http://news.mt.co.kr/mtview.php?no=2019080108102029757
5509,2019-08-01,대웅제약나보타균주소송비용부담목표가↓키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01607206622583056
5510,2019-08-01,대웅제약나보타흥행하반기도계속매수신영증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783313
5511,2019-08-01,KTB투자증권대웅제약소송이슈에가려진펀더멘탈개선주목목표가는↓”,http://www.newsway.co.kr/news/view?tp=1&ud=2019080108173311745
5512,2019-08-01,퀵리포트대웅제약중립으로유지목표가미제시미래에셋대우,http://www.itooza.com/common/iview.php?no=2019080108282218529
5513,2019-08-01,대웅제약목표주가낮아져나보타관련소송의불확실성은부담,http://www.businesspost.co.kr/BP?command=article_view&num=137742
5514,2019-08-01,대웅제약2Q미국향나보타수출증가로호실적키움증권,http://www.ebn.co.kr/news/view/995411
5515,2019-08-01,퀵리포트대웅제약매수유지목표가12↓22만원키움證,http://www.itooza.com/common/iview.php?no=2019080108525714114
5516,2019-08-01,대웅제약美나보타판매호조에최대분기매출경신,http://www.asiatoday.co.kr/view.php?key=20190801010000090
5517,2019-08-01,5000억원돌파한대웅제약2분기사상최대매출,http://www.monews.co.kr/news/articleView.html?idxno=204163
5518,2019-08-01,실시간분석대웅제약34상승2Q영업익170억,http://www.itooza.com/common/iview.php?no=2019080109014426949
5519,2019-08-01,퀵리포트대웅제약강력매수로상향목표가6↓28만원KTB證,http://www.itooza.com/common/iview.php?no=2019080108305314628
5520,2019-08-01,★주식인사이드대웅제약주가161500원8월1일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=954157
5521,2019-08-01,대웅제약나보타서프라이즈하반기에도유지신영증권,http://www.fnnews.com/news/201908010911313444
5522,2019-08-01,퀵리포트대웅제약매수유지목표가27만원유지대신證,http://www.itooza.com/common/iview.php?no=2019080107352516066
5523,2019-08-01,퀵리포트대웅제약매수유지목표가24만5000원유지신영證,http://www.itooza.com/common/iview.php?no=2019080108361918110
5524,2019-08-01,대웅제약2분기역대최대매출달성,http://www.wsobi.com/news/articleView.html?idxno=78754
5525,2019-08-01,8월1일대웅주식증권19315850원,http://nbntv.co.kr/news/view/535548
5526,2019-08-01,리포트브리핑대웅제약분기최대매출달성목표가200000원DB금융투자,http://www.newspim.com/news/view/20190801000228
5527,2019-08-01,GET투자리포트대웅제약투자의견보유유지DB금융투자,http://www.getnews.co.kr/view.php?ud=201908011030309082tpgetnews_16
5528,2019-08-01,퀵리포트대웅제약보유유지목표가20만원유지DB금투,http://www.itooza.com/common/iview.php?no=2019080109403914429
5529,2019-08-01,막말퇴진대웅제약윤재승회장자숙은생략뒤에숨어서실세경영,http://viewers.heraldcorp.com/news/articleView.html?idxno=41048
5530,2019-08-01,리포트브리핑대웅제약나보타효과반영목표가270000원대신증권,http://www.newspim.com/news/view/20190801000245
5531,2019-08-01,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=201908011030309088tpgetnews_16
5532,2019-08-01,빅5제약한미대웅GOOD종근당등3개사1조클럽활짝,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233420
5533,2019-08-01,GET투자리포트대웅제약투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201908011030309103tpgetnews_16
5534,2019-08-01,리포트브리핑대웅제약역대최대분기매출액달성목표가250000원KB증권,http://www.newspim.com/news/view/20190801000308
5535,2019-08-01,대웅제약소송비용없었다면2분기209억원영업이익도가능”,http://www.wikitree.co.kr/main/news_view.php?id=450483
5536,2019-08-01,대웅제약2분기매출2634억영업이익171억기록,http://www.bokuennews.com/news/article.html?no=179099
5537,2019-08-01,현재가대웅10시42분현재가15850원종목동정,http://aitimes.co.kr/news/view/95540
5538,2019-08-01,GET투자리포트대웅제약투자의견NotRated미래에셋대우,http://www.getnews.co.kr/view.php?ud=201908011030309121tpgetnews_16
5539,2019-08-01,리포트브리핑대웅제약2Q19사상최대분기매출로시장기대치충족NotRated미래에셋대우,http://www.newspim.com/news/view/20190801000453
5540,2019-08-01,8월1일대웅제약오늘주식162000원221,http://nbntv.co.kr/news/view/536083
5541,2019-08-01,실적속보대웅제약올해2Q영업이익대폭상승전분기보다676올라개별잠정,https://www.hankyung.com/finance/article/201908015969L
5542,2019-08-01,리포트브리핑대웅제약나보타로개선되는실적목표가260000원유안타증권,http://www.newspim.com/news/view/20190801000574
5543,2019-08-01,GET투자리포트대웅제약투자의견매수유안타증권,http://www.getnews.co.kr/view.php?ud=201908011030309149tpgetnews_16
5544,2019-08-01,GET투자리포트대웅제약투자의견매수유지키움증권,http://www.getnews.co.kr/view.php?ud=201908011030309160tpgetnews_16
5545,2019-08-01,리포트브리핑대웅제약뚜렷한실적개선목표가220000원키움증권,http://www.newspim.com/news/view/20190801000635
5546,2019-08-01,GET투자리포트대웅제약투자의견매수유지한국투자증권,http://www.getnews.co.kr/view.php?ud=201908011030309162tpgetnews_16
5547,2019-08-01,리포트브리핑대웅제약눈으로확인된Jeuveau효과목표가210000원한국투자증권,http://www.newspim.com/news/view/20190801000638
5548,2019-08-01,스타★주식인사이드대웅제약주가162500원8월1일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=954520
5549,2019-08-01,대웅제약2분기실적역대최대분기매출달성,http://www.sisaon.co.kr/news/articleView.html?idxno=98421
5550,2019-08-01,대웅제약주가증권그래프및주체별매매동향1일현재162500원,http://www.gokorea.kr/news/articleView.html?idxno=308711
5551,2019-08-01,퀵리포트대웅제약매수유지목표가19만5000원유지신한금투,http://www.itooza.com/common/iview.php?no=2019080114161313505
5552,2019-08-01,대웅제약나보타의美수출증가와실적개선기대”,http://www.wikitree.co.kr/main/news_view.php?id=450590
5553,2019-08-01,아쉬운선두유한실속챙긴대웅,http://www.newstomato.com/ReadNews.aspx?no=911497
5554,2019-08-01,8월1일장마감주가정보대웅제약161000원,http://www.newsinside.kr/news/articleView.html?idxno=955055
5555,2019-08-01,인기종목주가정보대웅주가16000원으로마감,http://aitimes.co.kr/news/view/96455
5556,2019-08-01,1일장마감매매동향대웅16000원마감,http://www.gokorea.kr/news/articleView.html?idxno=309128
5557,2019-08-01,인기주주가정보1일대웅마감증시16000원,http://nbntv.co.kr/news/view/537705
5558,2019-08-01,나보타효과대웅제약역대최대분기매출,http://www.fnnews.com/news/201908011706513948
5559,2019-08-01,대웅제약주보최고분기매출견인,http://www.whosaeng.com/111762
5560,2019-08-01,1일증시종목마감동향대웅제약주가161000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=309462
5561,2019-08-01,대웅제약리스크요인은끝나지않은균주소송”,http://www.wikitree.co.kr/main/news_view.php?id=450673
5562,2019-08-01,상장주주가정보1일대웅제약마감증시161000원,http://nbntv.co.kr/news/view/538243
5563,2019-08-02,더벨300성장나보타힘입어대웅제약최대분기매출,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908010100000290000022
5564,2019-08-02,★주식인사이드대웅제약주가157000원8월2일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=955977
5565,2019-08-02,8월2일대웅주식장15750원156,http://nbntv.co.kr/news/view/539897
5566,2019-08-02,현재가대웅10시32분현재가15700원종목동정,http://aitimes.co.kr/news/view/97402
5567,2019-08-02,대웅주가8월2일현재15750원,http://www.gokorea.kr/news/articleView.html?idxno=310796
5568,2019-08-02,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201908011030309231tpgetnews_16
5569,2019-08-02,8월2일대웅제약주식추천주280156500원,http://nbntv.co.kr/news/view/540428
5570,2019-08-02,GET투자리포트대웅제약투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201908011030309237tpgetnews_16
5571,2019-08-02,대웅제약2분기실적나보타美수출높은수익성확인,http://medipana.com/news/news_viewer.asp?NewsNum=243761&MainKind=A&NewsKind=5&vCount=12&vKind=1
5572,2019-08-02,대웅제약2분기매출2634억역대최대,http://www.munhwa.com/news/view.html?no=2019080201071827107001
5573,2019-08-02,대웅제약주가8월2일현재159500원,http://www.gokorea.kr/news/articleView.html?idxno=311350
5574,2019-08-02,대웅주가8월2일현재15850원및종목차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=128796
5575,2019-08-02,스타★주식인사이드대웅제약주가158000원8월2일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=956313
5576,2019-08-02,대웅제약통합정보시스템최신업그레이드,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87134
5577,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.segye.com/content/html/2019/08/02/20190802506718.html?OutUrl=naver
5578,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹강화,http://www.segyefn.com/newsView/20190802001721?OutUrl=naver
5579,2019-08-02,대웅제약IT인프라고도화글로벌헬스케어그룹기반강화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1783990
5580,2019-08-02,대웅제약19년2분기역대최대분기매출달성,http://www.kukinews.com/news/article.html?no=688131
5581,2019-08-02,대웅제약차세대SAPERP시스템구축글로벌헬스케어그룹도약할것”,http://inthenews.co.kr/article-10605/
5582,2019-08-02,대웅제약S4HANA시스템도입으로글로벌헬스케어그룹기반강화,http://www.businesskorea.co.kr/news/articleView.html?idxno=34557
5583,2019-08-02,대웅제약S4HANA시스템구축글로벌헬스케어기반강화,http://www.medisobizanews.com/news/articleView.html?idxno=61579
5584,2019-08-02,대웅제약SAPERP고도화시스템도입,http://www.newsis.com/view/?id=NISX20190802_0000730325&cID=13001&pID=13000
5585,2019-08-02,대웅제약S4HANA시스템도입글로벌헬스케어기반강화,http://www.seoulwire.com/news/articleView.html?idxno=188519
5586,2019-08-02,대웅제약전사적자원관리시스템도입글로벌헬스케어그룹기반강화,http://www.getnews.co.kr/view.php?ud=20190802142917145141d0c69529_16
5587,2019-08-02,대웅제약SAPERP고도화완료글로벌신경망구축,http://www.etnews.com/20190802000202
5588,2019-08-02,대웅제약차세대SAPERP시스템구축글로벌헬스케어기반강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=361407
5589,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.mhj21.com/123161
5590,2019-08-02,대웅제약표준화된글로벌신경망체제구축,http://www.bosa.co.kr/news/articleView.html?idxno=2110118
5591,2019-08-02,대웅제약IT인프라고도화작업착착,http://www.sisaon.co.kr/news/articleView.html?idxno=98522
5592,2019-08-02,대웅제약SAPERP고도화글로벌헬스케어그룹기반강화,http://medipana.com/news/news_viewer.asp?NewsNum=243765&MainKind=A&NewsKind=5&vCount=12&vKind=1
5593,2019-08-02,대웅제약차세대SAPERP시스템도입글로벌신경망체제구축,http://www.wolyo.co.kr/news/articleView.html?idxno=90303
5594,2019-08-02,대웅제약차세대SAPERP고도화글로벌신경망체제구축,http://www.ebn.co.kr/news/view/995678
5595,2019-08-02,대웅S4HANA시스템도입글로벌신경망체제구축,http://www.dailymedi.com/detail.php?number=845918&thread=22r05
5596,2019-08-02,식약처대웅제약니코프리패취에15일제조업무정지,http://daily.hankooki.com/lpage/ittech/201908/dh20190802150540145630.htm
5597,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233480
5598,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.medigatenews.com/news/2732154157
5599,2019-08-02,대웅제약SAPERP고도화S4프로젝트달성,http://www.wikileaks-kr.org/news/articleView.html?idxno=61906
5600,2019-08-02,알레락후쿠시마의약품대웅제약안전성문제없다,http://www.newsprime.co.kr/news/article.html?no=470130
5601,2019-08-02,대웅제약 SAPERP 고도화S4HANA 시스템 도입,http://www.ezyeconomy.com/news/articleView.html?idxno=92758
5602,2019-08-02,대웅제약제약업계최초로SAPERP최신버전구축해,http://news.mk.co.kr/newsRead.php?year=2019&no=593356
5603,2019-08-02,대웅제약전사IT인프라고도화글로벌헬스케어그룹기반강화,http://www.newspim.com/news/view/20190802000671
5604,2019-08-02,2일상장기업장마감정보대웅15850원마감,http://www.gokorea.kr/news/articleView.html?idxno=312525
5605,2019-08-02,8월2일장마감주가정보대웅제약155500원,http://www.newsinside.kr/news/articleView.html?idxno=956879
5606,2019-08-02,대웅제약차세대SAPERP시스템으로글로벌네트워크구축,http://www.newsfc.co.kr/news/articleView.html?idxno=37304
5607,2019-08-02,2일주식장마감동향대웅제약주가155500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=312765
5608,2019-08-02,대웅제약IT인프라업그레이드전승호일하는방식혁신,http://www.businesspost.co.kr/BP?command=article_view&num=138001
5609,2019-08-02,대웅제약S4HANA시스템도입글로벌기반강화,http://daily.hankooki.com/lpage/ittech/201908/dh20190802171352145630.htm
5610,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.lawissue.co.kr/view.php?ud=201908021722007523204ead0791_12
5611,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://sports.hankooki.com/lpage/economy/201908/sp20190802172408137020.htm
5612,2019-08-02,대웅제약IT인프라고도화글로벌헬스케어기반다져,http://www.econovill.com/news/articleView.html?idxno=368894
5613,2019-08-02,대웅제약차세대SAPERP고도화,http://biz.chosun.com/site/data/html_dir/2019/08/02/2019080202349.html
5614,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,https://www.kpanews.co.kr/article/show.asp?idx=205885&category=D
5615,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.newscj.com/news/articleView.html?idxno=656548
5616,2019-08-02,대웅제약SAPERP고도화S4HANA시스템도입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56627
5617,2019-08-03,대웅제약상반기원외처방3628억원9대성장,http://www.dailypharm.com/Users/News/NewsView.html?ID=255442&REFERER=NP
5618,2019-08-03,대웅제약SAPERP전사적자원관리시스템고도화시스템도입,http://www.econonews.co.kr/news/articleView.html?idxno=79626
5619,2019-08-04,대웅제약S4프로젝트완료글로벌헬스케어그룹기반강화,http://www.viva100.com/main/view.php?key=20190804010000898
5620,2019-08-04,대웅제약고도화ERP시스템도입으로글로벌그룹기반강화,http://www.metroseoul.co.kr/news/newsview?newscd=2019080400048
5621,2019-08-04,대웅제약ERPSAPS4HANA시스템업그레이드,http://weekly.cnbnews.com/news/article.html?no=129348
5622,2019-08-04,대웅제약차세대SAPERP시스템구축,http://www.whosaeng.com/111770
5623,2019-08-05,식약처대웅제약니코프리패취제조업무정지15일행정처분,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233501
5624,2019-08-05,★주식인사이드대웅제약주가157000원8월5일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=959839
5625,2019-08-05,대웅주가8월5일현재15550원,http://www.gokorea.kr/news/articleView.html?idxno=313812
5626,2019-08-05,대웅제약2분기매출액사상최대나보타美시장진출영향,http://www.rapportian.com/news/articleView.html?idxno=119134
5627,2019-08-05,주가정보대웅10시46분현재가15350원종목동정,http://aitimes.co.kr/news/view/99610
5628,2019-08-05,대웅제약주가8월5일현재148000원,http://www.gokorea.kr/news/articleView.html?idxno=314853
5629,2019-08-05,8월5일대웅제약증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=314849
5630,2019-08-05,스타★주식인사이드대웅제약주가148500원8월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=960193
5631,2019-08-05,대웅제약전사적자원관리시스템업그레이드,http://www.monews.co.kr/news/articleView.html?idxno=204219
5632,2019-08-05,대웅제약SAPERP고도화완료글로벌신경망구축,http://www.nbnnews.co.kr/news/articleView.html?idxno=301574
5633,2019-08-05,5일마감정보대웅주가14800원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=317244
5634,2019-08-05,8월5일장마감주가정보대웅제약145500원,http://www.newsinside.kr/news/articleView.html?idxno=960746
5635,2019-08-05,5일주가마감정보대웅제약145500원마감,http://www.gokorea.kr/news/articleView.html?idxno=317483
5636,2019-08-05,대웅대박2분기영업이익71↑매출도두자릿수↑,http://news.heraldcorp.com/view.php?ud=20190805000699
5637,2019-08-05,대웅제약올상반기대박터트렸다,http://www.beyondpost.co.kr/view.php?ud=2019080517234463546a9e4dd7f_30
5638,2019-08-05,대웅제약SAPERP고도화S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.thefirstmedia.net/news/articleView.html?idxno=47265
5639,2019-08-05,대웅제약ERP고도화로글로벌헬스케어그룹도약기반다진다,http://www.industrynews.co.kr/news/articleView.html?idxno=33767
5640,2019-08-06,뉴스팩트제약사상반기실적유한녹십자주춤대웅종근당맹추격,http://www.sportsseoul.com/news/read/801062
5641,2019-08-06,★주식인사이드대웅제약주가140000원8월6일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=961612
5642,2019-08-06,대웅제약SAPERP고도화S4HANA시스템도입,http://www.wsobi.com/news/articleView.html?idxno=79009
5643,2019-08-06,8월6일대웅003090종목그래프외증시동향439변동해,http://www.gokorea.kr/news/articleView.html?idxno=318107
5644,2019-08-06,주가정보대웅10시43분현재가14750원연중최고가얼마,http://aitimes.co.kr/news/view/101654
5645,2019-08-06,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201908011030309405tpgetnews_16
5646,2019-08-06,8월6일대웅제약종목그래프및주식시황069변동해,http://www.gokorea.kr/news/articleView.html?idxno=318699
5647,2019-08-06,대웅주가8월6일현재14800원및증권차트정보,http://www.cctvnews.co.kr/news/articleView.html?idxno=129350
5648,2019-08-06,스타★주식인사이드대웅제약주가148000원8월6일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=962273
5649,2019-08-06,8월6일장마감주가정보대웅제약142000원,http://www.newsinside.kr/news/articleView.html?idxno=962887
5650,2019-08-06,6일장마감매매동향대웅제약주가142000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=320317
5651,2019-08-07,★주식인사이드대웅제약주가145500원8월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=964053
5652,2019-08-07,8월7일대웅003090증권투자정보069변화,http://www.gokorea.kr/news/articleView.html?idxno=321114
5653,2019-08-07,종목시황대웅10시37분현재가14500원연중최고가얼마,http://aitimes.co.kr/news/view/103725
5654,2019-08-07,대웅제약주가0696208월7일오늘거래가141000원증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=321695
5655,2019-08-07,스타★주식인사이드대웅제약주가143000원8월7일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=964436
5656,2019-08-07,대웅003090오후2시36분기준및주식시황,https://www.dailysecu.com/news/articleView.html?idxno=61505
5657,2019-08-07,인기종목주가정보대웅주가14500원으로종료,http://aitimes.co.kr/news/view/104827
5658,2019-08-07,7일마감증시대웅제약주가143000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=323560
5659,2019-08-07,상반기실속빠진제약업계승자는한미약품대웅제약,http://weekly.cnbnews.com/news/article.html?no=129416
5660,2019-08-07,특징주종목정보8월7일대웅14500원으로장마감,http://nbntv.co.kr/news/view/544314
5661,2019-08-07,대웅제약S4HANA시스템도입글로벌헬스케어그룹기반강화,http://www.sisaweek.com/news/articleView.html?idxno=125028
5662,2019-08-07,인기주주가정보7일대웅제약마감증시143000원,http://nbntv.co.kr/news/view/544812
5663,2019-08-08,★주식인사이드대웅제약주가145500원8월8일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=965869
5664,2019-08-08,대웅주가8월8일현재14800원증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=324502
5665,2019-08-08,8월8일대웅제약증권매매210146000원,http://nbntv.co.kr/news/view/546519
5666,2019-08-08,주식현재가대웅10시46분현재가14950원종목동정,http://aitimes.co.kr/news/view/105805
5667,2019-08-08,대웅제약5이상상승뚜렷한실적개선키움증권BUY유지,https://www.hankyung.com/finance/article/201908081522L
5668,2019-08-08,특징주대웅제약152000원8일11시25분등락률629,http://www.getnews.co.kr/view.php?ud=201908081126141138c20b9ec572_16
5669,2019-08-08,대웅제약734상승중주가단기급락후반등시도,http://www.newspim.com/news/view/20190808001103
5670,2019-08-08,대웅제약주가오늘시세8일오늘거래가153500원거래,http://www.gokorea.kr/news/articleView.html?idxno=325098
5671,2019-08-08,일본약불매운동바람대웅제약일본산원료부터완제약까지좌불안석,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019080811330140580
5672,2019-08-08,스타★주식인사이드대웅제약주가153000원8월8일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=966231
5673,2019-08-08,잡인사이드대웅리틀베어어린이집상용직채용,http://www.newsinside.kr/news/articleView.html?idxno=966736
5674,2019-08-08,대웅003090오후2시32분기준및매매동향,https://www.dailysecu.com/news/articleView.html?idxno=61918
5675,2019-08-08,대웅5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/201908082380L
5676,2019-08-08,8월8일장마감주가정보대웅제약153000원,http://www.newsinside.kr/news/articleView.html?idxno=966899
5677,2019-08-08,특징주주가정보대웅주가15300원으로종료,http://aitimes.co.kr/news/view/106886
5678,2019-08-08,인기주종목정보8월8일대웅15300원으로장마감,http://nbntv.co.kr/news/view/547896
5679,2019-08-08,오늘Who전승호대웅제약제2의나보타될항궤양제개발에박차,http://www.businesspost.co.kr/BP?command=article_view&num=138765
5680,2019-08-09,★주식인사이드대웅제약주가154000원8월9일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=967912
5681,2019-08-09,대웅주가증권투자정보9일현재15350원,http://www.gokorea.kr/news/articleView.html?idxno=327510
5682,2019-08-09,주가차트대웅주가9일현재15350원,http://nbntv.co.kr/news/view/549772
5683,2019-08-09,국내주식시장현황9일대웅제약현재가격154000원,http://www.anewsa.com/detail.php?number=1910509&thread=18
5684,2019-08-09,주가정보9일대웅현재가격15400원,http://www.anewsa.com/detail.php?number=1910702&thread=18
5685,2019-08-09,8월9일대웅제약및증권시세및종목관련동향정보000변화해,http://www.gokorea.kr/news/articleView.html?idxno=328071
5686,2019-08-09,8월9일대웅제약배당주식065154000원,http://nbntv.co.kr/news/view/550329
5687,2019-08-09,스타★주식인사이드대웅제약주가155000원8월9일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=968746
5688,2019-08-09,대웅003090오후2시32분기준및주식시황,https://www.dailysecu.com/news/articleView.html?idxno=62311
5689,2019-08-09,8월9일장마감주가정보대웅제약154500원,http://www.newsinside.kr/news/articleView.html?idxno=969326
5690,2019-08-09,인기종목매매동향대웅주가15200원마감해,http://aitimes.co.kr/news/view/108485
5691,2019-08-09,9일상장기업장마감정보대웅제약주가154500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=329899
5692,2019-08-09,인기종목주가정보9일대웅마감증시15200원,http://nbntv.co.kr/news/view/552184
5693,2019-08-09,인기주매매동향8월9일대웅제약154500원으로장마감,http://nbntv.co.kr/news/view/552694
5694,2019-08-10,대웅제약글로벌전초기지8곳캐시카우될까,http://www.dailypharm.com/Users/News/NewsView.html?ID=255566&REFERER=NP
5695,2019-08-11,상반기제약업계한미약품대웅제약맑음유한양행흐림,http://www.m-i.kr/news/articleView.html?idxno=629074
5696,2019-08-12,★주식인사이드대웅제약주가155000원8월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=972428
5697,2019-08-12,증시실황12일대웅제약주가154000원,http://www.anewsa.com/detail.php?number=1912219&thread=18
5698,2019-08-12,주식현황대웅주가12일현재15150원,http://nbntv.co.kr/news/view/554239
5699,2019-08-12,대웅주가정보12일오늘가격15500원거래,http://www.gokorea.kr/news/articleView.html?idxno=331097
5700,2019-08-12,주가정보12일대웅증시현황15700원,http://www.anewsa.com/detail.php?number=1912461&thread=18
5701,2019-08-12,주가정보대웅10시48분현재가15450원연중최고가얼마,http://aitimes.co.kr/news/view/109572
5702,2019-08-12,실시간주식현황대웅제약주가12일현재160500원,http://nbntv.co.kr/news/view/554757
5703,2019-08-12,대웅제약주가8월12일현재161500원정보,http://www.gokorea.kr/news/articleView.html?idxno=331680
5704,2019-08-12,대웅주가증권그래프분석12일현재15500원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=130571
5705,2019-08-12,스타★주식인사이드대웅제약주가161500원8월12일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=972917
5706,2019-08-12,대웅제약5이상상승주가상승세단기이평선역배열구간,https://www.hankyung.com/finance/article/201908129256L
5707,2019-08-12,제약업종내상승종목이수앱지스1296삼성바이오로직스631대웅제약518순,http://aitimes.co.kr/news/view/110044
5708,2019-08-12,인기주분석종목정보대웅주가15800원마감해,http://aitimes.co.kr/news/view/110241
5709,2019-08-12,제약업종마감시황상승률상위종목이수앱지스1064삼성바이오로직스724대웅제약550등,http://www.gokorea.kr/news/articleView.html?idxno=333054
5710,2019-08-12,8월12일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=973463
5711,2019-08-12,특징주종목정보8월12일대웅15800원으로장마감,http://nbntv.co.kr/news/view/556336
5712,2019-08-12,특징주분석종목정보12일대웅제약마감증시163000원,http://nbntv.co.kr/news/view/556853
5713,2019-08-13,대웅제약상반기순항1조클럽굳히기,http://www.dailian.co.kr/news/view/817595/?sc=naver
5714,2019-08-13,대웅나보타첫미국매출발생발매45일만에28억,http://www.dailypharm.com/Users/News/NewsView.html?ID=255685&REFERER=NP
5715,2019-08-13,퀵리포트대웅제약강력매수유지목표가28만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019081308585514487
5716,2019-08-13,국내주식시장주가13일대웅제약현재주식거래가격161500원,http://www.anewsa.com/detail.php?number=1914271&thread=18
5717,2019-08-13,8월13일대웅투자주식12715600원,http://nbntv.co.kr/news/view/558378
5718,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://biz.chosun.com/site/data/html_dir/2019/08/13/2019081300812.html
5719,2019-08-13,대웅제약폐섬유증치료제美FDA희귀의약품지정,https://view.asiae.co.kr/article/2019081309415169708
5720,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1328991
5721,2019-08-13,8월13일대웅003090및증권시세외매매동향032변화,http://www.gokorea.kr/news/articleView.html?idxno=334173
5722,2019-08-13,대웅폐섬유증신약DWN12088美FDA희귀의약품지정,http://medipana.com/news/news_viewer.asp?NewsNum=244091&MainKind=A&NewsKind=5&vCount=12&vKind=1
5723,2019-08-13,대웅제약FDA로부터폐섬유증치료제ODD지정RD가속,http://moneys.mt.co.kr/news/mwView.php?no=2019081309358051158
5724,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://fn.segye.com/content/html/2019/08/13/20190813503233.html?OutUrl=naver
5725,2019-08-13,대웅제약폐섬유증신약美FDA서희귀의약품지정,http://www.asiatime.co.kr/news/articleView.html?idxno=263728
5726,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.newspim.com/news/view/20190813000246
5727,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정”,https://www.sedaily.com/NewsView/1VMYCPUWCR
5728,2019-08-13,대웅폐섬유증치료제후보FDA희귀의약품지정,http://www.dailypharm.com/Users/News/NewsView.html?ID=255690&REFERER=NP
5729,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://health.chosun.com/site/data/html_dir/2019/08/13/2019081300875.html
5730,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정쾌거,http://www.koreaittimes.com/news/articleView.html?idxno=92350
5731,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정,http://www.newstomato.com/ReadNews.aspx?no=913651
5732,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.viva100.com/main/view.php?key=20190813010003851
5733,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019081309582131205
5734,2019-08-13,대웅제약폐섬유증신약DWN12088미FDA희귀의약품지정,http://www.fnnews.com/news/201908130957475602
5735,2019-08-13,대웅제약폐섬유증혁신신약美FDA희귀의약품지정쾌거,http://www.medisobizanews.com/news/articleView.html?idxno=61768
5736,2019-08-13,대웅제약폐섬유증신약미FDA희귀의약품지정,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003684424
5737,2019-08-13,증시보고13일대웅주가15900원,http://www.anewsa.com/detail.php?number=1914547&thread=18
5738,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://yna.kr/AKR20190813050400017?did=1195m
5739,2019-08-13,대웅제약폐섬유증신약미국FDA희귀의약품지정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233771
5740,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.econovill.com/news/articleView.html?idxno=369598
5741,2019-08-13,美FDA대웅제약폐섬유증신약희귀의약품지정,http://news.mt.co.kr/mtview.php?no=2019081309473325101
5742,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.sisafocus.co.kr/news/articleView.html?idxno=217973
5743,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정쾌거달성,http://www.metroseoul.co.kr/news/newsview?newscd=2019081300041
5744,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.newsprime.co.kr/news/article.html?no=471304
5745,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.wsobi.com/news/articleView.html?idxno=79363
5746,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://www.asiatoday.co.kr/view.php?key=20190813010007007
5747,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://kormedi.com/?p=1299646
5748,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정쾌거,http://www.100ssd.co.kr/news/articleView.html?idxno=63396
5749,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.dailian.co.kr/news/view/817720/?sc=naver
5750,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정,https://www.paxnetnews.com/articles/51305
5751,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1787574
5752,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.ajunews.com/view/20190813102914424
5753,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거,http://www.newswatch.kr/news/articleView.html?idxno=22441
5754,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.seoulwire.com/news/articleView.html?idxno=195737
5755,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.edaily.co.kr/news/newspath.asp?newsid=02581366622586992
5756,2019-08-13,대웅제약폐섬유증치료제美FDA희귀의약품지정,http://www.insightkorea.co.kr//news/articleView.html?idxno=50438
5757,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908130142&t=NN
5758,2019-08-13,대웅제약주식장13일현재167000원,http://nbntv.co.kr/news/view/558923
5759,2019-08-13,대웅제약폐섬유증신약DWN12088FDA희귀의약품지정,http://www.newsis.com/view/?id=NISX20190813_0000739501&cID=13001&pID=13000
5760,2019-08-13,대웅나보타미국첫분기매출28억달성시장안착기대,http://medipana.com/news/news_viewer.asp?NewsNum=244100&MainKind=A&NewsKind=5&vCount=12&vKind=1
5761,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,https://www.hankyung.com/it/article/201908131276f
5762,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정영예,http://www.segye.com/content/html/2019/08/13/20190813504684.html?OutUrl=naver
5763,2019-08-13,대웅제약폐섬유증신약DWN12088미국FDA희귀의약품지정,http://www.ezyeconomy.com/news/articleView.html?idxno=92995
5764,2019-08-13,제약업종내상승종목이수앱지스350대웅제약245녹십자홀딩스2우222순,http://aitimes.co.kr/news/view/111433
5765,2019-08-13,8월13일대웅제약069620증권그래프153변동해,http://www.gokorea.kr/news/articleView.html?idxno=334753
5766,2019-08-13,대웅제약특발성폐섬유증PRS저해제美ODD지정,http://www.biospectator.com/view/news_view.php?varAtcId=8251
5767,2019-08-13,대웅제약폐섬유증치료제美FDA희귀의약품지정신약허가심사비용면제등혜택,http://www.updownnews.co.kr/news/articleView.html?idxno=207143
5768,2019-08-13,대웅제약폐섬유증신약미FDA희귀의약품지정,http://www.bosa.co.kr/news/articleView.html?idxno=2110593
5769,2019-08-13,대웅제약폐섬유증신약미FDA희귀의약품지정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1128292&REFERER=NP
5770,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.bokuennews.com/news/article.html?no=179526
5771,2019-08-13,대웅제약신약미국희귀의약품에지정전승호섬유질환연구확대,http://www.businesspost.co.kr/BP?command=article_view&num=139296
5772,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.ebn.co.kr/news/view/996983
5773,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.economytalk.kr/news/articleView.html?idxno=194266
5774,2019-08-13,美FDA대웅제약폐섬유증신약희귀의약품지정,http://www.dailymedi.com/detail.php?number=846313&thread=22r05
5775,2019-08-13,대웅주가8월13일현재15950원증권그래프분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=130856
5776,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.etnews.com/20190813000181
5777,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://news.mk.co.kr/newsRead.php?year=2019&no=624271
5778,2019-08-13,대웅제약폐섬유증신약미국FDA희귀의약품지정,http://news.bizwatch.co.kr/article/consumer/2019/08/13/0008/naver
5779,2019-08-13,스타★주식인사이드대웅제약주가166500원8월13일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=975454
5780,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.nbnnews.co.kr/news/articleView.html?idxno=304740
5781,2019-08-13,대웅제약보툴리눔톡신미국에서첫분기매출28억수출늘어난다,http://www.businesspost.co.kr/BP?command=article_view&num=139319
5782,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://news.heraldcorp.com/view.php?ud=20190813000591
5783,2019-08-13,대웅제약폐섬유증신약후보물질DWN12088美희귀약지정,http://www.sportsseoul.com/news/read/804598
5784,2019-08-13,대웅제약폐섬유증신약DWN12088FDA희귀의약품지정,http://www.k-health.com/news/articleView.html?idxno=45072
5785,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정 ,http://www.monews.co.kr/news/articleView.html?idxno=204366
5786,2019-08-13,대웅003090오후2시31분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=63157
5787,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.wolyo.co.kr/news/articleView.html?idxno=91158
5788,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://daily.hankooki.com/lpage/ittech/201908/dh20190813144025145630.htm
5789,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.wikileaks-kr.org/news/articleView.html?idxno=62811
5790,2019-08-13,대웅제약폐섬유증신약후보물질미국FDA희귀약지정,http://www.seoulfn.com/news/articleView.html?idxno=352539
5791,2019-08-13,대웅제약의특발성폐섬유증치료신약후보물질美FDA희귀의약품지정,http://news.mk.co.kr/newsRead.php?year=2019&no=624880
5792,2019-08-13,대웅제약폐섬유증신약FDA희귀의약품지정,http://sports.khan.co.kr/news/sk_index.html?art_id=201908131501003&sec_id=561801&pt=nv
5793,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.newsfc.co.kr/news/articleView.html?idxno=37436
5794,2019-08-13,대웅제약폐섬유증신약美FDA희귀의약품지정,http://www.kpinews.co.kr/news/articleView.html?idxno=101155
5795,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.medigatenews.com/news/2564202381
5796,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.ceoscoredaily.com/news/article.html?no=59227
5797,2019-08-13,대웅제약먹는폐섬유증신약美FDA희귀의약품지정,http://www.donga.com/news/article/all/20190813/96950167/1
5798,2019-08-13,대웅제약폐섬유증혁신신약시선집중,http://www.whosaeng.com/111959
5799,2019-08-13,대웅제약폐섬유증신약미FDA희귀약지정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87266
5800,2019-08-13,증시매매동향대웅주가15850원장마쳐,http://aitimes.co.kr/news/view/112006
5801,2019-08-13,8월13일장마감주가정보대웅제약163500원,http://www.newsinside.kr/news/articleView.html?idxno=976017
5802,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.lawissue.co.kr/view.php?ud=20190813161321795204ead0791_12
5803,2019-08-13,뉴스워커_대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.newsworker.co.kr/news/articleView.html?idxno=36452
5804,2019-08-13,대웅제약폐섬유증신약후보물질미FDA희귀의약품지정쾌거,http://www.mdtoday.co.kr/mdtoday/index.html?no=362214
5805,2019-08-13,대웅제약폐섬유증신약DWN12088미국FDA희귀의약품지정,http://www.dailysmart.co.kr/news/articleView.html?idxno=14404
5806,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56737
5807,2019-08-13,대웅제약폐섬유증신약후보물질美FDA희귀약지정,http://www.dt.co.kr/contents.html?article_no=2019081302109931102002&ref=naver
5808,2019-08-13,전승호다국적제약사당뇨치료제넘어설대웅제약신약개발에박차,http://www.businesspost.co.kr/BP?command=article_view&num=139365
5809,2019-08-13,상장주종목정보13일대웅마감증시15850원,http://nbntv.co.kr/news/view/560519
5810,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정,http://www.joseilbo.com/news/news_read.php?uid=382115&class=27&grp=
5811,2019-08-13,13일주가마감정보대웅제약주가163500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=336566
5812,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.getnews.co.kr/view.php?ud=20190813174738490041d0c69529_16
5813,2019-08-13,인기종목주가정보13일대웅제약마감증시163500원,http://nbntv.co.kr/news/view/561032
5814,2019-08-13,대웅제약특발성폐섬유증신약미국FDA희귀의약품지정,http://www.fnnews.com/news/201908131826396661
5815,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.businesskorea.co.kr/news/articleView.html?idxno=34901
5816,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.newscj.com/news/articleView.html?idxno=659049
5817,2019-08-13,대웅제약폐섬유증신약DWN12088美FDA희귀의약품지정쾌거달성,http://www.thefirstmedia.net/news/articleView.html?idxno=47499
5818,2019-08-14,대웅제약나보타잘나가네美서한달반만에2만3000명시술”,https://www.sedaily.com/NewsView/1VMYT270Q7
5819,2019-08-14,대웅제약나보타美초반인기한달반만에2만3000명시술,http://www.dt.co.kr/contents.html?article_no=2019081402109931102001&ref=naver
5820,2019-08-14,국내주식시장현황14일대웅제약현재가162500원,http://www.anewsa.com/detail.php?number=1916367&thread=18
5821,2019-08-14,대웅제약보톡스나보타미국서한달반만에2만3000명시술,http://www.asiatoday.co.kr/view.php?key=20190814010007662
5822,2019-08-14,★주식인사이드대웅제약주가162000원8월14일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=977349
5823,2019-08-14,8월14일대웅주식실시간16050원126,http://nbntv.co.kr/news/view/562676
5824,2019-08-14,대웅주가및증권시세14일오늘가격16050원형성,http://www.gokorea.kr/news/articleView.html?idxno=337491
5825,2019-08-14,종목상세정보14일대웅현재주가16050원,http://www.anewsa.com/detail.php?number=1916674&thread=18
5826,2019-08-14,대웅제약나보타미국출시한달반만에2만3000명시술,http://www.viva100.com/main/view.php?key=20190814010004301
5827,2019-08-14,8월14일대웅제약실시간주식현황092162000원,http://nbntv.co.kr/news/view/563235
5828,2019-08-14,대웅제약주가오늘시세14일오늘거래가162500원거래,http://www.gokorea.kr/news/articleView.html?idxno=338056
5829,2019-08-14,대웅폐섬유증신약美FDA희귀의약품지정,http://news.heraldcorp.com/view.php?ud=20190814000378
5830,2019-08-14,스타★주식인사이드대웅제약주가162000원8월14일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=978129
5831,2019-08-14,대웅003090오후2시28분기준및주체별매매동향,https://www.dailysecu.com/news/articleView.html?idxno=63528
5832,2019-08-14,대웅제약세계최초혁신신약DWN12088美FDA희귀의약품지정,http://www.ftoday.co.kr/news/articleView.html?idxno=110617
5833,2019-08-14,8월14일장마감주가정보대웅제약162000원,http://www.newsinside.kr/news/articleView.html?idxno=978574
5834,2019-08-14,특징주분석주가정보8월14일대웅15950원으로장마감,http://nbntv.co.kr/news/view/564937
5835,2019-08-14,14일마감정보대웅제약162000원마감,http://www.gokorea.kr/news/articleView.html?idxno=339992
5836,2019-08-14,인기종목종목정보14일대웅제약마감증시162000원,http://nbntv.co.kr/news/view/565450
5837,2019-08-14,대웅제약특발성폐섬유증신약DWN12088미국FDA희귀의약품지정,http://www.econonews.co.kr/news/articleView.html?idxno=81475
5838,2019-08-14,코스피대웅제약반기누적매출액5563억원영업이익354억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013604920&code=61141211&cp=nv
5839,2019-08-14,실적속보대웅제약2Q영업이익227억전년비165↑,http://www.itooza.com/common/iview.php?no=2019081423361780370
5840,2019-08-15,대웅제약보툴리눔톡신해외경쟁우위선점,http://www.newstomato.com/ReadNews.aspx?no=914029
5841,2019-08-15,전승호대웅제약보툴리눔톡신나보타로탈모치료가능성찾아,http://www.businesspost.co.kr/BP?command=article_view&num=139654
5842,2019-08-16,대웅제약특발성폐섬유증치료신약美희귀의약품지정,http://weekly.cnbnews.com/news/article.html?no=129604
5843,2019-08-16,★주식인사이드대웅제약주가161000원8월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=981011
5844,2019-08-16,주식종목16일대웅제약현재가160000원,http://www.anewsa.com/detail.php?number=1919138&thread=18
5845,2019-08-16,대웅주식추천주16일현재15600원,http://nbntv.co.kr/news/view/567415
5846,2019-08-16,대웅주가8월16일오늘거래가15650원오늘시세외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=341305
5847,2019-08-16,증시현황16일대웅현재가격15600원,http://www.anewsa.com/detail.php?number=1919453&thread=18
5848,2019-08-16,8월16일대웅제약오늘주식시세161500원031,http://nbntv.co.kr/news/view/567946
5849,2019-08-16,8월16일대웅제약069620종목그래프및종목동정과증시정보062변동,http://www.gokorea.kr/news/articleView.html?idxno=341889
5850,2019-08-16,스타★주식인사이드대웅제약주가161000원8월16일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=981456
5851,2019-08-16,8월16일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=981887
5852,2019-08-16,상장주매매동향16일대웅마감증시15650원,http://nbntv.co.kr/news/view/569620
5853,2019-08-16,제약리그테이블①엇갈린희비대웅한미웃었다,http://news.bizwatch.co.kr/article/consumer/2019/08/16/0024/naver
5854,2019-08-16,인기주종목정보8월16일대웅제약162500원으로장마감,http://nbntv.co.kr/news/view/570122
5855,2019-08-17,대웅제약상반기활짝올해최대실적기대,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071355
5856,2019-08-17,대웅제약美FDA로부터폐섬유증신약희귀의약품지정”,https://www.sedaily.com/NewsView/1VN07G4RBZ
5857,2019-08-18,국내보톡스업계희비대웅제약웃고메디톡스눈물,http://www.viva100.com/main/view.php?key=20190818010005136
5858,2019-08-19,대웅제약상반기매출11증가매출비RD비13,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233885
5859,2019-08-19,★주식인사이드대웅제약주가161500원8월19일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=985840
5860,2019-08-19,국내주가정보19일대웅제약현재주식거래가격161000원,http://www.anewsa.com/detail.php?number=1921906&thread=18
5861,2019-08-19,8월19일대웅시세보기15850원128,http://nbntv.co.kr/news/view/572261
5862,2019-08-19,8월19일대웅003090정보및매매동향064변동,http://www.gokorea.kr/news/articleView.html?idxno=344940
5863,2019-08-19,주식현재가대웅10시36분현재가15600원종목동정,http://aitimes.co.kr/news/view/114504
5864,2019-08-19,아통경제19일대웅현재가격15600원,http://www.anewsa.com/detail.php?number=1922244&thread=18
5865,2019-08-19,8월19일대웅제약오늘증시092161000원,http://nbntv.co.kr/news/view/572781
5866,2019-08-19,대웅제약주가종목그래프및주체별매매동향19일오늘거래가161000원거래,http://www.gokorea.kr/news/articleView.html?idxno=345525
5867,2019-08-19,스타★주식인사이드대웅제약주가162500원8월19일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=986560
5868,2019-08-19,대웅003090오후2시33분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=64275
5869,2019-08-19,대웅제약메디톡스보톡스포자감정종료곧승패나온다,http://www.finomy.com/news/articleView.html?idxno=68568
5870,2019-08-19,나보타업은대웅제약상반기굿올해최대실적찍나,http://www.ebn.co.kr/news/view/997564
5871,2019-08-19,8월19일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=987057
5872,2019-08-19,특징주분석주가정보19일대웅마감증시15800원,http://nbntv.co.kr/news/view/574399
5873,2019-08-19,19일증시종목마감동향대웅제약163000원마감,http://www.gokorea.kr/news/articleView.html?idxno=347380
5874,2019-08-19,무더위뒤건강관리대웅제약임팩타민활성비타민으로구성,https://www.sedaily.com/NewsView/1VN15CZWUX
5875,2019-08-19,상장주매매동향19일대웅제약마감증시163000원,http://nbntv.co.kr/news/view/574905
5876,2019-08-20,최다기술수출제약바이오기업대웅제약최다국가미국,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233969
5877,2019-08-20,★주식인사이드대웅제약주가163000원8월20일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=987994
5878,2019-08-20,장중시세20일대웅제약주가163000원,http://www.anewsa.com/detail.php?number=1924402&thread=18
5879,2019-08-20,8월20일대웅오늘증권시세06315900원,http://nbntv.co.kr/news/view/576532
5880,2019-08-20,8월20일대웅003090증권그래프032,http://www.gokorea.kr/news/articleView.html?idxno=348078
5881,2019-08-20,아통증시20일대웅현재가격15800원,http://www.anewsa.com/detail.php?number=1924729&thread=18
5882,2019-08-20,오늘주식시세대웅제약주가20일현재162500원,http://nbntv.co.kr/news/view/577043
5883,2019-08-20,대웅제약주가0696208월20일오늘가격162000원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=348659
5884,2019-08-20,스타★주식인사이드대웅제약주가162000원8월20일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=988443
5885,2019-08-20,대웅제약발달장애인질병증상이해도서참지마요기부,http://www.ebn.co.kr/news/view/997724
5886,2019-08-20,대웅제약참지마요도서기부발달장애인질병증상이해도울것”,https://www.sedaily.com/NewsView/1VN1LJ74WU
5887,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.newsway.co.kr/news/view?tp=1&ud=2019082015271815839
5888,2019-08-20,대웅제약발달장애인위한쉬운글도서참지마요기부,http://www.medisobizanews.com/news/articleView.html?idxno=61921
5889,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.koreaittimes.com/news/articleView.html?idxno=92465
5890,2019-08-20,대웅제약발달장애인의료진간소통위한도서참지마요기부,http://www.wolyo.co.kr/news/articleView.html?idxno=91607
5891,2019-08-20,대웅제약발달장애증상이해돕는도서참치마요기부,http://www.mhj21.com/123633
5892,2019-08-20,대웅발달장애인질병증상이해돕는도서참지마요기부,http://medipana.com/news/news_viewer.asp?NewsNum=244371&MainKind=A&NewsKind=5&vCount=12&vKind=1
5893,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.thefirstmedia.net/news/articleView.html?idxno=47651
5894,2019-08-20,대웅제약발달장애증상이해돕는도서참지마요4000권기부,http://www.newspim.com/news/view/20190820000931
5895,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.wsobi.com/news/articleView.html?idxno=79811
5896,2019-08-20,제약오늘대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.sisaon.co.kr/news/articleView.html?idxno=99485
5897,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.medigatenews.com/news/3041201799
5898,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.newsprime.co.kr/news/article.html?no=472154
5899,2019-08-20,8월20일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=988942
5900,2019-08-20,대웅제약발달장애인질병증상이해돕는서적참지마요기부,http://www.asiatime.co.kr/news/articleView.html?idxno=265031
5901,2019-08-20,대웅제약발달장애인증상이해돕는도서참지마요기부,http://www.econovill.com/news/articleView.html?idxno=370123
5902,2019-08-20,대웅제약전국특수학교병의원에참지마요도서기부,http://daily.hankooki.com/lpage/ittech/201908/dh20190820160931145630.htm
5903,2019-08-20,대웅제약발달장애인위한도서4000권기부,http://news.mt.co.kr/mtview.php?no=2019082015380738749
5904,2019-08-20,대웅제약발달장애인위한책참지마요기부,http://www.bosa.co.kr/news/articleView.html?idxno=2110929
5905,2019-08-20,대웅제약나보타업고올해최대실적달성하나,http://fn.segye.com/content/html/2019/08/20/20190820509358.html?OutUrl=naver
5906,2019-08-20,대웅제약발달장애인질병증상이해돕는책참지마요기부,http://www.enewstoday.co.kr/news/articleView.html?idxno=1330423
5907,2019-08-20,대웅제약발달장애인의질병이해돕는도서참지마요기부,http://www.dailian.co.kr/news/view/819436/?sc=naver
5908,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://fn.segye.com/content/html/2019/08/20/20190820509840.html?OutUrl=naver
5909,2019-08-20,대웅제약발달장애인위한교육도서4000권기부,http://health.chosun.com/site/data/html_dir/2019/08/20/2019082001960.html
5910,2019-08-20,대웅제약발달장애인위한질병증상표현법담은도서참지마요기부,http://news.mk.co.kr/newsRead.php?year=2019&no=645515
5911,2019-08-20,20일마감증시대웅주가15950원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=349754
5912,2019-08-20,대웅제약발달장애인위한도서참지마요4000권기부,http://sports.hankooki.com/lpage/economy/201908/sp20190820165757137020.htm
5913,2019-08-20,인기주분석종목정보20일대웅마감증시15950원,http://nbntv.co.kr/news/view/578320
5914,2019-08-20,대웅제약발달장애인질병증상이해돕는도서참지마요기부,http://www.donga.com/news/article/all/20190820/97038836/1
5915,2019-08-20,대웅제약발달장애인위한쉬운글도서참지마요4000권기부,http://www.etoday.co.kr/news/section/newsview.php?idxno=1789998
5916,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.lawissue.co.kr/view.php?ud=201908201732501582204ead0791_12
5917,2019-08-20,대웅제약발달장애인과의소통을위한참지마요도서기부,http://www.newsfc.co.kr/news/articleView.html?idxno=37514
5918,2019-08-20,대웅제약발달장애인위한참지마요프로젝트진행,http://www.kpinews.co.kr/news/articleView.html?idxno=101572
5919,2019-08-20,20일코스닥코스피마감정보대웅제약주가162500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=350148
5920,2019-08-20,대웅제약발달장애인에도서수천권제공,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87387
5921,2019-08-20,발달장애인아프면참지마요대웅제약쉬운글도서제작,http://www.newsis.com/view/?id=NISX20190820_0000745828&cID=13001&pID=13000
5922,2019-08-20,대웅제약발달장애인증상이해돕는도서참지마요기부,http://www.metroseoul.co.kr/news/newsview?newscd=2019082000218
5923,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.businesskorea.co.kr/news/articleView.html?idxno=35105
5924,2019-08-20,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.getnews.co.kr/view.php?ud=20190820185403194741d0c69529_16
5925,2019-08-20,특징주매매동향20일대웅제약마감증시162500원,http://nbntv.co.kr/news/view/579073
5926,2019-08-20,대웅제약발달장애이해높이는참지마요책기부,https://www.kpanews.co.kr/article/show.asp?idx=206115&category=D
5927,2019-08-20,셀트리온한미약품반기1000억이상RD투자유한양행GC녹십자대웅제약종근당JW중외제약도대폭늘려,http://www.econonews.co.kr/news/articleView.html?idxno=82387
5928,2019-08-21,대웅제약발달장애인위한질병증상표현법담은도서참지마요기부,http://www.nbnnews.co.kr/news/articleView.html?idxno=307352
5929,2019-08-21,대웅제약발달장애인의질병증상이해돕는도서참지마요기부,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56819
5930,2019-08-21,대웅제약발달장애인질병증상이해위한책참지마요기부,http://www.sportsseoul.com/news/read/807648
5931,2019-08-21,★주식인사이드대웅제약주가163000원8월21일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=990066
5932,2019-08-21,주식종목21일대웅제약현재가161500원,http://www.anewsa.com/detail.php?number=1926852&thread=18
5933,2019-08-21,참지마요대웅제약전국특수학교병원500곳에발달장애인돕는책기부,http://news.heraldcorp.com/view.php?ud=20190821000134
5934,2019-08-21,주식현재가대웅주가21일현재15850원,http://nbntv.co.kr/news/view/580716
5935,2019-08-21,8월21일대웅증권그래프063변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=351236
5936,2019-08-21,종목현재가대웅10시35분현재가15950원종목동정,http://aitimes.co.kr/news/view/116053
5937,2019-08-21,종목상세정보21일대웅현재주가16000원,http://www.anewsa.com/detail.php?number=1927197&thread=18
5938,2019-08-21,대웅제약발달장애인의질병증상이해돕는도서참지마요4000권기부,http://www.updownnews.co.kr/news/articleView.html?idxno=207402
5939,2019-08-21,8월21일대웅제약증권주식160500원123,http://nbntv.co.kr/news/view/581249
5940,2019-08-21,대웅제약주가8월21일오늘거래가160500원정보,http://www.gokorea.kr/news/articleView.html?idxno=351816
5941,2019-08-21,대웅제약발달장애인도서참지마요기부,http://www.dailymedi.com/detail.php?number=846571&thread=22r05
5942,2019-08-21,스타★주식인사이드대웅제약주가160000원8월21일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=990830
5943,2019-08-21,대웅나보타포자감정서제출균주전쟁종식되나,http://news.mt.co.kr/mtview.php?no=2019082110174067542
5944,2019-08-21,좋아요중소기업우수제품뉴대웅코크형약달임기,http://www.etnews.com/20190821000160
5945,2019-08-21,대웅003090오후2시32분기준외주식시황,https://www.dailysecu.com/news/articleView.html?idxno=64859
5946,2019-08-21,대웅제약발달장애인이해돕는도서참지마요전국특수학교및병의원에기부,http://www.ntoday.co.kr/news/articleView.html?idxno=68107
5947,2019-08-21,8월21일장마감주가정보대웅제약163000원,http://www.newsinside.kr/news/articleView.html?idxno=991257
5948,2019-08-21,대웅제약전국특수학교에서적참지마요기부,http://viewers.heraldcorp.com/news/articleView.html?idxno=42567
5949,2019-08-21,대웅제약전국특수학교병원에발달장애인돕는책기부,http://www.sisaweek.com/news/articleView.html?idxno=125449
5950,2019-08-21,21일마감증시대웅15950원마감,http://www.gokorea.kr/news/articleView.html?idxno=353280
5951,2019-08-21,상장주주식시세8월21일대웅15950원으로장마감,http://nbntv.co.kr/news/view/582867
5952,2019-08-21,21일마감주가정보대웅제약주가163000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=353724
5953,2019-08-21,상장주주가정보21일대웅제약마감증시163000원,http://nbntv.co.kr/news/view/583308
5954,2019-08-21,대웅제약발달장애인이해돕는도서참지마요기부,http://www.newscj.com/news/articleView.html?idxno=660999
5955,2019-08-22,영업활동현금유입‥대웅415억동국328억보령321억順,http://medipana.com/news/news_viewer.asp?NewsNum=244441&MainKind=A&NewsKind=5&vCount=12&vKind=1
5956,2019-08-22,제약사매출희비교차유한녹십자저조vs대웅한미호조,http://biz.newdaily.co.kr/site/data/html/2019/08/21/2019082100234.html
5957,2019-08-22,★주식인사이드대웅제약주가164000원8월22일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=992025
5958,2019-08-22,아통증시22일대웅제약주가164000원,http://www.anewsa.com/detail.php?number=1929383&thread=18
5959,2019-08-22,8월22일대웅주식실시간06316050원,http://nbntv.co.kr/news/view/584761
5960,2019-08-22,대웅주가0030908월22일오늘가격16100원오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=354611
5961,2019-08-22,장중수급포착대웅외국인3일연속순매수행진주가125,http://www.newspim.com/news/view/20190822000320
5962,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234094
5963,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,https://view.asiae.co.kr/article/2019082210232022406
5964,2019-08-22,대웅제약폐섬유증신약글로벌임상돌입,https://www.sedaily.com/NewsView/1VN2HFEXLK
5965,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2019082210254677127
5966,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.viva100.com/main/view.php?key=20190822010006700
5967,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://fn.segye.com/content/html/2019/08/22/20190822504626.html?OutUrl=naver
5968,2019-08-22,대웅제약개발폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newspim.com/news/view/20190822000395
5969,2019-08-22,대웅제약폐섬유증신약9월호주임상1상본격돌입,http://moneys.mt.co.kr/news/mwView.php?no=2019082210228091914
5970,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1790649
5971,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.sisafocus.co.kr/news/articleView.html?idxno=218738
5972,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019082210290532316
5973,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입美FDA희귀의약품지정돼향후신속심사지원받아,http://www.segye.com/content/html/2019/08/22/20190822504794.html?OutUrl=naver
5974,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=14648
5975,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.medisobizanews.com/news/articleView.html?idxno=61971
5976,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.ajunews.com/view/20190822103746377
5977,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.fnnews.com/news/201908221040097101
5978,2019-08-22,대웅제약폐섬유증신약미FDA희귀약달고글로벌첫발,http://www.econovill.com/news/articleView.html?idxno=370286
5979,2019-08-22,대웅제약9월폐섬유증신약후보물질글로벌임상1상돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=02256646622589944
5980,2019-08-22,종목현재가대웅10시46분현재가16050원연중최고가얼마,http://aitimes.co.kr/news/view/116860
5981,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.asiatime.co.kr/news/articleView.html?idxno=265423
5982,2019-08-22,대웅제약특발성폐섬유증신약글로벌임상돌입,http://www.mhj21.com/123704
5983,2019-08-22,대웅제약DWN12088글로벌임상1상돌입,http://medipana.com/news/news_viewer.asp?NewsNum=244465&MainKind=A&NewsKind=5&vCount=12&vKind=1
5984,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://kormedi.com/?p=1300285
5985,2019-08-22,대웅제약간질성폐질환신약글로벌임상9월돌입,http://news.heraldcorp.com/view.php?ud=20190822000261
5986,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1330889
5987,2019-08-22,대웅제약폐섬유증신약호주1상9월돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=255973&REFERER=NP
5988,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.donga.com/news/article/all/20190822/97065516/1
5989,2019-08-22,대웅제약폐섬유증신약호주서임상1상승인,http://news.mt.co.kr/mtview.php?no=2019082210512930200
5990,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상돌입,http://www.newsprime.co.kr/news/article.html?no=472424
5991,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=362973
5992,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌1상돌입,http://www.bosa.co.kr/news/articleView.html?idxno=2111052
5993,2019-08-22,대웅폐섬유증신약DWN12088글로벌임상1상돌입,http://www.dailymedi.com/detail.php?number=846606&thread=22r05
5994,2019-08-22,8월22일대웅제약주식증권092164500원,http://nbntv.co.kr/news/view/585299
5995,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://yna.kr/AKR20190822066800017?did=1195m
5996,2019-08-22,대웅제약세계최초PRS저해제글로벌임상1상돌입,http://daily.hankooki.com/lpage/ittech/201908/dh20190822111245145630.htm
5997,2019-08-22,대웅제약특발성폐섬유증치료후보물질글로벌임상돌입예정,http://news.mk.co.kr/newsRead.php?year=2019&no=651866
5998,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://news1.kr/articles/?3701252
5999,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상착수,http://www.newsis.com/view/?id=NISX20190822_0000747666&cID=13001&pID=13000
6000,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.ceoscoredaily.com/news/article.html?no=59527
6001,2019-08-22,대웅제약폐섬유증신약의글로벌임상1상9월부터시작,http://www.businesspost.co.kr/BP?command=article_view&num=140479
6002,2019-08-22,대웅제약PRS저해폐섬유증신약호주1상승인,http://www.biospectator.com/view/news_view.php?varAtcId=8314
6003,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,https://www.hankyung.com/it/article/201908220083f
6004,2019-08-22,대웅제약주가0696208월22일오늘거래가165000원및증권시세및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=355189
6005,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입 ,http://www.updownnews.co.kr/news/articleView.html?idxno=207453
6006,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://www.economytalk.kr/news/articleView.html?idxno=195069
6007,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.dailian.co.kr/news/view/819956/?sc=naver
6008,2019-08-22,대웅제약폐섬유증신약글로벌임상1상착수,http://www.etnews.com/20190822000116
6009,2019-08-22,대웅제약폐섬유증신약호주서글로벌임상1상돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2019082200060
6010,2019-08-22,대웅제약폐섬유증치료제글로벌임상1상돌입,http://www.finomy.com/news/articleView.html?idxno=68664
6011,2019-08-22,스타★주식인사이드대웅제약주가163500원8월22일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=992716
6012,2019-08-22,대웅제약폐섬유증신약DWN12088임상1상돌입,http://health.chosun.com/site/data/html_dir/2019/08/22/2019082201276.html
6013,2019-08-22,대웅제약개발폐섬유증신약호주임상승인,http://www.seoulfn.com/news/articleView.html?idxno=353365
6014,2019-08-22,대웅제약폐섬유증신약글로벌임상착수,http://www.insightkorea.co.kr//news/articleView.html?idxno=52781
6015,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://news.mk.co.kr/newsRead.php?year=2019&no=652513
6016,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.rpm9.com/news/article.html?id=20190822090019
6017,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.g-enews.com/ko-kr/news/article/news_all/201908221346457756aca1a8c21a_1/article.html
6018,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.lawissue.co.kr/view.php?ud=201908221401387799204ead0791_12
6019,2019-08-22,뉴스워커_대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newsworker.co.kr/news/articleView.html?idxno=37450
6020,2019-08-22,대웅제약폐섬유증신약글로벌임상착수,http://www.kpinews.co.kr/news/articleView.html?idxno=101691
6021,2019-08-22,대웅제약폐섬유증신약올해9월글로벌임상시험돌입,http://biz.chosun.com/site/data/html_dir/2019/08/22/2019082201447.html
6022,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.getnews.co.kr/view.php?ud=20190822140927306941d0c69529_16
6023,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://www.youthdaily.co.kr/news/article.html?no=16019
6024,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.medigatenews.com/news/1639057961
6025,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://www.asiatoday.co.kr/view.php?key=20190822010012363
6026,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56855
6027,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.bokuennews.com/news/article.html?no=179789
6028,2019-08-22,대웅제약폐섬유증신약호주서임상1상돌입,http://www.mediapen.com/news/view/456564
6029,2019-08-22,대웅제약페섬유증신약9월글로벌임상돌입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908220298&t=NN
6030,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.wolyo.co.kr/news/articleView.html?idxno=91804
6031,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.wsobi.com/news/articleView.html?idxno=79977
6032,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://inthenews.co.kr/article-13286/
6033,2019-08-22,대웅제약폐섬유증치료신약글로벌임상착수,http://www.shinailbo.co.kr/news/articleView.html?idxno=1197095
6034,2019-08-22,대웅제약신약DWN12088글로벌임상1상돌입,http://www.joseilbo.com/news/news_read.php?uid=382572&class=17&grp=
6035,2019-08-22,8월22일장마감주가정보대웅제약163500원,http://www.newsinside.kr/news/articleView.html?idxno=993109
6036,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.seoulwire.com/news/articleView.html?idxno=202909
6037,2019-08-22,대웅제약나보타미국수출성장견인,https://www.paxnetnews.com/articles/51596
6038,2019-08-22,22일주가마감정보대웅16050원마감,http://www.gokorea.kr/news/articleView.html?idxno=356883
6039,2019-08-22,인기종목종목정보22일대웅마감증시16050원,http://nbntv.co.kr/news/view/586935
6040,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://www.monews.co.kr/news/articleView.html?idxno=204529
6041,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=47729
6042,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상올9월본격돌입,http://www.newswatch.kr/news/articleView.html?idxno=22748
6043,2019-08-22,특징주분석매매동향8월22일대웅제약163500원으로장마감,http://nbntv.co.kr/news/view/587429
6044,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.businesskorea.co.kr/news/articleView.html?idxno=35222
6045,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌1상돌입,https://www.kpanews.co.kr/article/show.asp?idx=206170&category=D
6046,2019-08-22,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.newscj.com/news/articleView.html?idxno=661276
6047,2019-08-22,대웅제약폐섬유증신약글로벌임상1상돌입,http://www.ebn.co.kr/news/view/998133
6048,2019-08-22,대웅제약폐섬유증신약후보물질호주서임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3919448
6049,2019-08-23,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.polinews.co.kr/news/article.html?no=411978
6050,2019-08-23,★주식인사이드대웅제약주가162000원8월23일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=993946
6051,2019-08-23,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=308422
6052,2019-08-23,아통경제23일대웅제약거래가격162000원,http://www.anewsa.com/detail.php?number=1930971&thread=18
6053,2019-08-23,대웅제약특발성폐섬유증신약DWN12088글로벌임상1상돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=110826
6054,2019-08-23,대웅오늘증시23일현재15750원,http://nbntv.co.kr/news/view/589050
6055,2019-08-23,대웅주가8월23일현재15800원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=357885
6056,2019-08-23,주가정보23일대웅현재주식거래가격15750원,http://www.anewsa.com/detail.php?number=1931255&thread=18
6057,2019-08-23,대웅제약특발성폐섬유증신약DWN12088해외임상1상돌입,http://www.ezyeconomy.com/news/articleView.html?idxno=93209
6058,2019-08-23,8월23일대웅제약주식현황162500원061,http://nbntv.co.kr/news/view/589572
6059,2019-08-23,8월23일대웅제약069620종목그래프061변동,http://www.gokorea.kr/news/articleView.html?idxno=358470
6060,2019-08-23,대웅제약폐섬유증신약글로벌임상돌입호주서1상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071551
6061,2019-08-23,대웅제약특발성폐섬유증신약후보물질호주서임상1상승인,http://www.rapportian.com/news/articleView.html?idxno=119516
6062,2019-08-23,스타★주식인사이드대웅제약주가162500원8월23일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=994372
6063,2019-08-23,대웅003090오후2시35분기준외매매동향,https://www.dailysecu.com/news/articleView.html?idxno=65393
6064,2019-08-23,8월23일장마감주가정보대웅제약162500원,http://www.newsinside.kr/news/articleView.html?idxno=994802
6065,2019-08-23,23일코스닥코스피마감정보대웅15700원마감,http://www.gokorea.kr/news/articleView.html?idxno=360133
6066,2019-08-23,증시매매동향23일대웅마감증시15700원,http://nbntv.co.kr/news/view/591214
6067,2019-08-23,23일주식장마감동향대웅제약162500원마감,http://www.gokorea.kr/news/articleView.html?idxno=360429
6068,2019-08-23,특징주종목정보23일대웅제약마감증시162500원,http://nbntv.co.kr/news/view/591708
6069,2019-08-24,손습진제알리톡9월부터GSK판매대웅과계약종료,http://www.dailypharm.com/Users/News/NewsView.html?ID=256026&REFERER=NP
6070,2019-08-24,포토카트황제문호준대웅이형뭐하지,http://www.dailyesports.com/view.php?ud=20190824183440607974bcc1e038_27
6071,2019-08-26,퀵리포트대웅제약매수유지목표가22만원유지키움證,http://www.itooza.com/common/iview.php?no=2019082609152014287
6072,2019-08-26,대웅증권주식26일현재15400원,http://nbntv.co.kr/news/view/593491
6073,2019-08-26,종목상세정보26일대웅제약현재가격158500원,http://www.anewsa.com/detail.php?number=1932095&thread=18
6074,2019-08-26,대웅주가및증권시세26일오늘거래가15350원형성,http://www.gokorea.kr/news/articleView.html?idxno=361427
6075,2019-08-26,대웅제약2년내보톡스시장점유율2위달성이가능할듯”,http://www.wikitree.co.kr/main/news_view.php?id=457232
6076,2019-08-26,국내주식시장주가26일대웅현재가15250원,http://www.anewsa.com/detail.php?number=1932426&thread=18
6077,2019-08-26,8월26일대웅제약주식현황215159000원,http://nbntv.co.kr/news/view/594010
6078,2019-08-26,대웅003090오후12시13분기준외증시동향,https://www.dailysecu.com/news/articleView.html?idxno=65713
6079,2019-08-26,스타★주식인사이드대웅제약주가159500원8월26일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=997509
6080,2019-08-26,상반제약상반기영업익증감톱5제일국제에스텍종근당바이오대웅,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234197
6081,2019-08-26,대웅제약공격적마케팅으로미국보톡시시장점유율2위달성가능,http://www.businesspost.co.kr/BP?command=article_view&num=140918
6082,2019-08-26,8월26일장마감주가정보대웅제약157000원,http://www.newsinside.kr/news/articleView.html?idxno=997951
6083,2019-08-26,유한대웅종근당동아에스티내년수확의단맛,http://www.medisobizanews.com/news/articleView.html?idxno=62043
6084,2019-08-26,인기종목종목정보26일대웅마감증시15250원,http://nbntv.co.kr/news/view/595563
6085,2019-08-26,26일주가마감정보대웅제약157000원마감,http://www.gokorea.kr/news/articleView.html?idxno=363858
6086,2019-08-26,인기주분석종목정보8월26일대웅제약157000원으로장마감,http://nbntv.co.kr/news/view/596091
6087,2019-08-27,대웅제약심혈관계질환치료제임상3상진입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234227
6088,2019-08-27,★주식인사이드대웅제약주가158500원8월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=999041
6089,2019-08-27,주식시세27일대웅제약거래가격158500원,http://www.anewsa.com/detail.php?number=1934547&thread=18
6090,2019-08-27,8월27일대웅오늘주식장15450원131,http://nbntv.co.kr/news/view/597263
6091,2019-08-27,8월27일대웅및증권시세098변화,http://www.gokorea.kr/news/articleView.html?idxno=364625
6092,2019-08-27,장중주가27일대웅주가15400원,http://www.anewsa.com/detail.php?number=1934848&thread=18
6093,2019-08-27,8월27일대웅제약증권매매096155500원,http://nbntv.co.kr/news/view/597791
6094,2019-08-27,8월27일대웅제약및증권시세159변화해,http://www.gokorea.kr/news/articleView.html?idxno=365212
6095,2019-08-27,스타★주식인사이드대웅제약주가153500원8월27일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=999451
6096,2019-08-27,8월27일장마감주가정보대웅제약153500원,http://www.newsinside.kr/news/articleView.html?idxno=999964
6097,2019-08-27,27일마감정보대웅제약153500원마감,http://www.gokorea.kr/news/articleView.html?idxno=367088
6098,2019-08-27,27일기관순매도Top10현대차583억대덕전자32억대웅제약24억대상17억외국인순매도나서코스닥시장에서는헬릭스미스케이엠더블유테스상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=65127
6099,2019-08-28,대웅제약넥스트나보타연구개발에역량집중,http://www.rapportian.com/news/articleView.html?idxno=119609
6100,2019-08-28,전승호미국에서나보타순항으로대웅제약해외사업자신감커져,http://www.businesspost.co.kr/BP?command=article_view&num=141137
6101,2019-08-28,아통경제28일대웅제약거래가격153500원,http://www.anewsa.com/detail.php?number=1937106&thread=18
6102,2019-08-28,대웅주가8월28일현재14950원증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=367934
6103,2019-08-28,주식종목28일대웅주가15050원,http://www.anewsa.com/detail.php?number=1937404&thread=18
6104,2019-08-28,대웅제약폐섬유증혁신신약내달호주서글로벌임상돌입,http://news.heraldcorp.com/view.php?ud=20190828000490
6105,2019-08-28,대웅제약주가종목그래프외매매동향28일현재150000원,http://www.gokorea.kr/news/articleView.html?idxno=368529
6106,2019-08-28,대웅003090오후12시09분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=66297
6107,2019-08-28,대웅주가증권시세28일현재15050원및오늘거래가는,http://www.cctvnews.co.kr/news/articleView.html?idxno=133843
6108,2019-08-28,스타★주식인사이드대웅제약주가152000원8월28일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1001721
6109,2019-08-28,상장제약사상반기순이익증감률톱5삼성진양대화보령대웅,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234265
6110,2019-08-28,실시간분석대웅제약32상승증권사목표가22만원제시,http://www.itooza.com/common/iview.php?no=2019082814083515911
6111,2019-08-28,인기주분석종목정보8월27일대웅15250원으로장마감,http://nbntv.co.kr/news/view/599375
6112,2019-08-28,인기종목종목정보8월27일대웅제약153500원으로장마감,http://nbntv.co.kr/news/view/599895
6113,2019-08-28,8월28일대웅증권투자19714950원,http://nbntv.co.kr/news/view/601551
6114,2019-08-28,8월28일대웅제약오늘증권시세150000원228,http://nbntv.co.kr/news/view/602078
6115,2019-08-28,인기주종목정보8월28일대웅15500원으로장마감,http://nbntv.co.kr/news/view/603671
6116,2019-08-28,대웅제약폐섬유증신약글로벌임상,http://news.mk.co.kr/newsRead.php?year=2019&no=673748
6117,2019-08-29,대웅제약폐섬유증신약DWN12088글로벌임상1상돌입,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130722
6118,2019-08-29,★주식인사이드대웅제약주가157000원8월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1003225
6119,2019-08-29,희귀의약품분야에본격뛰어든대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=02050006622592240
6120,2019-08-29,국내주가정보29일대웅제약증시현황158500원,http://www.anewsa.com/detail.php?number=1939672&thread=18
6121,2019-08-29,대웅주식창29일현재15750원,http://nbntv.co.kr/news/view/605695
6122,2019-08-29,8월29일대웅및증권시세및매매동향097변화,http://www.gokorea.kr/news/articleView.html?idxno=370876
6123,2019-08-29,증시실황29일대웅현재가격15650원,http://www.anewsa.com/detail.php?number=1939956&thread=18
6124,2019-08-29,시세보기대웅제약주가29일현재156500원,http://nbntv.co.kr/news/view/606228
6125,2019-08-29,대웅제약주가8월29일오늘가격157000원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=371468
6126,2019-08-29,스타★주식인사이드대웅제약주가159000원8월29일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1003609
6127,2019-08-29,8월29일장마감주가정보대웅제약157500원,http://www.newsinside.kr/news/articleView.html?idxno=1004084
6128,2019-08-29,특징주종목정보8월29일대웅15750원으로장마감,http://nbntv.co.kr/news/view/607854
6129,2019-08-29,29일오늘의증시마감대웅15750원마감,http://www.gokorea.kr/news/articleView.html?idxno=373179
6130,2019-08-29,29일마감증시대웅제약157500원마감,http://www.gokorea.kr/news/articleView.html?idxno=373392
6131,2019-08-29,인기종목종목정보8월29일대웅제약157500원으로장마감,http://nbntv.co.kr/news/view/608372
6132,2019-08-30,대웅제약나보타포자나왔다메디톡스균주와달라1보,http://news1.kr/articles/?3707837
6133,2019-08-30,대웅제약나보타균주메디톡스제품과달라포자형성확인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083008561184522
6134,2019-08-30,대웅제약상승출발508이시각거래량5762주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908300059&t=NN
6135,2019-08-30,대웅제약나보타포자형성확인메디톡스와달라속보,http://www.newstomato.com/ReadNews.aspx?no=917122
6136,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234379
6137,2019-08-30,대웅제약급등전일대비857↑,http://www.newspim.com/news/view/20190830000102
6138,2019-08-30,대웅제약보툴리눔톡신균주포자형성메디톡스균주와다른것으로나타나,http://www.ceoscoredaily.com/news/article.html?no=59884
6139,2019-08-30,대웅제약5이상상승최근3일간기관대량순매도,https://www.hankyung.com/finance/article/201908308330L
6140,2019-08-30,대웅제약균주메디톡스와달라포자감정시험서입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019083009065978687
6141,2019-08-30,특징주대웅제약보톡스소송에유리한분석결과나와강세,http://news.mk.co.kr/newsRead.php?year=2019&no=679689
6142,2019-08-30,★주식인사이드대웅제약주가170500원8월30일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1005190
6143,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적입증,http://medipana.com/news/news_viewer.asp?NewsNum=244795&MainKind=A&NewsKind=5&vCount=12&vKind=1
6144,2019-08-30,3년끈보톡스분쟁종지부찍나대웅제약메디톡스균주와다르다는것입증,http://biz.chosun.com/site/data/html_dir/2019/08/30/2019083000795.html
6145,2019-08-30,대웅제약균주메디톡스와달라포자감정으로입증,http://www.dailypharm.com/Users/News/NewsView.html?ID=256234&REFERER=NP
6146,2019-08-30,대웅제약나보타균주메디톡스와달라포자감정시험입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1793601
6147,2019-08-30,특징주대웅제약균주논란종결발표에강세,http://news.mt.co.kr/mtview.php?no=2019083009125564546
6148,2019-08-30,종목추적30일대웅제약현재가166000원,http://www.anewsa.com/detail.php?number=1942356&thread=18
6149,2019-08-30,대웅제약나보타균주포자감정결과메디톡스균주와다른점입증돼,http://news.mk.co.kr/newsRead.php?year=2019&no=679732
6150,2019-08-30,대웅제약포자감정통해메디톡스균주와다름입증”,http://www.ajunews.com/view/20190830090058062
6151,2019-08-30,대웅제약메디톡스와보톡스균주달랐다,http://daily.hankooki.com/lpage/ittech/201908/dh20190830091839145630.htm
6152,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.fnnews.com/news/201908300920004995
6153,2019-08-30,특징주대웅제약보톡스소송에유리한분석소식에강세,http://www.newsis.com/view/?id=NISX20190830_0000755707&cID=10401&pID=10400
6154,2019-08-30,특징주대웅제약메디톡스와보톡스균주달라강세,http://www.asiatime.co.kr/news/articleView.html?idxno=267198
6155,2019-08-30,대웅제약나보타균주메디톡스와다르다는것명백히입증민형사상책임물을것,http://www.sisafocus.co.kr/news/articleView.html?idxno=219541
6156,2019-08-30,대웅제약메디톡스와균주달라포자감정시험통해과학적으로입증,http://www.segye.com/content/html/2019/08/30/20190830503128.html?OutUrl=naver
6157,2019-08-30,대웅제약포자형성확인메디톡스균주안훔쳤다,http://www.newsis.com/view/?id=NISX20190830_0000755693&cID=13001&pID=13000
6158,2019-08-30,대웅상승출발후현재571이시각거래량2만9442주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908300106&t=NN
6159,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://news.mk.co.kr/newsRead.php?year=2019&no=679803
6160,2019-08-30,대웅제약나보타균주메디톡스와달라포자감정시험서입증,http://www.seoulwire.com/news/articleView.html?idxno=208026
6161,2019-08-30,대웅제약나보타균주메디톡스와달라메디톡스에법적책임을물을것”,http://moneys.mt.co.kr/news/mwView.php?no=2019083009168013779
6162,2019-08-30,대웅제약나보타균주메디톡스와달라메디톡스에법적책임을물을것”,http://moneys.mt.co.kr/news/mwView.php?no=2019083009168013779
6163,2019-08-30,특징주대웅제약보톡스소송승소가능성에강세,http://www.ebn.co.kr/news/view/999164
6164,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.lawissue.co.kr/view.php?ud=201908300930469790204ead0791_12
6165,2019-08-30,특징주대웅제약보톡스소송유리한분석결과에강세,http://www.dailian.co.kr/news/view/822057/?sc=naver
6166,2019-08-30,대웅제약나보타포자형성확인메디톡스와달라,http://www.newspim.com/news/view/20190830000127
6167,2019-08-30,8월30일대웅증권투자44416450원,http://nbntv.co.kr/news/view/610029
6168,2019-08-30,특징주대웅제약메디톡스와다른균주입증에강세,http://www.inews24.com/view/1205343
6169,2019-08-30,대웅제약나보타포자감정시험결과발표메디톡스와달라책임물을것상보,http://www.newstomato.com/ReadNews.aspx?no=917130
6170,2019-08-30,대웅보톨리눔톡신균주메디톡신과달랐다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87576
6171,2019-08-30,뉴스워커_대웅제약대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.newsworker.co.kr/news/articleView.html?idxno=38508
6172,2019-08-30,뉴스워커_대웅제약대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.newsworker.co.kr/news/articleView.html?idxno=38508
6173,2019-08-30,대웅제약보툴리눔분쟁승소눈앞메디톡스것과다르다”확인,http://news.heraldcorp.com/view.php?ud=20190830000146
6174,2019-08-30,대웅균주메디톡스와달라법원포자감정서대웅勝,http://news.mt.co.kr/mtview.php?no=2019083009163885300
6175,2019-08-30,특징주대웅제약보톡스소송유리한분석결과에상승세,http://news1.kr/articles/?3707906
6176,2019-08-30,fnRASSI대웅제약571오르며거래량증가,http://www.fnnews.com/news/201908300941534793
6177,2019-08-30,대웅제약보툴리눔균주포자형성확인메디톡스에민형사책임물을것”,https://www.sedaily.com/NewsView/1VN65PS1JZ
6178,2019-08-30,대웅주가8월30일오늘거래가16450원증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=374283
6179,2019-08-30,대웅제약보툴리눔균주메디톡스와달라포자감정서입증,http://yna.kr/AKR20190830037200017?did=1195m
6180,2019-08-30,나보타균주포자형성대웅제약메디톡스출처논쟁종결되나,http://www.sportsseoul.com/news/read/812321
6181,2019-08-30,대웅제약균주메디톡스와달랐다”포자감정통해입증,http://www.dailian.co.kr/news/view/822050/?sc=naver
6182,2019-08-30,대웅제약보톡스민사소송유리한결과발표에강세특징주,http://www.kukinews.com/news/article.html?no=696460
6183,2019-08-30,대웅제약메디톡스와보톡스균주소송서결정적승기잡아,http://www.edaily.co.kr/news/newspath.asp?newsid=01882726622592568
6184,2019-08-30,법원대웅제약균주메디톡스와다르다결론,http://www.bosa.co.kr/news/articleView.html?idxno=2111501
6185,2019-08-30,대웅급등전일대비889↑긴조정끝내고골든크로스발생,http://www.newspim.com/news/view/20190830000242
6186,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.betanews.net:8080/article/1045474.html
6187,2019-08-30,특징주대웅제약메디톡스와다른균주입증8급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1793653
6188,2019-08-30,대웅제약나보타포자메디톡스균주와달라”검증시험서포자형성,http://www.viva100.com/main/view.php?key=20190830010009671
6189,2019-08-30,fnRASSI대웅003090전일대비921상승,http://www.fnnews.com/news/201908300957323472
6190,2019-08-30,대웅제약메디톡스에민형사책임물을것,http://www.whosaeng.com/112305
6191,2019-08-30,장중주가30일대웅현재가16850원,http://www.anewsa.com/detail.php?number=1942658&thread=18
6192,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=14991
6193,2019-08-30,대웅제약균주서포자생성확인메디톡스와다른균주,http://www.medisobizanews.com/news/articleView.html?idxno=62148
6194,2019-08-30,특징주대웅제약메디톡스와다른보톡스균주입증에급등,http://www.fntimes.com/html/view.php?ud=2019083009555223606c0eb6f11e_18
6195,2019-08-30,대웅제약나보타포자형성선명메디톡신과다름입증상보,http://www.fntoday.co.kr/news/articleView.html?idxno=201356
6196,2019-08-30,대웅제약메디톡스대웅제약발표이후희비엇갈려대웅제약급등VS메디톡스급락,http://www.econonews.co.kr/news/articleView.html?idxno=83979
6197,2019-08-30,특징주대웅제약메디톡스보톡스소송분석결과에명암,http://moneys.mt.co.kr/news/mwView.php?no=2019083010178022551
6198,2019-08-30,대웅제약균주입증소식에상승곡선,http://www.mdtoday.co.kr/mdtoday/index.html?no=363672
6199,2019-08-30,대웅제약균주전쟁서결정적승기잡아메디톡스와달라상보,http://www.newsis.com/view/?id=NISX20190830_0000755789&cID=13001&pID=13000
6200,2019-08-30,제약업종오전시황상승률상위종목현성바이탈1074대웅제약984대웅730등,http://www.gokorea.kr/news/articleView.html?idxno=374520
6201,2019-08-30,대웅제약보툴리눔균주메디톡스와다르다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908300156&t=NN
6202,2019-08-30,특징주대웅제약균주메디톡스와다르다는소식에강세,http://www.newsway.co.kr/news/view?tp=1&ud=2019083010225312865
6203,2019-08-30,균주포자형성입증한대웅제약명백한메디톡스음해,https://www.paxnetnews.com/articles/51782
6204,2019-08-30,대웅제약균주메디톡스와다르다,http://www.koreaittimes.com/news/articleView.html?idxno=92687
6205,2019-08-30,대웅제약자사보톨리눔톡신균주메디톡스와다르다”,http://www.kukinews.com/news/article.html?no=696498
6206,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.getnews.co.kr/view.php?ud=20190830102927947741d0c69529_16
6207,2019-08-30,특징주대웅제약보톡스원료도용논란일축에강세,http://yna.kr/AKR20190830056800008?did=1195m
6208,2019-08-30,대웅제약메디톡스균주포자형성하지않아,http://www.bokuennews.com/news/article.html?no=180137
6209,2019-08-30,대웅제약나보타균주메디톡스와다르다포자감정시험서포자형성,http://www.newsprime.co.kr/news/article.html?no=473398
6210,2019-08-30,대웅제약메디톡스와균주다르다”포자감정서입증,http://health.chosun.com/site/data/html_dir/2019/08/30/2019083001172.html
6211,2019-08-30,대웅제약균주포자감정시험통해메디톡스와다른것확인,http://www.asiatime.co.kr/news/articleView.html?idxno=267200
6212,2019-08-30,대웅제약보톡스원료도용논란일축에급등메디톡스는약세,http://www.seoulwire.com/news/articleView.html?idxno=208143
6213,2019-08-30,머니e종목대웅제약메디톡스와다른보톡스균주입증에상승,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083010501994126
6214,2019-08-30,주식증권대웅제약주가30일현재175000원,http://nbntv.co.kr/news/view/610566
6215,2019-08-30,메디톡스대웅제약균주입증소식에하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=363686
6216,2019-08-30,메디톡스대웅제약혐의는ITC에제출되는균주조사결과로완벽히밝혀질것,http://www.ceoscoredaily.com/news/article.html?no=59902
6217,2019-08-30,특징주대웅제약보톡스원료도용논란해명에상승세,http://www.ajunews.com/view/20190830105314178
6218,2019-08-30,대웅제약나보타균주메디톡스균주와다르다,http://www.econovill.com/news/articleView.html?idxno=370921
6219,2019-08-30,메디톡스대웅제약혐의미국ITC에제출되는균주조사결과로밝혀질것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56981
6220,2019-08-30,메디톡스대웅제약포자감정시험편협한해석동의할수없어,http://www.newspim.com/news/view/20190830000610
6221,2019-08-30,제약업종내상승종목대웅제약1079현성바이탈705대웅698등,http://www.anewsa.com/detail.php?number=1943375&thread=18
6222,2019-08-30,메디톡스대웅나보타균주의혹입증되지않아美ITC서밝혀질것,http://news.mk.co.kr/newsRead.php?year=2019&no=680548
6223,2019-08-30,대웅제약보툴리눔균주시험결과메디톡스와별개포자입증,http://www.kyeongin.com/main/view.php?key=20190830001110285
6224,2019-08-30,대웅제약나보타균주메디톡스와달라메디톡스美ITC에희망,http://biz.newdaily.co.kr/site/data/html/2019/08/30/2019083000072.html
6225,2019-08-30,승기잡은대웅제약떨어지는메디톡스기다릴이벤트는,http://news.mt.co.kr/mtview.php?no=2019083010163296746
6226,2019-08-30,특징주대웅제약보톡스소송유리한분석결과에강세,http://www.asiatoday.co.kr/view.php?key=20190830010017073
6227,2019-08-30,대웅제약도용혐의9월20일드러날것,http://www.whosaeng.com/112306
6228,2019-08-30,메디톡스대웅제약에반격美ITC균주조사까지지켜봐야,http://daily.hankooki.com/lpage/ittech/201908/dh20190830112923145630.htm
6229,2019-08-30,장중수급포착대웅외국인50475주대량순매수주가698,http://www.newspim.com/news/view/20190830000690
6230,2019-08-30,제약업종11시현재주식시황상승률상위종목대웅제약14500원921대웅1100원698코스맥스엔비티450원630,http://www.cctvnews.co.kr/news/articleView.html?idxno=134484
6231,2019-08-30,대웅제약주가0696208월30일오늘거래가172000원종목그래프및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=374882
6232,2019-08-30,대웅vs메디톡스4년균주전쟁1차전대웅勝,http://news.mt.co.kr/mtview.php?no=2019083010115465566
6233,2019-08-30,대웅제약나보타균주메디톡스와다르다”포자감정시험서포자형성,http://inthenews.co.kr/article-14333/
6234,2019-08-30,대웅제약포자감정에서독자균주입증메디톡스美서진실규명,https://www.ytn.co.kr/_ln/0103_201908301134014604
6235,2019-08-30,포자형성이가른향배대웅제약균주도용의혹해명,http://www.mhj21.com/123931
6236,2019-08-30,메디톡스대웅제약모든혐의美ITC통해밝혀질것반박,http://www.econovill.com/news/articleView.html?idxno=370929
6237,2019-08-30,대웅제약보툴리눔균주메디톡스와달라포자감정서입증,https://view.asiae.co.kr/article/2019083011362403928
6238,2019-08-30,대웅포자감정서메디톡스와다른균주입증편협한해석종합,http://yna.kr/AKR20190830037251017?did=1195m
6239,2019-08-30,나보타균주출처논란해소한대웅제약탄탄대로달리나,http://medipana.com/news/news_viewer.asp?NewsNum=244818&MainKind=A&NewsKind=5&vCount=12&vKind=1
6240,2019-08-30,대웅제약나보타균주메디톡스와달라포자감정시험으로입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019083000050
6241,2019-08-30,대웅제약메디톡스균주와달라포자검증서입증종합,https://view.asiae.co.kr/article/2019083011495852628
6242,2019-08-30,대웅제약균주메디톡스와달라과학적으로입증,http://www.economytalk.kr/news/articleView.html?idxno=196106
6243,2019-08-30,대웅제약포자소송서승기메디톡스ITC서밝혀질것종합,http://news1.kr/articles/?3708118
6244,2019-08-30,대웅제약나보타균주메디톡스균주와달라vs메디톡스美ITC조사로밝혀질것,http://www.updownnews.co.kr/news/articleView.html?idxno=207822
6245,2019-08-30,대웅003090오후12시09분기준및주체별매매동향,https://www.dailysecu.com/news/articleView.html?idxno=66911
6246,2019-08-30,한미가로지른대웅제약메디톡스전쟁최종결판언제종합,http://www.newsis.com/view/?id=NISX20190830_0000755984&cID=13001&pID=13000
6247,2019-08-30,대웅제약나보타균주메디톡스균주와다르다,http://www.dailymedi.com/detail.php?number=846921&thread=22r05
6248,2019-08-30,포자형성된나보타균주두고대웅다른균주입증메디톡스ITC결과기다려야,http://www.newstomato.com/ReadNews.aspx?no=917186
6249,2019-08-30,특징주대웅제약↑vs메디톡스↓보톡스논란일단락,http://www.enewstoday.co.kr/news/articleView.html?idxno=1332664
6250,2019-08-30,대웅제약보톡스법정다툼에서메디톡스이겼다,http://www.newsfc.co.kr/news/articleView.html?idxno=37659
6251,2019-08-30,대웅제약보툴리눔균주포자감정시험결과메디톡스와달라,http://www.joseilbo.com/news/news_read.php?uid=383088&class=27&grp=
6252,2019-08-30,메디톡스대웅제약주장은일부만부각한편협한해석절대동의못해,http://www.sisafocus.co.kr/news/articleView.html?idxno=219564
6253,2019-08-30,대웅제약보톡스균주포자형성확인메디톡스균주와달라,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071795
6254,2019-08-30,메디톡스대웅제약도용혐의여전미국서명확히밝혀질것,http://www.sportsseoul.com/news/read/812439
6255,2019-08-30,스타★주식인사이드대웅제약주가169500원8월30일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1005784
6256,2019-08-30,메디톡신대웅제약에아직끝나지않았다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87589
6257,2019-08-30,대웅제약메디톡스와보톡스전쟁서승기,http://news.bizwatch.co.kr/article/consumer/2019/08/30/0009/naver
6258,2019-08-30,종합대웅제약메디톡스와다른균주입증VS메디톡스美ITC서진실규명,http://www.etoday.co.kr/news/section/newsview.php?idxno=1793728
6259,2019-08-30,메디톡스대웅제약혐의美ITC균주조사로밝혀질것”,http://www.viva100.com/main/view.php?key=20190830010009785
6260,2019-08-30,메디톡스대웅제약혐의내달미국ITC결과로완벽히밝혀질것,http://www.ajunews.com/view/20190830134611257
6261,2019-08-30,제약업종오후시황상승률상위종목현성바이탈906대웅제약667코스맥스엔비티616등,http://www.gokorea.kr/news/articleView.html?idxno=375697
6262,2019-08-30,메디톡스미국ITC균주조사결과로대웅제약혐의밝힐것,http://www.dailian.co.kr/news/view/822117/?sc=naver
6263,2019-08-30,대웅제약보톡스원료도용논란일축에주가강세,http://www.ggilbo.com/news/articleView.html?idxno=699096
6264,2019-08-30,대웅제약보툴리눔톡신균주포자감정에서메디톡스와다름확인,http://www.businesspost.co.kr/BP?command=article_view&num=141583
6265,2019-08-30,특징주보톡스균주포자감정결과에대웅제약메디톡스희비엇갈려,http://news.mk.co.kr/newsRead.php?year=2019&no=681372
6266,2019-08-30,제약업종14시현재주식시황상승률상위종목대웅제약11000원698현성바이탈195원654씨케이에이치19원635,http://www.cctvnews.co.kr/news/articleView.html?idxno=134607
6267,2019-08-30,대웅제약주가상승세보톡스소송관련입장발표,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20190830.99099013304
6268,2019-08-30,대웅제약나보타균주포자생성확인메디톡스에민형사상책임물을것,http://www.sporbiz.co.kr/news/articleView.html?idxno=371041
6269,2019-08-30,Talk쏘는종목오이솔루션대웅제약삼륭물산GOvsSTOP,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083014062143115
6270,2019-08-30,간장약은우루사옛말셀트리온제약뜨고대웅제약지고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083013535757862
6271,2019-08-30,대웅제약나보타균주포자형성메디톡스와다른균주입증,http://www.rapportian.com/news/articleView.html?idxno=119694
6272,2019-08-30,메디톡스균주와달라대웅제약나보타균주포자형성확인,http://www.ezyeconomy.com/news/articleView.html?idxno=93408
6273,2019-08-30,제약업종내상승종목현성바이탈839대웅제약667코스맥스엔비티644등,http://www.anewsa.com/detail.php?number=1944710&thread=18
6274,2019-08-30,대웅제약포자감정서메디톡스와다른균주입증,https://www.hankyung.com/it/article/201908309563f
6275,2019-08-30,대웅제약메디톡스와4년째보톡스분쟁서승기잡나,http://www.insightkorea.co.kr//news/articleView.html?idxno=54622
6276,2019-08-30,특징주대웅제약보톡스원료도용논란일축에강세종합,http://yna.kr/AKR20190830056851008?did=1195m
6277,2019-08-30,대웅제약메디톡스와의보톡스분쟁서유리한고지선점,http://www.polinews.co.kr/news/article.html?no=413965
6278,2019-08-30,8월30일장마감주가정보대웅제약167500원,http://www.newsinside.kr/news/articleView.html?idxno=1006281
6279,2019-08-30,메디톡스일부만부각한편협한해석대웅제약반박,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908300398&t=NN
6280,2019-08-30,제약업종마감시황상승률상위종목코스맥스엔비티644대웅제약635씨케이에이치569등,http://www.gokorea.kr/news/articleView.html?idxno=376450
6281,2019-08-30,대웅제약균주포자로다름입증vs메디톡스인정못해,http://www.newspim.com/news/view/20190830001058
6282,2019-08-30,탐나는키워드대웅제약균주논란해소로주가탄탄대로,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019083015482260663
6283,2019-08-30,인기주종목정보30일대웅마감증시16500원,http://nbntv.co.kr/news/view/612207
6284,2019-08-30,대웅제약vs메디톡스보톡스전쟁재발,http://www.seoulfn.com/news/articleView.html?idxno=354383
6285,2019-08-30,대웅제약보톡스균주입증소식에상승마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=363727
6286,2019-08-30,30일주가마감정보대웅16500원마감,http://www.gokorea.kr/news/articleView.html?idxno=376574
6287,2019-08-30,대웅제약균주포자형성으로메디톡스와다른균주입증,http://www.news2day.co.kr/135573
6288,2019-08-30,대웅제약보톡스분쟁서승기잡아포자형성,http://www.finomy.com/news/articleView.html?idxno=68949
6289,2019-08-30,30일장마감증권시세대웅제약167500원마감,http://www.gokorea.kr/news/articleView.html?idxno=376802
6290,2019-08-30,대웅제약메티톡스균주와서로다름증명독자생산입증,http://www.100ssd.co.kr/news/articleView.html?idxno=63849
6291,2019-08-30,대웅제약포자감정시험서메디톡스와다른균주입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1332785
6292,2019-08-30,대웅제약포자감정에서독자균주입증메디톡스美서진실규명,https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&s_hcd=&key=201908301646387616
6293,2019-08-30,대웅제약균주포자생성한다메디톡스와달라,http://www.ftoday.co.kr/news/articleView.html?idxno=111044
6294,2019-08-30,나보타균주전쟁대웅제약선승균주조사결과촉각,http://www.shinailbo.co.kr/news/articleView.html?idxno=1199697
6295,2019-08-30,대웅보툴리눔균주메디톡스와차이입증,https://www.sedaily.com/NewsView/1VN67T0Y0K
6296,2019-08-30,대웅제일항궤양제신약개발속도전CJ케이캡에도전장,http://www.newsway.co.kr/news/view?tp=1&ud=2019083016250208498
6297,2019-08-30,균주전쟁승기잡은대웅제약메디톡스美ITC결과기다려야,http://www.ntoday.co.kr/news/articleView.html?idxno=68295
6298,2019-08-30,3년끈보톡스분쟁대웅제약유리한고지점령,http://news.mk.co.kr/newsRead.php?year=2019&no=682514
6299,2019-08-30,상장주매매동향8월30일대웅제약167500원으로장마감,http://nbntv.co.kr/news/view/612693
6300,2019-08-30,전승호균주분쟁벗어나대웅제약나보타점유율확대공격앞으로,http://www.businesspost.co.kr/BP?command=article_view&num=141639
6301,2019-08-30,대웅제약메디톡스와균주다르다포자감정서입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=311480
6302,2019-08-30,대웅제약보툴리눔균주메디톡스와달라메디톡스美서진실규명할것,https://cnbc.sbs.co.kr/article_hub/10000953685?division=NAVER
6303,2019-08-30,대웅제약균주포자감정시험통해과학적으로입증밝혀,http://www.thefirstmedia.net/news/articleView.html?idxno=47990
6304,2019-08-30,메디톡스미국ITC에제출되는균주조사결과로대웅제약혐의완벽히밝혀질것,http://www.thefirstmedia.net/news/articleView.html?idxno=47986
6305,2019-08-30,대웅제약균주메디톡스와달라포자감정시험통해과학적으로입증,http://www.newscj.com/news/articleView.html?idxno=663382
6306,2019-08-31,대웅제약메디톡스와보툴리눔톡신균주달라포자감정시험으로과학적입증,http://www.g-enews.com/ko-kr/news/article/news_all/20190830152054781469d76442fa_1/article.html
6307,2019-08-31,대웅제약독자균주입증메디톡스美서진실규명,https://www.ytn.co.kr/_ln/0103_201908310041571517
6308,2019-08-31,대웅제약나보타균주출처포자검증서입증메디톡스ITC서진실밝힐것,http://www.mdtoday.co.kr/mdtoday/index.html?no=363730
6309,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.ekn.kr/news/article.html?no=450759
6310,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.tourtimes.net/120387
6311,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://newsbrite.net/125830
6312,2019-08-31,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://newsbrite.net/125823
6313,2019-08-31,대웅제약vs메디톡스질긴악연의고리,https://www.sedaily.com/NewsView/1VN6N06P9T
6314,2019-09-01,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.idjnews.kr/news/articleView.html?idxno=89834
6315,2019-09-01,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.lawissue.co.kr/view.php?ud=2019083102401459326cf2d78c68_12
6316,2019-09-01,끝이보이는보톡스전쟁대웅제약승기잡나,http://www.sporbiz.co.kr/news/articleView.html?idxno=371251
6317,2019-09-01,절정치닫는보톡스분쟁대웅제약승기잡았다,http://www.skyedaily.com/news/news_view.html?ID=89632
6318,2019-09-01,대웅제약메디톡스서로다른균주소송전행방은,http://www.monews.co.kr/news/articleView.html?idxno=204688
6319,2019-09-01,대웅제약보툴리늄톡신생산사용균주포자형성확인메디톡스균주안훔쳤다,http://www.econonews.co.kr/news/articleView.html?idxno=84293
6320,2019-09-02,매출라이벌대웅제약종근당임상시험도맞대결,http://www.sportsseoul.com/news/read/813292
6321,2019-09-02,클릭e종목대웅제약균주소송우려해소,https://view.asiae.co.kr/article/2019090208013032323
6322,2019-09-02,대웅제약균주논란해소KTB투자증권,http://news.mt.co.kr/mtview.php?no=2019090207583655741
6323,2019-09-02,대웅제약균주소송우려해소강력매수,https://www.sedaily.com/NewsView/1VO38IKCL0
6324,2019-09-02,대웅제약균주소송우려해소에불확실성감소매수KTB증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1794125
6325,2019-09-02,하이로우대웅제약보톡스균주소송우려해소KTB투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019090208235219141
6326,2019-09-02,대웅제약주식상승가능보툴리눔톡신균주소송불확실성해소,http://www.businesspost.co.kr/BP?command=article_view&num=141780
6327,2019-09-02,대웅제약나보타균주논란해소전망KTB증권,http://www.seoulfn.com/news/articleView.html?idxno=354478
6328,2019-09-02,대웅제약균주소송우려해소KTB,http://www.fnnews.com/news/201909020833338637
6329,2019-09-02,HotLine대웅제약균주출처소송우려해소돼,http://news.mk.co.kr/newsRead.php?year=2019&no=686347
6330,2019-09-02,메디톡스대웅제약균주분쟁이달말ITC감정결과에주목”한국투자증권,http://www.fntimes.com/html/view.php?ud=201909020842097964f09e13944d_18
6331,2019-09-02,대웅제약균주소송우려해소로주가긍정적KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01584246622616184
6332,2019-09-02,가장혁신적인제약사20위권에한미약품대웅제약랭크,http://www.beyondpost.co.kr/view.php?ud=2019090208454951646a9e4dd7f_30
6333,2019-09-02,퀵리포트대웅제약매수로상향목표가10↑22만원DB금투,http://www.itooza.com/common/iview.php?no=2019090208584413177
6334,2019-09-02,한미약품대웅제약가장혁신적인제약사20위권랭크,http://www.newsis.com/view/?id=NISX20190901_0000757032&cID=13001&pID=13000
6335,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.gnmaeil.com/news/articleView.html?idxno=425126
6336,2019-09-02,한미대웅SKLG등국내12개제약사APAC혁신제약사선정,http://www.viva100.com/main/view.php?key=20190901010000059
6337,2019-09-02,한미대웅제넥신툴젠亞혁신바이오파마에올라,http://www.biospectator.com/view/news_view.php?varAtcId=8386
6338,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.thebigdata.co.kr/view.php?ud=2019083102410985246cf2d78c68_23
6339,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.kidstvnews.co.kr/view.php?ud=2019083102421078346cf2d78c68_29
6340,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.beyondpost.co.kr/view.php?ud=201908310242586436cf2d78c68_30
6341,2019-09-02,대웅제약폐섬유증신약글로벌임상1상돌입,http://weekly.hankooki.com/lpage/economy/201909/wk20190902090035146390.htm
6342,2019-09-02,APAC제약혁신랭킹한미약품대웅제약등포함,http://www.ebn.co.kr/news/view/999313
6343,2019-09-02,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증”,http://www.ksmnews.co.kr/default/index_view_page.php?idx=261239&part_idx=373
6344,2019-09-02,아태지역혁신적제약기업에한미11위대웅12위랭크,http://medipana.com/news/news_viewer.asp?NewsNum=244832&MainKind=A&NewsKind=5&vCount=12&vKind=1
6345,2019-09-02,한미약품대웅제약APAC의혁신적인대형제약사20위권등극,http://biz.newdaily.co.kr/site/data/html/2019/09/02/2019090200007.html
6346,2019-09-02,KTB투자대웅제약균주소송우려해소펀더멘탈개선전망”,http://www.sentv.co.kr/news/view/559869
6347,2019-09-02,퀵리포트대웅제약강력매수유지목표가28만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019090208060811959
6348,2019-09-02,대웅제약주가불확실성해소KTB투자증권,http://www.ajunews.com/view/20190902083535176
6349,2019-09-02,아태대형혁신제약사20위권내한미대웅이름올려,http://www.newspim.com/news/view/20190902000070
6350,2019-09-02,★주식인사이드대웅제약주가171000원9월2일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1009941
6351,2019-09-02,장중시세2일대웅제약거래가격172000원,http://www.anewsa.com/detail.php?number=1945557&thread=18
6352,2019-09-02,亞太20대혁신제약사에한미대웅,http://www.dt.co.kr/contents.html?article_no=2019090202109931102001&ref=naver
6353,2019-09-02,실시간분석대웅제약32상승증권사목표가22만원제시,http://www.itooza.com/common/iview.php?no=2019090209163113957
6354,2019-09-02,한미대웅APAC혁신제약사20위권내선정,http://www.monews.co.kr/news/articleView.html?idxno=204715
6355,2019-09-02,한미약품대웅제약제넥신휴온스APAC혁신제약사상위20위권내올라,http://www.medigatenews.com/news/1717109172
6356,2019-09-02,특징주보톡스균주논란일단락대웅제약메디톡스강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01846646622616184
6357,2019-09-02,메디톡스대웅제약의균주소송영향제한적,http://www.sisafocus.co.kr/news/articleView.html?idxno=219706
6358,2019-09-02,리포트브리핑대웅제약유리한고지를선점목표가220000원DB금융투자,http://www.newspim.com/news/view/20190902000147
6359,2019-09-02,GET투자리포트대웅제약투자의견매수상향DB금융투자,http://www.getnews.co.kr/view.php?ud=2019090210303010760tpgetnews_16
6360,2019-09-02,DB금융투자대웅제약포자감성서유리한고지선점”,http://www.polinews.co.kr/news/article.html?no=414632
6361,2019-09-02,한미약품대웅제약등혁신제약사분야에올라,http://www.bosa.co.kr/news/articleView.html?idxno=2111552
6362,2019-09-02,대웅종목검색2일현재17050원,http://nbntv.co.kr/news/view/614777
6363,2019-09-02,한미약품대웅제약APAC혁신제약사20위권랭크,http://www.seoulwire.com/news/articleView.html?idxno=209397
6364,2019-09-02,대웅주가0030909월2일오늘거래가16950원정보외주식시황,http://www.gokorea.kr/news/articleView.html?idxno=378029
6365,2019-09-02,KTB증권보톡스논란벗어난대웅제약강력매수의견,http://www.enewstoday.co.kr/news/articleView.html?idxno=1332978
6366,2019-09-02,주식시세2일대웅증시현황17050원,http://www.anewsa.com/detail.php?number=1945855&thread=18
6367,2019-09-02,한미대웅유한녹십자등亞太지역혁신제약사톱30위,http://www.medisobizanews.com/news/articleView.html?idxno=62182
6368,2019-09-02,대웅제약메디톡스모두매수세쏟아지며상승특히대웅제약전날급등이어강세,http://www.econonews.co.kr/news/articleView.html?idxno=84379
6369,2019-09-02,GET투자리포트대웅제약투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=2019083010303010782tpgetnews_16
6370,2019-09-02,대웅제약메디톡스와의균주도용의혹민사소송에서유리한고지를선점”,http://www.wikitree.co.kr/main/news_view.php?id=459497
6371,2019-09-02,9월2일대웅제약주식종목170500원179,http://nbntv.co.kr/news/view/615279
6372,2019-09-02,아태혁신제약사평가서한국기업순위는한미대웅분전,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071842
6373,2019-09-02,보톡스균주논란에도대웅제약메디톡스장중동반강세,http://www.choicenews.co.kr/news/articleView.html?idxno=63838
6374,2019-09-02,클래리베이트분석아시아혁신제약사한미약품대웅제약20위권,http://news1.kr/articles/?3709729
6375,2019-09-02,9월2일대웅제약증권투자정보및주식시황209변동해,http://www.gokorea.kr/news/articleView.html?idxno=378618
6376,2019-09-02,대웅003090오후12시08분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=67331
6377,2019-09-02,아태지역혁신제약사에한미대웅등국내21개社올라,http://www.dongascience.com/news/view/30880
6378,2019-09-02,루프린경쟁자대웅제약특허무효소송패소,http://www.dailypharm.com/Users/News/NewsView.html?ID=256304&REFERER=NP
6379,2019-09-02,한미대웅APAC혁신대형제약사11위12위,http://www.dailymedi.com/detail.php?number=846999&thread=22r05
6380,2019-09-02,한미약품대웅제약아태지역혁신제약사선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1200149
6381,2019-09-02,스타★주식인사이드대웅제약주가171000원9월2일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1010646
6382,2019-09-02,대웅제약나보타균주출처포자검증서입증메디톡스도나란히上,http://www.mdtoday.co.kr/mdtoday/index.html?no=363827
6383,2019-09-02,대웅제약보톡스균주논란일단락에주가↑DB금융매수로상향,http://www.whitepaper.co.kr/news/articleView.html?idxno=171270
6384,2019-09-02,아태지역혁신제약사에한미약품대웅제약각각1112위올라,http://www.sisajournal-e.com/news/articleView.html?idxno=205515
6385,2019-09-02,대웅제약국내민사소송결과가가시화되면ITC소송역시긍정적인방향으로”,http://www.wikitree.co.kr/main/news_view.php?id=459685
6386,2019-09-02,대웅제약RD강화로넥스타나보타기대높인다,http://www.newspim.com/news/view/20190902000822
6387,2019-09-02,공정위2일오전대웅제약본사상대조사,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019090215501427942
6388,2019-09-02,9월2일장마감주가정보대웅제약170000원,http://www.newsinside.kr/news/articleView.html?idxno=1011143
6389,2019-09-02,승기잡은대웅제약메디톡스와보툴리눔톡신전쟁끝내나,http://www.g-enews.com/ko-kr/news/article/news_all/2019090216042432269d76442fa_1/article.html
6390,2019-09-02,특징주주가정보2일대웅마감증시17050원,http://nbntv.co.kr/news/view/616875
6391,2019-09-02,대웅제약신기업문화로밀레니얼세대와通한다,http://www.ebn.co.kr/news/view/999552
6392,2019-09-02,2일마감증시대웅주가17050원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=380316
6393,2019-09-02,대웅제약메디톡스균주논란ITC결과까지가봐야,http://www.newsis.com/view/?id=NISX20190902_0000758350&cID=13001&pID=13000
6394,2019-09-02,대웅제약메디톡스균주전쟁끝나나,http://www.economytalk.kr/news/articleView.html?idxno=196428
6395,2019-09-02,대웅제약심혈관현대약품치매제약사들임상3상잇달아진입,https://www.hankyung.com/it/article/2019090246081
6396,2019-09-02,2일증시종목마감동향대웅제약170000원마감,http://www.gokorea.kr/news/articleView.html?idxno=380549
6397,2019-09-02,IR52장영실상시지바이오대웅제약망상골형골이식재,http://news.mk.co.kr/newsRead.php?year=2019&no=690099
6398,2019-09-02,상장주주가정보9월2일대웅제약170000원으로장마감,http://nbntv.co.kr/news/view/617358
6399,2019-09-02,국제혁신역량인정받은한미파트너십대웅신약개발,http://www.newspim.com/news/view/20190902000317
6400,2019-09-02,소송우려일단락대웅제약반등채비,http://www.fnnews.com/news/201909021807248109
6401,2019-09-02,아시아혁신제약사에한미대웅20위권,http://www.newsway.co.kr/news/view?tp=1&ud=2019090218294453528
6402,2019-09-02,대웅제약vs메디톡스보톡스균주도용20일ITC소송분수령,http://www.dt.co.kr/contents.html?article_no=2019090302101531102001&ref=naver
6403,2019-09-02,보툴리눔균주포자감정시험결과대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510932252
6404,2019-09-03,톡톡이상품뉴대웅코크형홍삼제조만능달임기,http://news.mk.co.kr/newsRead.php?year=2019&no=690828
6405,2019-09-03,대웅제약루프린6개월지속제형무효심서패소,http://www.mdtoday.co.kr/mdtoday/index.html?no=363873
6406,2019-09-03,★주식인사이드대웅제약주가170500원9월3일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1012218
6407,2019-09-03,주가정보3일대웅제약현재주식거래가격170500원,http://www.anewsa.com/detail.php?number=1948357&thread=18
6408,2019-09-03,실시간주식현황대웅주가3일현재16900원,http://nbntv.co.kr/news/view/618993
6409,2019-09-03,대웅주가0030909월3일오늘가격17000원오늘시세및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=381401
6410,2019-09-03,국내주가정보3일대웅증시현황17000원,http://www.anewsa.com/detail.php?number=1948642&thread=18
6411,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.dailysmart.co.kr/news/articleView.html?idxno=15115
6412,2019-09-03,대웅제약한국제약바이오산업채용박람회참가,http://www.ebn.co.kr/news/view/999659
6413,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.metroseoul.co.kr/news/newsview?newscd=2019090300034
6414,2019-09-03,대웅제약2019제약바이오산업채용박람회참가현장면접도,http://www.medisobizanews.com/news/articleView.html?idxno=62233
6415,2019-09-03,공정위대웅제약현장조사역지불합의사유,http://www.sisajournal-e.com/news/articleView.html?idxno=205548
6416,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2019090310431945671
6417,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가현장면접통해우수인재찾아하반기상시채용서류면제혜택제공,http://www.segye.com/content/html/2019/09/03/20190903505011.html?OutUrl=naver
6418,2019-09-03,증권주식대웅제약주가3일현재167000원,http://nbntv.co.kr/news/view/619497
6419,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.lawissue.co.kr/view.php?ud=201909031056507261204ead0791_12
6420,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://medipana.com/news/news_viewer.asp?NewsNum=244940&MainKind=A&NewsKind=5&vCount=12&vKind=1
6421,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://sports.hankooki.com/lpage/economy/201909/sp20190903111223137020.htm
6422,2019-09-03,뉴스워커_대웅제약 2019한국제약바이오산업채용박람회참가,http://www.newsworker.co.kr/news/articleView.html?idxno=40024
6423,2019-09-03,대웅제약제약바이오산업채용박람회참가현장면접진행,http://www.newsprime.co.kr/news/article.html?no=473808
6424,2019-09-03,대웅제약이원하는인재직무기업이해도높은사람,http://news.mt.co.kr/mtview.php?no=2019090310523261805
6425,2019-09-03,9월3일대웅제약오늘시세206,http://www.gokorea.kr/news/articleView.html?idxno=382016
6426,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.bokuennews.com/news/article.html?no=180308
6427,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.betanews.net:8080/article/1046696.html
6428,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.newswatch.kr/news/articleView.html?idxno=23079
6429,2019-09-03,스타★주식인사이드대웅제약주가168500원9월3일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1012944
6430,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57030
6431,2019-09-03,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.gukjenews.com/news/articleView.html?idxno=1166567
6432,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://fn.segye.com/content/html/2019/09/03/20190903507442.html?OutUrl=naver
6433,2019-09-03,대웅제약나보타균주포자감정시험통해메디톡스와다른균주입증,http://www.fntoday.co.kr/news/articleView.html?idxno=202022
6434,2019-09-03,대웅제약한국제약바이오산업채용박람회참가,http://www.asiatime.co.kr/news/articleView.html?idxno=268000
6435,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.wolyo.co.kr/news/articleView.html?idxno=92636
6436,2019-09-03,대웅제약제약바이오산업채용박람회참가,http://www.finomy.com/news/articleView.html?idxno=69036
6437,2019-09-03,대웅제약vs메디톡스보톡스전쟁종지부찍을까3년소송전승자는,http://ilyo.co.kr/?ac=article_view&entry_id=346423
6438,2019-09-03,쉴때도일할때도제대로밀레니얼세대눈길사로잡는대웅제약의기업문화,http://www.businesskorea.co.kr/news/articleView.html?idxno=35628
6439,2019-09-03,대웅제약제약바이오산업채용박람회참가해우수인재확보나서,http://news.mk.co.kr/newsRead.php?year=2019&no=693448
6440,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.viva100.com/main/view.php?key=20190903010001068
6441,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가국내외인재적극발굴,http://www.ntoday.co.kr/news/articleView.html?idxno=68325
6442,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.straightnews.co.kr/news/articleView.html?idxno=54838
6443,2019-09-03,나보타끌고OTC밀고대웅제약방긋,http://www.econovill.com/news/articleView.html?idxno=371211
6444,2019-09-03,9월3일장마감주가정보대웅제약167000원,http://www.newsinside.kr/news/articleView.html?idxno=1013472
6445,2019-09-03,특징주분석주가정보3일대웅마감증시17150원,http://nbntv.co.kr/news/view/621138
6446,2019-09-03,대웅제약제약바이오산업채용박람회참가현장면접진행,http://www.seoulwire.com/news/articleView.html?idxno=211155
6447,2019-09-03,3일주식장마감동향대웅제약주가167000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=383949
6448,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.joseilbo.com/news/news_read.php?uid=383329&class=17&grp=
6449,2019-09-03,대웅제약제약바이오산업채용박람회참가해우수인재확보나섰다,http://www.nbnnews.co.kr/news/articleView.html?idxno=312858
6450,2019-09-03,상장주매매동향9월3일대웅제약167000원으로장마감,http://nbntv.co.kr/news/view/621661
6451,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://www.newscj.com/news/articleView.html?idxno=664399
6452,2019-09-03,대웅제약2019한국제약바이오산업채용박람회참가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3928591
6453,2019-09-04,대웅제약2019한국제약바이오산업채용박람회참가,http://www.thefirstmedia.net/news/articleView.html?idxno=48126
6454,2019-09-04,대웅제약2019한국제약바이오산업채용박람회참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1333492
6455,2019-09-04,국내주식시장현황4일대웅제약현재가격167500원,http://www.anewsa.com/detail.php?number=1951219&thread=18
6456,2019-09-04,국내주식시장주가4일대웅제약현재주식거래가격167500원,http://www.anewsa.com/detail.php?number=1951214&thread=18
6457,2019-09-04,9월4일대웅배당주식16900원146,http://nbntv.co.kr/news/view/623460
6458,2019-09-04,대웅제약2019한국제약바이오산업채용박람회참가,http://www.wsobi.com/news/articleView.html?idxno=80668
6459,2019-09-04,9월4일대웅주식종목시세16950원117,http://nbntv.co.kr/news/view/623510
6460,2019-09-04,주식종목4일대웅현재주가17000원,http://www.anewsa.com/detail.php?number=1951608&thread=18
6461,2019-09-04,올해들어허가취소2131품목대웅제약64품목최다,http://medipana.com/news/news_viewer.asp?NewsNum=245013&MainKind=A&NewsKind=5&vCount=12&vKind=1
6462,2019-09-04,9월4일대웅제약주가차트167000원000,http://nbntv.co.kr/news/view/624448
6463,2019-09-04,9월4일대웅제약투자주식000167000원,http://nbntv.co.kr/news/view/624473
6464,2019-09-04,스타★주식인사이드대웅제약주가165500원9월4일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1015111
6465,2019-09-04,대웅제약주가오늘시세및주식시황4일오늘거래가165500원거래,http://www.gokorea.kr/news/articleView.html?idxno=386119
6466,2019-09-04,9월4일대웅제약069620오늘시세060변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=386140
6467,2019-09-04,단독대웅제약나보타ITC시험서도포자형성확인,http://news.mt.co.kr/mtview.php?no=2019090413411448788
6468,2019-09-04,대웅제약메디톡스보톡스균주와다름입증증권가매수제시,http://www.whitepaper.co.kr/news/articleView.html?idxno=171688
6469,2019-09-04,9월4일장마감주가정보대웅제약171000원,http://www.newsinside.kr/news/articleView.html?idxno=1015613
6470,2019-09-04,인기주분석매매동향9월4일대웅17450원으로장마감,http://nbntv.co.kr/news/view/626854
6471,2019-09-04,4일주식장마감동향대웅17450원마감,http://www.gokorea.kr/news/articleView.html?idxno=387957
6472,2019-09-04,4일장마감증권시세대웅제약주가171000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=388577
6473,2019-09-04,특징주주가정보4일대웅제약마감증시171000원,http://nbntv.co.kr/news/view/627788
6474,2019-09-05,대웅제약우루사우리몸의공장간기능살려체내노폐물배출촉진,http://news.mk.co.kr/newsRead.php?year=2019&no=700002
6475,2019-09-05,퀵리포트대웅제약매수유지목표가9↑24만원삼성證,http://www.itooza.com/common/iview.php?no=2019090507303122898
6476,2019-09-05,대웅제약美ITC소송감정시험서도균주포자형성확인,http://www.ebn.co.kr/news/view/999995
6477,2019-09-05,★주식인사이드대웅제약주가170000원9월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1016381
6478,2019-09-05,대웅제약나보타미국ITC소송감정에서도포자형성1보,http://news1.kr/articles/?3712855
6479,2019-09-05,대웅제약미국ITC소송의감정시험에서도포자형성입증,http://www.dailian.co.kr/news/view/823676/?sc=naver
6480,2019-09-05,대웅제약美ITC소송감정시험에서도균주포자형성확인,http://www.segye.com/content/html/2019/09/05/20190905503583.html?OutUrl=naver
6481,2019-09-05,대웅제약美ITC소송감정시험서도균주포자형성확인,http://www.viva100.com/main/view.php?key=20190905010001754
6482,2019-09-05,대웅제약美ITC소송감정시험서도 자사균주 포자형성  ,http://www.medisobizanews.com/news/articleView.html?idxno=62288
6483,2019-09-05,대웅제약美ITC소송서나보타균주포자형성확인,http://www.kpinews.co.kr/news/articleView.html?idxno=102609
6484,2019-09-05,보톡스분쟁대웅제약나보타미국ITC소송감정시험균주포자형성확인,http://biz.chosun.com/site/data/html_dir/2019/09/05/2019090500788.html
6485,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,https://www.sedaily.com/NewsView/1VO4LY0IVZ
6486,2019-09-05,장중시세5일대웅제약주가170000원,http://www.anewsa.com/detail.php?number=1953992&thread=18
6487,2019-09-05,대웅제약美ITC감정시험에서도메디톡스와다른균주규명”,http://www.ajunews.com/view/20190905092847119
6488,2019-09-05,미국ITC감정서도대웅제약메디톡스균주달랐다,http://news.heraldcorp.com/view.php?ud=20190905000148
6489,2019-09-05,대웅제약美ITC소송감정시험에서도균주포자형성확인,http://medipana.com/news/news_viewer.asp?NewsNum=245051&MainKind=A&NewsKind=5&vCount=12&vKind=1
6490,2019-09-05,대웅제약美ITC소송감정시험서도균주의포자형성확인,http://www.newsway.co.kr/news/view?tp=1&ud=2019090509340113198
6491,2019-09-05,대웅제약미국ITC소송서도균주포자형성확인,http://www.newsis.com/view/?id=NISX20190905_0000761570&cID=13001&pID=13000
6492,2019-09-05,대웅제약관계사디엔컴퍼니추석선물세트준비다양한혜택까지,http://moneys.mt.co.kr/news/mwView.php?no=2019090509278019502
6493,2019-09-05,대웅제약美ITC시험서도포자형성확인,https://view.asiae.co.kr/article/2019090509394431547
6494,2019-09-05,대웅제약美ITC소송감정시험서균주의포자형성확인,http://www.asiatime.co.kr/news/articleView.html?idxno=268592
6495,2019-09-05,GET투자리포트대웅제약투자의견매수삼성증권,http://www.getnews.co.kr/view.php?ud=2019090410303010841tpgetnews_16
6496,2019-09-05,대웅제약미국ITC소송서도균주포자형성확인메디톡스균주와다르다,http://moneys.mt.co.kr/news/mwView.php?no=2019090509358050875
6497,2019-09-05,대웅제약우리균포자형성입증메디톡스와다르다”,http://www.hankookilbo.com/news/npath/201909050941066100?did=NA
6498,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,http://www.kukinews.com/news/article.html?no=698367
6499,2019-09-05,9월5일대웅주가그래프05717350원,http://nbntv.co.kr/news/view/629438
6500,2019-09-05,대웅미국ITC감정시험서균주포자형성확인,http://www.dailypharm.com/Users/News/NewsView.html?ID=256424&REFERER=NP
6501,2019-09-05,대웅제약美ITC감정인이나보타균주포자형성확인”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1795728
6502,2019-09-05,보톡스전쟁승기잡은대웅제약美소송감정시험서도포자형성확인,http://www.newspim.com/news/view/20190905000198
6503,2019-09-05,대웅제약미국ITC소송서나보타균주포자형성확인,http://www.econovill.com/news/articleView.html?idxno=371377
6504,2019-09-05,대웅주가003090오늘시세5일현재17400원형성,http://www.gokorea.kr/news/articleView.html?idxno=390062
6505,2019-09-05,메디톡스미국소송도패색대웅ITC감정서포자형성상보,http://news1.kr/articles/?3712966
6506,2019-09-05,아통증시5일대웅현재주식거래가격17400원,http://www.anewsa.com/detail.php?number=1954282&thread=18
6507,2019-09-05,대웅제약미국ITC소송서균주포자형성확인,http://www.newsprime.co.kr/news/article.html?no=474143
6508,2019-09-05,대웅제약미국ITC소송서도균주포자형성확인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019090510165226544
6509,2019-09-05,대웅제약미ITC소송감정서도대웅균주포자형성,http://www.bosa.co.kr/news/articleView.html?idxno=2111884
6510,2019-09-05,대웅제약미국ITC소송의감정시험서도균주의포자형성확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=364152
6511,2019-09-05,투자종목삼성證대웅제약美향나보타수출순조롭게확대중,http://www.newswatch.kr/news/articleView.html?idxno=23156
6512,2019-09-05,대웅제약하고싶은거다해혁신기업문화,http://www.newspost.kr/news/articleView.html?idxno=72974
6513,2019-09-05,대웅제약美ITC소송감정시험서균주포자형성확인,http://www.ceoscoredaily.com/news/article.html?no=60111
6514,2019-09-05,추석특집추석명절과식으로더부룩한속에는대웅제약베아제,http://www.metroseoul.co.kr/news/newsview?newscd=2019090500047
6515,2019-09-05,대웅제약보툴리눔균주미국ITC소송에서도포자형성,http://www.sportsseoul.com/news/read/815152
6516,2019-09-05,대웅제약美ITC감정에서도균주포자형성확인,http://news.mk.co.kr/newsRead.php?year=2019&no=701177
6517,2019-09-05,대웅제약메디톡스균주소송서유리한고지선점,http://www.dailymedi.com/detail.php?number=847098&thread=22r05
6518,2019-09-05,대웅제약미국ITC소송의감정시험통해균주의포자형성을확인,http://www.updownnews.co.kr/news/articleView.html?idxno=208080
6519,2019-09-05,리포트브리핑대웅제약2019KBKoreaConference참가기업BUYKB증권,http://www.newspim.com/news/view/20190905000440
6520,2019-09-05,대웅제약美ITC소송감정시험서균주포자형성확인,http://www.seoulwire.com/news/articleView.html?idxno=212366
6521,2019-09-05,GET투자리포트대웅제약투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=2019090510303010881tpgetnews_16
6522,2019-09-05,대웅제약디엔컴퍼니셀리시스EX이지듀에스테메드등추석선물세트출시최대60할인,http://www.ezyeconomy.com/news/articleView.html?idxno=93565
6523,2019-09-05,대웅제약보톡스미국소송서도포자형성주장,http://www.edaily.co.kr/news/newspath.asp?newsid=02253366622617168
6524,2019-09-05,대웅제약ITC소송감정에서도균주명확하게포자형성,http://www.rapportian.com/news/articleView.html?idxno=119809
6525,2019-09-05,주식주가대웅제약주가5일현재169500원,http://nbntv.co.kr/news/view/629972
6526,2019-09-05,대웅제약미국ITC소송감정시험에서도균주의포자형성확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57072
6527,2019-09-05,보툴리눔균주출처논란대웅제약미국ITC서도승기,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1128749&REFERER=NP
6528,2019-09-05,대웅제약美ITC소송감정시험에서균주포자형성확인염기서열도불일치,http://www.ezyeconomy.com/news/articleView.html?idxno=93568
6529,2019-09-05,대웅제약미국ITC소송감정시험에서도균주포자형성확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=35727
6530,2019-09-05,대웅제약주가0696209월5일오늘가격169000원증권투자정보외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=390687
6531,2019-09-05,대웅제약나보타균주리스크완전해소기대감,http://medipana.com/news/news_viewer.asp?NewsNum=245066&MainKind=A&NewsKind=5&vCount=12&vKind=1
6532,2019-09-05,대웅제약메디톡스3년걸친보톡스전쟁끝나나,http://www.skyedaily.com/news/news_view.html?ID=89932
6533,2019-09-05,대웅균주美감정시험서도포자형성확인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87706
6534,2019-09-05,대웅제약美ITC소송서도균주포자형성확인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071977
6535,2019-09-05,스타★주식인사이드대웅제약주가169000원9월5일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1016792
6536,2019-09-05,대웅제약ITC감정서도포자형성”남은건염기서열검증,http://www.news2day.co.kr/136044
6537,2019-09-05,대웅제약미국ITC소송서균주포자형성확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=313769
6538,2019-09-05,대웅제약보툴리눔톡신균주분쟁해소로나보타가치평가받아,http://www.businesspost.co.kr/BP?command=article_view&num=142328
6539,2019-09-05,대웅제약나보타균주포자생성거듭주장메디톡스신뢰할수없다,https://www.hankyung.com/finance/article/2019090526356
6540,2019-09-05,대웅제약미국보툴리눔톡신균주소송에서도메디톡스에승기잡아,http://www.businesspost.co.kr/BP?command=article_view&num=142343
6541,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성을확인,http://www.lawissue.co.kr/view.php?ud=201909051443452659204ead0791_12
6542,2019-09-05,대웅제약미국ITC소송서도균주의포자형성확인,http://www.economytalk.kr/news/articleView.html?idxno=196807
6543,2019-09-05,점입가경보톡스전쟁대웅제약美ITC도포자확인”VS메디톡스대웅의말장난”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1795971
6544,2019-09-05,대웅제약美ITC소송서도균주포자형성확인,http://www.whosaeng.com/112442
6545,2019-09-05,대웅제약미국ITC소송감정시험에서도균주포자형성확인,http://www.ftoday.co.kr/news/articleView.html?idxno=111175
6546,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성을확인,http://www.newswatch.kr/news/articleView.html?idxno=23170
6547,2019-09-05,대웅제약미국ITC소송시험서균주포자형성확인,http://www.seoulfn.com/news/articleView.html?idxno=355066
6548,2019-09-05,9월5일장마감주가정보대웅제약168500원,http://www.newsinside.kr/news/articleView.html?idxno=1017248
6549,2019-09-05,뉴스워커_대웅제약 미국ITC소송의감정시험에서도균주의포자형성을확인,http://www.newsworker.co.kr/news/articleView.html?idxno=40489
6550,2019-09-05,인기종목주가정보5일대웅마감증시17450원,http://nbntv.co.kr/news/view/631576
6551,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,http://www.betanews.net:8080/article/1047711.html
6552,2019-09-05,대웅제약ITC감정서도포자형성확인염기서열결과에촉각,http://sports.hankooki.com/lpage/economy/201909/sp20190905164315137020.htm
6553,2019-09-05,5일마감증시대웅주가17450원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=392066
6554,2019-09-05,5일마감주가정보대웅제약주가168500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=392299
6555,2019-09-05,대웅제약美ITC소송의감정서도나보타균주의포자형성확인돼,http://news.mk.co.kr/newsRead.php?year=2019&no=704065
6556,2019-09-05,인기주매매동향5일대웅제약마감증시168500원,http://nbntv.co.kr/news/view/632088
6557,2019-09-05,대웅제약미국ITC소송의감정시험에서도균주의포자형성확인,http://www.getnews.co.kr/view.php?ud=20190905181248941041d0c69529_16
6558,2019-09-05,대웅제약미국ITC시험서도균주포자형성확인,http://www.newscj.com/news/articleView.html?idxno=665045
6559,2019-09-06,대웅제약미국ITC소송감정시험에서균주의포자형성확인,http://www.thefirstmedia.net/news/articleView.html?idxno=48222
6560,2019-09-06,대웅나보타미국발매3개월만에점유율3위등극,http://www.dailypharm.com/Users/News/NewsView.html?ID=256449&REFERER=NP
6561,2019-09-06,대웅vs메디톡스보톡스균주싸움끝까지간다,http://www.newsway.co.kr/news/view?tp=1&ud=2019090522072104002
6562,2019-09-06,대웅ICT소송감정에서도균주포자형성확인,http://www.monews.co.kr/news/articleView.html?idxno=204798
6563,2019-09-06,★주식인사이드대웅제약주가168000원9월6일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1018285
6564,2019-09-06,대웅제약VS메디톡스균주포자생성유무가핵심쟁점,http://inthenews.co.kr/article-15232/
6565,2019-09-06,주식종목6일대웅제약현재주가168500원,http://www.anewsa.com/detail.php?number=1956857&thread=18
6566,2019-09-06,대웅실시간주식현황6일현재17250원,http://nbntv.co.kr/news/view/633701
6567,2019-09-06,대웅주가0030909월6일오늘가격17150원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=393220
6568,2019-09-06,대웅제약나보타美ITC소송감정시험통해균주포자형성확인,http://www.donga.com/news/article/all/20190906/97303347/1
6569,2019-09-06,주식실황6일대웅현재주식거래가격17250원,http://www.anewsa.com/detail.php?number=1957149&thread=18
6570,2019-09-06,대웅제약美ITC소송의감정시험에서도균주포자형성확인,http://www.wsobi.com/news/articleView.html?idxno=80813
6571,2019-09-06,대웅제약주식종목6일현재167000원,http://nbntv.co.kr/news/view/634230
6572,2019-09-06,9월6일대웅제약증권그래프000변화,http://www.gokorea.kr/news/articleView.html?idxno=393814
6573,2019-09-06,스타★주식인사이드대웅제약주가168500원9월6일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=1019034
6574,2019-09-06,함양군함양읍대웅한우촌식당나눔복지로이웃사랑실천,http://www.anewsa.com/detail.php?number=1959247&thread=09r02
6575,2019-09-06,9월6일장마감주가정보대웅제약169000원,http://www.newsinside.kr/news/articleView.html?idxno=1019504
6576,2019-09-06,함양읍대웅한우촌식당나눔복지로이웃사랑실천,http://www.knnews.co.kr/news/articleView.php?idxno=1301953
6577,2019-09-06,특징주분석종목정보9월6일대웅17250원으로장마감,http://nbntv.co.kr/news/view/635841
6578,2019-09-06,6일마감증시대웅주가17250원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=395287
6579,2019-09-06,인기종목주가정보9월6일대웅제약169000원으로장마감,http://nbntv.co.kr/news/view/636361
6580,2019-09-06,대웅제약미국ITC소송감정서도균주포자확인,https://www.kpanews.co.kr/article/show.asp?idx=206532&category=D
6581,2019-09-07,포토긱스타대웅이덕에이겼다,http://www.dailyesports.com/view.php?ud=20190907193145347190ea4f0acc_27
6582,2019-09-08,대웅제약나보타미국진출후가동률업계1위등극,http://www.ceoscoredaily.com/news/article.html?no=60195
6583,2019-09-09,대웅전문약원외처방고공행진하반기도성장세지속,http://www.dailymedi.com/detail.php?number=847197&thread=22r05
6584,2019-09-09,대웅제약vs메디톡스균주전쟁최종결론은언제쯤,http://www.dailian.co.kr/news/view/824232/?sc=naver
6585,2019-09-09,종국으로치닫는보톡스전쟁1R대웅제약이웃었다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1334430
6586,2019-09-09,★주식인사이드대웅제약주가168500원9월9일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1022381
6587,2019-09-09,증시현황9일대웅제약현재가168000원,http://www.anewsa.com/detail.php?number=1960081&thread=18
6588,2019-09-09,9월9일대웅주식그래프05817150원,http://nbntv.co.kr/news/view/638364
6589,2019-09-09,9월9일대웅003090정보000변화,http://www.gokorea.kr/news/articleView.html?idxno=396785
6590,2019-09-09,종목상세정보9일대웅현재가17150원,http://www.anewsa.com/detail.php?number=1960380&thread=18
6591,2019-09-09,9월9일대웅제약주식현재가167000원118,http://nbntv.co.kr/news/view/638889
6592,2019-09-09,데일리주식정보대웅003090오후12시08분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=68918
6593,2019-09-09,대웅제약주가069620정보및종목동정과증시정보9일오늘가격166000원,http://www.gokorea.kr/news/articleView.html?idxno=397379
6594,2019-09-09,스타★주식인사이드대웅제약주가165500원9월9일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=1022634
6595,2019-09-09,9월9일장마감주가정보대웅제약166000원,http://www.newsinside.kr/news/articleView.html?idxno=1023120
6596,2019-09-09,인기주분석주가정보9월9일대웅16600원으로장마감,http://nbntv.co.kr/news/view/640466
6597,2019-09-09,9일상장기업장마감정보대웅주가16600원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=398980
6598,2019-09-09,인기주종목정보9월9일대웅제약166000원으로장마감,http://nbntv.co.kr/news/view/641002
6599,2019-09-10,대웅제약나보타탈모치료임상승인5번째적응증기대,http://www.medisobizanews.com/news/articleView.html?idxno=62367
6600,2019-09-10,★주식인사이드대웅제약주가167000원9월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1024447
6601,2019-09-10,장중주가10일대웅제약현재주가166000원,http://www.anewsa.com/detail.php?number=1962849&thread=18
6602,2019-09-10,대웅오늘주식시장10일현재16750원,http://nbntv.co.kr/news/view/641736
6603,2019-09-10,대웅주가0030909월10일오늘거래가16750원증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=400054
6604,2019-09-10,장중주가10일대웅현재주식거래가격16650원,http://www.anewsa.com/detail.php?number=1963142&thread=18
6605,2019-09-10,증권플러스대웅제약주가10일현재165500원,http://nbntv.co.kr/news/view/642271
6606,2019-09-10,9월10일대웅제약종목그래프및증권정보와종목동정000변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=400640
6607,2019-09-10,스타★주식인사이드대웅제약주가165500원9월10일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1025237
6608,2019-09-10,단독시그널시지바이오IPO추진대웅경영승계핵심되나,https://www.sedaily.com/NewsView/1VO6WY7HLG
6609,2019-09-10,기업은지원하고직원은성장하고대웅제약의남다른기업문화,http://www.dailysmart.co.kr/news/articleView.html?idxno=15450
6610,2019-09-10,9월10일장마감주가정보대웅제약165000원,http://www.newsinside.kr/news/articleView.html?idxno=1025683
6611,2019-09-10,특징주분석종목정보10일대웅마감증시16750원,http://nbntv.co.kr/news/view/643763
6612,2019-09-10,10일오늘의증시마감대웅16750원마감,http://www.gokorea.kr/news/articleView.html?idxno=402238
6613,2019-09-10,10일장마감매매동향대웅제약165000원마감,http://www.gokorea.kr/news/articleView.html?idxno=402501
6614,2019-09-11,대웅제약나보타탈모치료도국내2b상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072153
6615,2019-09-11,★주식인사이드대웅제약주가166500원9월11일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1026986
6616,2019-09-11,주식종목11일대웅제약현재가166500원,http://www.anewsa.com/detail.php?number=1965621&thread=18
6617,2019-09-11,9월11일대웅정보및매매동향030변동해,http://www.gokorea.kr/news/articleView.html?idxno=403382
6618,2019-09-11,종목추적11일대웅현재가격16850원,http://www.anewsa.com/detail.php?number=1965934&thread=18
6619,2019-09-11,9월11일대웅제약오늘주식시세165500원030,http://nbntv.co.kr/news/view/645524
6620,2019-09-11,대웅제약주가오늘시세외매매동향11일오늘가격166000원거래,http://www.gokorea.kr/news/articleView.html?idxno=403992
6621,2019-09-11,스타★주식인사이드대웅제약주가166000원9월11일13시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1027708
6622,2019-09-11,대웅제약상시공개채용실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=364687
6623,2019-09-11,글로벌헬스케어산업이끌맞춤형인재찾는다대웅제약 상시채용실시,http://www.businesskorea.co.kr/news/articleView.html?idxno=35944
6624,2019-09-11,GET투자리포트대웅투자의견매수유지상상인증권,http://www.getnews.co.kr/view.php?ud=2019091110303011051tpgetnews_16
6625,2019-09-11,대웅제약상시채용실시글로벌헬스케어산업이끌맞춤형인재찾는다,http://www.thefirstmedia.net/news/articleView.html?idxno=48455
6626,2019-09-11,대웅제약상시공개채용전환인재채용시작,http://www.sisafocus.co.kr/news/articleView.html?idxno=220792
6627,2019-09-11,리포트브리핑대웅자회사영업이익증가로기업가치상승이지속중이다목표가27000원상상인증권,http://www.newspim.com/news/view/20190911001019
6628,2019-09-11,대웅제약정기공채에서상시공개채용으로전환,http://www.sportsseoul.com/news/read/817696
6629,2019-09-11,대웅제약글로벌헬스케어산업이끌맞춤형인재찾는다,http://medipana.com/news/news_viewer.asp?NewsNum=245343&MainKind=A&NewsKind=5&vCount=12&vKind=1
6630,2019-09-11,글로벌인재찾는대웅제약연구개발직등상시공개채용,http://www.medisobizanews.com/news/articleView.html?idxno=62419
6631,2019-09-11,대웅제약맞춤형인재찾는다상시채용시작,http://www.ajunews.com/view/20190911155422755
6632,2019-09-11,글로벌헬스케어인재찾는다대웅제약상시채용시작,http://www.newsis.com/view/?id=NISX20190911_0000768257&cID=13001&pID=13000
6633,2019-09-11,9월11일장마감주가정보대웅제약165500원,http://www.newsinside.kr/news/articleView.html?idxno=1028168
6634,2019-09-11,대웅제약글로벌맞춤인재채용상시채용실시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234847
6635,2019-09-11,대웅제약글로벌헬스케어산업이끌맞춤형인재찾는다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57177
6636,2019-09-11,대웅제약현업부서가직접인재선발하는상시공개채용도입,http://news.mk.co.kr/newsRead.php?year=2019&no=724838
6637,2019-09-11,대웅제약글로벌맞춤형인재상시채용실시,http://www.joseilbo.com/news/news_read.php?uid=383928&class=17&grp=
6638,2019-09-11,대웅제약상시채용으로맞춤형인재찾는다,http://www.newspim.com/news/view/20190911001113
6639,2019-09-11,대웅제약글로벌헬스케어산업이끌맞춤형인재찾는다,http://www.medigatenews.com/news/2674944073
6640,2019-09-11,11일상장기업장마감정보대웅16600원마감,http://www.gokorea.kr/news/articleView.html?idxno=405713
6641,2019-09-11,대웅제약경력직상시공개채용진행서류접수24일까지,http://www.donga.com/news/article/all/20190911/97386641/1
6642,2019-09-11,인기주종목정보9월11일대웅제약165500원으로장마감,http://nbntv.co.kr/news/view/647333
6643,2019-09-11,대웅제약상시채용으로대웅인뽑아요,http://moneys.mt.co.kr/news/mwView.php?no=2019091117028048015
6644,2019-09-11,11일주식장마감동향대웅제약주가165500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=405941
6645,2019-09-11,대웅제약상시공개채용진행24일까지서류접수,http://weekly.cnbnews.com/news/article.html?no=130152
6646,2019-09-11,대웅제약상시채용실시글로벌헬스케어산업이끌맞춤형인재찾는다,http://www.wikileaks-kr.org/news/articleView.html?idxno=65301
6647,2019-09-11,대웅제약상시채용진행우수인재확보총력,https://www.kpanews.co.kr/article/show.asp?idx=206651&category=D
6648,2019-09-11,대웅제약상시공개채용전환연구개발등모집,http://www.biospectator.com/view/news_view.php?varAtcId=8467
6649,2019-09-12,대웅제약공기채용에서상시채용으로인재채용방식전환,http://www.ftoday.co.kr/news/articleView.html?idxno=111313
6650,2019-09-12,대웅제약상시채용으로전환맞춤형인재찾아요,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072189
6651,2019-09-12,대웅제약글로벌헬스케어산업이끌맞춤형인재상시채용,http://www.koreaittimes.com/news/articleView.html?idxno=92926
6652,2019-09-12,대웅제약현업서인재직접선발상시채용실시,http://www.ebn.co.kr/news/view/1001016
6653,2019-09-12,종목시세두산인프라코어주가6340원032샘표식품31450원032코오롱글로벌우16500원03대웅제약165500원03삼양패키징16700원03↑주가주식가격올,http://www.fintechpost.co.kr/news/articleView.html?idxno=70047
6654,2019-09-14,대웅제약영업연구생산부문등상시채용실시,http://www.finomy.com/news/articleView.html?idxno=69347
6655,2019-09-15,대웅제약상시공개채용방식전환글로벌인재찾는다”,http://www.viva100.com/main/view.php?key=20190915010004443
6656,2019-09-15,대웅제약맞춤형인재채용위한상시채용실시,http://www.g-enews.com/ko-kr/news/article/news_all/20190915142709435669d76442fa_1/article.html
6657,2019-09-16,대웅7월원외처방678억원하반기실적기대상승,http://www.dailypharm.com/Users/News/NewsView.html?ID=256627&REFERER=NP
6658,2019-09-16,대웅제약채용현업부서선배가주체정기→상시공채로,http://news.heraldcorp.com/view.php?ud=20190916000020
6659,2019-09-16,주식실황16일대웅제약현재가167000원,http://www.anewsa.com/detail.php?number=1968851&thread=18
6660,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO1400145001동시획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019091600021
6661,2019-09-16,대웅제약오송공장ISO14001ISO45001동시획득,http://medipana.com/news/news_viewer.asp?NewsNum=245388&MainKind=A&NewsKind=5&vCount=12&vKind=1
6662,2019-09-16,대웅오늘증권시세16일현재16800원,http://nbntv.co.kr/news/view/648679
6663,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.wsobi.com/news/articleView.html?idxno=81170
6664,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=15565
6665,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001동시획득,https://www.sedaily.com/NewsView/1VO9OOI1WY
6666,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO14001ISO45001획득,http://daily.hankooki.com/lpage/ittech/201909/dh20190916094411145630.htm
6667,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.fnnews.com/news/201909160948275195
6668,2019-09-16,대웅제약 전생산시설환경안전보건국제표준인증,http://www.medisobizanews.com/news/articleView.html?idxno=62437
6669,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001동시획득,http://www.asiatime.co.kr/news/articleView.html?idxno=270267
6670,2019-09-16,대웅제약생산시설국제표준인증획득환경안전우수성입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1335625
6671,2019-09-16,취업대웅제약하반기현업부문인재상시채용직무중심선발,http://www.ezyeconomy.com/news/articleView.html?idxno=93745
6672,2019-09-16,대웅제약오송공장환경안전보건국제표준ISO1400145001인증받아,http://news.mk.co.kr/newsRead.php?year=2019&no=730753
6673,2019-09-16,대웅제약오송공장환경안전보건국제인증획득,http://www.newspim.com/news/view/20190916000232
6674,2019-09-16,대웅제약환경안전보건인증ISO14001ISO45001동시획득,http://www.ebn.co.kr/news/view/1001164
6675,2019-09-16,대웅주가003090증권그래프16일오늘거래가16950원거래,http://www.gokorea.kr/news/articleView.html?idxno=407235
6676,2019-09-16,대웅제약오송공장환경안전보건국제표준인증획득,http://news.mt.co.kr/mtview.php?no=2019091609312661413
6677,2019-09-16,대웅제약오송공장환경안전보건국제인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2019091609538037112
6678,2019-09-16,대웅제약환경안전보건국제인증동시획득글로벌수준생산시설기반으로대내외고객신뢰도제고기대,http://www.segye.com/content/html/2019/09/16/20190916503717.html?OutUrl=naver
6679,2019-09-16,대웅제약환경안전보건국제인증동시획득,http://www.dailian.co.kr/news/view/826037/?sc=naver
6680,2019-09-16,대웅제약오송공장환경안전보건국제표준ISO1400145001인증받아,http://www.nbnnews.co.kr/news/articleView.html?idxno=317206
6681,2019-09-16,현업적합한인재찾는다대웅제약상시채용실시 ,http://www.monews.co.kr/news/articleView.html?idxno=204947
6682,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO14001ISO45001획득,http://www.sportsseoul.com/news/read/818774
6683,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019091609573677547
6684,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234875
6685,2019-09-16,장중주가16일대웅거래가격16750원,http://www.anewsa.com/detail.php?number=1969146&thread=18
6686,2019-09-16,대웅제약환경안전보건국제이증ISO1400145001동시획득,http://www.econovill.com/news/articleView.html?idxno=372157
6687,2019-09-16,제약오늘대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.sisaon.co.kr/news/articleView.html?idxno=101003
6688,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://fn.segye.com/content/html/2019/09/16/20190916504018.html?OutUrl=naver
6689,2019-09-16,대웅14001∙45001획득환경안전보건리딩,http://www.dailypharm.com/Users/News/NewsView.html?ID=256652&REFERER=NP
6690,2019-09-16,대웅제약오송공장ISO14001ISO45001동시획득,http://www.newsprime.co.kr/news/article.html?no=475043
6691,2019-09-16,대웅제약오송공장환경․안전우수입증,http://www.whosaeng.com/112558
6692,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newsfc.co.kr/news/articleView.html?idxno=37896
6693,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=364788
6694,2019-09-16,대웅제약오송공장환경경영안전경영시스템국제표준인증,http://www.rapportian.com/news/articleView.html?idxno=119974
6695,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001동시획득,http://www.seoulwire.com/news/articleView.html?idxno=217842
6696,2019-09-16,대웅제약환경안전보건경영시스템국제표준획득전생산시설국제인증확보,http://www.donga.com/news/article/all/20190916/97420292/1
6697,2019-09-16,대웅제약전생산시설환경안전보건국제인증획득,http://www.ftoday.co.kr/news/articleView.html?idxno=111355
6698,2019-09-16,9월16일대웅제약시세보기091167000원,http://nbntv.co.kr/news/view/649193
6699,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO400145001동시획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1798823
6700,2019-09-16,대웅제약ISO14001ISO45001동시획득,http://www.bokuennews.com/news/article.html?no=180722
6701,2019-09-16,대웅제약환경안전보건국제인증ISO1400145001획득,http://www.ajunews.com/view/20190916111658193
6702,2019-09-16,대웅제약오송공장ISO1400145001동시획득,http://www.mhj21.com/124272
6703,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.lawissue.co.kr/view.php?ud=201909161133379905204ead0791_12
6704,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newswatch.kr/news/articleView.html?idxno=23397
6705,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001획득,http://www.koreaittimes.com/news/articleView.html?idxno=92946
6706,2019-09-16,대웅제약환경안전보건국제인증2개동시획득,http://www.economytalk.kr/news/articleView.html?idxno=197924
6707,2019-09-16,9월16일대웅제약069620오늘시세및증권정보와종목동정181변동해,http://www.gokorea.kr/news/articleView.html?idxno=407823
6708,2019-09-16,대웅제약오송공장안전하고친환경적국제공인,http://www.bosa.co.kr/news/articleView.html?idxno=2112360
6709,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.updownnews.co.kr/news/articleView.html?idxno=208449
6710,2019-09-16,대웅제약오송공장환경안전보건국제인증동시획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072211
6711,2019-09-16,스타★주식인사이드대웅제약주가169000원9월16일13시1분기준,http://www.newsinside.kr/news/articleView.html?idxno=1034892
6712,2019-09-16,대웅제약오송공장국제표준인증ISO14001ISO45001동시획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=65428
6713,2019-09-16,대웅제약오송공장환경안전보건국제인증ISO14001ISO45001동시획득,http://www.viva100.com/main/view.php?key=20190916010004808
6714,2019-09-16,대웅제약오송공장환경안전보건ISO인증획득,http://www.dt.co.kr/contents.html?article_no=2019091602109931102003&ref=naver
6715,2019-09-16,대웅제약오송공장환경안전보건국제인증동시획득,http://www.etnews.com/20190916000187
6716,2019-09-16,대웅제약환경안전보건ISO인증2건동시획득,http://news.heraldcorp.com/view.php?ud=20190916000647
6717,2019-09-16,대웅제약환경안전보건국제인증 ISO14001ISO 45001 동시 획득 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=35986
6718,2019-09-16,뉴스워커_대웅제약환경안전보건국제인증ISO14001ISO45001동시획득 ,http://www.newsworker.co.kr/news/articleView.html?idxno=41655
6719,2019-09-16,대웅제약오송공장환경안전보건경영시스템국제인증획득,http://www.businesspost.co.kr/BP?command=article_view&num=143324
6720,2019-09-16,대웅제약오송공장환경안전보건국제인증동시획득,http://www.wolyo.co.kr/news/articleView.html?idxno=93503
6721,2019-09-16,대웅제약오송공장환경안전보건국제인증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909160358&t=NN
6722,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57194
6723,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=220992
6724,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.thefirstmedia.net/news/articleView.html?idxno=48492
6725,2019-09-16,9월16일장마감주가정보대웅제약168500원,http://www.newsinside.kr/news/articleView.html?idxno=1035316
6726,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.getnews.co.kr/view.php?ud=20190916161905952241d0c69529_16
6727,2019-09-16,16일주식장마감동향대웅주가16950원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=409240
6728,2019-09-16,16일주식장마감동향대웅제약168500원마감,http://www.gokorea.kr/news/articleView.html?idxno=409411
6729,2019-09-16,특징주주가정보16일대웅제약마감증시168500원,http://nbntv.co.kr/news/view/650990
6730,2019-09-16,대웅제약오송공장ISO1400145001동시획득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1204374
6731,2019-09-16,대웅제약오송공장환경안전국제인증2종획득,http://www.finomy.com/news/articleView.html?idxno=69423
6732,2019-09-16,제약산업대웅제약24일까지연구생산영업경영관리등채용外,http://www.kukinews.com/news/article.html?no=700721
6733,2019-09-16,대웅제약메디톡스보톡스전쟁20일분수령에촉각,http://www.newspim.com/news/view/20190916001165
6734,2019-09-16,대웅제약오송공장글로벌수준친환경생산시설공인,http://www.kpinews.co.kr/news/articleView.html?idxno=103387
6735,2019-09-16,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.newscj.com/news/articleView.html?idxno=667278
6736,2019-09-16,대웅제약오송공장ISO1400145001획득,http://www.seoulfn.com/news/articleView.html?idxno=355964
6737,2019-09-17,국내주가정보17일대웅제약현재주가167500원,http://www.anewsa.com/detail.php?number=1971593&thread=18
6738,2019-09-17,대웅주가003090종목그래프및주체별매매동향17일오늘거래가16900원형성,http://www.gokorea.kr/news/articleView.html?idxno=410117
6739,2019-09-17,종목추적17일대웅현재가16900원,http://www.anewsa.com/detail.php?number=1971906&thread=18
6740,2019-09-17,대웅제약환경안전보건국제인증ISO1400145001동시획득,http://www.straightnews.co.kr/news/articleView.html?idxno=55639
6741,2019-09-17,대웅제약주가정보17일오늘거래가169000원거래,http://www.gokorea.kr/news/articleView.html?idxno=410719
6742,2019-09-17,대웅제약환경안전보건국제인증ISO14001ISO45001동시획득,http://www.munhwa.com/news/view.html?no=20190917MW141900113614
6743,2019-09-18,대웅제약보톡스수출중장기성장세견인SK증권,http://www.dailian.co.kr/news/view/826686/?sc=naver
6744,2019-09-18,대웅제약보톡스균주논란점진적해소중,https://www.hankyung.com/it/article/2019091860776
6745,2019-09-18,대웅제약보톡스수출로체질개선균주논란점진적해소SK,http://www.edaily.co.kr/news/newspath.asp?newsid=01449766622621432
6746,2019-09-18,대웅제약보톡스수출로전통제약사체질개선SK증권,http://www.fnnews.com/news/201909180806132394
6747,2019-09-18,대웅제약보톡스수출로중장기성장견인,http://www.asiatoday.co.kr/view.php?key=20190918010009418
6748,2019-09-18,I리포트대웅제약보톡스수출로체질개선–SK證,http://www.inews24.com/view/1208961
6749,2019-09-18,대웅제약보톡스수출로체질개선시작매수SK증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1799720
6750,2019-09-18,SK證대웅제약美보톡스MS3위균주논란도점진적해소”,http://www.sentv.co.kr/news/view/560732
6751,2019-09-18,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2019091807404718294
6752,2019-09-18,대웅제약보톡스글로벌수출로체질개선,http://www.newsprime.co.kr/news/article.html?no=475408
6753,2019-09-18,대웅제약보톡스수출로중장기성장세견인SK證,http://www.seoulfn.com/news/articleView.html?idxno=356133
6754,2019-09-18,SK증권보톡스글로벌수출성장견인전망대웅제약매수,http://www.whitepaper.co.kr/news/articleView.html?idxno=173302
6755,2019-09-18,SK증권대웅제약나보타의미국보톡스시장내성장으로체질개선중”,http://www.lawissue.co.kr/view.php?ud=2019091809264971399817d053b9_12
6756,2019-09-18,아통경제18일대웅제약거래가격170500원,http://www.anewsa.com/detail.php?number=1974390&thread=18
6757,2019-09-18,대웅제약주가오를힘갖춰마국에서보톡스나보타판매호조,http://www.businesspost.co.kr/BP?command=article_view&num=143605
6758,2019-09-18,9월18일대웅003090증권투자정보060변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=412592
6759,2019-09-18,증시실황18일대웅주가16750원,http://www.anewsa.com/detail.php?number=1974656&thread=18
6760,2019-09-18,리포트브리핑대웅제약보톡스수출로체질개선시작목표가260000원SK증권,http://www.newspim.com/news/view/20190918000464
6761,2019-09-18,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019091810303011170tpgetnews_16
6762,2019-09-18,9월18일대웅제약069620종목그래프059변화해,http://www.gokorea.kr/news/articleView.html?idxno=412937
6763,2019-09-18,대웅제약보톡스수출로체질개선전망,http://www.skyedaily.com/news/news_view.html?ID=90498
6764,2019-09-18,대웅제약보톡스수출규모가3년안에1000억원을넘어설가능성높다”,http://www.wikitree.co.kr/main/news_view.php?id=464408
6765,2019-09-19,대웅제약나보타치료적응증다각적확대박차글로벌치료시장진출로미래큰성장동력기대,http://www.segye.com/content/html/2019/09/19/20190919503309.html?OutUrl=naver
6766,2019-09-19,주식실황19일대웅제약현재가격170000원,http://www.anewsa.com/detail.php?number=1976722&thread=18
6767,2019-09-19,9월19일대웅종목그래프외주식시황030변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=414153
6768,2019-09-19,9월19일대웅제약금일증시170000원059,http://nbntv.co.kr/news/view/652950
6769,2019-09-19,8월원외처방한미종근당대웅유한양행順,http://www.dailymedi.com/detail.php?number=847498&thread=22r05
6770,2019-09-19,대웅제약vs메디톡스균주전쟁끝날까20일ITC에보고서제출,http://www.metroseoul.co.kr/news/newsview?newscd=2019091900170
6771,2019-09-19,대웅제약나보타미용보다큰치료목적보톡스시장공략박차,http://news.mk.co.kr/newsRead.php?year=2019&no=746517
6772,2019-09-19,환절기건강관리대웅제약임팩타민프리미엄,https://www.sedaily.com/NewsView/1VOB2OUX05
6773,2019-09-20,직원성장기업성장밀레니얼세대품는대웅제약,http://www.sportsseoul.com/news/read/821413
6774,2019-09-20,대웅제약심각한적자난속고배당속내는,http://www.startuptoday.co.kr/news/articleView.html?idxno=31020
6775,2019-09-20,생생한취업정보전달대웅제약채용설명회성황,http://medipana.com/news/news_viewer.asp?NewsNum=245634&MainKind=A&NewsKind=5&vCount=12&vKind=1
6776,2019-09-20,아통증시20일대웅제약현재가168500원,http://www.anewsa.com/detail.php?number=1979177&thread=18
6777,2019-09-20,대웅제약채용설명회진행오는24일까지공채,http://www.wsobi.com/news/articleView.html?idxno=81494
6778,2019-09-20,대웅제약24일까지RD생산영업마케팅관리등부문별채용,http://daily.hankooki.com/lpage/ittech/201909/dh20190920093811145630.htm
6779,2019-09-20,예비대웅인모여라”대웅제약채용설명회성황,http://www.dailian.co.kr/news/view/827460/?sc=naver
6780,2019-09-20,대웅주가0030909월20일오늘거래가16700원정보및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=415790
6781,2019-09-20,대웅제약채용설명회개최,http://www.ceoscoredaily.com/news/article.html?no=60597
6782,2019-09-20,대웅제약직무별멘토단이정보공유해주는채용설명회개최,http://news.mk.co.kr/newsRead.php?year=2019&no=748233
6783,2019-09-20,예비대웅인모여라채용설명회열기후끈,http://moneys.mt.co.kr/news/mwView.php?no=2019092009418067867
6784,2019-09-20,예비대웅인모여라대웅제약채용설명회,http://www.newsis.com/view/?id=NISX20190920_0000775039&cID=13001&pID=13000
6785,2019-09-20,대웅제약채용설명회성황24일까지공채진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019092009462851603
6786,2019-09-20,대웅오늘주식20일현재16650원,http://nbntv.co.kr/news/view/654049
6787,2019-09-20,대웅제약취업준비생위해직무멘토링제공,http://www.econovill.com/news/articleView.html?idxno=372581
6788,2019-09-20,대웅제약채용길잡이직무멘토단이떴다,http://www.medisobizanews.com/news/articleView.html?idxno=62565
6789,2019-09-20,올해부터직무중심채용전환대웅제약채용설명회열어,http://www.jobnjoy.com/portal/job/hotnews_view.jsp?nidx=363059&depth1=1&depth2=1&depth3=2
6790,2019-09-20,예비대웅인모여라대웅제약채용설명회개최,http://www.newspim.com/news/view/20190920000162
6791,2019-09-20,대웅제약채용설명회개최예비대웅인모여라,http://www.viva100.com/main/view.php?key=20190920010006572
6792,2019-09-20,주식실황20일대웅현재가격16700원,http://www.anewsa.com/detail.php?number=1979426&thread=18
6793,2019-09-20,대웅제약채용설명회진행직무별취업정보제공,http://www.newsprime.co.kr/news/article.html?no=475845
6794,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.bosa.co.kr/news/articleView.html?idxno=2112652
6795,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://newsbrite.net/126768
6796,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.mdtoday.co.kr/mdtoday/index.html?no=365224
6797,2019-09-20,9월20일대웅제약종목검색168000원059,http://nbntv.co.kr/news/view/654374
6798,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.dailysmart.co.kr/news/articleView.html?idxno=15745
6799,2019-09-20,예비대웅인모여라대웅제약채용설명회성료,http://www.ekn.kr/news/article.html?no=454025
6800,2019-09-20,대웅제약채용설명회성황,http://www.lawissue.co.kr/view.php?ud=201909201107526982204ead0791_12
6801,2019-09-20,대웅제약취업준비생대상2019하반기신입사원채용설명회개최,http://www.ezyeconomy.com/news/articleView.html?idxno=93910
6802,2019-09-20,대웅제약채용설명회개최예비대웅인모여라,http://fn.segye.com/content/html/2019/09/20/20190920503766.html?OutUrl=naver
6803,2019-09-20,대웅제약유럽서​SGLT2당뇨병치료신약DWP16001임상결과발표 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=36188
6804,2019-09-20,9월20일대웅제약069620증권그래프및매매동향059변화,http://www.gokorea.kr/news/articleView.html?idxno=416260
6805,2019-09-20,대웅제약취준생대상채용설명회성황,http://www.dailymedi.com/detail.php?number=847544&thread=22r05
6806,2019-09-20,대웅제약SGLT2당뇨병치료신약DWP16001에대한임상1상결과포스터로발표,http://www.updownnews.co.kr/news/articleView.html?idxno=208722
6807,2019-09-20,대웅제약당뇨병치료제뛰어난혈당강하로최고신약도전,http://www.medisobizanews.com/news/articleView.html?idxno=62576
6808,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.joseilbo.com/news/news_read.php?uid=384316&class=27&grp=
6809,2019-09-20,대웅제약SGLT2i신약EASD서임상결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=245657&MainKind=A&NewsKind=5&vCount=12&vKind=1
6810,2019-09-20,대웅제약유럽당뇨병학회서신약DWP16001임상발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235095
6811,2019-09-20,대웅제약유럽당뇨병학회서​당뇨신약DWP16001임상결과발표,http://biz.chosun.com/site/data/html_dir/2019/09/20/2019092001017.html
6812,2019-09-20,대웅제약유럽당뇨병학회서신약DWP16001임상결과발표,http://www.newspim.com/news/view/20190920000476
6813,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상결과발표,http://www.mhj21.com/124391
6814,2019-09-20,EASD2019대웅제약당뇨병신약DWP16001임상결과발표,http://www.econovill.com/news/articleView.html?idxno=372598
6815,2019-09-20,대웅제약EASD서당뇨병신약DWP16001임상결과발표,http://inthenews.co.kr/article-16837/
6816,2019-09-20,대웅제약유럽서당뇨병치료신약임상결과발표,http://www.economytalk.kr/news/articleView.html?idxno=198487
6817,2019-09-20,대웅제약분비효능뛰어난당뇨신약유럽학회서임상결과발표,http://www.newsfc.co.kr/news/articleView.html?idxno=37986
6818,2019-09-20,예비대웅人모여라대웅제약채용설명회개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072383
6819,2019-09-20,대웅제약적자를기록해도고배당,http://www.upkorea.net/news/articleView.html?idxno=635020
6820,2019-09-20,대웅제약유럽당뇨병학회EASD서SGLT2당뇨병치료신약DWP16001임상결과발표,http://newsbrite.net/126787
6821,2019-09-20,대웅제약유럽당뇨병학회서당뇨신약DWP16001임상결과발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019092012400367850
6822,2019-09-20,대웅제약유럽당뇨병학회서SGLT2당뇨병치료신약임상결과발표,http://www.koreaittimes.com/news/articleView.html?idxno=93061
6823,2019-09-20,대웅제약유럽당뇨병학회서​SGLT2당뇨병치료신약임상결과발표,http://www.updownnews.co.kr/news/articleView.html?idxno=208730
6824,2019-09-20,대웅제약당뇨병치료신약DWP16001임상결과발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1336947
6825,2019-09-20,대웅제약당뇨병신약혈당강하효과입증,http://news.mt.co.kr/mtview.php?no=2019092013160065597
6826,2019-09-20,대웅제약취업준비생대상채용설명회개최 ,http://www.monews.co.kr/news/articleView.html?idxno=205100
6827,2019-09-20,대웅제약​유럽서당뇨병신약DWP16001임상결과발표,http://health.chosun.com/site/data/html_dir/2019/09/20/2019092001238.html
6828,2019-09-20,대웅제약유럽당뇨병학회서SGLT2억제제후보물질임상1상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=749380
6829,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약DWP16001임상결과발표,http://www.ceoscoredaily.com/news/article.html?no=60620
6830,2019-09-20,대웅제약당뇨병신약임상1상서혈당강화효과우수,https://view.asiae.co.kr/article/2019092013481464558
6831,2019-09-20,대웅제약채용설명회성황임직원직접생생한취업정보직무에대한멘토링제공,http://www.newswatch.kr/news/articleView.html?idxno=23592
6832,2019-09-20,대웅제약유럽당뇨병학회서SGLT2당뇨병신약DWP16001임상결과발표,http://www.newswatch.kr/news/articleView.html?idxno=23598
6833,2019-09-20,대웅제약유럽당뇨병학회서신약임상결과발표,https://www.sedaily.com/NewsView/1VOBJQHIOX
6834,2019-09-20,보톡스전쟁승패가를美ITC메디톡스대웅균주검사결과내일제출,http://biz.newdaily.co.kr/site/data/html/2019/09/20/2019092000097.html
6835,2019-09-20,대웅제약SGLT2당뇨병치료신약DWP16001임상결과발표,http://fn.segye.com/content/html/2019/09/20/20190920506832.html?OutUrl=naver
6836,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상결과발표,http://www.ebn.co.kr/news/view/1001894
6837,2019-09-20,대웅제약유럽당뇨병학회서SGLT2억제신약임상발표,http://www.newsis.com/view/?id=NISX20190920_0000775406&cID=13001&pID=13000
6838,2019-09-20,대웅제약EASD서SGLT2신약DWP16001임상결과발표,http://daily.hankooki.com/lpage/ittech/201909/dh20190920143718145630.htm
6839,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상결과발표,http://www.medigatenews.com/news/1459407111
6840,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.fnnews.com/news/201909201439528996
6841,2019-09-20,대웅제약당뇨병치료신약임상1상결과발표,http://www.newsprime.co.kr/news/article.html?no=475891
6842,2019-09-20,예비대웅인모여라대웅제약채용설명회성황,http://www.segye.com/content/html/2019/09/20/20190920507360.html?OutUrl=naver
6843,2019-09-20,대웅제약SGLT2억제제임상1상결과발표,http://www.biospectator.com/view/news_view.php?varAtcId=8513
6844,2019-09-20,대웅제약유럽당뇨병학회신약DWP16001임상결과발표,http://www.ezyeconomy.com/news/articleView.html?idxno=93924
6845,2019-09-20,대웅제약유럽당뇨병학회서DWP16001임상1상발표,http://www.rapportian.com/news/articleView.html?idxno=120108
6846,2019-09-20,대웅제약PPI넥시어드식약처허가AZ와동행은지속,http://daily.hankooki.com/lpage/ittech/201909/dh20190920151539145630.htm
6847,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.wolyo.co.kr/news/articleView.html?idxno=93923
6848,2019-09-20,대웅제약나보타적응증확보박차글로벌시장공략,http://www.wolyo.co.kr/news/articleView.html?idxno=93935
6849,2019-09-20,한미약품종근당대웅제약등유럽당뇨학회서임상결과발표눈길,http://www.asiatime.co.kr/news/articleView.html?idxno=271516
6850,2019-09-20,대웅제약유럽당뇨병학회EASD서​SGLT2당뇨병치료신약DWP16001임상결과발표,http://www.lawissue.co.kr/view.php?ud=201909201616564824204ead0791_12
6851,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약DWP16001임상결과발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57285
6852,2019-09-20,대웅제약채용설명회성황,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57283
6853,2019-09-20,대웅제약유럽당뇨병학회서신약후보물질1상결과발표,http://www.sportsseoul.com/news/read/821684
6854,2019-09-20,대웅제약유럽당뇨병학회서당뇨병신약임상결과발표,http://www.newstomato.com/ReadNews.aspx?no=921266
6855,2019-09-20,대웅제약유럽당뇨병학회당뇨병치료신약DWP16001임상결과발표,http://www.getnews.co.kr/view.php?ud=20190920164810150841d0c69529_16
6856,2019-09-20,대웅제약유럽당뇨병학회서당뇨병치료신약임상결과발표,http://www.dailian.co.kr/news/view/827685/?sc=naver
6857,2019-09-20,대웅제약유럽당뇨병학회서SGLT2당뇨병치료신약DWP16001임상결과발표,http://www.dailysmart.co.kr/news/articleView.html?idxno=15774
6858,2019-09-20,대웅제약취업준비생대상멘토링채용설명회성황,http://www.100ssd.co.kr/news/articleView.html?idxno=64207
6859,2019-09-20,대웅제약유럽당뇨병학회에신약의혈당강하효과발표,http://www.businesspost.co.kr/BP?command=article_view&num=144060
6860,2019-09-20,대웅제약아태지역혁신제약사12위비결은끊임없는연구개발,http://www.news2day.co.kr/137214
6861,2019-09-20,대웅제약유럽당뇨병학회서당뇨병신약임상1상결과발표,http://www.donga.com/news/article/all/20190920/97502251/1
6862,2019-09-20,단독대웅제약메디톡스미국균주소송내년6월결론,http://news1.kr/articles/?3724826
6863,2019-09-20,대웅DWP16001SGLT2중최고,http://www.whosaeng.com/112700
6864,2019-09-20,대웅제약예비대웅인모여라채용설명회성황,http://www.newscj.com/news/articleView.html?idxno=668533
6865,2019-09-20,대웅제약오송공장환경안전보건국제인증획득,http://www.womennews.co.kr/news/articleView.html?idxno=193056
6866,2019-09-20,대웅제약예비대웅인위한채용설명회개최,http://www.polinews.co.kr/news/article.html?no=419523
6867,2019-09-21,대웅제약오송공장환경안전보건국제인증획득,http://www.betanews.net:8080/article/1052203.html
6868,2019-09-21,대웅넥시움후발약허가코프로모션종료대비용,http://www.dailypharm.com/Users/News/NewsView.html?ID=256824&REFERER=NP
6869,2019-09-21,인재채용방식전환한대웅제약채용설명회성황,http://www.thefirstmedia.net/news/articleView.html?idxno=48738
6870,2019-09-21,대웅제약유럽당뇨병학회EASD서SGLT2당뇨병치료신약DWP16001임상결과발표,http://www.thefirstmedia.net/news/articleView.html?idxno=48733
6871,2019-09-22,대웅제약EASD서SGLT2당뇨병신약임상결과발표,http://www.bosa.co.kr/news/articleView.html?idxno=2112693
6872,2019-09-22,대웅제약당뇨신약DWP16001뛰어난혈당강하효과”,http://www.viva100.com/main/view.php?key=20190922010006932
6873,2019-09-22,대웅제약유럽당뇨병학회EASD서당뇨병신약임상결과발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019092200046
6874,2019-09-22,대웅제약유럽학회서당뇨치료신약효능공유,http://news.heraldcorp.com/view.php?ud=20190922000179
6875,2019-09-22,대웅제약SGLT2당뇨신약기존약물대비효과,http://www.dailymedi.com/detail.php?number=847588&thread=22r05
6876,2019-09-23,美ITC대웅제약보톡스균주유전자분석결과보게됐다,http://www.edaily.co.kr/news/newspath.asp?newsid=01426806622623072
6877,2019-09-23,대웅제약당뇨신약우수한혈당강하효과입증,http://www.monews.co.kr/news/articleView.html?idxno=205130
6878,2019-09-23,증시실황23일대웅제약주가169500원,http://www.anewsa.com/detail.php?number=1981928&thread=18
6879,2019-09-23,대웅주식실시간23일현재16900원,http://nbntv.co.kr/news/view/655558
6880,2019-09-23,대웅관계사시지바이오15년간6천억원대일수출계약,http://news.heraldcorp.com/view.php?ud=20190923000164
6881,2019-09-23,대웅제약실시간주식현황23일현재168000원,http://nbntv.co.kr/news/view/656083
6882,2019-09-23,대웅제약아태지역혁신제약사12위에선정돼,http://www.betanews.net:8080/article/1052517.html
6883,2019-09-23,경기침체우려속셀트리온유한양행동아에스티대웅제약일동제약GC녹십자이연제약한미약품광동제약등주목,http://www.econonews.co.kr/news/articleView.html?idxno=87589
6884,2019-09-24,대웅제약당뇨병신약DWP16001혈당강하효과우수”,http://www.polinews.co.kr/news/article.html?no=420315
6885,2019-09-24,주식종목24일대웅제약증시현황167000원,http://www.anewsa.com/detail.php?number=1984316&thread=18
6886,2019-09-24,9월24일대웅주식주가03016400원,http://nbntv.co.kr/news/view/657634
6887,2019-09-24,증시현황24일대웅현재주가16350원,http://www.anewsa.com/detail.php?number=1984614&thread=18
6888,2019-09-24,WhoIs윤재춘대웅제약대표이사사장,http://www.businesspost.co.kr/BP?command=article_view&num=144355
6889,2019-09-24,대웅제약주가9월24일오늘거래가167500원정보및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=501165
6890,2019-09-24,대웅제약주가그래프24일현재167500원,http://nbntv.co.kr/news/view/658165
6891,2019-09-24,대웅제약나보타치료적응증시장확대박차,http://www.seoulwire.com/news/articleView.html?idxno=224249
6892,2019-09-25,종목추적25일대웅제약거래가격161000원,http://www.anewsa.com/detail.php?number=1986694&thread=18
6893,2019-09-25,대웅주가및증권시세외주식시황25일오늘가격15700원형성,http://www.gokorea.kr/news/articleView.html?idxno=502578
6894,2019-09-25,9월25일대웅오늘증권시세15650원369,http://nbntv.co.kr/news/view/659400
6895,2019-09-25,fnRASSI대웅제약거래량확대되며3거래일연속하락,http://www.fnnews.com/news/201909251030588220
6896,2019-09-25,fnRASSI대웅거래량확대되며3거래일연속하락,http://www.fnnews.com/news/201909251031303886
6897,2019-09-25,종목추적25일대웅현재주식거래가격15750원,http://www.anewsa.com/detail.php?number=1987012&thread=18
6898,2019-09-25,9월25일대웅제약실시간증시160000원361,http://nbntv.co.kr/news/view/659919
6899,2019-09-25,금주의채용정보대웅제약하반기상시채용,http://www.news2day.co.kr/137571
6900,2019-09-25,대웅제약채용설명회합격자양분,http://www.newsclaim.co.kr/news/articleView.html?idxno=2032
6901,2019-09-25,대웅제약유럽당뇨병학회서SGLT2억제계열당뇨병신약임상발표,http://www.econonews.co.kr/news/articleView.html?idxno=87986
6902,2019-09-26,대웅제약라니티딘파동에직격탄600억증발위기,https://www.paxnetnews.com/articles/52431
6903,2019-09-26,대웅주식종목검색26일현재15000원,http://nbntv.co.kr/news/view/661593
6904,2019-09-26,라니티딘처방중지대웅제약알비스휘청 ,http://www.monews.co.kr/news/articleView.html?idxno=205239
6905,2019-09-26,대웅제약라니티딘사태발암우려위장약잔탁등판매중지에주가무너지나15만원선마저무너져,http://www.econonews.co.kr/news/articleView.html?idxno=88063
6906,2019-09-26,fnRASSI대웅당일거래량증가하며4거래일하락세지속,http://www.fnnews.com/news/201909261119349917
6907,2019-09-26,2019제6회대한민국보건의료대상대상식품의약품안전처장상대웅제약자체개발나보타FDA판매허가美시장진출,http://news.heraldcorp.com/view.php?ud=20190926000563
6908,2019-09-26,9월26일대웅제약증권투자577147000원,http://nbntv.co.kr/news/view/662107
6909,2019-09-26,데일리증권대웅003090오후12시06분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=71431
6910,2019-09-26,라니티딘제품판매중지GSK일동대웅제약등비상,http://www.dailymedi.com/detail.php?number=847777&thread=22r05
6911,2019-09-26,발암물질검출에대웅제약등급락하락과도,http://news.mt.co.kr/mtview.php?no=2019092613282039561
6912,2019-09-26,동성제약대웅제약제약주희비엇갈려잔탁등269개판매중지대웅제약하락락,http://www.econonews.co.kr/news/articleView.html?idxno=88117
6913,2019-09-26,식약처라니티딘약품잠정판매중지대웅일동제약직격타,http://www.asiatime.co.kr/news/articleView.html?idxno=272639
6914,2019-09-26,대웅제약메디톡스美균주소송전서승기잡아,http://www.newsclaim.co.kr/news/articleView.html?idxno=2040
6915,2019-09-26,대웅제약알비스일동제약큐란발암물질기준초과판매중단,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=109469
6916,2019-09-26,대웅메디톡스소송전내년6월결판,http://news.mt.co.kr/mtview.php?no=2019092613124198061
6917,2019-09-26,라니티딘성분의약품판매중지대웅일동대책마련분주,http://www.newsway.co.kr/news/view?tp=1&ud=2019092616432331024
6918,2019-09-26,26일외국인순매수Top10우리금융지주3554억호텔신라55억Famp;F28억대웅제약25억외국인순매수나서코스닥시장에서는헬릭스미스메지온케이엠더블유상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=73998
6919,2019-09-27,대웅제약알비스판매중지에대한우려목표가↓NH,https://www.hankyung.com/finance/article/2019092776336
6920,2019-09-27,퀵리포트대웅제약매수유지목표가5↓19만원NH證,http://www.itooza.com/common/iview.php?no=2019092707451410132
6921,2019-09-27,대웅제약알비스판매중지우려과도목표가하향NH투자,http://www.newstomato.com/ReadNews.aspx?no=922759
6922,2019-09-27,대웅제약알비스판매중지조치에실적하향불가피목표가↓KTB증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1803315
6923,2019-09-27,I리포트대웅제약알비스판매중지주가에기반영목표가↓KTB證,http://www.inews24.com/view/1211120
6924,2019-09-27,대웅제약역류성식도염치료제판매중지직격탄목표가↓NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01462886622624384
6925,2019-09-27,대웅제약목표주가낮아져소화성궤양치료제판매중지로실적부담,http://www.businesspost.co.kr/BP?command=article_view&num=144868
6926,2019-09-27,대웅제약알비스판매중지관련주가하락과도”NH證,http://www.newspim.com/news/view/20190927000054
6927,2019-09-27,클릭e종목대웅제약대표품목매출타격우려목표가↓,https://view.asiae.co.kr/article/2019092708391469967
6928,2019-09-27,KTB투자발암우려위장약여파로대웅제약매출감소,http://yna.kr/AKR20190927030500008?did=1195m
6929,2019-09-27,NH證대웅제약알비스판매중지우려주가하락지나쳐,http://www.newsis.com/view/?id=NISX20190927_0000782332&cID=10401&pID=10400
6930,2019-09-27,대웅제약알비스판매중지우려과도NH,http://www.ebn.co.kr/news/view/1002793
6931,2019-09-27,위장약269개품목서발암물질대웅제약주가하락과도”NH투자증권,http://www.fntimes.com/html/view.php?ud=20190927084958986f09e13944d_18
6932,2019-09-27,대웅제약대체의약품으로알비스매출하락일부방어대신,http://www.newspim.com/news/view/20190927000077
6933,2019-09-27,대웅제약위장약알비스판매중지로실적에영향예상,https://www.sedaily.com/NewsView/1VOEP7Q47M
6934,2019-09-27,대웅제약과도한주가하락에상승여력↑,http://www.newsprime.co.kr/news/article.html?no=476962
6935,2019-09-27,KTB투자대웅제약발암우려위장약실적에영향줄것목표가↓,http://www.seoulwire.com/news/articleView.html?idxno=226400
6936,2019-09-27,KTB투자證대웅제약발암우려위장약여파매출감소목표가7↓”,http://www.kukinews.com/news/article.html?no=704536
6937,2019-09-27,퀵리포트대웅제약강력매수유지목표가7↓26만원KTB證,http://www.itooza.com/common/iview.php?no=2019092707350714195
6938,2019-09-27,KTB투자발암우려위장약여파로대웅제약매출감소,http://nbntv.co.kr/news/view/663777
6939,2019-09-27,대웅제약라니티딘사태위장약잔탁등판매중지에도5거래일만에반등15만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=88281
6940,2019-09-27,9월27일대웅오늘주식장14600원034,http://nbntv.co.kr/news/view/663806
6941,2019-09-27,이슈발암우려식약처발표에대웅제약주춤,https://www.hankyung.com/economy/article/2019092779896
6942,2019-09-27,리포트브리핑대웅제약알비스판매중지에대한우려로과도한주가하락목표가190000원NH투자증권,http://www.newspim.com/news/view/20190927000318
6943,2019-09-27,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=2019092710303011437tpgetnews_16
6944,2019-09-27,특징주대웅제약알비스판매중지우려로과도한주가하락,http://www.sisaon.co.kr/news/articleView.html?idxno=101718
6945,2019-09-27,9월27일대웅제약및증권시세및증권정보와종목동정100변화해,http://www.gokorea.kr/news/articleView.html?idxno=507087
6946,2019-09-27,9월27일대웅제약투자주식067150500원,http://nbntv.co.kr/news/view/664326
6947,2019-09-27,증권가라니티딘직격탄맞은대웅주가선반영,http://www.dailypharm.com/Users/News/NewsView.html?ID=257067&REFERER=NP
6948,2019-09-27,NH투자증권알비스판매중지주가과도하게하락대웅제약매수,http://www.whitepaper.co.kr/news/articleView.html?idxno=174690
6949,2019-09-27,보툴리눔공방대웅제약으로기우나,http://www.insightkorea.co.kr//news/articleView.html?idxno=58618
6950,2019-09-28,라니티딘반품개시대웅알비스더샵에서처리,http://www.dailypharm.com/Users/News/NewsView.html?ID=257087&REFERER=NP
6951,2019-09-29,전승호대웅제약항궤양제알비스판매중단에대체약품개발서둘러,http://www.businesspost.co.kr/BP?command=article_view&num=145082
6952,2019-09-30,대웅제약보톨리눔톡신논쟁일단락짓나,http://www.bosa.co.kr/news/articleView.html?idxno=2113154
6953,2019-09-30,대웅제약3분기소송비용증가로이익부진목표가↓키움,http://www.dailian.co.kr/news/view/829710/?sc=naver
6954,2019-09-30,대웅제약목표주가하향알비스판매중단돼4분기실적기대이하,http://www.businesspost.co.kr/BP?command=article_view&num=145106
6955,2019-09-30,라니티딘위장약판매중지대웅일동제약영향클듯,http://www.rapportian.com/news/articleView.html?idxno=120285
6956,2019-09-30,대웅제약알비스판매중지반영목표가↓키움증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1804026
6957,2019-09-30,퀵리포트대웅제약매수유지목표가9↓20만원키움證,http://www.itooza.com/common/iview.php?no=2019093008483111491
6958,2019-09-30,하이로우대웅제약소송비용증가로매출부진예상키움증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019093008522739343
6959,2019-09-30,대웅제약알비스판매중단4분기영향목표주가↓키움증권,http://www.ajunews.com/view/20190930083629536
6960,2019-09-30,대웅제약3분기영업이익123억원전망,http://www.nspna.com/news/?mode=view&newsid=385408
6961,2019-09-30,메리츠證대웅제약라니티딘판매중단에수익성하락불가피,http://www.newsis.com/view/?id=NISX20190930_0000784232&cID=10401&pID=10400
6962,2019-09-30,대웅제약나보타국제피부외과학회서홍보,http://medipana.com/news/news_viewer.asp?NewsNum=246117&MainKind=A&NewsKind=5&vCount=12&vKind=1
6963,2019-09-30,대웅제약나보타국제피부외과학회참가경쟁력홍보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235462
6964,2019-09-30,대웅제약 국제피부외과학회서 나보타우수성 홍보,http://www.medisobizanews.com/news/articleView.html?idxno=62766
6965,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.segye.com/content/html/2019/09/30/20190930503566.html?OutUrl=naver
6966,2019-09-30,대웅주가0030909월30일현재14850원증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=508814
6967,2019-09-30,리포트브리핑대웅제약UpDown이모두존재목표가220000원메리츠종금증권,http://www.newspim.com/news/view/20190930000204
6968,2019-09-30,GET투자리포트대웅제약투자의견매수메리츠종금증권,http://www.getnews.co.kr/view.php?ud=2019093010303011463tpgetnews_16
6969,2019-09-30,오늘주식대웅주가30일현재14800원,http://nbntv.co.kr/news/view/666073
6970,2019-09-30,대웅제약국제피부외과학회서보톨리눔톡신제제나보타소개,https://www.sedaily.com/NewsView/1VOG3P16A6
6971,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.dailysmart.co.kr/news/articleView.html?idxno=16067
6972,2019-09-30,대웅제약나보타국제피부외과학회서최신임상결과알려,http://moneys.mt.co.kr/news/mwView.php?no=2019093009548017434
6973,2019-09-30,대웅제약알비스의빈자리를타제품이얼마나대체하는지가중요”,http://www.wikitree.co.kr/main/news_view.php?id=467959
6974,2019-09-30,대웅제약나보타글로벌학회서최신시술법시연및강의진행,http://www.econovill.com/news/articleView.html?idxno=373382
6975,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2019093010230324533
6976,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.ebn.co.kr/news/view/1003052
6977,2019-09-30,대웅제약국제피부외과학회통해나보타우수성홍보,http://www.ekn.kr/news/article.html?no=455587
6978,2019-09-30,대웅제약나보타국제피부외과학회참가경쟁력홍보,http://www.ceoscoredaily.com/news/article.html?no=60936
6979,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.wsobi.com/news/articleView.html?idxno=82080
6980,2019-09-30,대웅제약국제피부외과학회에서나보타홍보,http://www.newspim.com/news/view/20190930000297
6981,2019-09-30,대웅제약나보타국제피부외과학회서글로벌경쟁력과시,http://www.ftoday.co.kr/news/articleView.html?idxno=111676
6982,2019-09-30,GET투자리포트대웅제약투자의견매수유지키움증권,http://www.getnews.co.kr/view.php?ud=2019093010303011483tpgetnews_16
6983,2019-09-30,대웅제약ISDS2019참가세계대상나보타경쟁력홍보,http://www.wikileaks-kr.org/news/articleView.html?idxno=66548
6984,2019-09-30,대웅제약국제피부외과학회참가나보타홍보 ,http://www.monews.co.kr/news/articleView.html?idxno=205341
6985,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://newsbrite.net/127257
6986,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://fn.segye.com/content/html/2019/09/30/20190930503564.html?OutUrl=naver
6987,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.betanews.net:8080/article/1054950.html
6988,2019-09-30,대웅제약주가0696209월30일현재149000원정보,http://www.gokorea.kr/news/articleView.html?idxno=509267
6989,2019-09-30,대웅제약나보타글로벌무대서경쟁력홍보,http://www.newsprime.co.kr/news/article.html?no=477240
6990,2019-09-30,대웅제약영업력NOAC시장에서도빛났다,http://medipana.com/news/news_viewer.asp?NewsNum=246146&MainKind=A&NewsKind=5&vCount=12&vKind=1
6991,2019-09-30,대웅제약 나보타 국제피부외과학회참가 글로벌우수성알려,http://www.businesskorea.co.kr/news/articleView.html?idxno=36514
6992,2019-09-30,대웅제약나보타글로벌을무대서훨훨,http://www.whosaeng.com/112909
6993,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.newsis.com/view/?id=NISX20190930_0000784680&cID=13001&pID=13000
6994,2019-09-30,9월30일대웅제약실시간증시149500원033,http://nbntv.co.kr/news/view/666602
6995,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.polinews.co.kr/news/article.html?no=421861
6996,2019-09-30,대웅제약나보타국제피부외과학회서글로벌경쟁력과시,http://www.seoulwire.com/news/articleView.html?idxno=227702
6997,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.newswatch.kr/news/articleView.html?idxno=23919
6998,2019-09-30,대웅제약국제피부외과학회서나보타소개글로벌제품알리기박차,http://www.donga.com/news/article/all/20190930/97654553/1
6999,2019-09-30,대웅제약국제피부외과학회참가주름개선제나보타해외네트워크확대,http://www.sportsseoul.com/news/read/826119
7000,2019-09-30,대웅제약나보타국제피부외과학회서경쟁력홍보,http://daily.hankooki.com/lpage/ittech/201909/dh20190930135941145630.htm
7001,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.dailian.co.kr/news/view/829746/?sc=naver
7002,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌경쟁력홍보,http://www.metroseoul.co.kr/news/newsview?newscd=2019093000201
7003,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.lawissue.co.kr/view.php?ud=201909301501418395204ead0791_12
7004,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.medigatenews.com/news/1290015044
7005,2019-09-30,국제피부외과학회참가한대웅제약나보타국제무대서경쟁력알려,http://www.updownnews.co.kr/news/articleView.html?idxno=209140
7006,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1339108
7007,2019-09-30,대웅제약나보타글로벌무대서경쟁력홍보,http://www.wolyo.co.kr/news/articleView.html?idxno=94579
7008,2019-09-30,대웅제약국제학회서나보타경쟁력적극홍보,http://www.dailymedi.com/detail.php?number=847920&thread=22r05
7009,2019-09-30,대웅제약국제피부외과학회학술대회서나보타홍보나서,http://news.mk.co.kr/newsRead.php?year=2019&no=781834
7010,2019-09-30,대웅제약국제피부외과학회서나보타알려,http://weekly.cnbnews.com/news/article.html?no=130398
7011,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.getnews.co.kr/view.php?ud=20190930165233269241d0c69529_16
7012,2019-09-30,뉴스워커_대웅제약 나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.newsworker.co.kr/news/articleView.html?idxno=44175
7013,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.economytalk.kr/news/articleView.html?idxno=199145
7014,2019-09-30,대웅제약국제피부외과학회참가나보타세계무대서경쟁력홍보,http://www.newslock.co.kr/news/articleView.html?idxno=21787
7015,2019-09-30,대웅제약알비스판매중단사태로4분기실적불투명대체품목이관건,http://www.whitepaper.co.kr/news/articleView.html?idxno=175044
7016,2019-09-30,대웅제약나보타국제피부외과학회참가,http://www.newscj.com/news/articleView.html?idxno=671034
7017,2019-09-30,대웅제약나보타국제피부외과학회참가글로벌무대서경쟁력홍보,http://www.thefirstmedia.net/news/articleView.html?idxno=49066
7018,2019-10-01,아스트라제네카녹십자대웅판매품목일부회수,http://www.dailypharm.com/Users/News/NewsView.html?ID=257161&REFERER=NP
7019,2019-10-01,대웅제약국제피부외과학회에서나보타홍보,http://www.nbnnews.co.kr/news/articleView.html?idxno=323556
7020,2019-10-01,10월1일대웅오늘시세102변동해,http://www.gokorea.kr/news/articleView.html?idxno=510817
7021,2019-10-01,10월1일대웅투자주식14900원102,http://nbntv.co.kr/news/view/668246
7022,2019-10-01,대웅제약나보타임상비임상에서뛰어난역가지속력입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019100100034
7023,2019-10-01,대웅제약나보타임상비임상시험서뛰어난역가지속력입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235544
7024,2019-10-01,대웅제약나보타임상시험서효과지속력입증,http://biz.chosun.com/site/data/html_dir/2019/10/01/2019100100843.html
7025,2019-10-01,대웅나보타임상비임상서뛰어난역가지속력입증,http://www.dailypharm.com/Users/News/NewsView.html?ID=257192&REFERER=NP
7026,2019-10-01,대웅제약나보타효과SCI급국제피부과학학술지게재,http://news.heraldcorp.com/view.php?ud=20191001000149
7027,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019100109565502229
7028,2019-10-01,대웅제약 나보타 임상비임상서 역가 지속력으뜸,http://www.medisobizanews.com/news/articleView.html?idxno=62811
7029,2019-10-01,대웅제약나보타역가지속력우월성입증,http://medipana.com/news/news_viewer.asp?NewsNum=246213&MainKind=A&NewsKind=5&vCount=12&vKind=1
7030,2019-10-01,대웅제약나보타임상서효과유지력입증,http://health.chosun.com/site/data/html_dir/2019/10/01/2019100100875.html
7031,2019-10-01,대웅제약나보타임상비임상시험역가지속력입증피부과학학술지게재,http://www.newslock.co.kr/news/articleView.html?idxno=21822
7032,2019-10-01,대웅제약나보타역가지속력입증냉동보관에도효과유지,http://www.econovill.com/news/articleView.html?idxno=373503
7033,2019-10-01,장중수급포착대웅외국인5일연속순매수행진주가203,http://www.newspim.com/news/view/20191001000347
7034,2019-10-01,대웅제약나보타효과입증SCI급국제학술지에게재,http://www.koreaittimes.com/news/articleView.html?idxno=93250
7035,2019-10-01,대웅제약나보타임상비임상시험서역가지속력입증,http://www.newspim.com/news/view/20191001000353
7036,2019-10-01,대웅제약나보타임상시험서역가지속력입증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019100110180736870
7037,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.ceoscoredaily.com/news/article.html?no=60982
7038,2019-10-01,대웅제약나보타임상시험서효과유지력입증,https://www.sedaily.com/NewsView/1VPCPUCEN6
7039,2019-10-01,대웅제약나보타뛰어난역가지속력입증,http://www.newsprime.co.kr/news/article.html?no=477421
7040,2019-10-01,대웅제약나보타임상시험서역가지속력입증,http://www.ftoday.co.kr/news/articleView.html?idxno=111724
7041,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증활발한연구활동통해나보타의차별화된가치과학적으로입증할것,http://www.segye.com/content/html/2019/10/01/20191001505134.html?OutUrl=naver
7042,2019-10-01,대웅제약나보타임상연구서역가지속력입증 ,http://www.monews.co.kr/news/articleView.html?idxno=205379
7043,2019-10-01,대웅제약나보타뛰어난역가지속력입증,http://www.viva100.com/main/view.php?key=20191001010000143
7044,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=16135
7045,2019-10-01,대웅제약나보타희석후효과국내시판제품중최고”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1804730
7046,2019-10-01,대웅제약보툴리눔톡신나보타역가지속력입증,https://www.hankyung.com/it/article/201910016064f
7047,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://newsbrite.net/127348
7048,2019-10-01,대웅제약나보타임상비임상시험서역가지속력입증,http://www.newsis.com/view/?id=NISX20191001_0000785999&cID=13001&pID=13000
7049,2019-10-01,대웅제약주가10월1일현재152500원오늘시세및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=511270
7050,2019-10-01,대웅나보타임상비임상시험서효과지속력입증,http://news.mt.co.kr/mtview.php?no=2019100110575663362
7051,2019-10-01,10월1일대웅제약주식종목검색153500원302,http://nbntv.co.kr/news/view/668759
7052,2019-10-01,상위제약사이익신장기대대웅유한2020년기대치높아,http://medipana.com/news/news_viewer.asp?NewsNum=246230&MainKind=A&NewsKind=5&vCount=12&vKind=1
7053,2019-10-01,데일리주식정보대웅003090오후12시07분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=72081
7054,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=366162
7055,2019-10-01,대웅제약나보타역가지속력입증”SCI급국제학술지게재,http://www.donga.com/news/article/all/20191001/97674119/1
7056,2019-10-01,대웅제약전일대비503상승중이시각거래량3만2882주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910010308&t=NN
7057,2019-10-01,대웅제약5이상상승최근3일간외국인대량순매수,https://www.hankyung.com/finance/article/201910016472L
7058,2019-10-01,대웅제약나보타임상비임상통해역가지속력확인,http://www.rapportian.com/news/articleView.html?idxno=120355
7059,2019-10-01,라니티딘파동대웅일동제약울상종근당CJ헬스케어웃음,http://www.m-i.kr/news/articleView.html?idxno=642555
7060,2019-10-01,대웅제약나보타임상비임상서뛰어난역가지속력입증”,http://inthenews.co.kr/article-18397/
7061,2019-10-01,대웅제약나보타뛰어난역가지속력입증,http://news1.kr/articles/?3733169
7062,2019-10-01,대웅제약보툴리눔톡신나보타의뛰어난효과유지력입증,http://www.businesspost.co.kr/BP?command=article_view&num=145333
7063,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.lawissue.co.kr/view.php?ud=201910011458342904204ead0791_12
7064,2019-10-01,대웅제약나보타지속력안정성증명국내보툴리눔톡신중최우수,http://www.100ssd.co.kr/news/articleView.html?idxno=64399
7065,2019-10-01,대웅제약나보타임상시험서효과지속력입증SCI급국제피부과학학술지게재,http://www.updownnews.co.kr/news/articleView.html?idxno=209213
7066,2019-10-01,대웅제약비임상연구자임상결과나보타의역가지속력입증,http://news.mk.co.kr/newsRead.php?year=2019&no=786101
7067,2019-10-01,대웅제약나보타임상비임상에서뛰어난역가지속력입증,http://daily.hankooki.com/lpage/ittech/201910/dh20191001152947145630.htm
7068,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.wikileaks-kr.org/news/articleView.html?idxno=66718
7069,2019-10-01,대웅제약나보타임상비임상통해역가지속력입증,http://www.seoulwire.com/news/articleView.html?idxno=229291
7070,2019-10-01,대웅제약나보타임상비임상시험에서효과지속력확인,http://www.ajunews.com/view/20191001160902244
7071,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.wsobi.com/news/articleView.html?idxno=82156
7072,2019-10-01,대웅제약나보타역가지속력입증,http://www.economytalk.kr/news/articleView.html?idxno=199234
7073,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.medigatenews.com/news/2011359549
7074,2019-10-01,대웅제약나보타역가지속력임상시험서입증,http://www.wolyo.co.kr/news/articleView.html?idxno=94697
7075,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.getnews.co.kr/view.php?ud=20191001191213518541d0c69529_16
7076,2019-10-01,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.thefirstmedia.net/news/articleView.html?idxno=49119
7077,2019-10-02,대웅제약나보타임상비임상시험에서뛰어난역가지속력입증,http://www.betanews.net:8080/article/1055481.html
7078,2019-10-02,아스트라제네카녹십자대웅제약일부품목판권회수결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=366229
7079,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1339591
7080,2019-10-02,대웅제약보톡스누시바유럽허가내년발매,http://www.dailypharm.com/Users/News/NewsView.html?ID=257236&REFERER=NP
7081,2019-10-02,대웅제약보툴리눔톡신제제누시바유럽판매허가승인,http://www.fnnews.com/news/201910020750013338
7082,2019-10-02,대웅제약보툴리눔톡신유럽허가유럽30개국진출,https://view.asiae.co.kr/article/2019100207534292318
7083,2019-10-02,대웅보톨리눔톡신나보타유럽승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88176
7084,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235587
7085,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://biz.chosun.com/site/data/html_dir/2019/10/02/2019100200538.html
7086,2019-10-02,대웅제약보툴리눔톡신나보타글로벌연타석홈런,http://www.medisobizanews.com/news/articleView.html?idxno=62834
7087,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가,http://news.heraldcorp.com/view.php?ud=20191002000041
7088,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.newsis.com/view/?id=NISX20191002_0000787119&cID=13001&pID=13000
7089,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.ebn.co.kr/news/view/1003384
7090,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.lawissue.co.kr/view.php?ud=201910020841259116204ead0791_12
7091,2019-10-02,GC녹십자RD인력비중매출1조클럽중최고대웅제약최저,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534027
7092,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019100208483407652
7093,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.joseilbo.com/news/news_read.php?uid=384959&class=27&grp=
7094,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1209690
7095,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.seoulwire.com/news/articleView.html?idxno=229431
7096,2019-10-02,대웅제약누시바유럽판매허가획득‥연내캐나다발매,http://medipana.com/news/news_viewer.asp?NewsNum=246263&MainKind=A&NewsKind=5&vCount=12&vKind=1
7097,2019-10-02,대웅제약누시바유럽판매허가획득내년출시예정,https://www.hankyung.com/finance/article/2019100284696
7098,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.mhj21.com/124710
7099,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.dailian.co.kr/news/view/830403/?sc=naver
7100,2019-10-02,대웅제약보톡스유럽서내년부터판매,http://moneys.mt.co.kr/news/mwView.php?no=2019100209008066499
7101,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019100209030812619
7102,2019-10-02,대웅제약누시바유럽판매가능해졌다,http://www.ftoday.co.kr/news/articleView.html?idxno=111746
7103,2019-10-02,대웅제약보툴리눔톡신미국이어유럽진출내년출시예정,http://www.newspim.com/news/view/20191002000084
7104,2019-10-02,대웅제약나보타국산보툴리눔톡신최초로미국유럽동시진출,http://news.tf.co.kr/read/economy/1764287.htm
7105,2019-10-02,대웅제약누시바유럽판매허가획득2020년유럽발매,http://www.asiatoday.co.kr/view.php?key=20191002010001044
7106,2019-10-02,대웅제약보툴리눔톡신제제유럽판매승인,http://news.mt.co.kr/mtview.php?no=2019100208173799279
7107,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가획득,http://www.econovill.com/news/articleView.html?idxno=373617
7108,2019-10-02,대웅제약나보타미국에이어유럽판매승인,http://www.kpinews.co.kr/news/articleView.html?idxno=104496
7109,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가,http://yna.kr/AKR20191002034100017?did=1195m
7110,2019-10-02,대웅제약누시바미간주름적응증에유럽판매허가획득,http://www.getnews.co.kr/view.php?ud=20191002092344407041d0c69529_16
7111,2019-10-02,대웅제약미국에이어누시바유럽판매허가획득발표,http://www.newslock.co.kr/news/articleView.html?idxno=21858
7112,2019-10-02,대웅제약나보타국산보툴리눔톡신최초美이어유럽진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1805147
7113,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://daily.hankooki.com/lpage/ittech/201910/dh20191002093103145630.htm
7114,2019-10-02,대웅오늘주식시세2일현재15100원,http://nbntv.co.kr/news/view/670285
7115,2019-10-02,대웅제약보툴리눔톡신나보타유럽서시판허가받아,http://news.mk.co.kr/newsRead.php?year=2019&no=788458
7116,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가,http://www.fetv.co.kr/news/article.html?no=37325
7117,2019-10-02,대웅제약누시바유럽판매허가획득발표韓보툴리눔톡신최초미국유럽동시진출,http://www.segye.com/content/html/2019/10/02/20191002503841.html?OutUrl=naver
7118,2019-10-02,대웅보툴리눔톡신유럽대륙진출성공,http://www.whosaeng.com/112996
7119,2019-10-02,대웅제약나보타유럽판매허가획득,http://www.newstomato.com/ReadNews.aspx?no=923842
7120,2019-10-02,대웅제약나보타유럽판매허가획득캐나다출시도앞둬,http://www.rapportian.com/news/articleView.html?idxno=120380
7121,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.economytalk.kr/news/articleView.html?idxno=199257
7122,2019-10-02,대웅제약누시바유럽판매허가획득발표미국유럽동시진출쾌거,http://www.polinews.co.kr/news/article.html?no=422383
7123,2019-10-02,대웅제약누시바유럽시장본격진출,https://www.kpanews.co.kr/article/show.asp?idx=207155&category=D
7124,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.k-health.com/news/articleView.html?idxno=45753
7125,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.newsprime.co.kr/news/article.html?no=477614
7126,2019-10-02,대웅제약나보타유럽허가미국유럽모두진출,http://www.hankookilbo.com/news/npath/201910021065328299?did=NA
7127,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.dt.co.kr/contents.html?article_no=2019100202109931102001&ref=naver
7128,2019-10-02,대웅제약보톡스누시바미국이어유럽시장도뚫었다,http://www.edaily.co.kr/news/newspath.asp?newsid=02282886622648984
7129,2019-10-02,대웅누시바나보타유럽상품명유럽판매허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2113414
7130,2019-10-02,대웅제약유럽서보툴리눔톡신누시바판매승인,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910020186&t=NN
7131,2019-10-02,대웅제약누시바유럽판매허가획득,http://kormedi.com/?p=1303026
7132,2019-10-02,대웅제약보툴리눔톡신나보타유럽판매허가,http://news.mk.co.kr/newsRead.php?year=2019&no=788839
7133,2019-10-02,대웅제약누시바유럽품목허가2020년발매,http://news1.kr/articles/?3734192
7134,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57470
7135,2019-10-02,대웅제약나보타미국이어유럽진출국내보툴리눔톡신최초,http://www.upinews.kr/news/newsview.php?ncode=1065577077764237
7136,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.dailysmart.co.kr/news/articleView.html?idxno=16194
7137,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://newsbrite.net/127422
7138,2019-10-02,대웅제약누시바유럽판매허가획득,http://news.heraldcorp.com/view.php?ud=20191002000415
7139,2019-10-02,대웅제약보툴리눔톡신유럽진출판매허가획득성공,http://www.ceoscoredaily.com/news/article.html?no=61040
7140,2019-10-02,대웅제약주가069620증권그래프2일오늘가격157500원,http://www.gokorea.kr/news/articleView.html?idxno=513283
7141,2019-10-02,대웅제약보툴리눔톡신누시바美이어유럽판매허가획득,http://www.opinionnews.co.kr/news/articleView.html?idxno=24083
7142,2019-10-02,대웅제약해외주름개선제시장주름잡기도전장나보타유럽까지진출,http://www.sportsseoul.com/news/read/827392
7143,2019-10-02,대웅제약보톨리눔톡신누시바유럽판매허가획득발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019100200072
7144,2019-10-02,일교차심한가을비타민B중요대웅임팩타민인기,http://www.econovill.com/news/articleView.html?idxno=373643
7145,2019-10-02,증권투자대웅제약주가2일현재157500원,http://nbntv.co.kr/news/view/670759
7146,2019-10-02,2일데일리증권대웅003090오후12시07분기준및증권정보와종목동정,https://www.dailysecu.com/news/articleView.html?idxno=72260
7147,2019-10-02,대웅제약나보타유럽판매허가승인내년발매,http://www.donga.com/news/article/all/20191002/97694913/1
7148,2019-10-02,대웅제약나보타유럽판매허가획득2020년발매예정,http://inthenews.co.kr/article-18649/
7149,2019-10-02,대웅제약보툴리눔톡신누시바의유럽판매허가따내,http://www.businesspost.co.kr/BP?command=article_view&num=145541
7150,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.etnews.com/20191002000102
7151,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.betanews.net:8080/article/1055620.html
7152,2019-10-02,대웅제약보툴리눔톡신누시바유럽최종품목허가승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=366282
7153,2019-10-02,대웅제약누시바유럽판매허가획득,https://www.paxnetnews.com/articles/52630
7154,2019-10-02,대웅제약보툴리눔톡신제제유럽시장진출,http://www.sisafocus.co.kr/news/articleView.html?idxno=222556
7155,2019-10-02,대웅제약비임상연구자임상결과나보타의역가지속력입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=324359
7156,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.newswatch.kr/news/articleView.html?idxno=24015
7157,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.wsobi.com/news/articleView.html?idxno=82220
7158,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.nbnnews.co.kr/news/articleView.html?idxno=324413
7159,2019-10-02,대웅제약보툴리눔제제나보타유럽도진출,https://www.nocutnews.co.kr/news/5222172
7160,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.bokuennews.com/news/article.html?no=181481
7161,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매승인,http://www.medigatenews.com/news/3067458831
7162,2019-10-02,대웅제약개발나보타유럽판매허가획득,http://www.seoulfn.com/news/articleView.html?idxno=357841
7163,2019-10-02,대웅제약나보타이번엔유럽이다 ,http://www.monews.co.kr/news/articleView.html?idxno=205417
7164,2019-10-02,대웅제약누시바국산보툴리눔톡신최초유럽미국판매허가획득,http://www.updownnews.co.kr/news/articleView.html?idxno=209276
7165,2019-10-02,대웅제약유럽서보톡스누시바판매허가획득,http://www.finomy.com/news/articleView.html?idxno=70048
7166,2019-10-02,대웅등국내보톡스해외서경쟁력키운다,http://www.economytalk.kr/news/articleView.html?idxno=199287
7167,2019-10-02,대웅제약누시바유럽판매허가획득,https://www.sedaily.com/NewsView/1VPD7XE1D6
7168,2019-10-02,대웅제약나보타美이어유럽간다,https://www.hankyung.com/it/article/2019100299941
7169,2019-10-02,대웅제약보툴리눔톡신누시바유럽판매허가획득,http://www.ajunews.com/view/20191002172508172
7170,2019-10-02,대웅제약알비스복합제개발중단,https://www.paxnetnews.com/articles/52655
7171,2019-10-02,대웅제약누시바유럽판매허가획득,http://www.ekn.kr/news/article.html?no=456100
7172,2019-10-02,대웅제약보툴리눔톡신누시바국내최초유럽진출,http://www.100ssd.co.kr/news/articleView.html?idxno=64432
7173,2019-10-02,대웅제약누시바美유럽동시진출,http://www.fnnews.com/news/201910021824346710
7174,2019-10-02,대웅제약누시바유럽판매허가획득발표,http://www.newscj.com/news/articleView.html?idxno=671745
7175,2019-10-03,대웅제약토종주름개선제美이어유럽서팔린다,http://www.ajunews.com/view/20191002194527230
7176,2019-10-03,대웅제약자체개발보툴리눔톡신제제나보타국제피부외과학회참가,http://www.econonews.co.kr/news/articleView.html?idxno=89211
7177,2019-10-04,대웅제약삼중고윤재춘전승호대웅제약공동대표리더십시험대에,http://www.ajunews.com/view/20191003132307392
7178,2019-10-04,대웅주가003090및증권시세외매매동향4일현재14700원형성,http://www.gokorea.kr/news/articleView.html?idxno=514792
7179,2019-10-04,10월4일대웅주가그래프13414750원,http://nbntv.co.kr/news/view/672438
7180,2019-10-04,10월4일대웅제약069620및증권시세및주체별매매동향160,http://www.gokorea.kr/news/articleView.html?idxno=515233
7181,2019-10-04,시세보기대웅제약주가4일현재153000원,http://nbntv.co.kr/news/view/672967
7182,2019-10-04,데일리증권대웅003090오후12시04분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=72490
7183,2019-10-04,위클리제약바이오대웅제약나보타유럽품목허가획득外,http://www.etoday.co.kr/news/section/newsview.php?idxno=1806033
7184,2019-10-04,대웅제약누시바유럽판매허가획득발표,http://www.thefirstmedia.net/news/articleView.html?idxno=49178
7185,2019-10-05,대웅제약보툴리눔톡신제제나보타임상비임상시험서역가지속력입증,http://www.econonews.co.kr/news/articleView.html?idxno=89566
7186,2019-10-06,라니티딘성분처방량상위10개품목공개대웅제약알비스정1위,http://www.mdtoday.co.kr/mdtoday/index.html?no=366590
7187,2019-10-06,2019국감발암우려위장약3년간1억여건처방대웅제약알비스정최다,http://www.seoulwire.com/news/articleView.html?idxno=231321
7188,2019-10-06,발암물질라니티딘성분위장약최근3년처방1위는대웅알비스정,http://news.mk.co.kr/newsRead.php?year=2019&no=801199
7189,2019-10-06,대웅제약나보타역가지속력뛰어남입증”,http://weekly.cnbnews.com/news/article.html?no=130476
7190,2019-10-06,단독대웅메디톡스보톡스戰재점화양사균주서모두포자형성확인,http://news.mk.co.kr/newsRead.php?year=2019&no=802206
7191,2019-10-06,메디톡스자사균주도포자형성대웅과균주전쟁새국면,http://news.mt.co.kr/mtview.php?no=2019100619271199660
7192,2019-10-06,메디톡스대웅조건에서는자사보툴리눔톡신균주도포자형성,https://www.sedaily.com/NewsView/1VPF1JFRHT
7193,2019-10-07,라니티딘처방량대웅알비스정대웅바이오라비수정일동큐란정순,http://www.medigatenews.com/news/1115684033
7194,2019-10-07,대웅제약나보타미국서승승장구미용시장성장올라타,http://www.econovill.com/news/articleView.html?idxno=373859
7195,2019-10-07,10월7일대웅003090증권투자정보외증시동향034변동해,http://www.gokorea.kr/news/articleView.html?idxno=516761
7196,2019-10-07,특징주보톡스균주출처분쟁새국면에대웅제약메디톡스희비엇갈려,http://news.mk.co.kr/newsRead.php?year=2019&no=803118
7197,2019-10-07,대웅주식추천주7일현재14650원,http://nbntv.co.kr/news/view/674724
7198,2019-10-07,대웅제약메디톡스말바꾸기즉각중단해야,http://medipana.com/news/news_viewer.asp?NewsNum=246510&MainKind=A&NewsKind=5&vCount=12&vKind=1
7199,2019-10-07,메디톡스대웅제약보톡스균주분쟁관련주가희비교차,http://www.mdtoday.co.kr/mdtoday/index.html?no=366638
7200,2019-10-07,대웅제약제2인보사사태우려메디톡스균주출처부터검증받아야,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235742
7201,2019-10-07,대웅제약메디톡스균주출처검증받아야,http://www.medisobizanews.com/news/articleView.html?idxno=62918
7202,2019-10-07,대웅제약포자형성메디톡스거짓말멈춰야,http://news.mt.co.kr/mtview.php?no=2019100710173075040
7203,2019-10-07,10월7일대웅제약증권투자정보362변화해,http://www.gokorea.kr/news/articleView.html?idxno=517202
7204,2019-10-07,잠망경라니티딘1천억손실대웅제약스티렌제네릭으로방향,http://medipana.com/news/news_viewer.asp?NewsNum=246343&MainKind=A&NewsKind=5&vCount=12&vKind=1
7205,2019-10-07,주식추천주대웅제약주가7일현재146000원,http://nbntv.co.kr/news/view/675269
7206,2019-10-07,대웅메디톡스홀A하이퍼균주포자형성주장비판,http://www.dailypharm.com/Users/News/NewsView.html?ID=257446&REFERER=NP
7207,2019-10-07,대웅제약메디톡스포자시험조건처음부터동의,http://news1.kr/articles/?3737543
7208,2019-10-07,대웅제약메디톡스톡신균주도포자형성한다고,http://www.bosa.co.kr/news/articleView.html?idxno=2113645
7209,2019-10-07,동아에스티와일동손잡고대웅제약은자사제품대체유도,http://www.dailymedi.com/detail.php?number=848140&thread=22r05
7210,2019-10-07,대웅제약메디톡스균주포자형성스스로거짓말시인한것”,http://daily.hankooki.com/lpage/ittech/201910/dh20191007134726145630.htm
7211,2019-10-07,발암물질원료라니티딘성분처방량대웅제약알비스정최다,http://www.kukinews.com/news/article.html?no=707274
7212,2019-10-07,대웅제약메디톡스균주포자형성주장비판스스로거짓말시인한것,http://www.updownnews.co.kr/news/articleView.html?idxno=209412
7213,2019-10-07,동성제약대웅제약제약주희비엇갈려특히동성제약마감앞두고갑작스런급등,http://www.econonews.co.kr/news/articleView.html?idxno=89841
7214,2019-10-07,대웅제약메디톡스말바꾸기즉각중단하라,http://www.dailian.co.kr/news/view/831908/?sc=naver
7215,2019-10-07,함양대웅한우촌독거노인사랑의무료식사,http://www.cnbnews.com/news/article.html?no=423687
7216,2019-10-07,대웅제약메디톡스거짓말과말바꾸기즉각중단해야”,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534115
7217,2019-10-07,대웅메디톡스보톡스분쟁누군가는거짓말하고있다,http://news.mk.co.kr/newsRead.php?year=2019&no=805989
7218,2019-10-07,대웅한우촌독거노인사랑의무료식사,http://www.knnews.co.kr/news/articleView.php?idxno=1305554
7219,2019-10-07,메디톡스vs대웅제약분쟁재점화포자형성결과놓고기싸움,http://www.upinews.kr/newsView/upi201910070081
7220,2019-10-07,보톡스출처분쟁확전메디톡스이제염기서열분석vs대웅거짓말,http://news.mk.co.kr/newsRead.php?year=2019&no=806215
7221,2019-10-07,메디톡스보툴리눔톡신균주포자형성”대웅제약거짓말그만해야”,http://www.ajunews.com/view/20191007191250563
7222,2019-10-07,대웅제약메디톡스의포자형성주장은설득력떨어지는거짓말,http://www.businesspost.co.kr/BP?command=article_view&num=146120
7223,2019-10-07,대웅제약메디톡스균주포자형성주장스스로거짓말시인한것,http://www.businesskorea.co.kr/news/articleView.html?idxno=36748
7224,2019-10-08,대웅제약포자형성일반적인실험방법,http://www.mdtoday.co.kr/mdtoday/index.html?no=366684
7225,2019-10-08,메디톡스대웅제약미국소송에뉴욕검찰출신변호사선임,http://moneys.mt.co.kr/news/mwView.php?no=2019100809058051601
7226,2019-10-08,10월8일대웅003090오늘시세및매매동향104변화,http://www.gokorea.kr/news/articleView.html?idxno=518650
7227,2019-10-08,시세보기대웅주가8일현재14500원,http://nbntv.co.kr/news/view/677028
7228,2019-10-08,메디톡스거물변호사선임하고대웅제약과美법적다툼채비,http://www.edaily.co.kr/news/newspath.asp?newsid=01902406622650952
7229,2019-10-08,10월8일대웅제약069620및증권시세068변동,http://www.gokorea.kr/news/articleView.html?idxno=519089
7230,2019-10-08,10월8일대웅제약주식증권102148500원,http://nbntv.co.kr/news/view/677572
7231,2019-10-08,보톡스전쟁재점화메디톡스포자감정의미없어vs대웅말바꾸기,http://news.tf.co.kr/read/economy/1764821.htm
7232,2019-10-08,리포트브리핑대웅제약나보타해외수출이알비스관련실적악화를방어할전망목표가260000원SK증권,http://www.newspim.com/news/view/20191008000587
7233,2019-10-08,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019100810303011736tpgetnews_16
7234,2019-10-08,대웅제약말바꾸는메디톡스명백한소송사기,http://www.dailymedi.com/detail.php?number=848191&thread=22r05
7235,2019-10-08,메디톡스대웅제약과소송에미국검찰검사장출신선임,http://www.upinews.kr/newsView/upi201910080055
7236,2019-10-08,라니티딘판매중지후유증대웅일동제약대체약물관심집중,http://www.sisajournal-e.com/news/articleView.html?idxno=207186
7237,2019-10-08,메디톡스대웅제약과美ITC소송법정대리인에뉴욕검사장출신선임,http://biz.chosun.com/site/data/html_dir/2019/10/08/2019100801635.html
7238,2019-10-09,국내서보톡스전쟁대웅제약⋅메디톡스해외경쟁도가열,http://biz.chosun.com/site/data/html_dir/2019/10/08/2019100802455.html
7239,2019-10-09,메디톡스대웅제약과美ITC소송법정대리인에뉴욕검사장출신선임,http://www.updownnews.co.kr/news/articleView.html?idxno=209487
7240,2019-10-10,대웅제약vs메디톡스보툴리눔톡신자존심넘어회사명운사활,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235869
7241,2019-10-10,대웅주가00309010월10일오늘가격14650원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=520614
7242,2019-10-10,주식창대웅주가10일현재14550원,http://nbntv.co.kr/news/view/679450
7243,2019-10-10,장중수급포착대웅외국인10일연속순매수행진주가103,http://www.newspim.com/news/view/20191010000297
7244,2019-10-10,대웅제약주가10월10일현재151500원및증권시세및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=521040
7245,2019-10-10,10월10일대웅제약증권매매154000원233,http://nbntv.co.kr/news/view/679997
7246,2019-10-10,대웅제약메디톡스거짓말말바꾸기즉각중단해야”,http://www.skyedaily.com/news/news_view.html?ID=91730
7247,2019-10-10,대웅제약vs메디톡스보툴리눔톡신균주논란이어져,http://medicalworldnews.co.kr/news/view.php?idx=1510932747
7248,2019-10-11,대웅메디톡스보톡스분쟁서거짓말공방으로,http://www.dailian.co.kr/news/view/832716/?sc=naver
7249,2019-10-11,대웅주가증권그래프외증시동향11일현재14500원,http://www.gokorea.kr/news/articleView.html?idxno=522486
7250,2019-10-11,10월11일대웅실시간주식현황03414550원,http://nbntv.co.kr/news/view/681798
7251,2019-10-11,대웅제약실시간증시11일현재151500원,http://nbntv.co.kr/news/view/682354
7252,2019-10-11,대웅제약메디톡스균주포자형성에제2의인보사우려,http://www.newsprime.co.kr/news/article.html?no=478688
7253,2019-10-12,굿닥터글로벌블록버스터로기대감높이는대웅제약나보타,http://www.g-enews.com/ko-kr/news/article/news_all/20191010171147795569d76442fa_1/article.html
7254,2019-10-14,대웅주가종목그래프및주식시황14일오늘거래가14450원형성,http://www.gokorea.kr/news/articleView.html?idxno=524129
7255,2019-10-14,10월14일대웅주가차트03514400원,http://nbntv.co.kr/news/view/684146
7256,2019-10-14,장중수급포착대웅외국인12일연속순매수행진주가104,http://www.newspim.com/news/view/20191014000346
7257,2019-10-14,대웅제약주가종목그래프14일오늘가격150500원,http://www.gokorea.kr/news/articleView.html?idxno=524502
7258,2019-10-14,대웅제약증권주식14일현재150500원,http://nbntv.co.kr/news/view/684637
7259,2019-10-14,한올대웅바이오신약공동개발속도수출기대감,http://www.dailypharm.com/Users/News/NewsView.html?ID=257693&REFERER=NP
7260,2019-10-14,한올바이오파마대웅제약공동개발안구건조증치료제中임상2상완료,http://www.dt.co.kr/contents.html?article_no=2019101402109931102002&ref=naver
7261,2019-10-14,전승호대웅제약제2의나보타안구건조증치료제개발에속도붙여,http://www.businesspost.co.kr/BP?command=article_view&num=146853
7262,2019-10-15,대웅제약과메디톡스의균주유전적으로달라,http://www.newsway.co.kr/news/view?tp=1&ud=2019101507224418237
7263,2019-10-15,메디톡스대웅균주분석한전문가대웅이메디톡스균주훔쳤다결론내려,http://www.newsway.co.kr/news/view?tp=1&ud=2019101507244859886
7264,2019-10-15,대웅제약유전자분석결과메디톡스균주와달라1보,http://news1.kr/articles/?3743470
7265,2019-10-15,대웅제약메디톡스균주유전적으로다르다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101507362959886
7266,2019-10-15,메디톡스대웅이균주훔쳤다전문가보고서공개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101507334080876
7267,2019-10-15,메디톡스대웅제약보툴리눔균주메디톡스에서유래했다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236075
7268,2019-10-15,대웅제약메디톡스와균주유전적달라소송전승리자신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236074
7269,2019-10-15,대웅제약메디톡스균주유전적으로달라전문가통해입증,http://www.medisobizanews.com/news/articleView.html?idxno=63128
7270,2019-10-15,메디톡스대웅보툴리눔균주자사균주서유래확인,http://www.medisobizanews.com/news/articleView.html?idxno=63129
7271,2019-10-15,대웅제약보툴리눔균주메디톡스와유전적으로달라,http://www.newspim.com/news/view/20191015000049
7272,2019-10-15,대웅제약美ITC소송에서메디톡스와균주유전적으로다름입증”,http://www.ajunews.com/view/20191015083837833
7273,2019-10-15,메디톡스대웅제약이균주훔쳤다는분석나와,http://news.mt.co.kr/mtview.php?no=2019101508394333953
7274,2019-10-15,메디톡스대웅제약이균주도용했다는사실이명백해져,http://www.newspim.com/news/view/20191015000061
7275,2019-10-15,대웅제약메디톡스균주와유전적다름명백히입증상보,http://news1.kr/articles/?3743504
7276,2019-10-15,대웅제약메디톡스균주유전적으로달라,http://www.ebn.co.kr/news/view/1004775
7277,2019-10-15,메디톡스대웅이균주훔친게맞다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88376
7278,2019-10-15,대웅제약메디톡스균주유전적으로달라美소송자신,http://www.newsis.com/view/?id=NISX20191015_0000798735&cID=13001&pID=13000
7279,2019-10-15,메디톡스대웅보툴리눔균주자사균주서유래확인,http://www.ebn.co.kr/news/view/1004778
7280,2019-10-15,대웅제약나보타균주메디톡스균주와유전적으로달라,http://news.mt.co.kr/mtview.php?no=2019101508514716422
7281,2019-10-15,균주전쟁대웅제약메디톡스ITC제출자료로재충돌,http://www.newstomato.com/ReadNews.aspx?no=926139
7282,2019-10-15,대웅제약메디톡스균주유전적으로달라전문가통해입증,http://www.seoulwire.com/news/articleView.html?idxno=235632
7283,2019-10-15,메디톡스대웅제약균주전쟁점입가경우리가맞다,http://www.sisafocus.co.kr/news/articleView.html?idxno=223364
7284,2019-10-15,대웅제약보툴리눔균메디톡스균과유전적으로다르다,http://www.econovill.com/news/articleView.html?idxno=374652
7285,2019-10-15,메디톡스측전문가보고서는오류투성이대웅제약전문가반박보고서공개,http://www.segye.com/content/html/2019/10/15/20191015503123.html?OutUrl=naver
7286,2019-10-15,대웅제약메디톡스균주와유전형표현형차이입증했다”,http://daily.hankooki.com/lpage/ittech/201910/dh20191015091421145630.htm
7287,2019-10-15,대웅제약메디톡스의균주유전적으로달라美ITC소송에서전문가통해입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=16585
7288,2019-10-15,대웅주가003090오늘시세및매매동향15일오늘거래가14550원형성,http://www.gokorea.kr/news/articleView.html?idxno=525855
7289,2019-10-15,대웅제약메디톡스균주와다르다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88381
7290,2019-10-15,메디톡스대웅측전문가균주공동기원확인결론내려”,http://www.econovill.com/news/articleView.html?idxno=374658
7291,2019-10-15,메디톡스대웅제약균주메디톡스균주에서유래주장,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910150042&t=NN
7292,2019-10-15,메디톡스대웅제약끝나지않은보톡스전쟁美ITC소송보고서공개,https://biz.chosun.com/site/data/html_dir/2019/10/15/2019101500711.html
7293,2019-10-15,메디톡스전문가대웅이메디톡스균주훔쳤다결론,http://www.sportsseoul.com/news/read/833323
7294,2019-10-15,대웅주식현재가15일현재14600원,http://nbntv.co.kr/news/view/686380
7295,2019-10-15,메디톡스대웅제약이균주훔친것으로결론”대웅의견반박,http://daily.hankooki.com/lpage/ittech/201910/dh20191015093245145630.htm
7296,2019-10-15,메디톡스균주전문가대웅이메디톡스균주훔쳤다고결론”,http://www.ajunews.com/view/20191015085404852
7297,2019-10-15,종합끝없는보톡스전쟁대웅제약메디톡스ITC보고서도평행선,http://www.newspim.com/news/view/20191015000226
7298,2019-10-15,대웅제약자사균주메디톡스와유전자포자명확히달라,http://www.sportsseoul.com/news/read/833344
7299,2019-10-15,대웅제약메디톡스거짓말무고법적책임묻겠다,http://www.bosa.co.kr/news/articleView.html?idxno=2114064
7300,2019-10-15,대웅제약vs메디톡스균주전쟁점입가경美ITC판단은,http://news.mt.co.kr/mtview.php?no=2019101509491569672
7301,2019-10-15,10월15일대웅제약및증권시세및증권정보와종목동정000변동해,http://www.gokorea.kr/news/articleView.html?idxno=526289
7302,2019-10-15,대웅제약나보타치료적응증시장확대박차,http://www.lawissue.co.kr/view.php?ud=201910151034375250204ead0791_12
7303,2019-10-15,대웅제약메디톡스균주유전적으로달라ITC소송보고서공개,http://www.newsprime.co.kr/news/article.html?no=479015
7304,2019-10-15,대웅제약과메디톡스의균주유전적으로달라미국ITC소송에서유전자분석전문가통해입증,http://newsbrite.net/128116
7305,2019-10-15,이지보고서대웅제약메디톡스美ITC소송보고서공개균주감정결과입장차여전,http://www.ezyeconomy.com/news/articleView.html?idxno=94505
7306,2019-10-15,10월15일대웅제약주식장033150500원,http://nbntv.co.kr/news/view/686929
7307,2019-10-15,대웅제약메디톡스또진실게임ITC보고서도정면대립,https://www.hankyung.com/finance/article/2019101552686
7308,2019-10-15,대웅vs메디톡스서로소송전승리자신,https://view.asiae.co.kr/article/2019101511433876598
7309,2019-10-15,데일리증권대웅003090오후12시04분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=73943
7310,2019-10-15,대웅제약메디톡스상반된균주분석발표ITC판단주목,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073200
7311,2019-10-15,대웅제약메디톡스균주분석간극못좁힌채美공방시작,http://www.newsis.com/view/?id=NISX20191015_0000799216&cID=13001&pID=13000
7312,2019-10-15,균주놓고엇갈린분석대웅제약vs메디톡스공방전지속,http://www.monews.co.kr/news/articleView.html?idxno=205731
7313,2019-10-15,균주분석한전문가대웅이메디톡스균주훔쳤다결론내려,http://www.mdtoday.co.kr/mdtoday/index.html?no=367412
7314,2019-10-15,갈수록헷갈리는메디톡스대웅제약보톡스전쟁,http://www.seouleconews.com/news/articleView.html?idxno=51928
7315,2019-10-15,ITC보고서충돌메디톡스대웅이훔쳤다”VS대웅균주유전적달라”,http://www.viva100.com/main/view.php?key=20191015010004412
7316,2019-10-15,대웅제약메디톡스균주유전적으로달라미국ITC소송서유전자분석전문가통해입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=367414
7317,2019-10-15,메디톡스vs대웅제약불붙은보툴리눔톡신ITC공방전,http://asiatime.co.kr/news/newsview.php?ncode=1065588369003954
7318,2019-10-15,혁신형제약사정부지원작년923억으로19↓엘지대웅종근당순,http://www.medisobizanews.com/news/articleView.html?idxno=63161
7319,2019-10-15,더벨대웅제약복수주관사단구성수요부진의식했나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910140100022100001373
7320,2019-10-15,대웅메디톡스ITC보고서일부공개합의각각입장문발표,http://inthenews.co.kr/article-19839/
7321,2019-10-15,메디톡스대웅제약보톡스출처놓고ITC제출보고서결론공개,http://news.mk.co.kr/newsRead.php?year=2019&no=833320
7322,2019-10-15,대웅제약메디톡스의균주유전적으로달라,http://www.fnnews.com/news/201910151441162936
7323,2019-10-15,대웅제약메디톡스균주유전적으로달라전문가통해입증,https://www.kpanews.co.kr/article/show.asp?idx=207546&category=D
7324,2019-10-15,진흙탕싸움된보톡스공방메디톡스대웅제약메디톡신균주받아시험진행,http://www.newspim.com/news/view/20191015000815
7325,2019-10-15,사건의재구성메디톡스vs대웅보톡스균주주인놓고벌인4년전쟁,http://www.newsway.co.kr/news/view?tp=1&ud=2019101514390043046
7326,2019-10-15,메디톡스대웅제약셔먼박사보고서전체공개하라,http://www.newsprime.co.kr/news/article.html?no=479089
7327,2019-10-15,대웅제약메디톡스균주전쟁점입가경내년2월재판시작,http://www.etnews.com/20191015000262
7328,2019-10-15,메디톡스대웅ITC제출된전체보고서공개동의하라,http://biz.newdaily.co.kr/site/data/html/2019/10/15/2019101500136.html
7329,2019-10-15,나보타균주공방재가열대웅제약유전적으로달라vs메디톡스도용확실,http://www.etoday.co.kr/news/section/newsview.php?idxno=1809548
7330,2019-10-15,메디톡스대웅은ITC에제출된전체보고서공개에동의하라,http://news.mk.co.kr/newsRead.php?year=2019&no=833665
7331,2019-10-15,대웅제약메디톡스균주와유전적차이입증,https://www.hankyung.com/it/article/201910156011i
7332,2019-10-15,메디톡스대웅제약이메디톡스균주훔쳤다”,http://www.sporbiz.co.kr/news/articleView.html?idxno=383141
7333,2019-10-15,메디톡스vs대웅제약또정면충돌ITC보고서상반된결과,http://biz.newdaily.co.kr/site/data/html/2019/10/15/2019101500145.html
7334,2019-10-15,전체보고서공개하자메디톡스대웅제약압박,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101515501176834
7335,2019-10-15,포자에이어유전자까지대웅제약메디톡스보톡스전쟁2라운드,https://www.nocutnews.co.kr/news/5228154
7336,2019-10-15,메디톡스ITC제출보고서전체공개하자”대웅제약에제안,http://www.hankookilbo.com/news/npath/201910151575747080?did=NA
7337,2019-10-15,보톡스균주도용다툼대웅제약vs메디톡스장외공방전시끌,http://www.edaily.co.kr/news/newspath.asp?newsid=03719526622653248
7338,2019-10-15,메디톡스대웅제약균주한국에서분리동정불가능,https://www.hankyung.com/it/article/201910156177i
7339,2019-10-15,고혈압치료제강자아타칸판권향배는대웅제약종근당물망,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101511313923006
7340,2019-10-15,대웅제약나보타메디톡스의균주유전적으로달라,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57658
7341,2019-10-15,메디톡스대웅은ITC에제출된전체보고서공개에동의하라,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57660
7342,2019-10-15,메디톡스대웅균주분석한전문가대웅이메디톡스균주훔쳤다결론내려,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57659
7343,2019-10-15,대웅vs메디톡스독毒한싸움ITC보고서도정면대립,http://www.sisaweek.com/news/articleView.html?idxno=126898
7344,2019-10-15,대웅제약메디톡스보톡스전쟁의기원은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019101509541219396
7345,2019-10-15,메디톡스ITC제출보고서전체공개압박대웅제약입장은,http://inthenews.co.kr/article-19906/
7346,2019-10-15,내가맞다는메디톡스대웅둘중하나는치명상,https://www.sedaily.com/NewsView/1VPJ63MT9E
7347,2019-10-15,보톡스분쟁대웅메디톡스염기서열분석결과에정반대해석내놔,http://news.mk.co.kr/newsRead.php?year=2019&no=834473
7348,2019-10-15,메디톡스대웅제약ITC제출전문가보고서두고설전,http://www.upinews.kr/newsView/upi201910150093
7349,2019-10-15,궁지몰린메디톡스대웅제약균주소송전유리,http://www.newsclaim.co.kr/news/articleView.html?idxno=2273
7350,2019-10-15,대웅제약메디톡스ITC보고서혈투,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910150155&t=NNv
7351,2019-10-15,메디톡스대웅제약ITC에제출된전체보고서공개에동의해야,http://www.newstomato.com/ReadNews.aspx?no=926405
7352,2019-10-15,메디톡스대웅제약전체보고서공개에동의해야,http://www.ebn.co.kr/news/view/1004934
7353,2019-10-15,메디톡스대웅ITC에제출된전체보고서공개에동의해야”,http://www.ajunews.com/view/20191015175902576
7354,2019-10-15,메디톡스대웅제약보톡스균주출처두고서로다른결론공방,https://cnbc.sbs.co.kr/article_hub/10000958525?division=NAVER
7355,2019-10-15,질긴대웅제약과메디톡스보툴리눔톡신균주보고서결과로재충돌,http://www.businesspost.co.kr/BP?command=article_view&num=147046
7356,2019-10-15,대웅제약메디톡스美법정서도진흙탕싸움,http://www.dt.co.kr/contents.html?article_no=2019101602101531102002&ref=naver
7357,2019-10-15,메디톡스대웅은ITC에제출된전체보고서공개에동의하라,http://www.thefirstmedia.net/news/articleView.html?idxno=49481
7358,2019-10-15,대웅제약미국ITC전문가반박보고서공개대웅제약과메디톡스의균주유전적으로달라,http://www.thefirstmedia.net/news/articleView.html?idxno=49498
7359,2019-10-15,메디톡스대웅은ITC에제출된전체보고서공개에동의하라,http://www.insightkorea.co.kr//news/articleView.html?idxno=60491
7360,2019-10-16,대웅제약vs메디톡스균주두고논란지속미국ITC재판부제출보고서일부공개,http://medicalworldnews.co.kr/news/view.php?idx=1510932769
7361,2019-10-16,대웅제약메디톡스상대미국ICT소송승리자신,http://www.dailymedi.com/detail.php?number=848483&thread=22r05
7362,2019-10-16,대웅제약메디톡스ITC발표마다난타전왜,http://www.econovill.com/news/articleView.html?idxno=374770
7363,2019-10-16,대웅제약메디톡스보툴리눔균주논란누가거짓말하나,http://www.rapportian.com/news/articleView.html?idxno=120667
7364,2019-10-16,대웅제약메디톡스의균주유전적으로달라,http://www.nbnnews.co.kr/news/articleView.html?idxno=329155
7365,2019-10-16,대웅제약메디톡스보톡스균주전쟁심화ITC최종결론언제,http://moneys.mt.co.kr/news/mwView.php?no=2019101608558082775
7366,2019-10-16,10월16일대웅003090및증권시세및주식시황102변화해,http://www.gokorea.kr/news/articleView.html?idxno=527783
7367,2019-10-16,10월16일대웅증권투자14850원137,http://nbntv.co.kr/news/view/688727
7368,2019-10-16,보톡스균주출처논란메디톡스유전자분석내용전부공개하자대웅제약거부강력대응,http://www.wsobi.com/news/articleView.html?idxno=82847
7369,2019-10-16,한올․대웅공동개발안구건조증신약美주목,http://www.whosaeng.com/113272
7370,2019-10-16,대웅제약주가069620증권그래프및주식시황16일현재150500원,http://www.gokorea.kr/news/articleView.html?idxno=528199
7371,2019-10-16,보톡스균주주인은대웅제약메디톡스美서도공방,https://cnbc.sbs.co.kr/article_hub/10000958599?division=NAVER
7372,2019-10-16,대웅메디톡스같은보고서전혀다른입장ITC소송3가지핵심쟁점은,http://inthenews.co.kr/article-19984/
7373,2019-10-16,대웅제약주식실시간16일현재151500원,http://nbntv.co.kr/news/view/689281
7374,2019-10-16,대웅제약미국 ITC 소송서유전자전문가통해입증메디톡스균주우리와유전적차이있어,http://www.newslock.co.kr/news/articleView.html?idxno=22214
7375,2019-10-16,또엇갈린주장대웅제약메디톡스염기서열분석결과도달라,http://news.tf.co.kr/read/economy/1765532.htm
7376,2019-10-16,창업중소기업마켓22│뉴대웅가정에서홍삼만드는만능달임기,http://www.naeil.com/news_view/?id_art=328512
7377,2019-10-16,대웅제약vs메디톡스보톡스전쟁은계속된다상반된보고서공개,http://www.thevaluenews.co.kr/news/view.php?idx=157079
7378,2019-10-16,마켓인사이트대웅제약회사채1000억발행,https://www.hankyung.com/finance/article/201910168892u
7379,2019-10-16,보톡스전쟁혼전대웅제약균주독자발견에메디톡스반응은,http://www.sporbiz.co.kr/news/articleView.html?idxno=383444
7380,2019-10-16,대웅메디톡스균주다툼여전업계는산업발전저해걱정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1213922
7381,2019-10-16,대웅제약VS메디톡스보툴리눔균주전쟁브레이크가없다,http://www.straightnews.co.kr/news/articleView.html?idxno=57662
7382,2019-10-16,대웅제약1000억원규모회사채발행추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=367568
7383,2019-10-16,이슈체크메디톡스대웅제약보툴리눔보톡스균주공방,https://cnbc.sbs.co.kr/article_hub/10000958697?division=NAVER
7384,2019-10-17,대웅메디톡스균주전쟁누가거짓말하고있나,http://www.dailian.co.kr/news/view/834296/?sc=naver
7385,2019-10-17,대웅제약보톡스누시바캐나다본격출시,https://view.asiae.co.kr/article/2019101707215801579
7386,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.bosa.co.kr/news/articleView.html?idxno=2114205
7387,2019-10-17,대웅제약보툴리눔톡신제제누시바캐나다출시,https://www.hankyung.com/finance/article/2019101702366
7388,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.lawissue.co.kr/view.php?ud=20191017073945284204ead0791_12
7389,2019-10-17,대웅제약제조보툴리눔톡신캐나다출시,https://biz.chosun.com/site/data/html_dir/2019/10/17/2019101700569.html
7390,2019-10-17,대웅제약보톨리눔톡신캐나다출시,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88419
7391,2019-10-17,대웅제약나보타수출로영업이익개선기대매수신한금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1810331
7392,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시美유럽이어,http://www.medisobizanews.com/news/articleView.html?idxno=63212
7393,2019-10-17,대웅제약낮아진눈높이목표주가유지신한,http://news.mt.co.kr/mtview.php?no=2019101708103958092
7394,2019-10-17,대웅제약나보타수출확대이익증가기대신한금융투자,http://www.fnnews.com/news/201910170816201488
7395,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://news.heraldcorp.com/view.php?ud=20191017000024
7396,2019-10-17,신한금융투자대웅제약경쟁업체와불확실한소송여전낮아진눈높이”,http://www.newsway.co.kr/news/view?tp=1&ud=2019101708221558353
7397,2019-10-17,대웅제약내년영업익견조한증가세주가도상승전망신한금융투자,http://www.dailian.co.kr/news/view/834351/?sc=naver
7398,2019-10-17,대웅제약3분기실적시장기대치밑돌듯”,https://www.sedaily.com/NewsView/1VPK1OO3K4
7399,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시,http://www.ajunews.com/view/20191017081822593
7400,2019-10-17,대웅제약3분기영업이익151억원전망,http://www.nspna.com/news/?mode=view&newsid=388197
7401,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019101708302728802
7402,2019-10-17,대웅제약보툴리눔톡신국산최초미국이어캐나다출시,http://www.newsis.com/view/?id=NISX20191017_0000801330&cID=13001&pID=13000
7403,2019-10-17,대웅제약나보타수출증가내년실적견조할것신한,http://www.edaily.co.kr/news/newspath.asp?newsid=01689206622653904
7404,2019-10-17,대웅제약보톡스캐나다출시클라리온과맞손,http://moneys.mt.co.kr/news/mwView.php?no=2019101708408071077
7405,2019-10-17,대웅제약보툴리눔톡신제제누시바캐나다서출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=367613
7406,2019-10-17,대웅제약제조보툴리눔톡신누시바캐나다본격출시,http://www.ceoscoredaily.com/news/article.html?no=61487
7407,2019-10-17,대웅제약보툴리눔톡신나보타캐나다본격출시,http://www.sportsseoul.com/news/read/834559
7408,2019-10-17,신한금투대웅제약3Q영업익컨센서스하회예상,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910170054&t=NN
7409,2019-10-17,대웅제약국산보툴리눔톡신최초美이어캐나다출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1810373
7410,2019-10-17,대웅제약보톡스제품누시바캐나다출시,http://www.edaily.co.kr/news/newspath.asp?newsid=01738406622653904
7411,2019-10-17,대웅제약나보타미국유럽이어캐나다진출,http://www.newspim.com/news/view/20191017000059
7412,2019-10-17,대웅제약보툴리눔톡신나보타캐나다시장출시,http://medipana.com/news/news_viewer.asp?NewsNum=247074&MainKind=A&NewsKind=5&vCount=12&vKind=1
7413,2019-10-17,특징주대웅제약보툴리눔톡신캐나다수출소식에강세,http://www.newsis.com/view/?id=NISX20191017_0000801405&cID=10401&pID=10400
7414,2019-10-17,대웅제약제조보툴리눔톡신캐나다출시,http://www.ebn.co.kr/news/view/1005158
7415,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출사표,http://www.econovill.com/news/articleView.html?idxno=374928
7416,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.joseilbo.com/news/news_read.php?uid=385725&class=27&grp=
7417,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://news.mk.co.kr/newsRead.php?year=2019&no=840772
7418,2019-10-17,신한금투대웅제약내년실적예상보다낮아질듯목표주가는유지,http://www.newsis.com/view/?id=NISX20191017_0000801406&cID=10401&pID=10400
7419,2019-10-17,신한금융투자대웅제약3분기실적기대이하내년반등전망,http://www.viva100.com/main/view.php?key=20191017010005379
7420,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://daily.hankooki.com/lpage/ittech/201910/dh20191017091718145630.htm
7421,2019-10-17,대웅제약보툴리눔톡신 캐나다본격출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=37061
7422,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=16715
7423,2019-10-17,대웅제약보툴리눔톡신미국에이어캐나다본격출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019101700038
7424,2019-10-17,메디톡스메디톡신품질부적합회수폐기대웅과소송전악재만났다,http://www.dt.co.kr/contents.html?article_no=2019101702109931102002&ref=naver
7425,2019-10-17,10월17일대웅주식실시간14950원067,http://nbntv.co.kr/news/view/691072
7426,2019-10-17,대웅제약보툴리눔톡신캐나다출시,http://news.mt.co.kr/mtview.php?no=2019101709012395525
7427,2019-10-17,대웅제약보툴리눔톡신제제캐나다공식출시,http://www.mhj21.com/125047
7428,2019-10-17,대웅제약눈높이낮춰야할실적,http://www.newsprime.co.kr/news/article.html?no=479398
7429,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시,http://www.etnews.com/20191017000017
7430,2019-10-17,대웅제약제조보툴리눔톡신캐나다출시,http://www.rpm9.com/news/article.html?id=20191017090007
7431,2019-10-17,대웅제약나보타→제품명누시바로캐나다공식출시,http://inthenews.co.kr/article-20190/
7432,2019-10-17,대웅제약보툴리눔톡신캐나다출시,http://fn.segye.com/content/html/2019/10/17/20191017503944.html?OutUrl=naver
7433,2019-10-17,리포트브리핑대웅제약눈높이낮추어야할실적목표가195000원신한금융투자,http://www.newspim.com/news/view/20191017000238
7434,2019-10-17,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=2019101710303012083tpgetnews_16
7435,2019-10-17,대웅제약보툴리눔톡신美이어캐나다출시북미시장적극공략,http://www.newswatch.kr/news/articleView.html?idxno=24415
7436,2019-10-17,대웅제약누시바국산보톡스최초캐나다출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=257879&REFERER=NP
7437,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시로미주시장본격공략,http://www.getnews.co.kr/view.php?ud=2019101709562729841d0c69529_16
7438,2019-10-17,대웅제약국산보툴리눔톡신누시바캐나다진출본격화,http://www.newslock.co.kr/news/articleView.html?idxno=22256
7439,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236204
7440,2019-10-17,대웅제약보툴리눔톡신누시바캐나다본격출시,http://www.viva100.com/main/view.php?key=20191017010005426
7441,2019-10-17,특징주대웅제약투자의견매수목표주가19만5000원,http://www.sisaon.co.kr/news/articleView.html?idxno=102716
7442,2019-10-17,북미시장공략박차”대웅제약나보타美이어캐나다서공식출시,http://www.donga.com/news/article/all/20191017/97916821/1
7443,2019-10-17,대웅제약보툴리눔톡신제제누시바캐나다공식출시,http://www.newsprime.co.kr/news/article.html?no=479409
7444,2019-10-17,대웅제약캐나다서보툴리눔톡신제품출시,http://www.dailymedi.com/detail.php?number=848534&thread=22r05
7445,2019-10-17,대웅제약보톡스제제캐나다서공식출시,http://www.upinews.kr/newsView/upi201910170027
7446,2019-10-17,대웅제약보툴리눔톡신누시바캐나다출시소식에上,http://www.mdtoday.co.kr/mdtoday/index.html?no=367643
7447,2019-10-17,대웅제약3분기실적주춤보톡스수출장중주가반등,http://www.choicenews.co.kr/news/articleView.html?idxno=64981
7448,2019-10-17,대웅제약보툴리눔톡신제제누시바미국이어캐나다출시,http://www.updownnews.co.kr/news/articleView.html?idxno=209839
7449,2019-10-17,대웅제약주가및증권시세17일오늘가격150000원형성,http://www.gokorea.kr/news/articleView.html?idxno=530068
7450,2019-10-17,대웅제약보툴리눔툭신나보타캐나다공식출시,http://www.kpinews.co.kr/news/articleView.html?idxno=105331
7451,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57700
7452,2019-10-17,대웅제약국산보툴리눔톡신최초로캐나다진출북미시장적극공략,http://www.ekn.kr/news/article.html?no=458546
7453,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.asiatoday.co.kr/view.php?key=20191017010009569
7454,2019-10-17,10월17일대웅제약주식창033150000원,http://nbntv.co.kr/news/view/691608
7455,2019-10-17,대웅나보타제품명누시바로캐나다판매개시,http://www.doctorsnews.co.kr/news/articleView.html?idxno=131422
7456,2019-10-17,대웅제약누시바캐나다본격출시,http://www.economytalk.kr/news/articleView.html?idxno=199807
7457,2019-10-17,대웅제약캐나다서보툴리눔톡신누시바출시,http://news.mk.co.kr/newsRead.php?year=2019&no=841907
7458,2019-10-17,대웅제약제조보툴리눔톡신누시바캐나다본격출시,http://newsbrite.net/128290
7459,2019-10-17,대웅제약나보타캐나다시장출시현지제품명은누시바,http://www.rapportian.com/news/articleView.html?idxno=120711
7460,2019-10-17,대웅제약보툴리눔톡신누시바캐나다공식출시,http://www.youthdaily.co.kr/news/article.html?no=20248
7461,2019-10-17,대웅제약보툴리눔톡신제재나보타美이어캐나다에본격출시,https://www.sedaily.com/NewsView/1VPK2XVU9V
7462,2019-10-17,대웅제약자체개발보툴리눔톡신누시바를캐나다에서출시,http://www.businesspost.co.kr/BP?command=article_view&num=147308
7463,2019-10-17,대웅제약보툴리눔톡신나보타캐나다출시북미시장적극공략,http://www.g-enews.com/ko-kr/news/article/news_all/20191017143636478469d76442fa_1/article.html
7464,2019-10-17,대웅제약보툴리눔톡신제제나보타캐나다출시,http://yna.kr/AKR20191017112800017?did=1195m
7465,2019-10-17,대웅제약보툴리눔톡신캐나다본격출시누시바라는제품명으로북미시장출사표,http://www.segye.com/content/html/2019/10/17/20191017510786.html?OutUrl=naver
7466,2019-10-17,콜린알포재평가검토초읽기2700억시장양분한대웅바이오종근당촉각,http://www.sisajournal-e.com/news/articleView.html?idxno=207662
7467,2019-10-17,대웅제약토종주름개선제美이어캐나다진출,https://www.ajunews.com/view/20191017150719092
7468,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.bokuennews.com/news/article.html?no=182069
7469,2019-10-17,식약처회수명령받은메디톡스대웅제약과보톡스전쟁영향은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1810711
7470,2019-10-17,대웅제약보툴리눔톡신캐나다본격출시,http://health.chosun.com/site/data/html_dir/2019/10/17/2019101702034.html
7471,2019-10-17,대웅제약나보타캐나다본격출시,http://www.newstomato.com/ReadNews.aspx?no=926998
7472,2019-10-17,대웅제약제조보툴리눔톡신누시바캐나다공식출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=67884
7473,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.munhwa.com/news/view.html?no=20191017MW165308538640
7474,2019-10-17,대웅제약캐나다서보툴리눔톡신출시,http://www.finomy.com/news/articleView.html?idxno=70520
7475,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.wolyo.co.kr/news/articleView.html?idxno=95765
7476,2019-10-17,대웅제약메디톡스보툴리눔톡신전쟁중희비엇갈려,http://www.newspim.com/news/view/20191017001175
7477,2019-10-17,메디톡스대웅균주도용법정공방속희비,http://www.dt.co.kr/contents.html?article_no=2019101802101531102001&ref=naver
7478,2019-10-17,대웅제약보툴리눔톡신제제나보타캐나다출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3961772
7479,2019-10-17,대웅제약제조보툴리눔톡신캐나다본격출시,http://www.betanews.net:8080/article/1056937.html
7480,2019-10-18,대웅제약나보타균주출처논란에도잘나가는이유는,http://news.tf.co.kr/read/economy/1765665.htm
7481,2019-10-18,대웅주가00309010월18일오늘거래가14550원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=531527
7482,2019-10-18,오늘증시대웅주가18일현재14550원,http://nbntv.co.kr/news/view/693283
7483,2019-10-18,CEO뉴스해외통전승호글로벌대웅앞당긴다,http://www.seoulfn.com/news/articleView.html?idxno=359413
7484,2019-10-18,대웅제약나보타미국이어캐나다에서도출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1214595
7485,2019-10-18,소송중두회사의엇갈린행보메디톡스주춤vs대웅제약비상,http://kpenews.com/View.aspx?No=294306
7486,2019-10-18,10월18일대웅제약실시간증시067149500원,http://nbntv.co.kr/news/view/693823
7487,2019-10-18,대웅제약해외의사교육나보타마스터클래스통해우수성전파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236267
7488,2019-10-18,대웅제약보툴리눔톡신나보타캐나다진출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073332
7489,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://medipana.com/news/news_viewer.asp?NewsNum=247163&MainKind=A&NewsKind=5&vCount=12&vKind=1
7490,2019-10-18,대웅제약K뷰티세몰이각국의사상대나보타클래스릴레이,http://news.heraldcorp.com/view.php?ud=20191018000498
7491,2019-10-18,대웅제약나보타캐나다본격출시 ,http://www.monews.co.kr/news/articleView.html?idxno=205818
7492,2019-10-18,대웅제약해외의사대상나보타교육프로그램진행,http://news.mt.co.kr/mtview.php?no=2019101811403291928
7493,2019-10-18,대웅제약외국의사교육나보타 마스터클래스성료,http://www.medisobizanews.com/news/articleView.html?idxno=63259
7494,2019-10-18,대웅제약나보타마스터클래스해외의사교육으로나보타우수성전파,http://www.newslock.co.kr/news/articleView.html?idxno=22323
7495,2019-10-18,대웅제약해외의사교육나보타마스터클래스진행,http://www.bosa.co.kr/news/articleView.html?idxno=2114320
7496,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019101800059
7497,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://www.seoulwire.com/news/articleView.html?idxno=238593
7498,2019-10-18,대웅제약이틀간나보타마스터클래스진행해외의사초청,http://www.youthdaily.co.kr/news/article.html?no=20361
7499,2019-10-18,대웅제약나보타마스터클래스통해우수성전파,http://www.ebn.co.kr/news/view/1005372
7500,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://www.donga.com/news/article/all/20191018/97939594/1
7501,2019-10-18,대웅제약나보타해외전문의대상으로효능뽐내,http://www.econovill.com/news/articleView.html?idxno=375065
7502,2019-10-18,대웅제약나보타마스터클래스로해외의료진대상나보타우수성전파,http://www.getnews.co.kr/view.php?ud=20191018135055446041d0c69529_16
7503,2019-10-18,대웅제약나보타마스터클래스진행,http://moneys.mt.co.kr/news/mwView.php?no=2019101814048045924
7504,2019-10-18,대웅제약해외의료진대상나보타우수성전파,http://www.dailysmart.co.kr/news/articleView.html?idxno=16825
7505,2019-10-18,제약오늘대웅제약해외의사교육프로그램나보타마스터클래스진행,http://www.sisaon.co.kr/news/articleView.html?idxno=102822
7506,2019-10-18,대웅제약해외의사초청해보툴리눔톡신나보타우수성알려,http://www.businesspost.co.kr/BP?command=article_view&num=147481
7507,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스성료,http://www.ekn.kr/news/article.html?no=458797
7508,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스개최,http://www.dailian.co.kr/news/view/834987/?sc=naver
7509,2019-10-18,대웅제약나보타마스터클래스통해나보타우수성전파,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57721
7510,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://www.lawissue.co.kr/view.php?ud=201910181456317558204ead0791_12
7511,2019-10-18,대웅제약해외의사대상나보타마스터클래스개최,http://www.newspim.com/news/view/20191018000775
7512,2019-10-18,더벨대웅제약위축된A급투심이겨내나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910170100028130001756
7513,2019-10-18,대웅제약해외의사교육프로그램통해나보타우수성전파,http://daily.hankooki.com/lpage/ittech/201910/dh20191018152944145630.htm
7514,2019-10-18,대웅제약외국의사대상교육프로그램나보타마스터클래스개최,http://news.mk.co.kr/newsRead.php?year=2019&no=847727
7515,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스진행,http://fn.segye.com/content/html/2019/10/18/20191018509461.html?OutUrl=naver
7516,2019-10-18,대웅해외의사대상나보타마스터클래스성료,http://www.dailymedi.com/detail.php?number=848598&thread=22r05
7517,2019-10-18,대웅제약나보타해외의사교육프로그램나보타마스터클래스진행,https://www.sedaily.com/NewsView/1VPKJV4MXM
7518,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://newsbrite.net/128394
7519,2019-10-18,대웅제약나보타마스터클래스진행,http://www.wolyo.co.kr/news/articleView.html?idxno=95822
7520,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스성료,http://www.mdtoday.co.kr/mdtoday/index.html?no=367827
7521,2019-10-18,대웅제약해외의사교육프로그램진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1343175
7522,2019-10-18,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://www.businesskorea.co.kr/news/articleView.html?idxno=37151
7523,2019-10-18,대웅제약나보타마스터클래스로나보타우수성전파,http://www.newscj.com/news/articleView.html?idxno=676019
7524,2019-10-19,메디톡스대웅제약보톡스전쟁4년전말,https://view.asiae.co.kr/article/2019101900570047232
7525,2019-10-20,대웅제약나보타마스터클래스개최나보타우수성전파,http://www.viva100.com/main/view.php?key=20191020010006137
7526,2019-10-20,전승호대웅제약통증따라다른액상형진통제로시장공략공세,http://www.businesspost.co.kr/BP?command=article_view&num=147603
7527,2019-10-20,대웅제약자체개발보툴리눔톡신국산최초미국이어캐나다출시,http://www.econonews.co.kr/news/articleView.html?idxno=91536
7528,2019-10-20,대웅보툴리눔톡신캐나다출시,http://www.whosaeng.com/113365
7529,2019-10-21,대웅제약해외의사교육프로그램나보타마스터클래스통해나보타우수성전파,http://www.thefirstmedia.net/news/articleView.html?idxno=49656
7530,2019-10-21,대웅제약해외의사대상나보타마스터클래스개최,http://www.monews.co.kr/news/articleView.html?idxno=205822
7531,2019-10-21,대웅주가003090오늘시세21일현재14300원형성,http://www.gokorea.kr/news/articleView.html?idxno=533561
7532,2019-10-21,주식창대웅주가21일현재14350원,http://nbntv.co.kr/news/view/695601
7533,2019-10-21,대웅제약주가06962010월21일오늘거래가148500원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=533996
7534,2019-10-21,대웅제약증권매매21일현재148500원,http://nbntv.co.kr/news/view/696138
7535,2019-10-21,신용등급A대웅1천억회사채연타석흥행도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=257951&REFERER=NP
7536,2019-10-21,대웅제약무보증사채신용등급A,http://www.mdtoday.co.kr/mdtoday/index.html?no=367968
7537,2019-10-22,현대종합상사대웅제약A등급걱정털고자금조달성공할까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1812048
7538,2019-10-22,대웅제약전승호윤재춘대표체제서해외종속기업적자7배↑,http://www.datanews.co.kr/news/article.html?no=104869
7539,2019-10-22,대웅주가00309010월22일현재14500원정보,http://www.gokorea.kr/news/articleView.html?idxno=535522
7540,2019-10-22,10월22일대웅주식현재가03514500원,http://nbntv.co.kr/news/view/697893
7541,2019-10-22,보톡스전쟁에맥빠진메디톡스대웅제약승자는휴젤,http://www.enewstoday.co.kr/news/articleView.html?idxno=1343702
7542,2019-10-22,대웅제약미국신경과학회서만성통증치료제신약연구발표,http://www.newstomato.com/ReadNews.aspx?no=927804
7543,2019-10-22,대웅제약주가10월22일현재150000원종목그래프외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=535960
7544,2019-10-22,10월22일대웅제약주식추천주033149500원,http://nbntv.co.kr/news/view/698432
7545,2019-10-22,대웅제약美SFN서만성통증치료제신약연구발표,http://www.economytalk.kr/news/articleView.html?idxno=200002
7546,2019-10-22,22일데일리증권대웅003090오후12시06분기준및증권정보와종목동정,https://www.dailysecu.com/news/articleView.html?idxno=75041
7547,2019-10-22,CJ케이캡잡아라대웅제일항궤양제신약개발속도전,http://www.newsway.co.kr/news/view?tp=1&ud=2019102216505786917
7548,2019-10-23,대웅제약분기최고실적이위축된투자심리이겨낼까,https://www.ajunews.com/view/20191022154915878
7549,2019-10-23,10월23일대웅003090정보외매매동향000,http://www.gokorea.kr/news/articleView.html?idxno=537396
7550,2019-10-23,10월23일대웅주식종목03414550원,http://nbntv.co.kr/news/view/700126
7551,2019-10-23,대웅제약주가및증권시세및종목관련동향정보23일오늘가격150000원,http://www.gokorea.kr/news/articleView.html?idxno=537820
7552,2019-10-23,대웅제약증권매매23일현재149500원,http://nbntv.co.kr/news/view/700673
7553,2019-10-23,데일리주식정보대웅003090오후12시04분기준및매매동향,https://www.dailysecu.com/news/articleView.html?idxno=75265
7554,2019-10-23,대웅제약미국신경과학회서만성통증치료제신약연구발표,http://asiatime.co.kr/news/newsview.php?ncode=1065597679743859
7555,2019-10-23,제약업계3분기실적공개임박대웅제약동아ST주목,http://www.sisajournal-e.com/news/articleView.html?idxno=207912
7556,2019-10-24,10월24일대웅003090증권투자정보외주식시황000변동해,http://www.gokorea.kr/news/articleView.html?idxno=539244
7557,2019-10-24,10월24일대웅오늘증시00014450원,http://nbntv.co.kr/news/view/702360
7558,2019-10-24,대웅제약관계사디엔컴퍼니이지듀홈앤쇼핑서판매,http://moneys.mt.co.kr/news/mwView.php?no=2019102410128043898
7559,2019-10-24,대웅제약유럽서위식도역류질환치료제다인종임상1상결과발표,http://www.viva100.com/main/view.php?key=20191024010007859
7560,2019-10-24,대웅제약위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.ftoday.co.kr/news/articleView.html?idxno=112213
7561,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제1상발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236511
7562,2019-10-24,대웅제약유럽소화기학회서DWP14012다인종1상임상결과발표,http://www.newspim.com/news/view/20191024000558
7563,2019-10-24,대웅제약유럽소화기학회서DWP140121상임상결과발표,http://www.ebn.co.kr/news/view/1006179/?sc=naver
7564,2019-10-24,대웅제약유럽학회서차세대위식도역류질환치료제임상데이터발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1813421
7565,2019-10-24,대웅제약이지듀DWEGF프레좀RX크림홈앤쇼핑24일방송,http://www.news2day.co.kr/139997
7566,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://daily.hankooki.com/lpage/ittech/201910/dh20191024112044145630.htm
7567,2019-10-24,대웅제약위식도역류치료제다인종서약효확인,http://www.medisobizanews.com/news/articleView.html?idxno=63430
7568,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=368352
7569,2019-10-24,대웅제약유럽소화기학회서역류성식도염신약후보물질임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=867803
7570,2019-10-24,대웅제약DWP14012다인종1상임상결과발표,http://www.bosa.co.kr/news/articleView.html?idxno=2114671
7571,2019-10-24,대웅제약스페인서PPI약물DWP14012임상데이터공개,http://moneys.mt.co.kr/news/mwView.php?no=2019102411288077356
7572,2019-10-24,대웅제약인니재생의료사업지원RD생산기지구축착착,http://www.maeilnews.co.kr/news/article.html?no=5597
7573,2019-10-24,막말윤재승 대웅제약회장의막후경영노림수,http://www.ilyosisa.co.kr/news/articleView.html?idxno=209732
7574,2019-10-24,대웅제약유럽소화기학회서DWP14012다인종1상결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=247493&MainKind=A&NewsKind=5&vCount=12&vKind=1
7575,2019-10-24,대웅제약유럽소화기학회서위식도역류질환신약1상임상결과발표,https://biz.chosun.com/site/data/html_dir/2019/10/24/2019102401384.html
7576,2019-10-24,대웅제약유럽소화기학회에서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://newsbrite.net/128774
7577,2019-10-24,대웅제약위식도역류신약물질여러인종서동일한효능보여,http://news1.kr/articles/?3751672
7578,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제다인종1상임상결과발표,http://www.sisafocus.co.kr/news/articleView.html?idxno=224129
7579,2019-10-24,대웅위식도역류질환치료제1상임상결과 ,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88524
7580,2019-10-24,대웅제약 유럽소화기학회에서위식도역류질환치료제 DWP14012 다인종 1상임상결과발표,http://www.businesskorea.co.kr/news/articleView.html?idxno=37333
7581,2019-10-24,대웅제약위식도역류질환치료제DWP14012임상결과유럽소화기학회발표,http://www.getnews.co.kr/view.php?ud=20191024131141440541d0c69529_16
7582,2019-10-24,대웅위식도역류질환제DWP14012임상결과발표,http://www.dailypharm.com/Users/News/NewsView.html?ID=258178&REFERER=NP
7583,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제1상발표,http://www.seoulwire.com/news/articleView.html?idxno=241847
7584,2019-10-24,대웅제약위식도역류질환치료제BestinClass목표,http://www.econovill.com/news/articleView.html?idxno=375581
7585,2019-10-24,대웅제약DWP14012다인종1상임상결과발표,http://www.medigatenews.com/news/2756863562
7586,2019-10-24,대웅제약위식도역류질환치료제DWP14012다인종1상임상결과발표,http://kormedi.com/?p=1304288
7587,2019-10-24,대웅제약바르셀로나서위식도역류질환치료제발표,http://www.youthdaily.co.kr/news/article.html?no=20872
7588,2019-10-24,대웅제약유럽서위식도역류질환치료제임상결과발표,http://www.etnews.com/20191024000274
7589,2019-10-24,대웅제약위식도역류치료제DWP14012임상결과인종간차이없어,http://www.newslock.co.kr/news/articleView.html?idxno=22582
7590,2019-10-24,대웅제약유럽학회서위식도역류질환치료제임상발표,https://www.paxnetnews.com/articles/53213
7591,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://www.wolyo.co.kr/news/articleView.html?idxno=96257
7592,2019-10-24,대웅제약유럽서위식도역류질환치료제1상결과발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019102414381133801
7593,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표약력학적인종간차이없다,http://www.updownnews.co.kr/news/articleView.html?idxno=210165
7594,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57839
7595,2019-10-24,대웅제약유럽소화기학회위식도역류질환다인종1상발표,http://www.newsis.com/view/?id=NISX20191024_0000809084&cID=13001&pID=13000
7596,2019-10-24,대웅역류성식도염치료제임상결과발표,http://www.dailymedi.com/detail.php?number=848814&thread=22r05
7597,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://www.newstomato.com/ReadNews.aspx?no=928573
7598,2019-10-24,대웅제약유럽소화기학회서DW14012임상발표,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102415221873532
7599,2019-10-24,대웅제약유럽소화기학회서위식도역류질환신약1상임상결과발표,http://www.ajunews.com/view/20191024153543672
7600,2019-10-24,대웅제약위식도역류질환신약임상1상효과확인,http://news.mt.co.kr/mtview.php?no=2019102413140364503
7601,2019-10-24,대웅제약위식도역류질환치료제다인종1상결과발표,http://health.chosun.com/site/data/html_dir/2019/10/24/2019102402181.html
7602,2019-10-24,대웅제약위식도역류질환신약다인종임상1상서효과확인,https://view.asiae.co.kr/article/2019102416183381112
7603,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료신약임상연구결과공개,http://www.g-enews.com/ko-kr/news/article/news_all/20191024160859732169d76442fa_1/article.html
7604,2019-10-24,대웅제약위식도역류질환치료제임상1상다인종간효과확인,http://kpenews.com/View.aspx?No=300458
7605,2019-10-24,대웅제약유럽학회서위식도역류질환치료제DWP14012임상결과발표,http://www.news2day.co.kr/140056
7606,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제다인종1상임상결과발표,http://www.sporbiz.co.kr/news/articleView.html?idxno=385933
7607,2019-10-24,대웅제약유럽소화기학회서위식도역류질환치료제DWP140121상임상결과발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1344449
7608,2019-10-24,대웅제약유럽서위식도역류질환치료제임상결과발표,http://www.economytalk.kr/news/articleView.html?idxno=200164
7609,2019-10-24,대웅제약유럽학회서신약DWP14012임상결과발표,http://www.mhj21.com/125261
7610,2019-10-24,대웅제약위식도역류질환치료제다양한인종에효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=148281
7611,2019-10-24,대웅제약위식도역류질환신약후보물질DWP14012유럽소개,http://www.sportsseoul.com/news/read/838661
7612,2019-10-24,대웅제약유럽서위식도역류질환치료제펙수프라잔다인종임상결과발표,http://www.donga.com/news/article/all/20191024/98057445/1
7613,2019-10-24,대웅제약DWP14012위산분비억제효과확인,http://www.finomy.com/news/articleView.html?idxno=70840
7614,2019-10-24,대웅제약위식도역류질환치료제다인종1상임상결과발표,http://www.newscj.com/news/articleView.html?idxno=677623
7615,2019-10-24,대웅제약국민20가알레르기비염코메키나로잡으세요,http://www.getnews.co.kr/view.php?ud=20191024212109739341d0c69529_16
7616,2019-10-25,대웅제약위식도역류질환치료제다인종1상결과발표,http://www.nbnnews.co.kr/news/articleView.html?idxno=332999
7617,2019-10-25,대웅제약유럽소화기학회에서위식도역류질환치료제DWP14012다인종1상임상결과발표,http://www.betanews.net:8080/article/1057739.html
7618,2019-10-25,종근당락토핏TV홈쇼핑대박에대웅이지듀프레좀도진출,http://news.heraldcorp.com/view.php?ud=20191025000010
7619,2019-10-25,대웅제약차세대위식도역류질환치료제인종간차이없어 ,http://www.monews.co.kr/news/articleView.html?idxno=205976
7620,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://medipana.com/news/news_viewer.asp?NewsNum=247535&MainKind=A&NewsKind=5&vCount=12&vKind=1
7621,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://www.ebn.co.kr/news/view/1006323/?sc=naver
7622,2019-10-25,대웅주가오늘시세및증권정보와종목동정25일오늘거래가14400원거래,http://www.gokorea.kr/news/articleView.html?idxno=541053
7623,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236541
7624,2019-10-25,대웅제약액상형진통제이지엔6프로먹기편해졌다,http://www.econovill.com/news/articleView.html?idxno=375647
7625,2019-10-25,대웅제약이지엔6프로리뉴얼알약축소,http://moneys.mt.co.kr/news/mwView.php?no=2019102509118028350
7626,2019-10-25,대웅제약 작아진이지엔6프로출시복용편의성개선,http://www.medisobizanews.com/news/articleView.html?idxno=63448
7627,2019-10-25,대웅제약이지엔6프로리뉴얼로소비자복용편의성높인다,http://www.newspim.com/news/view/20191025000252
7628,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.dailysmart.co.kr/news/articleView.html?idxno=17156
7629,2019-10-25,주식그래프대웅주가25일현재14350원,http://nbntv.co.kr/news/view/704543
7630,2019-10-25,대웅제약복용편의성확대한이지엔6프로출시,http://www.viva100.com/main/view.php?key=20191025010008164
7631,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성개선,http://www.seoulwire.com/news/articleView.html?idxno=242104
7632,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://www.newsis.com/view/?id=NISX20191025_0000809734&cID=13001&pID=13000
7633,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성개선,http://www.dailymedi.com/detail.php?number=848843&thread=22r05
7634,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57845
7635,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://daily.hankooki.com/lpage/ittech/201910/dh20191025095329145630.htm
7636,2019-10-25,작아진이지엔6프로대웅제약약제리뉴얼,http://www.mhj21.com/125274
7637,2019-10-25,대웅제약DWP14012다인종1상임상결과발표,http://www.bokuennews.com/news/article.html?no=182419
7638,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.newsway.co.kr/news/view?tp=1&ud=2019102510384996188
7639,2019-10-25,대웅제약이지엔6프로리뉴얼,http://www.enewstoday.co.kr/news/articleView.html?idxno=1344627
7640,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.ceoscoredaily.com/news/article.html?no=61781
7641,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.bokuennews.com/news/article.html?no=182428
7642,2019-10-25,대웅제약이지엔6프로리뉴얼,http://www.bosa.co.kr/news/articleView.html?idxno=2114762
7643,2019-10-25,대웅제약크기줄인진통제이지엔6프로재출시,http://health.chosun.com/site/data/html_dir/2019/10/25/2019102500968.html
7644,2019-10-25,대웅제약실시간주식현황25일현재149500원,http://nbntv.co.kr/news/view/705079
7645,2019-10-25,대웅제약소비자의견반영해액상형진통제이지엔6프로리뉴얼,http://news.mk.co.kr/newsRead.php?year=2019&no=872384
7646,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.economytalk.kr/news/articleView.html?idxno=200198
7647,2019-10-25,대웅제약복용편의성개선위해작아진이지엔6프로출시,http://www.updownnews.co.kr/news/articleView.html?idxno=210227
7648,2019-10-25,대웅제약이지엔6프로리뉴얼로소비자복용편의성증대,http://www.polinews.co.kr/news/article.html?no=428273
7649,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성증대,http://www.youthdaily.co.kr/news/article.html?no=20975
7650,2019-10-25,대웅제약액상형진통제이지엔6프로리뉴얼소비자복용편의성증대,http://www.newslock.co.kr/news/articleView.html?idxno=22645
7651,2019-10-25,대웅제약이지엔6프로리뉴얼출시,http://www.ezyeconomy.com/news/articleView.html?idxno=94817
7652,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://newsbrite.net/128847
7653,2019-10-25,대웅제약이지엔6프로재출시크기줄여,http://www.finomy.com/news/articleView.html?idxno=70889
7654,2019-10-25,대웅제약이지엔6프로리뉴얼출시,http://www.ajunews.com/view/20191025152225377
7655,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.asiatoday.co.kr/view.php?key=20191025010014624
7656,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.news2day.co.kr/140155
7657,2019-10-25,대웅제약진통제이지엔6프로복용편의성개선,http://www.kpinews.co.kr/news/articleView.html?idxno=105938
7658,2019-10-25,대웅제약이지엔6프로리뉴얼제형크기줄여복용편의성증대,http://kpenews.com/View.aspx?No=301622
7659,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.segye.com/content/html/2019/10/25/20191025510899.html?OutUrl=naver
7660,2019-10-25,더작고부드럽게대웅제약복용편의성높아진이지엔6프로출시,http://www.100ssd.co.kr/news/articleView.html?idxno=64949
7661,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.getnews.co.kr/view.php?ud=20191025171637777641d0c69529_16
7662,2019-10-25,대웅제약이지엔6프로리뉴얼복용편의성높여,http://www.wikileaks-kr.org/news/articleView.html?idxno=68514
7663,2019-10-25,대웅제약이지엔6프로리뉴얼통한소비자복용편의성증대,http://www.wsobi.com/news/articleView.html?idxno=83365
7664,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.mdtoday.co.kr/mdtoday/index.html?no=368461
7665,2019-10-25,대웅제약이지엔6프로리뉴얼소비자복용편의성증대,http://www.newscj.com/news/articleView.html?idxno=677943
7666,2019-10-26,대웅제약크기줄인진통제이지엔6프로재출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=333422
7667,2019-10-27,대웅제약이지엔6프로리뉴얼로소비자편의성증대,http://asiatime.co.kr/news/newsview.php?ncode=1065577392331202
7668,2019-10-27,美수출5개월만에244억팔린대웅나보타,https://www.sedaily.com/NewsView/1VPOPA6G7M
7669,2019-10-28,이지돋보기라니티딘발암물질쇼크위장약시장재편초읽기대웅일동울상한미CJ보령미소,http://www.ezyeconomy.com/news/articleView.html?idxno=94831
7670,2019-10-28,갑질로물러난윤재승전대웅제약회장재단이사장등요직지키며영향력행사,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534514
7671,2019-10-28,대웅나보타수출5개월만에244억원어치팔렸다,https://cnbc.sbs.co.kr/article_hub/10000960004?division=NAVER
7672,2019-10-28,10월28일대웅주식장14150원035,http://nbntv.co.kr/news/view/707012
7673,2019-10-28,대웅제약유럽소화기학회서위식도역류질환치료제임상결과발표,http://www.ekn.kr/news/article.html?no=459906
7674,2019-10-28,대웅제약복용편의성높인이지엔6프로선봬,http://www.ekn.kr/news/article.html?no=460092
7675,2019-10-28,대웅제약주가069620및증권시세28일오늘거래가148500원형성,http://www.gokorea.kr/news/articleView.html?idxno=543449
7676,2019-10-28,오늘증권시세대웅제약주가28일현재148000원,http://nbntv.co.kr/news/view/707517
7677,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57871
7678,2019-10-28,대웅제약 인도네시아 소방관1000명대상의료봉사,http://www.medisobizanews.com/news/articleView.html?idxno=63492
7679,2019-10-28,대웅인도네시아현지소방관대상해외의료봉사,http://www.dailypharm.com/Users/News/NewsView.html?ID=258272&REFERER=NP
7680,2019-10-28,대웅제약인니소방관에의료봉사활동진행,http://moneys.mt.co.kr/news/mwView.php?no=2019102811258065945
7681,2019-10-28,대웅제약인도네시아현지서의료봉사진행,http://www.economytalk.kr/news/articleView.html?idxno=200262
7682,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://weekly.cnbnews.com/news/article.html?no=130834
7683,2019-10-28,대웅제약의료봉사와협업으로인도네시아시장적극공략,http://www.metroseoul.co.kr/news/newsview?newscd=2019102800096
7684,2019-10-28,대웅제약위역류치료제유럽임상1상서효과확인,http://www.munhwa.com/news/view.html?no=2019102801072327107001
7685,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.lawissue.co.kr/view.php?ud=201910281228149171204ead0791_12
7686,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.betanews.net:8080/article/1057974.html
7687,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.ekn.kr/news/article.html?no=460561
7688,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.viva100.com/main/view.php?key=20191028010009031
7689,2019-10-28,브릿지바이오코스닥행확정에유한양행대웅제약투자가치↑,http://news1.kr/articles/?3754281
7690,2019-10-28,대웅제약인니소방관상대현지의료봉사,https://www.nocutnews.co.kr/news/5234257
7691,2019-10-28,더벨대웅제약A급자존심세웠다첫1대금리조달,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910250100046250002884
7692,2019-10-28,대웅제약인니현지소방관에게의료봉사실시,http://asiatime.co.kr/news/newsview.php?ncode=1065588555826277
7693,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://news.mk.co.kr/newsRead.php?year=2019&no=881268
7694,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236612
7695,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.newsway.co.kr/news/view?tp=1&ud=2019102814463595516
7696,2019-10-28,대웅제약인도네시아소방관대상의료봉사활동전개,http://www.rapportian.com/news/articleView.html?idxno=120968
7697,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사향후지원대상확대할것,http://www.segye.com/content/html/2019/10/28/20191028509655.html?OutUrl=naver
7698,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사,http://www.bokuennews.com/news/article.html?no=182506
7699,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://www.kpinews.co.kr/news/articleView.html?idxno=106063
7700,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사,http://www.bosa.co.kr/news/articleView.html?idxno=2114884
7701,2019-10-28,사회공헌대웅제약인도네시아현지소방관대상의료봉사,http://www.ezyeconomy.com/news/articleView.html?idxno=94865
7702,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=368594
7703,2019-10-28,대웅제약인도네시아현지소방관대상의료봉사진행,http://www.seoulwire.com/news/articleView.html?idxno=243751
7704,2019-10-28,대웅제약인도네시아소방관대상의료봉사,http://news.mt.co.kr/mtview.php?no=2019102815224077407
7705,2019-10-28,대웅제약인도네시아소방관대상의료봉사진행,http://www.youthdaily.co.kr/news/article.html?no=21152
7706,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://newsbrite.net/129001
7707,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://medipana.com/news/news_viewer.asp?NewsNum=247649&MainKind=A&NewsKind=5&vCount=12&vKind=1
7708,2019-10-28,대웅제약인도네시아현지소방관1000여명에의료봉사진행인도네시아바이오산업발전에기여할것,http://www.updownnews.co.kr/news/articleView.html?idxno=210302
7709,2019-10-28,대웅제약인도네시아현지소방관대상의료봉사진행,http://www.dailian.co.kr/news/view/837927/?sc=naver
7710,2019-10-28,라니티딘퇴출대웅일동대체방안확보주력,http://www.wolyo.co.kr/news/articleView.html?idxno=96463
7711,2019-10-28,대웅제약인도네시아소방관대상의료봉사,http://www.skyedaily.com/news/news_view.html?ID=92776
7712,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사,http://www.dailysmart.co.kr/news/articleView.html?idxno=17277
7713,2019-10-28,대웅제약인도네시아와협력강화소방관대상의료봉사진행,http://www.econovill.com/news/articleView.html?idxno=375895
7714,2019-10-28,대웅제약그룹압수수색현장조사매출손실등겹악재에곤혹,http://www.sisajournal-e.com/news/articleView.html?idxno=208116
7715,2019-10-28,대웅제약印泥소방관대상해외의료봉사진행,http://daily.hankooki.com/lpage/ittech/201910/dh20191028174814145630.htm
7716,2019-10-28,대웅제약인도네시아소방관1000여명대상의료봉사,http://www.etoday.co.kr/news/section/newsview.php?idxno=1814871
7717,2019-10-28,대웅제약인도네시아현지소방관대상의료봉사진행,http://www.wikileaks-kr.org/news/articleView.html?idxno=68690
7718,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.getnews.co.kr/view.php?ud=20191028183450740541d0c69529_16
7719,2019-10-28,대웅제약인도네시아소방관대상해외의료봉사,http://www.news2day.co.kr/140339
7720,2019-10-28,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.newscj.com/news/articleView.html?idxno=678537
7721,2019-10-29,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.thefirstmedia.net/news/articleView.html?idxno=49983
7722,2019-10-29,대웅제약매출원가율줄여영업이익154↑,http://www.datanews.co.kr/news/article.html?no=104935
7723,2019-10-29,★주식인사이드대웅제약주가148500원10월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1042834
7724,2019-10-29,아이디에스앤트러스트SAPS4하나구축으로대웅제악업무혁신도와,http://www.ajunews.com/view/20191029093033146
7725,2019-10-29,10월29일대웅003090증권투자정보외매매동향000변화,http://www.gokorea.kr/news/articleView.html?idxno=544925
7726,2019-10-29,대웅제약SAPS4HANA로전사업무혁신,http://www.etnews.com/20191029000074
7727,2019-10-29,대웅오늘증권시세29일현재14000원,http://nbntv.co.kr/news/view/709277
7728,2019-10-29,대웅제약차세대ERPUX솔루션RPA로일하는방식바꿨다,http://www.dt.co.kr/contents.html?article_no=2019102902109931650004&ref=naver
7729,2019-10-29,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.polinews.co.kr/news/article.html?no=429343
7730,2019-10-29,대웅제약오늘주식시세29일현재149500원,http://nbntv.co.kr/news/view/709770
7731,2019-10-29,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1345415
7732,2019-10-29,더벨대웅제약고함량치매치료제출시두고고심,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910280100051920003237
7733,2019-10-29,대웅제약SAPS4HANARPA로업무방식개선,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20191029151917
7734,2019-10-29,대웅제약SAPS4HANA도입,http://www.ddaily.co.kr/news/article.html?no=187540
7735,2019-10-29,대웅제약SAPS4HANA도입해전사업무혁신,http://www.datanet.co.kr/news/articleView.html?idxno=138606
7736,2019-10-29,대웅제약SAP차세대EPR솔루션도입,http://www.inews24.com/view/1218268
7737,2019-10-29,제약산업대웅제약이지엔6프로복용편의성높여리뉴얼外,http://www.kukinews.com/news/article.html?no=714413
7738,2019-10-29,대웅제약인도네시아현지소방관대상해외의료봉사진행,http://www.g-enews.com/ko-kr/news/article/news_all/201910291912396109aca1a8c21a_1/article.html
7739,2019-10-30,유통대웅일동라니티딘정산비협조에약사회와공조할것,https://www.kpanews.co.kr/article/show.asp?idx=207981&category=D
7740,2019-10-30,★주식인사이드대웅제약주가149500원10월30일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1043320
7741,2019-10-30,10월30일대웅및증권시세071변동,http://www.gokorea.kr/news/articleView.html?idxno=546848
7742,2019-10-30,10월30일대웅증권매매14100원036,http://nbntv.co.kr/news/view/711506
7743,2019-10-30,대웅제약주가10월30일오늘거래가149500원및증권시세외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=547282
7744,2019-10-30,종목검색대웅제약주가30일현재149500원,http://nbntv.co.kr/news/view/712016
7745,2019-10-30,30일데일리증권대웅003090오후12시05분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=76479
7746,2019-10-31,대웅녹십자한미등대형제약사5000억대자금조달,http://www.dailymedi.com/detail.php?number=849033&thread=22r05
7747,2019-10-31,라니티딘직격탄맞은대웅일동제약회수문제두고유통사와갈등고조,https://asiatime.co.kr/news/newsview.php?ncode=1065589187549353
7748,2019-10-31,제약사오너일가지주사지분율높이기분주주대웅형제간분쟁으로지배력뚝,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534572
7749,2019-10-31,대웅주가00309010월31일오늘가격14100원종목그래프및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=548755
7750,2019-10-31,10월31일대웅오늘주식장03614100원,http://nbntv.co.kr/news/view/713748
7751,2019-10-31,대웅제약주가06962010월31일오늘가격151500원오늘시세및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=549174
7752,2019-10-31,대웅제약주식현재가31일현재151000원,http://nbntv.co.kr/news/view/714256
7753,2019-10-31,대웅에이비엘바이오유한얀센2019우수혁신형제약영예,http://medipana.com/news/news_viewer.asp?NewsNum=247863&MainKind=A&NewsKind=5&vCount=12&vKind=1
7754,2019-10-31,데일리주가정보대웅003090오후12시05분기준외주식시황,https://www.dailysecu.com/news/articleView.html?idxno=76680
7755,2019-10-31,2019우수혁신형제약유한대웅에이비엘바이오얀센,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236812
7756,2019-10-31,대웅제약인도네시아소방관대상의료봉사진행,http://www.wsobi.com/news/articleView.html?idxno=83712
7757,2019-11-01,국민연금나보타美수출길연대웅제약지분율높여,http://www.ceoscoredaily.com/news/article.html?no=62002
7758,2019-11-01,★주식인사이드대웅제약주가150500원11월1일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1044205
7759,2019-11-01,더벨대웅제약완판에도성과보수불가주관사입맛만,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910300100057710003586
7760,2019-11-01,대웅주가11월1일오늘거래가14300원종목그래프및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=550658
7761,2019-11-01,11월1일대웅시세보기03514300원,http://nbntv.co.kr/news/view/715940
7762,2019-11-01,대웅제약혁신형제약기업복지부장관상수상,http://www.viva100.com/main/view.php?key=20191101010000076
7763,2019-11-01,신약파이프확충대웅제약혁신형제약기업정부상받았다,http://news.heraldcorp.com/view.php?ud=20191101000172
7764,2019-11-01,나보타의글로벌진출대웅제약혁신형제약기업정부포상,http://www.dailysmart.co.kr/news/articleView.html?idxno=17516
7765,2019-11-01,대웅제약우수혁신형제약기업선정복지부장관상수상,http://moneys.mt.co.kr/news/mwView.php?no=2019110109488072936
7766,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.dailypharm.com/Users/News/NewsView.html?ID=258477&REFERER=NP
7767,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.mdtoday.co.kr/mdtoday/index.html?no=369045
7768,2019-11-01,대웅제약우수혁신형제약기업선정복지부장관상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817012
7769,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.econovill.com/news/articleView.html?idxno=376283
7770,2019-11-01,대웅제약우수혁신형제약기업보건복지부장관상수상,https://biz.chosun.com/site/data/html_dir/2019/11/01/2019110100935.html
7771,2019-11-01,대웅제약혁신형제약기업정부포상쾌거,http://www.todaykorea.co.kr/news/view.php?no=265434
7772,2019-11-01,대웅제약우수혁신형제약기업선정정부포상,http://www.medisobizanews.com/news/articleView.html?idxno=63641
7773,2019-11-01,대웅제약우수혁신형제약기업정부포상,http://medipana.com/news/news_viewer.asp?NewsNum=247947&MainKind=A&NewsKind=5&vCount=12&vKind=1
7774,2019-11-01,대웅제약우수혁신형제약기업포상받아,http://news.mk.co.kr/newsRead.php?year=2019&no=897305
7775,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.etnews.com/20191101000046
7776,2019-11-01,대웅제약혁신형기업정부포상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88699
7777,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.newsway.co.kr/news/view?tp=1&ud=2019110110215349444
7778,2019-11-01,대웅제약제약산업기여공로인정받아혁신형제약기업정부포상수여,https://asiatime.co.kr/news/newsview.php?ncode=1065574518204415
7779,2019-11-01,대웅제약혁신형제약기업복지부장관상등수상,http://www.rapportian.com/news/articleView.html?idxno=121097
7780,2019-11-01,대웅제약주가069620종목그래프1일오늘가격150500원거래,http://www.gokorea.kr/news/articleView.html?idxno=551092
7781,2019-11-01,대웅제약우수혁신형제약기업선정정부포상,http://www.ftoday.co.kr/news/articleView.html?idxno=112383
7782,2019-11-01,대웅제약신약개발로혁신형제약기업정부포상,http://www.getnews.co.kr/view.php?ud=20191101103200354641d0c69529_16
7783,2019-11-01,대웅제약2019보건산업성과교류회에서우수혁신형제약기업으로선정정부포상,http://newsbrite.net/129310
7784,2019-11-01,대웅제약혁신형제약기업정부포상나보타수출혁신신약개발공로”,https://www.sedaily.com/NewsView/1VQMNDH3RD
7785,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.newsis.com/view/?id=NISX20191101_0000816900&cID=13001&pID=13000
7786,2019-11-01,보툴리눔톡신성과인정대웅제약혁신형제약기업정부포상,http://kpenews.com/View.aspx?No=307890
7787,2019-11-01,11월1일대웅제약오늘주식시장150000원164,http://nbntv.co.kr/news/view/716439
7788,2019-11-01,대웅제약혁신형제약기업정부포상신약개발경쟁력강화에기여,http://www.newslock.co.kr/news/articleView.html?idxno=22923
7789,2019-11-01,제약워치대웅제약혁신형제약기업정부포상外,http://www.newswatch.kr/news/articleView.html?idxno=24780
7790,2019-11-01,대웅제약혁신형제약기업정부포상,http://news.mt.co.kr/mtview.php?no=2019110111190616886
7791,2019-11-01,대웅제약우수혁신형제약기업으로복지부장관상수상,http://www.newspim.com/news/view/20191101000352
7792,2019-11-01,1일데일리주식정보대웅003090오후12시05분기준외주식시황,https://www.dailysecu.com/news/articleView.html?idxno=76921
7793,2019-11-01,국민연금보톡스전쟁중인대웅제약지분꾸준히늘려왜,http://news.tf.co.kr/read/economy/1767147.htm
7794,2019-11-01,동정대웅제약혁신형제약기업정부포상,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073821
7795,2019-11-01,주식시황대웅003090현재14250원,http://www.woodkorea.co.kr/news/articleView.html?idxno=33087
7796,2019-11-01,대웅제약혁신형제약기업정부포상,https://view.asiae.co.kr/article/2019110113235104746
7797,2019-11-01,대웅제약혁신형제약기업선정,http://www.wikileaks-kr.org/news/articleView.html?idxno=69066
7798,2019-11-01,대웅제약혁신형제약기업정부포상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1346315
7799,2019-11-01,대웅제약우수혁신형제약기업선정보건복지부장관상수상,http://www.seoulwire.com/news/articleView.html?idxno=246942
7800,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.lawissue.co.kr/view.php?ud=201911011343068690204ead0791_12
7801,2019-11-01,대웅제약신약개발경쟁력인정혁신형제약기업정부포상,http://www.straightnews.co.kr/news/articleView.html?idxno=59162
7802,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.bosa.co.kr/news/articleView.html?idxno=2115239
7803,2019-11-01,대웅제약혁신형제약기업선정보건복지부장관상수상,http://www.youthdaily.co.kr/news/article.html?no=21542
7804,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.monews.co.kr/news/articleView.html?idxno=206178
7805,2019-11-01,대웅제약혁신형제약기업선정보건복지부장관상수상,http://www.donga.com/news/article/all/20191101/98175141/1
7806,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.bokuennews.com/news/article.html?no=182741
7807,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.fnnews.com/news/201911011442218519
7808,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.dailian.co.kr/news/view/839485/?sc=naver
7809,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57985
7810,2019-11-01,대웅제약혁신형제약기업선정정부포상,http://www.dailymedi.com/detail.php?number=849103&thread=22r05
7811,2019-11-01,혁신신약파이프라인강화인정받은대웅제약혁신형제약기업정부포상,http://www.updownnews.co.kr/news/articleView.html?idxno=210537
7812,2019-11-01,대웅제약혁신형제약기업선정돼정부포상,http://www.mhj21.com/125446
7813,2019-11-01,대웅제약3Q실적매출액2425억원전분기대비80감소영업이익836↓개별잠정,http://www.newspim.com/news/view/20191101001001
7814,2019-11-01,실적속보잠정대웅제약별도20193Q영업이익2801억원,http://www.fntimes.com/html/view.php?ud=2019110116350926105dfa8f3599_18
7815,2019-11-01,코스피대웅제약2019년3분기누적매출액7440억원영업이익301억원,http://news.kmib.co.kr/article/view.asp?arcid=0013885327&code=61141211&cp=nv
7816,2019-11-01,대웅제약3Q영업익28억원전년대비652감소,http://news.mt.co.kr/mtview.php?no=2019110116363456853
7817,2019-11-01,대웅제약3Q영업익28억전년비65↓,http://www.dailypharm.com/Users/News/NewsView.html?ID=258502&REFERER=NP
7818,2019-11-01,대웅제약3분기영업익28억원전년비65감소,http://www.edaily.co.kr/news/newspath.asp?newsid=03345606622681456
7819,2019-11-01,대웅제약3분기영업익28억원전년비652↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817273
7820,2019-11-01,대웅제약3분기영업이익28억원전년동기대비652감소,https://view.asiae.co.kr/article/2019110116531487362
7821,2019-11-01,공시대웅제약3분기영업익28억원전년比652감소,http://www.newsway.co.kr/news/view?tp=1&ud=2019110116525425369
7822,2019-11-01,대웅제약3Q영업익28억원전년比65감소,http://news1.kr/articles/?3758936
7823,2019-11-01,대웅제약3분기매출2425억원영업이익28억원,http://daily.hankooki.com/lpage/ittech/201911/dh20191101165856145630.htm
7824,2019-11-01,대웅제약3Q매출2425억원‥영업익65감소한28억,http://medipana.com/news/news_viewer.asp?NewsNum=247976&MainKind=A&NewsKind=5&vCount=12&vKind=1
7825,2019-11-01,대웅제약3분기영업익28억전년比652↓,http://www.economytalk.kr/news/articleView.html?idxno=200519
7826,2019-11-01,대웅제약3분기매출은증가단기비용도증가,http://news.heraldcorp.com/view.php?ud=20191101000661
7827,2019-11-01,대웅제약3분기영업익28억원전년비652감소,http://www.newsway.co.kr/news/view?tp=1&ud=2019110117044704716
7828,2019-11-01,대웅제약3분기매출2425억원달성,http://www.whosaeng.com/113693
7829,2019-11-01,대웅제약3분기매출2425억원영업이익28억원,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236895
7830,2019-11-01,소송및라니티딘회수비용에대웅제약3분기영업이익28억그쳐,http://news.mk.co.kr/newsRead.php?year=2019&no=899432
7831,2019-11-01,대웅제약3분기영업익28억원전년比65감소,http://www.seoulwire.com/news/articleView.html?idxno=247112
7832,2019-11-01,대웅제약3분기영업익28억나보타소송알비스회수에150억출혈,http://www.econovill.com/news/articleView.html?idxno=376352
7833,2019-11-01,대웅제약3Q영업익전년比65↓소송비회수비부담,http://www.newswatch.kr/news/articleView.html?idxno=24802
7834,2019-11-01,대웅제약3분기매출액2425억원45↑,http://www.dailian.co.kr/news/view/839602/?sc=naver
7835,2019-11-01,대웅제약3분기영업익28억원전년대비652↓,http://moneys.mt.co.kr/news/mwView.php?no=2019110117098091356
7836,2019-11-01,대웅제약3분기실적매출2425억원∙영업이익28억원성장세지속,http://www.getnews.co.kr/view.php?ud=20191101171540813041d0c69529_16
7837,2019-11-01,대웅제약3분기영업익28억전년比652감소,http://www.ajunews.com/view/20191101171324418
7838,2019-11-01,대웅제약3분기매출2425억원영업이익28억원성장세,http://www.asiatoday.co.kr/view.php?key=20191101010000429
7839,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.whosaeng.com/113694
7840,2019-11-01,대웅제약3분기영업이익28억원전년比65급감,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110117195559280
7841,2019-11-01,대웅제약3Q수익성뚝라니티딘회수비용반영,http://www.dailypharm.com/Users/News/NewsView.html?ID=258503&REFERER=NP
7842,2019-11-01,대웅제약3분기영업익28억원전년비652↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911010387&t=NN
7843,2019-11-01,대웅제약3분기영업익28억원나보타소송알비스회수비용등으로전년比65↓,http://www.dt.co.kr/contents.html?article_no=2019110102109931102002&ref=naver
7844,2019-11-01,대웅제약3Q영업익28억원전년比652감소,http://www.dailysmart.co.kr/news/articleView.html?idxno=17550
7845,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.medigatenews.com/news/2839359850
7846,2019-11-01,대웅제약혁신형제약기업정부포상나보타혁신신약연구덕”,http://inthenews.co.kr/article-22724/
7847,2019-11-01,대웅제약메디톡스와소송전여파로3분기영업익뒷걸음질,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817294
7848,2019-11-01,대웅제약3분기영업익65↓소송라니티딘회수비용탓,http://news.mt.co.kr/mtview.php?no=2019110117214653129
7849,2019-11-01,대웅제약3분기영업익652↓나보타소송라니티딘회수영향,http://www.newspim.com/news/view/20191101001078
7850,2019-11-01,대웅제약3분기어닝쇼크순익3억불과93급감,http://www.edaily.co.kr/news/newspath.asp?newsid=03480086622681456
7851,2019-11-01,대웅제약3분기매출2425억원전년比45↑,http://www.donga.com/news/article/all/20191101/98178501/1
7852,2019-11-01,대웅제약3분기매출2425억원영업이익28억원,http://www.medigatenews.com/news/1616286956
7853,2019-11-01,대웅제약3분기영업익65급감나보타소송라니티딘회수영향,http://sports.hankooki.com/lpage/economy/201911/sp20191101173050137020.htm
7854,2019-11-01,대웅제약3Q어닝쇼크메디톡스식약처에발목,http://www.upinews.kr/newsView/upi201911010091
7855,2019-11-01,대웅제약3분기영업익전년比652↓나보타소송라니티딘회수비용영향,http://www.newsprime.co.kr/news/article.html?no=481575
7856,2019-11-01,대웅제약3Q영업익28억전년比65↓나보타소송비용탓,http://www.newsis.com/view/?id=NISX20191101_0000817508&cID=13001&pID=13000
7857,2019-11-01,대웅제약3분기매출2425억원릭시아나등주력제품고른성장,http://www.medisobizanews.com/news/articleView.html?idxno=63664
7858,2019-11-01,대웅제약3분기영업익652↓나보타소송라니티딘회수영향,http://www.seoulwire.com/news/articleView.html?idxno=247128
7859,2019-11-01,대웅제약3분기매출2425억원영업이익28억원견고한영업이익성장세유지,http://newsbrite.net/129355
7860,2019-11-01,대웅제약3Q영업익28억652↓나보타소송라니티딘회수영향”,http://inthenews.co.kr/article-22733/
7861,2019-11-01,대웅제약3Q영업익65감소소송라니티딘회수비용영향상보,http://news1.kr/articles/?3759023
7862,2019-11-01,대웅제약매출증가했지만영업이익652감소소송라니티딘영향”,http://www.news2day.co.kr/140861
7863,2019-11-01,대웅제약3Q영업익28억원전년比652감소,http://www.viva100.com/main/view.php?key=20191101010000260
7864,2019-11-01,대웅제약3분기아쉬운실적내년유럽진출에따른이익성장기대,http://www.sisaweek.com/news/articleView.html?idxno=127621
7865,2019-11-01,대웅제약3분기영업익전년대비652↓라니티딘회수여파,http://www.newsworks.co.kr/news/articleView.html?idxno=407934
7866,2019-11-01,대웅제약올3분기영업익28억전년비652감소,http://www.finomy.com/news/articleView.html?idxno=71188
7867,2019-11-01,대웅제약나보타소송알비스회수로3Q영업익65↓,http://www.seoulfn.com/news/articleView.html?idxno=361162
7868,2019-11-01,대웅제약보툴리눔톡신소송포함일회성비용탓에3분기이익급감,http://www.businesspost.co.kr/BP?command=article_view&num=149495
7869,2019-11-01,흡연자는서류지원조차안받아인권침해지적받고있는대웅제약,https://www.insight.co.kr/news/253275
7870,2019-11-01,대웅제약3분기영업익28억전년比652↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=369119
7871,2019-11-01,대웅제약혁신형제약기업정부포상,http://www.newscj.com/news/articleView.html?idxno=679756
7872,2019-11-01,대웅제약3Q매출2425억영업익28억라니티딘회수비용반영,https://www.kpanews.co.kr/article/show.asp?idx=208093&category=D
7873,2019-11-01,기흥화성세무서관내녹십자한미약품경동제약대웅제약맑거나흐리거나,http://www.sejungilbo.com/news/articleView.html?idxno=18805
7874,2019-11-01,대웅제약혁신형제약기업정부포상영예,https://www.kpanews.co.kr/article/show.asp?idx=208097&category=D
7875,2019-11-02,대웅제약3분기매출2425억기록영업익은나보타소송비용으로652↓,http://www.g-enews.com/ko-kr/news/article/news_all/20191101181605805769d76442fa_1/article.html
7876,2019-11-02,대웅제약3분기매출액2425억원영업이익28억원기록,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57993
7877,2019-11-02,대웅제약3Q영업익65감소,http://www.fntoday.co.kr/news/articleView.html?idxno=207927
7878,2019-11-02,제약바이오이모저모대웅제약3분기어닝쇼크순익3억불과,http://www.edaily.co.kr/news/newspath.asp?newsid=01148006622681784
7879,2019-11-02,대웅제약3Q영업익28억원전년比65↓,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073839
7880,2019-11-02,대웅제약3분기나보타임펙타민매출상승견인,http://www.consumuch.com/news/articleView.html?idxno=46427
7881,2019-11-02,대웅제약3분기매출액2425억원달성ETCOTC성장이견인,http://www.todaykorea.co.kr/news/view.php?no=265468
7882,2019-11-02,대웅제약3분기실적발표매출2425억원영업이익28억원,http://www.betanews.net:8080/article/1058651.html
7883,2019-11-02,대웅제약3분기매출2425억원영업이익28억원기록,http://www.thefirstmedia.net/news/articleView.html?idxno=50244
7884,2019-11-02,대웅제약혁신형제약기업정부포상신약파이프라인강화공로인정,http://www.thefirstmedia.net/news/articleView.html?idxno=50250
7885,2019-11-02,대웅제약혁신형제약기업선정돼정부포상받아,http://www.metroseoul.co.kr/news/newsview?newscd=2019110200006
7886,2019-11-02,대웅제약3Q영업익65감소,http://www.fntoday.co.kr/news/articleView.html?idxno=207943
7887,2019-11-02,대웅제약3분기영업이익28억전년比65↓메디톡스와의나보타소송비용탓,http://www.econonews.co.kr/news/articleView.html?idxno=93219
7888,2019-11-02,녹십자한미대웅동아ST3분기호실적,http://weekly.cnbnews.com/news/article.html?no=130935
7889,2019-11-03,중견기업꼼수백태②대웅윤재승父子승계자금줄엠서클대웅바이오내부거래주목,http://www.maeilnews.co.kr/news/article.html?no=3646
7890,2019-11-03,대웅제약혁신형제약기업정부포상,http://www.ekn.kr/news/article.html?no=461496
7891,2019-11-03,대웅제약혁신형제약기업정부포상받아,http://weekly.cnbnews.com/news/article.html?no=130942
7892,2019-11-04,클릭e종목대웅제약나보타소송불확실성해소해야목표가↓,https://view.asiae.co.kr/article/2019110407362461100
7893,2019-11-04,대웅제약비용부담증가에실적추정치하향목표가↓NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817553
7894,2019-11-04,대웅제약실적개선주가상승불확실성해소관건⋯목표가↓한국투자증권,http://www.dailian.co.kr/news/view/839810/?sc=naver
7895,2019-11-04,대웅제약3분기실적발표매출2425억원영업이익28억원,http://www.ftoday.co.kr/news/articleView.html?idxno=112417
7896,2019-11-04,대웅제약예상치못한비용급증불확실성커져목표가↓한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01505526622682440
7897,2019-11-04,대웅제약3분기영업익컨센서스하회목표가하향한국투자증권,http://www.newstomato.com/ReadNews.aspx?no=930735
7898,2019-11-04,대웅제약예상치못한비용증가목표가↓,http://www.asiatoday.co.kr/view.php?key=20191104010001056
7899,2019-11-04,대웅제약목표주가하향균주소송불확실성해소돼야실적개선,http://www.businesspost.co.kr/BP?command=article_view&num=149604
7900,2019-11-04,하이로우3분기어닝쇼크대웅제약목표주가↓NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110408352041482
7901,2019-11-04,대웅제약비용급증및불확실성증가목표주가↓,https://www.sedaily.com/NewsView/1VQO192EBR
7902,2019-11-04,STOCK대웅제약당분간이익개선어렵다목표가↓,http://moneys.mt.co.kr/news/mwView.php?no=2019110408278080917
7903,2019-11-04,대웅제약메디톡스소송장기화에우울한3분기비용늘어어닝쇼크,https://www.hankyung.com/finance/article/2019110413946
7904,2019-11-04,대웅제약4분기일회성비용반영신한금투,http://news.mt.co.kr/mtview.php?no=2019110408132679690
7905,2019-11-04,대웅제약일회성비용으로어닝쇼크내년영업익증가폭클것신한금투,http://www.newspim.com/news/view/20191104000085
7906,2019-11-04,NH투자대웅제약나보타소송관련비용지출↑목표가하향,http://www.seoulwire.com/news/articleView.html?idxno=247342
7907,2019-11-04,NH투자證대웅제약나보타소송구조조정비용부담목표가5↓”,http://www.kukinews.com/news/article.html?no=715816
7908,2019-11-04,대웅제약4분기도일회성비용등으로실적부진전망목표가↓신한금융투자,http://www.fntimes.com/html/view.php?ud=201911040859423373f09e13944d_18
7909,2019-11-04,특징주대웅제약3분기영업이익급감약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817630
7910,2019-11-04,리포트브리핑대웅제약일회성비용등으로어닝쇼크목표가180000원신한금융투자,http://www.newspim.com/news/view/20191104000152
7911,2019-11-04,대웅제약메디톡스소송장기화에실적에도악영향끼치나,http://www.mdtoday.co.kr/mdtoday/index.html?no=369187
7912,2019-11-04,대웅제약3분기영업익28억전년비652↓,http://www.sportsseoul.com/news/read/843388
7913,2019-11-04,GET투자리포트대웅제약투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=2019110410303013417tpgetnews_16
7914,2019-11-04,대웅제약일회성비용에3Q어닝쇼크목표가↓신한,http://www.edaily.co.kr/news/newspath.asp?newsid=01836806622682440
7915,2019-11-04,리포트브리핑대웅제약20년회복을기다려보자목표가170000원키움증권,http://www.newspim.com/news/view/20191104000176
7916,2019-11-04,GET투자리포트대웅제약투자의견Outperform키움증권,http://www.getnews.co.kr/view.php?ud=2019110410303013426tpgetnews_16
7917,2019-11-04,NH투자증권대웅제약3분기실적부진에목표가↓,http://www.viva100.com/main/view.php?key=20191104010000690
7918,2019-11-04,대웅제약3분기매출액2425억영업이익28억,http://www.bokuennews.com/news/article.html?no=182787
7919,2019-11-04,GET투자리포트대웅제약투자의견매수삼성증권,http://www.getnews.co.kr/view.php?ud=2019110310303013427tpgetnews_16
7920,2019-11-04,특징주대웅제약올해3분기어닝쇼크실적에약세,http://www.inews24.com/view/1219400
7921,2019-11-04,특징주대웅제약3분기어닝쇼크에약세,http://news.mk.co.kr/newsRead.php?year=2019&no=903567
7922,2019-11-04,리포트브리핑대웅제약부진한실적4Q19까지이어질전망목표가210000원대신증권,http://www.newspim.com/news/view/20191104000225
7923,2019-11-04,GET투자리포트대웅제약투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=2019110410303013436tpgetnews_16
7924,2019-11-04,리포트브리핑대웅제약3Q19Review리스크해소를기다려야할때목표가210000원KB증권,http://www.newspim.com/news/view/20191104000266
7925,2019-11-04,11월4일대웅주식추천주21113900원,http://nbntv.co.kr/news/view/718063
7926,2019-11-04,GET투자리포트대웅제약투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=2019110410303013450tpgetnews_16
7927,2019-11-04,특징주대웅제약3분기어닝쇼크에하락세,http://www.seoulfn.com/news/articleView.html?idxno=361254
7928,2019-11-04,대웅제약3분기어닝쇼크실적부진에장초반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=369198
7929,2019-11-04,대웅제약3분기실적발표매출2425억원영업이익28억원,http://www.updownnews.co.kr/news/articleView.html?idxno=210565
7930,2019-11-04,대웅제약3분기영업익65↓나보타소송비용영향,http://www.rapportian.com/news/articleView.html?idxno=121145
7931,2019-11-04,리포트브리핑대웅제약비용부담증가로실적추정치하향목표가180000원NH투자증권,http://www.newspim.com/news/view/20191104000597
7932,2019-11-04,GET투자리포트대웅제약투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=2019110410303013484tpgetnews_16
7933,2019-11-04,리포트브리핑대웅제약설상가상아쉬운실적목표가220000원DB금융투자,http://www.newspim.com/news/view/20191104000682
7934,2019-11-04,GET투자리포트대웅제약투자의견매수유지DB금융투자,http://www.getnews.co.kr/view.php?ud=2019110410303013496tpgetnews_16
7935,2019-11-04,대웅제약나보타소송장기화로3분기어닝쇼크목표가↓,http://www.econovill.com/news/articleView.html?idxno=376477
7936,2019-11-04,대웅제약4분기에도실적악화예상내년에기저효과및악재해소기대”,http://www.wikitree.co.kr/main/news_view.php?id=477424
7937,2019-11-04,리포트브리핑대웅제약3Q19Review알비스사태늘어난판관비목표가250000원유안타증권,http://www.newspim.com/news/view/20191104000703
7938,2019-11-04,GET투자리포트대웅제약투자의견매수유지유안타증권,http://www.getnews.co.kr/view.php?ud=2019110410303013500tpgetnews_16
7939,2019-11-04,대웅제약3분기영업익652감소라니티딘사태직격탄,http://www.monews.co.kr/news/articleView.html?idxno=206204
7940,2019-11-04,대웅제약실적부진나보타수출국확대로회복기대감,http://medipana.com/news/news_viewer.asp?NewsNum=248041&MainKind=A&NewsKind=5&vCount=12&vKind=1
7941,2019-11-04,11월4일대웅제약실시간주식현황144000원368,http://nbntv.co.kr/news/view/718509
7942,2019-11-04,데일리증권대웅003090오후12시06분기준외증시동향,https://www.dailysecu.com/news/articleView.html?idxno=77253
7943,2019-11-04,리포트브리핑대웅제약예상치못한일격목표가180000원한국투자증권,http://www.newspim.com/news/view/20191104001009
7944,2019-11-04,GET투자리포트대웅제약투자의견매수유지한국투자증권,http://www.getnews.co.kr/view.php?ud=2019110410303013509tpgetnews_16
7945,2019-11-04,대웅제약알비스판매중단과나보타소송비용증가등악재겹쳤다”,http://www.wikitree.co.kr/main/news_view.php?id=477484
7946,2019-11-04,대웅제약알비스매출중단을반영하여매출액을하향조정”,http://www.wikitree.co.kr/main/news_view.php?id=477514
7947,2019-11-04,GET투자리포트대웅제약투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019110410303013522tpgetnews_16
7948,2019-11-04,대웅제약혁신형제약기업정부포상,http://www.skyedaily.com/news/news_view.html?ID=93192
7949,2019-11-04,대웅제약3분기어닝쇼크균주소송라니티딘사태직격탄,http://biz.newdaily.co.kr/site/data/html/2019/11/04/2019110400150.html
7950,2019-11-04,리포트브리핑대웅제약소송비용과알비스회수충당금으로3분기실적예상치하회목표가220000원SK증권,http://www.newspim.com/news/view/20191104001152
7951,2019-11-04,국내제약사1조클럽윤곽잡혔다대웅제약아슬아슬,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110414311073821
7952,2019-11-04,대웅제약실적쇼크나보타기대감여전,http://www.fnnews.com/news/201911041800375368
7953,2019-11-04,리포트브리핑대웅제약비경상적비용에따른아쉬운실적목표가230000원삼성증권,http://www.newspim.com/news/view/20191104001465
7954,2019-11-05,한미대웅이입증한글로벌시장진출성공방정식,http://www.edaily.co.kr/news/newspath.asp?newsid=01275926622682768
7955,2019-11-05,대웅SGLT2당뇨약임상확대병용신기능환자대상,http://www.dailypharm.com/Users/News/NewsView.html?ID=258556&REFERER=NP
7956,2019-11-05,주식실시간대웅주가5일현재13600원,http://nbntv.co.kr/news/view/720072
7957,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약,http://www.metroseoul.co.kr/news/newsview?newscd=2019110500036
7958,2019-11-05,한국머크대웅제약과콩코르국내판매계약체결,http://www.viva100.com/main/view.php?key=20191105010001275
7959,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://sports.khan.co.kr/news/sk_index.html?art_id=201911050956003&sec_id=561801&pt=nv
7960,2019-11-05,대웅제약주가실적충격에흔들목표가하향봇물,http://www.g-enews.com/ko-kr/news/article/news_all/201911050942456035c642673384_1/article.html
7961,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=248112&MainKind=A&NewsKind=5&vCount=12&vKind=1
7962,2019-11-05,한국머크바이오파마대웅제약과콩코르판매계약체결,http://www.ebn.co.kr/news/view/1007879/?sc=naver
7963,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://health.chosun.com/site/data/html_dir/2019/11/05/2019110501027.html
7964,2019-11-05,종목족보대웅25↓2개종목장중신저가,http://www.itooza.com/common/iview.php?no=2019110510111493780
7965,2019-11-05,한국머크바이오파마대웅제약과심혈관치료제콩코르판매계약,http://sports.chosun.com/news/ntype.htm?id=201911060100033510001959&servicedate=20191105
7966,2019-11-05,머크콩코르대웅제약이국내전담판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88763
7967,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1818257
7968,2019-11-05,한국머크대웅제약과콩코르국내판매계약,http://kormedi.com/?p=1304999
7969,2019-11-05,대웅제약주가069620정보외증시동향5일오늘가격143500원거래,http://www.gokorea.kr/news/articleView.html?idxno=554729
7970,2019-11-05,한국머크대웅제약콩코르국내판매계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2115397
7971,2019-11-05,머크바이오파마대웅제약콩코르국내판매계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237015
7972,2019-11-05,한국머크바이오파마대웅제약과심혈관약콩코르판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=63726
7973,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.seoulwire.com/news/articleView.html?idxno=248156
7974,2019-11-05,한국머크대웅제약과심부전치료제콩코르국내판매돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110510360729146
7975,2019-11-05,한국머크대웅제약과심혈관치료제공동판매계약체결,http://www.rapportian.com/news/articleView.html?idxno=121176
7976,2019-11-05,한국머크바이오파마대웅제약콩코르국내판매계약체결,http://daily.hankooki.com/lpage/ittech/201911/dh20191105104043145630.htm
7977,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.asiatoday.co.kr/view.php?key=20191105010002032
7978,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=369326
7979,2019-11-05,라니티딘쇼크로휘청대웅제약반등할까,http://www.econovill.com/news/articleView.html?idxno=376562
7980,2019-11-05,대웅제약주식종목5일현재144000원,http://nbntv.co.kr/news/view/720623
7981,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약,https://biz.chosun.com/site/data/html_dir/2019/11/05/2019110501262.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7982,2019-11-05,한국머크대웅제약과만성심부전치료제콩코르판매계약체결,http://www.sportsseoul.com/news/read/844138
7983,2019-11-05,머크대웅고혈압약콩코르국내판매계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=258582&REFERER=NP
7984,2019-11-05,머크대웅고혈압약콩코르국내판매계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=258582&REFERER=NP
7985,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://yna.kr/AKR20191105075000017?did=1195m
7986,2019-11-05,머크콩코르대웅제약손에떨어져,http://www.whosaeng.com/113756
7987,2019-11-05,대웅제약3분기이익참혹당기순이익3억여원,http://www.kukinews.com/news/article.html?no=716320
7988,2019-11-05,대웅나보타미국3분기매출153억점유율3위,http://www.dailypharm.com/Users/News/NewsView.html?ID=258584&REFERER=NP
7989,2019-11-05,주식현재가대웅00309012시42분현재13750원,http://www.woodkorea.co.kr/news/articleView.html?idxno=33736
7990,2019-11-05,머크대웅제약과심혈관치료제콩코르판매계약,http://www.newsis.com/view/?id=NISX20191105_0000820161&cID=13001&pID=13000
7991,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약,http://www.fnnews.com/news/201911051334383042
7992,2019-11-05,한국머크대웅제약과콩코르국내판매계약,http://www.finomy.com/news/articleView.html?idxno=71297
7993,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.etnews.com/20191105000121
7994,2019-11-05,크리스탈동아대웅과아셀렉스정공동판매추진,https://www.paxnetnews.com/articles/53523
7995,2019-11-05,대웅제약위장약반품과균주소송에따른비용4분기도이어져,http://www.businesspost.co.kr/BP?command=article_view&num=149835
7996,2019-11-05,한국머크대웅제약과심혈관치료제국내판매계약,http://news.heraldcorp.com/view.php?ud=20191105000718
7997,2019-11-05,한국머크바이오파마대웅제약과콩코르국내판매계약체결,http://www.medigatenews.com/news/3092437120
7998,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://www.seoulfn.com/news/articleView.html?idxno=361471
7999,2019-11-05,한국머크대웅제약과콩코르국내판매계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58032
8000,2019-11-05,한국머크대웅제약과심혈관치료제국내판매계약,http://www.whitepaper.co.kr/news/articleView.html?idxno=179960
8001,2019-11-05,채용서흡연자는제한한다대웅제약기본권침해논란,http://www.todaykorea.co.kr/news/view.php?no=265529
8002,2019-11-05,한국머크바이오파마대웅제약과심부전치료제콩코르국내판매계약체결,http://www.getnews.co.kr/view.php?ud=2019110518000427641d0c69529_16
8003,2019-11-05,대웅제약3분기어닝쇼크4분기비용반영문제이어질수있다”,http://www.wikitree.co.kr/main/news_view.php?id=477954
8004,2019-11-05,대체로맑지만균주소송대웅제약흐림,http://www.dt.co.kr/contents.html?article_no=2019110602101531102002&ref=naver
8005,2019-11-05,한국머크바이오파마대웅제약콩코르국내판매계약,https://www.kpanews.co.kr/article/show.asp?idx=208221&category=D
8006,2019-11-05,한국머크대웅제약심혈관질환치료제콩코르판매계약,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3977700
8007,2019-11-06,대웅제약흡연자취업제한공고사회적토론촉발,http://www.bosa.co.kr/news/articleView.html?idxno=2115452
8008,2019-11-06,대웅제약나보타미국연착륙분기첫매출153억원,http://news.heraldcorp.com/view.php?ud=20191106000018
8009,2019-11-06,대웅제약나보타美서3분기매출153억원달성,http://www.seoulwire.com/news/articleView.html?idxno=248831
8010,2019-11-06,대웅제약ETCOTC꾸준한성장매출확대견인,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132006
8011,2019-11-06,★주식인사이드대웅제약주가145500원11월6일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1044961
8012,2019-11-06,대웅제약보톡스나보타美서3분기150억매출,http://www.dt.co.kr/contents.html?article_no=2019110602109931102001&ref=naver
8013,2019-11-06,대웅제약관계사디엔컴퍼니이지듀메이크업라인선봬,http://moneys.mt.co.kr/news/mwView.php?no=2019110609138060475
8014,2019-11-06,대웅주가003090정보외주식시황6일오늘거래가14000원,http://www.gokorea.kr/news/articleView.html?idxno=556237
8015,2019-11-06,대웅제약디엔컴퍼니이지듀메이크업라인선봬,http://www.yakup.com/news/index.html?mode=view&cat=15&nid=237054
8016,2019-11-06,대웅실시간주식현황6일현재14000원,http://nbntv.co.kr/news/view/722380
8017,2019-11-06,대웅제약나보타미국서매출150억원달성,http://www.m-i.kr/news/articleView.html?idxno=652485
8018,2019-11-06,대웅제약이지듀EU권고알러지유발물질인공향배제,http://news.heraldcorp.com/view.php?ud=20191106000246
8019,2019-11-06,대웅제약관계사디엔컴퍼니이지듀메이크업라인선보여,https://www.sedaily.com/NewsView/1VQOY2SM4C
8020,2019-11-06,대웅제약주가06962011월6일오늘거래가144000원및증권시세및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=556666
8021,2019-11-06,대웅제약나보타미국서3분기매출150억원달성,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911060127&t=NN
8022,2019-11-06,대웅제약디엔컴퍼니건강한피부만들기메이크업라인2종출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1818829
8023,2019-11-06,11월6일대웅제약주식창144000원000,http://nbntv.co.kr/news/view/722905
8024,2019-11-06,대웅제약보톡스나보타미국서분기매출150억원,http://www.hani.co.kr/arti/economy/marketing/915980.html
8025,2019-11-06,주식동향대웅003090거래시세13900원,http://www.woodkorea.co.kr/news/articleView.html?idxno=34095
8026,2019-11-06,대웅제약미국내나보타분기매출150억원돌파,http://www.seoulfn.com/news/articleView.html?idxno=361595
8027,2019-11-06,대웅제약나보타美소비자마음잡았나,http://www.kpinews.co.kr/news/articleView.html?idxno=106573
8028,2019-11-06,올연매출1조원달성종근당유력vs대웅제약안갯속,http://www.sisajournal-e.com/news/articleView.html?idxno=208611
8029,2019-11-06,메디톡스대웅균주싸움앞으로1년더,https://www.paxnetnews.com/articles/53623
8030,2019-11-06,대웅제약흡연자채용제한응시기회박탈아닌금연독려,http://www.sisaweek.com/news/articleView.html?idxno=127764
8031,2019-11-06,대웅나보타美매출153억균주도용논란향후실적관건,http://www.dt.co.kr/contents.html?article_no=2019110702101531102001&ref=naver
8032,2019-11-06,법원대웅메톡美보고서제출하라ITC처럼검증,http://www.newsis.com/view/?id=NISX20191106_0000822092&cID=13001&pID=13000
8033,2019-11-07,1조클럽제약사올해는④1조클럽아슬아슬대웅제약,http://www.mdtoday.co.kr/mdtoday/index.html?no=369518
8034,2019-11-07,★주식인사이드대웅제약주가141500원11월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1045218
8035,2019-11-07,대웅주가종목그래프7일오늘가격14000원거래,http://www.gokorea.kr/news/articleView.html?idxno=558130
8036,2019-11-07,11월7일대웅주식종목시세13950원036,http://nbntv.co.kr/news/view/724633
8037,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.dailian.co.kr/news/view/841107/?sc=naver
8038,2019-11-07,대웅제약나보타의임상결과수술당일투약시우수한흉터개선효과입증,http://news.mk.co.kr/newsRead.php?year=2019&no=917259
8039,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.betanews.net:8080/article/1059739.html
8040,2019-11-07,대웅제약나보타수술당일투여때흉터관리높은효과,http://www.medisobizanews.com/news/articleView.html?idxno=63788
8041,2019-11-07,대웅제약수술환자흉터제거위한나보타투여최적기규명,http://news.heraldcorp.com/view.php?ud=20191107000163
8042,2019-11-07,대웅제약 나보타 연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=37758
8043,2019-11-07,대웅제약나보타이른투여에따른흉터개선효과입증,http://www.newspim.com/news/view/20191107000249
8044,2019-11-07,대웅제약나보타연구자임상통해투여시점따른흉터관리효과차이입증,http://www.segye.com/content/html/2019/11/07/20191107505124.html?OutUrl=naver
8045,2019-11-07,대웅제약나보타의흉터개선효과입증,http://news.mt.co.kr/mtview.php?no=2019110709564145513
8046,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://newsbrite.net/129595
8047,2019-11-07,대웅제약주가06962011월7일오늘가격142000원오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=558581
8048,2019-11-07,대웅제약나보타연구자임상서투여시기따른흉터관리입증,http://www.econovill.com/news/articleView.html?idxno=376823
8049,2019-11-07,대웅제약나보타투여시점에따른흉터개선효과확인,http://www.ceoscoredaily.com/news/article.html?no=62260
8050,2019-11-07,대웅제약보툴리눔톡신제제나보타통해흉터관리효과입증,https://www.sedaily.com/NewsView/1VQPFM5F9C
8051,2019-11-07,대웅제약임상통해보툴리눔나보타투여시점별흉터개선확인,http://www.newslock.co.kr/news/articleView.html?idxno=23085
8052,2019-11-07,대웅제약나보타투여시점따른흉터관리효과차확인,http://www.biospectator.com/view/news_view.php?varAtcId=8845
8053,2019-11-07,대웅제약나보타임상결과발표수술당일투여때흉터관리효과,http://www.updownnews.co.kr/news/articleView.html?idxno=210775
8054,2019-11-07,대웅제약나보타투여시점에따른흉터개선효과차이입증,http://www.newsprime.co.kr/news/article.html?no=482241
8055,2019-11-07,대웅제약나보타갑상선수술흉터개선효과개선,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911070259&t=NN
8056,2019-11-07,대웅제약주식주가7일현재142500원,http://nbntv.co.kr/news/view/725178
8057,2019-11-07,보톡스로흉터개선된다대웅제약나보타임상발표,http://moneys.mt.co.kr/news/mwView.php?no=2019110710178069051
8058,2019-11-07,흉터개선효과입증대웅제약나보타연구자임상결과발표,http://kpenews.com/View.aspx?No=314651
8059,2019-11-07,대웅제약나보타흉터관리시적절한보툴리눔톡신제제투여시점확인,http://www.k-health.com/news/articleView.html?idxno=46155
8060,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1819401
8061,2019-11-07,대웅제약나보타연구자임상통해흉터관리효과입증,http://www.etnews.com/20191107000104
8062,2019-11-07,대웅제약나보타투여시점따른흉터관리효과임상결과발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019110700086
8063,2019-11-07,대웅나보타투여시점따른흉터관리효과차이입증,http://medipana.com/news/news_viewer.asp?NewsNum=248235&MainKind=A&NewsKind=5&vCount=12&vKind=1
8064,2019-11-07,대웅제약나보타시점에따른흉터관리효과차이입증,http://daily.hankooki.com/lpage/ittech/201911/dh20191107115147145630.htm
8065,2019-11-07,대웅제약나보타흉터개선효과입증”,http://www.viva100.com/main/view.php?key=20191107010002288
8066,2019-11-07,7일데일리주가정보대웅003090오후12시05분기준및주체별매매동향,https://www.dailysecu.com/news/articleView.html?idxno=77936
8067,2019-11-07,대웅제약나보타수술후흉터에효과입증,http://news1.kr/articles/?3763181
8068,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.medigatenews.com/news/3084234829
8069,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.seoulwire.com/news/articleView.html?idxno=250228
8070,2019-11-07,대웅제약나보타투여시점별흉터개선차이입증,http://health.chosun.com/site/data/html_dir/2019/11/07/2019110701908.html
8071,2019-11-07,대웅제약나보타투여시점별흉터개선차이입증,http://inthenews.co.kr/article-23422/
8072,2019-11-07,대웅제약나보타흉터개선효과입증,https://view.asiae.co.kr/article/2019110714283067705
8073,2019-11-07,법원대웅제약메디톡스美ITC염기서열보고서제출요구,http://www.mdtoday.co.kr/mdtoday/index.html?no=369571
8074,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.newsway.co.kr/news/view?tp=1&ud=2019110714480699763
8075,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.lawissue.co.kr/view.php?ud=20191107145805614204ead0791_12
8076,2019-11-07,대웅제약보툴리눔톡신나보타의흉터관리효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=150172
8077,2019-11-07,대웅제약나보타투여시점따른흉터관리효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=17829
8078,2019-11-07,대웅제약연구자임상통해나보타투여시점별흉터관리효과차이입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1347695
8079,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=369589
8080,2019-11-07,대웅제약나보타흉터개선효과임상결과美SCI급학술지게재,http://www.donga.com/news/article/all/20191107/98262823/1
8081,2019-11-07,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.getnews.co.kr/view.php?ud=20191107164517748441d0c69529_16
8082,2019-11-07,대웅제약나보타연구자임상결과흉터관리효과차이입증,http://www.cnbnews.com/news/article.html?no=426837
8083,2019-11-07,대웅제약나보타흉터관리효과차이입증,http://www.ebn.co.kr/news/view/1008388/?sc=naver
8084,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과차이입증,http://www.wikileaks-kr.org/news/articleView.html?idxno=69599
8085,2019-11-07,대웅제약나보타연구자임상통해흉터관리효과차이입증,http://www.ekn.kr/news/article.html?no=462633
8086,2019-11-07,대웅제약나보타흉터개선효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=338517
8087,2019-11-07,대웅제약나보타투여시점에따른흉터관리효과입증,http://www.newscj.com/news/articleView.html?idxno=681365
8088,2019-11-08,★주식인사이드대웅제약주가143000원11월8일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1045507
8089,2019-11-08,대웅주가11월8일오늘거래가14000원및증권시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=560116
8090,2019-11-08,대웅제약약대생인턴십PharmDW참가자모집,http://www.ebn.co.kr/news/view/1008445/?sc=naver
8091,2019-11-08,대웅제약약대생심화실습 인턴십PharmDW참가자모집,http://www.medisobizanews.com/news/articleView.html?idxno=63820
8092,2019-11-08,11월8일대웅주식현재가03614000원,http://nbntv.co.kr/news/view/726910
8093,2019-11-08,대웅제약약대생인턴십프로그램PharmDW참가자모집,http://www.newsway.co.kr/news/view?tp=1&ud=2019110809423182972
8094,2019-11-08,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://newsbrite.net/129657
8095,2019-11-08,대웅제약심화실습인턴십프로그램PharmDW참가자모집,http://www.dailian.co.kr/news/view/841475/?sc=naver
8096,2019-11-08,대웅약학대생심화실습인턴십모집,http://www.bosa.co.kr/news/articleView.html?idxno=2115666
8097,2019-11-08,대웅제약약대생대상PharmDW참가자모집,http://medipana.com/news/news_viewer.asp?NewsNum=248302&MainKind=A&NewsKind=5&vCount=12&vKind=1
8098,2019-11-08,대웅제약올로맥스상위병원잇따라입성하며성장가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58094
8099,2019-11-08,대웅제약약대생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58098
8100,2019-11-08,대웅제약약학대학생심화인턴십PharmDW참가자모집,http://www.newspim.com/news/view/20191108000235
8101,2019-11-08,대웅제약약대생대상심화실습인턴십활동PharmDW참가자모집,http://www.ezyeconomy.com/news/articleView.html?idxno=95230
8102,2019-11-08,대웅제약 약학대학생대상심화실습인턴십프로그램 PharmDW 참가자모집,http://www.businesskorea.co.kr/news/articleView.html?idxno=37816
8103,2019-11-08,대웅제약약학전공인턴십프로그램PharmDW참가자모집,http://www.sportsseoul.com/news/read/845972
8104,2019-11-08,대웅제약주가11월8일현재143500원증권그래프및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=560571
8105,2019-11-08,대웅제약약대생대상인턴십PharmDW참가자모집,http://www.econovill.com/news/articleView.html?idxno=376929
8106,2019-11-08,대웅제약우수혁신형제약기업으로선정돼복지부장관상등수상,http://www.newsian.co.kr/news/articleView.html?idxno=37258
8107,2019-11-08,대웅제약팜DW참가자모집,https://asiatime.co.kr/news/newsview.php?ncode=1065575856901598
8108,2019-11-08,대웅제약약학대생인턴십프로그램팜DW참가자모집,http://www.dailysmart.co.kr/news/articleView.html?idxno=17868
8109,2019-11-08,대웅제약약학대학생심화실습인턴십프로그램참가자모집,http://www.enewstoday.co.kr/news/articleView.html?idxno=1347851
8110,2019-11-08,11월8일대웅제약투자주식143500원141,http://nbntv.co.kr/news/view/727446
8111,2019-11-08,약학대학생맞춤형인턴십프로그램대웅제약PharmDW진행,http://kpenews.com/View.aspx?No=315818
8112,2019-11-08,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.lawissue.co.kr/view.php?ud=20191108111233120204ead0791_12
8113,2019-11-08,안내대웅제약약학대생대상인턴십모집 ,http://www.monews.co.kr/news/articleView.html?idxno=206317
8114,2019-11-08,대웅제약약학대학생대상인턴십프로그램PharmDW참가자모집,http://www.ekn.kr/news/article.html?no=462795
8115,2019-11-08,대웅제약약대생심화실습PharmDW참가자모집,http://www.dailymedi.com/detail.php?number=849350&thread=22r05
8116,2019-11-08,대웅제약약대생인턴십프로그램PharmDW참가자모집,http://www.seoulwire.com/news/articleView.html?idxno=250800
8117,2019-11-08,대웅제약약학대학생대상팜DW50명모집,http://www.kpinews.co.kr/news/articleView.html?idxno=106687
8118,2019-11-08,대한민국굿잡스대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.newslock.co.kr/news/articleView.html?idxno=23145
8119,2019-11-08,대웅제약약학대학생심화실습인턴십프로그램운영,http://www.rapportian.com/news/articleView.html?idxno=121269
8120,2019-11-08,대웅제약약대생대상인턴십진행3개월간실무경험,http://moneys.mt.co.kr/news/mwView.php?no=2019110814168073952
8121,2019-11-08,대웅제약약대생대상심화실습인턴십팜DW참가자모집,http://news.mk.co.kr/newsRead.php?year=2019&no=923337
8122,2019-11-08,대웅제약약대생인턴십프로그램참가자모집,http://www.youthdaily.co.kr/news/article.html?no=22165
8123,2019-11-08,대웅제약약학대학생대상심화실습인턴십참가자모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=369682
8124,2019-11-08,대웅제약나보타연구자임상통해투여시점에따른흉터관리효과차이입증,http://www.thefirstmedia.net/news/articleView.html?idxno=50492
8125,2019-11-08,대웅제약약대생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.wikileaks-kr.org/news/articleView.html?idxno=69664
8126,2019-11-08,대웅제약약학대학생인턴십프로그램참가자모집,http://www.donga.com/news/article/all/20191108/98278700/1
8127,2019-11-08,대웅제약18일까지약학대학생인턴십모집,http://www.finomy.com/news/articleView.html?idxno=71520
8128,2019-11-08,대웅제약심화실습인턴십프로그램PharmDW참가자모집,http://www.getnews.co.kr/view.php?ud=20191108174546377941d0c69529_16
8129,2019-11-08,대웅제약약학대학생대상심화실습인턴십참가자모집,http://www.100ssd.co.kr/news/articleView.html?idxno=65302
8130,2019-11-08,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.wsobi.com/news/articleView.html?idxno=84869
8131,2019-11-08,대웅제약약학대학학생실습인턴십PharmDW참가자모집,http://www.news2day.co.kr/141512
8132,2019-11-08,대웅제약흉터관리나보타보툴리눔톡신제제투여시점확인,http://www.news2day.co.kr/141445
8133,2019-11-08,대웅제약약학대생대상인턴십프로그램PharmDW참가자모집,http://www.newscj.com/news/articleView.html?idxno=681673
8134,2019-11-09,대웅제약연구자임상으로나보타투여시점에따른흉터관리효과차이입증,http://www.g-enews.com/ko-kr/news/article/news_all/20191107155736627569d76442fa_1/article.html
8135,2019-11-10,대웅제약PharmDW참가자모집,http://weekly.cnbnews.com/news/article.html?no=131059
8136,2019-11-10,대웅제약약대생심화실습인턴십PharmDW참가자모집,http://www.viva100.com/main/view.php?key=20191110010003047
8137,2019-11-10,대웅제약약대생인턴십프로그램PharmDW참가자모집,http://www.metroseoul.co.kr/news/newsview?newscd=2019111000050
8138,2019-11-10,엇갈린보톡스3인방소송발목대웅제약메디톡스vs웃는휴젤,http://www.edaily.co.kr/news/newspath.asp?newsid=01820406622684408
8139,2019-11-10,대웅제약약대생대상심화실습인턴십팜DW참가자모집,http://www.nbnnews.co.kr/news/articleView.html?idxno=339310
8140,2019-11-11,상장사수익성분석③제약업종수익성개선두각대웅제약한미약품등선방,http://www.etoday.co.kr/news/section/newsview.php?idxno=1820125
8141,2019-11-11,★주식인사이드대웅제약주가142000원11월11일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1045852
8142,2019-11-11,대웅주가003090오늘시세11일오늘거래가13800원형성,http://www.gokorea.kr/news/articleView.html?idxno=562344
8143,2019-11-11,11월11일대웅주식주가13850원036,http://nbntv.co.kr/news/view/729194
8144,2019-11-11,대웅제약PharmDW참가자모집,http://www.bokuennews.com/news/article.html?no=183085
8145,2019-11-11,재계톡톡3분기어닝쇼크대웅제약안팎으로시끌,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=929466
8146,2019-11-11,대웅제약증권투자11일현재141500원,http://nbntv.co.kr/news/view/729730
8147,2019-11-11,종근당올1조클럽초읽기대웅제약아슬아슬,http://www.ebn.co.kr/news/view/1008727/?sc=naver
8148,2019-11-11,대웅제약약학대학생대상심화실습인턴십프로그램PharmDW참가자모집,http://www.thefirstmedia.net/news/articleView.html?idxno=50554
8149,2019-11-11,상장주주가정보11일대웅마감증시13800원,http://nbntv.co.kr/news/view/731135
8150,2019-11-12,더벨CPhIWorldwide2019대웅제약항궤양제신약임상3상완료,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911110100017040001061
8151,2019-11-12,★주식인사이드대웅제약주가141000원11월12일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1046149
8152,2019-11-12,대웅주가00309011월12일오늘거래가13750원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=564262
8153,2019-11-12,대웅실시간주식현황12일현재13800원,http://nbntv.co.kr/news/view/731401
8154,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=18000
8155,2019-11-12,대웅제약자가면역질환후보물질연구성과첫공개,http://www.bosa.co.kr/news/articleView.html?idxno=2115829
8156,2019-11-12,대웅제약미국서자가면역질환치료제연구성과첫공개,http://moneys.mt.co.kr/news/mwView.php?no=2019111210098030191
8157,2019-11-12,대웅제약차세대자가면역질환치료제저용량으로도효과확인,http://news.mt.co.kr/mtview.php?no=2019111210100231837
8158,2019-11-12,대웅제약주가11월12일오늘거래가140000원및증권시세및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=564697
8159,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.etnews.com/20191112000061
8160,2019-11-12,대웅제약차세대자가면역질환치료물질연구성과첫공개,http://www.medisobizanews.com/news/articleView.html?idxno=63906
8161,2019-11-12,대웅제약자가면역질환신약DWP212525전임상서효능확인,http://www.econovill.com/news/articleView.html?idxno=377214
8162,2019-11-12,대웅제약美류마티스학회서자가면역치료제DWP212525연구성과첫공개,http://www.newslock.co.kr/news/articleView.html?idxno=23225
8163,2019-11-12,대웅제약미국서자가면역질환후보물질연구성과첫공개,https://www.sedaily.com/NewsView/1VQRPCMPKO
8164,2019-11-12,대웅자가면역질환후보물질타깃선택적억제,http://www.dailypharm.com/Users/News/NewsView.html?ID=258818&REFERER=NP
8165,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=37916
8166,2019-11-12,대웅제약미국류마티스학회서자가면역질환치료제연구성과첫공개,http://www.newspim.com/news/view/20191112000390
8167,2019-11-12,대웅제약美학회서자가면역질환신약DWP212525연구성과첫공개,http://www.seoulwire.com/news/articleView.html?idxno=252122
8168,2019-11-12,대웅제약美류마티스학회서DWP212525성과공개,http://medipana.com/news/news_viewer.asp?NewsNum=248483&MainKind=A&NewsKind=5&vCount=12&vKind=1
8169,2019-11-12,대웅제약미류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.asiatoday.co.kr/view.php?key=20191112010006408
8170,2019-11-12,기존치료제보다우수대웅제약DWP212525연구성과공개,http://kpenews.com/View.aspx?No=318537
8171,2019-11-12,대웅제약자가면역질환치료제연구성과첫글로벌공개,http://news.heraldcorp.com/view.php?ud=20191112000316
8172,2019-11-12,대웅제약자가면역질환후보물질연구성과첫공개,http://www.newsway.co.kr/news/view?tp=1&ud=2019111210581041078
8173,2019-11-12,대웅제약美류마티스학회서자가면역질환연구첫공개,http://www.newsis.com/view/?id=NISX20191112_0000826953&cID=13001&pID=13000
8174,2019-11-12,오늘주식장대웅제약주가12일현재139000원,http://nbntv.co.kr/news/view/731942
8175,2019-11-12,대웅제약美류마티스학회서JAK3TFK동시표적의후보물질연구결과공개,http://news.mk.co.kr/newsRead.php?year=2019&no=933724
8176,2019-11-12,대웅제약자가면역질환신약연구성과첫공개내년임상진입”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1821134
8177,2019-11-12,대웅제약자가면역질환치료제전임상결과공개,http://health.chosun.com/site/data/html_dir/2019/11/12/2019111201321.html
8178,2019-11-12,대웅자가면역질환치료제연구성과첫공개,http://www.dailymedi.com/detail.php?number=849466&thread=22r05
8179,2019-11-12,대웅제약단백질JAK3TFK동시억제신약물질효과,http://news1.kr/articles/?3766714
8180,2019-11-12,대웅제약미국에서자가면역질환후보물질연구성과첫공개,http://www.joseilbo.com/news/news_read.php?uid=387191&class=27&grp=
8181,2019-11-12,대웅제약자가면역질환후보물질비임상결과공개,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1130173&REFERER=NP
8182,2019-11-12,대웅제약美학회서자가면역질환치료제연구최초공개,https://view.asiae.co.kr/article/2019111211400068905
8183,2019-11-12,대웅제약美류마티스학회서DWP212525전임상결과공개,http://www.sportsseoul.com/news/read/847457
8184,2019-11-12,대웅제약미류마티스학회에서자가면역질환후보물질연구성과공개,http://www.cnbnews.com/news/article.html?no=427225
8185,2019-11-12,데일리주가정보대웅003090오후12시03분기준및증권정보와종목동정,https://www.dailysecu.com/news/articleView.html?idxno=78754
8186,2019-11-12,대웅제약美류마티스학회서자가면역질환치료신약연구성과첫공개,http://www.metroseoul.co.kr/news/newsview?newscd=2019111200096
8187,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=369900
8188,2019-11-12,대웅제약미국류마티스학회에서자가면역질환치료제효과입증,http://www.businesspost.co.kr/BP?command=article_view&num=150763
8189,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://newsbrite.net/129855
8190,2019-11-12,제약워치대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개外,http://www.newswatch.kr/news/articleView.html?idxno=25004
8191,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.fnnews.com/news/201911121329574639
8192,2019-11-12,대웅제약美류마티스학회서자가면역질환치료후보물질연구첫공개,http://daily.hankooki.com/lpage/ittech/201911/dh20191112135640145630.htm
8193,2019-11-12,대웅제약자가면역질환후보물질DWP212525연구성과첫공개,http://www.newsian.co.kr/news/articleView.html?idxno=37512
8194,2019-11-12,대웅제약美류마티스학회서DWP212525연구성과첫공개,http://www.medigatenews.com/news/1073674233
8195,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1348675
8196,2019-11-12,대웅제약자가면역치료신약천포창질환개선율우수,http://www.monews.co.kr/news/articleView.html?idxno=206404
8197,2019-11-12,뉴스투데이L대웅제약자가면역질환후보물질연구미학회서첫공개,http://www.news2day.co.kr/141715
8198,2019-11-12,대웅제약美학회서자가면역질환후보물질DWP212525연구성과첫공개,http://kormedi.com/?p=1305562
8199,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질연구성과첫공개,http://www.ekn.kr/news/article.html?no=463422
8200,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질DWP212525연구성과첫공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58152
8201,2019-11-12,대웅제약미국류마티스학회서자가면역질환후보물질연구성과공개,http://www.newstomato.com/ReadNews.aspx?no=932763
8202,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525성과발표2020년말임상추진,http://www.ezyeconomy.com/news/articleView.html?idxno=95331
8203,2019-11-12,대웅제약미국류마티스학회서DWP212525연구성과공개,http://www.dailian.co.kr/news/view/842549/?sc=naver
8204,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.betanews.net:8080/article/1099527.html
8205,2019-11-12,대웅제약자가면역치료제연구결과공개2020년말임상목표,http://www.economytalk.kr/news/articleView.html?idxno=200891
8206,2019-11-12,대웅제약美서자가면역질환치료제후보물질전임상결과공개,http://www.donga.com/news/article/all/20191112/98324147/1
8207,2019-11-12,대웅제약美류마티스학회서자가면역질환후보물질연구성과첫공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=340112
8208,2019-11-12,대웅제약美류마티스학회서DWP212525연구성과첫공개,https://asiatime.co.kr/news/newsview.php?ncode=1065594162421399
8209,2019-11-12,대웅제약美학회서DWP212525연구성과공개,http://www.kpinews.co.kr/news/articleView.html?idxno=106871
8210,2019-11-12,대웅제약부작용은낮춘자가면역치료제개발美류마티스학회에서DWP212525연구성과첫공개,http://www.updownnews.co.kr/news/articleView.html?idxno=210992
8211,2019-11-12,대웅제약美서자가면역질환후보물질DWP212525연구성과첫공개,http://www.ajunews.com/view/20191112161136597
8212,2019-11-12,대웅제약미류마티스학회서DWP212525연구성과첫공개,https://www.kpanews.co.kr/article/show.asp?idx=208450&category=E
8213,2019-11-12,대웅제약美류마티스학회서DWP212525연구성과첫공개,http://inthenews.co.kr/article-24210/
8214,2019-11-12,대웅제약美서자가면역질환후보물질연구성과공개,http://www.whosaeng.com/113904
8215,2019-11-12,​대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.lawissue.co.kr/view.php?ud=201911121716109430204ead0791_12
8216,2019-11-12,대웅제약자가면역질환치료제후보물질연구결과발표,http://weekly.cnbnews.com/news/article.html?no=131127
8217,2019-11-12,대웅제약美학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.getnews.co.kr/view.php?ud=20191112190506583441d0c69529_16
8218,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.newscj.com/news/articleView.html?idxno=682612
8219,2019-11-12,대웅제약美류마티스학회에서자가면역질환후보물질DWP212525연구성과첫공개,http://www.thefirstmedia.net/news/articleView.html?idxno=50622
8220,2019-11-13,연속순매도기관대웅제약9일째팔아,http://www.itooza.com/common/iview.php?no=2019111217224961732
8221,2019-11-13,대웅제약美류마티스학회서자가면역질환후보물질연구성과공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1223073
8222,2019-11-13,홈앤쇼핑대웅제약프레좀RX크림방송판매실시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1348865
8223,2019-11-13,★주식인사이드대웅제약주가138500원11월13일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1046455
8224,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림단독방송,http://news1.kr/articles/?3767549
8225,2019-11-13,11월13일대웅003090증권투자정보외증시동향074변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=566325
8226,2019-11-13,11월13일대웅배당주식11113400원,http://nbntv.co.kr/news/view/733704
8227,2019-11-13,대웅제약DWP212525연구성과첫공개,http://www.bokuennews.com/news/article.html?no=183224
8228,2019-11-13,대웅나보타투여시점별흉터관리효과차이확인,http://www.dailymedi.com/detail.php?number=849500&thread=22r05
8229,2019-11-13,대웅제약美류마티스학회서자가면역질환후보물질DWP212525연구성과첫공개,http://www.polinews.co.kr/news/article.html?no=433146
8230,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림단독방송,http://4th.kr/View.aspx?No=319966
8231,2019-11-13,주식추천주대웅제약주가13일현재136500원,http://nbntv.co.kr/news/view/734235
8232,2019-11-13,홈앤쇼핑대웅제약프리미엄단백질솔루션크림판매,http://www.etnews.com/20191113000113
8233,2019-11-13,스물넷에창업4년만에대웅제약에매각트라이문김사랑대표,http://premium.mk.co.kr/view.php?no=27108
8234,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림선봬,http://www.cnbnews.com/news/article.html?no=427433
8235,2019-11-13,홈앤쇼핑대웅제약프레좀RX크림선봬,http://www.sisaon.co.kr/news/articleView.html?idxno=104235
8236,2019-11-13,홈앤쇼핑대웅제약DWEGF프레좀RX크림방송,http://www.edaily.co.kr/news/newspath.asp?newsid=03952406622685392
8237,2019-11-13,홈앤쇼핑15일대웅제약DWEGF프레좀RX크림단독방송,http://www.insightkorea.co.kr//news/articleView.html?idxno=65290
8238,2019-11-14,★주식인사이드대웅제약주가135000원11월14일9시2분기준,http://www.newsinside.kr/news/articleView.html?idxno=1046778
8239,2019-11-14,11월14일대웅003090및증권시세000변동,http://www.gokorea.kr/news/articleView.html?idxno=568332
8240,2019-11-14,11월14일대웅오늘주식13400원000,http://nbntv.co.kr/news/view/735978
8241,2019-11-14,대웅제약주가06962011월14일현재137000원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=568783
8242,2019-11-14,주식창대웅제약주가14일현재136500원,http://nbntv.co.kr/news/view/736485
8243,2019-11-14,코스피대웅제약3분기누적매출액8258억원영업이익416억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013930341&code=61141211&cp=nv
8244,2019-11-15,11월15일대웅증권투자정보112변화,http://www.gokorea.kr/news/articleView.html?idxno=570420
8245,2019-11-15,11월15일대웅증권매매07513500원,http://nbntv.co.kr/news/view/738313
8246,2019-11-15,대웅제약주가06962011월15일현재137000원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=570825
8247,2019-11-15,오늘증시대웅제약주가15일현재136500원,http://nbntv.co.kr/news/view/738854
8248,2019-11-15,MTN현장대웅제약메디톡스소송전에비용펑펑울고싶은주주도펑펑,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019111513084444028
8249,2019-11-18,대웅주가정보18일오늘가격13700원거래,http://www.gokorea.kr/news/articleView.html?idxno=572248
8250,2019-11-18,11월18일대웅주식종목13650원074,http://nbntv.co.kr/news/view/740416
8251,2019-11-18,대웅제약주가069620증권그래프및주식시황18일오늘가격139500원거래,http://www.gokorea.kr/news/articleView.html?idxno=572640
8252,2019-11-18,대웅재단우수인재육성프로젝트웅토링스쿨2기진행,http://medipana.com/news/news_viewer.asp?NewsNum=248780&MainKind=A&NewsKind=5&vCount=12&vKind=1
8253,2019-11-18,대웅재단글로벌우수인재배출사관학교우뚝,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237512
8254,2019-11-18,대웅제약주식종목18일현재139000원,http://nbntv.co.kr/news/view/740900
8255,2019-11-18,대웅재단웅토링스쿨글로벌인재육성사관학교자리매김,http://www.medisobizanews.com/news/articleView.html?idxno=64068
8256,2019-11-18,대웅재단글로벌리더양성웅토링스쿨2기진행,http://www.bosa.co.kr/news/articleView.html?idxno=2116192
8257,2019-11-18,대웅재단웅토링스쿨2기진행글로벌인재양성,http://www.dailypharm.com/Users/News/NewsView.html?ID=259032&REFERER=NP
8258,2019-11-18,대웅재단글로벌우수인재육성프로젝트웅토링스쿨2기진행,http://www.fnnews.com/news/201911181333078123
8259,2019-11-18,대웅재단글로벌우수인재육성프로젝트웅토링스쿨2기진행,http://www.viva100.com/main/view.php?key=20191118010006114
8260,2019-11-18,대웅재단글로벌우수인재육성프로젝트웅토링스쿨2기진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58251
8261,2019-11-18,제약1조클럽3Q하대웅제약과종근당누가마지막에웃을까,http://daily.hankooki.com/lpage/ittech/201911/dh20191118160707145630.htm
8262,2019-11-18,대웅재단글로벌우수인재육성프로그램웅토링스쿨2기진행,http://www.donga.com/news/article/all/20191118/98423100/1
8263,2019-11-18,대웅재단글로벌인재육성프로그램인기몰이,http://www.whosaeng.com/114026
8264,2019-11-19,★주식인사이드대웅제약주가138500원11월19일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1047497
8265,2019-11-19,11월19일대웅003090정보및매매동향111변동,http://www.gokorea.kr/news/articleView.html?idxno=574131
8266,2019-11-19,대웅실시간주식현황19일현재13400원,http://nbntv.co.kr/news/view/742592
8267,2019-11-19,11월19일대웅제약증권투자정보및증권정보와종목동정108변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=574587
8268,2019-11-19,대웅제약vs메디톡스혈투뒤에서미소짓는엘러간,http://www.segye.com/content/html/2019/11/18/20191118510320.html?OutUrl=naver
8269,2019-11-19,11월19일대웅제약시세보기072138500원,http://nbntv.co.kr/news/view/743145
8270,2019-11-19,대웅제약스마트오피스운영업무몰입도높인다,https://www.hankyung.com/economy/article/201911151498i
8271,2019-11-20,AT포커스1조클럽제약사변동가능성有아슬아슬한대웅제약,https://asiatime.co.kr/news/newsview.php?ncode=1065592790980189
8272,2019-11-20,★주식인사이드대웅제약주가136000원11월20일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1047803
8273,2019-11-20,대웅주가11월20일오늘가격13350원및증권시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=576059
8274,2019-11-20,오늘주식시장대웅주가20일현재13400원,http://nbntv.co.kr/news/view/744921
8275,2019-11-20,11월20일대웅제약069620증권그래프145변화,http://www.gokorea.kr/news/articleView.html?idxno=576488
8276,2019-11-20,대웅제약CSR필름페스티벌고용노동부장관상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237619
8277,2019-11-20,대웅제약고용노동부장관상수상‥참지마요도서제작,http://medipana.com/news/news_viewer.asp?NewsNum=248894&MainKind=A&NewsKind=5&vCount=12&vKind=1
8278,2019-11-20,대웅제약함께하는기업어워드서고용노동부장관상수상,http://daily.hankooki.com/lpage/ittech/201911/dh20191120105515145630.htm
8279,2019-11-20,대웅제약참지마요장관상함께하는기업어워드,http://news.heraldcorp.com/view.php?ud=20191120000353
8280,2019-11-20,대웅제약주식창20일현재135000원,http://nbntv.co.kr/news/view/745458
8281,2019-11-20,대웅제약CSR필름페스티벌서노동부장관상,http://www.medisobizanews.com/news/articleView.html?idxno=64136
8282,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=38272
8283,2019-11-20,대웅제약참지마요CSR필름페스티벌고용노동부장관상수상,http://www.newspim.com/news/view/20191120000500
8284,2019-11-20,대웅제약평등사회위한고용노동부장관상수상,http://www.newsis.com/view/?id=NISX20191120_0000835442&cID=13001&pID=13000
8285,2019-11-20,대웅제약함께하는기업어워드CSR필름페스티벌서고용노동부장관상수상,http://www.segye.com/content/html/2019/11/20/20191120506424.html?OutUrl=naver
8286,2019-11-20,대웅제약참지마요프로젝트CSR필름페스티벌고용노동부장관상수상,http://www.ezyeconomy.com/news/articleView.html?idxno=95549
8287,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://newsbrite.net/130225
8288,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.polinews.co.kr/news/article.html?no=434841
8289,2019-11-20,대웅제약함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.economytalk.kr/news/articleView.html?idxno=201163
8290,2019-11-20,대웅제약평등한사회부문고용노동부장관상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2116374
8291,2019-11-20,대웅제약참지마요고용노동부장관상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1350429
8292,2019-11-20,대웅003090오후12시05분기준외주식시황,https://www.dailysecu.com/news/articleView.html?idxno=80427
8293,2019-11-20,대웅제약CSR필름페스티벌서고용노동부장관상수상,http://www.ekn.kr/news/article.html?no=464979
8294,2019-11-20,대웅제약CRS필름페스티벌서고용노동부장관상수상,http://www.seoulwire.com/news/articleView.html?idxno=256804
8295,2019-11-20,대웅제약CSR필름페스티벌서고용부장관상수상,http://www.dailysmart.co.kr/news/articleView.html?idxno=18376
8296,2019-11-20,대웅제약CRS필름페스티벌고용부장관상수상,http://www.youthdaily.co.kr/news/article.html?no=23050
8297,2019-11-20,대웅제약2019CSR필름페스티벌고용노동부장관상,http://www.newspost.kr/news/articleView.html?idxno=73868
8298,2019-11-20,대웅제약CSR필름페스티벌에서고용노동부장관상수상,http://www.cnbnews.com/news/article.html?no=428110
8299,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상,http://www.wsobi.com/news/articleView.html?idxno=85437
8300,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.dailian.co.kr/news/view/845113/?sc=naver
8301,2019-11-20,대웅제약참지마요프로젝트고용노동부장관상수상,http://www.sportsseoul.com/news/read/851392
8302,2019-11-20,대웅제약발달장애위한참지마요프로젝트고용노동부장관상수상,http://www.metroseoul.co.kr/news/newsview?newscd=2019112000144
8303,2019-11-20,대웅제약참지마요로고용노동부장관상수상,http://www.finomy.com/news/articleView.html?idxno=71963
8304,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.newslock.co.kr/news/articleView.html?idxno=23522
8305,2019-11-20,대웅제약CSR필름페스티벌서고용노동부장관상수상,http://www.viva100.com/main/view.php?key=20191120010007108
8306,2019-11-20,대웅제약CSR페스티벌고용노동부장관상수상,http://www.etnews.com/20191120000278
8307,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58290
8308,2019-11-20,대웅제약참지마요제작과정CSR필름페스티벌서고용부장관상수상,http://news.mk.co.kr/newsRead.php?year=2019&no=966119
8309,2019-11-20,사회공헌활동인정받은대웅제약2019함께하는기업어워드CSR필름페스티벌에서고용노동부장관상수상 ,http://www.updownnews.co.kr/news/articleView.html?idxno=211347
8310,2019-11-20,대웅제약CSR페스티벌고용노동부장관상수상,http://www.econovill.com/news/articleView.html?idxno=378017
8311,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌평등사회부문고용노동부장관상수상,http://www.ftoday.co.kr/news/articleView.html?idxno=112755
8312,2019-11-20,대웅제약함께하는기업어워드＆CSR필름페스티벌고용부장관상,http://www.mdtoday.co.kr/mdtoday/index.html?no=370663
8313,2019-11-20,대웅제약CSR필름페스티벌고용노동부장관상수상,http://www.ntoday.co.kr/news/articleView.html?idxno=69527
8314,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.lawissue.co.kr/view.php?ud=201911201841589112204ead0791_12
8315,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.newscj.com/news/articleView.html?idxno=684938
8316,2019-11-20,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.thefirstmedia.net/news/articleView.html?idxno=50910
8317,2019-11-21,대웅제약시간장소얽매이지않는스마트워크구축,http://news.mk.co.kr/newsRead.php?year=2019&no=967357
8318,2019-11-21,대웅제약참지마요로고용노동부장관상수상,http://moneys.mt.co.kr/news/mwView.php?no=2019112108348026370
8319,2019-11-21,★주식인사이드대웅제약주가134000원11월21일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1048130
8320,2019-11-21,대웅주가11월21일오늘거래가13200원종목그래프외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=577983
8321,2019-11-21,11월21일대웅투자주식11313100원,http://nbntv.co.kr/news/view/747242
8322,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237669
8323,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://medipana.com/news/news_viewer.asp?NewsNum=248995&MainKind=A&NewsKind=5&vCount=12&vKind=1
8324,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.monews.co.kr/news/articleView.html?idxno=206631
8325,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상차별화된기업문화로삶의질향상을위한글로벌헬스케어그룹도약위해노력할것,http://www.segye.com/content/html/2019/11/21/20191121504839.html?OutUrl=naver
8326,2019-11-21,대웅제약일하기좋은100대기업,http://www.dt.co.kr/contents.html?article_no=2019112102109931102005&ref=naver
8327,2019-11-21,대웅제약대한민국일하기좋은 100대기업 대상수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=38311
8328,2019-11-21,대웅제약대한민국일하기좋은100대기업대상,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3990586
8329,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.metroseoul.co.kr/news/newsview?newscd=2019112100018
8330,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,https://www.sedaily.com/NewsView/1VQVUNA1MF
8331,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.mhj21.com/125829
8332,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.newspim.com/news/view/20191121000305
8333,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.newsway.co.kr/news/view?tp=1&ud=2019112110280209210
8334,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.viva100.com/main/view.php?key=20191121010007300
8335,2019-11-21,대웅제약GPTW대한민국일하기좋은100대기업에제약업계최초로선정돼,http://news.mk.co.kr/newsRead.php?year=2019&no=968330
8336,2019-11-21,대웅제약대한민국일하기좋은100대기업大賞국내제약사최초,http://www.medisobizanews.com/news/articleView.html?idxno=64164
8337,2019-11-21,대웅제약대한민국일하기좋은100대기업大賞국내제약사최초,http://www.medisobizanews.com/news/articleView.html?idxno=64164
8338,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.dailysmart.co.kr/news/articleView.html?idxno=18434
8339,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.bokuennews.com/news/article.html?no=183547
8340,2019-11-21,대웅대한민국일하기좋은100대기업대상,http://www.dailymedi.com/detail.php?number=849801&thread=22r05
8341,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.newsis.com/view/?id=NISX20191121_0000836661&cID=13001&pID=13000
8342,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.polinews.co.kr/news/article.html?no=435114
8343,2019-11-21,메디톡스vs대웅제약피튀는보톡스전쟁막전막후,http://www.ilyosisa.co.kr/news/articleView.html?idxno=210740
8344,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=370745
8345,2019-11-21,11월21일대웅제약시세보기149132500원,http://nbntv.co.kr/news/view/747787
8346,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.g-enews.com/ko-kr/news/article/news_all/20191121110027707869d76442fa_1/article.html
8347,2019-11-21,대한민국굿잡스대웅제약대한민국일하기좋은100대기업대상수상,http://www.newslock.co.kr/news/articleView.html?idxno=23572
8348,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1350706
8349,2019-11-21,주가동향대웅003090거래시세12800원,http://www.woodkorea.co.kr/news/articleView.html?idxno=38292
8350,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://newsbrite.net/130273
8351,2019-11-21,대웅제약대한민국일하기좋은100대기업선정,http://www.bosa.co.kr/news/articleView.html?idxno=2116464
8352,2019-11-21,대웅제약나보타원조보톡스에도전장유럽북미시장공략,http://news1.kr/articles/?3774726
8353,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.lawissue.co.kr/view.php?ud=201911211343293227204ead0791_12
8354,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.econovill.com/news/articleView.html?idxno=378100
8355,2019-11-21,대웅제약대한민국일하기좋은100대기업대상,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1228589
8356,2019-11-21,메디톡스대웅제약보톡스전쟁에개미등만터지나,http://ilyo.co.kr/?ac=article_view&entry_id=353900
8357,2019-11-21,모두가님으로존중받는대웅제약일하기좋은기업대상,http://www.newspost.kr/news/articleView.html?idxno=73909
8358,2019-11-21,대웅제약2019함께하는기업어워드CSR필름페스티벌고용노동부장관상수상,http://www.newsian.co.kr/news/articleView.html?idxno=37841
8359,2019-11-21,대웅제약대한민국일하기좋은100대기업서대상수상,https://asiatime.co.kr/news/newsview.php?ncode=1065591661104597
8360,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.donga.com/news/article/all/20191121/98477360/1
8361,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.sportsseoul.com/news/read/851939
8362,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.cnbnews.com/news/article.html?no=428267
8363,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.ebn.co.kr/news/view/1010271/?sc=naver
8364,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://daily.hankooki.com/lpage/ittech/201911/dh20191121165539145630.htm
8365,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58308
8366,2019-11-21,대웅제약일하기좋은100대기업대상수상,http://www.seoulwire.com/news/articleView.html?idxno=258174
8367,2019-11-21,대웅제약근무환경사회공헌인정연속수상영예,http://www.dailymedi.com/detail.php?number=849824&thread=22r05
8368,2019-11-21,대웅제약보툴리눔톡신나보타품질앞세워해외진출가속,http://www.businesspost.co.kr/BP?command=article_view&num=152126
8369,2019-11-21,뉴스투데이L대웅제약대한민국일하기좋은100대기업대상수상,http://www.news2day.co.kr/142564
8370,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.wikileaks-kr.org/news/articleView.html?idxno=70545
8371,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,http://www.getnews.co.kr/view.php?ud=20191121183535505841d0c69529_16
8372,2019-11-21,대웅제약대한민국일하기좋은100대기업대상수상,https://www.vop.co.kr/A00001449808.html
8373,2019-11-22,대웅제약대한민국일하기좋은100대기업대상수상,http://www.thefirstmedia.net/news/articleView.html?idxno=50979
8374,2019-11-22,대웅제약대한민국일하기좋은100대기업대상수상,http://news.heraldcorp.com/view.php?ud=20191122000069
8375,2019-11-22,대웅주가11월22일오늘거래가12800원증권그래프및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=579857
8376,2019-11-22,대웅배당주식22일현재12800원,http://nbntv.co.kr/news/view/749513
8377,2019-11-22,대웅제약주가증권투자정보및종목동정과증시정보22일오늘거래가133500원거래,http://www.gokorea.kr/news/articleView.html?idxno=580312
8378,2019-11-22,대웅제약주식실시간22일현재134000원,http://nbntv.co.kr/news/view/750066
8379,2019-11-22,주식현재가대웅13시59분현재가12700원연중최고가얼마,http://www.aitimes.com/news/articleView.html?idxno=122197
8380,2019-11-22,특징주종목정보11월22일대웅제약131500원으로장마감,http://nbntv.co.kr/news/view/751506
8381,2019-11-24,제품수출에그치지않는다대웅제약의글로벌시장승부수,http://www.edaily.co.kr/news/newspath.asp?newsid=01859766622689000
8382,2019-11-25,★주식인사이드대웅제약주가133000원11월25일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1048786
8383,2019-11-25,대웅나보타공장EUGMP인증갱신,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89123
8384,2019-11-25,대웅나보타공장EUGMP갱신제조시설우수성입증,http://www.dailypharm.com/Users/News/NewsView.html?ID=259287&REFERER=NP
8385,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.viva100.com/main/view.php?key=20191125010008326
8386,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.etnews.com/20191125000020
8387,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.etoday.co.kr/news/section/newsview.php?idxno=1826079
8388,2019-11-25,제조시설우수성재입증대웅제약나보타공장EUGMP인증갱신성공,http://kpenews.com/View.aspx?No=331562
8389,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://daily.hankooki.com/lpage/ittech/201911/dh20191125092457145630.htm
8390,2019-11-25,대웅제약나보타공장EU인증갱신성공,http://news.heraldcorp.com/view.php?ud=20191125000106
8391,2019-11-25,11월25일대웅003090및증권시세외주식시황276변화,http://www.gokorea.kr/news/articleView.html?idxno=581811
8392,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.medisobizanews.com/news/articleView.html?idxno=64225
8393,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.ceoscoredaily.com/news/article.html?no=62804
8394,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.newsway.co.kr/news/view?tp=1&ud=2019112509264252712
8395,2019-11-25,대웅제약나보타공장EUGMP인증갱신GMP실사완료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019112509285647947
8396,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성재입증,http://www.econovill.com/news/articleView.html?idxno=378356
8397,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,https://www.sedaily.com/NewsView/1VQXNZX8J4
8398,2019-11-25,대웅제약나보타공장EUGMP인증갱신‥우수성재입증,http://medipana.com/news/news_viewer.asp?NewsNum=249144&MainKind=A&NewsKind=5&vCount=12&vKind=1
8399,2019-11-25,대웅제약나보타공장유럽우수의약품제조관리기준인증갱신,http://www.newspim.com/news/view/20191125000189
8400,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.dailian.co.kr/news/view/846317/?sc=naver
8401,2019-11-25,11월25일대웅오늘주식시세13050원276,http://nbntv.co.kr/news/view/751954
8402,2019-11-25,대웅제약나보타공장의EUGMP갱신성공,http://news.mk.co.kr/newsRead.php?year=2019&no=979076
8403,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.fnnews.com/news/201911250937068480
8404,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://moneys.mt.co.kr/news/mwView.php?no=2019112509358031198
8405,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=18583
8406,2019-11-25,대웅제약나보타공장EUGMP인증갱신,https://biz.chosun.com/site/data/html_dir/2019/11/25/2019112500820.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8407,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성입증,https://asiatime.co.kr/news/newsview.php?ncode=1065573255406361
8408,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.newsis.com/view/?id=NISX20191125_0000839712&cID=13001&pID=13000
8409,2019-11-25,대웅제약나보타공장EUGMP인증갱신 ,http://www.monews.co.kr/news/articleView.html?idxno=206693
8410,2019-11-25,대웅제약주름개선제나보타생산공장유럽인증갱신,http://www.sportsseoul.com/news/read/853188
8411,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.dt.co.kr/contents.html?article_no=2019112502109931102002&ref=naver
8412,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.rapportian.com/news/articleView.html?idxno=121709
8413,2019-11-25,유럽의약품청대웅제약나보타공장적합인증,http://www.100ssd.co.kr/news/articleView.html?idxno=65621
8414,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성입증,http://www.metroseoul.co.kr/news/newsview?newscd=2019112500028
8415,2019-11-25,대웅제약나보타팩토리EUGMP인증갱신,http://www.newslock.co.kr/news/articleView.html?idxno=23648
8416,2019-11-25,대웅제약나보타공장우수성인증EUGMP인증갱신,http://www.newsprime.co.kr/news/article.html?no=484406
8417,2019-11-25,대웅제약 나보타공장 EUGMP 인증갱신성공 제조시설우수성재입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=38429
8418,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.consumuch.com/news/articleView.html?idxno=46660
8419,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://news.mt.co.kr/mtview.php?no=2019112509425070910
8420,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58352
8421,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237779
8422,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.lawissue.co.kr/view.php?ud=201911251058402423204ead0791_12
8423,2019-11-25,11월25일대웅제약종목검색133000원114,http://nbntv.co.kr/news/view/752488
8424,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.newstomato.com/ReadNews.aspx?no=935538
8425,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.bokuennews.com/news/article.html?no=183680
8426,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://newsbrite.net/130419
8427,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.bosa.co.kr/news/articleView.html?idxno=2116639
8428,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.koreaittimes.com/news/articleView.html?idxno=94254
8429,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.dailymedi.com/detail.php?number=849923&thread=22r05
8430,2019-11-25,대웅제약나보타공장EUGMP인증갱신제조시설우수성재입증,http://www.worktoday.co.kr/news/articleView.html?idxno=5163
8431,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074464
8432,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=370992
8433,2019-11-25,대웅제약나보타공장제조시설우수성재입증,http://www.edaily.co.kr/news/newspath.asp?newsid=03427606622689328
8434,2019-11-25,대웅제약나보타공장EU인증갱신제조시설우수성재입증,http://www.newspost.kr/news/articleView.html?idxno=73964
8435,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://inthenews.co.kr/article-25666/
8436,2019-11-25,대웅제약보툴리눔톡신공장유럽연합제조품질관리기준인증경신,http://www.businesspost.co.kr/BP?command=article_view&num=152460
8437,2019-11-25,국내제약사제조시설유럽에서도인정했다대웅제약나보타공장EUGMP인증갱신성공,http://www.updownnews.co.kr/news/articleView.html?idxno=211514
8438,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.ebn.co.kr/news/view/1010660/?sc=naver
8439,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.joseilbo.com/news/news_read.php?uid=387894&class=27&grp=
8440,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.polinews.co.kr/news/article.html?no=436032
8441,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.wsobi.com/news/articleView.html?idxno=85698
8442,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.wikileaks-kr.org/news/articleView.html?idxno=70794
8443,2019-11-25,대웅제약현지화통한글로벌헬스케어그룹세계시장공략도전이어가,http://www.newslock.co.kr/news/articleView.html?idxno=23682
8444,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.enewstoday.co.kr/news/articleView.html?idxno=1351556
8445,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.cnbnews.com/news/article.html?no=428622
8446,2019-11-25,대웅제약나보타공장EUGMP인증갱신,http://www.finomy.com/news/articleView.html?idxno=72151
8447,2019-11-25,뉴스투데이L대웅제약나보타공장EUGMP인증갱신,http://www.news2day.co.kr/142795
8448,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.medigatenews.com/news/2290989480
8449,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.getnews.co.kr/view.php?ud=2019112519011620041d0c69529_16
8450,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공,http://www.newscj.com/news/articleView.html?idxno=686097
8451,2019-11-25,대웅제약나보타공장EUGMP인증갱신성공제조시설우수성재입증,http://www.thefirstmedia.net/news/articleView.html?idxno=51094
8452,2019-11-26,11월26일대웅003090증권투자정보076변화해,http://www.gokorea.kr/news/articleView.html?idxno=583711
8453,2019-11-26,대웅투자주식26일현재13050원,http://nbntv.co.kr/news/view/754571
8454,2019-11-26,에어프라이어성능대우어플라이언스대웅키친아트우수,http://news1.kr/articles/?3778329
8455,2019-11-26,에어프라이어대우어플라이언스대웅등우수평가,http://www.newsis.com/view/?id=NISX20191126_0000841442&cID=13001&pID=13000
8456,2019-11-26,바삭바삭에어프라이어대우어플라이언스대웅키친아트성능우수”,http://www.ajunews.com/view/20191126094117595
8457,2019-11-26,소비자원일부에어프라이어바스켓세척주의해야대우대웅롯데알미늄조리속도빨라”,http://www.kukinews.com/news/article.html?no=722400
8458,2019-11-26,대웅제약주식장26일현재133500원,http://nbntv.co.kr/news/view/755058
8459,2019-11-26,국산에어프라이어성능비교대우대웅키친아트평가좋아,http://it.chosun.com/site/data/html_dir/2019/11/26/2019112602089.html
8460,2019-11-26,에어프라이어대우어플라이언스대웅키친아트성능안전성등서고르게좋음,http://kpenews.com/View.aspx?No=335005
8461,2019-11-27,대웅제약59년전통간장약1위브랜드강조,http://news.mk.co.kr/newsRead.php?year=2019&no=987602
8462,2019-11-27,11월27일대웅003090및증권시세148변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=585460
8463,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237892
8464,2019-11-27,대웅제약차세대위식도역류질환신약펙수프라잔임상3상완료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1827133
8465,2019-11-27,대웅제약PCAB제제Fexuprazan임상3상완료,http://medipana.com/news/news_viewer.asp?NewsNum=249293&MainKind=A&NewsKind=5&vCount=12&vKind=1
8466,2019-11-27,대웅제약위식도역류질환신약임상완료치료율99,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019112709415723144
8467,2019-11-27,대웅제약글로벌블록버스터신약기대감펙수프라잔임상3상완료,http://kpenews.com/View.aspx?No=335169
8468,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://daily.hankooki.com/lpage/ittech/201911/dh20191127094227145630.htm
8469,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상서유의성입증,http://www.viva100.com/main/view.php?key=20191127010009316
8470,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,https://www.sedaily.com/NewsView/1VQYL20IDG
8471,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.etnews.com/20191127000022
8472,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.dailian.co.kr/news/view/847098/?sc=naver
8473,2019-11-27,대웅제약신약펙수프라잔임상서위산분비억제확인,http://www.medisobizanews.com/news/articleView.html?idxno=64311
8474,2019-11-27,대웅제약위식도역류질환신약임상3상성공적완료,http://news.heraldcorp.com/view.php?ud=20191127000123
8475,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.newspim.com/news/view/20191127000233
8476,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://news.mk.co.kr/newsRead.php?year=2019&no=988294
8477,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://www.consumuch.com/news/articleView.html?idxno=46688
8478,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.metroseoul.co.kr/news/newsview?newscd=2019112700034
8479,2019-11-27,대웅제약위식도역류질환신약펙수프라잔3상완료,http://news.mt.co.kr/mtview.php?no=2019112709482866076
8480,2019-11-27,대웅제약자체개발차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.ceoscoredaily.com/news/article.html?no=62911
8481,2019-11-27,대웅제약자체개발차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.ceoscoredaily.com/news/article.html?no=62911
8482,2019-11-27,대웅제약 차세대위식도역류질환치료제 Fexuprazan 임상3상완료,http://www.businesskorea.co.kr/news/articleView.html?idxno=38544
8483,2019-11-27,대웅제약차세대역류성식도염약펙수프라잔3상완료,http://www.newsis.com/view/?id=NISX20191127_0000842521&cID=13001&pID=13000
8484,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.newswatch.kr/news/articleView.html?idxno=25309
8485,2019-11-27,대웅역류성식도염치료제펙수프라잔3상완료,http://www.dailypharm.com/Users/News/NewsView.html?ID=259394&REFERER=NP
8486,2019-11-27,대웅제약PCAB계열신약3상완료위산억제효과,http://health.chosun.com/site/data/html_dir/2019/11/27/2019112701159.html
8487,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://www.joseilbo.com/news/news_read.php?uid=388022&class=27&grp=
8488,2019-11-27,대웅제약위식도역류질환치료제임상3상완료,http://www.skyedaily.com/news/news_view.html?ID=94622
8489,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,https://view.asiae.co.kr/article/2019112710300836288
8490,2019-11-27,11월27일대웅제약증권투자정보037,http://www.gokorea.kr/news/articleView.html?idxno=585849
8491,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58420
8492,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.dailysmart.co.kr/news/articleView.html?idxno=18733
8493,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://kormedi.com/?p=1306552
8494,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.seoulwire.com/news/articleView.html?idxno=260283
8495,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://inthenews.co.kr/article-25975/
8496,2019-11-27,대웅제약위식도역류질환신약임상3상완료,http://www.youthdaily.co.kr/news/article.html?no=23549
8497,2019-11-27,대웅제약차세대위식도역류치료제임상완료,https://www.paxnetnews.com/articles/54278
8498,2019-11-27,대웅제약차세대위식도역류치료제펙수프라잔임상3상완료,https://asiatime.co.kr/news/newsview.php?ncode=1065574520582390
8499,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://news.mk.co.kr/newsRead.php?year=2019&no=988799
8500,2019-11-27,대웅차세대위식도역류질환치료제3상임상완료,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89181
8501,2019-11-27,대웅차세대위식도역류질환치료제3상임상완료,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89181
8502,2019-11-27,대웅제약위식도역류질환치료신약임상3상완료,http://www.monews.co.kr/news/articleView.html?idxno=206743
8503,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔Fexuprazan임상3상완료,http://www.newslock.co.kr/news/articleView.html?idxno=23739
8504,2019-11-27,대웅제약주식창27일현재134500원,http://nbntv.co.kr/news/view/756351
8505,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,https://biz.chosun.com/site/data/html_dir/2019/11/27/2019112701487.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8506,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://yna.kr/AKR20191127077700017?did=1195m
8507,2019-11-27,대웅제약ITC소송서엘러간은빠져라‥자격없다주장,http://medipana.com/news/news_viewer.asp?NewsNum=249310&MainKind=A&NewsKind=5&vCount=12&vKind=1
8508,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.economytalk.kr/news/articleView.html?idxno=201460
8509,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://newsbrite.net/130560
8510,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.newsprime.co.kr/news/article.html?no=484828
8511,2019-11-27,대웅제약위식도역류질환신약Fexuprazan3상완료,http://www.bosa.co.kr/news/articleView.html?idxno=2116814
8512,2019-11-27,대웅제약개발신약펙수프라잔임상3상완료,http://www.dailymedi.com/detail.php?number=850018&thread=22r05
8513,2019-11-27,대웅제약PCAB펙수프라잔3상임상완료,http://www.whosaeng.com/114267
8514,2019-11-27,대웅제약위식도역류질환치료제임상3상마쳐전승호연구집중,http://www.businesspost.co.kr/BP?command=article_view&num=152843
8515,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.rapportian.com/news/articleView.html?idxno=121784
8516,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.newsway.co.kr/news/view?tp=1&ud=2019112711434928135
8517,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔3상완료,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074561
8518,2019-11-27,대웅제약PCAB펙수프라잔임상3상완료시장진출예고,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132294
8519,2019-11-27,대웅제약차세대위식도역류질환치료신약펙수프라잔임상3상완료,http://www.getnews.co.kr/view.php?ud=20191127130100589941d0c69529_16
8520,2019-11-27,대웅제약신약펙수프라잔임상3상완료,http://www.smedaily.co.kr/news/articleView.html?idxno=87856
8521,2019-11-27,대웅제약위식도역류질환신약임상3상완료,http://www.koreastocknews.com/news/articleView.html?idxno=48369
8522,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상완료,http://www.asiatoday.co.kr/view.php?key=20191127010016181
8523,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상성공,http://www.econovill.com/news/articleView.html?idxno=378608
8524,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,https://www.hankyung.com/it/article/201911276478i
8525,2019-11-27,대웅제약역류성식도염신약국내임상3상완료,https://cnbc.sbs.co.kr/article_hub/10000963839?division=NAVER
8526,2019-11-27,대웅제약차세대위식도역류질환치료제Fexuprazan임상3상완료,http://www.lawissue.co.kr/view.php?ud=201911271443184106204ead0791_12
8527,2019-11-27,대웅제약펙수프라잔임상3상완료효과입증,http://www.mhj21.com/125929
8528,2019-11-27,대웅제약위식도역류치료제펙수프라잔임상3상완료,http://www.bokuennews.com/news/article.html?no=183834
8529,2019-11-27,대웅제약위식도역류질환치료제Fexuprazan임상3상완료,http://www.medigatenews.com/news/2278533550
8530,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.newstomato.com/ReadNews.aspx?no=936247
8531,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료”,http://sports.hankooki.com/lpage/economy/201911/sp20191127155121137020.htm
8532,2019-11-27,대웅제약진화된위식도역류질환치료제임상3상성공,http://www.edaily.co.kr/news/newspath.asp?newsid=03381686622689984
8533,2019-11-27,대웅제약위식도역류질환치료제펙수트라잔임상3상완료,http://www.updownnews.co.kr/news/articleView.html?idxno=211646
8534,2019-11-27,대웅제약나보타공장유럽GMP인증갱신성공제조시설우수성재입증,http://www.ekn.kr/news/article.html?no=465777
8535,2019-11-27,대웅제약역류성식도염신약임상3상완료,https://www.hankyung.com/it/article/2019112771771
8536,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상성공,http://www.newsfc.co.kr/news/articleView.html?idxno=38881
8537,2019-11-27,대웅제약차세대위식도역류질환치료제임상3상완료,http://www.shinailbo.co.kr/news/articleView.html?idxno=1227906
8538,2019-11-27,대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.wikileaks-kr.org/news/articleView.html?idxno=71012
8539,2019-11-27,뉴스투데이L대웅제약차세대위식도역류질환치료제펙수프라잔임상3상완료,http://www.news2day.co.kr/143019
8540,2019-11-27,대웅제약위식도역류질환치료제펙수프라잔임상3상완료,http://www.newscj.com/news/articleView.html?idxno=686842
8541,2019-11-27,대웅제약위식도역류질환신약펙수프라잔임상3상마쳐,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3995661
8542,2019-11-28,대웅제약위식도역류질환치료제펙수프라잔임상3상완료글로벌블록버스터신약으로성장기대,http://www.thefirstmedia.net/news/articleView.html?idxno=51190
8543,2019-11-28,대웅제약나보타성공이을후속신약개발위해RD확대,http://www.kukinews.com/news/article.html?no=723050
8544,2019-11-28,대웅제약위식도역류질환신약높은치료율내약성확인,http://www.seoulfn.com/news/articleView.html?idxno=363872
8545,2019-11-28,대웅그룹재주는우루사가실속은윤재승회장이,http://www.topdaily.kr/news/articleView.html?idxno=61359
8546,2019-11-28,대웅제약나보타공장EUGMP인증갱신제조시설우수성재입증,http://www.newsian.co.kr/news/articleView.html?idxno=38047
8547,2019-11-28,★주식인사이드대웅제약주가137000원11월28일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1049494
8548,2019-11-28,대웅제약차별화된전략으로글로벌헬스케어그룹도약,http://www.asiatoday.co.kr/view.php?key=20191128010016916
8549,2019-11-28,대웅제약위식도역류질환신약임상3상완료,http://www.ekn.kr/news/article.html?no=466644
8550,2019-11-28,대웅제약PCAB위식도역류질환신약3상완료,http://weekly.cnbnews.com/news/article.html?no=131364
8551,2019-11-28,대웅제약위식도역류질환신약임상3상완료,http://www.polinews.co.kr/news/article.html?no=436871
8552,2019-11-29,일할때는제대로몰입해일하고쉴때는제대로쉬는대웅제약,http://www.kukinews.com/news/article.html?no=723049
8553,2019-11-29,대웅제약펙수프라잔으로PCAB독주케이캡에도전장,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074708
8554,2019-11-29,한화證대웅제약실적부진은단기적이슈매수의견”,http://www.newsway.co.kr/news/view?tp=1&ud=2019112908490028342
8555,2019-11-29,대웅제약실적부진단기적이슈한화투자증권,http://www.ajunews.com/view/20191129084229300
8556,2019-11-29,한화證대웅제약실적부진은단기적이슈매수의견,http://www.newsis.com/view/?id=NISX20191129_0000845171&cID=10401&pID=10400
8557,2019-11-29,★주식인사이드대웅제약주가136000원11월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1049805
8558,2019-11-29,대웅제약하반기실적부진단기적이슈,http://www.newsprime.co.kr/news/article.html?no=485120
8559,2019-11-29,특징주대웅제약실적부진은단기이슈,http://www.sisaon.co.kr/news/articleView.html?idxno=105173
8560,2019-11-29,특징주대웅제약실적부진은단기적이슈목표주가23만원매수의견유지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1228436
8561,2019-11-29,리포트브리핑대웅제약실적부진은단기적이슈목표가230000원한화투자증권,http://www.newspim.com/news/view/20191129000487
8562,2019-11-29,GET투자리포트대웅제약투자의견매수유지한화투자증권,http://www.getnews.co.kr/view.php?ud=2019112910303014879tpgetnews_16
8563,2019-11-29,대웅제약소화성궤양치료제판매중단으로단기적실적부진불가피,http://www.businesspost.co.kr/BP?command=article_view&num=153220
8564,2019-11-29,대웅일동종근당등11곳年500억베타미가특허뚫어,http://www.dailymedi.com/detail.php?number=850203&thread=22r05
8565,2019-11-29,대웅제약3분기부진한수익성나보타소송비용4분기에도영향끼칠것”,http://www.wikitree.co.kr/main/news_view.php?id=484948
8566,2019-12-02,★주식인사이드대웅제약주가132500원12월2일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1050140
8567,2019-12-02,CJ케이캡항궤양제신약독주에도전장내민대웅제약,http://www.newsway.co.kr/news/view?tp=1&ud=2019112917455214370
8568,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=18985
8569,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dt.co.kr/contents.html?article_no=2019120202109931102002&ref=naver
8570,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.ceoscoredaily.com/news/article.html?no=63106
8571,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.etnews.com/20191202000051
8572,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238076
8573,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩4종출시,http://news.mk.co.kr/newsRead.php?year=2019&no=1004385
8574,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.asiatoday.co.kr/view.php?key=20191202010000704
8575,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.viva100.com/main/view.php?key=20191202010000367
8576,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.medisobizanews.com/news/articleView.html?idxno=64458
8577,2019-12-02,대웅제약구강연령별맞춤형치약덴티가드랩출시,https://asiatime.co.kr/news/newsview.php?ncode=1065576786568895
8578,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newswatch.kr/news/articleView.html?idxno=25419
8579,2019-12-02,대웅제약연령대별로골라쓰는맞춤치약덴티가드랩출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019120200062
8580,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://news.mt.co.kr/mtview.php?no=2019120211100603699
8581,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.newspim.com/news/view/20191202000446
8582,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://medipana.com/news/news_viewer.asp?NewsNum=249534&MainKind=A&NewsKind=5&vCount=12&vKind=1
8583,2019-12-02,대웅제약구강토탈솔루션시장진출,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912020258&t=NN
8584,2019-12-02,대웅제약서울대와구강생애주기별맞춤치약개발출시,http://www.newsis.com/view/?id=NISX20191202_0000847380&cID=13001&pID=13000
8585,2019-12-02,대웅제약구강주기별치약덴티가드랩출시,http://www.finomy.com/news/articleView.html?idxno=72436
8586,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.joseilbo.com/news/news_read.php?uid=388277&class=27&grp=
8587,2019-12-02,뉴스투데이L대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.news2day.co.kr/143282
8588,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.lawissue.co.kr/view.php?ud=201912021219055990204ead0791_12
8589,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019120212241060403
8590,2019-12-02,대웅제약치약도나이에맞춰쓰세요,https://www.nocutnews.co.kr/news/5252463
8591,2019-12-02,대웅제약이맞춤치약으로구강관리중요성내세워,http://www.polinews.co.kr/news/article.html?no=437910
8592,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.wsobi.com/news/articleView.html?idxno=86087
8593,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dailian.co.kr/news/view/848532/?sc=naver
8594,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.whosaeng.com/114378
8595,2019-12-02,대웅제약구강생애주기맞춤치약덴티가드랩출시,http://www.donga.com/news/article/all/20191202/98623281/1
8596,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://daily.hankooki.com/lpage/ittech/201912/dh20191202140516145630.htm
8597,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newspost.kr/news/articleView.html?idxno=74161
8598,2019-12-02,출시연령별차별화된구강관리기준제시대웅제약덴티가드랩,http://kpenews.com/View.aspx?No=340126
8599,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=371583
8600,2019-12-02,대웅제약생애주기별맞춤치약덴티가드랩출시,http://www.ebn.co.kr/news/view/1011677/?sc=naver
8601,2019-12-02,대웅제약연령대별구강관리덴티가드랩출시,http://www.koreastocknews.com/news/articleView.html?idxno=48496
8602,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.sportsseoul.com/news/read/856286
8603,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.getnews.co.kr/view.php?ud=20191202154900591141d0c69529_16
8604,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=347229
8605,2019-12-02,시지바이오대웅제약공동개발한노보시스IR52장영실상수상,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201912021610018&code=920509
8606,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://newsbrite.net/130822
8607,2019-12-02,치약도생애주기별로대웅제약덴티가드랩선보여,http://www.mhj21.com/126014
8608,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newslock.co.kr/news/articleView.html?idxno=23913
8609,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58506
8610,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.dailymedi.com/detail.php?number=850289&thread=22r05
8611,2019-12-02,대웅제약연령별맞춤형치약덴티가드랩출시,http://www.econovill.com/news/articleView.html?idxno=379043
8612,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩선봬,http://www.cnbnews.com/news/article.html?no=429376
8613,2019-12-02,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.newscj.com/news/articleView.html?idxno=688076
8614,2019-12-03,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.thefirstmedia.net/news/articleView.html?idxno=51404
8615,2019-12-03,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.betanews.net:8080/article/1108832.html
8616,2019-12-03,대웅제약구강생애주기별맞춤치약덴티가드랩출시,http://www.bosa.co.kr/news/articleView.html?idxno=2117146
8617,2019-12-03,제약바이오지배구조⑥대웅제약그룹자기주식재단통해경영권방어와승계1석2조,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535432
8618,2019-12-03,대웅재단글로벌인재육성웅토링스쿨2기수료식​,http://www.medisobizanews.com/news/articleView.html?idxno=64506
8619,2019-12-03,대웅재단2019웅토링스쿨2기수료식성료,http://medipana.com/news/news_viewer.asp?NewsNum=249634&MainKind=A&NewsKind=5&vCount=12&vKind=1
8620,2019-12-03,대웅재단2019웅토링스쿨2기수료식성료,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58530
8621,2019-12-03,대웅재단2019웅토링스쿨2기수료식성료,http://www.bosa.co.kr/news/articleView.html?idxno=2117214
8622,2019-12-03,대웅재단글로벌인재육성2019웅토링스쿨2기성료,http://www.viva100.com/main/view.php?key=20191203010000983
8623,2019-12-03,대웅재단2019웅토링스쿨2기수료식성료​,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238150
8624,2019-12-03,전승호대웅제약차세대위장약으로강자CJ헬스케어에맞설태세,http://www.businesspost.co.kr/BP?command=article_view&num=153680
8625,2019-12-04,제약업계단신광동제약동국제약대웅제약GC녹십자웰빙,http://www.g-enews.com/ko-kr/news/article/news_all/20191203154520135469d76442fa_1/article.html
8626,2019-12-04,★주식인사이드대웅제약주가131500원12월4일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1050640
8627,2019-12-04,12월4일대웅제약주식실시간075131500원,http://nbntv.co.kr/news/view/758041
8628,2019-12-04,대웅003090오후1시32분기준외매매동향,https://www.dailysecu.com/news/articleView.html?idxno=83247
8629,2019-12-04,대웅제약주가069620오늘시세및종목동정과증시정보4일오늘가격132500원형성,http://www.gokorea.kr/news/articleView.html?idxno=587562
8630,2019-12-05,대웅제약4단계치약덴티가드랩출시,http://weekly.cnbnews.com/news/article.html?no=131474
8631,2019-12-05,★주식인사이드대웅제약주가131500원12월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1050961
8632,2019-12-05,시지바이오국내최초뇌혈관스텐트식약처허가대웅제약판매,http://medipana.com/news/news_viewer.asp?NewsNum=249730&MainKind=A&NewsKind=5&vCount=12&vKind=1
8633,2019-12-05,대웅주가차트5일현재12100원,http://nbntv.co.kr/news/view/758593
8634,2019-12-05,5일데일리증권대웅003090오후3시23분기준및주체별매매동향,https://www.dailysecu.com/news/articleView.html?idxno=83694
8635,2019-12-05,대웅제약주요의약품중점자표시7개업계최다,http://www.finomy.com/news/articleView.html?idxno=72639
8636,2019-12-06,에어프라이어9개브랜드제품시험평가결과는대우어플라이언스대웅키친아트우수,http://medicalworldnews.co.kr/news/view.php?idx=1510933394
8637,2019-12-06,★주식인사이드대웅제약주가131000원12월6일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1051248
8638,2019-12-06,대웅주가003090증권그래프및종목동정과증시정보6일오늘가격12300원형성,http://www.gokorea.kr/news/articleView.html?idxno=588761
8639,2019-12-06,대웅주식현재가6일현재12300원,http://nbntv.co.kr/news/view/759556
8640,2019-12-06,대웅제약증권매매6일현재132000원,http://nbntv.co.kr/news/view/759761
8641,2019-12-06,대웅제약주가종목그래프및매매동향6일오늘가격132000원거래,http://www.gokorea.kr/news/articleView.html?idxno=589014
8642,2019-12-06,차세대나보타를찾아라대웅제약전승호RD가속페달,http://www.newsway.co.kr/news/view?tp=1&ud=2019120518163246806
8643,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.medisobizanews.com/news/articleView.html?idxno=64647
8644,2019-12-06,대웅제약연구개발활동우수성입증ISO9001인증획득,http://kpenews.com/View.aspx?No=345493
8645,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.ezyeconomy.com/news/articleView.html?idxno=96022
8646,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2019120600013
8647,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=227276
8648,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newswatch.kr/news/articleView.html?idxno=25573
8649,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newsprime.co.kr/news/article.html?no=486085
8650,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58591
8651,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://medipana.com/news/news_viewer.asp?NewsNum=249826&MainKind=A&NewsKind=5&vCount=12&vKind=1
8652,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.fnnews.com/news/201912061302273751
8653,2019-12-06,대웅제약품질경영시스템국제표준인증획득,http://www.koreastocknews.com/news/articleView.html?idxno=48641
8654,2019-12-06,대웅제약연구개발활동ISO9001국제인증받아,http://health.chosun.com/site/data/html_dir/2019/12/06/2019120601860.html
8655,2019-12-06,대웅제약국제표준ISO9001인증,http://www.polinews.co.kr/news/article.html?no=439379
8656,2019-12-06,대웅제약품질경영시스템ISO9001인증획득,http://www.whosaeng.com/114502
8657,2019-12-06,대웅제약품질경영인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2019120612168084120
8658,2019-12-06,대웅제약품질경영시스템국제표준인증획득,https://www.paxnetnews.com/articles/54634
8659,2019-12-06,대웅제약ISO9001인증획득,https://view.asiae.co.kr/article/2019120613442828770
8660,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.ftoday.co.kr/news/articleView.html?idxno=113087
8661,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1831120
8662,2019-12-06,대웅제약품질경영시스템국제표준인증획득,http://www.newspim.com/news/view/20191206000747
8663,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.seoulwire.com/news/articleView.html?idxno=261642
8664,2019-12-06,대웅제약품질경영국제표준ISO9001인증획득,http://www.youthdaily.co.kr/news/article.html?no=24268
8665,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.donga.com/news/article/all/20191206/98691156/1
8666,2019-12-06,대웅제약품질경영시스템ISO9001인증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912060198&t=NN
8667,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2117494
8668,2019-12-06,대웅제약품질경영시스템ISO9001획득,http://www.k-health.com/news/articleView.html?idxno=46519
8669,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newslock.co.kr/news/articleView.html?idxno=24057
8670,2019-12-06,대웅제약연구본부품질경영시스템국제표준ISO9001인증획득,http://news.mk.co.kr/newsRead.php?year=2019&no=1022329
8671,2019-12-06,대웅제약ISO9001인증획득연구개발활동우수성입증,http://www.getnews.co.kr/view.php?ud=20191206142521474641d0c69529_16
8672,2019-12-06,대웅제약품질경영ISO9001인증수출시신뢰제고,http://www.newsis.com/view/?id=NISX20191206_0000852798&cID=13001&pID=13000
8673,2019-12-06,대웅제약품질경영국제인증RD활동우수성입증”,http://news.heraldcorp.com/view.php?ud=20191206000524
8674,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.medigatenews.com/news/405438929
8675,2019-12-06,대웅제약나보타너마저나보타하반기미국매출부진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019120612053798790
8676,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.bokuennews.com/news/article.html?no=184246
8677,2019-12-06,대웅제약연구개발활동ISO9001인증획득,http://www.rapportian.com/news/articleView.html?idxno=122012
8678,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.dailymedi.com/detail.php?number=850466&thread=22r05
8679,2019-12-06,대웅제약ISO9001인증획득으로연구개발활동우수성입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=348798
8680,2019-12-06,뉴스투데이L대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.news2day.co.kr/143778
8681,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019120615374266548
8682,2019-12-06,대웅제약ISO9001인증획득,http://www.ebn.co.kr/news/view/1012471/?sc=naver
8683,2019-12-06,대웅ISO9001인증연구개발활동우수성입증,http://www.dailypharm.com/Users/News/NewsView.html?ID=259724&REFERER=NP
8684,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238312
8685,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득으로연구개발활동우수성입증,http://newsbrite.net/131067
8686,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://inthenews.co.kr/article-27208/
8687,2019-12-06,대웅제약품질경영시스템국제표준인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=19288
8688,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증,http://www.econovill.com/news/articleView.html?idxno=379466
8689,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득연구개발활동우수성입증,http://www.updownnews.co.kr/news/articleView.html?idxno=212063
8690,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.cnbnews.com/news/article.html?no=429931
8691,2019-12-06,대웅제약품질경영시스템ISO9001인증획득,http://www.finomy.com/news/articleView.html?idxno=72711
8692,2019-12-06,대웅제약품질경영국제표준ISO9001인증획득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1230926
8693,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.sportsseoul.com/news/read/858353
8694,2019-12-06,대웅제약ISO9001인증,http://www.seoulfn.com/news/articleView.html?idxno=364939
8695,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=372044
8696,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://daily.hankooki.com/lpage/ittech/201912/dh20191206181222145630.htm
8697,2019-12-06,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.newscj.com/news/articleView.html?idxno=689373
8698,2019-12-08,대웅제약품질경영시스템국제표준ISO9001인증획득연구개발활동우수성입증”,http://www.viva100.com/main/view.php?key=20191208010002524
8699,2019-12-08,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.dt.co.kr/contents.html?article_no=2019120802109931102002&ref=naver
8700,2019-12-08,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.ekn.kr/news/article.html?no=468474
8701,2019-12-09,대웅주식현황9일현재12400원,http://nbntv.co.kr/news/view/760845
8702,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019120900049
8703,2019-12-09,대웅제약주가증권투자정보9일오늘가격131000원형성,http://www.gokorea.kr/news/articleView.html?idxno=590967
8704,2019-12-09,대웅제약 퇴직사우모임 웅비회 제8회송년의밤개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=39000
8705,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.medisobizanews.com/news/articleView.html?idxno=64676
8706,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://medipana.com/news/news_viewer.asp?NewsNum=249901&MainKind=A&NewsKind=5&vCount=12&vKind=1
8707,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=19364
8708,2019-12-09,대웅제약웅비회제8회송년의밤개최전현직임원130명참석,http://www.viva100.com/main/view.php?key=20191209010002839
8709,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238353
8710,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58623
8711,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,https://asiatime.co.kr/news/newsview.php?ncode=1065575413307958
8712,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newsway.co.kr/news/view?tp=1&ud=2019120910533017587
8713,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤,http://www.polinews.co.kr/news/article.html?no=440173
8714,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://daily.hankooki.com/lpage/ittech/201912/dh20191209105815145630.htm
8715,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newswatch.kr/news/articleView.html?idxno=25610
8716,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newslock.co.kr/news/articleView.html?idxno=24098
8717,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤,http://www.bosa.co.kr/news/articleView.html?idxno=2117580
8718,2019-12-09,대웅제약퇴직사우모임제8회웅비회송년의밤개최,http://www.donga.com/news/article/all/20191209/98716875/1
8719,2019-12-09,대웅퇴직사우모임웅비회송년의밤개최,http://www.dailypharm.com/Users/News/NewsView.html?ID=259774&REFERER=NP
8720,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newspost.kr/news/articleView.html?idxno=74358
8721,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.econovill.com/news/articleView.html?idxno=379594
8722,2019-12-09,데일리주식정보대웅제약069620오후12시20분기준및주식시황,https://www.dailysecu.com/news/articleView.html?idxno=84595
8723,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://newsbrite.net/131131
8724,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.enewstoday.co.kr/news/articleView.html?idxno=1354421
8725,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.lawissue.co.kr/view.php?ud=201912091330454100204ead0791_12
8726,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019120900119
8727,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.cnbnews.com/news/article.html?no=430054
8728,2019-12-09,대웅제약만성통증치료제DWP17061연구발표,http://medipana.com/news/news_viewer.asp?NewsNum=249930&MainKind=A&NewsKind=5&vCount=12&vKind=1
8729,2019-12-09,대웅제약아시아통증심포지엄서신약연구발표,http://www.mhj21.com/126148
8730,2019-12-09,대웅제약만성통증치료물질글로벌혁신신약으로개발,http://www.medisobizanews.com/news/articleView.html?idxno=64690
8731,2019-12-09,대웅제약만성통증치료제신약연구발표글로벌파트너링가속”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1831842
8732,2019-12-09,대웅제약만성통증신약아시아통증심포지엄서주목,http://www.viva100.com/main/view.php?key=20191209010002975
8733,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.lawissue.co.kr/view.php?ud=201912091400532469204ead0791_12
8734,2019-12-09,대웅제약웅비회송년의밤개최,http://www.finomy.com/news/articleView.html?idxno=72766
8735,2019-12-09,대웅제약만성통증치료제신약연구발표글로벌임상1상준비,http://www.newsprime.co.kr/news/article.html?no=486302
8736,2019-12-09,대웅제약만성통증치료신약내년상반기글로벌임상1상,https://www.hankyung.com/it/article/201912091805i
8737,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제연구발표,http://daily.hankooki.com/lpage/ittech/201912/dh20191209142115145630.htm
8738,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.seoulwire.com/news/articleView.html?idxno=261903
8739,2019-12-09,대웅제약골관절염진통제신약전임상성공적,http://news.mt.co.kr/mtview.php?no=2019120914184004369
8740,2019-12-09,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.youthdaily.co.kr/news/article.html?no=24420
8741,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료신약발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238373
8742,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.dailian.co.kr/news/view/850906/?sc=naver
8743,2019-12-09,대웅제약만성통증치료후보물질효능우수,http://www.monews.co.kr/news/articleView.html?idxno=206974
8744,2019-12-09,대웅ISO9001인증연구개발활동우수성입증,http://www.monews.co.kr/news/articleView.html?idxno=206958
8745,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,https://www.kpanews.co.kr/article/show.asp?idx=209302&category=D
8746,2019-12-09,대웅제약APS서만성통증치료제신약연구발표주목,http://www.bosa.co.kr/news/articleView.html?idxno=2117605
8747,2019-12-09,대웅제약만성통증치료제DWP17061연구결과발표,http://www.donga.com/news/article/all/20191209/98721403/1
8748,2019-12-09,대웅제약만성통증치료제신약연구발표,http://www.joseilbo.com/news/news_read.php?uid=388736&class=27&grp=
8749,2019-12-09,대웅씨티LNG탱크홀딩타임213일세계적기술력입증,http://amenews.kr/news/view.php?idx=40976
8750,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료후보물질DWP17061연구발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=372200
8751,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=372201
8752,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=349222
8753,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.newspim.com/news/view/20191209000853
8754,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.nbnnews.co.kr/news/articleView.html?idxno=349230
8755,2019-12-09,대웅제약아시아통증심포지엄서만성통증신약후보물질전임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=1029121
8756,2019-12-09,아시아통증심포지엄대웅통증신약주목,http://www.whosaeng.com/114557
8757,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.medigatenews.com/news/2114361362
8758,2019-12-09,대웅제약2019아시아통증심포지엄에서만성통증치료제신약프로파일발표,http://www.ftoday.co.kr/news/articleView.html?idxno=113140
8759,2019-12-09,대웅제약국제학술대회서만성통증치료물질발표,http://moneys.mt.co.kr/news/mwView.php?no=2019120916178021434
8760,2019-12-09,대웅제약DWP17061프로파일발표,http://www.ebn.co.kr/news/view/1012725/?sc=naver
8761,2019-12-09,만성통증치료제적용력확인대웅제약DWP17061프로파일발표,http://kpenews.com/View.aspx?No=347685
8762,2019-12-09,대웅제약만성통증치료후보물질효능우수,http://www.seoulwire.com/news/articleView.html?idxno=261951
8763,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58638
8764,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://newsbrite.net/131167
8765,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.ekn.kr/news/article.html?no=468774
8766,2019-12-09,대웅제약만성통증치료제신약연구발표,http://www.economytalk.kr/news/articleView.html?idxno=201995
8767,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.businesskorea.co.kr/news/articleView.html?idxno=39036
8768,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표주목,http://www.getnews.co.kr/view.php?ud=20191209184328435941d0c69529_16
8769,2019-12-09,대웅제약아시아통증심포지엄에골관절염통증치료제신약연구발표,http://www.news2day.co.kr/143920
8770,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.news2day.co.kr/143921
8771,2019-12-09,대웅제약만성통증치료제신약연구발표,http://www.polinews.co.kr/news/article.html?no=440348
8772,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.getnews.co.kr/view.php?ud=20191209193151914541d0c69529_16
8773,2019-12-09,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.newscj.com/news/articleView.html?idxno=689879
8774,2019-12-09,대웅제약아시아통증심포지엄에서만성통증치료제신약연구발표,http://www.thefirstmedia.net/news/articleView.html?idxno=51686
8775,2019-12-09,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.thefirstmedia.net/news/articleView.html?idxno=51691
8776,2019-12-10,대웅제약아시아통증심포지엄서만성통증치료제신약연구발표,http://www.g-enews.com/ko-kr/news/article/news_all/201912091736469882aca1a8c21a_1/article.html
8777,2019-12-10,대웅제약품질경영시스템국제표준ISO9001인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=51705
8778,2019-12-10,★주식인사이드대웅제약주가130000원12월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1051934
8779,2019-12-10,대웅제약생애주기별맞춤치약덴티가드홈쇼핑서선봬,http://moneys.mt.co.kr/news/mwView.php?no=2019121009138034470
8780,2019-12-10,대웅제약생애주기별맞춤치약덴티가드랩홈쇼핑런칭,http://medipana.com/news/news_viewer.asp?NewsNum=249978&MainKind=A&NewsKind=5&vCount=12&vKind=1
8781,2019-12-10,대웅주가종목그래프및종목관련동향정보10일오늘가격12100원,http://www.gokorea.kr/news/articleView.html?idxno=592360
8782,2019-12-10,대웅주식창10일현재12150원,http://nbntv.co.kr/news/view/762598
8783,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.dailysmart.co.kr/news/articleView.html?idxno=19417
8784,2019-12-10,대웅제약생애주기별치약덴티가드랩NS홈쇼핑런칭,http://www.medisobizanews.com/news/articleView.html?idxno=64709
8785,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.enewstoday.co.kr/news/articleView.html?idxno=1354563
8786,2019-12-10,대웅제약12일NS홈쇼핑서생애주기별맞춤치약덴티가드랩판매,http://news.mk.co.kr/newsRead.php?year=2019&no=1031040
8787,2019-12-10,대웅제약덴티가드랩NS홈쇼핑론칭,http://www.ebn.co.kr/news/view/1012807/?sc=naver
8788,2019-12-10,대웅제약구강생애주기별치약덴티가드랩NS홈쇼핑론칭,https://asiatime.co.kr/news/newsview.php?ncode=1065573799041296
8789,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.metroseoul.co.kr/news/newsview?newscd=2019121000044
8790,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://newsbrite.net/131188
8791,2019-12-10,대웅제약연령대별구강생애주기맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.newslock.co.kr/news/articleView.html?idxno=24144
8792,2019-12-10,대웅제약연령별맞춤치약덴티가드랩12일NS홈쇼핑서판매,http://www.100ssd.co.kr/news/articleView.html?idxno=65954
8793,2019-12-10,대웅제약덴티가드랩NS홈쇼핑런칭,http://www.dailypharm.com/Users/News/NewsView.html?ID=259814&REFERER=NP
8794,2019-12-10,대웅제약구강생애주기맞춤치약판매채널확대,http://www.newsis.com/view/?id=NISX20191210_0000855408&cID=13001&pID=13000
8795,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.lawissue.co.kr/view.php?ud=201912101050189449204ead0791_12
8796,2019-12-10,대웅제약주가및증권시세10일오늘가격128500원형성,http://www.gokorea.kr/news/articleView.html?idxno=592945
8797,2019-12-10,주식장대웅제약주가10일현재129000원,http://nbntv.co.kr/news/view/763159
8798,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.newsway.co.kr/news/view?tp=1&ud=2019121011095586594
8799,2019-12-10,대웅제약덴티가드랩치약NS홈쇼핑런칭,http://www.bosa.co.kr/news/articleView.html?idxno=2117675
8800,2019-12-10,대웅제약덴티가드랩판매채널확대12일NS홈쇼핑판매,http://kpenews.com/View.aspx?No=348321
8801,2019-12-10,대웅제약덴티가드랩NS홈쇼핑런칭,http://www.cnbnews.com/news/article.html?no=430166
8802,2019-12-10,대웅제약빈혈치료제할랄인증마지막단계20억무슬림시장열린다,http://www.maeilnews.co.kr/news/article.html?no=7171
8803,2019-12-10,대웅제약DWP17061내년상반기글로벌임상1상준비,http://www.bokuennews.com/news/article.html?no=184373
8804,2019-12-10,대웅제약4단계치약덴티가드랩NS홈쇼핑론칭,http://www.polinews.co.kr/news/article.html?no=440546
8805,2019-12-10,대웅제약퇴직사우모임웅비회제8회송년의밤개최,http://www.newsian.co.kr/news/articleView.html?idxno=38410
8806,2019-12-10,대웅제약069620오후2시21분기준및매매동향,https://www.dailysecu.com/news/articleView.html?idxno=85105
8807,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩12일NS홈쇼핑서판매,http://www.updownnews.co.kr/news/articleView.html?idxno=212183
8808,2019-12-10,대웅제약당뇨약까지퍼진발암물질공포에깊은한숨,https://asiatime.co.kr/news/newsview.php?ncode=1065587297801912
8809,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩홈쇼핑런칭,http://www.econovill.com/news/articleView.html?idxno=379735
8810,2019-12-10,대웅제약ISO9001인증획득연구개발활동우수성입증,http://www.newsian.co.kr/news/articleView.html?idxno=38450
8811,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.getnews.co.kr/view.php?ud=20191210181633116441d0c69529_16
8812,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.newscj.com/news/articleView.html?idxno=690241
8813,2019-12-10,대웅제약연령별맞춤치약덴티가드랩NS홈쇼핑12일런칭,http://www.news2day.co.kr/144039
8814,2019-12-10,대웅제약구강생애주기별맞춤치약덴티가드랩홈쇼핑런칭,http://www.thefirstmedia.net/news/articleView.html?idxno=51751
8815,2019-12-11,대웅난공불락뇌졸중치매줄기세포치료제연구활발,http://www.ceoscoredaily.com/news/article.html?no=63504
8816,2019-12-11,12월11일대웅003090오늘시세080변동해,http://www.gokorea.kr/news/articleView.html?idxno=594864
8817,2019-12-11,대웅오늘증권시세11일현재12450원,http://nbntv.co.kr/news/view/764818
8818,2019-12-11,12월11일대웅제약증권그래프038변동,http://www.gokorea.kr/news/articleView.html?idxno=595449
8819,2019-12-11,대웅제약오늘주식시세11일현재130000원,http://nbntv.co.kr/news/view/765386
8820,2019-12-11,대웅제약품질경영국제표준ISO9001인증,http://news.heraldcorp.com/view.php?ud=20191211000318
8821,2019-12-11,데일리증권대웅003090오후2시06분기준,https://www.dailysecu.com/news/articleView.html?idxno=85467
8822,2019-12-11,대웅제약만성통증치료신약내년상반기글로벌임상1상추진,http://www.newsian.co.kr/news/articleView.html?idxno=38488
8823,2019-12-11,경영스코프대웅제약전통신규사업조화속글로벌정조준,http://www.newstomato.com/ReadNews.aspx?no=939132
8824,2019-12-11,대웅제약구강생애주기별맞춤치약덴티가드랩NS홈쇼핑런칭,http://www.wsobi.com/news/articleView.html?idxno=86643
8825,2019-12-12,★주식인사이드대웅제약주가131000원12월12일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1052429
8826,2019-12-12,주식종목시세대웅주가12일현재12500원,http://nbntv.co.kr/news/view/767029
8827,2019-12-12,대웅주가12월12일현재12500원정보및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=597311
8828,2019-12-12,메디톡스대웅제약소모적인보톡스소송국내업체美시장진출걸림돌일상톡톡플러스,http://www.segye.com/content/html/2019/12/12/20191212503099.html?OutUrl=naver
8829,2019-12-12,12월12일대웅제약주식현황000131000원,http://nbntv.co.kr/news/view/767579
8830,2019-12-12,대웅제약주가12월12일현재131000원종목그래프및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=597892
8831,2019-12-12,대웅제약 美혈액학회서 자가면역질환후보물질 DWP213388 연구성과공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=39178
8832,2019-12-12,자가면역질환후보물질질환개선효과확인대웅제약연구결과공개,http://kpenews.com/View.aspx?No=351615
8833,2019-12-12,대웅제약美혈액학회서자가면역질환치료후보물질성과공개,http://www.medisobizanews.com/news/articleView.html?idxno=64799
8834,2019-12-12,대웅제약美혈액학회서자가면역질환치료후보물질연구결과공개,http://news.mk.co.kr/newsRead.php?year=2019&no=1040776
8835,2019-12-12,대웅제약ASH서자가면역질환ITKBTK저해제첫공개,http://www.biospectator.com/view/news_view.php?varAtcId=9104
8836,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58721
8837,2019-12-12,대웅제약자가면역질환후보물질DWP213388공개,http://medipana.com/news/news_viewer.asp?NewsNum=250158&MainKind=A&NewsKind=5&vCount=12&vKind=1
8838,2019-12-12,대웅제약ASH서자가면역질환후보물질성과공개,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1130856&REFERER=NP
8839,2019-12-12,대웅제약美ASH서자가면역질환신약연구성과공개,http://www.bosa.co.kr/news/articleView.html?idxno=2117903
8840,2019-12-12,대웅제약미국서자가면역질환후보물질연구성과공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238552
8841,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.ezyeconomy.com/news/articleView.html?idxno=96190
8842,2019-12-12,대웅제약자가면역질환후보물질DWP213388연구성과공개,http://www.etnews.com/20191212000105
8843,2019-12-12,대웅제약美혈액학회서자가면역질환치료제후보물질연구성과공개,http://www.pressm.kr/news/articleView.html?idxno=26532
8844,2019-12-12,대웅제약자가면역질환치료제DWP213388전임상서효능확인,http://www.econovill.com/news/articleView.html?idxno=379928
8845,2019-12-12,대웅제약美학회서자가면역질환후보물질공개,https://www.paxnetnews.com/articles/54821
8846,2019-12-12,대웅제약美서자가면역질환치료제DWP213388연구결과첫공개,http://www.viva100.com/main/view.php?key=20191212010004409
8847,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388성과발표,http://news1.kr/articles/?3791667
8848,2019-12-12,대웅제약美학회서자가면역질환치료제연구성과공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=19569
8849,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.newsway.co.kr/news/view?tp=1&ud=2019121214114049844
8850,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구결과공개,http://www.newsprime.co.kr/news/article.html?no=486795
8851,2019-12-12,대웅제약美혈액학회서DWP213388연구성과공개,http://www.whosaeng.com/114656
8852,2019-12-12,대웅제약자가면역질환치료제생존율개선,https://www.sedaily.com/NewsView/1VS1NRYJ45
8853,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1833552
8854,2019-12-12,대웅제약美혈액학회서DWP213388연구성과공개,http://www.mhj21.com/126249
8855,2019-12-12,대웅제약美ASH서자가면역질환후보물질연구성과공개,http://inthenews.co.kr/article-27893/
8856,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구결과공개,http://www.newspim.com/news/view/20191212000984
8857,2019-12-12,대웅제약美혈액학회서자가면역질환ITKBTK저해제연구성과공개,http://www.updownnews.co.kr/news/articleView.html?idxno=212324
8858,2019-12-12,대웅제약美혈액학회서DWP213388자가면역질환후보물질연구성과알려,http://www.newslock.co.kr/news/articleView.html?idxno=24222
8859,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=372592
8860,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388성과발표,http://www.ajunews.com/view/20191212153000450
8861,2019-12-12,대웅제약미국서자가면역질환신약연구성과첫공개,http://moneys.mt.co.kr/news/mwView.php?no=2019121215308042898
8862,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.medigatenews.com/news/3018854375
8863,2019-12-12,대웅제약美혈액학회서자가면역질환치료제연구결과공개,http://www.koreastocknews.com/news/articleView.html?idxno=48809
8864,2019-12-12,대웅제약美혈액학회서자가면역질환신약연구발표,http://news.heraldcorp.com/view.php?ud=20191212000718
8865,2019-12-12,대웅제약자가면역치료제GvHD질환개선효과확인,http://www.monews.co.kr/news/articleView.html?idxno=207049
8866,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=350237
8867,2019-12-12,대웅제약美서자가면역질환후보물질연구성과공개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019121216503834231
8868,2019-12-12,대웅제약자가면역질환후보물질DWP213388연구성과美혈액학회서공개,http://www.thefirstmedia.net/news/articleView.html?idxno=51861
8869,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.g-enews.com/ko-kr/news/article/news_all/20191212142304354569d76442fa_1/article.html
8870,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과공개,http://newsbrite.net/131366
8871,2019-12-12,대웅제약미국서자가면역질환후보물질연구성과공개,http://www.economytalk.kr/news/articleView.html?idxno=202115
8872,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질DWP213388연구성과발표,http://www.getnews.co.kr/view.php?ud=20191212173216237241d0c69529_16
8873,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.dailian.co.kr/news/view/852164/?sc=naver
8874,2019-12-12,인터뷰ISO탱크컨테이너수출나선㈜대웅CT김태섭대표이사단열성능우수홀딩타임세계최고죠,http://www.gasnews.com/news/articleView.html?idxno=89706
8875,2019-12-12,대웅CTISO탱크컨테이너2000대수주,http://www.gasnews.com/news/articleView.html?idxno=89705
8876,2019-12-12,대웅제약美혈액학회서DWP213388연구성과공개,http://www.polinews.co.kr/news/article.html?no=441257
8877,2019-12-12,대웅제약자가면역질환신약동물실험서생존률개선,http://news.mt.co.kr/mtview.php?no=2019121218392198398
8878,2019-12-12,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.newscj.com/news/articleView.html?idxno=690885
8879,2019-12-13,★주식인사이드대웅제약주가133000원12월13일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1052743
8880,2019-12-13,대웅CTLNGISO탱크기술력과시2000대수출계약성사,http://www.todayenergy.kr/news/articleView.html?idxno=220640
8881,2019-12-13,12월13일대웅주식종목12550원162,http://nbntv.co.kr/news/view/769185
8882,2019-12-13,대웅주가12월13일오늘거래가12600원정보,http://www.gokorea.kr/news/articleView.html?idxno=599814
8883,2019-12-13,12월13일대웅제약종목그래프114변화,http://www.gokorea.kr/news/articleView.html?idxno=600400
8884,2019-12-13,대웅제약美혈액학회서자가면역질환후보물질연구성과공개,http://www.bokuennews.com/news/article.html?no=184548
8885,2019-12-13,대웅제약美혈액학회서자가면역질환신약연구결과첫공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075143
8886,2019-12-13,대웅제약차세대자가면역질환치료제후보물질연구결과공개,http://weekly.cnbnews.com/news/article.html?no=131596
8887,2019-12-15,한미대웅미국혈액학회서신약후보물질연구성과로주목,http://www.sportsseoul.com/news/read/861029
8888,2019-12-16,대웅뇌졸중줄기세포치료제내년상반기임상1상신청시설투자예정,http://www.ceoscoredaily.com/news/article.html?no=63645
8889,2019-12-16,★주식인사이드대웅제약주가132500원12월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1053115
8890,2019-12-16,대웅배당주식16일현재12750원,http://nbntv.co.kr/news/view/771207
8891,2019-12-16,12월16일대웅제약주가차트132000원112,http://nbntv.co.kr/news/view/771705
8892,2019-12-16,대웅제약세계최초최고신약개발로넥스트나보타앞당긴다,http://www.insightkorea.co.kr//news/articleView.html?idxno=71576
8893,2019-12-17,대웅제약나보타미국이어캐나다유럽진출,http://www.mhj21.com/126327
8894,2019-12-17,주식종목시세대웅주가17일현재12600원,http://nbntv.co.kr/news/view/773102
8895,2019-12-17,대웅제약06962017일227변동폭보여오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=602791
8896,2019-12-17,대웅제약나보타를필두로글로벌헬스케어기업도약,http://www.koreaittimes.com/news/articleView.html?idxno=94643
8897,2019-12-17,대웅제약증권투자17일현재130500원,http://nbntv.co.kr/news/view/773623
8898,2019-12-17,대웅003090오후2시06분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=87660
8899,2019-12-17,17일데일리증권대웅제약069620오후2시20분기준및증권정보와종목동정,https://www.dailysecu.com/news/articleView.html?idxno=87746
8900,2019-12-17,대웅제약나보타필두로글로벌헬스케어그룹도약할것”,http://inthenews.co.kr/article-28438/
8901,2019-12-17,대웅제약내년미국중국서펙수프라잔임상개시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912170337&t=NN
8902,2019-12-18,★주식인사이드대웅제약주가130500원12월18일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1053583
8903,2019-12-18,오늘주식장대웅주가18일현재12600원,http://nbntv.co.kr/news/view/775231
8904,2019-12-18,대웅제약투자주식18일현재131000원,http://nbntv.co.kr/news/view/775767
8905,2019-12-18,대웅제약이지듀6년연속대한민국퍼스트브랜드대상,http://www.medisobizanews.com/news/articleView.html?idxno=64998
8906,2019-12-18,대웅제약차세대나보타개발매진,http://www.seoulfn.com/news/articleView.html?idxno=366198
8907,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58826
8908,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드파이널리스트수상,http://www.viva100.com/main/view.php?key=20191218010006633
8909,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문본상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1835831
8910,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트상수상,http://www.medisobizanews.com/news/articleView.html?idxno=65003
8911,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드파이널리스트수상,http://www.getnews.co.kr/view.php?ud=20191218160128981841d0c69529_16
8912,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트수상,http://medipana.com/news/news_viewer.asp?NewsNum=250450&MainKind=A&NewsKind=5&vCount=12&vKind=1
8913,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=373101
8914,2019-12-18,대웅제약덴티가드랩핀업디자인어워드패키지디자인부분수상,https://asiatime.co.kr/news/newsview.php?ncode=1065597152232041
8915,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문 파이널리스트 수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=39352
8916,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://newsbrite.net/131621
8917,2019-12-18,대웅제약덴티가드랩핀업디자인어워드서파이널리스트상수상,http://news.mk.co.kr/newsRead.php?no=1061978&year=2019
8918,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드서파이널리스트상수상,http://www.ekn.kr/news/article.html?no=470819
8919,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트수상,http://www.newspim.com/news/view/20191218001096
8920,2019-12-18,메디톡스vs대웅제약국내소송보다美ITC소송에무게실리나,http://biz.newdaily.co.kr/site/data/html/2019/12/18/2019121800203.html
8921,2019-12-18,대웅제약메디톡스균주소송무한반복,http://www.newsis.com/view/?id=NISX20191218_0000864808&cID=13001&pID=13000
8922,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.m-i.kr/news/articleView.html?idxno=665522
8923,2019-12-18,대웅메디톡스균주소송6번째변론서도평행선,http://www.dailypharm.com/Users/News/NewsView.html?ID=260106&REFERER=NP
8924,2019-12-18,대웅이지듀6년연속대한민국퍼스트브랜드대상,http://www.dailymedi.com/detail.php?number=850945&thread=22r05
8925,2019-12-18,대웅제약덴티가드랩핀업디자인어워드파이널리스트수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1356494
8926,2019-12-18,대웅제약덴티가드랩핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.newswatch.kr/news/articleView.html?idxno=25879
8927,2019-12-18,대웅제약덴티가드랩패키지디자인본상수상,http://www.100ssd.co.kr/news/articleView.html?idxno=66153
8928,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.news2day.co.kr/144704
8929,2019-12-18,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.thefirstmedia.net/news/articleView.html?idxno=52113
8930,2019-12-18,대웅제약덴티가드랩치약수상,http://www.polinews.co.kr/news/article.html?no=443108
8931,2019-12-19,대웅제약덴티가드랩2019핀업디자인어워드수상,http://www.bosa.co.kr/news/articleView.html?idxno=2118331
8932,2019-12-19,메디톡스대웅제약지루한균주소송에판사도일침,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075323
8933,2019-12-19,★주식인사이드대웅제약주가130000원12월19일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1053868
8934,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장진출,http://www.etnews.com/20191219000017
8935,2019-12-19,대웅제약나보타할랄시장본격진출,http://www.consumuch.com/news/articleView.html?idxno=46967
8936,2019-12-19,대웅제약나보타할랄시장본격진출,http://www.koreastocknews.com/news/articleView.html?idxno=48986
8937,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238779
8938,2019-12-19,대웅제약나보타국내최초UAE인니품목허가획득,http://www.viva100.com/main/view.php?key=20191219010006861
8939,2019-12-19,대웅제약나보타내년상반기중동출시,http://www.hankookilbo.com/news/npath/201912190944081012?did=NA
8940,2019-12-19,대웅제약나보타국산보툴리눔톡신최초UAE인도네시아진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1836114
8941,2019-12-19,대웅제약나보타UAE∙인도네시아품목허가획득할랄시장본격진출,http://www.getnews.co.kr/view.php?ud=20191219092557121641d0c69529_16
8942,2019-12-19,대웅제약나보타UAE인니품목허가획득할랄시장저격,http://moneys.mt.co.kr/news/mwView.php?no=2019121909268022494
8943,2019-12-19,대웅제약UAE인도네시아서나보타품목허가획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912190135&t=NN
8944,2019-12-19,대웅제약나보타UAE인도네시아품목허가할랄시장본격진출,http://www.medisobizanews.com/news/articleView.html?idxno=65018
8945,2019-12-19,대웅제약06962019일115변동폭보여및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=604705
8946,2019-12-19,12월19일대웅증권플러스07912700원,http://nbntv.co.kr/news/view/777442
8947,2019-12-19,대웅제약나보타할랄시장뛰어든다UAE인니품목허가획득,http://daily.hankooki.com/lpage/ittech/201912/dh20191219093724145630.htm
8948,2019-12-19,대웅나보타UAE인도네시아품목허가획득전세계50개국째,http://medipana.com/news/news_viewer.asp?NewsNum=250482&MainKind=A&NewsKind=5&vCount=12&vKind=1
8949,2019-12-19,대웅제약보툴리눔톡신나보타UAE인도네시아허가,http://yna.kr/AKR20191219045300017?did=1195m
8950,2019-12-19,대웅제약나보타할랄시장진출,https://www.sedaily.com/NewsView/1VS4V68ZY0
8951,2019-12-19,대웅제약나보타할랄시장진출UAE인도네시아품목허가,http://news1.kr/articles/?3796934
8952,2019-12-19,대웅제약나보타아랍에미리트인도네시아품목허가획득할랄시장진출,http://www.ezyeconomy.com/news/articleView.html?idxno=96378
8953,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.newslock.co.kr/news/articleView.html?idxno=24422
8954,2019-12-19,대웅제약나보타UAE인니품목허가할랄시장본격진출,http://news.heraldcorp.com/view.php?ud=20191219000136
8955,2019-12-19,대웅제약덴티가드랩2019핀업디자인어워드패키지디자인부문파이널리스트수상,http://www.nbnnews.co.kr/news/articleView.html?idxno=351867
8956,2019-12-19,대웅제약나보타중동UAE인도네시아진출,http://health.chosun.com/site/data/html_dir/2019/12/19/2019121901092.html
8957,2019-12-19,대웅제약나보타중동할랄시장도진출,https://www.paxnetnews.com/articles/55054
8958,2019-12-19,대웅제약나보타UAE인니품목허가획득,http://www.ebn.co.kr/news/view/1014180/?sc=naver
8959,2019-12-19,대웅제약나보타UAE인도네시아서품목허가승인,http://www.newspim.com/news/view/20191219000332
8960,2019-12-19,대웅제약보툴리눔톡신나보타할랄시장진출,http://it.chosun.com/site/data/html_dir/2019/12/19/2019121901130.html
8961,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://newsbrite.net/131640
8962,2019-12-19,대웅제약나보타첫할랄진출,http://www.newstomato.com/ReadNews.aspx?no=940870
8963,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.newswatch.kr/news/articleView.html?idxno=25882
8964,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.ceoscoredaily.com/news/article.html?no=63847
8965,2019-12-19,대웅제약나보타할랄시장진출UAE인니허가,http://www.newsis.com/view/?id=NISX20191219_0000865278&cID=13001&pID=13000
8966,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58836
8967,2019-12-19,대웅나보타중동인니품목허가,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89600
8968,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.newsprime.co.kr/news/article.html?no=487567
8969,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=19906
8970,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.m-i.kr/news/articleView.html?idxno=665700
8971,2019-12-19,대웅제약나보타UAE인도네시아서도품목허가획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1356593
8972,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.nbnnews.co.kr/news/articleView.html?idxno=351891
8973,2019-12-19,대웅제약나보타UAE인도네시아서품목허가획득,http://www.econovill.com/news/articleView.html?idxno=380483
8974,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.newsfc.co.kr/news/articleView.html?idxno=39146
8975,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.ekn.kr/news/article.html?no=471005
8976,2019-12-19,대웅나보타글로벌브랜드행보가속화,http://www.whosaeng.com/114799
8977,2019-12-19,대웅제약나보타UAE인도네시아서품목허가,http://www.seoulfn.com/news/articleView.html?idxno=366295
8978,2019-12-19,대웅제약나보타UAE인니등할랄시장진출,http://kormedi.com/?p=1308072
8979,2019-12-19,대웅제약나보타UAE인도네시아품목허가,http://www.dailymedi.com/detail.php?number=850963&thread=22r05
8980,2019-12-19,대웅제약보툴리눔톡신나보타할랄시장진출UAE인도네시아품목허가”,http://sports.hankooki.com/lpage/economy/201912/sp20191219110613137020.htm
8981,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.pressm.kr/news/articleView.html?idxno=26684
8982,2019-12-19,대웅제약나보타UAE인니허가받아이슬람시장진출,http://news.mk.co.kr/newsRead.php?no=1064654&year=2019
8983,2019-12-19,대웅제약나보타UAE인도네시아서품목허가획득,http://www.rapportian.com/news/articleView.html?idxno=122264
8984,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.economytalk.kr/news/articleView.html?idxno=202333
8985,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.biospectator.com/view/news_view.php?varAtcId=9148
8986,2019-12-19,대웅제약UAE와인도네시아에서자체개발보툴리눔톡신허가따내,http://www.businesspost.co.kr/BP?command=article_view&num=155952
8987,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019121912154655864
8988,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장공략본격화,http://inthenews.co.kr/article-28681/
8989,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2118381
8990,2019-12-19,주식장대웅제약주가19일현재131500원,http://nbntv.co.kr/news/view/777938
8991,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=373199
8992,2019-12-19,대웅나보타할랄시장본격진출,http://news.mk.co.kr/newsRead.php?no=1065195&year=2019
8993,2019-12-19,대웅제약덴티가드랩2019핀업디자인어워드파이널리스트수상,http://www.newsian.co.kr/news/articleView.html?idxno=38763
8994,2019-12-19,대웅제약나보타UAE인도네시아허가획득할랄시장진출,http://www.metroseoul.co.kr/news/newsview?newscd=2019121900111
8995,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.medigatenews.com/news/3310868178
8996,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.lawissue.co.kr/view.php?ud=201912191405561021204ead0791_12
8997,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아허가,http://www.youthdaily.co.kr/news/article.html?no=25129
8998,2019-12-19,대웅제약나보타UAE인니서품목허가,https://www.nocutnews.co.kr/news/5261444
8999,2019-12-19,대웅제약나보타할랄시장진출,https://asiatime.co.kr/news/newsview.php?ncode=1065592036589418
9000,2019-12-19,대웅제약나보타아랍인도네시아판매허가획득,http://www.finomy.com/news/articleView.html?idxno=73236
9001,2019-12-19,대웅제약나보타인도네시아품목허가할랄시장본격진출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019121915153798736
9002,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.dailian.co.kr/news/view/854494/?sc=naver
9003,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장진출본격화,http://www.donga.com/news/article/all/20191219/98879927/1
9004,2019-12-19,대웅제약주름개선제나보타UAE인도네시아허가,http://www.sportsseoul.com/news/read/863375
9005,2019-12-19,대웅제약나보타아랍에미레이트인도네시아품목허가,https://cnbc.sbs.co.kr/article_hub/10000966477?division=NAVER
9006,2019-12-19,대웅덴티가드랩2019핀업디자인어워드파이널리스트,http://www.bokuennews.com/news/article.html?no=184789
9007,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.ftoday.co.kr/news/articleView.html?idxno=113377
9008,2019-12-19,메디톡스대웅제약보톡스소송갈수록치열,http://www.finomy.com/news/articleView.html?idxno=73280
9009,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.wsobi.com/news/articleView.html?idxno=87101
9010,2019-12-19,대웅제약펙수프라잔내년에전세계시장도전,http://news1.kr/articles/?3797657
9011,2019-12-19,대웅제약자체개발나보타UAE인니서품목허가획득,http://www.dt.co.kr/contents.html?article_no=2019122002101631102001&ref=naver
9012,2019-12-19,대웅제약나보타할랄시장본격진출UAE인도네시아품목허가획득,http://www.newscj.com/news/articleView.html?idxno=692889
9013,2019-12-19,대웅제약나보타할랄시장본격진출,http://www.bokuennews.com/news/article.html?no=184807
9014,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득,http://www.polinews.co.kr/news/article.html?no=443446
9015,2019-12-19,대웅제약나보타UAE인도네시아품목허가획득할랄시장본격진출,http://www.thefirstmedia.net/news/articleView.html?idxno=52195
9016,2019-12-20,대웅제약나보타UAE인도네시아허가획득할랄시장본격진출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075355
9017,2019-12-20,녹십자한미약품대웅제약등제약업계퇴직사우모임활발,http://www.rapportian.com/news/articleView.html?idxno=122275
9018,2019-12-20,대웅제약나보타UAE인도네시아품목허가획득할랄시장진출,http://www.newsian.co.kr/news/articleView.html?idxno=38789
9019,2019-12-20,12월20일대웅시황정보040변동,http://www.gokorea.kr/news/articleView.html?idxno=605498
9020,2019-12-20,12월20일대웅오늘주식시장07912550원,http://nbntv.co.kr/news/view/778708
9021,2019-12-20,대웅제약계열사한올바이오파마3개월제조정지위반사항적발,http://moneys.mt.co.kr/news/mwView.php?no=2019122010048021383
9022,2019-12-20,12월20일대웅제약금일증시000131500원,http://nbntv.co.kr/news/view/779242
9023,2019-12-20,20일데일리주식정보대웅003090오후12시05분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=89289
9024,2019-12-20,20일데일리주식정보대웅제약069620오후12시22분기준,https://www.dailysecu.com/news/articleView.html?idxno=89397
9025,2019-12-20,12월20일대웅제약시황정보000변동,http://www.gokorea.kr/news/articleView.html?idxno=606387
9026,2019-12-20,대웅제약라니티딘대체제파모트라정허가,http://weekly.hankooki.com/lpage/life/201912/wk20191220193511147650.htm
9027,2019-12-20,대웅제약보툴리눔톡신나보타로글로벌시장공략가속화,http://www.betanews.net:8080/article/1115327.html
9028,2019-12-21,대웅제약전사차원의ISO인증통해글로벌경영기반다져,http://www.nbnnews.co.kr/news/articleView.html?idxno=352591
9029,2019-12-21,해피컴퍼니회사가내게해주는것일과육아모두잡아요”대웅제약,http://www.econovill.com/news/articleView.html?idxno=379942
9030,2019-12-23,대웅제약치료용나보타해외수출강화한다,http://moneys.mt.co.kr/news/mwView.php?no=2019122309038092008
9031,2019-12-23,대웅제약나보타글로벌치료제시장출격이온바이오파마와맞손,http://www.viva100.com/main/view.php?key=20191223010007944
9032,2019-12-23,대웅제약보툴리눔톡신글로벌확대위해이온바이오파마와파트너십,http://www.etnews.com/20191223000013
9033,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2019122309102142680
9034,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약,http://daily.hankooki.com/lpage/ittech/201912/dh20191223091135145630.htm
9035,2019-12-23,대웅제약나보타글로벌치료제시장진출이온바이오파마와계약체결,http://www.newspim.com/news/view/20191223000161
9036,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238897
9037,2019-12-23,대웅제약 보툴리눔톡신글로벌치료사업파트너십계약,http://www.medisobizanews.com/news/articleView.html?idxno=65125
9038,2019-12-23,​​대웅제약보툴리눔톡신치료적응증확장글로벌파트너십체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1837173
9039,2019-12-23,대웅제약보툴리눔톡신치료적응증확장파트너십,http://www.biospectator.com/view/news_view.php?varAtcId=9170
9040,2019-12-23,보톡스보툴리눔톡신테마09시현재주식시황상승률상위종목메디톡스9700원325파마리서치프로덕트400원116대웅제약1500원114상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=153765
9041,2019-12-23,대웅23일040변동폭보여및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=607496
9042,2019-12-23,대웅제약이온바이오파마와파트너십계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=250640&MainKind=A&NewsKind=5&vCount=12&vKind=1
9043,2019-12-23,대웅제약이온바이오파마와파트너십체결나보타치료사업겨냥,http://inthenews.co.kr/article-29023/
9044,2019-12-23,대웅제약보툴리눔톡신글로벌미용넘어치료사업까지착수,http://news.heraldcorp.com/view.php?ud=20191223000124
9045,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약,http://www.metroseoul.co.kr/news/newsview?newscd=2019122300039
9046,2019-12-23,12월23일대웅주식종목검색12550원000,http://nbntv.co.kr/news/view/781092
9047,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약,https://www.sedaily.com/NewsView/1VS6PM70EI
9048,2019-12-23,대웅제약미국업체와나보타치료용공급계약체결,http://www.sportsseoul.com/news/read/864458
9049,2019-12-23,대웅제약美이온바이오파마와맞손나보타글로벌시장확대본격화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019122309420919881
9050,2019-12-23,대웅제약치료용보툴리눔톡신글로벌사업확대,http://yna.kr/AKR20191223040500017?did=1195m
9051,2019-12-23,대웅제약보툴리눔톡신글로벌파트너십계약3조원규모시장타겟,http://www.econovill.com/news/articleView.html?idxno=380754
9052,2019-12-23,대웅제약치료용보툴리눔톡신글로벌사업확대美이온바이오파마와파트너십체결,http://www.seoulwire.com/news/articleView.html?idxno=263688
9053,2019-12-23,대웅제약美이온바이오파마와나보타치료용공급계약체결,https://biz.chosun.com/site/data/html_dir/2019/12/23/2019122300925.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9054,2019-12-23,대웅제약 보툴리눔톡신글로벌사업위해이온바이오파마파트너십계약,http://www.newslock.co.kr/news/articleView.html?idxno=24522
9055,2019-12-23,대웅제약보툴리눔톡신치료적응증파트너십,http://www.ebn.co.kr/news/view/1014629/?sc=naver
9056,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=352794
9057,2019-12-23,대웅제약나보타미용이어치료분야적응증확대,https://www.paxnetnews.com/articles/55148
9058,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.getnews.co.kr/view.php?ud=20191223101015189141d0c69529_16
9059,2019-12-23,대웅제약치료용보톡스해외공략강화파트너사맞손,http://www.edaily.co.kr/news/newspath.asp?newsid=02089366622721472
9060,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.m-i.kr/news/articleView.html?idxno=666741
9061,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업탄력이온바이오파마와파트너십체결,http://kpenews.com/View.aspx?No=361999
9062,2019-12-23,대웅제약이온바이오파마와나보타글로벌진출협력,http://www.rapportian.com/news/articleView.html?idxno=122314
9063,2019-12-23,대웅제약보툴리눔톡신치료사업강화나서 ,http://www.monews.co.kr/news/articleView.html?idxno=207234
9064,2019-12-23,​​대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=373421
9065,2019-12-23,대웅제약나보타치료적응증글로벌파트너십체결,http://www.upinews.kr/newsView/upi201912230048
9066,2019-12-23,대웅제약이온바이오와보툴리눔톡신파트너십계약,http://www.bosa.co.kr/news/articleView.html?idxno=2118558
9067,2019-12-23,대웅제약ISO인증4관왕글로벌경영기반다졌다,http://daily.hankooki.com/lpage/ittech/201912/dh20191223104709145630.htm
9068,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=20081
9069,2019-12-23,대웅제약06962023일342변화및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=607928
9070,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업박차,http://www.newsprime.co.kr/news/article.html?no=487937
9071,2019-12-23,대웅제약보툴리눔톡신제제나보타판로확대,http://www.sisaweek.com/news/articleView.html?idxno=129254
9072,2019-12-23,대웅제약보툴리눔톡신치료사업글로벌확대,https://cnbc.sbs.co.kr/article_hub/10000966813?division=NAVER
9073,2019-12-23,대웅제약이온바이오파마보툴리눔톡신글로벌사업을위한파트너십계약체결,http://www.ekn.kr/news/article.html?no=471662
9074,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.ceoscoredaily.com/news/article.html?no=64006
9075,2019-12-23,주식증권대웅제약주가23일현재135500원,http://nbntv.co.kr/news/view/781621
9076,2019-12-23,대웅제약치료용보툴리눔톡신글로벌확대나섰다,http://it.chosun.com/site/data/html_dir/2019/12/23/2019122301280.html
9077,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약,http://www.newstomato.com/ReadNews.aspx?no=941537
9078,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.newswatch.kr/news/articleView.html?idxno=25954
9079,2019-12-23,대웅제약이온바이오파마와파트너십계약,http://www.dailymedi.com/detail.php?number=851084&thread=22r05
9080,2019-12-23,대웅제약이온바이오파마와보툴리눔톡신글로벌치료사업파트너십,http://news1.kr/articles/?3799588
9081,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약,https://asiatime.co.kr/news/newsview.php?ncode=1065578437062712
9082,2019-12-23,대웅제약미국이온바이오파마와맞손보툴리눔톡신치료사업확대”,http://sports.hankooki.com/lpage/economy/201912/sp20191223114908137020.htm
9083,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.pressm.kr/news/articleView.html?idxno=26759
9084,2019-12-23,대웅제약글로벌사업위한파트너십계약체결,http://www.economytalk.kr/news/articleView.html?idxno=202438
9085,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58884
9086,2019-12-23,대웅제약보톡스치료사업추진,http://www.finomy.com/news/articleView.html?idxno=73376
9087,2019-12-23,대웅제약나보타글로벌치료용시장진출본격화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075438
9088,2019-12-23,보톡스보툴리눔톡신테마오후시황상승률상위종목대웅제약228메디톡스211제테마075등,http://www.gokorea.kr/news/articleView.html?idxno=608535
9089,2019-12-23,23일13시보톡스보툴리눔톡신오후테마시황대웅제약메디톡스등이주도,http://nbntv.co.kr/news/view/782267
9090,2019-12-23,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목대웅제약4000원304메디톡스6300원211파마리서치프로덕트50원014상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=153950
9091,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://newsbrite.net/131809
9092,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.lawissue.co.kr/view.php?ud=201912231357268505204ead0791_12
9093,2019-12-23,치료용으로진화하는대웅제약나보타글로벌사업계약체결,http://www.donga.com/news/article/all/20191223/98931351/1
9094,2019-12-23,대웅제약치료목적보툴리눔톡신개발위해이온바이오파마와파트너십체결,http://news.mk.co.kr/newsRead.php?no=1076143&year=2019
9095,2019-12-23,대웅제약이온바이오파마와보툴리눔톡신으로해외치료시장진출,http://www.businesspost.co.kr/BP?command=article_view&num=156427
9096,2019-12-23,대웅제약치료용보톡스해외사업확대,http://www.seoulfn.com/news/articleView.html?idxno=366636
9097,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.segyebiz.com/newsView/20191223507588?OutUrl=naver
9098,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1357409
9099,2019-12-23,대웅제약나보타할랄시장본격진출글로벌행보속도,http://www.segyebiz.com/newsView/20191223507936?OutUrl=naver
9100,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.polinews.co.kr/news/article.html?no=444704
9101,2019-12-23,대웅제약이온바이오파마파트너십계약체결보툴리눔톡신글로벌치료사업목적,http://www.ftoday.co.kr/news/articleView.html?idxno=113439
9102,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업파트너십계약체결,http://www.iminju.net/news/articleView.html?idxno=51094
9103,2019-12-23,대웅나보타치료사업이온바이오파마와계약,http://www.whosaeng.com/114910
9104,2019-12-23,대웅제약보툴리눔톡신제제나보타판로확대이온바이오파마와맞손,http://www.updownnews.co.kr/news/articleView.html?idxno=212822
9105,2019-12-23,대웅제약보툴리눔톡신글로벌시장진출위해맞손,http://www.100ssd.co.kr/news/articleView.html?idxno=66247
9106,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업확대3조시장에성큼,http://www.newsian.co.kr/news/articleView.html?idxno=38870
9107,2019-12-23,대웅제약치료용보톡스이온바이오파마파트너계약,http://health.chosun.com/site/data/html_dir/2019/12/23/2019122302552.html
9108,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.medigatenews.com/news/1640616890
9109,2019-12-23,대웅제약美이온바이오파마와치료용보톡스사업확대,http://www.dt.co.kr/contents.html?article_no=2019122402101931102002&ref=naver
9110,2019-12-23,대웅제약이온바이오파마와계약으로글로벌진출박차,http://www.news2day.co.kr/144994
9111,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=39495
9112,2019-12-23,대웅제약보툴리눔톡신글로벌치료사업을위한파트너십계약체결,http://www.newscj.com/news/articleView.html?idxno=693757
9113,2019-12-23,대웅제약치료용보툴리눔톡신글로벌사업확대,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4016987
9114,2019-12-24,대웅자체조사통해메트포르민NDMA불검출확인,http://www.dailypharm.com/Users/News/NewsView.html?ID=260264&REFERER=NP
9115,2019-12-24,더벨대웅제약나보타글로벌사업미용치료로이원화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201912231112356120101744
9116,2019-12-24,12월24일대웅주식시황078변동,http://www.gokorea.kr/news/articleView.html?idxno=609343
9117,2019-12-24,12월24일대웅주식종목07812700원,http://nbntv.co.kr/news/view/783525
9118,2019-12-24,대웅제약오늘증시24일현재134000원,http://nbntv.co.kr/news/view/784053
9119,2019-12-24,대웅제약보툴리눔톡신글로벌치료사업파트너십체결,http://www.cnbnews.com/news/article.html?no=431821
9120,2019-12-24,대웅제약보툴리눔톡신글로벌치료사업위한파트너십계약체결,http://www.wsobi.com/news/articleView.html?idxno=87350
9121,2019-12-24,〔단독〕FDA심각한호흡곤란가바펜티노이드경고대웅제약유한양행녹십자등100여개사판매중,http://www.anewsa.com/detail.php?number=2039125&thread=10r03
9122,2019-12-24,대웅한올연말에도신경쓰이네메트포르민제조정지에우려,http://www.sisajournal-e.com/news/articleView.html?idxno=211162
9123,2019-12-24,대웅에스앤티첨단종합사회복지관에지정후원금전달,http://www.wikitree.co.kr/main/news_view.php?id=491963
9124,2019-12-24,대웅제약아프면참지마요질병증상이해돕는사회공헌활동펼쳐,http://www.newscj.com/news/articleView.html?idxno=694150
9125,2019-12-25,대웅에스앤티광산구에후원금전달,http://www.honam.co.kr/article.php?aid=1577236979605790233
9126,2019-12-26,대웅제약발달장애인위한참지마요진행질병표현교육,http://www.meconomynews.com/news/articleView.html?idxno=36526
9127,2019-12-26,대웅제약당뇨폐섬유증등난치성질환치료제개발순항,http://www.donga.com/news/article/all/20191225/98956366/1
9128,2019-12-26,★주식인사이드대웅제약주가132500원12월26일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1054724
9129,2019-12-26,12월26일대웅오늘주식장12600원118,http://nbntv.co.kr/news/view/785930
9130,2019-12-26,선택과집중으로경쟁력확보대웅제약차별화된전략으로글로벌헬스케어그룹도약,http://www.updownnews.co.kr/news/articleView.html?idxno=212901
9131,2019-12-26,대웅26일078변화증권시세및거래동향,http://www.gokorea.kr/news/articleView.html?idxno=611635
9132,2019-12-26,12월26일대웅제약시황정보000변동,http://www.gokorea.kr/news/articleView.html?idxno=611781
9133,2019-12-26,증권플러스대웅제약주가26일현재132500원,http://nbntv.co.kr/news/view/786423
9134,2019-12-26,대웅SNT첨단복지관에후원금1300만원전달,http://www.upkorea.net/news/articleView.html?idxno=689778
9135,2019-12-26,12월26일대웅제약종목정보000변동,http://www.gokorea.kr/news/articleView.html?idxno=611922
9136,2019-12-26,대웅SNT광주시광산구첨단복지관에후원금1300만원전달,http://www.wikitree.co.kr/main/news_view.php?id=492296
9137,2019-12-26,보톨리눔톡신대전2대웅제약vs메디톡스해외확장치열한경쟁,http://www.metroseoul.co.kr/news/newsview?newscd=2019122600170
9138,2019-12-26,대웅제약등43개사로부터행사지원받은건대충주병원김영란법위반여부논란,http://www.sisajournal-e.com/news/articleView.html?idxno=211231
9139,2019-12-26,대웅SNT첨단복지관에후원금1300만원전달,http://www.gwangnam.co.kr/read.php3?aid=1577347777345248023
9140,2019-12-27,대웅제약차세대신약파이프라인개발순항,http://www.kukinews.com/news/article.html?no=731737
9141,2019-12-27,★주식인사이드대웅제약주가133000원12월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1055033
9142,2019-12-27,대웅00309027일078변동증권그래프분석,http://www.gokorea.kr/news/articleView.html?idxno=614084
9143,2019-12-27,대웅오늘증시27일현재12900원,http://nbntv.co.kr/news/view/788239
9144,2019-12-27,대웅제약2019년글로벌신약파이프라인넥스트나보타잇는성과기대,http://www.lawissue.co.kr/view.php?ud=201912271028187603204ead0791_12
9145,2019-12-27,대웅제약글로벌보툴리눔톡신치료시장정조준,http://www.m-i.kr/news/articleView.html?idxno=667669
9146,2019-12-27,대웅제약27일037변동증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=614512
9147,2019-12-27,27일데일리주가정보대웅003090오전11시04분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=90315
9148,2019-12-27,대웅제약실시간주식현황27일현재134000원,http://nbntv.co.kr/news/view/788767
9149,2019-12-27,대웅제약나보타글로벌치료적응증시장확대박차,http://www.upinews.kr/newsView/upi201912270058
9150,2019-12-27,대웅제약아프면참지마요질병증상이해돕는사회공헌활동펼쳐,http://www.wsobi.com/news/articleView.html?idxno=87478
9151,2019-12-27,대웅제약ISO4관왕글로벌2025비전포석마련,http://www.meconomynews.com/news/articleView.html?idxno=36570
9152,2019-12-28,브릿지바이오대웅제약궤양성대장염신약물질中임상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075600
9153,2019-12-30,★주식인사이드대웅제약주가136000원12월30일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1055312
9154,2019-12-30,12월30일대웅시황정보078변동,http://www.gokorea.kr/news/articleView.html?idxno=615999
9155,2019-12-30,12월30일대웅오늘주식시장13000원078,http://nbntv.co.kr/news/view/790695
9156,2019-12-30,대웅제약06962030일111변동증권투자정보외매매동향,http://www.gokorea.kr/news/articleView.html?idxno=616465
9157,2019-12-30,12월30일대웅제약종목검색111137000원,http://nbntv.co.kr/news/view/791218
9158,2019-12-30,아프면참지마요대웅제약장애인질병증상이해돕는사회공헌활동,http://news.tf.co.kr/read/economy/1773590.htm
9159,2019-12-31,대웅제약차세대신약파이프라인개발순항,http://www.economytalk.kr/news/articleView.html?idxno=202638
9160,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239143
9161,2019-12-31,대웅제약보툴리눔톡신나보타중국3상착수,http://www.newsis.com/view/?id=NISX20191231_0000875536&cID=13001&pID=13000
9162,2019-12-31,대웅제약나보타중국임상3상본격착수2022년발매목표,http://www.viva100.com/main/view.php?key=20191231010010564
9163,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상진행,http://www.fnnews.com/news/201912310936042610
9164,2019-12-31,대웅제약나보타中임상3상착수,https://asiatime.co.kr/news/newsview.php?ncode=1065573093876166
9165,2019-12-31,대웅제약나보타중국임상3상본격착수연구자회의개최,http://www.getnews.co.kr/view.php?ud=20191231093854466741d0c69529_16
9166,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상착수,http://yna.kr/AKR20191231038200017?did=1195m
9167,2019-12-31,대웅제약나보타중국임상3상착수,http://www.ebn.co.kr/news/view/1015572/?sc=naver
9168,2019-12-31,대웅제약2022년발매목표나보타中임상3상착수,http://www.dailysmart.co.kr/news/articleView.html?idxno=20405
9169,2019-12-31,대웅제약나보타미간주름개선중국임상3상본격착수,http://www.medisobizanews.com/news/articleView.html?idxno=65381
9170,2019-12-31,대웅제약2022년발매목표나보타中임상3상착수,http://www.dailysmart.co.kr/news/articleView.html?idxno=20405
9171,2019-12-31,대웅제약中서나보타임상연구자회의,http://news.mt.co.kr/mtview.php?no=2019123109235397949
9172,2019-12-31,대웅제약나보타중국임상3상본격착수,https://www.sedaily.com/NewsView/1VSAEAA4RO
9173,2019-12-31,대웅제약나보타中임상3상착수,http://news.mk.co.kr/newsRead.php?no=1099072&year=2019
9174,2019-12-31,대웅제약나보타중국임상3상본격착수,https://biz.chosun.com/site/data/html_dir/2019/12/31/2019123100741.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9175,2019-12-31,대웅제약나보타중국임상3상본격착수,http://it.chosun.com/site/data/html_dir/2019/12/31/2019123100750.html
9176,2019-12-31,대웅제약나보타중국임상착수2022년출시목표,http://moneys.mt.co.kr/news/mwView.php?no=2019123109488054434
9177,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상본격착수,http://www.newspim.com/news/view/20191231000160
9178,2019-12-31,대웅제약나보타 중국임상3상본격착수 중국임상연구자회의개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=39694
9179,2019-12-31,대웅제약나보타중국임상착수2020년출시목표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1839891
9180,2019-12-31,대웅제약보툴리눔톡신나보타中임상3상본격착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=374018
9181,2019-12-31,대웅제약보툴리눔톡신제제나보타중국임상3상본격착수,http://www.newslock.co.kr/news/articleView.html?idxno=24720
9182,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상착수,http://www.fetv.co.kr/news/article.html?no=44083
9183,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.ceoscoredaily.com/news/article.html?no=64318
9184,2019-12-31,대웅제약나보타중국임상3상착수,http://www.etnews.com/20191231000022
9185,2019-12-31,대웅제약나보타중국임상3상착수2022년발매목표,http://www.seoulfn.com/news/articleView.html?idxno=367421
9186,2019-12-31,대웅제약보툴리눔톡신나보타中임상3상착수,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132756
9187,2019-12-31,대웅제약나보타중국임상3상착수,http://www.dailymedi.com/detail.php?number=851317&thread=22r05
9188,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.pressm.kr/news/articleView.html?idxno=26885
9189,2019-12-31,대웅제약나보타中임상3상본격착수2022년출시목표,http://news1.kr/articles/?3805558
9190,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.newswatch.kr/news/articleView.html?idxno=26174
9191,2019-12-31,대웅제약나보타중국임상3상준비본격화,http://www.dailypharm.com/Users/News/NewsView.html?ID=260497&REFERER=NP
9192,2019-12-31,대웅제약나보타中임상착수2022년출시목표,http://www.koreastocknews.com/news/articleView.html?idxno=49279
9193,2019-12-31,대웅제약나보타中임상3상착수2022년출시목표,http://www.rapportian.com/news/articleView.html?idxno=122472
9194,2019-12-31,대웅제약나보타중국임상3상본격착수,http://news.heraldcorp.com/view.php?ud=20191231000238
9195,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://newsbrite.net/132130
9196,2019-12-31,대웅제약나보타中3상착수2022년발매목표,http://www.biospectator.com/view/news_view.php?varAtcId=9225
9197,2019-12-31,대웅제약나보타중국임상3상본격착수임상연구자회의개최,http://www.econovill.com/news/articleView.html?idxno=381430
9198,2019-12-31,대웅제약중국서나보타임상3상본격착수,http://kormedi.com/?p=1308687
9199,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.ezyeconomy.com/news/articleView.html?idxno=96723
9200,2019-12-31,대웅나보타中2022년발매목표,http://www.whosaeng.com/114998
9201,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.lawissue.co.kr/view.php?ud=201912311124484342204ead0791_12
9202,2019-12-31,대웅제약중국서나보타임상3상돌입,http://www.finomy.com/news/articleView.html?idxno=73637
9203,2019-12-31,대웅제약나보타中임상3상본격착수,http://www.newsprime.co.kr/news/article.html?no=488702
9204,2019-12-31,대웅제약나보타중국임상3상착수중국임상연구자회의개최,http://www.metroseoul.co.kr/news/newsview?newscd=2019123100026
9205,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.economytalk.kr/news/articleView.html?idxno=202650
9206,2019-12-31,대웅제약자체개발한보툴리눔톡신의중국임상3상본격착수,http://www.businesspost.co.kr/BP?command=article_view&num=157532
9207,2019-12-31,대웅제약나보타중국임상3상본격착수2022년중국시장에서발매목표,http://www.segye.com/content/html/2019/12/31/20191231506199.html?OutUrl=naver
9208,2019-12-31,대웅제약나보타中서안전성입증임상3상본격착수,http://www.newsclaim.co.kr/news/articleView.html?idxno=3449
9209,2019-12-31,대웅제약 경구용장티푸스백신 비보티프 발매,http://www.businesskorea.co.kr/news/articleView.html?idxno=39706
9210,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.lawissue.co.kr/view.php?ud=201912311235264928204ead0791_12
9211,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://medipana.com/news/news_viewer.asp?NewsNum=251003&MainKind=A&NewsKind=5&vCount=12&vKind=1
9212,2019-12-31,ISO4관왕에서잇딴수상등대웅제약연말상복터지네,http://www.pressm.kr/news/articleView.html?idxno=26892
9213,2019-12-31,대웅제약국내유일먹는장티푸스백신비보티프판매개시,http://www.medisobizanews.com/news/articleView.html?idxno=65397
9214,2019-12-31,대웅제약美FDA유럽EMA승인경구용장티푸스백신비보티프발매,http://www.getnews.co.kr/view.php?ud=20191231124634121641d0c69529_16
9215,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://newsbrite.net/132143
9216,2019-12-31,대웅제약경구용장티푸스백신비보티프출시,http://www.newsis.com/view/?id=NISX20191231_0000875877&cID=13001&pID=13000
9217,2019-12-31,게시판대웅제약장티푸스백신비보티프발매,http://yna.kr/AKR20191231074900017?did=1195m
9218,2019-12-31,대웅제약FDAEMA승인경구용장티푸스백신비보티프발매,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239150
9219,2019-12-31,대웅제약국내유일의경구용장티푸스백신비보티프발매,http://www.ftoday.co.kr/news/articleView.html?idxno=113580
9220,2019-12-31,대웅제약장티푸스백신비보티프발매,http://yna.kr/PYH20191231071100017?did=1196m
9221,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.mdtoday.co.kr/mdtoday/index.html?no=374039
9222,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.metroseoul.co.kr/news/newsview?newscd=2019123100048
9223,2019-12-31,대웅제약경구용장티푸스백신비보티프국내에발매,http://news1.kr/articles/?3805800
9224,2019-12-31,대웅제약접종편의성높인경구용장티푸스백신국내판매시작,http://www.businesspost.co.kr/BP?command=article_view&num=157546
9225,2019-12-31,대웅제약나보타中서임상3상착수,https://view.asiae.co.kr/article/2019123113445963869
9226,2019-12-31,대웅제약보톡스제품나보타중국임상3상본격착수,http://www.edaily.co.kr/news/newspath.asp?newsid=02177926622724096
9227,2019-12-31,대웅제약경구용장티푸스백신국내론칭,http://moneys.mt.co.kr/news/mwView.php?no=2019123113528050508
9228,2019-12-31,대웅제약글로벌톡신치료시장정조준적응증확대할것,http://www.meconomynews.com/news/articleView.html?idxno=36680
9229,2019-12-31,대웅제약경구용장티푸스백신비보티프발매국내유일,http://www.edaily.co.kr/news/newspath.asp?newsid=02217286622724096
9230,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.bosa.co.kr/news/articleView.html?idxno=2119060
9231,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4022572
9232,2019-12-31,대웅제약보툴리눔톡신나보타중국임상3상돌입,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4022588
9233,2019-12-31,대웅제약나보타중국임상3상본격착수2022년발매목표,http://www.newsian.co.kr/news/articleView.html?idxno=39084
9234,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,https://www.sedaily.com/NewsView/1VSAEXCQ6M
9235,2019-12-31,대웅제약경구용장티푸스백신국내판매,http://www.shinailbo.co.kr/news/articleView.html?idxno=1238135
9236,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.ceoscoredaily.com/news/article.html?no=64346
9237,2019-12-31,뉴스투데이L대웅제약경구용장티푸스백신비보티프발매,http://www.news2day.co.kr/145506
9238,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.etoday.co.kr/news/section/newsview.php?idxno=1840042
9239,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.bokuennews.com/news/article.html?no=185199
9240,2019-12-31,신상품대웅제약장티푸스백신비보티프,http://www.seoulfn.com/news/articleView.html?idxno=367477
9241,2019-12-31,대웅제약나보타중국임상3상착수임상연구자회의개최,http://inthenews.co.kr/article-29987/
9242,2019-12-31,대웅제약경구용장티푸스백신비보티프판매,http://www.sporbiz.co.kr/news/articleView.html?idxno=405134
9243,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.wikileaks-kr.org/news/articleView.html?idxno=73768
9244,2019-12-31,대웅제약경구용장티푸스백신비보티프도입판매,http://www.sportsseoul.com/news/read/867222
9245,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.updownnews.co.kr/news/articleView.html?idxno=213139
9246,2019-12-31,대웅제약경구용장티푸스백신비보티프국내판매시작,http://www.lcnews.co.kr/news/articleView.html?idxno=2117
9247,2019-12-31,대웅제약먹는장티푸스백신비보티프출시,https://biz.chosun.com/site/data/html_dir/2019/12/31/2019123101766.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9248,2019-12-31,장티푸스예방주사로안맞아도된다대웅제약경구용장티푸스백신비보티프출시,https://www.sisa-news.com/news/article.html?no=122909
9249,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.nbnnews.co.kr/news/articleView.html?idxno=355165
9250,2019-12-31,대웅제약나보타중국임상3상본격화,http://www.news2day.co.kr/145534
9251,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=355174
9252,2019-12-31,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.thefirstmedia.net/news/articleView.html?idxno=52552
9253,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.thefirstmedia.net/news/articleView.html?idxno=52545
9254,2019-12-31,대웅제약 경구용장티푸스백신 비보티프판매시작,http://www.newslock.co.kr/news/articleView.html?idxno=24741
9255,2019-12-31,대웅제약경구용장티푸스백신비보티프발매,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59001
9256,2019-12-31,대웅제약나보타중국임상3상본격착수,http://www.newscj.com/news/articleView.html?idxno=695757
9257,2019-12-31,대웅제약나보타中임상3상착수오는2022년발매목표,http://www.donga.com/news/article/all/20191231/99033888/1
